*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 86 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 86 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 250 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 86 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 A 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 A 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 A 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 86 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 A 49 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 86 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 250 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 A 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 86 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 A 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 A 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 A 49 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -41.15 97.96 -3.49 -39.81 98.24 -2.76 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o00 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 63 SER^? 10.35 ZN ZN A 402 A 524 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 556 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER A 328 SER~? 11.01 ZN ZN A 402 A 524 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 556 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER B 63 SER^? 10.37 ZN ZN B 401 A 524 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 556 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER B 328 SER~? 10.89 ZN ZN B 401 A 524 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 556 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -40.92 100.43 6.30 -42.93 100.06 6.77 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 63 SER^? 10.35 ZN ZN A 402 A 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 44.17 25.61 37.60 45.21 25.56 35.81 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 39.85 24.35 34.94 41.12 25.58 33.83 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER A 63 SER^? 10.35 ZN ZN A 402 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 44.17 25.61 37.60 45.21 25.56 35.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 A 98 SER A 63 SER^? 10.35 ZN ZN A 402 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 44.17 25.61 37.60 45.21 25.56 35.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 A 98 SER A 328 SER~? 11.01 ZN ZN A 402 A 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 45.74 29.80 42.79 47.58 31.06 41.64 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 44.17 25.61 37.60 45.21 25.56 35.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 39.85 24.35 34.94 41.12 25.58 33.83 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 A 98 SER B 63 SER^? 10.37 ZN ZN B 401 A 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 45.74 29.80 42.79 47.58 31.06 41.64 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 44.17 25.61 37.60 45.21 25.56 35.81 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 39.85 24.35 34.94 41.12 25.58 33.83 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 A 98 SER B 63 SER^? 10.37 ZN ZN B 401 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 45.74 29.80 42.79 47.58 31.06 41.64 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 44.17 25.61 37.60 45.21 25.56 35.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 39.85 24.35 34.94 41.12 25.58 33.83 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 A 98 SER B 63 SER^? 10.37 ZN ZN B 401 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 45.74 29.80 42.79 47.58 31.06 41.64 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 44.17 25.61 37.60 45.21 25.56 35.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 39.85 24.35 34.94 41.12 25.58 33.83 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 A 98 SER B 328 SER~? 10.89 ZN ZN B 401 A 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 44.17 25.61 37.60 45.21 25.56 35.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 39.85 24.35 34.94 41.12 25.58 33.83 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o00 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 37.97 47.82 5.46 38.65 48.02 7.40 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 41.02 51.33 13.36 40.18 47.06 9.99 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 39.17 42.30 8.54 40.94 44.26 7.78 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 37.97 47.82 5.46 38.65 48.02 7.40 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 41.02 51.33 13.36 40.18 47.06 9.99 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 39.17 42.30 8.54 40.94 44.26 7.78 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 5 2dln_c00 D-ALANINE--D-ALANINE LIGASE user 1 5 # 1 15 GLU A 329 GLU~? 2.55 ZN ZN A 401s 150 SER A 328 SER~? 11.01 ZN ZN A 402 216 TYR A 327 TYR~? 10.33 ZN ZN A 402 255 ARG A 267 ARG^? 13.45 ZN ZN B 401 276 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 18.72 1.95 50.27 17.22 2.99 49.29 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 20.89 3.58 46.02 20.41 4.18 48.30 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 25.64 7.68 49.08 22.95 7.02 48.68 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 15.80 13.82 43.70 16.77 10.99 44.40 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 18.03 11.13 50.74 17.53 11.78 50.39 -36.73 108.01 -6.68 -37.53 107.81 -6.81 2dln_c00 source 2dln D-ALANINE--D-ALANINE LIGASE : 1 hits 2dln_c00 naa= 5 ULMN 4 1a4l_c03 ADENOSINE DEAMINASE user 1 4 # 1 D1717 GLU B 329 GLU~? 2.54 ZN ZN B 402s D1738 HIS B 326 HIS~? -3.48 ZN ZN B 401s D1740 TYR B 327 TYR~? 10.21 ZN ZN B 401 D1795 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 79.46 66.71 96.16 78.02 67.53 97.49 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 77.62 63.23 97.06 75.99 64.55 97.16 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 79.86 61.53 92.34 77.28 61.88 93.36 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 70.75 65.08 97.32 72.46 65.59 98.49 -40.41 105.08 4.17 -40.72 103.08 3.51 1a4l_c03 source 1a4l ADENOSINE DEAMINASE : 1 hits 1a4l_c03 naa= 4 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 1 4 # 1 A 193 SER A 285 SER.? 7.68 ZN ZN A 402 A 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 28.44 32.05 73.53 28.64 31.12 71.24 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 2 4 # 2 A 193 SER A 285 SER.? 7.68 ZN ZN A 402 A 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 28.44 32.05 73.53 28.64 31.12 71.24 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 3 4 # 3 A 193 SER B 285 SER.? 7.72 ZN ZN B 401 A 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 28.44 32.05 73.53 28.64 31.12 71.24 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 4 4 # 4 A 193 SER B 285 SER.? 7.72 ZN ZN B 401 A 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 28.44 32.05 73.53 28.64 31.12 71.24 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 5 4 # 5 A 193 SER B 328 SER~? 10.89 ZN ZN B 401 A 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 28.44 32.05 73.53 28.64 31.12 71.24 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 1aj8_c02 source 1aj8 CITRATE SYNTHASE : 5 hits 1aj8_c02 naa= 4 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 1 4 # 1 B 193 SER A 285 SER.? 7.68 ZN ZN A 402 B 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 24.20 33.47 87.18 22.82 34.14 89.12 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 2 4 # 2 B 193 SER A 285 SER.? 7.68 ZN ZN A 402 B 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 24.20 33.47 87.18 22.82 34.14 89.12 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 3 4 # 3 B 193 SER B 285 SER.? 7.72 ZN ZN B 401 B 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 24.20 33.47 87.18 22.82 34.14 89.12 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 4 4 # 4 B 193 SER B 285 SER.? 7.72 ZN ZN B 401 B 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 24.20 33.47 87.18 22.82 34.14 89.12 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 5 4 # 5 B 193 SER B 328 SER~? 10.89 ZN ZN B 401 B 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 24.20 33.47 87.18 22.82 34.14 89.12 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 1aj8_c03 source 1aj8 CITRATE SYNTHASE : 5 hits 1aj8_c03 naa= 4 ULMN 4 1ako_c01 EXONUCLEASE III user 1 4 # 1 109 TYR A 80 TYR~? 13.91 ZN ZN A 402 151 ASP B 313 ASP~? 12.28 ZN ZN A 402 229 ASP B 310 ASP~? 12.35 ZN ZN A 402 259 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 33.16 18.85 -1.53 34.64 16.76 -2.64 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 35.04 17.56 3.16 36.71 16.39 2.64 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 35.23 15.91 8.28 35.41 14.90 6.45 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.93 11.62 4.24 36.26 12.70 3.02 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 4 1ako_c01 EXONUCLEASE III user 2 4 # 2 109 TYR B 80 TYR~? 13.91 ZN ZN B 401 151 ASP A 313 ASP~? 12.18 ZN ZN B 401 229 ASP A 310 ASP~? 12.24 ZN ZN B 401 259 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 33.16 18.85 -1.53 34.64 16.76 -2.64 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 35.04 17.56 3.16 36.71 16.39 2.64 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 35.23 15.91 8.28 35.41 14.90 6.45 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.93 11.62 4.24 36.26 12.70 3.02 -45.80 98.45 2.85 -45.82 97.45 4.71 1ako_c01 source 1ako EXONUCLEASE III : 2 hits 1ako_c01 naa= 4 ULMN 4 1al6_c01 CITRATE SYNTHASE user 1 4 # 1 244 SER B 285 SER.? 7.72 ZN ZN B 401 274 HIS B 326 HIS~? -3.48 ZN ZN B 401s 320 HIS B 64 HIS.? -3.45 ZN ZN B 402s 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 1al6_c01 source 1al6 CITRATE SYNTHASE : 1 hits 1al6_c01 naa= 4 ULMN 4 1bcr_c00 SERINE CARBOXYPEPTIDASE II user 1 4 # 1 A 146 SER A 328 SER~? 11.01 ZN ZN A 402 A 147 TYR A 330 TYR~? 12.28 ZN ZN A 402 B 338 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 397 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 66.05 29.20 71.20 67.54 30.99 71.60 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 69.74 28.84 76.21 71.42 27.25 77.79 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 65.80 31.83 62.23 66.99 32.08 63.95 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 65.11 33.35 66.77 66.04 32.32 68.30 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 4 1bcr_c00 SERINE CARBOXYPEPTIDASE II user 2 4 # 2 A 146 SER B 328 SER~? 10.89 ZN ZN B 401 A 147 TYR B 330 TYR~? 12.23 ZN ZN B 401 B 338 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 397 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 66.05 29.20 71.20 67.54 30.99 71.60 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 69.74 28.84 76.21 71.42 27.25 77.79 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 65.80 31.83 62.23 66.99 32.08 63.95 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 65.11 33.35 66.77 66.04 32.32 68.30 -40.92 100.43 6.30 -42.93 100.06 6.77 1bcr_c00 source 1bcr SERINE CARBOXYPEPTIDASE II : 2 hits 1bcr_c00 naa= 4 ULMN 4 1bix_c01 AP ENDONUCLEASE 1 user 1 4 # 1 171 TYR A 80 TYR~? 13.91 ZN ZN A 402 210 ASP B 313 ASP~? 12.28 ZN ZN A 402 283 ASP B 310 ASP~? 12.35 ZN ZN A 402 309 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 32.75 -6.95 16.46 30.72 -8.80 16.93 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 29.79 -3.36 18.55 28.79 -4.80 19.77 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 27.02 0.98 19.66 26.61 -0.92 18.94 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 24.07 -3.82 17.50 25.23 -4.93 18.86 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 4 1bix_c01 AP ENDONUCLEASE 1 user 2 4 # 2 171 TYR B 80 TYR~? 13.91 ZN ZN B 401 210 ASP A 313 ASP~? 12.18 ZN ZN B 401 283 ASP A 310 ASP~? 12.24 ZN ZN B 401 309 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 32.75 -6.95 16.46 30.72 -8.80 16.93 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 29.79 -3.36 18.55 28.79 -4.80 19.77 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 27.02 0.98 19.66 26.61 -0.92 18.94 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 24.07 -3.82 17.50 25.23 -4.93 18.86 -45.80 98.45 2.85 -45.82 97.45 4.71 1bix_c01 source 1bix AP ENDONUCLEASE 1 : 2 hits 1bix_c01 naa= 4 ULMN 4 1bvz_c06 ALPHA-AMYLASE II user 1 4 # 1 A 244 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 325 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 354 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 421 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 38.32 48.73 66.97 37.08 50.15 66.21 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 31.05 49.37 64.51 31.97 51.11 63.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 29.07 50.42 58.36 29.02 52.18 59.49 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 30.82 59.76 58.47 31.12 59.02 60.40 -33.57 107.34 6.30 -34.87 106.07 5.21 1bvz_c06 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c06 naa= 4 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 1 4 # 1 B 244 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 325 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 354 GLU A 290 GLU~? 16.18 ZN ZN A 402 B 421 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 18.86 7.90 56.29 20.11 7.10 54.89 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 25.90 8.19 53.87 25.36 6.97 52.29 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 27.87 10.66 47.95 27.82 8.60 48.27 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 26.02 1.87 43.38 25.90 1.97 45.49 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 2 4 # 2 B 244 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 325 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 354 GLU B 290 GLU~? 16.07 ZN ZN B 401 B 421 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 18.86 7.90 56.29 20.11 7.10 54.89 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 25.90 8.19 53.87 25.36 6.97 52.29 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 27.87 10.66 47.95 27.82 8.60 48.27 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 26.02 1.87 43.38 25.90 1.97 45.49 -33.57 107.34 6.30 -34.87 106.07 5.21 1bvz_c07 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c07 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 23 ASP.? 8.14 ZN ZN A 401 M 206 SER A 265 SER.? 18.83 ZN ZN A 402 M 210 ARG B 267 ARG^? 13.63 ZN ZN A 402 M 214 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP B 23 ASP.? 8.15 ZN ZN B 402 M 206 SER B 265 SER.? 18.70 ZN ZN B 401 M 210 ARG A 267 ARG^? 13.45 ZN ZN B 401 M 214 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -26.94 101.98 3.65 -27.40 103.69 1.94 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -31.91 109.24 -4.57 -30.97 107.55 -3.66 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 2 hits 1c17_c11 naa= 4 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 1 4 # 1 A 72 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 141 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 143 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 148 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 86.21 51.78 11.27 86.87 50.27 12.61 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 77.92 48.13 25.32 78.70 49.17 23.61 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 79.83 48.98 19.95 81.76 49.72 20.33 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 76.11 54.71 19.44 77.75 55.81 18.59 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 2 4 # 2 A 72 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 141 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 143 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 148 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 86.21 51.78 11.27 86.87 50.27 12.61 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 77.92 48.13 25.32 78.70 49.17 23.61 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 79.83 48.98 19.95 81.76 49.72 20.33 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 76.11 54.71 19.44 77.75 55.81 18.59 -40.29 98.42 11.20 -42.37 98.57 11.02 1cd5_c00 source 1cd5 GLUCOSAMINE 6-PHOSPHATE DEAMINASE : 2 hits 1cd5_c00 naa= 4 ULMN 4 1dco_c01 DCOH user 1 4 # 1 B 62 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 63 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 80 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 89 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 30.13 28.91 18.82 29.78 26.89 19.27 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 30.80 33.19 23.94 30.03 35.03 23.38 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 25.47 25.21 25.04 27.09 24.88 26.31 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 32.70 23.27 17.35 31.06 23.48 18.68 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1dco_c01 DCOH user 2 4 # 2 B 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 63 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 80 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 89 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 30.13 28.91 18.82 29.78 26.89 19.27 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 30.80 33.19 23.94 30.03 35.03 23.38 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 25.47 25.21 25.04 27.09 24.88 26.31 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 32.70 23.27 17.35 31.06 23.48 18.68 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 4 1dco_c01 DCOH user 3 4 # 3 B 62 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 63 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 80 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 89 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 30.13 28.91 18.82 29.78 26.89 19.27 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 30.80 33.19 23.94 30.03 35.03 23.38 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 25.47 25.21 25.04 27.09 24.88 26.31 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 32.70 23.27 17.35 31.06 23.48 18.68 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1dco_c01 DCOH user 4 4 # 4 B 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 63 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 80 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 89 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 30.13 28.91 18.82 29.78 26.89 19.27 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 30.80 33.19 23.94 30.03 35.03 23.38 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 25.47 25.21 25.04 27.09 24.88 26.31 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 32.70 23.27 17.35 31.06 23.48 18.68 -54.33 98.57 11.88 -52.50 97.53 11.52 1dco_c01 source 1dco DCOH : 4 hits 1dco_c01 naa= 4 ULMN 4 1dco_c02 DCOH user 1 4 # 1 C 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 63 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 80 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 89 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 29.60 51.54 13.33 29.70 53.54 12.79 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 35.52 48.78 13.63 35.21 46.77 13.20 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 33.83 55.44 5.53 34.68 55.77 3.67 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 27.62 57.06 14.62 28.16 56.67 12.64 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 4 1dco_c02 DCOH user 2 4 # 2 C 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 63 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 80 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 89 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 29.60 51.54 13.33 29.70 53.54 12.79 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 35.52 48.78 13.63 35.21 46.77 13.20 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 33.83 55.44 5.53 34.68 55.77 3.67 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 27.62 57.06 14.62 28.16 56.67 12.64 -54.33 98.57 11.88 -52.50 97.53 11.52 1dco_c02 source 1dco DCOH : 2 hits 1dco_c02 naa= 4 ULMN 4 1dco_c03 DCOH user 1 4 # 1 D 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 63 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 80 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 89 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 57.14 54.52 28.76 58.02 56.20 27.93 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 50.55 54.00 30.19 50.52 53.10 32.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 55.23 64.51 29.49 55.46 66.50 28.94 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 60.71 56.13 24.08 59.92 57.52 25.41 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 4 1dco_c03 DCOH user 2 4 # 2 D 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 63 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 80 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 89 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 57.14 54.52 28.76 58.02 56.20 27.93 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 50.55 54.00 30.19 50.52 53.10 32.06 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 55.23 64.51 29.49 55.46 66.50 28.94 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 60.71 56.13 24.08 59.92 57.52 25.41 -54.33 98.57 11.88 -52.50 97.53 11.52 1dco_c03 source 1dco DCOH : 2 hits 1dco_c03 naa= 4 ULMN 4 1dco_c04 DCOH user 1 4 # 1 E 62 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 80 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 89 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 19.60 57.21 59.85 19.08 56.80 57.88 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 16.21 54.27 64.44 16.08 55.68 65.97 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 11.87 56.63 56.75 11.79 54.55 56.99 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 21.75 55.40 54.53 20.13 56.68 54.67 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 4 1dco_c04 DCOH user 2 4 # 2 E 62 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 63 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 80 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 89 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 19.60 57.21 59.85 19.08 56.80 57.88 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 16.21 54.27 64.44 16.08 55.68 65.97 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 11.87 56.63 56.75 11.79 54.55 56.99 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 21.75 55.40 54.53 20.13 56.68 54.67 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1dco_c04 DCOH user 3 4 # 3 E 62 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 63 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 80 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 89 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 19.60 57.21 59.85 19.08 56.80 57.88 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 16.21 54.27 64.44 16.08 55.68 65.97 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 11.87 56.63 56.75 11.79 54.55 56.99 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 21.75 55.40 54.53 20.13 56.68 54.67 -43.07 90.95 4.66 -43.22 93.08 4.74 1dco_c04 source 1dco DCOH : 3 hits 1dco_c04 naa= 4 ULMN 4 1dco_c05 DCOH user 1 4 # 1 F 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 63 HIS A 64 HIS.? -3.42 ZN ZN A 401s F 80 HIS B 309 HIS~? 5.48 ZN ZN A 402 F 89 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 12.05 28.43 70.32 10.75 27.97 68.79 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.14 32.02 68.53 18.69 31.37 69.75 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 14.97 24.19 61.54 16.03 23.48 59.90 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 5.92 28.03 68.57 7.27 26.97 67.43 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 4 1dco_c05 DCOH user 2 4 # 2 F 62 HIS A 308 HIS~? 6.49 ZN ZN B 401 F 63 HIS A 309 HIS~? 5.45 ZN ZN B 401 F 80 HIS B 64 HIS.? -3.45 ZN ZN B 402s F 89 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 12.05 28.43 70.32 10.75 27.97 68.79 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.14 32.02 68.53 18.69 31.37 69.75 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 14.97 24.19 61.54 16.03 23.48 59.90 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 5.92 28.03 68.57 7.27 26.97 67.43 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 4 1dco_c05 DCOH user 3 4 # 3 F 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 63 HIS B 64 HIS.? -3.45 ZN ZN B 402s F 80 HIS A 309 HIS~? 5.45 ZN ZN B 401 F 89 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 12.05 28.43 70.32 10.75 27.97 68.79 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.14 32.02 68.53 18.69 31.37 69.75 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 14.97 24.19 61.54 16.03 23.48 59.90 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 5.92 28.03 68.57 7.27 26.97 67.43 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 4 1dco_c05 DCOH user 4 4 # 4 F 62 HIS B 308 HIS~? 6.54 ZN ZN A 402 F 63 HIS B 309 HIS~? 5.48 ZN ZN A 402 F 80 HIS A 64 HIS.? -3.42 ZN ZN A 401s F 89 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 12.05 28.43 70.32 10.75 27.97 68.79 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.14 32.02 68.53 18.69 31.37 69.75 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 14.97 24.19 61.54 16.03 23.48 59.90 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 5.92 28.03 68.57 7.27 26.97 67.43 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1dco_c05 source 1dco DCOH : 4 hits 1dco_c05 naa= 4 ULMN 4 1dco_c06 DCOH user 1 4 # 1 G 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 G 63 HIS A 64 HIS.? -3.42 ZN ZN A 401s G 80 HIS B 309 HIS~? 5.48 ZN ZN A 402 G 89 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 27.23 31.17 87.27 28.54 31.18 88.89 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.77 36.07 86.61 21.15 35.09 85.77 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 24.24 31.95 96.92 23.16 32.10 98.71 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 33.04 31.03 88.73 31.44 31.21 90.04 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 4 1dco_c06 DCOH user 2 4 # 2 G 62 HIS A 308 HIS~? 6.49 ZN ZN B 401 G 63 HIS A 309 HIS~? 5.45 ZN ZN B 401 G 80 HIS B 64 HIS.? -3.45 ZN ZN B 402s G 89 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 27.23 31.17 87.27 28.54 31.18 88.89 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.77 36.07 86.61 21.15 35.09 85.77 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 24.24 31.95 96.92 23.16 32.10 98.71 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 33.04 31.03 88.73 31.44 31.21 90.04 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 4 1dco_c06 DCOH user 3 4 # 3 G 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 G 63 HIS B 64 HIS.? -3.45 ZN ZN B 402s G 80 HIS A 309 HIS~? 5.45 ZN ZN B 401 G 89 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 27.23 31.17 87.27 28.54 31.18 88.89 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.77 36.07 86.61 21.15 35.09 85.77 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 24.24 31.95 96.92 23.16 32.10 98.71 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 33.04 31.03 88.73 31.44 31.21 90.04 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 4 1dco_c06 DCOH user 4 4 # 4 G 62 HIS B 308 HIS~? 6.54 ZN ZN A 402 G 63 HIS B 309 HIS~? 5.48 ZN ZN A 402 G 80 HIS A 64 HIS.? -3.42 ZN ZN A 401s G 89 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 27.23 31.17 87.27 28.54 31.18 88.89 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.77 36.07 86.61 21.15 35.09 85.77 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 24.24 31.95 96.92 23.16 32.10 98.71 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 33.04 31.03 88.73 31.44 31.21 90.04 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1dco_c06 source 1dco DCOH : 4 hits 1dco_c06 naa= 4 ULMN 4 1dco_c07 DCOH user 1 4 # 1 H 62 HIS A 65 HIS.? -3.39 ZN ZN A 402s H 63 HIS A 98 HIS~? 4.98 ZN ZN A 401 H 80 HIS A 326 HIS~? -3.60 ZN ZN A 402s H 89 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 25.41 62.31 81.97 26.41 62.87 83.70 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 27.91 57.00 79.64 28.08 57.36 77.58 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 32.94 62.32 86.32 31.68 60.75 86.87 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 22.93 64.49 87.27 24.97 64.23 86.95 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1dco_c07 DCOH user 2 4 # 2 H 62 HIS A 309 HIS~? 5.45 ZN ZN B 401 H 63 HIS B 326 HIS~? -3.48 ZN ZN B 401s H 80 HIS B 64 HIS.? -3.45 ZN ZN B 402s H 89 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 25.41 62.31 81.97 26.41 62.87 83.70 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 27.91 57.00 79.64 28.08 57.36 77.58 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 32.94 62.32 86.32 31.68 60.75 86.87 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 22.93 64.49 87.27 24.97 64.23 86.95 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1dco_c07 DCOH user 3 4 # 3 H 62 HIS A 309 HIS~? 5.45 ZN ZN B 401 H 63 HIS B 326 HIS~? -3.48 ZN ZN B 401s H 80 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 89 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 25.41 62.31 81.97 26.41 62.87 83.70 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 27.91 57.00 79.64 28.08 57.36 77.58 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 32.94 62.32 86.32 31.68 60.75 86.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.93 64.49 87.27 24.97 64.23 86.95 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1dco_c07 DCOH user 4 4 # 4 H 62 HIS B 65 HIS.? -3.43 ZN ZN B 401s H 63 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 80 HIS B 326 HIS~? -3.48 ZN ZN B 401s H 89 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 25.41 62.31 81.97 26.41 62.87 83.70 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 27.91 57.00 79.64 28.08 57.36 77.58 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 32.94 62.32 86.32 31.68 60.75 86.87 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 22.93 64.49 87.27 24.97 64.23 86.95 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 4 1dco_c07 DCOH user 5 4 # 5 H 62 HIS B 309 HIS~? 5.48 ZN ZN A 402 H 63 HIS A 326 HIS~? -3.60 ZN ZN A 402s H 80 HIS A 64 HIS.? -3.42 ZN ZN A 401s H 89 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 25.41 62.31 81.97 26.41 62.87 83.70 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 27.91 57.00 79.64 28.08 57.36 77.58 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 32.94 62.32 86.32 31.68 60.75 86.87 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 22.93 64.49 87.27 24.97 64.23 86.95 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 4 1dco_c07 DCOH user 6 4 # 6 H 62 HIS B 309 HIS~? 5.48 ZN ZN A 402 H 63 HIS A 326 HIS~? -3.60 ZN ZN A 402s H 80 HIS A 98 HIS~? 4.98 ZN ZN A 401 H 89 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 25.41 62.31 81.97 26.41 62.87 83.70 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 27.91 57.00 79.64 28.08 57.36 77.58 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 32.94 62.32 86.32 31.68 60.75 86.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.93 64.49 87.27 24.97 64.23 86.95 -33.96 122.51 -3.83 -35.32 120.86 -3.91 1dco_c07 source 1dco DCOH : 6 hits 1dco_c07 naa= 4 ULMN 4 1ddj_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 741 ALA B 96 ALA^? 10.72 ZN ZN B 402 A 742 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -55.22 89.41 14.53 -54.89 89.43 13.78 1ddj_c04 source 1ddj PLASMINOGEN : 1 hits 1ddj_c04 naa= 4 ULMN 4 1ddj_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 741 ALA B 96 ALA^? 10.72 ZN ZN B 402 B 742 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -50.76 89.87 12.12 -51.42 90.77 11.02 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -55.22 89.41 14.53 -54.89 89.43 13.78 1ddj_c05 source 1ddj PLASMINOGEN : 1 hits 1ddj_c05 naa= 4 ULMN 4 1ddj_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 741 ALA A 96 ALA^? 10.78 ZN ZN A 401 C 742 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 13.55 54.01 62.74 13.86 55.50 62.79 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 16.36 51.81 61.40 15.69 51.50 61.72 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 4 1ddj_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 741 ALA B 96 ALA^? 10.72 ZN ZN B 402 C 742 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 13.55 54.01 62.74 13.86 55.50 62.79 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 16.36 51.81 61.40 15.69 51.50 61.72 -55.22 89.41 14.53 -54.89 89.43 13.78 1ddj_c06 source 1ddj PLASMINOGEN : 2 hits 1ddj_c06 naa= 4 ULMN 4 1ddj_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 741 ALA A 96 ALA^? 10.78 ZN ZN A 401 D 742 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 4 1ddj_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 741 ALA B 96 ALA^? 10.72 ZN ZN B 402 D 742 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -50.76 89.87 12.12 -51.42 90.77 11.02 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -55.22 89.41 14.53 -54.89 89.43 13.78 1ddj_c07 source 1ddj PLASMINOGEN : 2 hits 1ddj_c07 naa= 4 ULMN 4 1df9_c00 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR user 1 4 # 1 A 51 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 75 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 135 SER B 328 SER~? 10.89 ZN ZN B 401 A 153 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 82.73 13.99 81.18 84.11 13.14 79.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 79.95 16.88 76.33 81.62 16.87 77.62 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 87.55 10.17 77.17 86.98 9.59 79.47 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 79.86 4.56 77.77 79.43 4.83 78.44 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 4 1df9_c00 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR user 2 4 # 2 A 51 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 75 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 135 SER A 328 SER~? 11.01 ZN ZN A 402 A 153 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 82.73 13.99 81.18 84.11 13.14 79.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 79.95 16.88 76.33 81.62 16.87 77.62 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 87.55 10.17 77.17 86.98 9.59 79.47 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 79.86 4.56 77.77 79.43 4.83 78.44 -36.73 108.01 -6.68 -37.53 107.81 -6.81 1df9_c00 source 1df9 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR : 2 hits 1df9_c00 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 159 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 376 ILE A 62 ILE^? 13.50 ZN ZN A 401 A 377 THR A 41 THR^? 14.11 ZN ZN A 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 11.32 57.46 110.35 12.85 58.48 111.39 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 15.00 65.23 121.40 15.42 63.95 122.00 -34.66 128.81 -14.07 -35.18 128.94 -15.41 coo 15.65 69.77 121.40 17.38 70.64 120.41 -30.25 126.98 -12.77 -29.68 126.19 -14.66 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 159 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 376 ILE A 83 ILE~? 16.75 ZN ZN A 402 A 377 THR A 46 THR~? 14.02 ZN ZN A 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 11.32 57.46 110.35 12.85 58.48 111.39 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 15.00 65.23 121.40 15.42 63.95 122.00 -35.09 130.83 0.93 -34.69 129.58 0.43 coo 15.65 69.77 121.40 17.38 70.64 120.41 -31.91 126.83 -1.04 -30.53 125.17 -1.13 ULMN 4 1e6e_c00 ADRENODOXIN user 3 4 # 3 A 55 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 159 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 376 ILE A 62 ILE^? 13.50 ZN ZN A 401 A 377 THR A 41 THR^? 14.11 ZN ZN A 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 11.32 57.46 110.35 12.85 58.48 111.39 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 15.00 65.23 121.40 15.42 63.95 122.00 -34.66 128.81 -14.07 -35.18 128.94 -15.41 coo 15.65 69.77 121.40 17.38 70.64 120.41 -30.25 126.98 -12.77 -29.68 126.19 -14.66 ULMN 4 1e6e_c00 ADRENODOXIN user 4 4 # 4 A 55 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 159 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 376 ILE A 282 ILE.? 8.29 ZN ZN A 401 A 377 THR A 303 THR^? 9.94 ZN ZN A 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 11.32 57.46 110.35 12.85 58.48 111.39 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 15.00 65.23 121.40 15.42 63.95 122.00 -41.08 108.84 -13.73 -42.55 109.16 -13.89 coo 15.65 69.77 121.40 17.38 70.64 120.41 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 4 1e6e_c00 ADRENODOXIN user 5 4 # 5 A 55 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 159 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 376 ILE A 62 ILE^? 13.50 ZN ZN A 401 A 377 THR A 41 THR^? 14.11 ZN ZN A 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 11.32 57.46 110.35 12.85 58.48 111.39 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 15.00 65.23 121.40 15.42 63.95 122.00 -34.66 128.81 -14.07 -35.18 128.94 -15.41 coo 15.65 69.77 121.40 17.38 70.64 120.41 -30.25 126.98 -12.77 -29.68 126.19 -14.66 ULMN 4 1e6e_c00 ADRENODOXIN user 6 4 # 6 A 55 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 159 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 376 ILE B 62 ILE^? 13.54 ZN ZN B 402 A 377 THR B 41 THR^? 14.16 ZN ZN B 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 11.32 57.46 110.35 12.85 58.48 111.39 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 15.00 65.23 121.40 15.42 63.95 122.00 -46.87 85.79 14.69 -47.39 85.98 16.05 coo 15.65 69.77 121.40 17.38 70.64 120.41 -42.12 84.98 13.35 -41.18 85.38 15.28 ULMN 4 1e6e_c00 ADRENODOXIN user 7 4 # 7 A 55 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 159 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 376 ILE B 83 ILE~? 16.86 ZN ZN B 401 A 377 THR B 46 THR~? 13.88 ZN ZN B 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 11.32 57.46 110.35 12.85 58.48 111.39 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 15.00 65.23 121.40 15.42 63.95 122.00 -48.53 84.68 -0.37 -47.40 85.47 0.16 coo 15.65 69.77 121.40 17.38 70.64 120.41 -43.66 86.34 1.76 -41.66 87.08 1.85 ULMN 4 1e6e_c00 ADRENODOXIN user 8 4 # 8 A 55 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 159 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 376 ILE B 62 ILE^? 13.54 ZN ZN B 402 A 377 THR B 41 THR^? 14.16 ZN ZN B 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 11.32 57.46 110.35 12.85 58.48 111.39 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 15.00 65.23 121.40 15.42 63.95 122.00 -46.87 85.79 14.69 -47.39 85.98 16.05 coo 15.65 69.77 121.40 17.38 70.64 120.41 -42.12 84.98 13.35 -41.18 85.38 15.28 ULMN 4 1e6e_c00 ADRENODOXIN user 9 4 # 9 A 55 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 159 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 376 ILE B 282 ILE.? 8.31 ZN ZN B 402 A 377 THR B 303 THR^? 9.94 ZN ZN B 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 11.32 57.46 110.35 12.85 58.48 111.39 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 15.00 65.23 121.40 15.42 63.95 122.00 -41.66 106.21 14.73 -43.02 106.75 14.92 coo 15.65 69.77 121.40 17.38 70.64 120.41 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 4 1e6e_c00 ADRENODOXIN user 10 4 # 10 A 55 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 159 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 376 ILE B 62 ILE^? 13.54 ZN ZN B 402 A 377 THR B 41 THR^? 14.16 ZN ZN B 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 11.32 57.46 110.35 12.85 58.48 111.39 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 15.00 65.23 121.40 15.42 63.95 122.00 -46.87 85.79 14.69 -47.39 85.98 16.05 coo 15.65 69.77 121.40 17.38 70.64 120.41 -42.12 84.98 13.35 -41.18 85.38 15.28 1e6e_c00 source 1e6e ADRENODOXIN : 10 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS A 13 HIS~? 19.28 ZN ZN A 401 C 159 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 376 ILE A 62 ILE^? 13.50 ZN ZN A 401 C 377 THR A 41 THR^? 14.11 ZN ZN A 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -34.66 128.81 -14.07 -35.18 128.94 -15.41 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -30.25 126.98 -12.77 -29.68 126.19 -14.66 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 159 ASP A 91 ASP.? 28.84 ZN ZN A 402 C 376 ILE A 83 ILE~? 16.75 ZN ZN A 402 C 377 THR A 46 THR~? 14.02 ZN ZN A 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -35.09 130.83 0.93 -34.69 129.58 0.43 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -31.91 126.83 -1.04 -30.53 125.17 -1.13 ULMN 4 1e6e_c01 ADRENODOXIN user 3 4 # 3 C 55 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 159 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 376 ILE A 62 ILE^? 13.50 ZN ZN A 401 C 377 THR A 41 THR^? 14.11 ZN ZN A 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -34.66 128.81 -14.07 -35.18 128.94 -15.41 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -30.25 126.98 -12.77 -29.68 126.19 -14.66 ULMN 4 1e6e_c01 ADRENODOXIN user 4 4 # 4 C 55 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 159 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 376 ILE A 282 ILE.? 8.29 ZN ZN A 401 C 377 THR A 303 THR^? 9.94 ZN ZN A 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -41.08 108.84 -13.73 -42.55 109.16 -13.89 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 4 1e6e_c01 ADRENODOXIN user 5 4 # 5 C 55 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 159 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 376 ILE A 62 ILE^? 13.50 ZN ZN A 401 C 377 THR A 41 THR^? 14.11 ZN ZN A 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -34.66 128.81 -14.07 -35.18 128.94 -15.41 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -30.25 126.98 -12.77 -29.68 126.19 -14.66 ULMN 4 1e6e_c01 ADRENODOXIN user 6 4 # 6 C 55 HIS B 13 HIS~? 19.30 ZN ZN B 402 C 159 ASP B 11 ASP~? 18.05 ZN ZN B 402 C 376 ILE B 62 ILE^? 13.54 ZN ZN B 402 C 377 THR B 41 THR^? 14.16 ZN ZN B 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -46.87 85.79 14.69 -47.39 85.98 16.05 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -42.12 84.98 13.35 -41.18 85.38 15.28 ULMN 4 1e6e_c01 ADRENODOXIN user 7 4 # 7 C 55 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 159 ASP B 91 ASP.? 28.82 ZN ZN B 401 C 376 ILE B 83 ILE~? 16.86 ZN ZN B 401 C 377 THR B 46 THR~? 13.88 ZN ZN B 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -48.53 84.68 -0.37 -47.40 85.47 0.16 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -43.66 86.34 1.76 -41.66 87.08 1.85 ULMN 4 1e6e_c01 ADRENODOXIN user 8 4 # 8 C 55 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 159 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 376 ILE B 62 ILE^? 13.54 ZN ZN B 402 C 377 THR B 41 THR^? 14.16 ZN ZN B 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -46.87 85.79 14.69 -47.39 85.98 16.05 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -42.12 84.98 13.35 -41.18 85.38 15.28 ULMN 4 1e6e_c01 ADRENODOXIN user 9 4 # 9 C 55 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 159 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 376 ILE B 282 ILE.? 8.31 ZN ZN B 402 C 377 THR B 303 THR^? 9.94 ZN ZN B 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -41.66 106.21 14.73 -43.02 106.75 14.92 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 4 1e6e_c01 ADRENODOXIN user 10 4 # 10 C 55 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 159 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 376 ILE B 62 ILE^? 13.54 ZN ZN B 402 C 377 THR B 41 THR^? 14.16 ZN ZN B 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -46.87 85.79 14.69 -47.39 85.98 16.05 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -42.12 84.98 13.35 -41.18 85.38 15.28 1e6e_c01 source 1e6e ADRENODOXIN : 10 hits 1e6e_c01 naa= 4 ULMN 4 1ec9_c11 GLUCARATE DEHYDRATASE user 1 4 # 1 D 207 LYS A 70 LYS.? 15.41 ZN ZN A 402 D 313 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 339 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 373 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 12.06 1.87 22.99 13.29 2.38 24.60 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 13.74 -1.84 22.10 15.79 -1.45 22.35 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 13.94 -5.98 40.88 13.74 -7.36 42.48 -39.98 115.46 11.22 -41.44 114.62 9.91 1ec9_c11 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c11 naa= 4 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 135 SER A 285 SER.? 7.68 ZN ZN A 402 B 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 36.51 108.90 17.50 37.10 110.80 16.19 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 4 # 2 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 135 SER A 285 SER.? 7.68 ZN ZN A 402 B 144 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 36.51 108.90 17.50 37.10 110.80 16.19 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 4 # 3 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 135 SER B 285 SER.? 7.72 ZN ZN B 401 B 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 36.51 108.90 17.50 37.10 110.80 16.19 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 4 # 4 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 135 SER B 285 SER.? 7.72 ZN ZN B 401 B 144 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 36.51 108.90 17.50 37.10 110.80 16.19 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 -44.34 101.21 -3.37 -45.95 102.39 -2.67 1grc_c01 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 4 hits 1grc_c01 naa= 4 ULMN 4 1j00_c00 THIOESTERASE I user 1 4 # 1 A 44 GLY A 304 GLY.? 8.93 ZN ZN A 402 A 73 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 154 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 157 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 5.31 35.31 46.19 5.56 34.58 46.17 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 1.82 33.37 49.33 3.83 34.09 49.37 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 8.45 43.15 56.37 9.67 41.50 55.89 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 9.95 38.09 54.06 8.12 38.46 53.08 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 4 1j00_c00 THIOESTERASE I user 2 4 # 2 A 44 GLY B 304 GLY.? 8.91 ZN ZN B 401 A 73 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 154 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 157 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 5.31 35.31 46.19 5.56 34.58 46.17 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 1.82 33.37 49.33 3.83 34.09 49.37 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 8.45 43.15 56.37 9.67 41.50 55.89 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 9.95 38.09 54.06 8.12 38.46 53.08 -45.80 98.45 2.85 -45.82 97.45 4.71 1j00_c00 source 1j00 THIOESTERASE I : 2 hits 1j00_c00 naa= 4 ULMN 4 1j00_c01 THIOESTERASE I user 1 4 # 1 A 44 GLY A 304 GLY.? 8.93 ZN ZN A 402 A 73 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 154 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 157 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 5.31 35.31 46.19 5.56 34.58 46.17 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 1.82 33.37 49.33 3.83 34.09 49.37 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 8.45 43.15 56.37 9.67 41.50 55.89 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 9.95 38.09 54.06 8.12 38.46 53.08 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 4 1j00_c01 THIOESTERASE I user 2 4 # 2 A 44 GLY B 304 GLY.? 8.91 ZN ZN B 401 A 73 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 154 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 157 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 5.31 35.31 46.19 5.56 34.58 46.17 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 1.82 33.37 49.33 3.83 34.09 49.37 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 8.45 43.15 56.37 9.67 41.50 55.89 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 9.95 38.09 54.06 8.12 38.46 53.08 -45.80 98.45 2.85 -45.82 97.45 4.71 1j00_c01 source 1j00 THIOESTERASE I : 2 hits 1j00_c01 naa= 4 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 1 4 # 1 B 142 SER A 63 SER^? 10.35 ZN ZN A 402 B 143 ALA A 42 ALA^? 12.34 ZN ZN A 402 B 169 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 259 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -22.50 44.77 16.45 -24.28 43.38 17.37 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo -24.61 43.93 13.40 -25.95 43.19 13.46 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -16.98 43.09 16.07 -15.37 42.66 17.38 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -20.12 38.81 19.97 -21.75 39.57 18.89 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 2 4 # 2 B 142 SER B 63 SER^? 10.37 ZN ZN B 401 B 143 ALA B 42 ALA^? 12.31 ZN ZN B 401 B 169 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 259 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo -22.50 44.77 16.45 -24.28 43.38 17.37 -46.04 88.60 10.98 -47.67 89.08 9.23 coo -24.61 43.93 13.40 -25.95 43.19 13.46 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -16.98 43.09 16.07 -15.37 42.66 17.38 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -20.12 38.81 19.97 -21.75 39.57 18.89 -45.27 94.95 7.47 -43.74 96.36 7.67 1kez_c01 source 1kez ERYTHRONOLIDE SYNTHASE : 2 hits 1kez_c01 naa= 4 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 4 # 1 166 LYS A 333 LYS~? 13.50 ZN ZN A 402 270 ASP A 305 ASP.? 7.62 ZN ZN A 402 297 HIS A 326 HIS~? -3.60 ZN ZN A 402s 317 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 27.27 1.43 25.09 29.18 5.25 22.89 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 29.40 9.25 9.79 31.51 9.14 10.05 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 29.05 8.65 14.00 30.25 7.04 14.30 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 29.25 11.66 19.43 29.42 9.79 18.51 -35.80 114.72 -10.28 -37.63 115.69 -10.11 1mdr_c00 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 1 hits 1mdr_c00 naa= 4 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 4 # 1 A 50 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 55 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 84 LYS A 315 LYS~? 18.17 ZN ZN B 401 A 117 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo 11.09 42.89 24.44 11.32 42.06 22.49 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 4.60 40.33 20.42 7.25 39.50 20.05 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 9.71 44.83 15.47 10.13 41.43 19.93 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 9.34 39.83 14.67 8.39 39.19 16.43 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 4 # 2 A 50 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 55 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 84 LYS B 315 LYS~? 18.28 ZN ZN A 402 A 117 HIS B 317 HIS~? 18.53 ZN ZN A 402 coo 11.09 42.89 24.44 11.32 42.06 22.49 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 4.60 40.33 20.42 7.25 39.50 20.05 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 9.71 44.83 15.47 10.13 41.43 19.93 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 9.34 39.83 14.67 8.39 39.19 16.43 -38.40 123.74 9.47 -39.77 124.82 8.30 1mrq_c00 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c00 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 103 VAL~? 8.69 ZN ZN A 401 A 194 GLY A 107 GLY~? 9.03 ZN ZN A 401 A 417 ILE B 124 ILE.? 15.01 ZN ZN B 402 A 457 ALA B 280 ALA^? 15.00 ZN ZN B 402 coo 60.43 93.31 8.03 62.16 94.30 8.93 -43.08 116.22 -19.23 -45.08 116.92 -18.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 -36.84 117.84 -20.01 -36.52 117.15 -20.30 coo 39.61 128.90 22.54 40.04 128.24 23.80 -42.82 109.38 22.97 -41.58 109.66 22.37 coo 43.27 124.32 20.47 43.79 125.29 21.53 -36.85 109.46 19.16 -37.78 110.59 18.83 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 103 VAL~? 8.69 ZN ZN A 401 A 194 GLY A 107 GLY~? 9.03 ZN ZN A 401 A 417 ILE B 124 ILE.? 15.01 ZN ZN B 402 A 457 ALA B 293 ALA~? 16.28 ZN ZN B 402 coo 60.43 93.31 8.03 62.16 94.30 8.93 -43.08 116.22 -19.23 -45.08 116.92 -18.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 -36.84 117.84 -20.01 -36.52 117.15 -20.30 coo 39.61 128.90 22.54 40.04 128.24 23.80 -42.82 109.38 22.97 -41.58 109.66 22.37 coo 43.27 124.32 20.47 43.79 125.29 21.53 -40.44 114.49 18.56 -39.75 113.50 17.61 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL B 103 VAL~? 8.70 ZN ZN B 402 A 194 GLY B 107 GLY~? 9.03 ZN ZN B 402 A 417 ILE A 124 ILE.? 14.97 ZN ZN A 401 A 457 ALA A 280 ALA^? 15.08 ZN ZN A 401 coo 60.43 93.31 8.03 62.16 94.30 8.93 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 -42.81 96.22 20.86 -42.14 96.60 21.16 coo 39.61 128.90 22.54 40.04 128.24 23.80 -43.81 106.60 -21.82 -42.93 105.72 -21.17 coo 43.27 124.32 20.47 43.79 125.29 21.53 -38.75 103.47 -18.17 -40.17 102.98 -17.87 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 151 VAL B 103 VAL~? 8.70 ZN ZN B 402 A 194 GLY B 107 GLY~? 9.03 ZN ZN B 402 A 417 ILE A 124 ILE.? 14.97 ZN ZN A 401 A 457 ALA A 293 ALA~? 16.37 ZN ZN A 401 coo 60.43 93.31 8.03 62.16 94.30 8.93 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 -42.81 96.22 20.86 -42.14 96.60 21.16 coo 39.61 128.90 22.54 40.04 128.24 23.80 -43.81 106.60 -21.82 -42.93 105.72 -21.17 coo 43.27 124.32 20.47 43.79 125.29 21.53 -44.42 101.07 -17.63 -43.28 101.58 -16.75 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 151 VAL B 353 VAL^? 19.87 ZN ZN B 402 A 194 GLY B 38 GLY.? 23.53 ZN ZN B 402 A 417 ILE A 257 ILE~? 16.95 ZN ZN A 401 A 457 ALA A 254 ALA~? 20.55 ZN ZN A 402 coo 60.43 93.31 8.03 62.16 94.30 8.93 -41.01 79.46 18.27 -42.10 81.06 19.35 coo 59.34 89.99 13.88 59.24 89.18 13.73 -45.02 75.58 15.94 -45.75 75.90 15.58 coo 39.61 128.90 22.54 40.04 128.24 23.80 -27.83 104.40 -13.77 -29.11 103.71 -14.11 coo 43.27 124.32 20.47 43.79 125.29 21.53 -28.06 99.81 -11.39 -28.64 99.01 -10.20 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 5 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 103 VAL~? 8.69 ZN ZN A 401 B 194 GLY A 107 GLY~? 9.03 ZN ZN A 401 B 417 ILE B 124 ILE.? 15.01 ZN ZN B 402 B 457 ALA B 280 ALA^? 15.00 ZN ZN B 402 coo 52.95 126.71 13.21 51.34 125.24 13.19 -43.08 116.22 -19.23 -45.08 116.92 -18.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 -36.84 117.84 -20.01 -36.52 117.15 -20.30 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.38 22.97 -41.58 109.66 22.37 coo 65.50 91.13 17.77 64.65 89.88 18.00 -36.85 109.46 19.16 -37.78 110.59 18.83 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 103 VAL~? 8.69 ZN ZN A 401 B 194 GLY A 107 GLY~? 9.03 ZN ZN A 401 B 417 ILE B 124 ILE.? 15.01 ZN ZN B 402 B 457 ALA B 293 ALA~? 16.28 ZN ZN B 402 coo 52.95 126.71 13.21 51.34 125.24 13.19 -43.08 116.22 -19.23 -45.08 116.92 -18.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 -36.84 117.84 -20.01 -36.52 117.15 -20.30 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.38 22.97 -41.58 109.66 22.37 coo 65.50 91.13 17.77 64.65 89.88 18.00 -40.44 114.49 18.56 -39.75 113.50 17.61 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL A 115 VAL~? 15.02 ZN ZN A 401 B 194 GLY A 335 GLY~? 12.90 ZN ZN A 401 B 417 ILE B 124 ILE.? 15.01 ZN ZN B 402 B 457 ALA B 280 ALA^? 15.00 ZN ZN B 402 coo 52.95 126.71 13.21 51.34 125.24 13.19 -26.88 110.98 -18.55 -26.78 112.31 -16.83 coo 50.40 126.23 20.48 50.46 127.00 20.75 -29.44 120.06 -18.71 -29.40 120.83 -18.33 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.38 22.97 -41.58 109.66 22.37 coo 65.50 91.13 17.77 64.65 89.88 18.00 -36.85 109.46 19.16 -37.78 110.59 18.83 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 B 151 VAL A 115 VAL~? 15.02 ZN ZN A 401 B 194 GLY A 335 GLY~? 12.90 ZN ZN A 401 B 417 ILE B 124 ILE.? 15.01 ZN ZN B 402 B 457 ALA B 293 ALA~? 16.28 ZN ZN B 402 coo 52.95 126.71 13.21 51.34 125.24 13.19 -26.88 110.98 -18.55 -26.78 112.31 -16.83 coo 50.40 126.23 20.48 50.46 127.00 20.75 -29.44 120.06 -18.71 -29.40 120.83 -18.33 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.38 22.97 -41.58 109.66 22.37 coo 65.50 91.13 17.77 64.65 89.88 18.00 -40.44 114.49 18.56 -39.75 113.50 17.61 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 B 151 VAL B 103 VAL~? 8.70 ZN ZN B 402 B 194 GLY B 107 GLY~? 9.03 ZN ZN B 402 B 417 ILE A 124 ILE.? 14.97 ZN ZN A 401 B 457 ALA A 280 ALA^? 15.08 ZN ZN A 401 coo 52.95 126.71 13.21 51.34 125.24 13.19 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 -42.81 96.22 20.86 -42.14 96.60 21.16 coo 68.38 85.45 19.33 67.41 85.52 20.41 -43.81 106.60 -21.82 -42.93 105.72 -21.17 coo 65.50 91.13 17.77 64.65 89.88 18.00 -38.75 103.47 -18.17 -40.17 102.98 -17.87 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 B 151 VAL B 103 VAL~? 8.70 ZN ZN B 402 B 194 GLY B 107 GLY~? 9.03 ZN ZN B 402 B 417 ILE A 124 ILE.? 14.97 ZN ZN A 401 B 457 ALA A 293 ALA~? 16.37 ZN ZN A 401 coo 52.95 126.71 13.21 51.34 125.24 13.19 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 -42.81 96.22 20.86 -42.14 96.60 21.16 coo 68.38 85.45 19.33 67.41 85.52 20.41 -43.81 106.60 -21.82 -42.93 105.72 -21.17 coo 65.50 91.13 17.77 64.65 89.88 18.00 -44.42 101.07 -17.63 -43.28 101.58 -16.75 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 B 151 VAL B 115 VAL~? 15.24 ZN ZN B 402 B 194 GLY B 335 GLY~? 12.98 ZN ZN B 402 B 417 ILE A 124 ILE.? 14.97 ZN ZN A 401 B 457 ALA A 280 ALA^? 15.08 ZN ZN A 401 coo 52.95 126.71 13.21 51.34 125.24 13.19 -30.58 96.84 19.47 -31.11 95.55 17.76 coo 50.40 126.23 20.48 50.46 127.00 20.75 -37.70 90.31 19.42 -38.03 89.63 19.05 coo 68.38 85.45 19.33 67.41 85.52 20.41 -43.81 106.60 -21.82 -42.93 105.72 -21.17 coo 65.50 91.13 17.77 64.65 89.88 18.00 -38.75 103.47 -18.17 -40.17 102.98 -17.87 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 B 151 VAL B 115 VAL~? 15.24 ZN ZN B 402 B 194 GLY B 335 GLY~? 12.98 ZN ZN B 402 B 417 ILE A 124 ILE.? 14.97 ZN ZN A 401 B 457 ALA A 293 ALA~? 16.37 ZN ZN A 401 coo 52.95 126.71 13.21 51.34 125.24 13.19 -30.58 96.84 19.47 -31.11 95.55 17.76 coo 50.40 126.23 20.48 50.46 127.00 20.75 -37.70 90.31 19.42 -38.03 89.63 19.05 coo 68.38 85.45 19.33 67.41 85.52 20.41 -43.81 106.60 -21.82 -42.93 105.72 -21.17 coo 65.50 91.13 17.77 64.65 89.88 18.00 -44.42 101.07 -17.63 -43.28 101.58 -16.75 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 B 151 VAL B 353 VAL^? 19.87 ZN ZN B 402 B 194 GLY B 38 GLY.? 23.53 ZN ZN B 402 B 417 ILE A 257 ILE~? 16.95 ZN ZN A 401 B 457 ALA A 254 ALA~? 20.55 ZN ZN A 402 coo 52.95 126.71 13.21 51.34 125.24 13.19 -41.01 79.46 18.27 -42.10 81.06 19.35 coo 50.40 126.23 20.48 50.46 127.00 20.75 -45.02 75.58 15.94 -45.75 75.90 15.58 coo 68.38 85.45 19.33 67.41 85.52 20.41 -27.83 104.40 -13.77 -29.11 103.71 -14.11 coo 65.50 91.13 17.77 64.65 89.88 18.00 -28.06 99.81 -11.39 -28.64 99.01 -10.20 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 9 hits 1pix_c01 naa= 4 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 A 28 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 115 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 477 GLU B 229 GLU^? 28.52 ZN ZN B 402 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 5.56 18.52 30.85 3.87 17.54 30.36 -65.20 109.92 29.95 -64.70 111.14 28.31 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 2 4 # 2 A 28 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 115 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 477 GLU A 229 GLU^? 28.63 ZN ZN A 401 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 5.56 18.52 30.85 3.87 17.54 30.36 -62.71 117.83 -29.19 -63.22 116.50 -27.60 1pvd_c00 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 2 hits 1pvd_c00 naa= 4 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 B 28 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 115 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 477 GLU B 229 GLU^? 28.52 ZN ZN B 402 coo 7.54 16.02 24.50 8.40 15.18 26.23 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.56 11.13 24.12 12.84 11.07 26.21 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 8.02 10.56 23.37 8.23 11.43 25.26 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 -65.20 109.92 29.95 -64.70 111.14 28.31 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 2 4 # 2 B 28 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 115 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 477 GLU A 229 GLU^? 28.63 ZN ZN A 401 coo 7.54 16.02 24.50 8.40 15.18 26.23 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.56 11.13 24.12 12.84 11.07 26.21 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 8.02 10.56 23.37 8.23 11.43 25.26 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 -62.71 117.83 -29.19 -63.22 116.50 -27.60 1pvd_c01 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 2 hits 1pvd_c01 naa= 4 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 1 4 # 1 A 10 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 41 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 118 SER A 285 SER.? 7.68 ZN ZN A 402 A 180 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 20.70 13.03 9.13 22.27 11.81 9.81 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 23.00 19.17 17.85 22.49 17.70 15.19 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 17.70 9.25 13.10 16.68 11.30 13.99 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 26.47 11.43 10.70 25.16 9.82 11.06 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 2 4 # 2 A 10 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 41 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 118 SER B 285 SER.? 7.72 ZN ZN B 401 A 180 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 20.70 13.03 9.13 22.27 11.81 9.81 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 23.00 19.17 17.85 22.49 17.70 15.19 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 17.70 9.25 13.10 16.68 11.30 13.99 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 26.47 11.43 10.70 25.16 9.82 11.06 -33.57 107.34 6.30 -34.87 106.07 5.21 1qh9_c01 source 1qh9 2-HALOACID DEHALOGENASE : 2 hits 1qh9_c01 naa= 4 ULMN 4 1qi9_c03 VANADIUM BROMOPEROXIDASE user 1 4 # 1 B 341 LYS A 307 LYS~? 10.65 ZN ZN B 401 B 411 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 418 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 486 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 86.78 4.06 6.95 85.81 5.85 7.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 81.39 11.93 10.46 82.24 12.93 8.84 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 78.14 5.23 9.11 80.26 5.28 9.20 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 4 1qi9_c03 VANADIUM BROMOPEROXIDASE user 2 4 # 2 B 341 LYS B 307 LYS~? 11.14 ZN ZN A 402 B 411 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 418 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 486 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 86.78 4.06 6.95 85.81 5.85 7.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 81.39 11.93 10.46 82.24 12.93 8.84 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 78.14 5.23 9.11 80.26 5.28 9.20 -38.08 120.38 -6.61 -37.64 118.32 -6.74 1qi9_c03 source 1qi9 VANADIUM BROMOPEROXIDASE : 2 hits 1qi9_c03 naa= 4 ULMN 4 1qrz_c00 PLASMINOGEN user 1 4 # 1 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 A 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.18 113.19 10.25 -44.48 113.02 10.77 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 4 1qrz_c00 PLASMINOGEN user 2 4 # 2 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 A 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.18 113.19 10.25 -44.48 113.02 10.77 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.52 104.99 8.17 -43.54 106.03 6.21 1qrz_c00 source 1qrz PLASMINOGEN : 2 hits 1qrz_c00 naa= 4 ULMN 4 1qrz_c03 PLASMINOGEN user 1 4 # 1 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 D 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -45.18 113.19 10.25 -44.48 113.02 10.77 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -42.52 104.99 8.17 -43.54 106.03 6.21 1qrz_c03 source 1qrz PLASMINOGEN : 1 hits 1qrz_c03 naa= 4 ULMN 4 1qrz_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 741 SER A 285 SER.? 7.68 ZN ZN A 402 A 742 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 4 1qrz_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 741 SER A 285 SER.? 7.68 ZN ZN A 402 A 742 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 4 1qrz_c04 PLASMINOGEN user 3 4 # 3 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 741 SER B 285 SER.? 7.72 ZN ZN B 401 A 742 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 4 1qrz_c04 PLASMINOGEN user 4 4 # 4 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 741 SER B 285 SER.? 7.72 ZN ZN B 401 A 742 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.82 107.61 10.95 -42.53 107.90 10.27 1qrz_c04 source 1qrz PLASMINOGEN : 4 hits 1qrz_c04 naa= 4 ULMN 4 1qrz_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 741 SER A 285 SER.? 7.68 ZN ZN A 402 B 742 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 4 1qrz_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 741 SER B 285 SER.? 7.72 ZN ZN B 401 B 742 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 -42.82 107.61 10.95 -42.53 107.90 10.27 1qrz_c05 source 1qrz PLASMINOGEN : 2 hits 1qrz_c05 naa= 4 ULMN 4 1qrz_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 741 SER A 285 SER.? 7.68 ZN ZN A 402 C 742 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 4 1qrz_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 741 SER B 285 SER.? 7.72 ZN ZN B 401 C 742 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -42.82 107.61 10.95 -42.53 107.90 10.27 1qrz_c06 source 1qrz PLASMINOGEN : 2 hits 1qrz_c06 naa= 4 ULMN 4 1qrz_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 741 SER A 285 SER.? 7.68 ZN ZN A 402 D 742 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 4 1qrz_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 741 SER B 285 SER.? 7.72 ZN ZN B 401 D 742 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -42.82 107.61 10.95 -42.53 107.90 10.27 1qrz_c07 source 1qrz PLASMINOGEN : 2 hits 1qrz_c07 naa= 4 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 1 4 # 1 B 10 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 83 TRP A 343 TRP~? 17.17 ZN ZN A 401 B 186 ASN A 100 ASN~? 9.95 ZN ZN A 401 B 260 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 32.41 24.46 38.87 30.66 25.57 39.24 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 21.58 23.61 33.02 20.95 24.04 36.89 -33.98 126.57 -26.65 -35.54 125.95 -23.07 coo 27.66 25.11 45.19 28.06 26.34 43.52 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 25.52 34.62 42.47 24.97 33.24 42.72 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 2 4 # 2 B 10 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 83 TRP A 22 TRP.? 10.39 ZN ZN A 401 B 186 ASN A 100 ASN~? 9.95 ZN ZN A 401 B 260 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 32.41 24.46 38.87 30.66 25.57 39.24 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 21.58 23.61 33.02 20.95 24.04 36.89 -51.58 117.82 -9.56 -47.69 118.06 -9.02 coo 27.66 25.11 45.19 28.06 26.34 43.52 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 25.52 34.62 42.47 24.97 33.24 42.72 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 3 4 # 3 B 10 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 83 TRP B 343 TRP~? 17.23 ZN ZN B 402 B 186 ASN B 100 ASN~? 9.88 ZN ZN B 402 B 260 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 32.41 24.46 38.87 30.66 25.57 39.24 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 21.58 23.61 33.02 20.95 24.04 36.89 -44.99 87.08 27.38 -45.87 88.61 23.86 coo 27.66 25.11 45.19 28.06 26.34 43.52 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 25.52 34.62 42.47 24.97 33.24 42.72 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 4 4 # 4 B 10 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 83 TRP B 22 TRP.? 10.34 ZN ZN B 402 B 186 ASN B 100 ASN~? 9.88 ZN ZN B 402 B 260 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 32.41 24.46 38.87 30.66 25.57 39.24 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 21.58 23.61 33.02 20.95 24.04 36.89 -55.25 104.25 10.67 -52.18 101.86 10.02 coo 27.66 25.11 45.19 28.06 26.34 43.52 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 25.52 34.62 42.47 24.97 33.24 42.72 -50.76 89.87 12.12 -51.42 90.77 11.02 1r4f_c01 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 4 hits 1r4f_c01 naa= 4 ULMN 4 1rgq_c00 NS4A PEPTIDE user 1 4 # 1 A 60 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 84 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 140 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 142 SER B 328 SER~? 10.89 ZN ZN B 401 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -39.59 102.15 13.09 -40.35 102.56 13.10 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 4 1rgq_c00 NS4A PEPTIDE user 2 4 # 2 A 60 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 84 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 140 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 142 SER B 328 SER~? 10.89 ZN ZN B 401 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -39.59 102.15 13.09 -40.35 102.56 13.10 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 4 1rgq_c00 NS4A PEPTIDE user 3 4 # 3 A 60 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 84 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 140 GLY B 284 GLY.? 4.14 ZN ZN B 401 A 142 SER B 285 SER.? 7.72 ZN ZN B 401 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -41.31 101.77 9.74 -40.78 102.45 9.84 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 4 1rgq_c00 NS4A PEPTIDE user 4 4 # 4 A 60 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 84 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 140 GLY B 304 GLY.? 8.91 ZN ZN B 401 A 142 SER B 285 SER.? 7.72 ZN ZN B 401 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -37.52 104.72 7.61 -38.13 105.28 7.78 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 4 1rgq_c00 NS4A PEPTIDE user 5 4 # 5 A 60 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 84 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 140 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 142 SER A 328 SER~? 11.01 ZN ZN A 402 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 4 1rgq_c00 NS4A PEPTIDE user 6 4 # 6 A 60 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 84 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 140 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 142 SER A 328 SER~? 11.01 ZN ZN A 402 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -31.13 112.55 -9.15 -30.14 110.33 -8.98 1rgq_c00 source 1rgq NS4A PEPTIDE : 6 hits 1rgq_c00 naa= 4 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 1 4 # 1 A 170 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 202 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 448 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 473 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 15.19 27.99 11.95 13.02 28.03 12.03 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 4.95 34.38 14.49 6.71 33.17 14.61 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 16.78 26.00 16.74 15.90 26.28 14.86 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 2 4 # 2 A 170 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 202 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 448 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 473 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 15.19 27.99 11.95 13.02 28.03 12.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 4.95 34.38 14.49 6.71 33.17 14.61 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 16.78 26.00 16.74 15.90 26.28 14.86 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 3 4 # 3 A 170 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 202 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 448 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 473 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 15.19 27.99 11.95 13.02 28.03 12.03 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 4.95 34.38 14.49 6.71 33.17 14.61 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.73 30.70 11.43 8.79 30.60 11.04 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 16.78 26.00 16.74 15.90 26.28 14.86 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 4 4 # 4 A 170 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 202 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 448 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 473 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 15.19 27.99 11.95 13.02 28.03 12.03 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 4.95 34.38 14.49 6.71 33.17 14.61 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 16.78 26.00 16.74 15.90 26.28 14.86 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 5 4 # 5 A 170 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 202 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 448 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 473 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 15.19 27.99 11.95 13.02 28.03 12.03 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 4.95 34.38 14.49 6.71 33.17 14.61 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.73 30.70 11.43 8.79 30.60 11.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.78 26.00 16.74 15.90 26.28 14.86 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 6 4 # 6 A 170 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 202 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 448 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 473 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 15.19 27.99 11.95 13.02 28.03 12.03 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 4.95 34.38 14.49 6.71 33.17 14.61 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.73 30.70 11.43 8.79 30.60 11.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 16.78 26.00 16.74 15.90 26.28 14.86 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 7 4 # 7 A 170 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 202 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 448 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 473 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 15.19 27.99 11.95 13.02 28.03 12.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 4.95 34.38 14.49 6.71 33.17 14.61 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.73 30.70 11.43 8.79 30.60 11.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 16.78 26.00 16.74 15.90 26.28 14.86 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 8 4 # 8 A 170 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 202 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 448 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 473 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 15.19 27.99 11.95 13.02 28.03 12.03 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 4.95 34.38 14.49 6.71 33.17 14.61 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 16.78 26.00 16.74 15.90 26.28 14.86 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 9 4 # 9 A 170 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 202 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 448 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 473 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 15.19 27.99 11.95 13.02 28.03 12.03 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 4.95 34.38 14.49 6.71 33.17 14.61 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.73 30.70 11.43 8.79 30.60 11.04 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 16.78 26.00 16.74 15.90 26.28 14.86 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 10 4 # 10 A 170 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 202 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 448 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 473 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 15.19 27.99 11.95 13.02 28.03 12.03 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 4.95 34.38 14.49 6.71 33.17 14.61 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.73 30.70 11.43 8.79 30.60 11.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.78 26.00 16.74 15.90 26.28 14.86 -40.41 105.08 4.17 -40.72 103.08 3.51 1v0y_c00 source 1v0y PHOSPHOLIPASE D : 10 hits 1v0y_c00 naa= 4 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 1 4 # 1 44 ASP A 310 ASP~? 12.24 ZN ZN B 401 49 TYR A 291 TYR~? 19.48 ZN ZN B 401 79 LYS A 315 LYS~? 18.17 ZN ZN B 401 112 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 2 4 # 2 44 ASP B 310 ASP~? 12.35 ZN ZN A 402 49 TYR B 291 TYR~? 19.42 ZN ZN A 402 79 LYS B 315 LYS~? 18.28 ZN ZN A 402 112 HIS B 317 HIS~? 18.53 ZN ZN A 402 coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -38.40 123.74 9.47 -39.77 124.82 8.30 2alr_c00 source 2alr ALDEHYDE REDUCTASE : 2 hits 2alr_c00 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 100 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 116 GLN A 364 GLN^? 21.84 ZN ZN A 402 coo 32.24 20.09 5.34 30.38 19.04 5.27 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 26.40 25.34 6.28 26.15 22.33 7.25 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 26.74 21.94 13.78 27.57 20.97 12.08 -23.65 112.84 4.68 -22.28 114.13 5.68 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 100 ARG B 278 ARG^? 23.19 ZN ZN B 402 A 116 GLN B 247 GLN^? 30.66 ZN ZN B 402 coo 32.24 20.09 5.34 30.38 19.04 5.27 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 26.40 25.34 6.28 26.15 22.33 7.25 -33.11 114.47 25.89 -35.97 114.81 26.88 coo 26.74 21.94 13.78 27.57 20.97 12.08 -23.26 114.62 23.41 -22.24 116.39 24.06 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 100 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 116 GLN B 364 GLN^? 21.76 ZN ZN B 401 coo 32.24 20.09 5.34 30.38 19.04 5.27 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 26.40 25.34 6.28 26.15 22.33 7.25 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 26.74 21.94 13.78 27.57 20.97 12.08 -29.16 93.68 -3.73 -28.66 91.97 -4.89 12as_c00 source 12as ASPARAGINE SYNTHETASE : 3 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 100 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 116 GLN A 364 GLN^? 21.84 ZN ZN A 402 coo 32.18 48.37 12.48 33.96 49.46 12.97 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 39.04 43.25 11.37 38.30 45.35 13.56 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 37.43 42.63 19.41 36.76 44.08 17.97 -23.65 112.84 4.68 -22.28 114.13 5.68 12as_c01 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 80 TYR~? 13.91 ZN ZN A 402 B 190 LYS B 315 LYS~? 18.28 ZN ZN A 402 B 222 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 7.17 16.59 41.26 8.01 19.20 40.73 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 13.38 20.00 35.06 11.43 22.49 39.53 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 9.76 26.58 38.10 11.63 25.78 38.76 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 132 TYR^? 30.56 ZN ZN A 401 B 190 LYS A 231 LYS^? 23.23 ZN ZN A 401 B 222 ASP A 129 ASP^? 19.65 ZN ZN A 401 coo 7.17 16.59 41.26 8.01 19.20 40.73 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo 13.38 20.00 35.06 11.43 22.49 39.53 -57.94 114.56 -29.95 -58.70 114.72 -24.54 coo 9.76 26.58 38.10 11.63 25.78 38.76 -52.93 118.26 -28.24 -51.00 118.44 -27.37 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR A 291 TYR~? 19.48 ZN ZN B 401 B 190 LYS A 315 LYS~? 18.17 ZN ZN B 401 B 222 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 7.17 16.59 41.26 8.01 19.20 40.73 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 13.38 20.00 35.06 11.43 22.49 39.53 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR B 80 TYR~? 13.91 ZN ZN B 401 B 190 LYS A 315 LYS~? 18.17 ZN ZN B 401 B 222 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 7.17 16.59 41.26 8.01 19.20 40.73 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 13.38 20.00 35.06 11.43 22.49 39.53 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR B 132 TYR^? 30.83 ZN ZN B 402 B 190 LYS B 231 LYS^? 25.02 ZN ZN B 402 B 222 ASP B 129 ASP^? 19.14 ZN ZN B 402 coo 7.17 16.59 41.26 8.01 19.20 40.73 -67.13 105.92 32.85 -67.85 106.57 30.23 coo 13.38 20.00 35.06 11.43 22.49 39.53 -59.06 109.88 30.77 -61.50 111.95 25.23 coo 9.76 26.58 38.10 11.63 25.78 38.76 -57.17 104.15 28.46 -55.58 103.29 27.35 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR B 291 TYR~? 19.42 ZN ZN A 402 B 190 LYS B 315 LYS~? 18.28 ZN ZN A 402 B 222 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 7.17 16.59 41.26 8.01 19.20 40.73 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 13.38 20.00 35.06 11.43 22.49 39.53 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 9.76 26.58 38.10 11.63 25.78 38.76 -40.42 114.63 4.44 -42.44 114.56 3.83 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 231 LYS^? 23.23 ZN ZN A 401 A 222 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 140 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -57.94 114.56 -29.95 -58.70 114.72 -24.54 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 1.51 16.60 24.17 0.82 19.23 24.79 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 315 LYS~? 18.17 ZN ZN B 401 A 222 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 140 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 1.51 16.60 24.17 0.82 19.23 24.79 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS A 315 LYS~? 18.17 ZN ZN B 401 A 222 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 140 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 1.51 16.60 24.17 0.82 19.23 24.79 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS B 231 LYS^? 25.02 ZN ZN B 402 A 222 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 140 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -59.06 109.88 30.77 -61.50 111.95 25.23 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 1.51 16.60 24.17 0.82 19.23 24.79 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS B 315 LYS~? 18.28 ZN ZN A 402 A 222 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 140 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -33.07 120.28 7.09 -27.74 119.98 5.88 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 1.51 16.60 24.17 0.82 19.23 24.79 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS B 315 LYS~? 18.28 ZN ZN A 402 A 222 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 140 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -33.07 120.28 7.09 -27.74 119.98 5.88 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 1.51 16.60 24.17 0.82 19.23 24.79 -41.81 119.15 12.42 -40.61 119.58 9.91 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 195 SER A 63 SER^? 10.35 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 20.90 36.72 61.65 22.18 37.53 63.52 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 102 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 195 SER A 328 SER~? 11.01 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 22.33 45.48 59.73 23.35 43.67 60.06 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 20.90 36.72 61.65 22.18 37.53 63.52 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 195 SER B 63 SER^? 10.37 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 20.90 36.72 61.65 22.18 37.53 63.52 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 102 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 195 SER B 328 SER~? 10.89 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 20.90 36.72 61.65 22.18 37.53 63.52 -35.17 97.75 10.01 -33.21 99.13 9.77 1a0j_c00 source 1a0j TRYPSIN : 4 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 195 SER A 63 SER^? 10.35 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 48.11 50.52 52.24 48.62 48.46 53.13 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 102 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 195 SER A 328 SER~? 11.01 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 48.11 50.52 52.24 48.62 48.46 53.13 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 195 SER B 63 SER^? 10.37 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 48.11 50.52 52.24 48.62 48.46 53.13 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 102 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 195 SER B 328 SER~? 10.89 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 48.11 50.52 52.24 48.62 48.46 53.13 -35.17 97.75 10.01 -33.21 99.13 9.77 1a0j_c01 source 1a0j TRYPSIN : 4 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 195 SER A 63 SER^? 10.35 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 36.16 46.87 75.66 34.01 46.43 74.59 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 102 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 195 SER A 328 SER~? 11.01 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 36.16 46.87 75.66 34.01 46.43 74.59 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 195 SER B 63 SER^? 10.37 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 36.16 46.87 75.66 34.01 46.43 74.59 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 102 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 195 SER B 328 SER~? 10.89 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 36.16 46.87 75.66 34.01 46.43 74.59 -35.17 97.75 10.01 -33.21 99.13 9.77 1a0j_c02 source 1a0j TRYPSIN : 4 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 195 SER A 63 SER^? 10.35 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 6.63 21.03 97.42 6.71 19.20 98.95 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 102 ASP A 305 ASP.? 7.62 ZN ZN A 402 D 195 SER A 328 SER~? 11.01 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.63 21.03 97.42 6.71 19.20 98.95 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 195 SER B 63 SER^? 10.37 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 6.63 21.03 97.42 6.71 19.20 98.95 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 102 ASP B 305 ASP.? 7.64 ZN ZN B 401 D 195 SER B 328 SER~? 10.89 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.63 21.03 97.42 6.71 19.20 98.95 -35.17 97.75 10.01 -33.21 99.13 9.77 1a0j_c03 source 1a0j TRYPSIN : 4 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 22.57 32.23 64.13 21.98 32.82 64.22 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.33 45.48 59.73 23.35 43.67 60.06 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.33 45.48 59.73 23.35 43.67 60.06 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c12 TRYPSIN user 6 3 # 6 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.33 45.48 59.73 23.35 43.67 60.06 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c12 TRYPSIN user 7 3 # 7 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 22.57 32.23 64.13 21.98 32.82 64.22 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1a0j_c12 TRYPSIN user 8 3 # 8 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c12 TRYPSIN user 9 3 # 9 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c12 TRYPSIN user 10 3 # 10 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c12 TRYPSIN user 11 3 # 11 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c12 TRYPSIN user 12 3 # 12 A 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c12 TRYPSIN user 13 3 # 13 A 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c12 TRYPSIN user 14 3 # 14 A 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c12 TRYPSIN user 15 3 # 15 A 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 193 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 22.57 32.23 64.13 21.98 32.82 64.22 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1a0j_c12 TRYPSIN user 16 3 # 16 A 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1a0j_c12 TRYPSIN user 17 3 # 17 A 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c12 TRYPSIN user 18 3 # 18 A 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c12 TRYPSIN user 19 3 # 19 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.33 45.48 59.73 23.35 43.67 60.06 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 22.57 32.23 64.13 21.98 32.82 64.22 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1a0j_c12 TRYPSIN user 20 3 # 20 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.33 45.48 59.73 23.35 43.67 60.06 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c12 TRYPSIN user 21 3 # 21 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.33 45.48 59.73 23.35 43.67 60.06 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c12 TRYPSIN user 22 3 # 22 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 22.57 32.23 64.13 21.98 32.82 64.22 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1a0j_c12 TRYPSIN user 23 3 # 23 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c12 TRYPSIN user 24 3 # 24 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c12 TRYPSIN user 25 3 # 25 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.33 45.48 59.73 23.35 43.67 60.06 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c12 TRYPSIN user 26 3 # 26 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.33 45.48 59.73 23.35 43.67 60.06 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c12 TRYPSIN user 27 3 # 27 A 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c12 TRYPSIN user 28 3 # 28 A 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c12 TRYPSIN user 29 3 # 29 A 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 22.33 45.48 59.73 23.35 43.67 60.06 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c12 TRYPSIN user 30 3 # 30 A 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 22.33 45.48 59.73 23.35 43.67 60.06 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.26 132.56 4.99 -38.51 132.20 4.81 1a0j_c12 source 1a0j TRYPSIN : 30 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 50.46 51.91 56.90 50.65 51.62 56.14 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 193 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 43.04 44.75 47.18 43.31 45.51 49.13 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 43.04 44.75 47.18 43.31 45.51 49.13 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 43.04 44.75 47.18 43.31 45.51 49.13 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 50.46 51.91 56.90 50.65 51.62 56.14 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1a0j_c13 TRYPSIN user 7 3 # 7 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c13 TRYPSIN user 8 3 # 8 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c13 TRYPSIN user 9 3 # 9 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c13 TRYPSIN user 10 3 # 10 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c13 TRYPSIN user 11 3 # 11 B 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 50.46 51.91 56.90 50.65 51.62 56.14 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c13 TRYPSIN user 12 3 # 12 B 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c13 TRYPSIN user 13 3 # 13 B 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 50.46 51.91 56.90 50.65 51.62 56.14 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c13 TRYPSIN user 14 3 # 14 B 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 193 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 50.46 51.91 56.90 50.65 51.62 56.14 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1a0j_c13 TRYPSIN user 15 3 # 15 B 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 50.46 51.91 56.90 50.65 51.62 56.14 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1a0j_c13 TRYPSIN user 16 3 # 16 B 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1a0j_c13 TRYPSIN user 17 3 # 17 B 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c13 TRYPSIN user 18 3 # 18 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 193 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 43.04 44.75 47.18 43.31 45.51 49.13 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 50.46 51.91 56.90 50.65 51.62 56.14 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1a0j_c13 TRYPSIN user 19 3 # 19 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 43.04 44.75 47.18 43.31 45.51 49.13 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c13 TRYPSIN user 20 3 # 20 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 43.04 44.75 47.18 43.31 45.51 49.13 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 50.46 51.91 56.90 50.65 51.62 56.14 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c13 TRYPSIN user 21 3 # 21 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 50.46 51.91 56.90 50.65 51.62 56.14 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1a0j_c13 TRYPSIN user 22 3 # 22 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c13 TRYPSIN user 23 3 # 23 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c13 TRYPSIN user 24 3 # 24 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 43.04 44.75 47.18 43.31 45.51 49.13 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c13 TRYPSIN user 25 3 # 25 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 43.04 44.75 47.18 43.31 45.51 49.13 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c13 TRYPSIN user 26 3 # 26 B 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c13 TRYPSIN user 27 3 # 27 B 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c13 TRYPSIN user 28 3 # 28 B 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c13 TRYPSIN user 29 3 # 29 B 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.26 132.56 4.99 -38.51 132.20 4.81 ULMN 3 1a0j_c13 TRYPSIN user 30 3 # 30 B 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 193 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 50.46 51.91 56.90 50.65 51.62 56.14 -28.43 117.43 9.69 -27.94 117.09 9.08 1a0j_c13 source 1a0j TRYPSIN : 30 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 35.43 51.03 72.12 35.20 50.72 72.87 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 193 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c14 TRYPSIN user 7 3 # 7 C 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 35.43 51.03 72.12 35.20 50.72 72.87 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1a0j_c14 TRYPSIN user 8 3 # 8 C 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c14 TRYPSIN user 9 3 # 9 C 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c14 TRYPSIN user 10 3 # 10 C 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c14 TRYPSIN user 11 3 # 11 C 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c14 TRYPSIN user 12 3 # 12 C 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c14 TRYPSIN user 13 3 # 13 C 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c14 TRYPSIN user 14 3 # 14 C 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c14 TRYPSIN user 15 3 # 15 C 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 C 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 193 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 35.43 51.03 72.12 35.20 50.72 72.87 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1a0j_c14 TRYPSIN user 16 3 # 16 C 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 C 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 193 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 35.43 51.03 72.12 35.20 50.72 72.87 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1a0j_c14 TRYPSIN user 17 3 # 17 C 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 35.43 51.03 72.12 35.20 50.72 72.87 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1a0j_c14 TRYPSIN user 18 3 # 18 C 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1a0j_c14 TRYPSIN user 19 3 # 19 C 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c14 TRYPSIN user 20 3 # 20 C 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c14 TRYPSIN user 21 3 # 21 C 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 193 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 34.89 38.34 78.12 35.11 39.59 76.42 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 35.43 51.03 72.12 35.20 50.72 72.87 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1a0j_c14 TRYPSIN user 22 3 # 22 C 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 34.89 38.34 78.12 35.11 39.59 76.42 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c14 TRYPSIN user 23 3 # 23 C 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 34.89 38.34 78.12 35.11 39.59 76.42 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c14 TRYPSIN user 24 3 # 24 C 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 35.43 51.03 72.12 35.20 50.72 72.87 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1a0j_c14 TRYPSIN user 25 3 # 25 C 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c14 TRYPSIN user 26 3 # 26 C 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c14 TRYPSIN user 27 3 # 27 C 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 34.89 38.34 78.12 35.11 39.59 76.42 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c14 TRYPSIN user 28 3 # 28 C 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 34.89 38.34 78.12 35.11 39.59 76.42 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c14 TRYPSIN user 29 3 # 29 C 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c14 TRYPSIN user 30 3 # 30 C 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c14 TRYPSIN user 31 3 # 31 C 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c14 TRYPSIN user 32 3 # 32 C 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 C 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.26 132.56 4.99 -38.51 132.20 4.81 ULMN 3 1a0j_c14 TRYPSIN user 33 3 # 33 C 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 C 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 193 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 35.43 51.03 72.12 35.20 50.72 72.87 -28.43 117.43 9.69 -27.94 117.09 9.08 1a0j_c14 source 1a0j TRYPSIN : 33 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 1.80 21.25 100.04 2.61 21.42 100.18 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 193 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 13.53 16.28 93.98 11.45 16.21 94.40 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 13.53 16.28 93.98 11.45 16.21 94.40 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 13.53 16.28 93.98 11.45 16.21 94.40 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c15 TRYPSIN user 6 3 # 6 D 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 1.80 21.25 100.04 2.61 21.42 100.18 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1a0j_c15 TRYPSIN user 7 3 # 7 D 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c15 TRYPSIN user 8 3 # 8 D 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c15 TRYPSIN user 9 3 # 9 D 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c15 TRYPSIN user 10 3 # 10 D 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c15 TRYPSIN user 11 3 # 11 D 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 1.80 21.25 100.04 2.61 21.42 100.18 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c15 TRYPSIN user 12 3 # 12 D 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1a0j_c15 TRYPSIN user 13 3 # 13 D 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 1.80 21.25 100.04 2.61 21.42 100.18 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c15 TRYPSIN user 14 3 # 14 D 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 D 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 193 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 1.80 21.25 100.04 2.61 21.42 100.18 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1a0j_c15 TRYPSIN user 15 3 # 15 D 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 1.80 21.25 100.04 2.61 21.42 100.18 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1a0j_c15 TRYPSIN user 16 3 # 16 D 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1a0j_c15 TRYPSIN user 17 3 # 17 D 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c15 TRYPSIN user 18 3 # 18 D 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 193 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 13.53 16.28 93.98 11.45 16.21 94.40 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 1.80 21.25 100.04 2.61 21.42 100.18 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1a0j_c15 TRYPSIN user 19 3 # 19 D 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 13.53 16.28 93.98 11.45 16.21 94.40 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1a0j_c15 TRYPSIN user 20 3 # 20 D 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 13.53 16.28 93.98 11.45 16.21 94.40 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 1.80 21.25 100.04 2.61 21.42 100.18 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1a0j_c15 TRYPSIN user 21 3 # 21 D 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 1.80 21.25 100.04 2.61 21.42 100.18 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1a0j_c15 TRYPSIN user 22 3 # 22 D 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c15 TRYPSIN user 23 3 # 23 D 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c15 TRYPSIN user 24 3 # 24 D 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 13.53 16.28 93.98 11.45 16.21 94.40 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1a0j_c15 TRYPSIN user 25 3 # 25 D 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 13.53 16.28 93.98 11.45 16.21 94.40 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c15 TRYPSIN user 26 3 # 26 D 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c15 TRYPSIN user 27 3 # 27 D 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1a0j_c15 TRYPSIN user 28 3 # 28 D 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1a0j_c15 TRYPSIN user 29 3 # 29 D 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 D 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.26 132.56 4.99 -38.51 132.20 4.81 ULMN 3 1a0j_c15 TRYPSIN user 30 3 # 30 D 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 D 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 193 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 1.80 21.25 100.04 2.61 21.42 100.18 -28.43 117.43 9.69 -27.94 117.09 9.08 1a0j_c15 source 1a0j TRYPSIN : 30 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 267 ARG^? 13.45 ZN ZN B 401 265 HIS A 308 HIS~? 6.49 ZN ZN B 401 274 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 0.94 52.26 9.16 1.95 54.78 9.91 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 267 ARG^? 13.63 ZN ZN A 402 265 HIS B 308 HIS~? 6.54 ZN ZN A 402 274 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 0.94 52.26 9.16 1.95 54.78 9.91 -41.81 119.15 12.42 -40.61 119.58 9.91 1a41_c01 source 1a41 TOPOISOMERASE I : 2 hits 1a41_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 B 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 114 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 4 3 # 4 B 13 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 5 3 # 5 B 13 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 40 LYS A 315 LYS~? 18.17 ZN ZN B 401 B 114 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 6 3 # 6 B 13 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 B 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -57.09 96.40 2.21 -54.35 101.68 2.27 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 7 3 # 7 B 13 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 8 3 # 8 B 13 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 114 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 9 3 # 9 B 13 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 40 LYS B 315 LYS~? 18.28 ZN ZN A 402 B 114 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -33.07 120.28 7.09 -27.74 119.98 5.88 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -38.08 120.38 -6.61 -37.64 118.32 -6.74 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 9 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 E 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 E 114 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 E 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 4 3 # 4 E 13 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 E 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 5 3 # 5 E 13 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 40 LYS A 315 LYS~? 18.17 ZN ZN B 401 E 114 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 6 3 # 6 E 13 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 40 LYS A 315 LYS~? 18.17 ZN ZN B 401 E 114 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 7 3 # 7 E 13 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 40 LYS A 307 LYS~? 10.65 ZN ZN B 401 E 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 8 3 # 8 E 13 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 E 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 9 3 # 9 E 13 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 E 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 10 3 # 10 E 13 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 E 114 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 11 3 # 11 E 13 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 E 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 12 3 # 12 E 13 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 40 LYS B 315 LYS~? 18.28 ZN ZN A 402 E 114 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 13 3 # 13 E 13 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 40 LYS B 315 LYS~? 18.28 ZN ZN A 402 E 114 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 14 3 # 14 E 13 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 40 LYS B 307 LYS~? 11.14 ZN ZN A 402 E 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -45.80 98.45 2.85 -45.82 97.45 4.71 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 14 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 229 GLU^? 28.63 ZN ZN A 401 A 60 ASP A 226 ASP^? 42.28 ZN ZN A 401 A 175 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 46.10 28.27 19.27 45.48 26.99 20.84 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 56.42 28.06 12.93 55.01 27.92 14.50 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 45.02 22.04 15.38 46.16 24.00 13.76 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 60 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 175 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 46.10 28.27 19.27 45.48 26.99 20.84 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 56.42 28.06 12.93 55.01 27.92 14.50 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 45.02 22.04 15.38 46.16 24.00 13.76 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 60 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 175 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 46.10 28.27 19.27 45.48 26.99 20.84 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 56.42 28.06 12.93 55.01 27.92 14.50 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 45.02 22.04 15.38 46.16 24.00 13.76 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 60 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 175 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 56.42 28.06 12.93 55.01 27.92 14.50 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 45.02 22.04 15.38 46.16 24.00 13.76 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 60 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 175 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 56.42 28.06 12.93 55.01 27.92 14.50 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 45.02 22.04 15.38 46.16 24.00 13.76 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU B 195 GLU^? 52.10 ZN ZN B 402 A 60 ASP B 141 ASP.? 56.65 ZN ZN B 402 A 175 TYR B 220 TYR.? 54.58 ZN ZN B 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -77.28 109.06 51.77 -78.42 110.03 50.31 coo 56.42 28.06 12.93 55.01 27.92 14.50 -75.94 101.33 59.57 -77.56 101.84 58.29 coo 45.02 22.04 15.38 46.16 24.00 13.76 -84.07 105.41 48.45 -83.30 105.50 51.17 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU B 229 GLU^? 28.52 ZN ZN B 402 A 60 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 175 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -65.20 109.92 29.95 -64.70 111.14 28.31 coo 56.42 28.06 12.93 55.01 27.92 14.50 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 45.02 22.04 15.38 46.16 24.00 13.76 -60.00 104.47 33.20 -57.62 103.10 32.62 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 60 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 175 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 56.42 28.06 12.93 55.01 27.92 14.50 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 45.02 22.04 15.38 46.16 24.00 13.76 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 9 3 # 9 A 49 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 60 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 175 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 45.02 22.04 15.38 46.16 24.00 13.76 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 10 3 # 10 A 49 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 60 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 175 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 46.10 28.27 19.27 45.48 26.99 20.84 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 45.02 22.04 15.38 46.16 24.00 13.76 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 11 3 # 11 A 49 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 60 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 175 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 46.10 28.27 19.27 45.48 26.99 20.84 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 45.02 22.04 15.38 46.16 24.00 13.76 -34.63 93.02 10.28 -32.00 93.52 11.20 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 11 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 125 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 156 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 137 TYR^? 46.12 ZN ZN B 402 A 125 HIS B 218 HIS~? 47.61 ZN ZN B 402 A 156 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR B 220 TYR.? 54.58 ZN ZN B 402 A 125 HIS B 218 HIS~? 47.61 ZN ZN B 402 A 156 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -84.07 105.41 48.45 -83.30 105.50 51.17 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR B 220 TYR.? 54.58 ZN ZN B 402 A 125 HIS B 218 HIS~? 47.61 ZN ZN B 402 A 156 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -84.07 105.41 48.45 -83.30 105.50 51.17 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -70.80 108.71 48.92 -67.91 112.78 45.19 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 125 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 156 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 125 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 156 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR B 80 TYR~? 13.91 ZN ZN B 401 B 125 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 156 LYS B 76 LYS.? 26.34 ZN ZN B 401 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -55.68 83.88 -8.02 -56.83 88.29 -11.63 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 125 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 156 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 5 3 # 5 B 115 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 125 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 156 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -38.73 88.63 14.36 -36.14 88.00 9.08 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 5 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR B 137 TYR^? 46.12 ZN ZN B 402 C 125 HIS B 218 HIS~? 47.61 ZN ZN B 402 C 156 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 220 TYR.? 54.58 ZN ZN B 402 C 125 HIS B 218 HIS~? 47.61 ZN ZN B 402 C 156 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -84.07 105.41 48.45 -83.30 105.50 51.17 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR B 220 TYR.? 54.58 ZN ZN B 402 C 125 HIS B 218 HIS~? 47.61 ZN ZN B 402 C 156 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -84.07 105.41 48.45 -83.30 105.50 51.17 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -70.80 108.71 48.92 -67.91 112.78 45.19 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 3 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 327 TYR~? 10.33 ZN ZN A 402 D 125 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 156 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 54.10 1.42 85.16 54.14 4.17 85.62 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 61.27 5.43 85.32 62.73 6.38 86.49 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 60.28 4.62 76.00 58.35 6.41 80.65 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR A 327 TYR~? 10.33 ZN ZN A 402 D 125 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 156 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 54.10 1.42 85.16 54.14 4.17 85.62 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 61.27 5.43 85.32 62.73 6.38 86.49 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 60.28 4.62 76.00 58.35 6.41 80.65 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR B 137 TYR^? 46.12 ZN ZN B 402 D 125 HIS B 218 HIS~? 47.61 ZN ZN B 402 D 156 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 54.10 1.42 85.16 54.14 4.17 85.62 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 61.27 5.43 85.32 62.73 6.38 86.49 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 60.28 4.62 76.00 58.35 6.41 80.65 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR B 327 TYR~? 10.21 ZN ZN B 401 D 125 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 156 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 54.10 1.42 85.16 54.14 4.17 85.62 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 61.27 5.43 85.32 62.73 6.38 86.49 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 60.28 4.62 76.00 58.35 6.41 80.65 -41.26 92.47 -6.07 -36.28 89.98 -4.98 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 328 SER~? 11.01 ZN ZN A 402 A 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 257 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 9.47 41.64 34.15 9.10 39.28 33.93 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 2.03 38.95 28.44 3.60 38.60 29.83 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.85 37.62 29.99 7.50 38.47 31.78 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER B 328 SER~? 10.89 ZN ZN B 401 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 257 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 9.47 41.64 34.15 9.10 39.28 33.93 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 2.03 38.95 28.44 3.60 38.60 29.83 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.85 37.62 29.99 7.50 38.47 31.78 -40.92 100.43 6.30 -42.93 100.06 6.77 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 2 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 328 SER~? 11.01 ZN ZN A 402 B 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 257 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 28.35 71.07 3.94 30.08 69.46 4.49 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 32.76 68.02 0.70 31.21 68.44 2.05 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER B 328 SER~? 10.89 ZN ZN B 401 B 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 257 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 28.35 71.07 3.94 30.08 69.46 4.49 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 32.76 68.02 0.70 31.21 68.44 2.05 -40.92 100.43 6.30 -42.93 100.06 6.77 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 2 hits 1a7u_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 42 ALA^? 12.34 ZN ZN A 402 19 HIS A 64 HIS.? -3.42 ZN ZN A 401s 22 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 46.88 33.59 48.26 46.24 34.32 46.40 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 48.05 31.12 44.60 48.20 33.05 43.77 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 42 ALA^? 12.34 ZN ZN A 402 19 HIS A 65 HIS.? -3.39 ZN ZN A 402s 22 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 46.88 33.59 48.26 46.24 34.32 46.40 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 48.05 31.12 44.60 48.20 33.05 43.77 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA A 96 ALA^? 10.78 ZN ZN A 401 19 HIS A 64 HIS.? -3.42 ZN ZN A 401s 22 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 46.88 33.59 48.26 46.24 34.32 46.40 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 48.05 31.12 44.60 48.20 33.05 43.77 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA A 96 ALA^? 10.78 ZN ZN A 401 19 HIS A 64 HIS.? -3.42 ZN ZN A 401s 22 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 46.88 33.59 48.26 46.24 34.32 46.40 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 48.05 31.12 44.60 48.20 33.05 43.77 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 5 3 # 5 16 ALA A 96 ALA^? 10.78 ZN ZN A 401 19 HIS A 65 HIS.? -3.39 ZN ZN A 402s 22 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 46.88 33.59 48.26 46.24 34.32 46.40 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 48.05 31.12 44.60 48.20 33.05 43.77 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 6 3 # 6 16 ALA A 96 ALA^? 10.78 ZN ZN A 401 19 HIS A 65 HIS.? -3.39 ZN ZN A 402s 22 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 46.88 33.59 48.26 46.24 34.32 46.40 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 48.05 31.12 44.60 48.20 33.05 43.77 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 7 3 # 7 16 ALA A 96 ALA^? 10.78 ZN ZN A 401 19 HIS A 98 HIS~? 4.98 ZN ZN A 401 22 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 46.88 33.59 48.26 46.24 34.32 46.40 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 48.05 31.12 44.60 48.20 33.05 43.77 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 8 3 # 8 16 ALA A 96 ALA^? 10.78 ZN ZN A 401 19 HIS A 98 HIS~? 4.98 ZN ZN A 401 22 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 46.88 33.59 48.26 46.24 34.32 46.40 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 48.05 31.12 44.60 48.20 33.05 43.77 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 9 3 # 9 16 ALA A 311 ALA~? 12.40 ZN ZN B 401 19 HIS A 308 HIS~? 6.49 ZN ZN B 401 22 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 46.88 33.59 48.26 46.24 34.32 46.40 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 10 3 # 10 16 ALA A 311 ALA~? 12.40 ZN ZN B 401 19 HIS A 309 HIS~? 5.45 ZN ZN B 401 22 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 48.05 31.12 44.60 48.20 33.05 43.77 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 11 3 # 11 16 ALA B 42 ALA^? 12.31 ZN ZN B 401 19 HIS B 64 HIS.? -3.45 ZN ZN B 402s 22 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 46.88 33.59 48.26 46.24 34.32 46.40 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 12 3 # 12 16 ALA B 42 ALA^? 12.31 ZN ZN B 401 19 HIS B 65 HIS.? -3.43 ZN ZN B 401s 22 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 13 3 # 13 16 ALA B 96 ALA^? 10.72 ZN ZN B 402 19 HIS B 64 HIS.? -3.45 ZN ZN B 402s 22 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 46.88 33.59 48.26 46.24 34.32 46.40 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 14 3 # 14 16 ALA B 96 ALA^? 10.72 ZN ZN B 402 19 HIS B 64 HIS.? -3.45 ZN ZN B 402s 22 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 46.88 33.59 48.26 46.24 34.32 46.40 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 48.05 31.12 44.60 48.20 33.05 43.77 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 15 3 # 15 16 ALA B 96 ALA^? 10.72 ZN ZN B 402 19 HIS B 65 HIS.? -3.43 ZN ZN B 401s 22 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 16 3 # 16 16 ALA B 96 ALA^? 10.72 ZN ZN B 402 19 HIS B 65 HIS.? -3.43 ZN ZN B 401s 22 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 17 3 # 17 16 ALA B 96 ALA^? 10.72 ZN ZN B 402 19 HIS B 98 HIS~? 5.02 ZN ZN B 402 22 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 46.88 33.59 48.26 46.24 34.32 46.40 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 48.05 31.12 44.60 48.20 33.05 43.77 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 18 3 # 18 16 ALA B 96 ALA^? 10.72 ZN ZN B 402 19 HIS B 98 HIS~? 5.02 ZN ZN B 402 22 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 46.88 33.59 48.26 46.24 34.32 46.40 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 19 3 # 19 16 ALA B 311 ALA~? 12.53 ZN ZN A 402 19 HIS B 308 HIS~? 6.54 ZN ZN A 402 22 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 53.27 36.51 45.29 51.98 36.45 44.47 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 46.88 33.59 48.26 46.24 34.32 46.40 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 48.05 31.12 44.60 48.20 33.05 43.77 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 20 3 # 20 16 ALA B 311 ALA~? 12.53 ZN ZN A 402 19 HIS B 309 HIS~? 5.48 ZN ZN A 402 22 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 53.27 36.51 45.29 51.98 36.45 44.47 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 46.88 33.59 48.26 46.24 34.32 46.40 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 48.05 31.12 44.60 48.20 33.05 43.77 -35.94 115.60 -2.36 -34.88 117.34 -2.86 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 20 hits 1a8h_c02 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 63 SER^? 10.35 ZN ZN A 402 223 ASP A 44 ASP.? 7.09 ZN ZN A 402 252 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 40.95 0.07 3.20 39.54 1.39 4.66 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 41.54 1.64 9.09 40.82 1.05 7.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER A 328 SER~? 11.01 ZN ZN A 402 223 ASP A 305 ASP.? 7.62 ZN ZN A 402 252 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 40.95 0.07 3.20 39.54 1.39 4.66 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 41.54 1.64 9.09 40.82 1.05 7.19 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER B 328 SER~? 10.89 ZN ZN B 401 223 ASP B 305 ASP.? 7.64 ZN ZN B 401 252 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 40.95 0.07 3.20 39.54 1.39 4.66 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 41.54 1.64 9.09 40.82 1.05 7.19 -40.92 100.43 6.30 -42.93 100.06 6.77 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 3 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 328 SER~? 11.01 ZN ZN A 402 224 ASP A 305 ASP.? 7.62 ZN ZN A 402 253 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 16.00 80.13 58.60 16.16 82.12 59.96 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 8.47 84.84 62.27 10.52 84.40 62.08 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 13.14 83.03 63.68 14.37 82.62 62.02 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER B 328 SER~? 10.89 ZN ZN B 401 224 ASP B 305 ASP.? 7.64 ZN ZN B 401 253 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 16.00 80.13 58.60 16.16 82.12 59.96 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 8.47 84.84 62.27 10.52 84.40 62.08 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 13.14 83.03 63.68 14.37 82.62 62.02 -40.92 100.43 6.30 -42.93 100.06 6.77 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 2 hits 1a8s_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 262 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 262 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 262 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 262 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 5 3 # 5 A 223 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 6 3 # 6 A 223 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 7 3 # 7 A 223 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 8 3 # 8 A 223 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 9 3 # 9 A 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 10 3 # 10 A 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 11 3 # 11 A 223 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 262 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 38.54 36.60 66.38 37.88 34.77 67.15 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 12 3 # 12 A 223 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 262 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 13 3 # 13 A 223 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 262 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 38.54 36.60 66.38 37.88 34.77 67.15 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 14 3 # 14 A 223 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 262 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 15 3 # 15 A 223 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 16 3 # 16 A 223 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 17 3 # 17 A 223 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 18 3 # 18 A 223 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 30.62 37.23 61.07 30.08 35.73 62.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 19 3 # 19 A 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 20 3 # 20 A 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.95 4.66 -43.22 93.08 4.74 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 20 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 262 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 262 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 262 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 262 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 5 3 # 5 B 223 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 6 3 # 6 B 223 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 7 3 # 7 B 223 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 8 3 # 8 B 223 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 9 3 # 9 B 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 10 3 # 10 B 223 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 11 3 # 11 B 223 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 262 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 29.35 31.42 99.15 28.72 33.09 98.04 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 12 3 # 12 B 223 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 262 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 13 3 # 13 B 223 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 262 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 29.35 31.42 99.15 28.72 33.09 98.04 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 14 3 # 14 B 223 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 262 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 15 3 # 15 B 223 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 16 3 # 16 B 223 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 17 3 # 17 B 223 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 262 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 18 3 # 18 B 223 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 262 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 312 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.42 28.25 99.26 20.25 29.62 97.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 19 3 # 19 B 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 262 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 20 3 # 20 B 223 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 262 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 312 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.95 4.66 -43.22 93.08 4.74 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 20 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 64 HIS.? -3.42 ZN ZN A 401s 320 HIS A 326 HIS~? -3.60 ZN ZN A 402s 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 64 HIS.? -3.42 ZN ZN A 401s 320 HIS B 309 HIS~? 5.48 ZN ZN A 402 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS A 98 HIS~? 4.98 ZN ZN A 401 320 HIS A 326 HIS~? -3.60 ZN ZN A 402s 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS A 98 HIS~? 4.98 ZN ZN A 401 320 HIS B 309 HIS~? 5.48 ZN ZN A 402 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 5 3 # 5 274 HIS A 308 HIS~? 6.49 ZN ZN B 401 320 HIS B 64 HIS.? -3.45 ZN ZN B 402s 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 6 3 # 6 274 HIS A 308 HIS~? 6.49 ZN ZN B 401 320 HIS B 98 HIS~? 5.02 ZN ZN B 402 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 7 3 # 7 274 HIS A 309 HIS~? 5.45 ZN ZN B 401 320 HIS B 64 HIS.? -3.45 ZN ZN B 402s 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 8 3 # 8 274 HIS A 309 HIS~? 5.45 ZN ZN B 401 320 HIS B 98 HIS~? 5.02 ZN ZN B 402 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 9 3 # 9 274 HIS A 326 HIS~? -3.60 ZN ZN A 402s 320 HIS A 64 HIS.? -3.42 ZN ZN A 401s 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 10 3 # 10 274 HIS A 326 HIS~? -3.60 ZN ZN A 402s 320 HIS A 98 HIS~? 4.98 ZN ZN A 401 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 11 3 # 11 274 HIS B 64 HIS.? -3.45 ZN ZN B 402s 320 HIS A 309 HIS~? 5.45 ZN ZN B 401 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 12 3 # 12 274 HIS B 64 HIS.? -3.45 ZN ZN B 402s 320 HIS B 326 HIS~? -3.48 ZN ZN B 401s 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 13 3 # 13 274 HIS B 98 HIS~? 5.02 ZN ZN B 402 320 HIS A 309 HIS~? 5.45 ZN ZN B 401 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 14 3 # 14 274 HIS B 98 HIS~? 5.02 ZN ZN B 402 320 HIS B 326 HIS~? -3.48 ZN ZN B 401s 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 15 3 # 15 274 HIS B 308 HIS~? 6.54 ZN ZN A 402 320 HIS A 64 HIS.? -3.42 ZN ZN A 401s 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 16 3 # 16 274 HIS B 308 HIS~? 6.54 ZN ZN A 402 320 HIS A 98 HIS~? 4.98 ZN ZN A 401 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 17 3 # 17 274 HIS B 309 HIS~? 5.48 ZN ZN A 402 320 HIS A 64 HIS.? -3.42 ZN ZN A 401s 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 18 3 # 18 274 HIS B 309 HIS~? 5.48 ZN ZN A 402 320 HIS A 98 HIS~? 4.98 ZN ZN A 401 375 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1al6_c00 CITRATE SYNTHASE user 19 3 # 19 274 HIS B 326 HIS~? -3.48 ZN ZN B 401s 320 HIS B 64 HIS.? -3.45 ZN ZN B 402s 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1al6_c00 CITRATE SYNTHASE user 20 3 # 20 274 HIS B 326 HIS~? -3.48 ZN ZN B 401s 320 HIS B 98 HIS~? 5.02 ZN ZN B 402 375 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.95 4.66 -43.22 93.08 4.74 1al6_c00 source 1al6 CITRATE SYNTHASE : 20 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A -1 ASP.? 33.70 ZN ZN A 401 187 GLU A 347 GLU~? 25.70 ZN ZN A 401 229 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -34.82 134.94 -29.37 -35.77 133.46 -30.53 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 91 ASP.? 28.84 ZN ZN A 402 187 GLU A 35 GLU.? 32.19 ZN ZN A 401 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 203 ASP.? 24.56 ZN ZN A 401 187 GLU A 229 GLU^? 28.63 ZN ZN A 401 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP A 226 ASP^? 42.28 ZN ZN A 401 187 GLU A 211 GLU~? 36.90 ZN ZN A 401 229 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -67.20 130.35 -33.30 -67.69 130.05 -31.26 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP A 299 ASP.? 24.38 ZN ZN A 401 187 GLU A 243 GLU^? 24.16 ZN ZN A 401 229 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP B -1 ASP.? 32.96 ZN ZN B 402 187 GLU B 347 GLU~? 25.41 ZN ZN B 402 229 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -55.89 71.67 27.30 -54.45 72.03 28.78 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -50.18 80.14 30.04 -50.60 82.14 30.54 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP B 91 ASP.? 28.82 ZN ZN B 401 187 GLU B 35 GLU.? 31.39 ZN ZN B 402 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -52.36 70.88 17.88 -52.36 69.23 19.26 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP B 141 ASP.? 56.65 ZN ZN B 402 187 GLU B 162 GLU^? 46.76 ZN ZN B 402 229 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -75.94 101.33 59.57 -77.56 101.84 58.29 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -66.72 104.17 51.47 -67.64 102.80 52.82 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP B 148 ASP~? 45.03 ZN ZN B 402 187 GLU B 199 GLU^? 40.09 ZN ZN B 402 229 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -65.13 107.83 45.37 -64.79 109.92 45.13 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 10 3 # 10 33 ASP B 226 ASP^? 42.35 ZN ZN B 402 187 GLU B 211 GLU~? 39.18 ZN ZN B 402 229 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -75.90 102.21 34.20 -77.49 103.04 33.09 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 11 3 # 11 33 ASP B 299 ASP.? 24.19 ZN ZN B 402 187 GLU B 243 GLU^? 24.39 ZN ZN B 402 229 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -30.57 108.69 27.52 -30.74 110.20 29.01 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 12 3 # 12 33 ASP B 352 ASP.? 26.97 ZN ZN B 402 187 GLU B 35 GLU.? 31.39 ZN ZN B 402 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -52.36 70.88 17.88 -52.36 69.23 19.26 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -55.28 75.86 19.60 -60.60 72.43 20.00 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 12 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -33.57 107.34 6.30 -34.87 106.07 5.21 1am5_c04 source 1am5 PEPSIN : 2 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A -1 ASP.? 33.70 ZN ZN A 401 214 ASP A 44 ASP.? 7.09 ZN ZN A 402 289 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 26.86 59.76 46.36 25.42 58.23 45.92 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A -1 ASP.? 33.70 ZN ZN A 401 214 ASP A 102 ASP~? -1.98 ZN ZN A 401s 289 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 26.86 59.76 46.36 25.42 58.23 45.92 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A -1 ASP.? 33.70 ZN ZN A 401 214 ASP A 129 ASP^? 19.65 ZN ZN A 401 289 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 23 ASP.? 8.14 ZN ZN A 401 214 ASP A 256 ASP~? 22.47 ZN ZN A 401 289 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 33 ASP.? 31.33 ZN ZN A 401 214 ASP A 129 ASP^? 19.65 ZN ZN A 401 289 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 33 ASP.? 31.33 ZN ZN A 401 214 ASP B 313 ASP~? 12.28 ZN ZN A 402 289 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 44 ASP.? 7.09 ZN ZN A 402 214 ASP A 252 ASP~? 28.57 ZN ZN A 401 289 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 44 ASP.? 7.09 ZN ZN A 402 214 ASP B 102 ASP~? -1.99 ZN ZN B 402s 289 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 245 ASP^? 25.73 ZN ZN A 401 214 ASP A 44 ASP.? 7.09 ZN ZN A 402 289 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 245 ASP^? 25.73 ZN ZN A 401 214 ASP A 313 ASP~? 12.18 ZN ZN B 401 289 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP A 245 ASP^? 25.73 ZN ZN A 401 214 ASP B 305 ASP.? 7.64 ZN ZN B 401 289 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP A 310 ASP~? 12.24 ZN ZN B 401 214 ASP B 252 ASP~? 28.52 ZN ZN B 402 289 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP A 310 ASP~? 12.24 ZN ZN B 401 214 ASP B 252 ASP~? 28.52 ZN ZN B 402 289 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP A 310 ASP~? 12.24 ZN ZN B 401 214 ASP B 252 ASP~? 28.52 ZN ZN B 402 289 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP A 313 ASP~? 12.18 ZN ZN B 401 214 ASP B 5 ASP~? 27.35 ZN ZN B 402 289 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP A 313 ASP~? 12.18 ZN ZN B 401 214 ASP B 33 ASP.? 29.43 ZN ZN B 402 289 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP A 313 ASP~? 12.18 ZN ZN B 401 214 ASP B 256 ASP~? 22.51 ZN ZN B 402 289 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP A 361 ASP.? 11.77 ZN ZN A 402 214 ASP A 5 ASP~? 27.21 ZN ZN A 401 289 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP B 23 ASP.? 8.15 ZN ZN B 402 214 ASP B 245 ASP^? 25.30 ZN ZN B 402 289 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP B 23 ASP.? 8.15 ZN ZN B 402 214 ASP B 256 ASP~? 22.51 ZN ZN B 402 289 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP B 33 ASP.? 29.43 ZN ZN B 402 214 ASP A 313 ASP~? 12.18 ZN ZN B 401 289 ASP B 91 ASP.? 28.82 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -53.83 73.30 7.14 -55.54 72.50 6.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP B 33 ASP.? 29.43 ZN ZN B 402 214 ASP B 129 ASP^? 19.14 ZN ZN B 402 289 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 26.86 59.76 46.36 25.42 58.23 45.92 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP B 44 ASP.? 7.11 ZN ZN B 401 214 ASP A 102 ASP~? -1.98 ZN ZN A 401s 289 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.86 59.76 46.36 25.42 58.23 45.92 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP B 44 ASP.? 7.11 ZN ZN B 401 214 ASP B 252 ASP~? 28.52 ZN ZN B 402 289 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP B 245 ASP^? 25.30 ZN ZN B 402 214 ASP A 305 ASP.? 7.62 ZN ZN A 402 289 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP B 245 ASP^? 25.30 ZN ZN B 402 214 ASP A 305 ASP.? 7.62 ZN ZN A 402 289 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP B 245 ASP^? 25.30 ZN ZN B 402 214 ASP A 323 ASP^? 12.30 ZN ZN A 402 289 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP B 245 ASP^? 25.30 ZN ZN B 402 214 ASP A 323 ASP^? 12.30 ZN ZN A 402 289 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP B 245 ASP^? 25.30 ZN ZN B 402 214 ASP B 44 ASP.? 7.11 ZN ZN B 401 289 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP B 305 ASP.? 7.64 ZN ZN B 401 214 ASP A 245 ASP^? 25.73 ZN ZN A 401 289 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP B 310 ASP~? 12.35 ZN ZN A 402 214 ASP A 252 ASP~? 28.57 ZN ZN A 401 289 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP B 310 ASP~? 12.35 ZN ZN A 402 214 ASP A 252 ASP~? 28.57 ZN ZN A 401 289 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 33 3 # 33 179 ASP B 310 ASP~? 12.35 ZN ZN A 402 214 ASP A 252 ASP~? 28.57 ZN ZN A 401 289 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 34 3 # 34 179 ASP B 313 ASP~? 12.28 ZN ZN A 402 214 ASP A 5 ASP~? 27.21 ZN ZN A 401 289 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 35 3 # 35 179 ASP B 313 ASP~? 12.28 ZN ZN A 402 214 ASP A 33 ASP.? 31.33 ZN ZN A 401 289 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 26.86 59.76 46.36 25.42 58.23 45.92 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 36 3 # 36 179 ASP B 313 ASP~? 12.28 ZN ZN A 402 214 ASP A 256 ASP~? 22.47 ZN ZN A 401 289 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 37 3 # 37 179 ASP B 361 ASP.? 11.71 ZN ZN B 401 214 ASP B 5 ASP~? 27.35 ZN ZN B 402 289 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.95 4.66 -43.22 93.08 4.74 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 37 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 23 ASP.? 8.14 ZN ZN A 401 204 GLU A 20 GLU.? 10.86 ZN ZN A 401 289 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 4.34 62.44 32.05 4.22 64.48 32.53 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 33 ASP.? 31.33 ZN ZN A 401 204 GLU A 32 GLU.? 25.81 ZN ZN A 401 289 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 4.34 62.44 32.05 4.22 64.48 32.53 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 33 ASP.? 31.33 ZN ZN A 401 204 GLU A 35 GLU.? 32.19 ZN ZN A 401 289 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 4.34 62.44 32.05 4.22 64.48 32.53 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 23 ASP.? 8.15 ZN ZN B 402 204 GLU B 20 GLU.? 11.09 ZN ZN B 402 289 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 4.34 62.44 32.05 4.22 64.48 32.53 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.20 100.05 15.92 -45.42 99.37 14.07 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 44 ASP.? 7.09 ZN ZN A 402 227 GLU B 271 GLU.? 25.84 ZN ZN A 402 289 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 44 ASP.? 7.09 ZN ZN A 402 227 GLU B 290 GLU~? 16.07 ZN ZN B 401 289 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 3.96 55.76 41.24 4.83 57.69 41.17 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 203 ASP.? 24.56 ZN ZN A 401 227 GLU A 199 GLU.? 39.53 ZN ZN A 401 289 ASP A 129 ASP^? 19.65 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -61.23 119.64 -44.31 -61.84 117.61 -44.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.93 118.26 -28.24 -51.00 118.44 -27.37 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 310 ASP~? 12.24 ZN ZN B 401 227 GLU A 271 GLU.? 22.11 ZN ZN B 401 289 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 310 ASP~? 12.24 ZN ZN B 401 227 GLU A 329 GLU~? 2.55 ZN ZN A 401s 289 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 3.96 55.76 41.24 4.83 57.69 41.17 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 310 ASP~? 12.24 ZN ZN B 401 227 GLU B 329 GLU~? 2.54 ZN ZN B 402s 289 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 310 ASP~? 12.24 ZN ZN B 401 227 GLU B 329 GLU~? 2.54 ZN ZN B 402s 289 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 313 ASP~? 12.18 ZN ZN B 401 227 GLU A 271 GLU.? 22.11 ZN ZN B 401 289 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 323 ASP^? 12.30 ZN ZN A 402 227 GLU A 271 GLU.? 22.11 ZN ZN B 401 289 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 361 ASP.? 11.77 ZN ZN A 402 227 GLU B 271 GLU.? 25.84 ZN ZN A 402 289 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP A 361 ASP.? 11.77 ZN ZN A 402 227 GLU B 290 GLU~? 16.07 ZN ZN B 401 289 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 44 ASP.? 7.11 ZN ZN B 401 227 GLU A 271 GLU.? 22.11 ZN ZN B 401 289 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP B 44 ASP.? 7.11 ZN ZN B 401 227 GLU A 290 GLU~? 16.18 ZN ZN A 402 289 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP B 310 ASP~? 12.35 ZN ZN A 402 227 GLU A 329 GLU~? 2.55 ZN ZN A 401s 289 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP B 310 ASP~? 12.35 ZN ZN A 402 227 GLU A 329 GLU~? 2.55 ZN ZN A 401s 289 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP B 310 ASP~? 12.35 ZN ZN A 402 227 GLU B 271 GLU.? 25.84 ZN ZN A 402 289 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP B 310 ASP~? 12.35 ZN ZN A 402 227 GLU B 329 GLU~? 2.54 ZN ZN B 402s 289 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP B 313 ASP~? 12.28 ZN ZN A 402 227 GLU B 271 GLU.? 25.84 ZN ZN A 402 289 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP B 323 ASP^? 12.28 ZN ZN B 401 227 GLU B 271 GLU.? 25.84 ZN ZN A 402 289 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP B 361 ASP.? 11.71 ZN ZN B 401 227 GLU A 290 GLU~? 16.18 ZN ZN A 402 289 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.95 4.66 -43.22 93.08 4.74 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 20 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 36 SER A 285 SER.? 7.68 ZN ZN A 402 E 213 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 26.30 12.96 16.78 25.46 12.99 18.72 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 28.33 15.15 21.27 28.70 13.12 19.97 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 20.15 16.04 19.79 21.65 14.49 19.86 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP B 305 ASP.? 7.64 ZN ZN B 401 E 36 SER B 285 SER.? 7.72 ZN ZN B 401 E 213 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 26.30 12.96 16.78 25.46 12.99 18.72 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 28.33 15.15 21.27 28.70 13.12 19.97 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 20.15 16.04 19.79 21.65 14.49 19.86 -33.57 107.34 6.30 -34.87 106.07 5.21 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 2 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 326 HIS~? -3.60 ZN ZN A 402s 254 LYS B 307 LYS~? 11.14 ZN ZN A 402 333 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 26.09 4.87 14.60 27.89 3.33 10.26 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 37.35 7.47 11.84 34.90 6.11 10.60 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 326 HIS~? -3.48 ZN ZN B 401s 254 LYS A 307 LYS~? 10.65 ZN ZN B 401 333 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 26.09 4.87 14.60 27.89 3.33 10.26 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 37.35 7.47 11.84 34.90 6.11 10.60 -31.38 108.30 2.45 -33.79 107.47 0.72 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 2 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 21 SER.? 15.75 ZN ZN A 401 A 292 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 322 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 36.34 32.23 39.60 36.43 34.62 39.93 -53.09 121.68 -12.53 -54.91 120.14 -12.04 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 41.69 45.14 46.60 41.78 47.19 46.18 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 63 SER^? 10.35 ZN ZN A 402 A 292 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 322 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 41.69 45.14 46.60 41.78 47.19 46.18 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 63 SER^? 10.35 ZN ZN A 402 A 292 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 322 HIS A 13 HIS~? 19.28 ZN ZN A 401 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 41.69 45.14 46.60 41.78 47.19 46.18 -37.83 126.93 -26.50 -37.00 127.82 -28.21 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 356 SER.? 15.95 ZN ZN A 402 A 292 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 322 HIS A 90 HIS~? 26.77 ZN ZN A 402 coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.62 125.96 -9.58 -26.36 125.95 -7.28 coo 19.73 19.18 41.39 21.50 18.65 40.34 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 41.69 45.14 46.60 41.78 47.19 46.18 -30.00 140.26 -1.63 -28.87 140.48 0.12 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 63 SER^? 10.37 ZN ZN B 401 A 292 ASP B 33 ASP.? 29.43 ZN ZN B 402 A 322 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 19.73 19.18 41.39 21.50 18.65 40.34 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 41.69 45.14 46.60 41.78 47.19 46.18 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 208 SER~? 33.04 ZN ZN B 402 A 292 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 322 HIS B 218 HIS~? 47.61 ZN ZN B 402 coo 36.34 32.23 39.60 36.43 34.62 39.93 -73.42 98.79 31.27 -72.28 96.96 30.17 coo 19.73 19.18 41.39 21.50 18.65 40.34 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 41.69 45.14 46.60 41.78 47.19 46.18 -78.43 101.94 45.47 -77.59 103.59 46.47 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 356 SER.? 15.96 ZN ZN B 401 A 292 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 322 HIS B 90 HIS~? 26.84 ZN ZN B 401 coo 36.34 32.23 39.60 36.43 34.62 39.93 -37.69 83.51 10.20 -38.30 83.95 7.88 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 41.69 45.14 46.60 41.78 47.19 46.18 -49.12 73.85 2.19 -48.21 73.06 0.48 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 7 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 63 SER^? 10.35 ZN ZN A 402 B 292 ASP A 33 ASP.? 31.33 ZN ZN A 401 B 322 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 48.81 64.16 26.34 49.30 62.16 26.73 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 63 SER^? 10.37 ZN ZN B 401 B 292 ASP B 33 ASP.? 29.43 ZN ZN B 402 B 322 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 24.74 78.07 5.59 24.32 79.03 7.46 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 48.81 64.16 26.34 49.30 62.16 26.73 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 208 SER~? 33.04 ZN ZN B 402 B 292 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 322 HIS B 218 HIS~? 47.61 ZN ZN B 402 coo 35.42 71.28 22.94 36.24 69.06 22.37 -73.42 98.79 31.27 -72.28 96.96 30.17 coo 24.74 78.07 5.59 24.32 79.03 7.46 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 48.81 64.16 26.34 49.30 62.16 26.73 -78.43 101.94 45.47 -77.59 103.59 46.47 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 265 SER.? 18.70 ZN ZN B 401 B 292 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 322 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 35.42 71.28 22.94 36.24 69.06 22.37 -26.94 101.98 3.65 -27.40 103.69 1.94 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 48.81 64.16 26.34 49.30 62.16 26.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 4 hits 1aql_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 35 SER A 285 SER.? 7.68 ZN ZN A 402 A 217 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 35 SER A 285 SER.? 7.68 ZN ZN A 402 A 217 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 35 SER B 285 SER.? 7.72 ZN ZN B 401 A 217 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 35 SER B 285 SER.? 7.72 ZN ZN B 401 A 217 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -33.57 107.34 6.30 -34.87 106.07 5.21 1avf_c04 source 1avf GASTRICSIN : 4 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 J 35 SER A 285 SER.? 7.68 ZN ZN A 402 J 217 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 J 35 SER A 285 SER.? 7.68 ZN ZN A 402 J 217 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 J 35 SER B 285 SER.? 7.72 ZN ZN B 401 J 217 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -33.57 107.34 6.30 -34.87 106.07 5.21 1avf_c05 source 1avf GASTRICSIN : 3 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 265 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 19.99 54.53 64.11 20.55 58.78 68.33 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 223 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 223 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 265 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 19.99 54.53 64.11 20.55 58.78 68.33 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 223 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 265 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 19.99 54.53 64.11 20.55 58.78 68.33 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 265 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 19.99 54.53 64.11 20.55 58.78 68.33 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 223 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.71 103.60 27.70 -26.87 107.57 30.82 1ax4_c04 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 B 265 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 5.43 58.06 80.08 8.57 53.00 79.37 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 B 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 223 ASP A 299 ASP.? 24.38 ZN ZN A 401 B 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 223 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 265 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 5.43 58.06 80.08 8.57 53.00 79.37 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 223 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 265 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 5.43 58.06 80.08 8.57 53.00 79.37 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 B 265 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 5.43 58.06 80.08 8.57 53.00 79.37 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 B 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 223 ASP B 299 ASP.? 24.19 ZN ZN B 402 B 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.71 103.60 27.70 -26.87 107.57 30.82 1ax4_c05 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 C 265 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 C 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 223 ASP A 299 ASP.? 24.38 ZN ZN A 401 C 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 223 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 265 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 223 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 265 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 C 265 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 C 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 223 ASP B 299 ASP.? 24.19 ZN ZN B 402 C 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.71 103.60 27.70 -26.87 107.57 30.82 1ax4_c06 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 D 265 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 223 ASP A 256 ASP~? 22.47 ZN ZN A 401 D 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 223 ASP A 299 ASP.? 24.38 ZN ZN A 401 D 265 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 223 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 265 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 223 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 265 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 D 265 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 223 ASP B 256 ASP~? 22.51 ZN ZN B 402 D 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 223 ASP B 299 ASP.? 24.19 ZN ZN B 402 D 265 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.71 103.60 27.70 -26.87 107.57 30.82 1ax4_c07 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 328 SER~? 11.01 ZN ZN A 402 A 266 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 294 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 32.07 25.76 77.83 34.46 26.05 77.46 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 33.07 35.01 79.81 33.39 33.02 79.13 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 35.53 30.26 79.89 34.62 28.71 78.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER B 328 SER~? 10.89 ZN ZN B 401 A 266 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 294 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 32.07 25.76 77.83 34.46 26.05 77.46 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 33.07 35.01 79.81 33.39 33.02 79.13 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 35.53 30.26 79.89 34.62 28.71 78.80 -40.92 100.43 6.30 -42.93 100.06 6.77 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 2 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 328 SER~? 11.01 ZN ZN A 402 B 266 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 294 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 51.18 33.22 36.61 49.29 31.79 37.02 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 44.19 39.32 34.54 45.21 37.66 35.38 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 45.79 34.26 34.63 47.54 33.80 35.70 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER B 328 SER~? 10.89 ZN ZN B 401 B 266 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 294 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 51.18 33.22 36.61 49.29 31.79 37.02 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 44.19 39.32 34.54 45.21 37.66 35.38 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 45.79 34.26 34.63 47.54 33.80 35.70 -40.92 100.43 6.30 -42.93 100.06 6.77 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 2 hits 1azw_c01 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 171 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 190 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 22.59 2.26 43.22 21.17 3.47 42.27 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 13.63 3.81 28.83 14.49 2.91 31.59 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 24.97 7.47 37.69 21.24 10.69 35.89 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 171 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 190 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 22.59 2.26 43.22 21.17 3.47 42.27 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 13.63 3.81 28.83 14.49 2.91 31.59 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 24.97 7.47 37.69 21.24 10.69 35.89 -33.07 120.28 7.09 -27.74 119.98 5.88 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 2 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 171 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 190 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 2.83 4.83 10.84 1.96 4.32 7.97 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 171 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 190 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 2.83 4.83 10.84 1.96 4.32 7.97 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -33.07 120.28 7.09 -27.74 119.98 5.88 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 2 hits 1azy_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 182 GLU A 35 GLU.? 32.19 ZN ZN A 401 A 286 ASN A 93 ASN^? 23.13 ZN ZN A 401 coo 26.03 44.66 108.90 25.67 42.61 108.82 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 18.06 44.02 105.38 18.08 45.37 107.03 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 25.47 38.28 112.06 27.26 39.30 111.54 -36.46 137.39 -10.90 -36.25 139.51 -10.83 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 182 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 286 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 26.03 44.66 108.90 25.67 42.61 108.82 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 18.06 44.02 105.38 18.08 45.37 107.03 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 25.47 38.28 112.06 27.26 39.30 111.54 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 182 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 286 ASN A 109 ASN~? 6.71 ZN ZN A 401 coo 26.03 44.66 108.90 25.67 42.61 108.82 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 18.06 44.02 105.38 18.08 45.37 107.03 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 25.47 38.28 112.06 27.26 39.30 111.54 -37.82 111.74 -18.14 -38.65 111.91 -16.17 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 182 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 286 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 26.03 44.66 108.90 25.67 42.61 108.82 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 18.06 44.02 105.38 18.08 45.37 107.03 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 25.47 38.28 112.06 27.26 39.30 111.54 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 182 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 286 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 26.03 44.66 108.90 25.67 42.61 108.82 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 18.06 44.02 105.38 18.08 45.37 107.03 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.36 96.74 22.46 -46.71 95.57 24.21 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 182 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 286 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 26.03 44.66 108.90 25.67 42.61 108.82 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 18.06 44.02 105.38 18.08 45.37 107.03 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.36 96.74 22.46 -46.71 95.57 24.21 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 6 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 31 ASP.? 28.20 ZN ZN A 401 B 182 GLU A 35 GLU.? 32.19 ZN ZN A 401 B 286 ASN A 93 ASN^? 23.13 ZN ZN A 401 coo 13.82 69.26 132.27 11.87 70.14 132.51 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 8.74 63.05 136.42 9.87 62.19 134.79 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 8.26 72.60 129.22 10.14 73.45 129.80 -36.46 137.39 -10.90 -36.25 139.51 -10.83 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 182 GLU A 20 GLU.? 10.86 ZN ZN A 401 B 286 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 13.82 69.26 132.27 11.87 70.14 132.51 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 8.74 63.05 136.42 9.87 62.19 134.79 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 8.26 72.60 129.22 10.14 73.45 129.80 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 182 GLU A 20 GLU.? 10.86 ZN ZN A 401 B 286 ASN A 109 ASN~? 6.71 ZN ZN A 401 coo 13.82 69.26 132.27 11.87 70.14 132.51 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 8.74 63.05 136.42 9.87 62.19 134.79 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 8.26 72.60 129.22 10.14 73.45 129.80 -37.82 111.74 -18.14 -38.65 111.91 -16.17 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 182 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 286 ASN A 100 ASN~? 9.95 ZN ZN A 401 coo 13.82 69.26 132.27 11.87 70.14 132.51 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 8.26 72.60 129.22 10.14 73.45 129.80 -44.05 122.82 -17.82 -42.95 124.35 -16.78 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 182 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 286 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 13.82 69.26 132.27 11.87 70.14 132.51 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 8.26 72.60 129.22 10.14 73.45 129.80 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 182 GLU B 20 GLU.? 11.09 ZN ZN B 402 B 286 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 13.82 69.26 132.27 11.87 70.14 132.51 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 8.74 63.05 136.42 9.87 62.19 134.79 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 8.26 72.60 129.22 10.14 73.45 129.80 -46.36 96.74 22.46 -46.71 95.57 24.21 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 B 109 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 182 GLU B 20 GLU.? 11.09 ZN ZN B 402 B 286 ASN B 109 ASN~? 6.75 ZN ZN B 402 coo 13.82 69.26 132.27 11.87 70.14 132.51 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 8.74 63.05 136.42 9.87 62.19 134.79 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 8.26 72.60 129.22 10.14 73.45 129.80 -40.37 101.87 19.09 -41.17 102.25 17.16 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 B 109 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 182 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 286 ASN B 100 ASN~? 9.88 ZN ZN B 402 coo 13.82 69.26 132.27 11.87 70.14 132.51 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 8.74 63.05 136.42 9.87 62.19 134.79 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 8.26 72.60 129.22 10.14 73.45 129.80 -51.48 95.86 18.73 -51.39 94.02 17.58 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 B 109 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 182 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 286 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 13.82 69.26 132.27 11.87 70.14 132.51 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 8.74 63.05 136.42 9.87 62.19 134.79 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 8.26 72.60 129.22 10.14 73.45 129.80 -46.36 96.74 22.46 -46.71 95.57 24.21 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 9 hits 1b57_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 52 GLU~? 18.80 ZN ZN A 402 B 88 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 89 HIS B 12 HIS~? 21.73 ZN ZN B 402 coo 44.53 38.98 5.35 43.53 40.60 6.22 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 60.89 12.20 60.42 60.43 13.81 61.68 -52.58 88.71 29.10 -52.20 89.31 31.07 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 52 GLU~? 18.78 ZN ZN B 401 B 88 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 89 HIS A 12 HIS~? 21.70 ZN ZN A 401 coo 44.53 38.98 5.35 43.53 40.60 6.22 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 58.74 13.49 55.78 58.72 14.38 57.67 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 -41.32 129.27 -28.34 -41.29 128.49 -30.29 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU B 162 GLU^? 46.76 ZN ZN B 402 B 88 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 89 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo 44.53 38.98 5.35 43.53 40.60 6.22 -66.72 104.17 51.47 -67.64 102.80 52.82 coo 58.74 13.49 55.78 58.72 14.38 57.67 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU B 167 GLU^? 53.31 ZN ZN B 402 B 88 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 89 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 44.53 38.98 5.35 43.53 40.60 6.22 -79.62 113.37 49.20 -81.22 112.07 48.69 coo 58.74 13.49 55.78 58.72 14.38 57.67 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 60.89 12.20 60.42 60.43 13.81 61.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 4 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 52 GLU~? 18.80 ZN ZN A 402 B 88 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 89 HIS B 12 HIS~? 21.73 ZN ZN B 402 coo 44.53 38.98 5.35 43.53 40.60 6.22 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 60.89 12.20 60.42 60.43 13.81 61.68 -52.58 88.71 29.10 -52.20 89.31 31.07 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 52 GLU~? 18.78 ZN ZN B 401 B 88 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 89 HIS A 12 HIS~? 21.70 ZN ZN A 401 coo 44.53 38.98 5.35 43.53 40.60 6.22 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 58.74 13.49 55.78 58.72 14.38 57.67 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 60.89 12.20 60.42 60.43 13.81 61.68 -41.32 129.27 -28.34 -41.29 128.49 -30.29 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU B 162 GLU^? 46.76 ZN ZN B 402 B 88 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 89 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo 44.53 38.98 5.35 43.53 40.60 6.22 -66.72 104.17 51.47 -67.64 102.80 52.82 coo 58.74 13.49 55.78 58.72 14.38 57.67 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU B 167 GLU^? 53.31 ZN ZN B 402 B 88 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 89 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 44.53 38.98 5.35 43.53 40.60 6.22 -79.62 113.37 49.20 -81.22 112.07 48.69 coo 58.74 13.49 55.78 58.72 14.38 57.67 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 60.89 12.20 60.42 60.43 13.81 61.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 4 hits 1b66_c02 naa= 3 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 1 3 # 1 124 ASP A 23 ASP.? 8.14 ZN ZN A 401 260 ASP A 102 ASP~? -1.98 ZN ZN A 401s 289 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 30.43 27.27 28.31 29.04 28.69 29.00 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 34.79 33.03 22.11 33.47 32.83 23.76 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 30.83 30.57 23.91 30.62 30.06 25.92 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 2 3 # 2 124 ASP A 102 ASP~? -1.98 ZN ZN A 401s 260 ASP A 23 ASP.? 8.14 ZN ZN A 401 289 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 30.43 27.27 28.31 29.04 28.69 29.00 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 34.79 33.03 22.11 33.47 32.83 23.76 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 30.83 30.57 23.91 30.62 30.06 25.92 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 3 3 # 3 124 ASP B 23 ASP.? 8.15 ZN ZN B 402 260 ASP B 102 ASP~? -1.99 ZN ZN B 402s 289 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 30.43 27.27 28.31 29.04 28.69 29.00 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 34.79 33.03 22.11 33.47 32.83 23.76 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 30.83 30.57 23.91 30.62 30.06 25.92 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 4 3 # 4 124 ASP B 102 ASP~? -1.99 ZN ZN B 402s 260 ASP B 23 ASP.? 8.15 ZN ZN B 402 289 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 30.43 27.27 28.31 29.04 28.69 29.00 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 34.79 33.03 22.11 33.47 32.83 23.76 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 30.83 30.57 23.91 30.62 30.06 25.92 -49.25 96.40 11.26 -48.45 97.80 9.92 1b6g_c00 source 1b6g HALOALKANE DEHALOGENASE : 4 hits 1b6g_c00 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 2.97 11.64 107.87 6.59 15.13 107.03 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 230 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 273 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 1.45 22.80 104.16 2.58 21.02 104.01 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 2.97 11.64 107.87 6.59 15.13 107.03 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 273 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 2.97 11.64 107.87 6.59 15.13 107.03 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 2.97 11.64 107.87 6.59 15.13 107.03 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 2.97 11.64 107.87 6.59 15.13 107.03 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 230 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 1.45 22.80 104.16 2.58 21.02 104.01 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 2.97 11.64 107.87 6.59 15.13 107.03 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 230 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 273 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 9.23 21.44 106.88 10.18 19.34 105.31 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 2.97 11.64 107.87 6.59 15.13 107.03 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 230 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 273 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 9.23 21.44 106.88 10.18 19.34 105.31 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 1.45 22.80 104.16 2.58 21.02 104.01 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 2.97 11.64 107.87 6.59 15.13 107.03 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR B 137 TYR^? 46.12 ZN ZN B 402 A 230 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 273 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 2.97 11.64 107.87 6.59 15.13 107.03 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 A 145 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 230 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.23 21.44 106.88 10.18 19.34 105.31 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 1.45 22.80 104.16 2.58 21.02 104.01 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 2.97 11.64 107.87 6.59 15.13 107.03 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 A 145 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 230 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 273 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 9.23 21.44 106.88 10.18 19.34 105.31 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 1.45 22.80 104.16 2.58 21.02 104.01 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 2.97 11.64 107.87 6.59 15.13 107.03 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 A 145 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 230 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 273 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 9.23 21.44 106.88 10.18 19.34 105.31 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 1.45 22.80 104.16 2.58 21.02 104.01 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 2.97 11.64 107.87 6.59 15.13 107.03 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 A 145 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 230 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 273 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 9.23 21.44 106.88 10.18 19.34 105.31 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 2.97 11.64 107.87 6.59 15.13 107.03 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 A 145 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 230 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.23 21.44 106.88 10.18 19.34 105.31 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 2.97 11.64 107.87 6.59 15.13 107.03 -40.89 103.09 -0.15 -45.35 106.49 1.62 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 14 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 80 TYR~? 13.91 ZN ZN A 402 B 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.10 2.31 76.60 10.24 7.24 75.62 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 80 TYR~? 13.91 ZN ZN A 402 B 230 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 273 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 19.17 11.01 76.14 17.26 10.42 76.77 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 11.10 2.31 76.60 10.24 7.24 75.62 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 273 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.10 2.31 76.60 10.24 7.24 75.62 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.10 2.31 76.60 10.24 7.24 75.62 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 230 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.10 2.31 76.60 10.24 7.24 75.62 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 230 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 19.17 11.01 76.14 17.26 10.42 76.77 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 11.10 2.31 76.60 10.24 7.24 75.62 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 230 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 273 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 11.81 13.41 73.03 10.00 13.03 75.12 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 11.10 2.31 76.60 10.24 7.24 75.62 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR B 80 TYR~? 13.91 ZN ZN B 401 B 230 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 273 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 11.81 13.41 73.03 10.00 13.03 75.12 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 19.17 11.01 76.14 17.26 10.42 76.77 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 11.10 2.31 76.60 10.24 7.24 75.62 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR B 137 TYR^? 46.12 ZN ZN B 402 B 230 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 273 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 11.10 2.31 76.60 10.24 7.24 75.62 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 B 145 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 230 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 11.81 13.41 73.03 10.00 13.03 75.12 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 19.17 11.01 76.14 17.26 10.42 76.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.10 2.31 76.60 10.24 7.24 75.62 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 B 145 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 230 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 273 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 11.81 13.41 73.03 10.00 13.03 75.12 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 19.17 11.01 76.14 17.26 10.42 76.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.10 2.31 76.60 10.24 7.24 75.62 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 B 145 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 230 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 273 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 11.81 13.41 73.03 10.00 13.03 75.12 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 19.17 11.01 76.14 17.26 10.42 76.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.10 2.31 76.60 10.24 7.24 75.62 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 B 145 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 230 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 273 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 11.81 13.41 73.03 10.00 13.03 75.12 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 11.10 2.31 76.60 10.24 7.24 75.62 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 B 145 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 230 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 11.81 13.41 73.03 10.00 13.03 75.12 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 11.10 2.31 76.60 10.24 7.24 75.62 -40.89 103.09 -0.15 -45.35 106.49 1.62 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 14 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 200 PHE^? 37.51 ZN ZN A 401 A 159 ASP A 226 ASP^? 42.28 ZN ZN A 401 A 188 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -59.41 125.80 -41.67 -61.08 127.73 -40.51 coo 20.97 28.40 16.26 20.19 30.15 15.34 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 22.55 41.65 15.60 18.92 37.20 14.63 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 159 ASP A 245 ASP^? 25.73 ZN ZN A 401 A 188 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 22.55 41.65 15.60 18.92 37.20 14.63 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 159 ASP A 245 ASP^? 25.73 ZN ZN A 401 A 188 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 22.55 41.65 15.60 18.92 37.20 14.63 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 159 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 188 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 22.55 41.65 15.60 18.92 37.20 14.63 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 159 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 188 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 22.55 41.65 15.60 18.92 37.20 14.63 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 159 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 188 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 22.55 41.65 15.60 18.92 37.20 14.63 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 159 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 188 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 20.97 28.40 16.26 20.19 30.15 15.34 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 22.55 41.65 15.60 18.92 37.20 14.63 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 159 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 188 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 20.97 28.40 16.26 20.19 30.15 15.34 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 22.55 41.65 15.60 18.92 37.20 14.63 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE A 344 PHE~? 21.75 ZN ZN A 401 A 159 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 188 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -30.23 132.91 -23.69 -31.48 133.59 -21.26 coo 20.97 28.40 16.26 20.19 30.15 15.34 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 22.55 41.65 15.60 18.92 37.20 14.63 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE A 363 PHE.? 13.25 ZN ZN A 402 A 159 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 188 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 22.55 41.65 15.60 18.92 37.20 14.63 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 146 PHE~? 50.49 ZN ZN B 402 A 159 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 188 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 20.97 28.40 16.26 20.19 30.15 15.34 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 22.55 41.65 15.60 18.92 37.20 14.63 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 159 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 188 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 20.97 28.40 16.26 20.19 30.15 15.34 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 22.55 41.65 15.60 18.92 37.20 14.63 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 159 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 188 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 20.97 28.40 16.26 20.19 30.15 15.34 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 22.55 41.65 15.60 18.92 37.20 14.63 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 159 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 188 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 159 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 188 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 159 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 188 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 159 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 188 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 22.55 41.65 15.60 18.92 37.20 14.63 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 18 3 # 18 A 88 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 159 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 188 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 20.97 28.40 16.26 20.19 30.15 15.34 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 19 3 # 19 A 88 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 159 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 188 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 20.97 28.40 16.26 20.19 30.15 15.34 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 20 3 # 20 A 88 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 159 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 188 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 20.97 28.40 16.26 20.19 30.15 15.34 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 21 3 # 21 A 88 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 159 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 188 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 20.97 28.40 16.26 20.19 30.15 15.34 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 22 3 # 22 A 88 PHE B 344 PHE~? 21.77 ZN ZN B 402 A 159 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 188 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -45.25 79.78 24.19 -46.74 79.97 21.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 22.55 41.65 15.60 18.92 37.20 14.63 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 23 3 # 23 A 88 PHE B 363 PHE^? 13.11 ZN ZN B 401 A 159 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 188 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 13.91 34.58 14.67 12.95 36.00 12.47 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.53 111.12 1.13 -44.30 110.60 0.01 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 23 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 61.19 45.85 78.73 62.86 45.48 77.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 66.00 46.17 80.29 64.31 47.92 79.91 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 61.19 45.85 78.73 62.86 45.48 77.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 66.00 46.17 80.29 64.31 47.92 79.91 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 61.19 45.85 78.73 62.86 45.48 77.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 63.61 40.10 74.06 64.05 42.07 74.70 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 61.19 45.85 78.73 62.86 45.48 77.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 63.61 40.10 74.06 64.05 42.07 74.70 -33.57 107.34 6.30 -34.87 106.07 5.21 1bbs_c06 source 1bbs RENIN : 4 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 61.19 45.85 78.73 62.86 45.48 77.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 66.00 46.17 80.29 64.31 47.92 79.91 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 61.19 45.85 78.73 62.86 45.48 77.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 66.00 46.17 80.29 64.31 47.92 79.91 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 61.19 45.85 78.73 62.86 45.48 77.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 63.61 40.10 74.06 64.05 42.07 74.70 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 61.19 45.85 78.73 62.86 45.48 77.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 63.61 40.10 74.06 64.05 42.07 74.70 -33.57 107.34 6.30 -34.87 106.07 5.21 1bbs_c07 source 1bbs RENIN : 4 hits 1bbs_c07 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 11 ASP~? 18.10 ZN ZN A 401 16 HIS A 12 HIS~? 21.70 ZN ZN A 401 67 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 11 ASP~? 18.10 ZN ZN A 401 16 HIS A 13 HIS~? 19.28 ZN ZN A 401 67 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 11 ASP~? 18.10 ZN ZN A 401 16 HIS A 13 HIS~? 19.28 ZN ZN A 401 67 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 23 ASP.? 8.14 ZN ZN A 401 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 67 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP A 23 ASP.? 8.14 ZN ZN A 401 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 67 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -39.26 132.56 4.99 -38.51 132.20 4.81 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP A 44 ASP.? 7.09 ZN ZN A 402 16 HIS A 65 HIS.? -3.39 ZN ZN A 402s 67 GLY A 288 GLY.? 14.54 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -47.81 104.86 -9.26 -47.13 104.59 -9.75 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP A 44 ASP.? 7.09 ZN ZN A 402 16 HIS A 65 HIS.? -3.39 ZN ZN A 402s 67 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP A 44 ASP.? 7.09 ZN ZN A 402 16 HIS A 65 HIS.? -3.39 ZN ZN A 402s 67 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP A 44 ASP.? 7.09 ZN ZN A 402 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 67 GLY A 237 GLY^? 12.04 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -45.65 113.20 -21.30 -44.96 113.62 -21.16 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP A 44 ASP.? 7.09 ZN ZN A 402 16 HIS B 309 HIS~? 5.48 ZN ZN A 402 67 GLY A 237 GLY^? 12.04 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -45.65 113.20 -21.30 -44.96 113.62 -21.16 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP A 44 ASP.? 7.09 ZN ZN A 402 16 HIS B 309 HIS~? 5.48 ZN ZN A 402 67 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s 16 HIS A 64 HIS.? -3.42 ZN ZN A 401s 67 GLY A 30 GLY.? 22.34 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -40.03 138.80 -8.81 -40.82 138.90 -8.71 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s 16 HIS A 64 HIS.? -3.42 ZN ZN A 401s 67 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 14 3 # 14 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS A 326 HIS~? -3.60 ZN ZN A 402s 67 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 15 3 # 15 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS A 326 HIS~? -3.60 ZN ZN A 402s 67 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 16 3 # 16 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS A 326 HIS~? -3.60 ZN ZN A 402s 67 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 17 3 # 17 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS A 326 HIS~? -3.60 ZN ZN A 402s 67 GLY A 117 GLY.? 19.67 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -26.13 106.90 -22.05 -26.86 106.68 -21.78 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 18 3 # 18 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS A 326 HIS~? -3.60 ZN ZN A 402s 67 GLY B 318 GLY.? 21.53 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -32.98 122.14 11.89 -33.67 121.77 11.74 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 19 3 # 19 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 67 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 20 3 # 20 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 67 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 21 3 # 21 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 67 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 22 3 # 22 14 ASP A 310 ASP~? 12.24 ZN ZN B 401 16 HIS A 309 HIS~? 5.45 ZN ZN B 401 67 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 23 3 # 23 14 ASP A 313 ASP~? 12.18 ZN ZN B 401 16 HIS A 317 HIS~? 18.34 ZN ZN B 401 67 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 24 3 # 24 14 ASP A 361 ASP.? 11.77 ZN ZN A 402 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 67 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -39.26 132.56 4.99 -38.51 132.20 4.81 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 25 3 # 25 14 ASP A 361 ASP.? 11.77 ZN ZN A 402 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 67 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 26 3 # 26 14 ASP A 361 ASP.? 11.77 ZN ZN A 402 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 67 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 27 3 # 27 14 ASP B 11 ASP~? 18.05 ZN ZN B 402 16 HIS B 12 HIS~? 21.73 ZN ZN B 402 67 GLY B 154 GLY~? 39.11 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -69.92 90.56 40.93 -69.24 90.91 41.18 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 28 3 # 28 14 ASP B 11 ASP~? 18.05 ZN ZN B 402 16 HIS B 12 HIS~? 21.73 ZN ZN B 402 67 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 29 3 # 29 14 ASP B 11 ASP~? 18.05 ZN ZN B 402 16 HIS B 13 HIS~? 19.30 ZN ZN B 402 67 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 30 3 # 30 14 ASP B 11 ASP~? 18.05 ZN ZN B 402 16 HIS B 13 HIS~? 19.30 ZN ZN B 402 67 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 31 3 # 31 14 ASP B 23 ASP.? 8.15 ZN ZN B 402 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 67 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 32 3 # 32 14 ASP B 23 ASP.? 8.15 ZN ZN B 402 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 67 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 33 3 # 33 14 ASP B 44 ASP.? 7.11 ZN ZN B 401 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 67 GLY B 237 GLY^? 12.12 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -47.85 104.85 22.36 -47.42 104.12 22.23 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 34 3 # 34 14 ASP B 44 ASP.? 7.11 ZN ZN B 401 16 HIS A 309 HIS~? 5.45 ZN ZN B 401 67 GLY B 237 GLY^? 12.12 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -47.85 104.85 22.36 -47.42 104.12 22.23 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 35 3 # 35 14 ASP B 44 ASP.? 7.11 ZN ZN B 401 16 HIS A 309 HIS~? 5.45 ZN ZN B 401 67 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 36 3 # 36 14 ASP B 44 ASP.? 7.11 ZN ZN B 401 16 HIS B 65 HIS.? -3.43 ZN ZN B 401s 67 GLY A 288 GLY.? 14.54 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -47.81 104.86 -9.26 -47.13 104.59 -9.75 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 37 3 # 37 14 ASP B 44 ASP.? 7.11 ZN ZN B 401 16 HIS B 65 HIS.? -3.43 ZN ZN B 401s 67 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 38 3 # 38 14 ASP B 44 ASP.? 7.11 ZN ZN B 401 16 HIS B 65 HIS.? -3.43 ZN ZN B 401s 67 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 39 3 # 39 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s 16 HIS B 64 HIS.? -3.45 ZN ZN B 402s 67 GLY B 30 GLY.? 22.35 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -56.71 80.35 9.42 -57.43 80.74 9.40 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 40 3 # 40 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s 16 HIS B 64 HIS.? -3.45 ZN ZN B 402s 67 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 41 3 # 41 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 67 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 42 3 # 42 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 67 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 43 3 # 43 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 67 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 44 3 # 44 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS B 326 HIS~? -3.48 ZN ZN B 401s 67 GLY A 318 GLY.? 21.36 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.31 90.61 -10.78 -42.69 91.31 -10.63 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 45 3 # 45 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS B 326 HIS~? -3.48 ZN ZN B 401s 67 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 46 3 # 46 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS B 326 HIS~? -3.48 ZN ZN B 401s 67 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 47 3 # 47 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS B 326 HIS~? -3.48 ZN ZN B 401s 67 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 48 3 # 48 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 16 HIS B 326 HIS~? -3.48 ZN ZN B 401s 67 GLY B 117 GLY.? 19.78 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -27.68 99.96 22.74 -28.26 100.51 22.53 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 49 3 # 49 14 ASP B 310 ASP~? 12.35 ZN ZN A 402 16 HIS B 309 HIS~? 5.48 ZN ZN A 402 67 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 50 3 # 50 14 ASP B 313 ASP~? 12.28 ZN ZN A 402 16 HIS B 317 HIS~? 18.53 ZN ZN A 402 67 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 51 3 # 51 14 ASP B 361 ASP.? 11.71 ZN ZN B 401 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 67 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 52 3 # 52 14 ASP B 361 ASP.? 11.71 ZN ZN B 401 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 67 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 53 3 # 53 14 ASP B 361 ASP.? 11.71 ZN ZN B 401 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 67 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -53.02 85.53 -4.18 -52.23 85.45 -4.06 1be1_c02 source 1be1 GLUTAMATE MUTASE : 53 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 23 ASP.? 8.14 ZN ZN A 401 435 GLU A 20 GLU.? 10.86 ZN ZN A 401 510 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 88.62 69.90 41.16 89.05 70.67 43.04 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 89.52 76.11 40.17 89.01 75.16 41.97 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 84.89 77.60 46.67 85.63 75.79 46.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 33 ASP.? 31.33 ZN ZN A 401 435 GLU A 32 GLU.? 25.81 ZN ZN A 401 510 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 88.62 69.90 41.16 89.05 70.67 43.04 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 89.52 76.11 40.17 89.01 75.16 41.97 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 84.89 77.60 46.67 85.63 75.79 46.03 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP A 33 ASP.? 31.33 ZN ZN A 401 435 GLU A 35 GLU.? 32.19 ZN ZN A 401 510 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 88.62 69.90 41.16 89.05 70.67 43.04 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 89.52 76.11 40.17 89.01 75.16 41.97 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 84.89 77.60 46.67 85.63 75.79 46.03 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP B 23 ASP.? 8.15 ZN ZN B 402 435 GLU B 20 GLU.? 11.09 ZN ZN B 402 510 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 88.62 69.90 41.16 89.05 70.67 43.04 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 89.52 76.11 40.17 89.01 75.16 41.97 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 84.89 77.60 46.67 85.63 75.79 46.03 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP B 33 ASP.? 29.43 ZN ZN B 402 435 GLU B 32 GLU.? 22.53 ZN ZN B 402 510 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 88.62 69.90 41.16 89.05 70.67 43.04 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 89.52 76.11 40.17 89.01 75.16 41.97 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 84.89 77.60 46.67 85.63 75.79 46.03 -55.09 78.54 23.42 -56.64 77.16 23.83 1bf2_c00 source 1bf2 ISOAMYLASE : 5 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 55 GLU~? 25.21 ZN ZN A 402 A 503 TYR A 58 TYR.? 23.12 ZN ZN A 401 A 537 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 24.06 146.21 11.09 22.89 146.18 9.36 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 15.91 140.69 8.32 15.71 143.39 9.13 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 16.65 144.44 13.24 18.34 145.22 12.33 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 55 GLU~? 25.91 ZN ZN B 401 A 503 TYR B 58 TYR.? 23.40 ZN ZN B 402 A 537 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 24.06 146.21 11.09 22.89 146.18 9.36 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 15.91 140.69 8.32 15.71 143.39 9.13 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 16.65 144.44 13.24 18.34 145.22 12.33 -38.47 79.19 7.21 -37.79 81.13 7.79 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 55 GLU~? 25.21 ZN ZN A 402 A 504 TYR A 58 TYR.? 23.12 ZN ZN A 401 A 540 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 81.34 87.29 87.22 82.36 86.09 88.61 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 80.85 81.34 94.77 81.70 80.16 92.41 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 79.94 80.46 88.84 81.11 81.36 87.27 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 52 GLU~? 18.78 ZN ZN B 401 A 504 TYR B 58 TYR.? 23.40 ZN ZN B 402 A 540 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 81.34 87.29 87.22 82.36 86.09 88.61 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 80.85 81.34 94.77 81.70 80.16 92.41 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 79.94 80.46 88.84 81.11 81.36 87.27 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU B 55 GLU~? 25.91 ZN ZN B 401 A 504 TYR B 58 TYR.? 23.40 ZN ZN B 402 A 540 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 81.34 87.29 87.22 82.36 86.09 88.61 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 80.85 81.34 94.77 81.70 80.16 92.41 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 79.94 80.46 88.84 81.11 81.36 87.27 -38.47 79.19 7.21 -37.79 81.13 7.79 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 52 GLU~? 18.80 ZN ZN A 402 B 504 TYR A 58 TYR.? 23.12 ZN ZN A 401 B 540 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo 86.52 35.28 112.74 87.08 36.38 110.99 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 84.93 40.21 105.31 85.72 41.45 107.72 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 83.38 41.19 112.55 85.47 40.59 112.72 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 55 GLU~? 25.21 ZN ZN A 402 B 504 TYR A 58 TYR.? 23.12 ZN ZN A 401 B 540 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 86.52 35.28 112.74 87.08 36.38 110.99 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 84.93 40.21 105.31 85.72 41.45 107.72 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 83.38 41.19 112.55 85.47 40.59 112.72 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU B 52 GLU~? 18.78 ZN ZN B 401 B 504 TYR B 58 TYR.? 23.40 ZN ZN B 402 B 540 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 86.52 35.28 112.74 87.08 36.38 110.99 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 84.93 40.21 105.31 85.72 41.45 107.72 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 83.38 41.19 112.55 85.47 40.59 112.72 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU B 55 GLU~? 25.91 ZN ZN B 401 B 504 TYR B 58 TYR.? 23.40 ZN ZN B 402 B 540 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 86.52 35.28 112.74 87.08 36.38 110.99 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 84.93 40.21 105.31 85.72 41.45 107.72 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 83.38 41.19 112.55 85.47 40.59 112.72 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 5 3 # 5 B 451 GLU B 167 GLU^? 53.31 ZN ZN B 402 B 504 TYR B 220 TYR.? 54.58 ZN ZN B 402 B 540 GLU B 195 GLU^? 52.10 ZN ZN B 402 coo 86.52 35.28 112.74 87.08 36.38 110.99 -79.62 113.37 49.20 -81.22 112.07 48.69 coo 84.93 40.21 105.31 85.72 41.45 107.72 -84.07 105.41 48.45 -83.30 105.50 51.17 coo 83.38 41.19 112.55 85.47 40.59 112.72 -77.28 109.06 51.77 -78.42 110.03 50.31 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 6 3 # 6 B 451 GLU B 195 GLU^? 52.10 ZN ZN B 402 B 504 TYR B 220 TYR.? 54.58 ZN ZN B 402 B 540 GLU B 167 GLU^? 53.31 ZN ZN B 402 coo 86.52 35.28 112.74 87.08 36.38 110.99 -77.28 109.06 51.77 -78.42 110.03 50.31 coo 84.93 40.21 105.31 85.72 41.45 107.72 -84.07 105.41 48.45 -83.30 105.50 51.17 coo 83.38 41.19 112.55 85.47 40.59 112.72 -79.62 113.37 49.20 -81.22 112.07 48.69 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c03 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 759 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 810 SER A 21 SER.? 15.75 ZN ZN A 401 coo 30.11 61.02 29.12 29.36 59.77 27.63 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 30.94 56.62 25.28 29.94 54.94 26.14 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 25.05 62.74 29.97 26.88 61.45 29.19 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 759 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 810 SER A 285 SER.? 7.68 ZN ZN A 402 coo 30.11 61.02 29.12 29.36 59.77 27.63 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.94 56.62 25.28 29.94 54.94 26.14 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 25.05 62.74 29.97 26.88 61.45 29.19 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 A 757 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 759 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 810 SER B 21 SER.? 15.71 ZN ZN B 402 coo 30.11 61.02 29.12 29.36 59.77 27.63 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 30.94 56.62 25.28 29.94 54.94 26.14 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 25.05 62.74 29.97 26.88 61.45 29.19 -58.60 101.69 13.65 -59.34 103.93 13.19 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 A 757 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 759 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 810 SER B 285 SER.? 7.72 ZN ZN B 401 coo 30.11 61.02 29.12 29.36 59.77 27.63 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.94 56.62 25.28 29.94 54.94 26.14 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 25.05 62.74 29.97 26.88 61.45 29.19 -42.52 104.99 8.17 -43.54 106.03 6.21 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 759 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 810 SER A 21 SER.? 15.75 ZN ZN A 401 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 1.96 66.39 3.07 2.10 68.48 3.58 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 759 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 810 SER A 285 SER.? 7.68 ZN ZN A 402 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 1.96 66.39 3.07 2.10 68.48 3.58 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 B 757 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 759 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 810 SER B 21 SER.? 15.71 ZN ZN B 402 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 1.96 66.39 3.07 2.10 68.48 3.58 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -58.60 101.69 13.65 -59.34 103.93 13.19 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 B 757 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 759 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 810 SER B 285 SER.? 7.72 ZN ZN B 401 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 1.96 66.39 3.07 2.10 68.48 3.58 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -42.52 104.99 8.17 -43.54 106.03 6.21 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c05 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 105 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 109 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 105 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 109 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1bol_c00 RIBONUCLEASE RH user 3 3 # 3 A 46 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 105 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 109 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1bol_c00 RIBONUCLEASE RH user 4 3 # 4 A 46 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 105 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 109 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1bol_c00 RIBONUCLEASE RH user 5 3 # 5 A 46 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 105 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 109 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1bol_c00 RIBONUCLEASE RH user 6 3 # 6 A 46 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 105 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 109 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1bol_c00 RIBONUCLEASE RH user 7 3 # 7 A 46 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 105 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 109 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1bol_c00 RIBONUCLEASE RH user 8 3 # 8 A 46 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 105 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 109 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1bol_c00 RIBONUCLEASE RH user 9 3 # 9 A 46 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 105 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 109 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1bol_c00 RIBONUCLEASE RH user 10 3 # 10 A 46 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 105 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 109 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1bol_c00 RIBONUCLEASE RH user 11 3 # 11 A 46 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 105 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 109 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1bol_c00 RIBONUCLEASE RH user 12 3 # 12 A 46 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 105 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 109 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -45.27 94.95 7.47 -43.74 96.36 7.67 1bol_c00 source 1bol RIBONUCLEASE RH : 12 hits 1bol_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 26 GLY^? 14.60 ZN ZN A 401 48 HIS A 98 HIS~? 4.98 ZN ZN A 401 99 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 12.38 5.55 24.25 13.27 5.59 24.39 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 18.80 12.68 24.53 17.69 13.54 26.08 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY A 81 GLY~? 20.61 ZN ZN A 402 48 HIS B 317 HIS~? 18.53 ZN ZN A 402 99 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -39.26 132.56 4.99 -38.51 132.20 4.81 coo 18.80 12.68 24.53 17.69 13.54 26.08 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 17.07 18.51 26.62 16.67 17.07 28.09 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY A 107 GLY~? 9.03 ZN ZN A 401 48 HIS A 13 HIS~? 19.28 ZN ZN A 401 99 ASP A 11 ASP~? 18.10 ZN ZN A 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -36.84 117.84 -20.01 -36.52 117.15 -20.30 coo 18.80 12.68 24.53 17.69 13.54 26.08 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 17.07 18.51 26.62 16.67 17.07 28.09 -44.11 130.33 -22.09 -46.09 129.62 -22.27 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY A 107 GLY~? 9.03 ZN ZN A 401 48 HIS A 98 HIS~? 4.98 ZN ZN A 401 99 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -36.84 117.84 -20.01 -36.52 117.15 -20.30 coo 18.80 12.68 24.53 17.69 13.54 26.08 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.07 18.51 26.62 16.67 17.07 28.09 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 5 3 # 5 30 GLY A 283 GLY.? 5.77 ZN ZN A 401 48 HIS A 65 HIS.? -3.39 ZN ZN A 402s 99 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 18.80 12.68 24.53 17.69 13.54 26.08 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 6 3 # 6 30 GLY A 283 GLY.? 5.77 ZN ZN A 401 48 HIS A 98 HIS~? 4.98 ZN ZN A 401 99 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 18.80 12.68 24.53 17.69 13.54 26.08 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.07 18.51 26.62 16.67 17.07 28.09 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 7 3 # 7 30 GLY A 283 GLY.? 5.77 ZN ZN A 401 48 HIS B 308 HIS~? 6.54 ZN ZN A 402 99 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 18.80 12.68 24.53 17.69 13.54 26.08 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 8 3 # 8 30 GLY A 283 GLY.? 5.77 ZN ZN A 401 48 HIS B 308 HIS~? 6.54 ZN ZN A 402 99 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 18.80 12.68 24.53 17.69 13.54 26.08 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 9 3 # 9 30 GLY A 284 GLY.? 4.19 ZN ZN A 402 48 HIS A 65 HIS.? -3.39 ZN ZN A 402s 99 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo 18.80 12.68 24.53 17.69 13.54 26.08 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 10 3 # 10 30 GLY A 284 GLY.? 4.19 ZN ZN A 402 48 HIS A 98 HIS~? 4.98 ZN ZN A 401 99 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo 18.80 12.68 24.53 17.69 13.54 26.08 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.07 18.51 26.62 16.67 17.07 28.09 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 11 3 # 11 30 GLY A 284 GLY.? 4.19 ZN ZN A 402 48 HIS B 309 HIS~? 5.48 ZN ZN A 402 99 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo 18.80 12.68 24.53 17.69 13.54 26.08 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 12 3 # 12 30 GLY A 284 GLY.? 4.19 ZN ZN A 402 48 HIS B 309 HIS~? 5.48 ZN ZN A 402 99 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo 18.80 12.68 24.53 17.69 13.54 26.08 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.07 18.51 26.62 16.67 17.07 28.09 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 13 3 # 13 30 GLY A 284 GLY.? 4.19 ZN ZN A 402 48 HIS B 309 HIS~? 5.48 ZN ZN A 402 99 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo 18.80 12.68 24.53 17.69 13.54 26.08 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.07 18.51 26.62 16.67 17.07 28.09 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 14 3 # 14 30 GLY A 304 GLY.? 8.93 ZN ZN A 402 48 HIS B 308 HIS~? 6.54 ZN ZN A 402 99 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 18.80 12.68 24.53 17.69 13.54 26.08 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 15 3 # 15 30 GLY A 304 GLY.? 8.93 ZN ZN A 402 48 HIS B 308 HIS~? 6.54 ZN ZN A 402 99 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 18.80 12.68 24.53 17.69 13.54 26.08 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 16 3 # 16 30 GLY A 304 GLY.? 8.93 ZN ZN A 402 48 HIS B 308 HIS~? 6.54 ZN ZN A 402 99 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 18.80 12.68 24.53 17.69 13.54 26.08 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 17 3 # 17 30 GLY A 304 GLY.? 8.93 ZN ZN A 402 48 HIS B 309 HIS~? 5.48 ZN ZN A 402 99 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 18.80 12.68 24.53 17.69 13.54 26.08 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 18 3 # 18 30 GLY A 304 GLY.? 8.93 ZN ZN A 402 48 HIS B 309 HIS~? 5.48 ZN ZN A 402 99 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 18.80 12.68 24.53 17.69 13.54 26.08 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.07 18.51 26.62 16.67 17.07 28.09 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 19 3 # 19 30 GLY A 335 GLY~? 12.90 ZN ZN A 401 48 HIS A 64 HIS.? -3.42 ZN ZN A 401s 99 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 12.38 5.55 24.25 13.27 5.59 24.39 -29.44 120.06 -18.71 -29.40 120.83 -18.33 coo 18.80 12.68 24.53 17.69 13.54 26.08 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 20 3 # 20 30 GLY B 26 GLY^? 14.44 ZN ZN B 402 48 HIS B 98 HIS~? 5.02 ZN ZN B 402 99 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 12.38 5.55 24.25 13.27 5.59 24.39 -55.22 89.41 14.53 -54.89 89.43 13.78 coo 18.80 12.68 24.53 17.69 13.54 26.08 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.07 18.51 26.62 16.67 17.07 28.09 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 21 3 # 21 30 GLY B 81 GLY~? 20.66 ZN ZN B 401 48 HIS A 317 HIS~? 18.34 ZN ZN B 401 99 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -53.02 85.53 -4.18 -52.23 85.45 -4.06 coo 18.80 12.68 24.53 17.69 13.54 26.08 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 17.07 18.51 26.62 16.67 17.07 28.09 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 22 3 # 22 30 GLY B 107 GLY~? 9.03 ZN ZN B 402 48 HIS B 13 HIS~? 19.30 ZN ZN B 402 99 ASP B 11 ASP~? 18.05 ZN ZN B 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -42.81 96.22 20.86 -42.14 96.60 21.16 coo 18.80 12.68 24.53 17.69 13.54 26.08 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 17.07 18.51 26.62 16.67 17.07 28.09 -55.43 89.37 22.82 -56.66 91.02 23.20 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 23 3 # 23 30 GLY B 107 GLY~? 9.03 ZN ZN B 402 48 HIS B 98 HIS~? 5.02 ZN ZN B 402 99 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -42.81 96.22 20.86 -42.14 96.60 21.16 coo 18.80 12.68 24.53 17.69 13.54 26.08 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.07 18.51 26.62 16.67 17.07 28.09 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 24 3 # 24 30 GLY B 283 GLY.? 5.97 ZN ZN B 402 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 99 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 25 3 # 25 30 GLY B 283 GLY.? 5.97 ZN ZN B 402 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 99 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 26 3 # 26 30 GLY B 283 GLY.? 5.97 ZN ZN B 402 48 HIS B 65 HIS.? -3.43 ZN ZN B 401s 99 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 18.80 12.68 24.53 17.69 13.54 26.08 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 17.07 18.51 26.62 16.67 17.07 28.09 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 27 3 # 27 30 GLY B 283 GLY.? 5.97 ZN ZN B 402 48 HIS B 98 HIS~? 5.02 ZN ZN B 402 99 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 18.80 12.68 24.53 17.69 13.54 26.08 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.07 18.51 26.62 16.67 17.07 28.09 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 28 3 # 28 30 GLY B 284 GLY.? 4.14 ZN ZN B 401 48 HIS A 309 HIS~? 5.45 ZN ZN B 401 99 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -41.31 101.77 9.74 -40.78 102.45 9.84 coo 18.80 12.68 24.53 17.69 13.54 26.08 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.07 18.51 26.62 16.67 17.07 28.09 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 29 3 # 29 30 GLY B 284 GLY.? 4.14 ZN ZN B 401 48 HIS A 309 HIS~? 5.45 ZN ZN B 401 99 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -41.31 101.77 9.74 -40.78 102.45 9.84 coo 18.80 12.68 24.53 17.69 13.54 26.08 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.07 18.51 26.62 16.67 17.07 28.09 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 30 3 # 30 30 GLY B 284 GLY.? 4.14 ZN ZN B 401 48 HIS A 309 HIS~? 5.45 ZN ZN B 401 99 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -41.31 101.77 9.74 -40.78 102.45 9.84 coo 18.80 12.68 24.53 17.69 13.54 26.08 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.07 18.51 26.62 16.67 17.07 28.09 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 31 3 # 31 30 GLY B 284 GLY.? 4.14 ZN ZN B 401 48 HIS B 65 HIS.? -3.43 ZN ZN B 401s 99 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -41.31 101.77 9.74 -40.78 102.45 9.84 coo 18.80 12.68 24.53 17.69 13.54 26.08 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 17.07 18.51 26.62 16.67 17.07 28.09 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 32 3 # 32 30 GLY B 284 GLY.? 4.14 ZN ZN B 401 48 HIS B 98 HIS~? 5.02 ZN ZN B 402 99 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 12.38 5.55 24.25 13.27 5.59 24.39 -41.31 101.77 9.74 -40.78 102.45 9.84 coo 18.80 12.68 24.53 17.69 13.54 26.08 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.07 18.51 26.62 16.67 17.07 28.09 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 33 3 # 33 30 GLY B 304 GLY.? 8.91 ZN ZN B 401 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 99 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 34 3 # 34 30 GLY B 304 GLY.? 8.91 ZN ZN B 401 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 99 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 35 3 # 35 30 GLY B 304 GLY.? 8.91 ZN ZN B 401 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 99 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 36 3 # 36 30 GLY B 304 GLY.? 8.91 ZN ZN B 401 48 HIS A 309 HIS~? 5.45 ZN ZN B 401 99 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 18.80 12.68 24.53 17.69 13.54 26.08 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.07 18.51 26.62 16.67 17.07 28.09 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 37 3 # 37 30 GLY B 304 GLY.? 8.91 ZN ZN B 401 48 HIS A 309 HIS~? 5.45 ZN ZN B 401 99 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 18.80 12.68 24.53 17.69 13.54 26.08 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.07 18.51 26.62 16.67 17.07 28.09 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 38 3 # 38 30 GLY B 335 GLY~? 12.98 ZN ZN B 402 48 HIS B 64 HIS.? -3.45 ZN ZN B 402s 99 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.70 90.31 19.42 -38.03 89.63 19.05 coo 18.80 12.68 24.53 17.69 13.54 26.08 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.07 18.51 26.62 16.67 17.07 28.09 -46.20 100.05 15.92 -45.42 99.37 14.07 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 38 hits 1bp2_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 308 HIS~? 6.49 ZN ZN B 401 B1168 ARG B 267 ARG^? 13.63 ZN ZN A 402 B1187 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 35.03 5.72 103.61 36.82 5.00 102.79 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 41.91 5.48 91.85 40.59 6.81 94.28 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS B 326 HIS~? -3.48 ZN ZN B 401s B1168 ARG B 267 ARG^? 13.63 ZN ZN A 402 B1187 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 35.03 5.72 103.61 36.82 5.00 102.79 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 41.91 5.48 91.85 40.59 6.81 94.28 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -40.89 103.09 -0.15 -45.35 106.49 1.62 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 16 PHE~? 14.00 ZN ZN A 401 A 205 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 236 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 4.14 2.10 36.34 6.69 3.08 36.92 -44.69 128.21 -17.73 -42.08 129.17 -17.23 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 205 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 236 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 205 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 236 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 4.14 2.10 36.34 6.69 3.08 36.92 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 205 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 236 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 4.14 2.10 36.34 6.69 3.08 36.92 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 205 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 236 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 4.14 2.10 36.34 6.69 3.08 36.92 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 205 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 236 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 4.14 2.10 36.34 6.69 3.08 36.92 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 205 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 236 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 4.14 2.10 36.34 6.69 3.08 36.92 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -28.04 112.73 23.24 -26.21 110.17 27.80 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 7 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 212 GLN~? 38.73 ZN ZN B 402 A 91 LEU B 213 LEU~? 39.65 ZN ZN B 402 A 133 GLU B 211 GLU~? 39.18 ZN ZN B 402 coo 43.58 43.67 66.73 42.32 42.78 68.15 -77.18 95.70 33.92 -76.97 93.83 32.91 coo 38.58 45.09 70.44 38.28 45.21 72.59 -73.88 95.43 39.49 -72.94 93.55 38.86 coo 44.05 36.87 70.65 43.15 38.64 69.97 -75.90 102.21 34.20 -77.49 103.04 33.09 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 274 GLN.? 26.97 ZN ZN A 402 A 91 LEU B 250 LEU~? 23.28 ZN ZN B 402 A 133 GLU B 271 GLU.? 25.84 ZN ZN A 402 coo 43.58 43.67 66.73 42.32 42.78 68.15 -26.92 118.19 15.60 -27.10 120.29 15.87 coo 38.58 45.09 70.44 38.28 45.21 72.59 -25.70 113.88 13.60 -27.64 113.69 12.63 coo 44.05 36.87 70.65 43.15 38.64 69.97 -25.27 121.46 10.97 -24.72 123.08 12.43 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN B 212 GLN~? 38.73 ZN ZN B 402 B 591 LEU B 213 LEU~? 39.65 ZN ZN B 402 B 633 GLU B 211 GLU~? 39.18 ZN ZN B 402 coo 88.06 44.34 57.19 89.06 45.53 55.74 -77.18 95.70 33.92 -76.97 93.83 32.91 coo 86.70 48.66 52.61 87.15 48.69 50.51 -73.88 95.43 39.49 -72.94 93.55 38.86 coo 95.42 44.52 54.43 93.46 45.31 54.70 -75.90 102.21 34.20 -77.49 103.04 33.09 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 274 GLN.? 26.97 ZN ZN A 402 B 591 LEU B 250 LEU~? 23.28 ZN ZN B 402 B 633 GLU B 271 GLU.? 25.84 ZN ZN A 402 coo 88.06 44.34 57.19 89.06 45.53 55.74 -26.92 118.19 15.60 -27.10 120.29 15.87 coo 86.70 48.66 52.61 87.15 48.69 50.51 -25.70 113.88 13.60 -27.64 113.69 12.63 coo 95.42 44.52 54.43 93.46 45.31 54.70 -25.27 121.46 10.97 -24.72 123.08 12.43 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN B 212 GLN~? 38.73 ZN ZN B 402 C1091 LEU B 213 LEU~? 39.65 ZN ZN B 402 C1133 GLU B 211 GLU~? 39.18 ZN ZN B 402 coo 68.29 34.44 43.03 66.67 34.74 44.37 -77.18 95.70 33.92 -76.97 93.83 32.91 coo 65.83 38.95 47.05 65.46 38.90 49.20 -73.88 95.43 39.49 -72.94 93.55 38.86 coo 63.14 29.39 46.25 63.84 31.31 45.74 -75.90 102.21 34.20 -77.49 103.04 33.09 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 274 GLN.? 26.97 ZN ZN A 402 C1091 LEU B 250 LEU~? 23.28 ZN ZN B 402 C1133 GLU B 271 GLU.? 25.84 ZN ZN A 402 coo 68.29 34.44 43.03 66.67 34.74 44.37 -26.92 118.19 15.60 -27.10 120.29 15.87 coo 65.83 38.95 47.05 65.46 38.90 49.20 -25.70 113.88 13.60 -27.64 113.69 12.63 coo 63.14 29.39 46.25 63.84 31.31 45.74 -25.27 121.46 10.97 -24.72 123.08 12.43 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 212 GLN~? 38.73 ZN ZN B 402 A 91 LEU B 213 LEU~? 39.65 ZN ZN B 402 A 133 GLU B 211 GLU~? 39.18 ZN ZN B 402 coo 38.23 53.34 67.59 38.84 53.87 69.56 -77.18 95.70 33.92 -76.97 93.83 32.91 coo 35.40 53.22 73.30 35.37 54.87 74.74 -73.88 95.43 39.49 -72.94 93.55 38.86 coo 45.08 56.04 70.60 43.15 55.19 70.77 -75.90 102.21 34.20 -77.49 103.04 33.09 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 1 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 354 GLU A 32 GLU.? 25.81 ZN ZN A 401 A 421 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 31.05 49.37 64.51 31.97 51.11 63.85 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 30.82 59.76 58.47 31.12 59.02 60.40 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 354 GLU A 32 GLU.? 25.81 ZN ZN A 401 A 421 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 31.05 49.37 64.51 31.97 51.11 63.85 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 30.82 59.76 58.47 31.12 59.02 60.40 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 354 GLU A 35 GLU.? 32.19 ZN ZN A 401 A 421 ASP A -1 ASP.? 33.70 ZN ZN A 401 coo 31.05 49.37 64.51 31.97 51.11 63.85 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 30.82 59.76 58.47 31.12 59.02 60.40 -34.17 145.98 -27.25 -35.93 146.68 -26.30 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 354 GLU A 35 GLU.? 32.19 ZN ZN A 401 A 421 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 31.05 49.37 64.51 31.97 51.11 63.85 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 30.82 59.76 58.47 31.12 59.02 60.40 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 354 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 421 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 31.05 49.37 64.51 31.97 51.11 63.85 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 29.07 50.42 58.36 29.02 52.18 59.49 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 30.82 59.76 58.47 31.12 59.02 60.40 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP B 31 ASP.? 28.05 ZN ZN B 402 A 354 GLU B 32 GLU.? 22.53 ZN ZN B 402 A 421 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 31.05 49.37 64.51 31.97 51.11 63.85 -58.98 76.97 11.28 -60.60 75.86 12.07 coo 29.07 50.42 58.36 29.02 52.18 59.49 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 30.82 59.76 58.47 31.12 59.02 60.40 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP B 33 ASP.? 29.43 ZN ZN B 402 A 354 GLU B 32 GLU.? 22.53 ZN ZN B 402 A 421 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 31.05 49.37 64.51 31.97 51.11 63.85 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 29.07 50.42 58.36 29.02 52.18 59.49 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 30.82 59.76 58.47 31.12 59.02 60.40 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 354 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 421 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 31.05 49.37 64.51 31.97 51.11 63.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 29.07 50.42 58.36 29.02 52.18 59.49 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 30.82 59.76 58.47 31.12 59.02 60.40 -33.57 107.34 6.30 -34.87 106.07 5.21 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 8 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 31 ASP.? 28.20 ZN ZN A 401 B 354 GLU A 32 GLU.? 25.81 ZN ZN A 401 B 421 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 25.90 8.19 53.87 25.36 6.97 52.29 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 26.02 1.87 43.38 25.90 1.97 45.49 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 33 ASP.? 31.33 ZN ZN A 401 B 354 GLU A 32 GLU.? 25.81 ZN ZN A 401 B 421 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 25.90 8.19 53.87 25.36 6.97 52.29 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 26.02 1.87 43.38 25.90 1.97 45.49 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 33 ASP.? 31.33 ZN ZN A 401 B 354 GLU A 35 GLU.? 32.19 ZN ZN A 401 B 421 ASP A -1 ASP.? 33.70 ZN ZN A 401 coo 25.90 8.19 53.87 25.36 6.97 52.29 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 26.02 1.87 43.38 25.90 1.97 45.49 -34.17 145.98 -27.25 -35.93 146.68 -26.30 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP A 33 ASP.? 31.33 ZN ZN A 401 B 354 GLU A 35 GLU.? 32.19 ZN ZN A 401 B 421 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 25.90 8.19 53.87 25.36 6.97 52.29 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 26.02 1.87 43.38 25.90 1.97 45.49 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP A 33 ASP.? 31.33 ZN ZN A 401 B 354 GLU A 35 GLU.? 32.19 ZN ZN A 401 B 421 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo 25.90 8.19 53.87 25.36 6.97 52.29 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 26.02 1.87 43.38 25.90 1.97 45.49 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 354 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 421 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 25.90 8.19 53.87 25.36 6.97 52.29 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 27.87 10.66 47.95 27.82 8.60 48.27 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 26.02 1.87 43.38 25.90 1.97 45.49 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP A 245 ASP^? 25.73 ZN ZN A 401 B 354 GLU A 243 GLU^? 24.16 ZN ZN A 401 B 421 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 25.90 8.19 53.87 25.36 6.97 52.29 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 27.87 10.66 47.95 27.82 8.60 48.27 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 26.02 1.87 43.38 25.90 1.97 45.49 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 354 GLU A 290 GLU~? 16.18 ZN ZN A 402 B 421 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 25.90 8.19 53.87 25.36 6.97 52.29 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 27.87 10.66 47.95 27.82 8.60 48.27 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 26.02 1.87 43.38 25.90 1.97 45.49 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP B 31 ASP.? 28.05 ZN ZN B 402 B 354 GLU B 32 GLU.? 22.53 ZN ZN B 402 B 421 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 25.90 8.19 53.87 25.36 6.97 52.29 -58.98 76.97 11.28 -60.60 75.86 12.07 coo 27.87 10.66 47.95 27.82 8.60 48.27 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 26.02 1.87 43.38 25.90 1.97 45.49 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 10 3 # 10 B 325 ASP B 33 ASP.? 29.43 ZN ZN B 402 B 354 GLU B 32 GLU.? 22.53 ZN ZN B 402 B 421 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 25.90 8.19 53.87 25.36 6.97 52.29 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 27.87 10.66 47.95 27.82 8.60 48.27 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 26.02 1.87 43.38 25.90 1.97 45.49 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 11 3 # 11 B 325 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 354 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 421 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 25.90 8.19 53.87 25.36 6.97 52.29 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 27.87 10.66 47.95 27.82 8.60 48.27 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 26.02 1.87 43.38 25.90 1.97 45.49 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 12 3 # 12 B 325 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 354 GLU B 290 GLU~? 16.07 ZN ZN B 401 B 421 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 25.90 8.19 53.87 25.36 6.97 52.29 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 27.87 10.66 47.95 27.82 8.60 48.27 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 26.02 1.87 43.38 25.90 1.97 45.49 -33.57 107.34 6.30 -34.87 106.07 5.21 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 12 hits 1bvz_c09 naa= 3 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 1 3 # 1 191 ASN A 325 ASN~? 12.89 ZN ZN A 402 194 HIS A 326 HIS~? -3.60 ZN ZN A 402s 196 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 40.94 71.26 25.74 40.29 70.59 23.82 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 38.86 67.47 19.31 37.78 65.73 19.79 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 41.10 73.64 20.13 38.52 73.39 19.02 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 2 3 # 2 191 ASN A 325 ASN~? 12.89 ZN ZN A 402 194 HIS B 308 HIS~? 6.54 ZN ZN A 402 196 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 40.94 71.26 25.74 40.29 70.59 23.82 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 38.86 67.47 19.31 37.78 65.73 19.79 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 41.10 73.64 20.13 38.52 73.39 19.02 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 3 3 # 3 191 ASN B 104 ASN.? 12.46 ZN ZN B 402 194 HIS B 13 HIS~? 19.30 ZN ZN B 402 196 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo 40.94 71.26 25.74 40.29 70.59 23.82 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 38.86 67.47 19.31 37.78 65.73 19.79 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 41.10 73.64 20.13 38.52 73.39 19.02 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 4 3 # 4 191 ASN B 325 ASN~? 12.86 ZN ZN B 401 194 HIS A 308 HIS~? 6.49 ZN ZN B 401 196 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 40.94 71.26 25.74 40.29 70.59 23.82 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 38.86 67.47 19.31 37.78 65.73 19.79 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 41.10 73.64 20.13 38.52 73.39 19.02 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 5 3 # 5 191 ASN B 325 ASN~? 12.86 ZN ZN B 401 194 HIS B 326 HIS~? -3.48 ZN ZN B 401s 196 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 40.94 71.26 25.74 40.29 70.59 23.82 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 38.86 67.47 19.31 37.78 65.73 19.79 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 41.10 73.64 20.13 38.52 73.39 19.02 -35.81 95.23 5.63 -35.48 92.50 6.11 1bwl_c01 source 1bwl NADPH DEHYDROGENASE 1 : 5 hits 1bwl_c01 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 24 ASN.? 14.49 ZN ZN A 402 192 ASP A 44 ASP.? 7.09 ZN ZN A 402 195 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN A 24 ASN.? 14.49 ZN ZN A 402 192 ASP A 102 ASP~? -1.98 ZN ZN A 401s 195 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN A 51 ASN~? 22.86 ZN ZN A 402 192 ASP A 91 ASP.? 28.84 ZN ZN A 402 195 HIS A 90 HIS~? 26.77 ZN ZN A 402 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -30.00 140.26 -1.63 -28.87 140.48 0.12 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 4 3 # 4 104 ASN A 104 ASN.? 12.54 ZN ZN A 401 192 ASP A 23 ASP.? 8.14 ZN ZN A 401 195 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 5 3 # 5 104 ASN A 320 ASN.? 23.41 ZN ZN B 401 192 ASP A 313 ASP~? 12.18 ZN ZN B 401 195 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -37.23 94.97 -12.31 -37.23 92.90 -12.72 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 6 3 # 6 104 ASN A 325 ASN~? 12.89 ZN ZN A 402 192 ASP B 310 ASP~? 12.35 ZN ZN A 402 195 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 7 3 # 7 104 ASN B 24 ASN.? 14.57 ZN ZN B 401 192 ASP A 313 ASP~? 12.18 ZN ZN B 401 195 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 8 3 # 8 104 ASN B 24 ASN.? 14.57 ZN ZN B 401 192 ASP B 44 ASP.? 7.11 ZN ZN B 401 195 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 9 3 # 9 104 ASN B 24 ASN.? 14.57 ZN ZN B 401 192 ASP B 102 ASP~? -1.99 ZN ZN B 402s 195 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 10 3 # 10 104 ASN B 51 ASN~? 22.98 ZN ZN B 401 192 ASP B 91 ASP.? 28.82 ZN ZN B 401 195 HIS B 90 HIS~? 26.84 ZN ZN B 401 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -49.12 73.85 2.19 -48.21 73.06 0.48 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 11 3 # 11 104 ASN B 104 ASN.? 12.46 ZN ZN B 402 192 ASP B 23 ASP.? 8.15 ZN ZN B 402 195 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 12 3 # 12 104 ASN B 320 ASN.? 23.67 ZN ZN A 402 192 ASP B 313 ASP~? 12.28 ZN ZN A 402 195 HIS B 317 HIS~? 18.53 ZN ZN A 402 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -31.14 115.93 13.50 -30.16 117.79 13.90 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -38.40 123.74 9.47 -39.77 124.82 8.30 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 13 3 # 13 104 ASN B 325 ASN~? 12.86 ZN ZN B 401 192 ASP A 310 ASP~? 12.24 ZN ZN B 401 195 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -45.80 98.45 2.85 -45.82 97.45 4.71 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 13 hits 1bwp_c01 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 24 ASN.? 14.49 ZN ZN A 402 A 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 16.88 2.43 18.09 16.20 3.65 19.72 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 16.00 9.54 19.61 16.53 10.80 21.20 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.15 8.89 19.42 18.82 8.12 20.82 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 A 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 16.88 2.43 18.09 16.20 3.65 19.72 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 16.00 9.54 19.61 16.53 10.80 21.20 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.15 8.89 19.42 18.82 8.12 20.82 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 16.88 2.43 18.09 16.20 3.65 19.72 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 16.00 9.54 19.61 16.53 10.80 21.20 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 20.15 8.89 19.42 18.82 8.12 20.82 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN B 24 ASN.? 14.57 ZN ZN B 401 A 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 16.88 2.43 18.09 16.20 3.65 19.72 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 16.00 9.54 19.61 16.53 10.80 21.20 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.15 8.89 19.42 18.82 8.12 20.82 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 A 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 A 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 16.88 2.43 18.09 16.20 3.65 19.72 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 16.00 9.54 19.61 16.53 10.80 21.20 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.15 8.89 19.42 18.82 8.12 20.82 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 A 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 16.88 2.43 18.09 16.20 3.65 19.72 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 16.00 9.54 19.61 16.53 10.80 21.20 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 20.15 8.89 19.42 18.82 8.12 20.82 -40.41 105.08 4.17 -40.72 103.08 3.51 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 6 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 24 ASN.? 14.49 ZN ZN A 402 B 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 35.12 16.22 2.69 37.05 17.04 2.40 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 B 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 35.12 16.22 2.69 37.05 17.04 2.40 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 35.12 16.22 2.69 37.05 17.04 2.40 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN B 24 ASN.? 14.57 ZN ZN B 401 B 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 35.12 16.22 2.69 37.05 17.04 2.40 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 B 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 B 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 35.12 16.22 2.69 37.05 17.04 2.40 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 35.12 16.22 2.69 37.05 17.04 2.40 -40.41 105.08 4.17 -40.72 103.08 3.51 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 6 hits 1c2t_c03 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 328 SER~? 11.01 ZN ZN A 402 A 235 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 263 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 30.32 56.27 16.76 31.62 57.99 17.94 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 31.33 62.80 9.68 31.68 62.04 11.62 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.23 62.32 14.77 30.86 60.47 15.53 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 2 3 # 2 A 110 SER B 328 SER~? 10.89 ZN ZN B 401 A 235 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 263 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 30.32 56.27 16.76 31.62 57.99 17.94 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 31.33 62.80 9.68 31.68 62.04 11.62 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.23 62.32 14.77 30.86 60.47 15.53 -40.92 100.43 6.30 -42.93 100.06 6.77 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 2 hits 1c4x_c00 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 399 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 408 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1c82_c00 HYALURONATE LYASE user 2 3 # 2 A 349 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 399 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 408 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1c82_c00 HYALURONATE LYASE user 3 3 # 3 A 349 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 399 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 408 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1c82_c00 HYALURONATE LYASE user 4 3 # 4 A 349 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 399 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 408 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -35.81 95.23 5.63 -35.48 92.50 6.11 1c82_c00 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c00 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 67 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 16 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 67 GLY A 30 GLY.? 22.34 ZN ZN A 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -40.03 138.80 -8.81 -40.82 138.90 -8.71 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 16 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 67 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 16 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 67 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 67 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 67 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 7 3 # 7 A 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 67 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 8 3 # 8 A 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 67 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 9 3 # 9 A 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 67 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 10 3 # 10 A 14 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 67 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 11 3 # 11 A 14 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 16 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 67 GLY B 30 GLY.? 22.35 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -56.71 80.35 9.42 -57.43 80.74 9.40 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 12 3 # 12 A 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 16 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 67 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 13 3 # 13 A 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 16 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 67 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 14 3 # 14 A 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 67 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 15 3 # 15 A 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 67 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 16 3 # 16 A 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 67 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 17 3 # 17 A 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 67 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 18 3 # 18 A 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 67 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 19 3 # 19 A 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 67 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -42.82 107.61 10.95 -42.53 107.90 10.27 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 19 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 67 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 6.38 39.80 88.71 6.88 38.89 86.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 91 ASP.? 28.84 ZN ZN A 402 C 16 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 67 GLY A 30 GLY.? 22.34 ZN ZN A 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 6.38 39.80 88.71 6.88 38.89 86.87 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 17.63 42.50 89.25 18.11 42.29 88.64 -40.03 138.80 -8.81 -40.82 138.90 -8.71 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 16 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 67 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.38 39.80 88.71 6.88 38.89 86.87 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.63 42.50 89.25 18.11 42.29 88.64 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 16 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 67 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.38 39.80 88.71 6.88 38.89 86.87 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 67 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.38 39.80 88.71 6.88 38.89 86.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 67 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.38 39.80 88.71 6.88 38.89 86.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 7 3 # 7 C 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 67 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.38 39.80 88.71 6.88 38.89 86.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 8 3 # 8 C 14 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 16 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 67 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.38 39.80 88.71 6.88 38.89 86.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 9 3 # 9 C 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 67 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.38 39.80 88.71 6.88 38.89 86.87 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.63 42.50 89.25 18.11 42.29 88.64 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 10 3 # 10 C 14 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 16 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 67 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.38 39.80 88.71 6.88 38.89 86.87 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 11 3 # 11 C 14 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 67 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 6.38 39.80 88.71 6.88 38.89 86.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 12 3 # 12 C 14 ASP B 91 ASP.? 28.82 ZN ZN B 401 C 16 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 67 GLY B 30 GLY.? 22.35 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 6.38 39.80 88.71 6.88 38.89 86.87 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 17.63 42.50 89.25 18.11 42.29 88.64 -56.71 80.35 9.42 -57.43 80.74 9.40 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 13 3 # 13 C 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 16 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 67 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.38 39.80 88.71 6.88 38.89 86.87 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 14 3 # 14 C 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 16 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 67 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.38 39.80 88.71 6.88 38.89 86.87 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 15 3 # 15 C 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 67 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.38 39.80 88.71 6.88 38.89 86.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 16 3 # 16 C 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 67 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.38 39.80 88.71 6.88 38.89 86.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 17 3 # 17 C 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 67 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.38 39.80 88.71 6.88 38.89 86.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 18 3 # 18 C 14 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 16 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 67 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.38 39.80 88.71 6.88 38.89 86.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 19 3 # 19 C 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 67 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.38 39.80 88.71 6.88 38.89 86.87 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 20 3 # 20 C 14 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 16 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 67 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 10.04 44.27 88.44 9.47 42.32 89.03 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.38 39.80 88.71 6.88 38.89 86.87 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 -42.82 107.61 10.95 -42.53 107.90 10.27 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 20 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN A 78 ASN.? 23.55 ZN ZN A 402 A 225 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 234 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 26.32 35.76 46.63 26.28 33.63 46.67 -37.79 131.52 10.85 -37.74 129.57 11.59 coo 27.04 28.61 41.75 26.86 28.65 43.84 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 21.80 30.48 43.67 23.70 29.06 45.12 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 225 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 234 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 26.32 35.76 46.63 26.28 33.63 46.67 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 27.04 28.61 41.75 26.86 28.65 43.84 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 21.80 30.48 43.67 23.70 29.06 45.12 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1cb8_c00 CHONDROITINASE AC user 3 3 # 3 A 175 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 225 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 234 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 26.32 35.76 46.63 26.28 33.63 46.67 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 27.04 28.61 41.75 26.86 28.65 43.84 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 21.80 30.48 43.67 23.70 29.06 45.12 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1cb8_c00 CHONDROITINASE AC user 4 3 # 4 A 175 ASN B 78 ASN~? 23.25 ZN ZN B 401 A 225 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 234 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 26.32 35.76 46.63 26.28 33.63 46.67 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo 27.04 28.61 41.75 26.86 28.65 43.84 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 21.80 30.48 43.67 23.70 29.06 45.12 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1cb8_c00 CHONDROITINASE AC user 5 3 # 5 A 175 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 225 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 234 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 26.32 35.76 46.63 26.28 33.63 46.67 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 27.04 28.61 41.75 26.86 28.65 43.84 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 21.80 30.48 43.67 23.70 29.06 45.12 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1cb8_c00 CHONDROITINASE AC user 6 3 # 6 A 175 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 225 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 234 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 26.32 35.76 46.63 26.28 33.63 46.67 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 27.04 28.61 41.75 26.86 28.65 43.84 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 21.80 30.48 43.67 23.70 29.06 45.12 -35.81 95.23 5.63 -35.48 92.50 6.11 1cb8_c00 source 1cb8 CHONDROITINASE AC : 6 hits 1cb8_c00 naa= 3 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 1 3 # 1 183 GLU A 48 GLU~? 19.37 ZN ZN A 402 324 ASN A 51 ASN~? 22.86 ZN ZN A 402 397 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 39.31 34.78 85.95 38.51 34.50 84.04 -25.72 127.18 1.29 -24.86 125.22 1.74 coo 43.16 34.25 82.88 42.98 32.71 84.39 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 42.23 29.47 82.87 40.46 30.21 83.67 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 2 3 # 2 183 GLU A 52 GLU~? 18.80 ZN ZN A 402 324 ASN A 51 ASN~? 22.86 ZN ZN A 402 397 GLU A 48 GLU~? 19.37 ZN ZN A 402 coo 39.31 34.78 85.95 38.51 34.50 84.04 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 43.16 34.25 82.88 42.98 32.71 84.39 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 42.23 29.47 82.87 40.46 30.21 83.67 -25.72 127.18 1.29 -24.86 125.22 1.74 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 3 3 # 3 183 GLU A 52 GLU~? 18.80 ZN ZN A 402 324 ASN A 51 ASN~? 22.86 ZN ZN A 402 397 GLU A 55 GLU~? 25.21 ZN ZN A 402 coo 39.31 34.78 85.95 38.51 34.50 84.04 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 43.16 34.25 82.88 42.98 32.71 84.39 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 42.23 29.47 82.87 40.46 30.21 83.67 -20.38 134.54 -4.38 -20.41 132.67 -3.34 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 4 3 # 4 183 GLU A 55 GLU~? 25.21 ZN ZN A 402 324 ASN A 51 ASN~? 22.86 ZN ZN A 402 397 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 39.31 34.78 85.95 38.51 34.50 84.04 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 43.16 34.25 82.88 42.98 32.71 84.39 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 42.23 29.47 82.87 40.46 30.21 83.67 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 5 3 # 5 183 GLU B 48 GLU~? 19.33 ZN ZN B 401 324 ASN B 51 ASN~? 22.98 ZN ZN B 401 397 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 39.31 34.78 85.95 38.51 34.50 84.04 -38.69 82.94 -0.70 -36.82 83.91 -1.11 coo 43.16 34.25 82.88 42.98 32.71 84.39 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 42.23 29.47 82.87 40.46 30.21 83.67 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 6 3 # 6 183 GLU B 52 GLU~? 18.78 ZN ZN B 401 324 ASN B 51 ASN~? 22.98 ZN ZN B 401 397 GLU B 48 GLU~? 19.33 ZN ZN B 401 coo 39.31 34.78 85.95 38.51 34.50 84.04 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 43.16 34.25 82.88 42.98 32.71 84.39 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 42.23 29.47 82.87 40.46 30.21 83.67 -38.69 82.94 -0.70 -36.82 83.91 -1.11 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 7 3 # 7 183 GLU B 52 GLU~? 18.78 ZN ZN B 401 324 ASN B 51 ASN~? 22.98 ZN ZN B 401 397 GLU B 55 GLU~? 25.91 ZN ZN B 401 coo 39.31 34.78 85.95 38.51 34.50 84.04 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 43.16 34.25 82.88 42.98 32.71 84.39 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 42.23 29.47 82.87 40.46 30.21 83.67 -39.07 73.47 3.56 -37.44 74.53 2.68 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 8 3 # 8 183 GLU B 55 GLU~? 25.91 ZN ZN B 401 324 ASN B 51 ASN~? 22.98 ZN ZN B 401 397 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 39.31 34.78 85.95 38.51 34.50 84.04 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 43.16 34.25 82.88 42.98 32.71 84.39 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 42.23 29.47 82.87 40.46 30.21 83.67 -38.47 79.19 7.21 -37.79 81.13 7.79 1cbg_c00 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 8 hits 1cbg_c00 naa= 3 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -40.41 105.08 4.17 -40.72 103.08 3.51 1cde_c04 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c04 naa= 3 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -40.41 105.08 4.17 -40.72 103.08 3.51 1cde_c05 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c05 naa= 3 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -40.41 105.08 4.17 -40.72 103.08 3.51 1cde_c06 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c06 naa= 3 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -40.41 105.08 4.17 -40.72 103.08 3.51 1cde_c07 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c07 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 44 ASP.? 7.09 ZN ZN A 402 264 GLU B 271 GLU.? 25.84 ZN ZN A 402 328 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 59.69 92.71 39.85 58.53 92.03 41.47 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 44 ASP.? 7.09 ZN ZN A 402 264 GLU B 271 GLU.? 25.84 ZN ZN A 402 328 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 59.69 92.71 39.85 58.53 92.03 41.47 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 305 ASP.? 7.62 ZN ZN A 402 264 GLU B 329 GLU~? 2.54 ZN ZN B 402s 328 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 59.69 92.71 39.85 58.53 92.03 41.47 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 310 ASP~? 12.24 ZN ZN B 401 264 GLU A 20 GLU.? 10.86 ZN ZN A 401 328 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP A 310 ASP~? 12.24 ZN ZN B 401 264 GLU A 251 GLU~? 26.78 ZN ZN B 401 328 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 45.39 90.72 40.63 45.07 89.14 41.90 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP A 310 ASP~? 12.24 ZN ZN B 401 264 GLU B 20 GLU.? 11.09 ZN ZN B 402 328 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP A 310 ASP~? 12.24 ZN ZN B 401 264 GLU B 290 GLU~? 16.07 ZN ZN B 401 328 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP A 310 ASP~? 12.24 ZN ZN B 401 264 GLU B 290 GLU~? 16.07 ZN ZN B 401 328 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP A 323 ASP^? 12.30 ZN ZN A 402 264 GLU B 290 GLU~? 16.07 ZN ZN B 401 328 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 59.69 92.71 39.85 58.53 92.03 41.47 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP A 323 ASP^? 12.30 ZN ZN A 402 264 GLU B 329 GLU~? 2.54 ZN ZN B 402s 328 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 59.69 92.71 39.85 58.53 92.03 41.47 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 45.39 90.72 40.63 45.07 89.14 41.90 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP A 361 ASP.? 11.77 ZN ZN A 402 264 GLU B 290 GLU~? 16.07 ZN ZN B 401 328 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 59.69 92.71 39.85 58.53 92.03 41.47 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP B 148 ASP~? 45.03 ZN ZN B 402 264 GLU B 167 GLU^? 53.31 ZN ZN B 402 328 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 59.69 92.71 39.85 58.53 92.03 41.47 -79.62 113.37 49.20 -81.22 112.07 48.69 coo 45.39 90.72 40.63 45.07 89.14 41.90 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP B 305 ASP.? 7.64 ZN ZN B 401 264 GLU A 329 GLU~? 2.55 ZN ZN A 401s 328 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 59.69 92.71 39.85 58.53 92.03 41.47 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP B 310 ASP~? 12.35 ZN ZN A 402 264 GLU A 20 GLU.? 10.86 ZN ZN A 401 328 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP B 310 ASP~? 12.35 ZN ZN A 402 264 GLU A 290 GLU~? 16.18 ZN ZN A 402 328 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP B 310 ASP~? 12.35 ZN ZN A 402 264 GLU A 290 GLU~? 16.18 ZN ZN A 402 328 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP B 310 ASP~? 12.35 ZN ZN A 402 264 GLU B 20 GLU.? 11.09 ZN ZN B 402 328 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 59.69 92.71 39.85 58.53 92.03 41.47 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP B 323 ASP^? 12.28 ZN ZN B 401 264 GLU A 329 GLU~? 2.55 ZN ZN A 401s 328 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 59.69 92.71 39.85 58.53 92.03 41.47 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP B 361 ASP.? 11.71 ZN ZN B 401 264 GLU A 290 GLU~? 16.18 ZN ZN A 402 328 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.41 105.08 4.17 -40.72 103.08 3.51 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 19 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 23 ASP.? 8.14 ZN ZN A 401 257 GLU A 20 GLU.? 10.86 ZN ZN A 401 328 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 45.62 80.42 43.69 45.65 82.01 45.07 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 48.97 85.16 40.39 47.18 86.25 40.47 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 102 ASP~? -1.98 ZN ZN A 401s 257 GLU A 20 GLU.? 10.86 ZN ZN A 401 328 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 48.97 85.16 40.39 47.18 86.25 40.47 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 23 ASP.? 8.15 ZN ZN B 402 257 GLU B 20 GLU.? 11.09 ZN ZN B 402 328 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 45.62 80.42 43.69 45.65 82.01 45.07 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 48.97 85.16 40.39 47.18 86.25 40.47 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 102 ASP~? -1.99 ZN ZN B 402s 257 GLU B 20 GLU.? 11.09 ZN ZN B 402 328 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 45.62 80.42 43.69 45.65 82.01 45.07 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 48.97 85.16 40.39 47.18 86.25 40.47 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 -54.33 98.57 11.88 -52.50 97.53 11.52 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 4 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS B 218 HIS~? 47.61 ZN ZN B 402 A 262 GLU B 195 GLU^? 52.10 ZN ZN B 402 A 358 GLU B 167 GLU^? 53.31 ZN ZN B 402 coo 26.19 60.87 43.98 27.48 59.27 43.30 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 27.13 54.07 50.45 26.96 54.19 48.35 -77.28 109.06 51.77 -78.42 110.03 50.31 coo 27.06 50.43 44.36 27.99 52.27 44.74 -79.62 113.37 49.20 -81.22 112.07 48.69 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 1 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS B 218 HIS~? 47.61 ZN ZN B 402 B 262 GLU B 195 GLU^? 52.10 ZN ZN B 402 B 358 GLU B 167 GLU^? 53.31 ZN ZN B 402 coo 44.98 77.01 48.39 44.42 78.67 47.18 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 41.60 83.57 54.16 42.46 83.24 52.25 -77.28 109.06 51.77 -78.42 110.03 50.31 coo 44.05 87.61 48.73 43.15 85.67 48.52 -79.62 113.37 49.20 -81.22 112.07 48.69 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 1 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 237 GLY^? 12.04 ZN ZN A 401 A 228 SER A 234 SER^? 16.92 ZN ZN A 401 A 549 ASP A 129 ASP^? 19.65 ZN ZN A 401 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -45.65 113.20 -21.30 -44.96 113.62 -21.16 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -49.27 115.09 -27.36 -48.74 116.76 -25.71 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -52.93 118.26 -28.24 -51.00 118.44 -27.37 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 228 SER A 285 SER.? 7.68 ZN ZN A 402 A 549 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 154 GLY~? 39.11 ZN ZN B 402 A 228 SER B 151 SER~? 41.75 ZN ZN B 402 A 549 ASP B 148 ASP~? 45.03 ZN ZN B 402 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -69.92 90.56 40.93 -69.24 90.91 41.18 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -68.50 97.10 50.23 -68.22 99.17 50.65 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 237 GLY^? 12.12 ZN ZN B 402 A 228 SER B 234 SER^? 16.76 ZN ZN B 402 A 549 ASP B 129 ASP^? 19.14 ZN ZN B 402 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -47.85 104.85 22.36 -47.42 104.12 22.23 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -51.96 104.93 28.41 -52.09 103.33 26.64 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -57.17 104.15 28.46 -55.58 103.29 27.35 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 228 SER B 285 SER.? 7.72 ZN ZN B 401 A 549 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -40.41 105.08 4.17 -40.72 103.08 3.51 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 5 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 237 GLY^? 12.04 ZN ZN A 401 B1228 SER A 234 SER^? 16.92 ZN ZN A 401 B1549 ASP A 129 ASP^? 19.65 ZN ZN A 401 coo 126.34 72.75 125.66 125.95 73.27 126.11 -45.65 113.20 -21.30 -44.96 113.62 -21.16 coo 131.65 74.68 129.41 130.31 72.73 128.82 -49.27 115.09 -27.36 -48.74 116.76 -25.71 coo 134.72 69.43 130.42 133.03 70.65 130.08 -52.93 118.26 -28.24 -51.00 118.44 -27.37 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 283 GLY.? 5.77 ZN ZN A 401 B1228 SER A 285 SER.? 7.68 ZN ZN A 402 B1549 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 126.34 72.75 125.66 125.95 73.27 126.11 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 131.65 74.68 129.41 130.31 72.73 128.82 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 134.72 69.43 130.42 133.03 70.65 130.08 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 154 GLY~? 39.11 ZN ZN B 402 B1228 SER B 151 SER~? 41.75 ZN ZN B 402 B1549 ASP B 148 ASP~? 45.03 ZN ZN B 402 coo 126.34 72.75 125.66 125.95 73.27 126.11 -69.92 90.56 40.93 -69.24 90.91 41.18 coo 131.65 74.68 129.41 130.31 72.73 128.82 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 134.72 69.43 130.42 133.03 70.65 130.08 -68.50 97.10 50.23 -68.22 99.17 50.65 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 237 GLY^? 12.12 ZN ZN B 402 B1228 SER B 234 SER^? 16.76 ZN ZN B 402 B1549 ASP B 129 ASP^? 19.14 ZN ZN B 402 coo 126.34 72.75 125.66 125.95 73.27 126.11 -47.85 104.85 22.36 -47.42 104.12 22.23 coo 131.65 74.68 129.41 130.31 72.73 128.82 -51.96 104.93 28.41 -52.09 103.33 26.64 coo 134.72 69.43 130.42 133.03 70.65 130.08 -57.17 104.15 28.46 -55.58 103.29 27.35 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 283 GLY.? 5.97 ZN ZN B 402 B1228 SER B 285 SER.? 7.72 ZN ZN B 401 B1549 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 126.34 72.75 125.66 125.95 73.27 126.11 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 131.65 74.68 129.41 130.31 72.73 128.82 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 134.72 69.43 130.42 133.03 70.65 130.08 -40.41 105.08 4.17 -40.72 103.08 3.51 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 5 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 305 ASP.? 7.62 ZN ZN A 402 37 SER A 285 SER.? 7.68 ZN ZN A 402 216 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 16.90 26.20 29.49 16.22 24.50 28.41 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 12.23 24.31 30.40 14.55 23.96 31.03 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 13.93 25.52 22.10 14.75 24.44 23.75 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP A 305 ASP.? 7.62 ZN ZN A 402 37 SER A 285 SER.? 7.68 ZN ZN A 402 216 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 16.90 26.20 29.49 16.22 24.50 28.41 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 12.23 24.31 30.40 14.55 23.96 31.03 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 13.93 25.52 22.10 14.75 24.44 23.75 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP B 305 ASP.? 7.64 ZN ZN B 401 37 SER B 285 SER.? 7.72 ZN ZN B 401 216 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 16.90 26.20 29.49 16.22 24.50 28.41 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 12.23 24.31 30.40 14.55 23.96 31.03 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 13.93 25.52 22.10 14.75 24.44 23.75 -33.57 107.34 6.30 -34.87 106.07 5.21 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 3 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 55 GLU~? 25.21 ZN ZN A 402 A 89 GLU A 354 GLU^? 23.23 ZN ZN A 401 A 120 SER A 356 SER.? 15.95 ZN ZN A 402 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -25.62 125.96 -9.58 -26.36 125.95 -7.28 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 55 GLU~? 25.91 ZN ZN B 401 A 89 GLU B 354 GLU^? 23.36 ZN ZN B 402 A 120 SER B 356 SER.? 15.96 ZN ZN B 401 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -39.07 73.47 3.56 -37.44 74.53 2.68 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -37.43 78.09 15.20 -36.78 76.82 13.66 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -37.69 83.51 10.20 -38.30 83.95 7.88 1cns_c00 source 1cns CHITINASE : 2 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 55 GLU~? 25.21 ZN ZN A 402 B 89 GLU A 354 GLU^? 23.23 ZN ZN A 401 B 120 SER A 356 SER.? 15.95 ZN ZN A 402 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -25.62 125.96 -9.58 -26.36 125.95 -7.28 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 55 GLU~? 25.91 ZN ZN B 401 B 89 GLU B 354 GLU^? 23.36 ZN ZN B 402 B 120 SER B 356 SER.? 15.96 ZN ZN B 401 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -37.69 83.51 10.20 -38.30 83.95 7.88 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 162 GLU^? 46.76 ZN ZN B 402 B 89 GLU B 158 GLU.? 36.73 ZN ZN B 402 B 120 SER B 151 SER~? 41.75 ZN ZN B 402 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -66.72 104.17 51.47 -67.64 102.80 52.82 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -60.87 94.33 46.47 -60.36 92.90 44.98 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -70.52 94.90 44.12 -71.51 97.15 44.18 1cns_c01 source 1cns CHITINASE : 3 hits 1cns_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 20 GLU.? 10.86 ZN ZN A 401 447 HIS A 98 HIS~? 4.98 ZN ZN A 401 485 ASN A 100 ASN~? 9.95 ZN ZN A 401 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -44.05 122.82 -17.82 -42.95 124.35 -16.78 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 2 3 # 2 361 GLU A 329 GLU~? 2.55 ZN ZN A 401s 447 HIS B 308 HIS~? 6.54 ZN ZN A 402 485 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 3 3 # 3 361 GLU B 20 GLU.? 11.09 ZN ZN B 402 447 HIS B 98 HIS~? 5.02 ZN ZN B 402 485 ASN B 100 ASN~? 9.88 ZN ZN B 402 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -52.94 103.12 14.27 -53.36 104.69 15.60 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -51.48 95.86 18.73 -51.39 94.02 17.58 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 4 3 # 4 361 GLU B 329 GLU~? 2.54 ZN ZN B 402s 447 HIS A 308 HIS~? 6.49 ZN ZN B 401 485 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -34.08 101.07 5.49 -32.41 102.02 4.50 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 4 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 173 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 24.35 4.55 25.11 25.94 3.23 25.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 173 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 48 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 24.35 4.55 25.11 25.94 3.23 25.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 173 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 48 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 24.35 4.55 25.11 25.94 3.23 25.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 173 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 24.35 4.55 25.11 25.94 3.23 25.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -31.38 108.30 2.45 -33.79 107.47 0.72 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 101 TYR A 365 TYR^? 16.07 ZN ZN A 402 C 173 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 32.27 5.62 48.15 31.93 6.48 51.06 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 29.64 3.64 57.39 31.22 5.14 55.65 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 101 TYR B 327 TYR~? 10.21 ZN ZN B 401 C 173 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 32.27 5.62 48.15 31.93 6.48 51.06 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 29.64 3.64 57.39 31.22 5.14 55.65 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 101 TYR A 327 TYR~? 10.33 ZN ZN A 402 C 173 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 32.27 5.62 48.15 31.93 6.48 51.06 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 29.64 3.64 57.39 31.22 5.14 55.65 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 101 TYR B 365 TYR^? 15.98 ZN ZN B 401 C 173 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 32.27 5.62 48.15 31.93 6.48 51.06 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 29.64 3.64 57.39 31.22 5.14 55.65 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -34.85 93.86 2.41 -34.87 96.02 2.16 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 267 ARG^? 13.45 ZN ZN B 401 D 101 TYR A 365 TYR^? 16.07 ZN ZN A 402 D 173 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 69.08 8.58 32.60 69.70 10.81 30.58 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 71.77 11.86 24.26 70.23 12.22 26.56 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 71.60 6.14 19.25 70.26 6.87 20.69 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 D 101 TYR A 327 TYR~? 10.33 ZN ZN A 402 D 173 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 69.08 8.58 32.60 69.70 10.81 30.58 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 71.77 11.86 24.26 70.23 12.22 26.56 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 71.60 6.14 19.25 70.26 6.87 20.69 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 D 101 TYR B 365 TYR^? 15.98 ZN ZN B 401 D 173 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 69.08 8.58 32.60 69.70 10.81 30.58 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 71.77 11.86 24.26 70.23 12.22 26.56 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 71.60 6.14 19.25 70.26 6.87 20.69 -34.85 93.86 2.41 -34.87 96.02 2.16 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 173 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 173 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 48 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 173 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 48 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 173 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 48 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -31.38 108.30 2.45 -33.79 107.47 0.72 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 77 ALA.? 26.87 ZN ZN A 402 A 74 ASN A 78 ASN.? 23.55 ZN ZN A 402 A 75 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -36.92 135.43 9.04 -36.12 136.57 9.66 coo 1.20 66.40 122.20 2.03 64.53 121.46 -37.79 131.52 10.85 -37.74 129.57 11.59 coo 4.68 65.84 125.52 4.11 65.60 126.05 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 77 ALA.? 26.95 ZN ZN B 401 A 74 ASN B 78 ASN~? 23.25 ZN ZN B 401 A 75 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -52.41 81.95 -8.48 -52.31 80.63 -9.24 coo 1.20 66.40 122.20 2.03 64.53 121.46 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo 4.68 65.84 125.52 4.11 65.60 126.05 -48.98 87.93 -6.69 -49.20 87.16 -6.43 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 77 ALA.? 26.87 ZN ZN A 402 B 74 ASN A 78 ASN.? 23.55 ZN ZN A 402 B 75 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo 39.21 14.97 27.55 40.19 16.01 27.08 -36.92 135.43 9.04 -36.12 136.57 9.66 coo 43.06 12.94 25.74 42.26 11.81 27.44 -37.79 131.52 10.85 -37.74 129.57 11.59 coo 46.38 13.54 29.18 46.14 14.29 29.26 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 77 ALA.? 26.95 ZN ZN B 401 B 74 ASN B 78 ASN~? 23.25 ZN ZN B 401 B 75 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo 39.21 14.97 27.55 40.19 16.01 27.08 -52.41 81.95 -8.48 -52.31 80.63 -9.24 coo 43.06 12.94 25.74 42.26 11.81 27.44 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo 46.38 13.54 29.18 46.14 14.29 29.26 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA B 77 ALA.? 26.95 ZN ZN B 401 B 74 ASN B 78 ASN~? 23.25 ZN ZN B 401 B 75 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 39.21 14.97 27.55 40.19 16.01 27.08 -52.41 81.95 -8.48 -52.31 80.63 -9.24 coo 43.06 12.94 25.74 42.26 11.81 27.44 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo 46.38 13.54 29.18 46.14 14.29 29.26 -53.02 85.53 -4.18 -52.23 85.45 -4.06 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 3 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 77 ALA.? 26.87 ZN ZN A 402 C 74 ASN A 78 ASN.? 23.55 ZN ZN A 402 C 75 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo 16.14 15.08 36.63 15.28 14.65 37.81 -36.92 135.43 9.04 -36.12 136.57 9.66 coo 11.60 16.13 36.70 12.80 17.74 35.96 -37.79 131.52 10.85 -37.74 129.57 11.59 coo 10.99 19.23 40.32 11.50 18.77 40.74 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 77 ALA.? 26.95 ZN ZN B 401 C 74 ASN B 78 ASN~? 23.25 ZN ZN B 401 C 75 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo 16.14 15.08 36.63 15.28 14.65 37.81 -52.41 81.95 -8.48 -52.31 80.63 -9.24 coo 11.60 16.13 36.70 12.80 17.74 35.96 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo 10.99 19.23 40.32 11.50 18.77 40.74 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA B 77 ALA.? 26.95 ZN ZN B 401 C 74 ASN B 78 ASN~? 23.25 ZN ZN B 401 C 75 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 16.14 15.08 36.63 15.28 14.65 37.81 -52.41 81.95 -8.48 -52.31 80.63 -9.24 coo 11.60 16.13 36.70 12.80 17.74 35.96 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo 10.99 19.23 40.32 11.50 18.77 40.74 -53.02 85.53 -4.18 -52.23 85.45 -4.06 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 3 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 77 ALA.? 26.87 ZN ZN A 402 D 74 ASN A 78 ASN.? 23.55 ZN ZN A 402 D 75 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -36.92 135.43 9.04 -36.12 136.57 9.66 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -37.79 131.52 10.85 -37.74 129.57 11.59 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 77 ALA.? 26.95 ZN ZN B 401 D 74 ASN B 78 ASN~? 23.25 ZN ZN B 401 D 75 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -52.41 81.95 -8.48 -52.31 80.63 -9.24 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA B 77 ALA.? 26.95 ZN ZN B 401 D 74 ASN B 78 ASN~? 23.25 ZN ZN B 401 D 75 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -52.41 81.95 -8.48 -52.31 80.63 -9.24 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -53.02 85.53 -4.18 -52.23 85.45 -4.06 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 3 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 23 ASP.? 8.14 ZN ZN A 401 315 GLU A 20 GLU.? 10.86 ZN ZN A 401 390 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 32.46 99.13 19.34 30.94 100.38 20.07 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 32.04 94.22 18.23 30.57 94.75 16.88 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 21.10 94.74 18.36 23.09 96.71 18.59 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 23 ASP.? 8.15 ZN ZN B 402 315 GLU B 20 GLU.? 11.09 ZN ZN B 402 390 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 32.46 99.13 19.34 30.94 100.38 20.07 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 32.04 94.22 18.23 30.57 94.75 16.88 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 21.10 94.74 18.36 23.09 96.71 18.59 -50.67 100.24 25.02 -50.96 97.90 26.55 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 2 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 340 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 395 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 340 GLU A 32 GLU.? 25.81 ZN ZN A 401 A 395 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 340 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 395 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -52.94 103.12 14.27 -53.36 104.69 15.60 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP B 33 ASP.? 29.43 ZN ZN B 402 A 340 GLU B 32 GLU.? 22.53 ZN ZN B 402 A 395 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -61.26 74.82 15.61 -62.97 76.13 15.50 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -60.68 81.34 15.57 -59.87 82.93 16.69 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -55.09 78.54 23.42 -56.64 77.16 23.83 1cwy_c00 source 1cwy AMYLOMALTASE : 4 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 56 ILE A 83 ILE~? 16.75 ZN ZN A 402 A 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -35.09 130.83 0.93 -34.69 129.58 0.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 56 ILE A 84 ILE~? 19.03 ZN ZN A 402 A 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -39.50 133.79 0.55 -40.78 133.29 0.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 56 ILE B 316 ILE~? 16.17 ZN ZN A 402 A 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -35.12 124.50 5.59 -36.00 125.53 5.05 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 56 ILE A 123 ILE^? 13.60 ZN ZN A 401 A 82 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -42.37 111.59 -24.59 -42.44 112.43 -23.33 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 56 ILE A 202 ILE^? 32.06 ZN ZN A 401 A 82 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -58.55 126.16 -35.21 -59.50 126.41 -34.93 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP A 226 ASP^? 42.28 ZN ZN A 401 A 56 ILE A 202 ILE^? 32.06 ZN ZN A 401 A 82 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -58.55 126.16 -35.21 -59.50 126.41 -34.93 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP A 226 ASP^? 42.28 ZN ZN A 401 A 56 ILE A 230 ILE^? 30.67 ZN ZN A 401 A 82 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -59.63 116.03 -34.09 -59.81 115.87 -35.09 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 56 ILE A 282 ILE.? 8.29 ZN ZN A 401 A 82 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -41.08 108.84 -13.73 -42.55 109.16 -13.89 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 56 ILE A 316 ILE~? 15.52 ZN ZN B 401 A 82 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -45.28 90.15 -4.45 -45.68 89.80 -3.16 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 56 ILE B 366 ILE.? 22.82 ZN ZN A 402 A 82 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -25.45 98.14 -5.79 -25.88 98.28 -6.68 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -29.29 98.99 -0.08 -31.62 99.98 1.12 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 11 3 # 11 A 37 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 56 ILE B 83 ILE~? 16.86 ZN ZN B 401 A 82 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -48.53 84.68 -0.37 -47.40 85.47 0.16 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 12 3 # 12 A 37 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 56 ILE B 84 ILE~? 19.15 ZN ZN B 401 A 82 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -53.77 84.46 0.19 -54.63 85.53 0.45 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 13 3 # 13 A 37 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 56 ILE B 123 ILE^? 13.64 ZN ZN B 402 A 82 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -44.12 104.39 25.62 -44.56 103.69 24.38 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -50.67 100.24 25.02 -50.96 97.90 26.55 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 14 3 # 14 A 37 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 56 ILE B 202 ILE^? 32.20 ZN ZN B 402 A 82 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -65.91 100.86 35.75 -67.21 101.12 35.73 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 15 3 # 15 A 37 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 56 ILE B 202 ILE^? 32.20 ZN ZN B 402 A 82 TYR B 205 TYR.? 27.03 ZN ZN B 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -65.91 100.86 35.75 -67.21 101.12 35.73 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -65.21 96.58 29.25 -63.97 94.97 31.18 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 16 3 # 16 A 37 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 56 ILE B 214 ILE~? 41.81 ZN ZN B 402 A 82 TYR B 217 TYR~? 45.33 ZN ZN B 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -75.46 100.59 40.76 -74.65 101.72 40.90 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -76.80 93.86 44.47 -76.40 91.42 43.11 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 17 3 # 17 A 37 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 56 ILE B 202 ILE^? 32.20 ZN ZN B 402 A 82 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -65.91 100.86 35.75 -67.21 101.12 35.73 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 18 3 # 18 A 37 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 56 ILE B 230 ILE^? 30.36 ZN ZN B 402 A 82 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -61.42 109.27 34.74 -60.97 110.26 35.79 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 19 3 # 19 A 37 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 56 ILE B 282 ILE.? 8.31 ZN ZN B 402 A 82 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -41.66 106.21 14.73 -43.02 106.75 14.92 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 20 3 # 20 A 37 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 56 ILE B 316 ILE~? 16.17 ZN ZN A 402 A 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -35.12 124.50 5.59 -36.00 125.53 5.05 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 21 3 # 21 A 37 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 56 ILE A 366 ILE^? 22.68 ZN ZN B 401 A 82 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -22.84 106.79 6.58 -23.22 107.47 7.80 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -26.53 108.54 0.92 -29.08 108.89 -0.28 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 21 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 56 ILE A 83 ILE~? 16.75 ZN ZN A 402 B 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -35.09 130.83 0.93 -34.69 129.58 0.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 56 ILE A 84 ILE~? 19.03 ZN ZN A 402 B 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -39.50 133.79 0.55 -40.78 133.29 0.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 56 ILE B 316 ILE~? 16.17 ZN ZN A 402 B 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -35.12 124.50 5.59 -36.00 125.53 5.05 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 56 ILE A 123 ILE^? 13.60 ZN ZN A 401 B 82 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -42.37 111.59 -24.59 -42.44 112.43 -23.33 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 56 ILE A 202 ILE^? 32.06 ZN ZN A 401 B 82 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -58.55 126.16 -35.21 -59.50 126.41 -34.93 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP A 226 ASP^? 42.28 ZN ZN A 401 B 56 ILE A 202 ILE^? 32.06 ZN ZN A 401 B 82 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -58.55 126.16 -35.21 -59.50 126.41 -34.93 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP A 226 ASP^? 42.28 ZN ZN A 401 B 56 ILE A 230 ILE^? 30.67 ZN ZN A 401 B 82 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -59.63 116.03 -34.09 -59.81 115.87 -35.09 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 56 ILE A 282 ILE.? 8.29 ZN ZN A 401 B 82 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -41.08 108.84 -13.73 -42.55 109.16 -13.89 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 56 ILE A 316 ILE~? 15.52 ZN ZN B 401 B 82 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -45.28 90.15 -4.45 -45.68 89.80 -3.16 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 10 3 # 10 B 37 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 56 ILE B 366 ILE.? 22.82 ZN ZN A 402 B 82 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -25.45 98.14 -5.79 -25.88 98.28 -6.68 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -29.29 98.99 -0.08 -31.62 99.98 1.12 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 11 3 # 11 B 37 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 56 ILE A 316 ILE~? 15.52 ZN ZN B 401 B 82 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -45.28 90.15 -4.45 -45.68 89.80 -3.16 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 12 3 # 12 B 37 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 56 ILE B 83 ILE~? 16.86 ZN ZN B 401 B 82 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -48.53 84.68 -0.37 -47.40 85.47 0.16 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 13 3 # 13 B 37 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 56 ILE B 84 ILE~? 19.15 ZN ZN B 401 B 82 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -53.77 84.46 0.19 -54.63 85.53 0.45 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 14 3 # 14 B 37 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 56 ILE B 123 ILE^? 13.64 ZN ZN B 402 B 82 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -44.12 104.39 25.62 -44.56 103.69 24.38 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -50.67 100.24 25.02 -50.96 97.90 26.55 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 15 3 # 15 B 37 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 56 ILE B 202 ILE^? 32.20 ZN ZN B 402 B 82 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -65.91 100.86 35.75 -67.21 101.12 35.73 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 16 3 # 16 B 37 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 56 ILE B 202 ILE^? 32.20 ZN ZN B 402 B 82 TYR B 205 TYR.? 27.03 ZN ZN B 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -65.91 100.86 35.75 -67.21 101.12 35.73 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -65.21 96.58 29.25 -63.97 94.97 31.18 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 17 3 # 17 B 37 ASP B 148 ASP~? 45.03 ZN ZN B 402 B 56 ILE B 214 ILE~? 41.81 ZN ZN B 402 B 82 TYR B 217 TYR~? 45.33 ZN ZN B 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -75.46 100.59 40.76 -74.65 101.72 40.90 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -76.80 93.86 44.47 -76.40 91.42 43.11 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 18 3 # 18 B 37 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 56 ILE B 202 ILE^? 32.20 ZN ZN B 402 B 82 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -65.91 100.86 35.75 -67.21 101.12 35.73 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 19 3 # 19 B 37 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 56 ILE B 230 ILE^? 30.36 ZN ZN B 402 B 82 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -61.42 109.27 34.74 -60.97 110.26 35.79 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 20 3 # 20 B 37 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 56 ILE B 282 ILE.? 8.31 ZN ZN B 402 B 82 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -41.66 106.21 14.73 -43.02 106.75 14.92 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 21 3 # 21 B 37 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 56 ILE B 316 ILE~? 16.17 ZN ZN A 402 B 82 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -35.12 124.50 5.59 -36.00 125.53 5.05 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 22 3 # 22 B 37 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 56 ILE A 366 ILE^? 22.68 ZN ZN B 401 B 82 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -22.84 106.79 6.58 -23.22 107.47 7.80 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -26.53 108.54 0.92 -29.08 108.89 -0.28 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 22 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 58 TYR.? 23.12 ZN ZN A 401 A 243 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 272 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 243 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 272 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 14.13 45.79 13.40 14.25 49.41 18.30 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 106 TYR.? 16.47 ZN ZN A 401 A 243 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 272 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -35.63 118.61 -26.09 -35.73 117.84 -28.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 14.13 45.79 13.40 14.25 49.41 18.30 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 205 TYR~? 27.31 ZN ZN A 401 A 243 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 272 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo 16.93 55.67 9.65 17.16 54.23 11.19 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.13 45.79 13.40 14.25 49.41 18.30 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR A 236 TYR^? 14.83 ZN ZN A 401 A 243 ASP A 5 ASP~? 27.21 ZN ZN A 401 A 272 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo 16.93 55.67 9.65 17.16 54.23 11.19 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 14.13 45.79 13.40 14.25 49.41 18.30 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR A 289 TYR~? 11.74 ZN ZN A 401 A 243 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 272 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -46.60 106.88 -13.53 -48.07 109.27 -13.63 coo 16.93 55.67 9.65 17.16 54.23 11.19 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR A 289 TYR~? 11.74 ZN ZN A 401 A 243 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 272 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -46.60 106.88 -13.53 -48.07 109.27 -13.63 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 243 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 272 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 14.13 45.79 13.40 14.25 49.41 18.30 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 243 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 272 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 243 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 272 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 243 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 272 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 14.13 45.79 13.40 14.25 49.41 18.30 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 243 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 272 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.13 45.79 13.40 14.25 49.41 18.30 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 243 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 272 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 243 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 272 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.13 45.79 13.40 14.25 49.41 18.30 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 243 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 272 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 173 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 243 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 272 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 17 3 # 17 A 173 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 243 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 272 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.13 45.79 13.40 14.25 49.41 18.30 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 18 3 # 18 A 173 TYR B 58 TYR.? 23.40 ZN ZN B 402 A 243 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 272 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 16.93 55.67 9.65 17.16 54.23 11.19 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.13 45.79 13.40 14.25 49.41 18.30 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 19 3 # 19 A 173 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 243 ASP B 31 ASP.? 28.05 ZN ZN B 402 A 272 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 -58.98 76.97 11.28 -60.60 75.86 12.07 coo 14.13 45.79 13.40 14.25 49.41 18.30 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 20 3 # 20 A 173 TYR B 106 TYR.? 16.25 ZN ZN B 402 A 243 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 272 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -42.51 94.75 26.81 -43.21 95.38 29.42 coo 16.93 55.67 9.65 17.16 54.23 11.19 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 14.13 45.79 13.40 14.25 49.41 18.30 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 21 3 # 21 A 173 TYR B 106 TYR.? 16.25 ZN ZN B 402 A 243 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 272 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -42.51 94.75 26.81 -43.21 95.38 29.42 coo 16.93 55.67 9.65 17.16 54.23 11.19 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 14.13 45.79 13.40 14.25 49.41 18.30 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 22 3 # 22 A 173 TYR B 205 TYR.? 27.03 ZN ZN B 402 A 243 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 272 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -65.21 96.58 29.25 -63.97 94.97 31.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 23 3 # 23 A 173 TYR B 236 TYR^? 14.81 ZN ZN B 402 A 243 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 272 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -50.67 100.24 25.02 -50.96 97.90 26.55 coo 16.93 55.67 9.65 17.16 54.23 11.19 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 24 3 # 24 A 173 TYR B 289 TYR~? 11.74 ZN ZN B 402 A 243 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 272 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -45.28 110.80 14.60 -47.79 109.56 14.66 coo 16.93 55.67 9.65 17.16 54.23 11.19 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.13 45.79 13.40 14.25 49.41 18.30 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 25 3 # 25 A 173 TYR B 289 TYR~? 11.74 ZN ZN B 402 A 243 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 272 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -45.28 110.80 14.60 -47.79 109.56 14.66 coo 16.93 55.67 9.65 17.16 54.23 11.19 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.13 45.79 13.40 14.25 49.41 18.30 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 26 3 # 26 A 173 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 243 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 272 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 16.93 55.67 9.65 17.16 54.23 11.19 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 14.13 45.79 13.40 14.25 49.41 18.30 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 27 3 # 27 A 173 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 243 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 272 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 2.03 68.31 21.46 0.66 68.36 23.90 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 16.93 55.67 9.65 17.16 54.23 11.19 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 28 3 # 28 A 173 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 243 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 272 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 16.93 55.67 9.65 17.16 54.23 11.19 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 29 3 # 29 A 173 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 243 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 272 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 30 3 # 30 A 173 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 243 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 272 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 14.13 45.79 13.40 14.25 49.41 18.30 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 31 3 # 31 A 173 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 243 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 272 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 32 3 # 32 A 173 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 243 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 272 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 16.93 55.67 9.65 17.16 54.23 11.19 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 33 3 # 33 A 173 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 243 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 272 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.13 45.79 13.40 14.25 49.41 18.30 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 34 3 # 34 A 173 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 243 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 272 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 14.13 45.79 13.40 14.25 49.41 18.30 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 35 3 # 35 A 173 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 243 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 272 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 2.03 68.31 21.46 0.66 68.36 23.90 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 14.13 45.79 13.40 14.25 49.41 18.30 -28.04 112.73 23.24 -26.21 110.17 27.80 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 35 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 114 LYS~? 19.79 ZN ZN A 401 A 177 GLU A 243 GLU^? 24.16 ZN ZN A 401 A 201 LEU A 118 LEU.? 17.93 ZN ZN A 401 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -30.67 105.34 -22.45 -30.63 104.16 -20.59 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 275 LYS^? 30.46 ZN ZN A 401 A 177 GLU A 251 GLU~? 26.78 ZN ZN B 401 A 201 LEU A 250 LEU~? 23.30 ZN ZN A 401 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -31.53 93.90 -12.58 -33.05 95.11 -11.68 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 275 LYS^? 30.46 ZN ZN A 401 A 177 GLU A 271 GLU.? 22.11 ZN ZN B 401 A 201 LEU A 250 LEU~? 23.30 ZN ZN A 401 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -31.53 93.90 -12.58 -33.05 95.11 -11.68 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS A 315 LYS~? 18.17 ZN ZN B 401 A 177 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 201 LEU A 321 LEU^? 17.19 ZN ZN A 402 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -38.24 99.25 -8.68 -40.42 99.39 -8.43 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 177 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 201 LEU A 43 LEU.? 6.88 ZN ZN A 402 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -32.46 120.53 -8.10 -33.63 118.65 -7.87 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 177 GLU B 243 GLU^? 24.39 ZN ZN B 402 A 201 LEU B 118 LEU.? 17.96 ZN ZN B 402 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -30.73 103.70 23.32 -30.35 104.63 21.37 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS B 275 LYS^? 32.38 ZN ZN B 402 A 177 GLU B 251 GLU~? 27.55 ZN ZN A 402 A 201 LEU B 250 LEU~? 23.28 ZN ZN B 402 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -20.38 111.90 11.61 -18.92 112.78 10.34 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -25.70 113.88 13.60 -27.64 113.69 12.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS B 275 LYS^? 32.38 ZN ZN B 402 A 177 GLU B 271 GLU.? 25.84 ZN ZN A 402 A 201 LEU B 250 LEU~? 23.28 ZN ZN B 402 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -25.70 113.88 13.60 -27.64 113.69 12.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS B 315 LYS~? 18.28 ZN ZN A 402 A 177 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 201 LEU B 321 LEU^? 17.10 ZN ZN B 401 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -34.15 112.90 9.63 -36.13 113.84 9.47 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 177 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 201 LEU B 43 LEU.? 6.82 ZN ZN B 401 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -40.65 91.81 8.75 -40.59 94.01 8.67 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 10 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 114 LYS~? 19.79 ZN ZN A 401 B 177 GLU A 243 GLU^? 24.16 ZN ZN A 401 B 201 LEU A 118 LEU.? 17.93 ZN ZN A 401 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 27.00 6.35 51.01 26.30 4.53 50.18 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -30.67 105.34 -22.45 -30.63 104.16 -20.59 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 275 LYS^? 30.46 ZN ZN A 401 B 177 GLU A 251 GLU~? 26.78 ZN ZN B 401 B 201 LEU A 250 LEU~? 23.30 ZN ZN A 401 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 27.00 6.35 51.01 26.30 4.53 50.18 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -31.53 93.90 -12.58 -33.05 95.11 -11.68 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 315 LYS~? 18.17 ZN ZN B 401 B 177 GLU A 290 GLU~? 16.18 ZN ZN A 402 B 201 LEU A 321 LEU^? 17.19 ZN ZN A 402 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 27.00 6.35 51.01 26.30 4.53 50.18 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -38.24 99.25 -8.68 -40.42 99.39 -8.43 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 177 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 201 LEU A 43 LEU.? 6.88 ZN ZN A 402 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 27.00 6.35 51.01 26.30 4.53 50.18 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -32.46 120.53 -8.10 -33.63 118.65 -7.87 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 114 LYS~? 19.44 ZN ZN B 402 B 177 GLU B 243 GLU^? 24.39 ZN ZN B 402 B 201 LEU B 118 LEU.? 17.96 ZN ZN B 402 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 27.00 6.35 51.01 26.30 4.53 50.18 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -30.73 103.70 23.32 -30.35 104.63 21.37 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS B 275 LYS^? 32.38 ZN ZN B 402 B 177 GLU B 251 GLU~? 27.55 ZN ZN A 402 B 201 LEU B 250 LEU~? 23.28 ZN ZN B 402 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 27.00 6.35 51.01 26.30 4.53 50.18 -20.38 111.90 11.61 -18.92 112.78 10.34 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -25.70 113.88 13.60 -27.64 113.69 12.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS B 315 LYS~? 18.28 ZN ZN A 402 B 177 GLU B 290 GLU~? 16.07 ZN ZN B 401 B 201 LEU B 321 LEU^? 17.10 ZN ZN B 401 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 27.00 6.35 51.01 26.30 4.53 50.18 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -34.15 112.90 9.63 -36.13 113.84 9.47 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 177 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 201 LEU B 43 LEU.? 6.82 ZN ZN B 401 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 27.00 6.35 51.01 26.30 4.53 50.18 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -40.65 91.81 8.75 -40.59 94.01 8.67 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 8 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 233 THR^? 21.55 ZN ZN A 401 A 156 TYR A 131 TYR^? 29.63 ZN ZN A 401 A 160 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 10.50 56.87 17.73 11.24 57.93 19.43 -51.48 112.38 -28.84 -50.80 110.31 -28.76 coo 11.64 63.07 23.95 11.76 62.47 21.20 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 5.78 61.30 21.65 8.04 62.89 17.54 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR A 357 THR.? 20.18 ZN ZN A 402 A 156 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 160 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 10.50 56.87 17.73 11.24 57.93 19.43 -22.69 123.90 -8.22 -21.02 125.26 -8.45 coo 11.64 63.07 23.95 11.76 62.47 21.20 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 5.78 61.30 21.65 8.04 62.89 17.54 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 3 3 # 3 A 132 THR B 233 THR^? 21.46 ZN ZN B 402 A 156 TYR B 131 TYR^? 25.51 ZN ZN B 402 A 160 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 10.50 56.87 17.73 11.24 57.93 19.43 -52.42 108.39 29.83 -50.75 109.78 29.75 coo 11.64 63.07 23.95 11.76 62.47 21.20 -60.00 104.47 33.20 -57.62 103.10 32.62 coo 5.78 61.30 21.65 8.04 62.89 17.54 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 4 3 # 4 A 132 THR B 357 THR.? 20.15 ZN ZN B 401 A 156 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 160 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 10.50 56.87 17.73 11.24 57.93 19.43 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 11.64 63.07 23.95 11.76 62.47 21.20 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 5.78 61.30 21.65 8.04 62.89 17.54 -38.73 88.63 14.36 -36.14 88.00 9.08 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 4 hits 1db3_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 49.66 36.74 42.37 48.88 35.30 43.64 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 63 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 89 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 49.93 35.76 35.94 51.58 36.96 35.47 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.15 35.33 47.12 47.46 33.99 46.29 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1dco_c00 DCOH user 3 3 # 3 A 62 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 63 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 89 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 49.93 35.76 35.94 51.58 36.96 35.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 46.15 35.33 47.12 47.46 33.99 46.29 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1dco_c00 DCOH user 4 3 # 4 A 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 63 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 89 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 49.93 35.76 35.94 51.58 36.96 35.47 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 46.15 35.33 47.12 47.46 33.99 46.29 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1dco_c00 DCOH user 5 3 # 5 A 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1dco_c00 DCOH user 6 3 # 6 A 62 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 49.66 36.74 42.37 48.88 35.30 43.64 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1dco_c00 DCOH user 7 3 # 7 A 62 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 63 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 89 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 46.15 35.33 47.12 47.46 33.99 46.29 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1dco_c00 DCOH user 8 3 # 8 A 62 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1dco_c00 DCOH user 9 3 # 9 A 62 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1dco_c00 DCOH user 10 3 # 10 A 62 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1dco_c00 DCOH user 11 3 # 11 A 62 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1dco_c00 DCOH user 12 3 # 12 A 62 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 63 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 89 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 49.93 35.76 35.94 51.58 36.96 35.47 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 46.15 35.33 47.12 47.46 33.99 46.29 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1dco_c00 DCOH user 13 3 # 13 A 62 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 63 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 89 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 49.93 35.76 35.94 51.58 36.96 35.47 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 46.15 35.33 47.12 47.46 33.99 46.29 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1dco_c00 DCOH user 14 3 # 14 A 62 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1dco_c00 DCOH user 15 3 # 15 A 62 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 49.66 36.74 42.37 48.88 35.30 43.64 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1dco_c00 DCOH user 16 3 # 16 A 62 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 63 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 89 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 49.93 35.76 35.94 51.58 36.96 35.47 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.15 35.33 47.12 47.46 33.99 46.29 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1dco_c00 DCOH user 17 3 # 17 A 62 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 63 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 89 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 49.93 35.76 35.94 51.58 36.96 35.47 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 46.15 35.33 47.12 47.46 33.99 46.29 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1dco_c00 DCOH user 18 3 # 18 A 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 63 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 89 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 49.93 35.76 35.94 51.58 36.96 35.47 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 46.15 35.33 47.12 47.46 33.99 46.29 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1dco_c00 DCOH user 19 3 # 19 A 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1dco_c00 DCOH user 20 3 # 20 A 62 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 49.66 36.74 42.37 48.88 35.30 43.64 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1dco_c00 DCOH user 21 3 # 21 A 62 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1dco_c00 DCOH user 22 3 # 22 A 62 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1dco_c00 DCOH user 23 3 # 23 A 62 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 63 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 89 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 49.93 35.76 35.94 51.58 36.96 35.47 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 46.15 35.33 47.12 47.46 33.99 46.29 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1dco_c00 DCOH user 24 3 # 24 A 62 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1dco_c00 DCOH user 25 3 # 25 A 62 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 63 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 89 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 49.93 35.76 35.94 51.58 36.96 35.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.15 35.33 47.12 47.46 33.99 46.29 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1dco_c00 DCOH user 26 3 # 26 A 62 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 63 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 89 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 49.93 35.76 35.94 51.58 36.96 35.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 46.15 35.33 47.12 47.46 33.99 46.29 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1dco_c00 DCOH user 27 3 # 27 A 62 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 63 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 89 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 49.66 36.74 42.37 48.88 35.30 43.64 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 49.93 35.76 35.94 51.58 36.96 35.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 46.15 35.33 47.12 47.46 33.99 46.29 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1dco_c00 DCOH user 28 3 # 28 A 62 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 63 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 89 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 49.66 36.74 42.37 48.88 35.30 43.64 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 49.93 35.76 35.94 51.58 36.96 35.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 -40.41 105.08 4.17 -40.72 103.08 3.51 1dco_c00 source 1dco DCOH : 28 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 12 HIS~? 21.70 ZN ZN A 401 A 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.37 50.89 2.29 11.05 51.63 2.25 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.37 50.89 2.29 11.05 51.63 2.25 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 646 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 739 GLY A 38 GLY.? 23.39 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 11.37 50.89 2.29 11.05 51.63 2.25 -27.76 136.39 -15.64 -28.52 136.55 -15.28 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 237 GLY^? 12.04 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 -45.65 113.20 -21.30 -44.96 113.62 -21.16 ULMN 3 1ddj_c12 PLASMINOGEN user 11 3 # 11 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c12 PLASMINOGEN user 12 3 # 12 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ddj_c12 PLASMINOGEN user 13 3 # 13 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c12 PLASMINOGEN user 14 3 # 14 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c12 PLASMINOGEN user 15 3 # 15 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.37 50.89 2.29 11.05 51.63 2.25 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c12 PLASMINOGEN user 16 3 # 16 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c12 PLASMINOGEN user 17 3 # 17 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.37 50.89 2.29 11.05 51.63 2.25 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c12 PLASMINOGEN user 18 3 # 18 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.37 50.89 2.29 11.05 51.63 2.25 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ddj_c12 PLASMINOGEN user 19 3 # 19 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c12 PLASMINOGEN user 20 3 # 20 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c12 PLASMINOGEN user 21 3 # 21 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 11.37 50.89 2.29 11.05 51.63 2.25 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c12 PLASMINOGEN user 22 3 # 22 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.37 50.89 2.29 11.05 51.63 2.25 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ddj_c12 PLASMINOGEN user 23 3 # 23 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.37 50.89 2.29 11.05 51.63 2.25 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ddj_c12 PLASMINOGEN user 24 3 # 24 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c12 PLASMINOGEN user 25 3 # 25 A 603 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 11.37 50.89 2.29 11.05 51.63 2.25 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c12 PLASMINOGEN user 26 3 # 26 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 11.37 50.89 2.29 11.05 51.63 2.25 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c12 PLASMINOGEN user 27 3 # 27 A 603 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c12 PLASMINOGEN user 28 3 # 28 A 603 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c12 PLASMINOGEN user 29 3 # 29 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.37 50.89 2.29 11.05 51.63 2.25 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ddj_c12 PLASMINOGEN user 30 3 # 30 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c12 PLASMINOGEN user 31 3 # 31 A 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.37 50.89 2.29 11.05 51.63 2.25 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ddj_c12 PLASMINOGEN user 32 3 # 32 A 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c12 PLASMINOGEN user 33 3 # 33 A 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ddj_c12 PLASMINOGEN user 34 3 # 34 A 603 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 646 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 739 GLY B 38 GLY.? 23.53 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 11.37 50.89 2.29 11.05 51.63 2.25 -45.02 75.58 15.94 -45.75 75.90 15.58 ULMN 3 1ddj_c12 PLASMINOGEN user 35 3 # 35 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.37 50.89 2.29 11.05 51.63 2.25 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c12 PLASMINOGEN user 36 3 # 36 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c12 PLASMINOGEN user 37 3 # 37 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 237 GLY^? 12.12 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.37 50.89 2.29 11.05 51.63 2.25 -47.85 104.85 22.36 -47.42 104.12 22.23 ULMN 3 1ddj_c12 PLASMINOGEN user 38 3 # 38 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1ddj_c12 PLASMINOGEN user 39 3 # 39 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.37 50.89 2.29 11.05 51.63 2.25 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ddj_c12 PLASMINOGEN user 40 3 # 40 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c12 PLASMINOGEN user 41 3 # 41 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c12 PLASMINOGEN user 42 3 # 42 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.37 50.89 2.29 11.05 51.63 2.25 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c12 PLASMINOGEN user 43 3 # 43 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c12 PLASMINOGEN user 44 3 # 44 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 11.37 50.89 2.29 11.05 51.63 2.25 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c12 PLASMINOGEN user 45 3 # 45 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ddj_c12 PLASMINOGEN user 46 3 # 46 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ddj_c12 PLASMINOGEN user 47 3 # 47 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c12 PLASMINOGEN user 48 3 # 48 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ddj_c12 PLASMINOGEN user 49 3 # 49 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 11.37 50.89 2.29 11.05 51.63 2.25 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c12 PLASMINOGEN user 50 3 # 50 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 11.37 50.89 2.29 11.05 51.63 2.25 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c12 PLASMINOGEN user 51 3 # 51 A 603 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 11.37 50.89 2.29 11.05 51.63 2.25 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c12 PLASMINOGEN user 52 3 # 52 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.47 105.54 19.38 -42.87 105.20 20.03 1ddj_c12 source 1ddj PLASMINOGEN : 52 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 12 HIS~? 21.70 ZN ZN A 401 B 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 13 HIS~? 19.28 ZN ZN A 401 B 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ddj_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 646 ASP A 91 ASP.? 28.84 ZN ZN A 402 B 739 GLY A 38 GLY.? 23.39 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -27.76 136.39 -15.64 -28.52 136.55 -15.28 ULMN 3 1ddj_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c13 PLASMINOGEN user 11 3 # 11 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 237 GLY^? 12.04 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -45.65 113.20 -21.30 -44.96 113.62 -21.16 ULMN 3 1ddj_c13 PLASMINOGEN user 12 3 # 12 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c13 PLASMINOGEN user 13 3 # 13 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ddj_c13 PLASMINOGEN user 14 3 # 14 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c13 PLASMINOGEN user 15 3 # 15 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c13 PLASMINOGEN user 16 3 # 16 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c13 PLASMINOGEN user 17 3 # 17 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c13 PLASMINOGEN user 18 3 # 18 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c13 PLASMINOGEN user 19 3 # 19 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ddj_c13 PLASMINOGEN user 20 3 # 20 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c13 PLASMINOGEN user 21 3 # 21 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c13 PLASMINOGEN user 22 3 # 22 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c13 PLASMINOGEN user 23 3 # 23 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ddj_c13 PLASMINOGEN user 24 3 # 24 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ddj_c13 PLASMINOGEN user 25 3 # 25 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c13 PLASMINOGEN user 26 3 # 26 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c13 PLASMINOGEN user 27 3 # 27 B 603 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -52.58 88.71 29.10 -52.20 89.31 31.07 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c13 PLASMINOGEN user 28 3 # 28 B 603 HIS B 13 HIS~? 19.30 ZN ZN B 402 B 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c13 PLASMINOGEN user 29 3 # 29 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ddj_c13 PLASMINOGEN user 30 3 # 30 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c13 PLASMINOGEN user 31 3 # 31 B 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ddj_c13 PLASMINOGEN user 32 3 # 32 B 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c13 PLASMINOGEN user 33 3 # 33 B 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ddj_c13 PLASMINOGEN user 34 3 # 34 B 603 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 646 ASP B 91 ASP.? 28.82 ZN ZN B 401 B 739 GLY B 38 GLY.? 23.53 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -45.02 75.58 15.94 -45.75 75.90 15.58 ULMN 3 1ddj_c13 PLASMINOGEN user 35 3 # 35 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c13 PLASMINOGEN user 36 3 # 36 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c13 PLASMINOGEN user 37 3 # 37 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 237 GLY^? 12.12 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -47.85 104.85 22.36 -47.42 104.12 22.23 ULMN 3 1ddj_c13 PLASMINOGEN user 38 3 # 38 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1ddj_c13 PLASMINOGEN user 39 3 # 39 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ddj_c13 PLASMINOGEN user 40 3 # 40 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c13 PLASMINOGEN user 41 3 # 41 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c13 PLASMINOGEN user 42 3 # 42 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c13 PLASMINOGEN user 43 3 # 43 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c13 PLASMINOGEN user 44 3 # 44 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c13 PLASMINOGEN user 45 3 # 45 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ddj_c13 PLASMINOGEN user 46 3 # 46 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ddj_c13 PLASMINOGEN user 47 3 # 47 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c13 PLASMINOGEN user 48 3 # 48 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ddj_c13 PLASMINOGEN user 49 3 # 49 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c13 PLASMINOGEN user 50 3 # 50 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c13 PLASMINOGEN user 51 3 # 51 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c13 PLASMINOGEN user 52 3 # 52 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.47 105.54 19.38 -42.87 105.20 20.03 1ddj_c13 source 1ddj PLASMINOGEN : 52 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 12 HIS~? 21.70 ZN ZN A 401 C 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 16.06 55.72 54.73 15.97 56.49 56.70 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 9.38 49.29 65.28 9.01 50.03 65.31 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 9.38 49.29 65.28 9.01 50.03 65.31 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 9.38 49.29 65.28 9.01 50.03 65.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.38 49.29 65.28 9.01 50.03 65.31 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.38 49.29 65.28 9.01 50.03 65.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.38 49.29 65.28 9.01 50.03 65.31 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 646 ASP A 91 ASP.? 28.84 ZN ZN A 402 C 739 GLY A 38 GLY.? 23.39 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 9.38 49.29 65.28 9.01 50.03 65.31 -27.76 136.39 -15.64 -28.52 136.55 -15.28 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 9.38 49.29 65.28 9.01 50.03 65.31 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 9.38 49.29 65.28 9.01 50.03 65.31 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c14 PLASMINOGEN user 10 3 # 10 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 237 GLY^? 12.04 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 9.38 49.29 65.28 9.01 50.03 65.31 -45.65 113.20 -21.30 -44.96 113.62 -21.16 ULMN 3 1ddj_c14 PLASMINOGEN user 11 3 # 11 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 9.38 49.29 65.28 9.01 50.03 65.31 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c14 PLASMINOGEN user 12 3 # 12 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c14 PLASMINOGEN user 13 3 # 13 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 9.38 49.29 65.28 9.01 50.03 65.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c14 PLASMINOGEN user 14 3 # 14 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 9.38 49.29 65.28 9.01 50.03 65.31 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ddj_c14 PLASMINOGEN user 15 3 # 15 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 9.38 49.29 65.28 9.01 50.03 65.31 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c14 PLASMINOGEN user 16 3 # 16 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c14 PLASMINOGEN user 17 3 # 17 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.38 49.29 65.28 9.01 50.03 65.31 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c14 PLASMINOGEN user 18 3 # 18 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 16.06 55.72 54.73 15.97 56.49 56.70 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 9.38 49.29 65.28 9.01 50.03 65.31 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ddj_c14 PLASMINOGEN user 19 3 # 19 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 16.06 55.72 54.73 15.97 56.49 56.70 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c14 PLASMINOGEN user 20 3 # 20 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 16.06 55.72 54.73 15.97 56.49 56.70 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c14 PLASMINOGEN user 21 3 # 21 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 16.06 55.72 54.73 15.97 56.49 56.70 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 9.38 49.29 65.28 9.01 50.03 65.31 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c14 PLASMINOGEN user 22 3 # 22 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 16.06 55.72 54.73 15.97 56.49 56.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.38 49.29 65.28 9.01 50.03 65.31 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ddj_c14 PLASMINOGEN user 23 3 # 23 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 16.06 55.72 54.73 15.97 56.49 56.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.38 49.29 65.28 9.01 50.03 65.31 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ddj_c14 PLASMINOGEN user 24 3 # 24 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 16.06 55.72 54.73 15.97 56.49 56.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c14 PLASMINOGEN user 25 3 # 25 C 603 HIS A 317 HIS~? 18.34 ZN ZN B 401 C 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 16.06 55.72 54.73 15.97 56.49 56.70 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 9.38 49.29 65.28 9.01 50.03 65.31 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c14 PLASMINOGEN user 26 3 # 26 C 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 16.06 55.72 54.73 15.97 56.49 56.70 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 9.38 49.29 65.28 9.01 50.03 65.31 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c14 PLASMINOGEN user 27 3 # 27 C 603 HIS B 12 HIS~? 21.73 ZN ZN B 402 C 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 C 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 16.06 55.72 54.73 15.97 56.49 56.70 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c14 PLASMINOGEN user 28 3 # 28 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 16.06 55.72 54.73 15.97 56.49 56.70 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 9.38 49.29 65.28 9.01 50.03 65.31 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ddj_c14 PLASMINOGEN user 29 3 # 29 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 16.06 55.72 54.73 15.97 56.49 56.70 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c14 PLASMINOGEN user 30 3 # 30 C 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 16.06 55.72 54.73 15.97 56.49 56.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.38 49.29 65.28 9.01 50.03 65.31 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ddj_c14 PLASMINOGEN user 31 3 # 31 C 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 16.06 55.72 54.73 15.97 56.49 56.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c14 PLASMINOGEN user 32 3 # 32 C 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 16.06 55.72 54.73 15.97 56.49 56.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ddj_c14 PLASMINOGEN user 33 3 # 33 C 603 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 646 ASP B 91 ASP.? 28.82 ZN ZN B 401 C 739 GLY B 38 GLY.? 23.53 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 16.06 55.72 54.73 15.97 56.49 56.70 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 9.38 49.29 65.28 9.01 50.03 65.31 -45.02 75.58 15.94 -45.75 75.90 15.58 ULMN 3 1ddj_c14 PLASMINOGEN user 34 3 # 34 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 9.38 49.29 65.28 9.01 50.03 65.31 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c14 PLASMINOGEN user 35 3 # 35 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c14 PLASMINOGEN user 36 3 # 36 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 237 GLY^? 12.12 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 9.38 49.29 65.28 9.01 50.03 65.31 -47.85 104.85 22.36 -47.42 104.12 22.23 ULMN 3 1ddj_c14 PLASMINOGEN user 37 3 # 37 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1ddj_c14 PLASMINOGEN user 38 3 # 38 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c14 PLASMINOGEN user 39 3 # 39 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c14 PLASMINOGEN user 40 3 # 40 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.06 55.72 54.73 15.97 56.49 56.70 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ddj_c14 PLASMINOGEN user 41 3 # 41 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.38 49.29 65.28 9.01 50.03 65.31 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c14 PLASMINOGEN user 42 3 # 42 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.06 55.72 54.73 15.97 56.49 56.70 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c14 PLASMINOGEN user 43 3 # 43 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.06 55.72 54.73 15.97 56.49 56.70 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 9.38 49.29 65.28 9.01 50.03 65.31 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c14 PLASMINOGEN user 44 3 # 44 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ddj_c14 PLASMINOGEN user 45 3 # 45 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ddj_c14 PLASMINOGEN user 46 3 # 46 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 16.06 55.72 54.73 15.97 56.49 56.70 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ddj_c14 PLASMINOGEN user 47 3 # 47 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 16.06 55.72 54.73 15.97 56.49 56.70 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c14 PLASMINOGEN user 48 3 # 48 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 16.06 55.72 54.73 15.97 56.49 56.70 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 9.38 49.29 65.28 9.01 50.03 65.31 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c14 PLASMINOGEN user 49 3 # 49 C 603 HIS B 317 HIS~? 18.53 ZN ZN A 402 C 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 16.06 55.72 54.73 15.97 56.49 56.70 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 9.38 49.29 65.28 9.01 50.03 65.31 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c14 PLASMINOGEN user 50 3 # 50 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 16.06 55.72 54.73 15.97 56.49 56.70 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.47 105.54 19.38 -42.87 105.20 20.03 1ddj_c14 source 1ddj PLASMINOGEN : 50 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 12 HIS~? 21.70 ZN ZN A 401 D 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 D 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS A 90 HIS~? 26.77 ZN ZN A 402 D 646 ASP A 91 ASP.? 28.84 ZN ZN A 402 D 739 GLY A 38 GLY.? 23.39 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -27.76 136.39 -15.64 -28.52 136.55 -15.28 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 237 GLY^? 12.04 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -45.65 113.20 -21.30 -44.96 113.62 -21.16 ULMN 3 1ddj_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c15 PLASMINOGEN user 11 3 # 11 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c15 PLASMINOGEN user 12 3 # 12 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ddj_c15 PLASMINOGEN user 13 3 # 13 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ddj_c15 PLASMINOGEN user 14 3 # 14 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1ddj_c15 PLASMINOGEN user 15 3 # 15 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY A 318 GLY.? 21.36 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.31 90.61 -10.78 -42.69 91.31 -10.63 ULMN 3 1ddj_c15 PLASMINOGEN user 16 3 # 16 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 D 739 GLY A 288 GLY.? 14.54 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -47.81 104.86 -9.26 -47.13 104.59 -9.75 ULMN 3 1ddj_c15 PLASMINOGEN user 17 3 # 17 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 739 GLY A 318 GLY.? 21.36 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.31 90.61 -10.78 -42.69 91.31 -10.63 ULMN 3 1ddj_c15 PLASMINOGEN user 18 3 # 18 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1ddj_c15 PLASMINOGEN user 19 3 # 19 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c15 PLASMINOGEN user 20 3 # 20 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c15 PLASMINOGEN user 21 3 # 21 D 603 HIS A 317 HIS~? 18.34 ZN ZN B 401 D 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c15 PLASMINOGEN user 22 3 # 22 D 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 D 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1ddj_c15 PLASMINOGEN user 23 3 # 23 D 603 HIS B 12 HIS~? 21.73 ZN ZN B 402 D 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 D 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -52.58 88.71 29.10 -52.20 89.31 31.07 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ddj_c15 PLASMINOGEN user 24 3 # 24 D 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c15 PLASMINOGEN user 25 3 # 25 D 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ddj_c15 PLASMINOGEN user 26 3 # 26 D 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c15 PLASMINOGEN user 27 3 # 27 D 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ddj_c15 PLASMINOGEN user 28 3 # 28 D 603 HIS B 90 HIS~? 26.84 ZN ZN B 401 D 646 ASP B 91 ASP.? 28.82 ZN ZN B 401 D 739 GLY B 38 GLY.? 23.53 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -45.02 75.58 15.94 -45.75 75.90 15.58 ULMN 3 1ddj_c15 PLASMINOGEN user 29 3 # 29 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1ddj_c15 PLASMINOGEN user 30 3 # 30 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 237 GLY^? 12.12 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -47.85 104.85 22.36 -47.42 104.12 22.23 ULMN 3 1ddj_c15 PLASMINOGEN user 31 3 # 31 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1ddj_c15 PLASMINOGEN user 32 3 # 32 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1ddj_c15 PLASMINOGEN user 33 3 # 33 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ddj_c15 PLASMINOGEN user 34 3 # 34 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ddj_c15 PLASMINOGEN user 35 3 # 35 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1ddj_c15 PLASMINOGEN user 36 3 # 36 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY B 318 GLY.? 21.53 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -32.98 122.14 11.89 -33.67 121.77 11.74 ULMN 3 1ddj_c15 PLASMINOGEN user 37 3 # 37 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 D 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1ddj_c15 PLASMINOGEN user 38 3 # 38 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 739 GLY B 318 GLY.? 21.53 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -32.98 122.14 11.89 -33.67 121.77 11.74 ULMN 3 1ddj_c15 PLASMINOGEN user 39 3 # 39 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1ddj_c15 PLASMINOGEN user 40 3 # 40 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1ddj_c15 PLASMINOGEN user 41 3 # 41 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c15 PLASMINOGEN user 42 3 # 42 D 603 HIS B 317 HIS~? 18.53 ZN ZN A 402 D 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -38.40 123.74 9.47 -39.77 124.82 8.30 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1ddj_c15 PLASMINOGEN user 43 3 # 43 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 D 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.47 105.54 19.38 -42.87 105.20 20.03 1ddj_c15 source 1ddj PLASMINOGEN : 43 hits 1ddj_c15 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 96 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 137 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 1.83 2.95 4.76 1.26 0.98 4.81 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 2 3 # 2 A 50 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 96 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 137 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 1.83 2.95 4.76 1.26 0.98 4.81 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 3 3 # 3 A 50 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 96 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 137 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 1.83 2.95 4.76 1.26 0.98 4.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 4 3 # 4 A 50 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 96 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 137 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 1.83 2.95 4.76 1.26 0.98 4.81 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 5 3 # 5 A 50 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 96 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 137 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 1.83 2.95 4.76 1.26 0.98 4.81 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 6 3 # 6 A 50 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 96 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 137 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 1.83 2.95 4.76 1.26 0.98 4.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -49.25 96.40 11.26 -48.45 97.80 9.92 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 6 hits 1de3_c00 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 243 GLU^? 24.16 ZN ZN A 401 A 226 THR A 233 THR^? 21.55 ZN ZN A 401 A 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 9.66 102.78 70.07 9.79 101.18 71.42 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 7.24 97.46 49.60 8.11 95.69 48.80 -51.48 112.38 -28.84 -50.80 110.31 -28.76 coo 10.53 97.56 43.71 9.33 93.71 47.17 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 251 GLU~? 26.78 ZN ZN B 401 A 226 THR B 357 THR.? 20.15 ZN ZN B 401 A 229 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 9.66 102.78 70.07 9.79 101.18 71.42 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 7.24 97.46 49.60 8.11 95.69 48.80 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 10.53 97.56 43.71 9.33 93.71 47.17 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU B 243 GLU^? 24.39 ZN ZN B 402 A 226 THR B 233 THR^? 21.46 ZN ZN B 402 A 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 9.66 102.78 70.07 9.79 101.18 71.42 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 7.24 97.46 49.60 8.11 95.69 48.80 -52.42 108.39 29.83 -50.75 109.78 29.75 coo 10.53 97.56 43.71 9.33 93.71 47.17 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 251 GLU~? 27.55 ZN ZN A 402 A 226 THR A 357 THR.? 20.18 ZN ZN A 402 A 229 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 9.66 102.78 70.07 9.79 101.18 71.42 -20.38 111.90 11.61 -18.92 112.78 10.34 coo 7.24 97.46 49.60 8.11 95.69 48.80 -22.69 123.90 -8.22 -21.02 125.26 -8.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 271 GLU.? 25.84 ZN ZN A 402 A 226 THR A 357 THR.? 20.18 ZN ZN A 402 A 229 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 9.66 102.78 70.07 9.79 101.18 71.42 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 7.24 97.46 49.60 8.11 95.69 48.80 -22.69 123.90 -8.22 -21.02 125.26 -8.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 -29.32 122.04 -13.64 -26.61 121.37 -8.37 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 5 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 243 GLU^? 24.16 ZN ZN A 401 B 226 THR A 233 THR^? 21.55 ZN ZN A 401 B 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 15.90 87.61 49.61 13.92 86.96 49.36 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 20.74 95.78 68.68 19.29 96.84 69.83 -51.48 112.38 -28.84 -50.80 110.31 -28.76 coo 22.32 101.61 71.64 17.89 98.63 71.55 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 251 GLU~? 26.78 ZN ZN B 401 B 226 THR B 357 THR.? 20.15 ZN ZN B 401 B 229 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 15.90 87.61 49.61 13.92 86.96 49.36 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 20.74 95.78 68.68 19.29 96.84 69.83 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 22.32 101.61 71.64 17.89 98.63 71.55 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU B 243 GLU^? 24.39 ZN ZN B 402 B 226 THR B 233 THR^? 21.46 ZN ZN B 402 B 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 15.90 87.61 49.61 13.92 86.96 49.36 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 20.74 95.78 68.68 19.29 96.84 69.83 -52.42 108.39 29.83 -50.75 109.78 29.75 coo 22.32 101.61 71.64 17.89 98.63 71.55 -59.06 109.88 30.77 -61.50 111.95 25.23 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 243 GLU^? 24.16 ZN ZN A 401 C 226 THR A 233 THR^? 21.55 ZN ZN A 401 C 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 5.43 40.40 61.63 4.27 41.99 60.90 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 22.16 45.88 73.63 23.23 47.70 73.25 -51.48 112.38 -28.84 -50.80 110.31 -28.76 coo 28.90 45.91 73.55 25.22 49.72 72.97 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 251 GLU~? 26.78 ZN ZN B 401 C 226 THR B 357 THR.? 20.15 ZN ZN B 401 C 229 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 5.43 40.40 61.63 4.27 41.99 60.90 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 22.16 45.88 73.63 23.23 47.70 73.25 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 28.90 45.91 73.55 25.22 49.72 72.97 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU B 243 GLU^? 24.39 ZN ZN B 402 C 226 THR B 233 THR^? 21.46 ZN ZN B 402 C 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 5.43 40.40 61.63 4.27 41.99 60.90 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 22.16 45.88 73.63 23.23 47.70 73.25 -52.42 108.39 29.83 -50.75 109.78 29.75 coo 28.90 45.91 73.55 25.22 49.72 72.97 -59.06 109.88 30.77 -61.50 111.95 25.23 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 243 GLU^? 24.16 ZN ZN A 401 D 226 THR A 233 THR^? 21.55 ZN ZN A 401 D 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 26.07 55.89 66.14 25.33 56.50 68.01 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 11.79 47.62 52.67 10.10 46.51 53.39 -51.48 112.38 -28.84 -50.80 110.31 -28.76 coo 10.05 41.79 49.80 7.94 44.71 53.76 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 251 GLU~? 26.78 ZN ZN B 401 D 226 THR B 357 THR.? 20.15 ZN ZN B 401 D 229 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 26.07 55.89 66.14 25.33 56.50 68.01 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 11.79 47.62 52.67 10.10 46.51 53.39 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 10.05 41.79 49.80 7.94 44.71 53.76 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU B 243 GLU^? 24.39 ZN ZN B 402 D 226 THR B 233 THR^? 21.46 ZN ZN B 402 D 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 26.07 55.89 66.14 25.33 56.50 68.01 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 11.79 47.62 52.67 10.10 46.51 53.39 -52.42 108.39 29.83 -50.75 109.78 29.75 coo 10.05 41.79 49.80 7.94 44.71 53.76 -59.06 109.88 30.77 -61.50 111.95 25.23 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 A 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 229 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 0.84 91.24 49.01 2.91 91.61 49.23 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 10.53 97.56 43.71 9.33 93.71 47.17 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 A 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 229 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 0.84 91.24 49.01 2.91 91.61 49.23 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 10.53 97.56 43.71 9.33 93.71 47.17 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 200 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 0.84 91.24 49.01 2.91 91.61 49.23 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 10.53 97.56 43.71 9.33 93.71 47.17 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 10.53 97.56 43.71 9.33 93.71 47.17 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 0.84 91.24 49.01 2.91 91.61 49.23 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 10.53 97.56 43.71 9.33 93.71 47.17 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 0.84 91.24 49.01 2.91 91.61 49.23 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 10.53 97.56 43.71 9.33 93.71 47.17 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 200 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 0.84 91.24 49.01 2.91 91.61 49.23 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 0.84 91.24 49.01 2.91 91.61 49.23 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 10.53 97.56 43.71 9.33 93.71 47.17 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 123 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 0.84 91.24 49.01 2.91 91.61 49.23 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 229 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 0.84 91.24 49.01 2.91 91.61 49.23 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 229 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 0.84 91.24 49.01 2.91 91.61 49.23 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 0.84 91.24 49.01 2.91 91.61 49.23 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 10.53 97.56 43.71 9.33 93.71 47.17 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 123 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 0.84 91.24 49.01 2.91 91.61 49.23 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 10.53 97.56 43.71 9.33 93.71 47.17 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 10.53 97.56 43.71 9.33 93.71 47.17 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 0.84 91.24 49.01 2.91 91.61 49.23 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 10.53 97.56 43.71 9.33 93.71 47.17 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 123 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 0.84 91.24 49.01 2.91 91.61 49.23 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 0.84 91.24 49.01 2.91 91.61 49.23 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 10.53 97.56 43.71 9.33 93.71 47.17 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 0.84 91.24 49.01 2.91 91.61 49.23 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 10.53 97.56 43.71 9.33 93.71 47.17 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 200 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 1.13 77.49 40.64 0.62 75.57 39.98 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 0.84 91.24 49.01 2.91 91.61 49.23 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 A 123 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 1.13 77.49 40.64 0.62 75.57 39.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 0.84 91.24 49.01 2.91 91.61 49.23 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 B 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 229 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 17.54 90.31 75.01 17.17 92.01 73.80 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 22.32 101.61 71.64 17.89 98.63 71.55 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 B 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 229 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 17.54 90.31 75.01 17.17 92.01 73.80 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 22.32 101.61 71.64 17.89 98.63 71.55 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS A 13 HIS~? 19.28 ZN ZN A 401 B 200 ASP A 203 ASP.? 24.56 ZN ZN A 401 B 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 17.54 90.31 75.01 17.17 92.01 73.80 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 22.32 101.61 71.64 17.89 98.63 71.55 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 22.32 101.61 71.64 17.89 98.63 71.55 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.54 90.31 75.01 17.17 92.01 73.80 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 22.32 101.61 71.64 17.89 98.63 71.55 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 17.54 90.31 75.01 17.17 92.01 73.80 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 22.32 101.61 71.64 17.89 98.63 71.55 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 200 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.54 90.31 75.01 17.17 92.01 73.80 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.54 90.31 75.01 17.17 92.01 73.80 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 22.32 101.61 71.64 17.89 98.63 71.55 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 123 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 17.54 90.31 75.01 17.17 92.01 73.80 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 229 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 17.54 90.31 75.01 17.17 92.01 73.80 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 229 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 17.54 90.31 75.01 17.17 92.01 73.80 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 B 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 17.54 90.31 75.01 17.17 92.01 73.80 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 22.32 101.61 71.64 17.89 98.63 71.55 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 123 HIS B 13 HIS~? 19.30 ZN ZN B 402 B 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 B 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 17.54 90.31 75.01 17.17 92.01 73.80 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 22.32 101.61 71.64 17.89 98.63 71.55 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 22.32 101.61 71.64 17.89 98.63 71.55 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.54 90.31 75.01 17.17 92.01 73.80 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 22.32 101.61 71.64 17.89 98.63 71.55 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 123 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 17.54 90.31 75.01 17.17 92.01 73.80 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.54 90.31 75.01 17.17 92.01 73.80 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 22.32 101.61 71.64 17.89 98.63 71.55 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 B 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.54 90.31 75.01 17.17 92.01 73.80 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 22.32 101.61 71.64 17.89 98.63 71.55 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 B 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 200 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 9.24 94.26 88.22 8.02 94.07 89.92 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.54 90.31 75.01 17.17 92.01 73.80 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 B 123 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 9.24 94.26 88.22 8.02 94.07 89.92 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 17.54 90.31 75.01 17.17 92.01 73.80 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 C 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 C 229 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 19.52 52.01 79.59 20.28 51.65 77.65 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 28.90 45.91 73.55 25.22 49.72 72.97 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 C 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 C 229 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 19.52 52.01 79.59 20.28 51.65 77.65 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 28.90 45.91 73.55 25.22 49.72 72.97 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS A 13 HIS~? 19.28 ZN ZN A 401 C 200 ASP A 203 ASP.? 24.56 ZN ZN A 401 C 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 19.52 52.01 79.59 20.28 51.65 77.65 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 28.90 45.91 73.55 25.22 49.72 72.97 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 28.90 45.91 73.55 25.22 49.72 72.97 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.52 52.01 79.59 20.28 51.65 77.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 28.90 45.91 73.55 25.22 49.72 72.97 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 19.52 52.01 79.59 20.28 51.65 77.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 28.90 45.91 73.55 25.22 49.72 72.97 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 200 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.52 52.01 79.59 20.28 51.65 77.65 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.52 52.01 79.59 20.28 51.65 77.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 28.90 45.91 73.55 25.22 49.72 72.97 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 123 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.52 52.01 79.59 20.28 51.65 77.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 C 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 C 229 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 19.52 52.01 79.59 20.28 51.65 77.65 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 C 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 C 229 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 19.52 52.01 79.59 20.28 51.65 77.65 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 C 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 C 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 19.52 52.01 79.59 20.28 51.65 77.65 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 28.90 45.91 73.55 25.22 49.72 72.97 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 123 HIS B 13 HIS~? 19.30 ZN ZN B 402 C 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 C 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 19.52 52.01 79.59 20.28 51.65 77.65 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 28.90 45.91 73.55 25.22 49.72 72.97 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 28.90 45.91 73.55 25.22 49.72 72.97 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 C 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.52 52.01 79.59 20.28 51.65 77.65 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 28.90 45.91 73.55 25.22 49.72 72.97 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 123 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 19.52 52.01 79.59 20.28 51.65 77.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.52 52.01 79.59 20.28 51.65 77.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 28.90 45.91 73.55 25.22 49.72 72.97 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 C 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 C 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.52 52.01 79.59 20.28 51.65 77.65 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 28.90 45.91 73.55 25.22 49.72 72.97 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 C 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 200 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 26.77 65.84 83.49 27.06 67.76 84.27 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.52 52.01 79.59 20.28 51.65 77.65 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 C 123 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 26.77 65.84 83.49 27.06 67.76 84.27 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.52 52.01 79.59 20.28 51.65 77.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 D 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 D 229 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 4.60 52.95 52.50 5.57 51.29 53.40 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 10.05 41.79 49.80 7.94 44.71 53.76 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS A 12 HIS~? 21.70 ZN ZN A 401 D 200 ASP A 129 ASP^? 19.65 ZN ZN A 401 D 229 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 4.60 52.95 52.50 5.57 51.29 53.40 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 10.05 41.79 49.80 7.94 44.71 53.76 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS A 13 HIS~? 19.28 ZN ZN A 401 D 200 ASP A 203 ASP.? 24.56 ZN ZN A 401 D 229 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 4.60 52.95 52.50 5.57 51.29 53.40 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 10.05 41.79 49.80 7.94 44.71 53.76 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 D 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 10.05 41.79 49.80 7.94 44.71 53.76 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 4.60 52.95 52.50 5.57 51.29 53.40 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 10.05 41.79 49.80 7.94 44.71 53.76 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 4.60 52.95 52.50 5.57 51.29 53.40 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 200 ASP A 11 ASP~? 18.10 ZN ZN A 401 D 229 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 10.05 41.79 49.80 7.94 44.71 53.76 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 200 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 4.60 52.95 52.50 5.57 51.29 53.40 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 229 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 4.60 52.95 52.50 5.57 51.29 53.40 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 10.05 41.79 49.80 7.94 44.71 53.76 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 123 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 4.60 52.95 52.50 5.57 51.29 53.40 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 D 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 D 229 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 4.60 52.95 52.50 5.57 51.29 53.40 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 D 200 ASP B 129 ASP^? 19.14 ZN ZN B 402 D 229 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 4.60 52.95 52.50 5.57 51.29 53.40 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 123 HIS B 12 HIS~? 21.73 ZN ZN B 402 D 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 D 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 4.60 52.95 52.50 5.57 51.29 53.40 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 10.05 41.79 49.80 7.94 44.71 53.76 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 123 HIS B 13 HIS~? 19.30 ZN ZN B 402 D 200 ASP B 203 ASP^? 26.15 ZN ZN B 402 D 229 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 4.60 52.95 52.50 5.57 51.29 53.40 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 10.05 41.79 49.80 7.94 44.71 53.76 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 10.05 41.79 49.80 7.94 44.71 53.76 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 D 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 4.60 52.95 52.50 5.57 51.29 53.40 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 10.05 41.79 49.80 7.94 44.71 53.76 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 123 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 4.60 52.95 52.50 5.57 51.29 53.40 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 229 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 4.60 52.95 52.50 5.57 51.29 53.40 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 10.05 41.79 49.80 7.94 44.71 53.76 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 D 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 200 ASP B 11 ASP~? 18.05 ZN ZN B 402 D 229 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 4.60 52.95 52.50 5.57 51.29 53.40 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 10.05 41.79 49.80 7.94 44.71 53.76 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 D 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 200 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 229 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 4.60 52.95 52.50 5.57 51.29 53.40 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 D 123 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 229 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 4.60 52.95 52.50 5.57 51.29 53.40 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c15 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 58 TYR.? 23.12 ZN ZN A 401 150 LYS A 56 LYS~? 22.91 ZN ZN A 402 186 ASN A 350 ASN.? 30.79 ZN ZN A 401 coo 32.88 50.55 24.33 31.89 51.78 26.65 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 27.04 52.42 22.30 26.88 49.99 27.00 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo 36.98 50.30 37.29 35.85 50.29 35.50 -24.92 138.63 -25.22 -24.60 138.40 -27.31 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR B 58 TYR.? 23.40 ZN ZN B 402 150 LYS B 56 LYS~? 22.19 ZN ZN B 401 186 ASN B 350 ASN.? 30.96 ZN ZN B 402 coo 32.88 50.55 24.33 31.89 51.78 26.65 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 27.04 52.42 22.30 26.88 49.99 27.00 -40.15 73.23 9.47 -36.32 78.07 10.66 coo 36.98 50.30 37.29 35.85 50.29 35.50 -43.56 72.18 25.31 -43.16 71.77 27.37 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 217 TYR~? 45.33 ZN ZN B 402 150 LYS B 215 LYS~? 43.78 ZN ZN B 402 186 ASN B 160 ASN.? 40.65 ZN ZN B 402 coo 32.88 50.55 24.33 31.89 51.78 26.65 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 27.04 52.42 22.30 26.88 49.99 27.00 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 36.98 50.30 37.29 35.85 50.29 35.50 -64.74 101.16 47.93 -66.09 99.91 46.81 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 3 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 131 TYR^? 29.63 ZN ZN A 401 A 183 LYS A 133 LYS^? 35.89 ZN ZN A 401 A 278 ASP A 226 ASP^? 42.28 ZN ZN A 401 coo 19.43 18.53 42.32 17.66 18.80 40.15 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 21.92 15.80 36.19 17.64 19.44 36.35 -61.15 120.63 -37.55 -60.60 115.73 -40.56 coo 15.46 19.03 31.40 15.01 18.25 33.31 -69.19 121.99 -38.15 -70.92 121.97 -39.34 1do8_c00 source 1do8 MALIC ENZYME : 1 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 131 TYR^? 29.63 ZN ZN A 401 B 183 LYS A 133 LYS^? 35.89 ZN ZN A 401 B 278 ASP A 226 ASP^? 42.28 ZN ZN A 401 coo 58.62 15.99 58.34 60.98 14.60 58.93 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 60.11 10.60 53.63 62.59 10.74 58.67 -61.15 120.63 -37.55 -60.60 115.73 -40.56 coo 66.50 7.32 58.45 66.26 9.42 58.23 -69.19 121.99 -38.15 -70.92 121.97 -39.34 1do8_c01 source 1do8 MALIC ENZYME : 1 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 131 TYR^? 29.63 ZN ZN A 401 C 183 LYS A 133 LYS^? 35.89 ZN ZN A 401 C 278 ASP A 226 ASP^? 42.28 ZN ZN A 401 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -61.15 120.63 -37.55 -60.60 115.73 -40.56 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -69.19 121.99 -38.15 -70.92 121.97 -39.34 1do8_c02 source 1do8 MALIC ENZYME : 1 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 131 TYR^? 29.63 ZN ZN A 401 D 183 LYS A 133 LYS^? 35.89 ZN ZN A 401 D 278 ASP A 226 ASP^? 42.28 ZN ZN A 401 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -61.15 120.63 -37.55 -60.60 115.73 -40.56 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -69.19 121.99 -38.15 -70.92 121.97 -39.34 1do8_c03 source 1do8 MALIC ENZYME : 1 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 4.57 20.60 30.29 4.74 21.36 30.66 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 4.57 20.60 30.29 4.74 21.36 30.66 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.90 32.83 25.96 10.83 30.68 25.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 E 193 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.90 32.83 25.96 10.83 30.68 25.98 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 4.57 20.60 30.29 4.74 21.36 30.66 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 5 3 # 5 E 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 E 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.90 32.83 25.96 10.83 30.68 25.98 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 6 3 # 6 E 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 E 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.90 32.83 25.96 10.83 30.68 25.98 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 4.57 20.60 30.29 4.74 21.36 30.66 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 7 3 # 7 E 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 4.57 20.60 30.29 4.74 21.36 30.66 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 8 3 # 8 E 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 4.57 20.60 30.29 4.74 21.36 30.66 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 9 3 # 9 E 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 10 3 # 10 E 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 E 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 4.57 20.60 30.29 4.74 21.36 30.66 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 11 3 # 11 E 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 E 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.90 32.83 25.96 10.83 30.68 25.98 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 4.57 20.60 30.29 4.74 21.36 30.66 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 12 3 # 12 E 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 E 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.90 32.83 25.96 10.83 30.68 25.98 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 13 3 # 13 E 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 E 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.90 32.83 25.96 10.83 30.68 25.98 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 4.57 20.60 30.29 4.74 21.36 30.66 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 14 3 # 14 E 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 10.90 32.83 25.96 10.83 30.68 25.98 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 4.57 20.60 30.29 4.74 21.36 30.66 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 15 3 # 15 E 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 10.90 32.83 25.96 10.83 30.68 25.98 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 16 3 # 16 E 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.90 32.83 25.96 10.83 30.68 25.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 4.57 20.60 30.29 4.74 21.36 30.66 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 17 3 # 17 E 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 E 193 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.90 32.83 25.96 10.83 30.68 25.98 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 4.57 20.60 30.29 4.74 21.36 30.66 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 18 3 # 18 E 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 E 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.90 32.83 25.96 10.83 30.68 25.98 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 4.57 20.60 30.29 4.74 21.36 30.66 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 19 3 # 19 E 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 E 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.90 32.83 25.96 10.83 30.68 25.98 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 4.57 20.60 30.29 4.74 21.36 30.66 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 20 3 # 20 E 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.90 32.83 25.96 10.83 30.68 25.98 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 4.57 20.60 30.29 4.74 21.36 30.66 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 21 3 # 21 E 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.90 32.83 25.96 10.83 30.68 25.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 22 3 # 22 E 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.90 32.83 25.96 10.83 30.68 25.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 4.57 20.60 30.29 4.74 21.36 30.66 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 23 3 # 23 E 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 E 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 11.39 26.86 25.95 9.85 26.64 27.36 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.90 32.83 25.96 10.83 30.68 25.98 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 24 3 # 24 E 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 E 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.90 32.83 25.96 10.83 30.68 25.98 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 4.57 20.60 30.29 4.74 21.36 30.66 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 25 3 # 25 E 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 E 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.90 32.83 25.96 10.83 30.68 25.98 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 4.57 20.60 30.29 4.74 21.36 30.66 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 26 3 # 26 E 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 E 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.90 32.83 25.96 10.83 30.68 25.98 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 4.57 20.60 30.29 4.74 21.36 30.66 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 27 3 # 27 E 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 E 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 E 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 11.39 26.86 25.95 9.85 26.64 27.36 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 10.90 32.83 25.96 10.83 30.68 25.98 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 4.57 20.60 30.29 4.74 21.36 30.66 -39.26 132.56 4.99 -38.51 132.20 4.81 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 27 hits 1ds2_c02 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 328 SER~? 11.01 ZN ZN A 402 A 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 236 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 49.19 42.85 125.39 50.92 43.54 123.63 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 57.80 42.94 129.59 56.47 43.28 127.93 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 55.54 41.70 125.00 53.71 42.50 124.53 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 328 SER~? 10.89 ZN ZN B 401 A 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 236 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 49.19 42.85 125.39 50.92 43.54 123.63 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 57.80 42.94 129.59 56.47 43.28 127.93 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 55.54 41.70 125.00 53.71 42.50 124.53 -40.92 100.43 6.30 -42.93 100.06 6.77 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 2 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 328 SER~? 11.01 ZN ZN A 402 B 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 236 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 55.25 19.46 97.60 53.04 19.32 98.76 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 57.34 11.46 102.30 56.11 13.10 101.70 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 55.03 16.17 103.08 54.39 17.23 101.45 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 2 3 # 2 B 80 SER B 328 SER~? 10.89 ZN ZN B 401 B 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 236 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 55.25 19.46 97.60 53.04 19.32 98.76 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 57.34 11.46 102.30 56.11 13.10 101.70 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 55.03 16.17 103.08 54.39 17.23 101.45 -40.92 100.43 6.30 -42.93 100.06 6.77 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 2 hits 1dwo_c01 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 215 LYS A 76 LYS.? 26.59 ZN ZN A 402 A 277 LYS A 86 LYS~? 24.82 ZN ZN A 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 13.06 30.79 51.73 11.40 35.76 53.48 -40.70 135.50 8.63 -43.88 132.62 12.69 coo 13.04 31.88 60.72 10.57 35.34 57.49 -33.51 137.11 0.86 -27.79 135.78 2.74 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 215 LYS A 114 LYS~? 19.79 ZN ZN A 401 A 277 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 0.50 24.09 51.68 1.51 29.34 52.35 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 13.06 30.79 51.73 11.40 35.76 53.48 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 13.04 31.88 60.72 10.57 35.34 57.49 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 215 LYS A 119 LYS^? 25.23 ZN ZN A 401 A 277 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 0.50 24.09 51.68 1.51 29.34 52.35 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 13.06 30.79 51.73 11.40 35.76 53.48 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 277 LYS^? 27.09 ZN ZN A 401 A 215 LYS A 114 LYS~? 19.79 ZN ZN A 401 A 277 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 0.50 24.09 51.68 1.51 29.34 52.35 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 13.06 30.79 51.73 11.40 35.76 53.48 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 13.04 31.88 60.72 10.57 35.34 57.49 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 215 LYS A 114 LYS~? 19.79 ZN ZN A 401 A 277 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 0.50 24.09 51.68 1.51 29.34 52.35 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 13.06 30.79 51.73 11.40 35.76 53.48 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 13.04 31.88 60.72 10.57 35.34 57.49 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS A 337 LYS~? 20.91 ZN ZN A 401 A 215 LYS A 114 LYS~? 19.79 ZN ZN A 401 A 277 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 0.50 24.09 51.68 1.51 29.34 52.35 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 13.06 30.79 51.73 11.40 35.76 53.48 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 13.04 31.88 60.72 10.57 35.34 57.49 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 215 LYS B 140 LYS.? 53.20 ZN ZN B 402 A 277 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 13.06 30.79 51.73 11.40 35.76 53.48 -74.22 104.46 56.49 -70.63 102.62 58.58 coo 13.04 31.88 60.72 10.57 35.34 57.49 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS B 207 LYS~? 33.65 ZN ZN B 402 A 215 LYS B 215 LYS~? 43.78 ZN ZN B 402 A 277 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -70.47 101.07 32.25 -71.74 107.13 30.32 coo 13.06 30.79 51.73 11.40 35.76 53.48 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS B 215 LYS~? 43.78 ZN ZN B 402 A 215 LYS B 197 LYS^? 42.64 ZN ZN B 402 A 277 LYS B 140 LYS.? 53.20 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 13.06 30.79 51.73 11.40 35.76 53.48 -70.80 108.71 48.92 -67.91 112.78 45.19 coo 13.04 31.88 60.72 10.57 35.34 57.49 -74.22 104.46 56.49 -70.63 102.62 58.58 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS B 215 LYS~? 43.78 ZN ZN B 402 A 215 LYS B 207 LYS~? 33.65 ZN ZN B 402 A 277 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 13.06 30.79 51.73 11.40 35.76 53.48 -70.47 101.07 32.25 -71.74 107.13 30.32 coo 13.04 31.88 60.72 10.57 35.34 57.49 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 215 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 277 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 13.06 30.79 51.73 11.40 35.76 53.48 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 215 LYS B 119 LYS^? 26.96 ZN ZN B 402 A 277 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 13.06 30.79 51.73 11.40 35.76 53.48 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 13.04 31.88 60.72 10.57 35.34 57.49 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS B 277 LYS^? 26.47 ZN ZN B 402 A 215 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 277 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 13.06 30.79 51.73 11.40 35.76 53.48 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 215 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 277 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 13.06 30.79 51.73 11.40 35.76 53.48 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS B 337 LYS~? 20.93 ZN ZN B 402 A 215 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 277 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 0.50 24.09 51.68 1.51 29.34 52.35 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 13.06 30.79 51.73 11.40 35.76 53.48 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.65 97.38 15.05 -24.29 100.72 20.18 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 15 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 215 LYS A 114 LYS~? 19.79 ZN ZN A 401 B 277 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 6.78 45.91 16.15 7.82 40.81 15.84 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 17.88 38.77 19.81 16.38 34.23 17.24 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 20.33 37.78 11.20 16.77 34.53 13.47 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 215 LYS A 119 LYS^? 25.23 ZN ZN A 401 B 277 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 6.78 45.91 16.15 7.82 40.81 15.84 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 17.88 38.77 19.81 16.38 34.23 17.24 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 277 LYS^? 27.09 ZN ZN A 401 B 215 LYS A 114 LYS~? 19.79 ZN ZN A 401 B 277 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 6.78 45.91 16.15 7.82 40.81 15.84 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 17.88 38.77 19.81 16.38 34.23 17.24 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 20.33 37.78 11.20 16.77 34.53 13.47 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 215 LYS A 114 LYS~? 19.79 ZN ZN A 401 B 277 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 6.78 45.91 16.15 7.82 40.81 15.84 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 17.88 38.77 19.81 16.38 34.23 17.24 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 20.33 37.78 11.20 16.77 34.53 13.47 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 215 LYS B 140 LYS.? 53.20 ZN ZN B 402 B 277 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 17.88 38.77 19.81 16.38 34.23 17.24 -74.22 104.46 56.49 -70.63 102.62 58.58 coo 20.33 37.78 11.20 16.77 34.53 13.47 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS B 197 LYS^? 42.64 ZN ZN B 402 B 215 LYS B 133 LYS^? 36.11 ZN ZN B 402 B 277 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -70.80 108.71 48.92 -67.91 112.78 45.19 coo 17.88 38.77 19.81 16.38 34.23 17.24 -65.38 107.19 38.20 -61.64 109.75 42.23 coo 20.33 37.78 11.20 16.77 34.53 13.47 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS B 207 LYS~? 33.65 ZN ZN B 402 B 215 LYS B 215 LYS~? 43.78 ZN ZN B 402 B 277 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -70.47 101.07 32.25 -71.74 107.13 30.32 coo 17.88 38.77 19.81 16.38 34.23 17.24 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS B 215 LYS~? 43.78 ZN ZN B 402 B 215 LYS B 207 LYS~? 33.65 ZN ZN B 402 B 277 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 17.88 38.77 19.81 16.38 34.23 17.24 -70.47 101.07 32.25 -71.74 107.13 30.32 coo 20.33 37.78 11.20 16.77 34.53 13.47 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 215 LYS B 114 LYS~? 19.44 ZN ZN B 402 B 277 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 17.88 38.77 19.81 16.38 34.23 17.24 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 215 LYS B 119 LYS^? 26.96 ZN ZN B 402 B 277 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 17.88 38.77 19.81 16.38 34.23 17.24 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 20.33 37.78 11.20 16.77 34.53 13.47 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS B 277 LYS^? 26.47 ZN ZN B 402 B 215 LYS B 114 LYS~? 19.44 ZN ZN B 402 B 277 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 17.88 38.77 19.81 16.38 34.23 17.24 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 215 LYS B 114 LYS~? 19.44 ZN ZN B 402 B 277 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 6.78 45.91 16.15 7.82 40.81 15.84 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 17.88 38.77 19.81 16.38 34.23 17.24 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 -25.65 97.38 15.05 -24.29 100.72 20.18 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 12 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 132 TYR^? 30.56 ZN ZN A 401 A 40 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 103 ASP A 203 ASP.? 24.56 ZN ZN A 401 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -54.58 125.94 -31.48 -53.46 125.13 -29.87 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 205 TYR~? 27.31 ZN ZN A 401 A 40 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 103 ASP A 203 ASP.? 24.56 ZN ZN A 401 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -54.58 125.94 -31.48 -53.46 125.13 -29.87 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 40 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 103 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 132 TYR^? 30.83 ZN ZN B 402 A 40 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 103 ASP B 203 ASP^? 26.15 ZN ZN B 402 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -67.13 105.92 32.85 -67.85 106.57 30.23 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -62.37 99.36 31.88 -60.64 98.73 32.96 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 40 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 103 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -34.85 93.86 2.41 -34.87 96.02 2.16 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 5 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 132 TYR^? 30.56 ZN ZN A 401 B 40 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 103 ASP A 203 ASP.? 24.56 ZN ZN A 401 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -54.58 125.94 -31.48 -53.46 125.13 -29.87 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 205 TYR~? 27.31 ZN ZN A 401 B 40 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 103 ASP A 203 ASP.? 24.56 ZN ZN A 401 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -54.58 125.94 -31.48 -53.46 125.13 -29.87 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 330 TYR~? 12.28 ZN ZN A 402 B 40 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 103 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 132 TYR^? 30.83 ZN ZN B 402 B 40 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 103 ASP B 203 ASP^? 26.15 ZN ZN B 402 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -67.13 105.92 32.85 -67.85 106.57 30.23 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -62.37 99.36 31.88 -60.64 98.73 32.96 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 330 TYR~? 12.23 ZN ZN B 401 B 40 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 103 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -34.85 93.86 2.41 -34.87 96.02 2.16 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 5 hits 1e3v_c03 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 13 HIS~? 19.28 ZN ZN A 401 B 43 HIS A 12 HIS~? 21.70 ZN ZN A 401 B 65 GLU A 347 GLU~? 25.70 ZN ZN A 401 coo 20.15 22.08 34.36 20.84 20.10 34.21 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 19.55 18.91 30.27 18.21 18.65 31.84 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 10.90 21.31 28.81 12.14 22.15 30.31 -34.82 134.94 -29.37 -35.77 133.46 -30.53 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 43 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 65 GLU A 20 GLU.? 10.86 ZN ZN A 401 coo 20.15 22.08 34.36 20.84 20.10 34.21 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.55 18.91 30.27 18.21 18.65 31.84 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.90 21.31 28.81 12.14 22.15 30.31 -48.90 117.49 -13.24 -50.05 116.06 -14.24 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 43 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 65 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 20.15 22.08 34.36 20.84 20.10 34.21 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.55 18.91 30.27 18.21 18.65 31.84 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.90 21.31 28.81 12.14 22.15 30.31 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 43 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 65 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 20.15 22.08 34.36 20.84 20.10 34.21 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.55 18.91 30.27 18.21 18.65 31.84 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.90 21.31 28.81 12.14 22.15 30.31 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 43 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 65 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 20.15 22.08 34.36 20.84 20.10 34.21 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.55 18.91 30.27 18.21 18.65 31.84 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.90 21.31 28.81 12.14 22.15 30.31 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 43 HIS B 13 HIS~? 19.30 ZN ZN B 402 B 65 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo 20.15 22.08 34.36 20.84 20.10 34.21 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 19.55 18.91 30.27 18.21 18.65 31.84 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 10.90 21.31 28.81 12.14 22.15 30.31 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS B 13 HIS~? 19.30 ZN ZN B 402 B 43 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 65 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo 20.15 22.08 34.36 20.84 20.10 34.21 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 19.55 18.91 30.27 18.21 18.65 31.84 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 10.90 21.31 28.81 12.14 22.15 30.31 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 8 3 # 8 B 41 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 43 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 65 GLU B 20 GLU.? 11.09 ZN ZN B 402 coo 20.15 22.08 34.36 20.84 20.10 34.21 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.55 18.91 30.27 18.21 18.65 31.84 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.90 21.31 28.81 12.14 22.15 30.31 -52.94 103.12 14.27 -53.36 104.69 15.60 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 9 3 # 9 B 41 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 43 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 65 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 20.15 22.08 34.36 20.84 20.10 34.21 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.55 18.91 30.27 18.21 18.65 31.84 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.90 21.31 28.81 12.14 22.15 30.31 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 10 3 # 10 B 41 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 43 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 65 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 20.15 22.08 34.36 20.84 20.10 34.21 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.55 18.91 30.27 18.21 18.65 31.84 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.90 21.31 28.81 12.14 22.15 30.31 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 11 3 # 11 B 41 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 43 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 65 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 20.15 22.08 34.36 20.84 20.10 34.21 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.55 18.91 30.27 18.21 18.65 31.84 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.90 21.31 28.81 12.14 22.15 30.31 -35.80 114.72 -10.28 -37.63 115.69 -10.11 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 11 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 204 ALA.? 24.74 ZN ZN A 401 A 136 TYR A 132 TYR^? 30.56 ZN ZN A 401 A 140 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 55.90 7.49 23.83 56.71 8.23 22.76 -57.53 125.49 -28.34 -56.79 125.26 -27.00 coo 59.38 10.02 17.51 59.95 9.89 20.21 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo 59.52 3.69 18.67 62.31 6.19 22.58 -62.26 128.30 -31.49 -66.46 124.09 -29.25 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 1 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 35 SER A 285 SER.? 7.68 ZN ZN A 402 A 218 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 47.22 22.34 8.57 45.16 22.02 9.13 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 43.58 20.85 5.15 44.62 23.01 5.76 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 44.05 16.99 12.67 44.05 18.89 11.74 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 35 SER B 285 SER.? 7.72 ZN ZN B 401 A 218 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 47.22 22.34 8.57 45.16 22.02 9.13 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 43.58 20.85 5.15 44.62 23.01 5.76 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 44.05 16.99 12.67 44.05 18.89 11.74 -33.57 107.34 6.30 -34.87 106.07 5.21 1eag_c04 source 1eag PEPTIDE INHIBITOR : 2 hits 1eag_c04 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 275 LYS^? 30.46 ZN ZN A 401 A 207 LYS A 277 LYS^? 27.09 ZN ZN A 401 A 366 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 207 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 366 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -38.53 111.12 1.13 -44.30 110.60 0.01 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS B 119 LYS^? 26.96 ZN ZN B 402 A 207 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 366 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -30.71 103.60 27.70 -26.87 107.57 30.82 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -32.38 97.99 22.64 -33.06 97.84 28.07 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS B 275 LYS^? 32.38 ZN ZN B 402 A 207 LYS B 277 LYS^? 26.47 ZN ZN B 402 A 366 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -24.21 116.63 19.13 -19.07 117.25 20.30 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -28.04 112.73 23.24 -26.21 110.17 27.80 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 207 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 366 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -38.53 111.12 1.13 -44.30 110.60 0.01 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -33.57 107.34 6.30 -34.87 106.07 5.21 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 5 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 275 LYS^? 30.46 ZN ZN A 401 B 207 LYS A 277 LYS^? 27.09 ZN ZN A 401 B 366 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 307 LYS~? 10.65 ZN ZN B 401 B 207 LYS B 307 LYS~? 11.14 ZN ZN A 402 B 366 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -38.53 111.12 1.13 -44.30 110.60 0.01 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS B 119 LYS^? 26.96 ZN ZN B 402 B 207 LYS B 114 LYS~? 19.44 ZN ZN B 402 B 366 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -30.71 103.60 27.70 -26.87 107.57 30.82 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -32.38 97.99 22.64 -33.06 97.84 28.07 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 275 LYS^? 32.38 ZN ZN B 402 B 207 LYS B 277 LYS^? 26.47 ZN ZN B 402 B 366 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -24.21 116.63 19.13 -19.07 117.25 20.30 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -28.04 112.73 23.24 -26.21 110.17 27.80 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS B 307 LYS~? 11.14 ZN ZN A 402 B 207 LYS A 307 LYS~? 10.65 ZN ZN B 401 B 366 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -38.53 111.12 1.13 -44.30 110.60 0.01 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -33.57 107.34 6.30 -34.87 106.07 5.21 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 5 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 275 LYS^? 30.46 ZN ZN A 401 C 207 LYS A 277 LYS^? 27.09 ZN ZN A 401 C 366 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS A 307 LYS~? 10.65 ZN ZN B 401 C 207 LYS B 307 LYS~? 11.14 ZN ZN A 402 C 366 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS B 119 LYS^? 26.96 ZN ZN B 402 C 207 LYS B 114 LYS~? 19.44 ZN ZN B 402 C 366 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS B 275 LYS^? 32.38 ZN ZN B 402 C 207 LYS B 277 LYS^? 26.47 ZN ZN B 402 C 366 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS B 307 LYS~? 11.14 ZN ZN A 402 C 207 LYS A 307 LYS~? 10.65 ZN ZN B 401 C 366 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -33.57 107.34 6.30 -34.87 106.07 5.21 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 5 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 275 LYS^? 30.46 ZN ZN A 401 D 207 LYS A 277 LYS^? 27.09 ZN ZN A 401 D 366 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 307 LYS~? 10.65 ZN ZN B 401 D 207 LYS B 307 LYS~? 11.14 ZN ZN A 402 D 366 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS B 119 LYS^? 26.96 ZN ZN B 402 D 207 LYS B 114 LYS~? 19.44 ZN ZN B 402 D 366 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS B 275 LYS^? 32.38 ZN ZN B 402 D 207 LYS B 277 LYS^? 26.47 ZN ZN B 402 D 366 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS B 307 LYS~? 11.14 ZN ZN A 402 D 207 LYS A 307 LYS~? 10.65 ZN ZN B 401 D 366 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -33.57 107.34 6.30 -34.87 106.07 5.21 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 5 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 177 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 203 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 18.07 52.81 49.62 14.17 49.99 48.07 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 177 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 203 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 177 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 203 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 18.07 52.81 49.62 14.17 49.99 48.07 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 177 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 203 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 11.68 42.31 52.96 12.05 43.92 51.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 18.07 52.81 49.62 14.17 49.99 48.07 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 177 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 203 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 177 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 203 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 18.07 52.81 49.62 14.17 49.99 48.07 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 7 3 # 7 A 99 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 177 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 203 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 18.07 52.81 49.62 14.17 49.99 48.07 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 8 3 # 8 A 99 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 177 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 203 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 11.68 42.31 52.96 12.05 43.92 51.65 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 18.07 52.81 49.62 14.17 49.99 48.07 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 9 3 # 9 A 99 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 177 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 203 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 11.68 42.31 52.96 12.05 43.92 51.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 18.07 52.81 49.62 14.17 49.99 48.07 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 10 3 # 10 A 99 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 177 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 203 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 11.68 42.31 52.96 12.05 43.92 51.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 18.07 52.81 49.62 14.17 49.99 48.07 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 11 3 # 11 A 99 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 177 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 203 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 11.68 42.31 52.96 12.05 43.92 51.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 12 3 # 12 A 99 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 177 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 203 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 11.68 42.31 52.96 12.05 43.92 51.65 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 18.07 52.81 49.62 14.17 49.99 48.07 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 13 3 # 13 A 99 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 177 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 203 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 11.68 42.31 52.96 12.05 43.92 51.65 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 14 3 # 14 A 99 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 177 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 203 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 18.07 52.81 49.62 14.17 49.99 48.07 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 15 3 # 15 A 99 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 177 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 203 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 11.68 42.31 52.96 12.05 43.92 51.65 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 18.07 52.81 49.62 14.17 49.99 48.07 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 16 3 # 16 A 99 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 177 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 203 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 8.74 45.76 47.19 9.33 46.93 45.56 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 11.68 42.31 52.96 12.05 43.92 51.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 18.07 52.81 49.62 14.17 49.99 48.07 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 17 3 # 17 A 99 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 177 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 203 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 18.07 52.81 49.62 14.17 49.99 48.07 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 18 3 # 18 A 99 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 177 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 203 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 8.74 45.76 47.19 9.33 46.93 45.56 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 11.68 42.31 52.96 12.05 43.92 51.65 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 18.07 52.81 49.62 14.17 49.99 48.07 -48.76 125.53 -1.26 -51.29 120.16 0.88 1ecx_c02 source 1ecx AMINOTRANSFERASE : 18 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 177 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 203 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 177 ASP A 91 ASP.? 28.84 ZN ZN A 402 B 203 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 15.87 92.46 27.37 14.46 91.76 25.94 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 3.60 91.42 23.52 8.20 89.55 22.63 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 177 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 203 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 15.87 92.46 27.37 14.46 91.76 25.94 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 3.60 91.42 23.52 8.20 89.55 22.63 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 177 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 203 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 177 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 203 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 14.87 88.04 21.51 13.64 87.90 19.81 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 3.60 91.42 23.52 8.20 89.55 22.63 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 177 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 203 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 14.87 88.04 21.51 13.64 87.90 19.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 15.87 92.46 27.37 14.46 91.76 25.94 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 3.60 91.42 23.52 8.20 89.55 22.63 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 7 3 # 7 B 99 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 177 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 203 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 14.87 88.04 21.51 13.64 87.90 19.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 15.87 92.46 27.37 14.46 91.76 25.94 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 3.60 91.42 23.52 8.20 89.55 22.63 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 8 3 # 8 B 99 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 177 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 203 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 14.87 88.04 21.51 13.64 87.90 19.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 15.87 92.46 27.37 14.46 91.76 25.94 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 3.60 91.42 23.52 8.20 89.55 22.63 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 9 3 # 9 B 99 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 177 ASP B 91 ASP.? 28.82 ZN ZN B 401 B 203 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 14.87 88.04 21.51 13.64 87.90 19.81 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 15.87 92.46 27.37 14.46 91.76 25.94 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 3.60 91.42 23.52 8.20 89.55 22.63 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 10 3 # 10 B 99 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 177 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 203 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 14.87 88.04 21.51 13.64 87.90 19.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 15.87 92.46 27.37 14.46 91.76 25.94 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 11 3 # 11 B 99 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 177 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 203 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 15.87 92.46 27.37 14.46 91.76 25.94 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 3.60 91.42 23.52 8.20 89.55 22.63 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 12 3 # 12 B 99 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 177 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 203 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 14.87 88.04 21.51 13.64 87.90 19.81 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 15.87 92.46 27.37 14.46 91.76 25.94 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 3.60 91.42 23.52 8.20 89.55 22.63 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 13 3 # 13 B 99 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 177 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 203 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 15.87 92.46 27.37 14.46 91.76 25.94 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 3.60 91.42 23.52 8.20 89.55 22.63 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 14 3 # 14 B 99 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 177 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 203 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 15.87 92.46 27.37 14.46 91.76 25.94 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 3.60 91.42 23.52 8.20 89.55 22.63 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 15 3 # 15 B 99 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 177 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 203 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 14.87 88.04 21.51 13.64 87.90 19.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 15.87 92.46 27.37 14.46 91.76 25.94 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 3.60 91.42 23.52 8.20 89.55 22.63 -48.76 125.53 -1.26 -51.29 120.16 0.88 1ecx_c03 source 1ecx AMINOTRANSFERASE : 15 hits 1ecx_c03 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 P 35 SER A 285 SER.? 7.68 ZN ZN A 402 P 215 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 10.15 33.41 11.98 7.98 33.66 12.07 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.57 37.60 10.00 8.86 37.02 12.03 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 4.04 29.97 8.82 4.78 31.15 10.46 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 P 35 SER A 285 SER.? 7.68 ZN ZN A 402 P 215 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 10.15 33.41 11.98 7.98 33.66 12.07 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.57 37.60 10.00 8.86 37.02 12.03 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 4.04 29.97 8.82 4.78 31.15 10.46 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 P 35 SER B 285 SER.? 7.72 ZN ZN B 401 P 215 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 10.15 33.41 11.98 7.98 33.66 12.07 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.57 37.60 10.00 8.86 37.02 12.03 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 4.04 29.97 8.82 4.78 31.15 10.46 -33.57 107.34 6.30 -34.87 106.07 5.21 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 3 hits 1eed_c04 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 110 GLY A 318 GLY.? 21.36 ZN ZN B 401 A 140 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo 24.53 0.12 1.91 23.47 1.90 2.27 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 22.96 1.26 5.85 23.32 1.32 6.60 -42.31 90.61 -10.78 -42.69 91.31 -10.63 coo 21.28 7.32 1.28 21.07 5.14 3.02 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 A 66 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 110 GLY A 284 GLY.? 4.19 ZN ZN A 402 A 140 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 24.53 0.12 1.91 23.47 1.90 2.27 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 22.96 1.26 5.85 23.32 1.32 6.60 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo 21.28 7.32 1.28 21.07 5.14 3.02 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 A 66 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 110 GLY A 304 GLY.? 8.93 ZN ZN A 402 A 140 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 24.53 0.12 1.91 23.47 1.90 2.27 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 22.96 1.26 5.85 23.32 1.32 6.60 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 21.28 7.32 1.28 21.07 5.14 3.02 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 A 66 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 110 GLY B 318 GLY.? 21.53 ZN ZN A 402 A 140 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo 24.53 0.12 1.91 23.47 1.90 2.27 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 22.96 1.26 5.85 23.32 1.32 6.60 -32.98 122.14 11.89 -33.67 121.77 11.74 coo 21.28 7.32 1.28 21.07 5.14 3.02 -41.81 119.15 12.42 -40.61 119.58 9.91 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 5 3 # 5 A 66 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 110 GLY B 284 GLY.? 4.14 ZN ZN B 401 A 140 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 24.53 0.12 1.91 23.47 1.90 2.27 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 22.96 1.26 5.85 23.32 1.32 6.60 -41.31 101.77 9.74 -40.78 102.45 9.84 coo 21.28 7.32 1.28 21.07 5.14 3.02 -35.81 95.23 5.63 -35.48 92.50 6.11 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 5 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 110 GLY A 284 GLY.? 4.19 ZN ZN A 402 B 140 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 15.25 42.02 9.50 15.08 40.17 8.54 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 16.54 37.86 10.86 17.07 37.78 11.48 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo 8.70 35.97 10.91 11.44 36.02 10.35 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 110 GLY A 304 GLY.? 8.93 ZN ZN A 402 B 140 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 15.25 42.02 9.50 15.08 40.17 8.54 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 16.54 37.86 10.86 17.07 37.78 11.48 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 8.70 35.97 10.91 11.44 36.02 10.35 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 B 66 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 110 GLY B 284 GLY.? 4.14 ZN ZN B 401 B 140 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 15.25 42.02 9.50 15.08 40.17 8.54 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 16.54 37.86 10.86 17.07 37.78 11.48 -41.31 101.77 9.74 -40.78 102.45 9.84 coo 8.70 35.97 10.91 11.44 36.02 10.35 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 B 66 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 110 GLY B 304 GLY.? 8.91 ZN ZN B 401 B 140 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 15.25 42.02 9.50 15.08 40.17 8.54 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 16.54 37.86 10.86 17.07 37.78 11.48 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 8.70 35.97 10.91 11.44 36.02 10.35 -35.81 95.23 5.63 -35.48 92.50 6.11 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 110 GLY A 284 GLY.? 4.19 ZN ZN A 402 C 140 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -38.37 112.47 -8.74 -38.34 111.64 -8.92 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 110 GLY A 304 GLY.? 8.93 ZN ZN A 402 C 140 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 C 66 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 110 GLY B 284 GLY.? 4.14 ZN ZN B 401 C 140 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -41.31 101.77 9.74 -40.78 102.45 9.84 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 C 66 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 110 GLY B 304 GLY.? 8.91 ZN ZN B 401 C 140 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -37.52 104.72 7.61 -38.13 105.28 7.78 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -35.81 95.23 5.63 -35.48 92.50 6.11 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c02 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 275 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 22.84 50.35 52.24 23.24 48.32 52.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.67 42.94 48.26 27.49 41.07 48.73 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 A 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 275 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 28.44 37.56 46.79 26.87 37.11 48.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.84 50.35 52.24 23.24 48.32 52.90 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 26.67 42.94 48.26 27.49 41.07 48.73 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 A 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 246 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 275 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 28.44 37.56 46.79 26.87 37.11 48.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.84 50.35 52.24 23.24 48.32 52.90 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 26.67 42.94 48.26 27.49 41.07 48.73 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 A 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 246 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.84 50.35 52.24 23.24 48.32 52.90 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 26.67 42.94 48.26 27.49 41.07 48.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 A 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 246 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 22.84 50.35 52.24 23.24 48.32 52.90 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 26.67 42.94 48.26 27.49 41.07 48.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 A 107 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 275 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 28.44 37.56 46.79 26.87 37.11 48.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 22.84 50.35 52.24 23.24 48.32 52.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.67 42.94 48.26 27.49 41.07 48.73 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 A 107 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 275 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 22.84 50.35 52.24 23.24 48.32 52.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.67 42.94 48.26 27.49 41.07 48.73 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 A 107 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 275 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 28.44 37.56 46.79 26.87 37.11 48.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 22.84 50.35 52.24 23.24 48.32 52.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.67 42.94 48.26 27.49 41.07 48.73 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 A 107 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 22.84 50.35 52.24 23.24 48.32 52.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.67 42.94 48.26 27.49 41.07 48.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 A 107 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 246 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 275 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 28.44 37.56 46.79 26.87 37.11 48.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 22.84 50.35 52.24 23.24 48.32 52.90 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 26.67 42.94 48.26 27.49 41.07 48.73 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 A 107 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 246 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 22.84 50.35 52.24 23.24 48.32 52.90 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 26.67 42.94 48.26 27.49 41.07 48.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 A 107 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 22.84 50.35 52.24 23.24 48.32 52.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.67 42.94 48.26 27.49 41.07 48.73 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 13 3 # 13 A 107 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 246 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 22.84 50.35 52.24 23.24 48.32 52.90 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 26.67 42.94 48.26 27.49 41.07 48.73 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 14 3 # 14 A 107 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 246 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 22.84 50.35 52.24 23.24 48.32 52.90 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 26.67 42.94 48.26 27.49 41.07 48.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 15 3 # 15 A 107 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 246 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 22.84 50.35 52.24 23.24 48.32 52.90 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 26.67 42.94 48.26 27.49 41.07 48.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 16 3 # 16 A 107 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 275 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 22.84 50.35 52.24 23.24 48.32 52.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.67 42.94 48.26 27.49 41.07 48.73 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 17 3 # 17 A 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 246 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.84 50.35 52.24 23.24 48.32 52.90 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 18 3 # 18 A 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 275 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 28.44 37.56 46.79 26.87 37.11 48.10 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.84 50.35 52.24 23.24 48.32 52.90 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 26.67 42.94 48.26 27.49 41.07 48.73 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 19 3 # 19 A 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 246 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 275 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 28.44 37.56 46.79 26.87 37.11 48.10 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.84 50.35 52.24 23.24 48.32 52.90 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 26.67 42.94 48.26 27.49 41.07 48.73 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 20 3 # 20 A 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 246 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 22.84 50.35 52.24 23.24 48.32 52.90 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 21 3 # 21 A 107 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 275 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 28.44 37.56 46.79 26.87 37.11 48.10 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 22.84 50.35 52.24 23.24 48.32 52.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.67 42.94 48.26 27.49 41.07 48.73 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 22 3 # 22 A 107 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 275 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 22.84 50.35 52.24 23.24 48.32 52.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.67 42.94 48.26 27.49 41.07 48.73 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 23 3 # 23 A 107 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 246 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 22.84 50.35 52.24 23.24 48.32 52.90 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 24 3 # 24 A 107 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 22.84 50.35 52.24 23.24 48.32 52.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 25 3 # 25 A 107 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 275 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 28.44 37.56 46.79 26.87 37.11 48.10 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 22.84 50.35 52.24 23.24 48.32 52.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.67 42.94 48.26 27.49 41.07 48.73 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 26 3 # 26 A 107 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 246 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 275 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 28.44 37.56 46.79 26.87 37.11 48.10 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 22.84 50.35 52.24 23.24 48.32 52.90 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 26.67 42.94 48.26 27.49 41.07 48.73 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 27 3 # 27 A 107 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 22.84 50.35 52.24 23.24 48.32 52.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.67 42.94 48.26 27.49 41.07 48.73 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 28 3 # 28 A 107 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 246 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 28.44 37.56 46.79 26.87 37.11 48.10 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 22.84 50.35 52.24 23.24 48.32 52.90 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 26.67 42.94 48.26 27.49 41.07 48.73 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 29 3 # 29 A 107 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 246 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 22.84 50.35 52.24 23.24 48.32 52.90 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 30 3 # 30 A 107 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 246 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.44 37.56 46.79 26.87 37.11 48.10 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 22.84 50.35 52.24 23.24 48.32 52.90 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.00 97.85 3.28 -40.98 95.80 3.73 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 30 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 275 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 34.84 56.77 81.62 34.95 54.74 82.03 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 43.18 49.30 68.39 44.75 49.87 69.78 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 38.73 55.10 77.62 36.80 55.01 78.46 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 275 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 34.84 56.77 81.62 34.95 54.74 82.03 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 43.18 49.30 68.39 44.75 49.87 69.78 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 38.73 55.10 77.62 36.80 55.01 78.46 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 246 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 34.84 56.77 81.62 34.95 54.74 82.03 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 43.18 49.30 68.39 44.75 49.87 69.78 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 38.73 55.10 77.62 36.80 55.01 78.46 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 246 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 34.84 56.77 81.62 34.95 54.74 82.03 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 43.18 49.30 68.39 44.75 49.87 69.78 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 38.73 55.10 77.62 36.80 55.01 78.46 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 34.84 56.77 81.62 34.95 54.74 82.03 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 43.18 49.30 68.39 44.75 49.87 69.78 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 38.73 55.10 77.62 36.80 55.01 78.46 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 B 107 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 34.84 56.77 81.62 34.95 54.74 82.03 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 43.18 49.30 68.39 44.75 49.87 69.78 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 38.73 55.10 77.62 36.80 55.01 78.46 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 B 107 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 246 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 34.84 56.77 81.62 34.95 54.74 82.03 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 43.18 49.30 68.39 44.75 49.87 69.78 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 38.73 55.10 77.62 36.80 55.01 78.46 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 B 107 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 275 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 34.84 56.77 81.62 34.95 54.74 82.03 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 43.18 49.30 68.39 44.75 49.87 69.78 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 38.73 55.10 77.62 36.80 55.01 78.46 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 B 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 246 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 34.84 56.77 81.62 34.95 54.74 82.03 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 43.18 49.30 68.39 44.75 49.87 69.78 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 38.73 55.10 77.62 36.80 55.01 78.46 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 B 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 275 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 34.84 56.77 81.62 34.95 54.74 82.03 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 43.18 49.30 68.39 44.75 49.87 69.78 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 38.73 55.10 77.62 36.80 55.01 78.46 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 B 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 246 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 34.84 56.77 81.62 34.95 54.74 82.03 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 43.18 49.30 68.39 44.75 49.87 69.78 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 38.73 55.10 77.62 36.80 55.01 78.46 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 B 107 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 34.84 56.77 81.62 34.95 54.74 82.03 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 43.18 49.30 68.39 44.75 49.87 69.78 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 38.73 55.10 77.62 36.80 55.01 78.46 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 13 3 # 13 B 107 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 34.84 56.77 81.62 34.95 54.74 82.03 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 43.18 49.30 68.39 44.75 49.87 69.78 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 38.73 55.10 77.62 36.80 55.01 78.46 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 14 3 # 14 B 107 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 246 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 34.84 56.77 81.62 34.95 54.74 82.03 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 43.18 49.30 68.39 44.75 49.87 69.78 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 38.73 55.10 77.62 36.80 55.01 78.46 -41.00 97.85 3.28 -40.98 95.80 3.73 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 14 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 246 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 275 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 12.03 20.33 71.56 10.48 19.25 70.56 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 3.92 29.96 71.75 4.22 31.96 72.31 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 246 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 12.03 20.33 71.56 10.48 19.25 70.56 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 3.92 29.96 71.75 4.22 31.96 72.31 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 246 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 12.03 20.33 71.56 10.48 19.25 70.56 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 3.92 29.96 71.75 4.22 31.96 72.31 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 246 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 275 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 1.90 35.26 72.76 3.20 35.74 71.18 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 12.03 20.33 71.56 10.48 19.25 70.56 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 3.92 29.96 71.75 4.22 31.96 72.31 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.03 20.33 71.56 10.48 19.25 70.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 3.92 29.96 71.75 4.22 31.96 72.31 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 246 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.03 20.33 71.56 10.48 19.25 70.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 3.92 29.96 71.75 4.22 31.96 72.31 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 C 107 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 12.03 20.33 71.56 10.48 19.25 70.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 3.92 29.96 71.75 4.22 31.96 72.31 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 C 107 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 246 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 12.03 20.33 71.56 10.48 19.25 70.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 3.92 29.96 71.75 4.22 31.96 72.31 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 C 107 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 246 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 12.03 20.33 71.56 10.48 19.25 70.56 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 3.92 29.96 71.75 4.22 31.96 72.31 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 C 107 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 246 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 275 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 12.03 20.33 71.56 10.48 19.25 70.56 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 3.92 29.96 71.75 4.22 31.96 72.31 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 C 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 246 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 12.03 20.33 71.56 10.48 19.25 70.56 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 3.92 29.96 71.75 4.22 31.96 72.31 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 C 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 246 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 12.03 20.33 71.56 10.48 19.25 70.56 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 3.92 29.96 71.75 4.22 31.96 72.31 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 13 3 # 13 C 107 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 246 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 275 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 1.90 35.26 72.76 3.20 35.74 71.18 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 12.03 20.33 71.56 10.48 19.25 70.56 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 3.92 29.96 71.75 4.22 31.96 72.31 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 14 3 # 14 C 107 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.03 20.33 71.56 10.48 19.25 70.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 3.92 29.96 71.75 4.22 31.96 72.31 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 15 3 # 15 C 107 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 246 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.03 20.33 71.56 10.48 19.25 70.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 3.92 29.96 71.75 4.22 31.96 72.31 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 16 3 # 16 C 107 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 1.90 35.26 72.76 3.20 35.74 71.18 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 12.03 20.33 71.56 10.48 19.25 70.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 3.92 29.96 71.75 4.22 31.96 72.31 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 17 3 # 17 C 107 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 246 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 12.03 20.33 71.56 10.48 19.25 70.56 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 3.92 29.96 71.75 4.22 31.96 72.31 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 18 3 # 18 C 107 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 246 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 1.90 35.26 72.76 3.20 35.74 71.18 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 12.03 20.33 71.56 10.48 19.25 70.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 3.92 29.96 71.75 4.22 31.96 72.31 -41.00 97.85 3.28 -40.98 95.80 3.73 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 18 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 246 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 275 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 37.41 19.89 81.58 37.64 21.98 81.53 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 23.50 26.43 88.52 24.76 26.47 90.29 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 33.16 21.44 85.29 34.07 21.53 83.40 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 275 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 37.41 19.89 81.58 37.64 21.98 81.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 23.50 26.43 88.52 24.76 26.47 90.29 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 21.44 85.29 34.07 21.53 83.40 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 246 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 37.41 19.89 81.58 37.64 21.98 81.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 23.50 26.43 88.52 24.76 26.47 90.29 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 33.16 21.44 85.29 34.07 21.53 83.40 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 37.41 19.89 81.58 37.64 21.98 81.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 23.50 26.43 88.52 24.76 26.47 90.29 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 21.44 85.29 34.07 21.53 83.40 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 275 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 37.41 19.89 81.58 37.64 21.98 81.53 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 23.50 26.43 88.52 24.76 26.47 90.29 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 21.44 85.29 34.07 21.53 83.40 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 D 107 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 246 ASP B 305 ASP.? 7.64 ZN ZN B 401 D 275 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 37.41 19.89 81.58 37.64 21.98 81.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 23.50 26.43 88.52 24.76 26.47 90.29 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 33.16 21.44 85.29 34.07 21.53 83.40 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 D 107 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 246 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 275 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 37.41 19.89 81.58 37.64 21.98 81.53 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 23.50 26.43 88.52 24.76 26.47 90.29 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 33.16 21.44 85.29 34.07 21.53 83.40 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 D 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 246 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 275 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 37.41 19.89 81.58 37.64 21.98 81.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 23.50 26.43 88.52 24.76 26.47 90.29 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 33.16 21.44 85.29 34.07 21.53 83.40 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 D 107 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 246 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 275 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 37.41 19.89 81.58 37.64 21.98 81.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 23.50 26.43 88.52 24.76 26.47 90.29 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 21.44 85.29 34.07 21.53 83.40 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 D 107 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 37.41 19.89 81.58 37.64 21.98 81.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 23.50 26.43 88.52 24.76 26.47 90.29 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 21.44 85.29 34.07 21.53 83.40 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 D 107 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 246 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 275 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 37.41 19.89 81.58 37.64 21.98 81.53 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 23.50 26.43 88.52 24.76 26.47 90.29 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 21.44 85.29 34.07 21.53 83.40 -40.27 117.69 -1.83 -39.84 118.53 -3.70 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 11 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 223 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 223 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 197 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 223 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 197 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 223 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 197 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 223 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 197 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 223 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 197 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 223 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 A 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 197 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 223 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 A 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 197 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 223 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 A 114 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 197 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 223 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 A 114 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 197 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 223 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 A 114 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 197 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 223 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 A 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 223 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 A 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 197 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 223 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 A 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 197 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 223 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 A 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 223 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 A 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 197 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 223 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 18 3 # 18 A 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 197 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 223 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 19 3 # 19 A 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 197 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 223 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -48.76 125.53 -1.26 -51.29 120.16 0.88 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 19 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 197 ASP A 91 ASP.? 28.84 ZN ZN A 402 B 223 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 197 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 223 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 197 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 223 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 197 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 223 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 197 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 223 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 197 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 223 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 197 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 223 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 B 114 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 197 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 223 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 B 114 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 197 ASP B 91 ASP.? 28.82 ZN ZN B 401 B 223 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 B 114 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 197 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 223 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 B 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 223 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 B 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 197 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 223 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 B 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 197 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 223 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 B 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 223 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 B 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 197 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 223 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 B 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 197 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 223 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 B 114 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 197 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 223 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -48.76 125.53 -1.26 -51.29 120.16 0.88 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 17 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 242 ALA^? 17.05 ZN ZN A 401 A 257 ALA A 280 ALA^? 15.08 ZN ZN A 401 A 328 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 39.84 24.12 8.44 38.50 24.23 9.11 -35.28 104.10 -23.67 -34.41 105.16 -22.99 coo 43.22 26.73 5.37 41.81 27.09 5.79 -38.75 103.47 -18.17 -40.17 102.98 -17.87 coo 38.17 34.10 6.67 37.72 32.06 6.84 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 280 ALA^? 15.08 ZN ZN A 401 A 257 ALA A 242 ALA^? 17.05 ZN ZN A 401 A 328 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 39.84 24.12 8.44 38.50 24.23 9.11 -38.75 103.47 -18.17 -40.17 102.98 -17.87 coo 43.22 26.73 5.37 41.81 27.09 5.79 -35.28 104.10 -23.67 -34.41 105.16 -22.99 coo 38.17 34.10 6.67 37.72 32.06 6.84 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 280 ALA^? 15.08 ZN ZN A 401 A 257 ALA A 293 ALA~? 16.37 ZN ZN A 401 A 328 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 39.84 24.12 8.44 38.50 24.23 9.11 -38.75 103.47 -18.17 -40.17 102.98 -17.87 coo 43.22 26.73 5.37 41.81 27.09 5.79 -44.42 101.07 -17.63 -43.28 101.58 -16.75 coo 38.17 34.10 6.67 37.72 32.06 6.84 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 293 ALA~? 16.37 ZN ZN A 401 A 257 ALA A 280 ALA^? 15.08 ZN ZN A 401 A 328 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 39.84 24.12 8.44 38.50 24.23 9.11 -44.42 101.07 -17.63 -43.28 101.58 -16.75 coo 43.22 26.73 5.37 41.81 27.09 5.79 -38.75 103.47 -18.17 -40.17 102.98 -17.87 coo 38.17 34.10 6.67 37.72 32.06 6.84 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 314 ALA~? 16.60 ZN ZN B 401 A 257 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 328 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 39.84 24.12 8.44 38.50 24.23 9.11 -43.51 95.31 -7.19 -42.51 96.46 -7.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 38.17 34.10 6.67 37.72 32.06 6.84 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA B 113 ALA~? 14.04 ZN ZN B 402 A 257 ALA B 242 ALA^? 17.24 ZN ZN B 402 A 328 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 39.84 24.12 8.44 38.50 24.23 9.11 -33.76 101.16 20.95 -34.69 101.89 21.96 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.17 107.07 24.62 -33.83 105.72 24.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 242 ALA^? 17.24 ZN ZN B 402 A 257 ALA B 280 ALA^? 15.00 ZN ZN B 402 A 328 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.17 107.07 24.62 -33.83 105.72 24.06 coo 43.22 26.73 5.37 41.81 27.09 5.79 -36.85 109.46 19.16 -37.78 110.59 18.83 coo 38.17 34.10 6.67 37.72 32.06 6.84 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 280 ALA^? 15.00 ZN ZN B 402 A 257 ALA B 242 ALA^? 17.24 ZN ZN B 402 A 328 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 39.84 24.12 8.44 38.50 24.23 9.11 -36.85 109.46 19.16 -37.78 110.59 18.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.17 107.07 24.62 -33.83 105.72 24.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 280 ALA^? 15.00 ZN ZN B 402 A 257 ALA B 293 ALA~? 16.28 ZN ZN B 402 A 328 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 39.84 24.12 8.44 38.50 24.23 9.11 -36.85 109.46 19.16 -37.78 110.59 18.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 -40.44 114.49 18.56 -39.75 113.50 17.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 293 ALA~? 16.28 ZN ZN B 402 A 257 ALA B 280 ALA^? 15.00 ZN ZN B 402 A 328 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 39.84 24.12 8.44 38.50 24.23 9.11 -40.44 114.49 18.56 -39.75 113.50 17.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -36.85 109.46 19.16 -37.78 110.59 18.83 coo 38.17 34.10 6.67 37.72 32.06 6.84 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA B 314 ALA~? 16.61 ZN ZN A 402 A 257 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 328 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 39.84 24.12 8.44 38.50 24.23 9.11 -36.50 118.91 8.14 -36.25 117.42 8.39 coo 43.22 26.73 5.37 41.81 27.09 5.79 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -33.57 107.34 6.30 -34.87 106.07 5.21 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 11 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER B 151 SER~? 41.75 ZN ZN B 402 A 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 A 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 34.67 35.79 48.83 33.57 37.88 49.47 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 29.60 38.99 53.89 30.10 37.88 51.36 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 32.73 32.94 54.42 29.29 32.83 50.35 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER B 151 SER~? 41.75 ZN ZN B 402 A 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 A 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo 34.67 35.79 48.83 33.57 37.88 49.47 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 29.60 38.99 53.89 30.10 37.88 51.36 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 32.73 32.94 54.42 29.29 32.83 50.35 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER B 151 SER~? 41.75 ZN ZN B 402 B 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 B 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 30.90 35.65 89.60 29.85 37.72 88.83 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 24.43 38.83 86.53 27.07 38.03 86.12 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 25.13 32.62 89.49 27.74 32.61 84.91 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER B 151 SER~? 41.75 ZN ZN B 402 B 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 B 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo 30.90 35.65 89.60 29.85 37.72 88.83 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 24.43 38.83 86.53 27.07 38.03 86.12 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 25.13 32.62 89.49 27.74 32.61 84.91 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER B 151 SER~? 41.75 ZN ZN B 402 C 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 C 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -70.52 94.90 44.12 -71.51 97.15 44.18 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -76.80 93.86 44.47 -76.40 91.42 43.11 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER B 151 SER~? 41.75 ZN ZN B 402 C 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 C 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -70.52 94.90 44.12 -71.51 97.15 44.18 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -76.80 93.86 44.47 -76.40 91.42 43.11 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER B 151 SER~? 41.75 ZN ZN B 402 D 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 D 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -70.52 94.90 44.12 -71.51 97.15 44.18 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -76.80 93.86 44.47 -76.40 91.42 43.11 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER B 151 SER~? 41.75 ZN ZN B 402 D 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 D 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -70.52 94.90 44.12 -71.51 97.15 44.18 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -76.80 93.86 44.47 -76.40 91.42 43.11 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER B 151 SER~? 41.75 ZN ZN B 402 E 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 E 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER B 151 SER~? 41.75 ZN ZN B 402 E 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 E 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER B 151 SER~? 41.75 ZN ZN B 402 F 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 F 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 55.30 92.46 56.72 55.15 90.39 55.38 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 54.49 89.31 49.65 53.35 90.16 52.06 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 56.78 95.62 51.15 51.59 95.31 52.37 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER B 151 SER~? 41.75 ZN ZN B 402 F 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 F 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo 55.30 92.46 56.72 55.15 90.39 55.38 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 54.49 89.31 49.65 53.35 90.16 52.06 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 56.78 95.62 51.15 51.59 95.31 52.37 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER B 151 SER~? 41.75 ZN ZN B 402 G 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 G 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 76.25 95.63 21.56 75.29 93.40 21.36 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 69.78 91.62 20.06 71.51 92.68 22.02 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 71.19 98.21 18.32 70.69 97.75 23.67 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER B 151 SER~? 41.75 ZN ZN B 402 G 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 G 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo 76.25 95.63 21.56 75.29 93.40 21.36 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 69.78 91.62 20.06 71.51 92.68 22.02 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 71.19 98.21 18.32 70.69 97.75 23.67 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER B 151 SER~? 41.75 ZN ZN B 402 H 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 H 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 15.45 90.62 47.70 16.55 88.57 46.97 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 21.92 87.58 44.67 19.30 88.41 44.23 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 21.26 93.70 47.67 18.47 93.68 43.08 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER B 151 SER~? 41.75 ZN ZN B 402 H 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 H 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo 15.45 90.62 47.70 16.55 88.57 46.97 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 21.92 87.58 44.67 19.30 88.41 44.23 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 21.26 93.70 47.67 18.47 93.68 43.08 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER B 151 SER~? 41.75 ZN ZN B 402 I 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 I 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 11.78 90.82 7.18 12.84 88.72 7.93 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 16.78 87.76 12.19 16.39 88.69 9.59 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 13.67 93.83 12.65 17.08 93.94 8.58 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER B 151 SER~? 41.75 ZN ZN B 402 I 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 I 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo 11.78 90.82 7.18 12.84 88.72 7.93 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 16.78 87.76 12.19 16.39 88.69 9.59 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 13.67 93.83 12.65 17.08 93.94 8.58 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER B 151 SER~? 41.75 ZN ZN B 402 J 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 J 144 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -73.22 97.33 48.85 -74.87 100.01 44.50 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER B 151 SER~? 41.75 ZN ZN B 402 J 140 TYR B 217 TYR~? 45.33 ZN ZN B 402 J 144 LYS B 149 LYS~? 48.62 ZN ZN B 402 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -69.50 93.01 49.28 -67.77 93.79 54.77 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 86 LYS~? 24.82 ZN ZN A 402 A 193 GLU A 48 GLU~? 19.37 ZN ZN A 402 A 217 VAL A 50 VAL~? 19.23 ZN ZN A 402 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -33.51 137.11 0.86 -27.79 135.78 2.74 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -25.72 127.18 1.29 -24.86 125.22 1.74 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -29.56 132.44 -3.36 -31.35 133.31 -2.44 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 315 LYS~? 18.17 ZN ZN B 401 A 193 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 217 VAL A 319 VAL.? 20.98 ZN ZN B 401 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -41.97 94.33 -11.50 -43.49 95.81 -11.95 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 193 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 217 VAL A 331 VAL~? 10.48 ZN ZN A 401 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -29.21 116.62 -13.66 -29.67 114.51 -14.21 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS B 86 LYS~? 24.89 ZN ZN B 401 A 193 GLU B 48 GLU~? 19.33 ZN ZN B 401 A 217 VAL B 50 VAL~? 19.22 ZN ZN B 401 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -50.53 78.48 -0.34 -44.96 76.41 -1.96 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -38.69 82.94 -0.70 -36.82 83.91 -1.11 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -44.61 80.22 3.98 -46.57 80.59 3.08 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS B 315 LYS~? 18.28 ZN ZN A 402 A 193 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 217 VAL B 319 VAL.? 21.03 ZN ZN A 402 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -33.07 120.28 7.09 -27.74 119.98 5.88 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -34.86 118.87 12.59 -37.01 118.35 12.88 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 193 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 217 VAL B 331 VAL~? 10.43 ZN ZN B 402 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -35.72 93.30 14.48 -35.07 95.38 15.07 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 6 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 37 THR.? 27.03 ZN ZN A 401 A 159 LYS A 2 LYS~? 31.84 ZN ZN A 401 A 193 GLU A 347 GLU~? 25.70 ZN ZN A 401 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -28.34 140.20 -15.53 -28.28 141.11 -13.55 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -36.47 141.55 -19.14 -38.98 147.34 -19.86 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -34.82 134.94 -29.37 -35.77 133.46 -30.53 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 60 THR^? 20.22 ZN ZN A 401 A 159 LYS A 2 LYS~? 31.84 ZN ZN A 401 A 193 GLU A 347 GLU~? 25.70 ZN ZN A 401 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -32.53 135.36 -12.03 -33.54 135.78 -13.89 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -36.47 141.55 -19.14 -38.98 147.34 -19.86 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -34.82 134.94 -29.37 -35.77 133.46 -30.53 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 338 THR~? 18.04 ZN ZN A 401 A 159 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 193 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -27.48 123.82 -21.98 -26.41 122.05 -22.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR A 338 THR~? 18.04 ZN ZN A 401 A 159 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 193 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -27.48 123.82 -21.98 -26.41 122.05 -22.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR A 357 THR.? 20.18 ZN ZN A 402 A 159 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 193 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -22.69 123.90 -8.22 -21.02 125.26 -8.45 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR A 360 THR.? 11.95 ZN ZN A 402 A 159 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 193 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -28.53 120.60 -2.22 -29.42 121.92 -3.70 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR B 37 THR.? 27.08 ZN ZN B 402 A 159 LYS B 2 LYS~? 31.85 ZN ZN B 402 A 193 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -47.65 72.83 15.84 -48.15 72.05 13.90 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -55.28 75.86 19.60 -60.60 72.43 20.00 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR B 60 THR^? 20.14 ZN ZN B 402 A 159 LYS B 2 LYS~? 31.85 ZN ZN B 402 A 193 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -48.67 79.24 12.49 -49.70 79.48 14.38 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -55.28 75.86 19.60 -60.60 72.43 20.00 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR B 136 THR^? 43.30 ZN ZN B 402 A 159 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 193 GLU B 158 GLU.? 36.73 ZN ZN B 402 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -73.17 106.15 44.31 -73.94 104.19 43.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -73.22 97.33 48.85 -74.87 100.01 44.50 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -60.87 94.33 46.47 -60.36 92.90 44.98 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR B 136 THR^? 43.30 ZN ZN B 402 A 159 LYS B 215 LYS~? 43.78 ZN ZN B 402 A 193 GLU B 221 GLU.? 57.93 ZN ZN B 402 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -73.17 106.15 44.31 -73.94 104.19 43.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -79.75 99.05 40.27 -81.86 101.81 35.01 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -89.64 105.62 45.28 -91.08 107.11 45.80 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR B 338 THR~? 18.00 ZN ZN B 402 A 159 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 193 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -38.01 86.11 22.61 -36.16 87.10 23.19 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR B 338 THR~? 18.00 ZN ZN B 402 A 159 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 193 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -38.01 86.11 22.61 -36.16 87.10 23.19 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 38 THR B 357 THR.? 20.15 ZN ZN B 401 A 159 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 193 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 38 THR B 360 THR.? 11.92 ZN ZN B 401 A 159 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 193 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -37.37 89.63 2.92 -38.80 89.04 4.49 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -37.43 78.09 15.20 -36.78 76.82 13.66 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 14 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 44 ASP.? 7.09 ZN ZN A 402 260 GLU A 329 GLU~? 2.55 ZN ZN A 401s 370 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 129 ASP^? 19.65 ZN ZN A 401 260 GLU A 229 GLU^? 28.63 ZN ZN A 401 370 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP A 226 ASP^? 42.28 ZN ZN A 401 260 GLU A 229 GLU^? 28.63 ZN ZN A 401 370 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP A 305 ASP.? 7.62 ZN ZN A 402 260 GLU A 290 GLU~? 16.18 ZN ZN A 402 370 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP A 305 ASP.? 7.62 ZN ZN A 402 260 GLU A 329 GLU~? 2.55 ZN ZN A 401s 370 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP A 323 ASP^? 12.30 ZN ZN A 402 260 GLU A 329 GLU~? 2.55 ZN ZN A 401s 370 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP B 44 ASP.? 7.11 ZN ZN B 401 260 GLU B 329 GLU~? 2.54 ZN ZN B 402s 370 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP B 129 ASP^? 19.14 ZN ZN B 402 260 GLU B 229 GLU^? 28.52 ZN ZN B 402 370 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -65.20 109.92 29.95 -64.70 111.14 28.31 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1euu_c00 SIALIDASE user 9 3 # 9 92 ASP B 226 ASP^? 42.35 ZN ZN B 402 260 GLU B 229 GLU^? 28.52 ZN ZN B 402 370 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -65.20 109.92 29.95 -64.70 111.14 28.31 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1euu_c00 SIALIDASE user 10 3 # 10 92 ASP B 305 ASP.? 7.64 ZN ZN B 401 260 GLU B 290 GLU~? 16.07 ZN ZN B 401 370 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1euu_c00 SIALIDASE user 11 3 # 11 92 ASP B 305 ASP.? 7.64 ZN ZN B 401 260 GLU B 329 GLU~? 2.54 ZN ZN B 402s 370 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1euu_c00 SIALIDASE user 12 3 # 12 92 ASP B 323 ASP^? 12.28 ZN ZN B 401 260 GLU B 329 GLU~? 2.54 ZN ZN B 402s 370 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -35.81 95.23 5.63 -35.48 92.50 6.11 1euu_c00 source 1euu SIALIDASE : 12 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 251 GLU~? 26.78 ZN ZN B 401 A 260 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 270 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 50.99 29.43 12.86 52.11 29.45 14.65 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 39.80 27.50 22.98 42.20 26.56 21.34 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 271 GLU.? 22.11 ZN ZN B 401 A 260 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 270 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 50.99 29.43 12.86 52.11 29.45 14.65 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 39.80 27.50 22.98 42.20 26.56 21.34 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 48.83 21.70 19.50 47.44 24.99 15.25 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 260 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 270 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 50.99 29.43 12.86 52.11 29.45 14.65 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 39.80 27.50 22.98 42.20 26.56 21.34 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 48.83 21.70 19.50 47.44 24.99 15.25 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 260 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 270 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 50.99 29.43 12.86 52.11 29.45 14.65 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 39.80 27.50 22.98 42.20 26.56 21.34 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 48.83 21.70 19.50 47.44 24.99 15.25 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 251 GLU~? 27.55 ZN ZN A 402 A 260 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 270 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 50.99 29.43 12.86 52.11 29.45 14.65 -20.38 111.90 11.61 -18.92 112.78 10.34 coo 39.80 27.50 22.98 42.20 26.56 21.34 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 48.83 21.70 19.50 47.44 24.99 15.25 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 271 GLU.? 25.84 ZN ZN A 402 A 260 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 270 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 50.99 29.43 12.86 52.11 29.45 14.65 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 39.80 27.50 22.98 42.20 26.56 21.34 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 48.83 21.70 19.50 47.44 24.99 15.25 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 260 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 270 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 50.99 29.43 12.86 52.11 29.45 14.65 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 39.80 27.50 22.98 42.20 26.56 21.34 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 48.83 21.70 19.50 47.44 24.99 15.25 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 260 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 270 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 50.99 29.43 12.86 52.11 29.45 14.65 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 39.80 27.50 22.98 42.20 26.56 21.34 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 48.83 21.70 19.50 47.44 24.99 15.25 -40.89 103.09 -0.15 -45.35 106.49 1.62 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 8 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 74 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 98 GLU A 20 GLU.? 10.86 ZN ZN A 401 coo 17.19 9.05 25.28 15.77 9.98 26.53 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 15.99 8.54 17.36 14.96 7.80 19.05 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 16.31 12.85 18.11 16.71 11.79 19.90 -48.90 117.49 -13.24 -50.05 116.06 -14.24 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 2 3 # 2 A 68 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 74 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 98 GLU A 251 GLU~? 26.78 ZN ZN B 401 coo 17.19 9.05 25.28 15.77 9.98 26.53 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 15.99 8.54 17.36 14.96 7.80 19.05 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 16.31 12.85 18.11 16.71 11.79 19.90 -25.70 93.68 -9.35 -24.99 91.85 -8.59 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 3 3 # 3 A 68 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 74 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 98 GLU B 20 GLU.? 11.09 ZN ZN B 402 coo 17.19 9.05 25.28 15.77 9.98 26.53 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 15.99 8.54 17.36 14.96 7.80 19.05 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 16.31 12.85 18.11 16.71 11.79 19.90 -52.94 103.12 14.27 -53.36 104.69 15.60 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 4 3 # 4 A 68 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 74 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 98 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 17.19 9.05 25.28 15.77 9.98 26.53 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 15.99 8.54 17.36 14.96 7.80 19.05 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 16.31 12.85 18.11 16.71 11.79 19.90 -20.38 111.90 11.61 -18.92 112.78 10.34 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 4 hits 1eyi_c00 naa= 3 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 1 3 # 1 A 233 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 254 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 301 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 2 3 # 2 A 233 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 254 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 301 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 3 3 # 3 A 233 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 254 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 301 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 4 3 # 4 A 233 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 254 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 301 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -54.33 98.57 11.88 -52.50 97.53 11.52 1ez2_c00 source 1ez2 PHOSPHOTRIESTERASE : 4 hits 1ez2_c00 naa= 3 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 1 3 # 1 B 233 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 254 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 301 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 2 3 # 2 B 233 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 254 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 301 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 3 3 # 3 B 233 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 254 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 301 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 4 3 # 4 B 233 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 254 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 301 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -54.33 98.57 11.88 -52.50 97.53 11.52 1ez2_c01 source 1ez2 PHOSPHOTRIESTERASE : 4 hits 1ez2_c01 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 33 ASP.? 31.33 ZN ZN A 401 C 117 GLU A 35 GLU.? 32.19 ZN ZN A 401 C 131 GLU A 32 GLU.? 25.81 ZN ZN A 401 coo 68.01 56.37 72.57 68.42 56.10 70.51 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 66.59 62.50 67.44 67.57 60.64 67.12 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 69.24 52.27 71.96 69.91 50.26 71.89 -43.68 141.75 -15.46 -45.31 141.26 -16.67 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 1 hits 1f6d_c02 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 159 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 162 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 29.80 39.37 7.24 28.18 38.06 7.48 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 30.26 35.04 5.34 28.61 35.92 4.39 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 2 3 # 2 A 156 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 159 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 162 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 29.80 39.37 7.24 28.18 38.06 7.48 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 30.26 35.04 5.34 28.61 35.92 4.39 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 3 3 # 3 A 156 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 159 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 162 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 29.80 39.37 7.24 28.18 38.06 7.48 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 30.26 35.04 5.34 28.61 35.92 4.39 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 4 3 # 4 A 156 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 159 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 162 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 29.80 39.37 7.24 28.18 38.06 7.48 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 30.26 35.04 5.34 28.61 35.92 4.39 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 5 3 # 5 A 156 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 159 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 162 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 29.80 39.37 7.24 28.18 38.06 7.48 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 30.26 35.04 5.34 28.61 35.92 4.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 6 3 # 6 A 156 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 159 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 162 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 29.80 39.37 7.24 28.18 38.06 7.48 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 30.26 35.04 5.34 28.61 35.92 4.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 7 3 # 7 A 156 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 159 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 162 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 29.80 39.37 7.24 28.18 38.06 7.48 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 30.26 35.04 5.34 28.61 35.92 4.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 8 3 # 8 A 156 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 159 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 162 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 29.80 39.37 7.24 28.18 38.06 7.48 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 30.26 35.04 5.34 28.61 35.92 4.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 8 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 62 LYS A 56 LYS~? 22.91 ZN ZN A 402 F 35 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 19.95 18.98 4.81 18.82 20.94 10.49 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo 16.32 15.30 17.19 17.71 14.73 18.69 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 62 LYS A 333 LYS~? 13.50 ZN ZN A 402 F 35 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 15.40 22.79 16.66 13.93 24.10 15.98 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.95 18.98 4.81 18.82 20.94 10.49 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 16.32 15.30 17.19 17.71 14.73 18.69 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 62 LYS B 307 LYS~? 11.14 ZN ZN A 402 F 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 62 LYS B 333 LYS~? 13.39 ZN ZN B 401 F 35 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 16.32 15.30 17.19 17.71 14.73 18.69 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 62 LYS B 70 LYS.? 12.56 ZN ZN B 401 F 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.95 18.98 4.81 18.82 20.94 10.49 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 62 LYS B 70 LYS.? 12.56 ZN ZN B 401 F 35 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.95 18.98 4.81 18.82 20.94 10.49 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 16.32 15.30 17.19 17.71 14.73 18.69 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 62 LYS B 70 LYS.? 12.56 ZN ZN B 401 F 35 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.95 18.98 4.81 18.82 20.94 10.49 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 16.32 15.30 17.19 17.71 14.73 18.69 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 8 3 # 8 A 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 62 LYS B 307 LYS~? 11.14 ZN ZN A 402 F 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 16.32 15.30 17.19 17.71 14.73 18.69 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 9 3 # 9 A 105 HIS A 317 HIS~? 18.34 ZN ZN B 401 C 62 LYS B 70 LYS.? 12.56 ZN ZN B 401 F 35 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 19.95 18.98 4.81 18.82 20.94 10.49 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 16.32 15.30 17.19 17.71 14.73 18.69 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 10 3 # 10 A 105 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 62 LYS B 56 LYS~? 22.19 ZN ZN B 401 F 35 ASP B 91 ASP.? 28.82 ZN ZN B 401 coo 15.40 22.79 16.66 13.93 24.10 15.98 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 19.95 18.98 4.81 18.82 20.94 10.49 -40.15 73.23 9.47 -36.32 78.07 10.66 coo 16.32 15.30 17.19 17.71 14.73 18.69 -53.83 73.30 7.14 -55.54 72.50 6.14 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 11 3 # 11 A 105 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 62 LYS B 333 LYS~? 13.39 ZN ZN B 401 F 35 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 15.40 22.79 16.66 13.93 24.10 15.98 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 16.32 15.30 17.19 17.71 14.73 18.69 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 12 3 # 12 A 105 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 62 LYS A 307 LYS~? 10.65 ZN ZN B 401 F 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.95 18.98 4.81 18.82 20.94 10.49 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 13 3 # 13 A 105 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 62 LYS A 333 LYS~? 13.50 ZN ZN A 402 F 35 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.95 18.98 4.81 18.82 20.94 10.49 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 16.32 15.30 17.19 17.71 14.73 18.69 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 14 3 # 14 A 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 F 35 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 16.32 15.30 17.19 17.71 14.73 18.69 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 15 3 # 15 A 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 F 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 16 3 # 16 A 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 F 35 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 16.32 15.30 17.19 17.71 14.73 18.69 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 17 3 # 17 A 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 62 LYS A 307 LYS~? 10.65 ZN ZN B 401 F 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 18 3 # 18 A 105 HIS B 317 HIS~? 18.53 ZN ZN A 402 C 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 F 35 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 15.40 22.79 16.66 13.93 24.10 15.98 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 19.95 18.98 4.81 18.82 20.94 10.49 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 16.32 15.30 17.19 17.71 14.73 18.69 -39.61 120.08 5.22 -40.78 120.61 3.53 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 18 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 56 LYS~? 22.91 ZN ZN A 402 C 105 HIS A 90 HIS~? 26.77 ZN ZN A 402 D 35 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo 34.93 19.72 17.37 34.72 18.17 15.98 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 41.01 23.02 20.83 40.65 24.26 22.55 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 C 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 35 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 C 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 C 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 35 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS A 70 LYS.? 15.41 ZN ZN A 402 C 105 HIS B 317 HIS~? 18.53 ZN ZN A 402 D 35 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 34.93 19.72 17.37 34.72 18.17 15.98 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 41.01 23.02 20.83 40.65 24.26 22.55 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS A 76 LYS.? 26.59 ZN ZN A 402 C 105 HIS B 317 HIS~? 18.53 ZN ZN A 402 D 35 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -40.70 135.50 8.63 -43.88 132.62 12.69 coo 34.93 19.72 17.37 34.72 18.17 15.98 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 41.01 23.02 20.83 40.65 24.26 22.55 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS A 307 LYS~? 10.65 ZN ZN B 401 C 105 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 34.93 19.72 17.37 34.72 18.17 15.98 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS A 307 LYS~? 10.65 ZN ZN B 401 C 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 34.93 19.72 17.37 34.72 18.17 15.98 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 9 3 # 9 B 62 LYS A 333 LYS~? 13.50 ZN ZN A 402 C 105 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 35 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 38.76 28.25 7.87 36.33 26.41 13.58 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 34.93 19.72 17.37 34.72 18.17 15.98 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 41.01 23.02 20.83 40.65 24.26 22.55 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 10 3 # 10 B 62 LYS A 333 LYS~? 13.50 ZN ZN A 402 C 105 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 35 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 34.93 19.72 17.37 34.72 18.17 15.98 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 41.01 23.02 20.83 40.65 24.26 22.55 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 11 3 # 11 B 62 LYS A 337 LYS~? 20.91 ZN ZN A 401 C 105 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 35 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 38.76 28.25 7.87 36.33 26.41 13.58 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 34.93 19.72 17.37 34.72 18.17 15.98 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 41.01 23.02 20.83 40.65 24.26 22.55 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 12 3 # 12 B 62 LYS B 56 LYS~? 22.19 ZN ZN B 401 C 105 HIS B 90 HIS~? 26.84 ZN ZN B 401 D 35 ASP B 91 ASP.? 28.82 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -40.15 73.23 9.47 -36.32 78.07 10.66 coo 34.93 19.72 17.37 34.72 18.17 15.98 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 41.01 23.02 20.83 40.65 24.26 22.55 -53.83 73.30 7.14 -55.54 72.50 6.14 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 13 3 # 13 B 62 LYS B 70 LYS.? 12.56 ZN ZN B 401 C 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 34.93 19.72 17.37 34.72 18.17 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 14 3 # 14 B 62 LYS B 70 LYS.? 12.56 ZN ZN B 401 C 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 35 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 34.93 19.72 17.37 34.72 18.17 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 41.01 23.02 20.83 40.65 24.26 22.55 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 15 3 # 15 B 62 LYS B 70 LYS.? 12.56 ZN ZN B 401 C 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 35 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 34.93 19.72 17.37 34.72 18.17 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 41.01 23.02 20.83 40.65 24.26 22.55 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 16 3 # 16 B 62 LYS B 307 LYS~? 11.14 ZN ZN A 402 C 105 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 34.93 19.72 17.37 34.72 18.17 15.98 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 17 3 # 17 B 62 LYS B 307 LYS~? 11.14 ZN ZN A 402 C 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 34.93 19.72 17.37 34.72 18.17 15.98 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 41.01 23.02 20.83 40.65 24.26 22.55 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 18 3 # 18 B 62 LYS B 333 LYS~? 13.39 ZN ZN B 401 C 105 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 35 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 34.93 19.72 17.37 34.72 18.17 15.98 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 19 3 # 19 B 62 LYS B 333 LYS~? 13.39 ZN ZN B 401 C 105 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 35 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 34.93 19.72 17.37 34.72 18.17 15.98 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 41.01 23.02 20.83 40.65 24.26 22.55 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 20 3 # 20 B 62 LYS B 337 LYS~? 20.93 ZN ZN B 402 C 105 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 35 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 38.76 28.25 7.87 36.33 26.41 13.58 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 34.93 19.72 17.37 34.72 18.17 15.98 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 41.01 23.02 20.83 40.65 24.26 22.55 -43.07 90.95 4.66 -43.22 93.08 4.74 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 20 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 56 LYS~? 22.91 ZN ZN A 402 B 105 HIS A 90 HIS~? 26.77 ZN ZN A 402 E 35 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo 20.51 39.76 8.83 21.23 37.38 14.18 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo 27.18 37.56 20.68 29.07 38.28 20.13 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 19.97 40.39 22.03 18.53 39.30 23.18 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 105 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 35 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 20.51 39.76 8.83 21.23 37.38 14.18 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 27.18 37.56 20.68 29.07 38.28 20.13 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 19.97 40.39 22.03 18.53 39.30 23.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS A 307 LYS~? 10.65 ZN ZN B 401 B 105 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 35 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 20.51 39.76 8.83 21.23 37.38 14.18 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 27.18 37.56 20.68 29.07 38.28 20.13 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.97 40.39 22.03 18.53 39.30 23.18 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS A 307 LYS~? 10.65 ZN ZN B 401 B 105 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 20.51 39.76 8.83 21.23 37.38 14.18 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 27.18 37.56 20.68 29.07 38.28 20.13 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS A 307 LYS~? 10.65 ZN ZN B 401 B 105 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 35 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 20.51 39.76 8.83 21.23 37.38 14.18 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 6 3 # 6 A 62 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 105 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 35 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 20.51 39.76 8.83 21.23 37.38 14.18 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 27.18 37.56 20.68 29.07 38.28 20.13 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.97 40.39 22.03 18.53 39.30 23.18 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 7 3 # 7 A 62 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 105 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 35 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 20.51 39.76 8.83 21.23 37.38 14.18 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 27.18 37.56 20.68 29.07 38.28 20.13 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 19.97 40.39 22.03 18.53 39.30 23.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 8 3 # 8 A 62 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 105 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 35 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 20.51 39.76 8.83 21.23 37.38 14.18 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 27.18 37.56 20.68 29.07 38.28 20.13 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.97 40.39 22.03 18.53 39.30 23.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 9 3 # 9 A 62 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 105 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 35 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 20.51 39.76 8.83 21.23 37.38 14.18 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 19.97 40.39 22.03 18.53 39.30 23.18 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 10 3 # 10 A 62 LYS B 307 LYS~? 11.14 ZN ZN A 402 B 105 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 35 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 27.18 37.56 20.68 29.07 38.28 20.13 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.97 40.39 22.03 18.53 39.30 23.18 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 11 3 # 11 A 62 LYS B 307 LYS~? 11.14 ZN ZN A 402 B 105 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 27.18 37.56 20.68 29.07 38.28 20.13 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 12 3 # 12 A 62 LYS B 307 LYS~? 11.14 ZN ZN A 402 B 105 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 35 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 27.18 37.56 20.68 29.07 38.28 20.13 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.97 40.39 22.03 18.53 39.30 23.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 13 3 # 13 A 62 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 105 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 35 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 27.18 37.56 20.68 29.07 38.28 20.13 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 14 3 # 14 A 62 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 105 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 35 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 27.18 37.56 20.68 29.07 38.28 20.13 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.97 40.39 22.03 18.53 39.30 23.18 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 15 3 # 15 A 62 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 105 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 35 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 20.51 39.76 8.83 21.23 37.38 14.18 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 27.18 37.56 20.68 29.07 38.28 20.13 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 19.97 40.39 22.03 18.53 39.30 23.18 -34.85 93.86 2.41 -34.87 96.02 2.16 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 15 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 69 PHE.? 10.08 ZN ZN A 402 A 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -46.18 122.83 -3.97 -47.90 120.78 -4.97 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 227 PHE^? 35.88 ZN ZN A 401 A 210 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 244 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -65.47 125.21 -34.29 -64.76 127.80 -35.05 coo 10.51 37.86 19.71 9.07 39.38 20.04 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 210 ASP A 245 ASP^? 25.73 ZN ZN A 401 A 244 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 210 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 244 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 210 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 244 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 210 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 244 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 210 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 210 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 210 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -1.20 42.34 17.67 3.19 45.13 19.06 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE A 344 PHE~? 21.75 ZN ZN A 401 A 210 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -30.23 132.91 -23.69 -31.48 133.59 -21.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo -1.20 42.34 17.67 3.19 45.13 19.06 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE A 363 PHE.? 13.25 ZN ZN A 402 A 210 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 244 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -1.20 42.34 17.67 3.19 45.13 19.06 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE A 363 PHE.? 13.25 ZN ZN A 402 A 210 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE B 69 PHE.? 9.95 ZN ZN B 401 A 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -53.31 97.22 4.88 -53.54 99.70 6.20 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE B 146 PHE~? 50.49 ZN ZN B 402 A 210 ASP B 141 ASP.? 56.65 ZN ZN B 402 A 244 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 10.51 37.86 19.71 9.07 39.38 20.04 -75.94 101.33 59.57 -77.56 101.84 58.29 coo -1.20 42.34 17.67 3.19 45.13 19.06 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 112 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 210 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 244 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 112 PHE B 227 PHE^? 36.29 ZN ZN B 402 A 210 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 244 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -71.43 105.73 35.02 -72.67 103.28 35.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 -62.37 99.36 31.88 -60.64 98.73 32.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 112 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 210 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 244 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -23.71 105.07 26.59 -24.46 103.20 27.20 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 112 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 210 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 244 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 210 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 210 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 244 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.51 37.86 19.71 9.07 39.38 20.04 -20.29 109.25 15.64 -18.38 109.99 15.02 coo -1.20 42.34 17.67 3.19 45.13 19.06 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 210 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 244 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.51 37.86 19.71 9.07 39.38 20.04 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 210 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 244 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 10.51 37.86 19.71 9.07 39.38 20.04 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 112 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 210 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 112 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 210 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 112 PHE B 344 PHE~? 21.77 ZN ZN B 402 A 210 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 244 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -45.25 79.78 24.19 -46.74 79.97 21.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -1.20 42.34 17.67 3.19 45.13 19.06 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 A 112 PHE B 344 PHE~? 21.77 ZN ZN B 402 A 210 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -45.25 79.78 24.19 -46.74 79.97 21.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 A 112 PHE B 363 PHE^? 13.11 ZN ZN B 401 A 210 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.23 46.77 25.11 11.48 48.39 24.76 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 A 112 PHE B 363 PHE^? 13.11 ZN ZN B 401 A 210 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 244 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 9.23 46.77 25.11 11.48 48.39 24.76 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 -25.96 101.08 10.72 -22.73 101.83 5.25 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 28 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 69 PHE.? 10.08 ZN ZN A 402 B 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -46.18 122.83 -3.97 -47.90 120.78 -4.97 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 227 PHE^? 35.88 ZN ZN A 401 B 210 ASP A 203 ASP.? 24.56 ZN ZN A 401 B 244 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -65.47 125.21 -34.29 -64.76 127.80 -35.05 coo 9.06 56.85 40.30 7.71 55.27 39.90 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 253 PHE~? 19.21 ZN ZN A 401 B 210 ASP A 245 ASP^? 25.73 ZN ZN A 401 B 244 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 253 PHE~? 19.21 ZN ZN A 401 B 210 ASP A 299 ASP.? 24.38 ZN ZN A 401 B 244 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 210 ASP A 252 ASP~? 28.57 ZN ZN A 401 B 244 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 210 ASP A 256 ASP~? 22.47 ZN ZN A 401 B 244 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 210 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE A 301 PHE^? 12.99 ZN ZN A 401 B 210 ASP A 299 ASP.? 24.38 ZN ZN A 401 B 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE A 301 PHE^? 12.99 ZN ZN A 401 B 210 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -2.38 51.82 41.62 2.07 49.19 40.42 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE A 344 PHE~? 21.75 ZN ZN A 401 B 210 ASP A 352 ASP.? 27.02 ZN ZN A 401 B 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -30.23 132.91 -23.69 -31.48 133.59 -21.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo -2.38 51.82 41.62 2.07 49.19 40.42 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE A 363 PHE.? 13.25 ZN ZN A 402 B 210 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 244 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -2.38 51.82 41.62 2.07 49.19 40.42 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE A 363 PHE.? 13.25 ZN ZN A 402 B 210 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE B 69 PHE.? 9.95 ZN ZN B 401 B 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -53.31 97.22 4.88 -53.54 99.70 6.20 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE B 146 PHE~? 50.49 ZN ZN B 402 B 210 ASP B 141 ASP.? 56.65 ZN ZN B 402 B 244 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 9.06 56.85 40.30 7.71 55.27 39.90 -75.94 101.33 59.57 -77.56 101.84 58.29 coo -2.38 51.82 41.62 2.07 49.19 40.42 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 112 PHE B 200 PHE^? 37.57 ZN ZN B 402 B 210 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 244 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 112 PHE B 227 PHE^? 36.29 ZN ZN B 402 B 210 ASP B 203 ASP^? 26.15 ZN ZN B 402 B 244 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -71.43 105.73 35.02 -72.67 103.28 35.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 -62.37 99.36 31.88 -60.64 98.73 32.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 112 PHE B 253 PHE~? 19.22 ZN ZN B 402 B 210 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 244 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -23.71 105.07 26.59 -24.46 103.20 27.20 coo -2.38 51.82 41.62 2.07 49.19 40.42 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 112 PHE B 253 PHE~? 19.22 ZN ZN B 402 B 210 ASP B 299 ASP.? 24.19 ZN ZN B 402 B 244 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 210 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 210 ASP B 252 ASP~? 28.52 ZN ZN B 402 B 244 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 -20.29 109.25 15.64 -18.38 109.99 15.02 coo -2.38 51.82 41.62 2.07 49.19 40.42 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 210 ASP B 256 ASP~? 22.51 ZN ZN B 402 B 244 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 112 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 210 ASP B 256 ASP~? 22.51 ZN ZN B 402 B 244 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 112 PHE B 301 PHE^? 12.96 ZN ZN B 402 B 210 ASP B 299 ASP.? 24.19 ZN ZN B 402 B 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 112 PHE B 301 PHE^? 12.96 ZN ZN B 402 B 210 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 B 112 PHE B 344 PHE~? 21.77 ZN ZN B 402 B 210 ASP B 352 ASP.? 26.97 ZN ZN B 402 B 244 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -45.25 79.78 24.19 -46.74 79.97 21.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -2.38 51.82 41.62 2.07 49.19 40.42 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 B 112 PHE B 344 PHE~? 21.77 ZN ZN B 402 B 210 ASP B 352 ASP.? 26.97 ZN ZN B 402 B 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -45.25 79.78 24.19 -46.74 79.97 21.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 B 112 PHE B 363 PHE^? 13.11 ZN ZN B 401 B 210 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 8.76 47.85 34.91 11.08 46.36 35.41 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 B 112 PHE B 363 PHE^? 13.11 ZN ZN B 401 B 210 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 244 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 8.76 47.85 34.91 11.08 46.36 35.41 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 -25.96 101.08 10.72 -22.73 101.83 5.25 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 28 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 210 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 244 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 210 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 10.51 37.86 19.71 9.07 39.38 20.04 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -1.20 42.34 17.67 3.19 45.13 19.06 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 210 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 210 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -1.20 42.34 17.67 3.19 45.13 19.06 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 210 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 136 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 210 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 244 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.51 37.86 19.71 9.07 39.38 20.04 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 136 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 136 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 210 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 244 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 10.51 37.86 19.71 9.07 39.38 20.04 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 136 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 136 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 136 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 136 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 210 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 244 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 10.51 37.86 19.71 9.07 39.38 20.04 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 136 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 210 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 210 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -1.20 42.34 17.67 3.19 45.13 19.06 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 210 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 210 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 11.28 44.53 18.60 9.91 46.00 19.20 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 136 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 136 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 210 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 244 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 11.28 44.53 18.60 9.91 46.00 19.20 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 10.51 37.86 19.71 9.07 39.38 20.04 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -1.20 42.34 17.67 3.19 45.13 19.06 -48.76 125.53 -1.26 -51.29 120.16 0.88 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 25 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 210 ASP A 91 ASP.? 28.84 ZN ZN A 402 B 244 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 210 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.06 56.85 40.30 7.71 55.27 39.90 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -2.38 51.82 41.62 2.07 49.19 40.42 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 210 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 244 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 210 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -2.38 51.82 41.62 2.07 49.19 40.42 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 136 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 210 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 136 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 210 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 244 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.06 56.85 40.30 7.71 55.27 39.90 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 136 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 136 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 136 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 244 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 136 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 210 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 136 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 210 ASP B 91 ASP.? 28.82 ZN ZN B 401 B 244 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 9.06 56.85 40.30 7.71 55.27 39.90 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 136 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 210 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 244 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 210 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 244 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -2.38 51.82 41.62 2.07 49.19 40.42 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 210 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 136 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 210 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 244 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 10.08 50.18 41.78 8.91 48.61 41.04 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 136 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 210 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 244 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 136 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 210 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 244 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 10.08 50.18 41.78 8.91 48.61 41.04 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.06 56.85 40.30 7.71 55.27 39.90 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -2.38 51.82 41.62 2.07 49.19 40.42 -48.76 125.53 -1.26 -51.29 120.16 0.88 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 24 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 142 LEU A 112 LEU~? 9.24 ZN ZN A 401 A 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -32.96 110.91 -16.20 -33.15 111.44 -14.07 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 142 LEU A 261 LEU~? 13.92 ZN ZN A 401 A 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -26.62 109.63 -11.66 -28.35 109.88 -12.96 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 142 LEU B 112 LEU~? 9.28 ZN ZN B 402 A 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -35.81 100.08 17.08 -36.25 99.68 14.97 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 142 LEU B 261 LEU~? 13.92 ZN ZN B 402 A 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -29.82 97.75 12.63 -31.44 98.34 13.87 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -38.73 88.63 14.36 -36.14 88.00 9.08 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 B 142 LEU A 112 LEU~? 9.24 ZN ZN A 401 B 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -32.96 110.91 -16.20 -33.15 111.44 -14.07 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 B 142 LEU A 261 LEU~? 13.92 ZN ZN A 401 B 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -26.62 109.63 -11.66 -28.35 109.88 -12.96 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 B 142 LEU B 112 LEU~? 9.28 ZN ZN B 402 B 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -35.81 100.08 17.08 -36.25 99.68 14.97 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 B 142 LEU B 261 LEU~? 13.92 ZN ZN B 402 B 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -29.82 97.75 12.63 -31.44 98.34 13.87 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -38.73 88.63 14.36 -36.14 88.00 9.08 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 C 142 LEU A 112 LEU~? 9.24 ZN ZN A 401 C 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -32.96 110.91 -16.20 -33.15 111.44 -14.07 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 C 142 LEU A 261 LEU~? 13.92 ZN ZN A 401 C 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -26.62 109.63 -11.66 -28.35 109.88 -12.96 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 C 142 LEU B 112 LEU~? 9.28 ZN ZN B 402 C 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -35.81 100.08 17.08 -36.25 99.68 14.97 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 C 142 LEU B 261 LEU~? 13.92 ZN ZN B 402 C 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -29.82 97.75 12.63 -31.44 98.34 13.87 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -38.73 88.63 14.36 -36.14 88.00 9.08 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 D 142 LEU A 112 LEU~? 9.24 ZN ZN A 401 D 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -32.96 110.91 -16.20 -33.15 111.44 -14.07 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 330 TYR~? 12.28 ZN ZN A 402 D 142 LEU A 261 LEU~? 13.92 ZN ZN A 401 D 165 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -26.62 109.63 -11.66 -28.35 109.88 -12.96 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 D 142 LEU B 112 LEU~? 9.28 ZN ZN B 402 D 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -35.81 100.08 17.08 -36.25 99.68 14.97 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR B 330 TYR~? 12.23 ZN ZN B 401 D 142 LEU B 261 LEU~? 13.92 ZN ZN B 402 D 165 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -29.82 97.75 12.63 -31.44 98.34 13.87 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -38.73 88.63 14.36 -36.14 88.00 9.08 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 356 SER.? 15.95 ZN ZN A 402 A 48 THR A 41 THR^? 14.11 ZN ZN A 401 A 165 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -25.62 125.96 -9.58 -26.36 125.95 -7.28 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -30.25 126.98 -12.77 -29.68 126.19 -14.66 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 356 SER.? 15.95 ZN ZN A 402 A 48 THR A 357 THR.? 20.18 ZN ZN A 402 A 165 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -25.62 125.96 -9.58 -26.36 125.95 -7.28 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -22.69 123.90 -8.22 -21.02 125.26 -8.45 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER B 356 SER.? 15.96 ZN ZN B 401 A 48 THR B 41 THR^? 14.16 ZN ZN B 402 A 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -37.69 83.51 10.20 -38.30 83.95 7.88 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -42.12 84.98 13.35 -41.18 85.38 15.28 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER B 356 SER.? 15.96 ZN ZN B 401 A 48 THR B 357 THR.? 20.15 ZN ZN B 401 A 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -37.69 83.51 10.20 -38.30 83.95 7.88 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -34.09 83.81 8.88 -33.33 81.74 8.97 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.15 73.23 9.47 -36.32 78.07 10.66 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER B 356 SER.? 15.96 ZN ZN B 401 B 48 THR B 41 THR^? 14.16 ZN ZN B 402 B 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -37.69 83.51 10.20 -38.30 83.95 7.88 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -42.12 84.98 13.35 -41.18 85.38 15.28 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 356 SER.? 15.96 ZN ZN B 401 B 48 THR B 357 THR.? 20.15 ZN ZN B 401 B 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -37.69 83.51 10.20 -38.30 83.95 7.88 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.15 73.23 9.47 -36.32 78.07 10.66 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 356 SER.? 15.95 ZN ZN A 402 C 48 THR A 41 THR^? 14.11 ZN ZN A 401 C 165 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -25.62 125.96 -9.58 -26.36 125.95 -7.28 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -30.25 126.98 -12.77 -29.68 126.19 -14.66 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 356 SER.? 15.95 ZN ZN A 402 C 48 THR A 357 THR.? 20.18 ZN ZN A 402 C 165 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -25.62 125.96 -9.58 -26.36 125.95 -7.28 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -22.69 123.90 -8.22 -21.02 125.26 -8.45 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER B 356 SER.? 15.96 ZN ZN B 401 C 48 THR B 41 THR^? 14.16 ZN ZN B 402 C 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -37.69 83.51 10.20 -38.30 83.95 7.88 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -42.12 84.98 13.35 -41.18 85.38 15.28 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER B 356 SER.? 15.96 ZN ZN B 401 C 48 THR B 357 THR.? 20.15 ZN ZN B 401 C 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -37.69 83.51 10.20 -38.30 83.95 7.88 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -34.09 83.81 8.88 -33.33 81.74 8.97 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.15 73.23 9.47 -36.32 78.07 10.66 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER B 356 SER.? 15.96 ZN ZN B 401 D 48 THR B 41 THR^? 14.16 ZN ZN B 402 D 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -37.69 83.51 10.20 -38.30 83.95 7.88 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -42.12 84.98 13.35 -41.18 85.38 15.28 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 356 SER.? 15.96 ZN ZN B 401 D 48 THR B 357 THR.? 20.15 ZN ZN B 401 D 165 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -37.69 83.51 10.20 -38.30 83.95 7.88 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -34.09 83.81 8.88 -33.33 81.74 8.97 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.15 73.23 9.47 -36.32 78.07 10.66 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c07 naa= 3 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 1 3 # 1 B 267 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 268 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 334 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 2 3 # 2 B 267 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 268 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 334 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 3 3 # 3 B 267 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 268 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 334 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 4 3 # 4 B 267 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 268 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 334 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -41.81 119.15 12.42 -40.61 119.58 9.91 1fgj_c01 source 1fgj HYDROXYLAMINE OXIDOREDUCTASE : 4 hits 1fgj_c01 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 281 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 289 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 54.86 40.00 47.23 55.57 38.60 48.67 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 52.08 40.18 50.14 50.83 38.93 47.73 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 57.82 31.70 50.73 57.94 34.00 49.17 -26.53 108.54 0.92 -29.08 108.89 -0.28 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 281 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 289 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 54.86 40.00 47.23 55.57 38.60 48.67 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 52.08 40.18 50.14 50.83 38.93 47.73 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 57.82 31.70 50.73 57.94 34.00 49.17 -29.29 98.99 -0.08 -31.62 99.98 1.12 1foh_c00 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 281 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 289 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 90.56 80.24 98.04 90.36 81.53 96.34 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 86.62 80.67 97.51 87.37 82.00 100.10 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 91.83 88.28 92.88 92.60 85.93 94.14 -26.53 108.54 0.92 -29.08 108.89 -0.28 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 281 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 289 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 90.56 80.24 98.04 90.36 81.53 96.34 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 86.62 80.67 97.51 87.37 82.00 100.10 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 91.83 88.28 92.88 92.60 85.93 94.14 -29.29 98.99 -0.08 -31.62 99.98 1.12 1foh_c01 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 281 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 289 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 42.34 76.83 49.10 43.06 78.59 50.01 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 46.12 77.15 48.13 44.44 77.61 45.70 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 42.69 86.18 51.69 41.59 83.63 51.54 -26.53 108.54 0.92 -29.08 108.89 -0.28 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 281 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 289 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 42.34 76.83 49.10 43.06 78.59 50.01 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 46.12 77.15 48.13 44.44 77.61 45.70 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 42.69 86.18 51.69 41.59 83.63 51.54 -29.29 98.99 -0.08 -31.62 99.98 1.12 1foh_c02 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 281 ARG A 267 ARG^? 13.45 ZN ZN B 401 D 289 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 75.05 45.80 106.18 74.73 43.88 105.51 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 78.52 44.93 104.78 78.72 44.49 107.76 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 72.35 36.51 104.82 72.00 39.20 105.46 -26.53 108.54 0.92 -29.08 108.89 -0.28 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 281 ARG B 267 ARG^? 13.63 ZN ZN A 402 D 289 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 75.05 45.80 106.18 74.73 43.88 105.51 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 78.52 44.93 104.78 78.72 44.49 107.76 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 72.35 36.51 104.82 72.00 39.20 105.46 -29.29 98.99 -0.08 -31.62 99.98 1.12 1foh_c03 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c03 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 331 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 188 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 130.22 155.23 83.49 125.21 153.71 84.04 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 120.90 152.23 75.28 120.94 153.09 77.19 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 122.04 152.80 81.06 120.71 154.37 81.46 -40.92 100.43 6.30 -42.93 100.06 6.77 1fuq_c00 source 1fuq FUMARASE C : 1 hits 1fuq_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 201 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 201 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 204 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 201 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 4 3 # 4 A 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 201 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 5 3 # 5 A 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 201 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 5 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 20 GLU.? 10.86 ZN ZN A 401 516 HIS A 64 HIS.? -3.42 ZN ZN A 401s 559 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 49.01 14.50 52.53 46.99 14.61 52.78 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 41.59 7.83 54.15 41.16 9.87 53.87 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 42.22 14.55 52.50 43.91 14.87 53.60 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU A 329 GLU~? 2.55 ZN ZN A 401s 516 HIS A 98 HIS~? 4.98 ZN ZN A 401 559 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 49.01 14.50 52.53 46.99 14.61 52.78 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 41.59 7.83 54.15 41.16 9.87 53.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 42.22 14.55 52.50 43.91 14.87 53.60 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU A 329 GLU~? 2.55 ZN ZN A 401s 516 HIS A 98 HIS~? 4.98 ZN ZN A 401 559 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 49.01 14.50 52.53 46.99 14.61 52.78 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 41.59 7.83 54.15 41.16 9.87 53.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 42.22 14.55 52.50 43.91 14.87 53.60 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU A 329 GLU~? 2.55 ZN ZN A 401s 516 HIS B 309 HIS~? 5.48 ZN ZN A 402 559 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 49.01 14.50 52.53 46.99 14.61 52.78 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 41.59 7.83 54.15 41.16 9.87 53.87 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 42.22 14.55 52.50 43.91 14.87 53.60 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU A 329 GLU~? 2.55 ZN ZN A 401s 516 HIS B 309 HIS~? 5.48 ZN ZN A 402 559 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 49.01 14.50 52.53 46.99 14.61 52.78 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 41.59 7.83 54.15 41.16 9.87 53.87 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 42.22 14.55 52.50 43.91 14.87 53.60 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU B 20 GLU.? 11.09 ZN ZN B 402 516 HIS B 64 HIS.? -3.45 ZN ZN B 402s 559 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 49.01 14.50 52.53 46.99 14.61 52.78 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 41.59 7.83 54.15 41.16 9.87 53.87 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 42.22 14.55 52.50 43.91 14.87 53.60 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 7 3 # 7 412 GLU B 329 GLU~? 2.54 ZN ZN B 402s 516 HIS A 309 HIS~? 5.45 ZN ZN B 401 559 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 49.01 14.50 52.53 46.99 14.61 52.78 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 41.59 7.83 54.15 41.16 9.87 53.87 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 42.22 14.55 52.50 43.91 14.87 53.60 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 8 3 # 8 412 GLU B 329 GLU~? 2.54 ZN ZN B 402s 516 HIS A 309 HIS~? 5.45 ZN ZN B 401 559 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 49.01 14.50 52.53 46.99 14.61 52.78 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 41.59 7.83 54.15 41.16 9.87 53.87 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 42.22 14.55 52.50 43.91 14.87 53.60 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 9 3 # 9 412 GLU B 329 GLU~? 2.54 ZN ZN B 402s 516 HIS B 98 HIS~? 5.02 ZN ZN B 402 559 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 49.01 14.50 52.53 46.99 14.61 52.78 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 41.59 7.83 54.15 41.16 9.87 53.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 42.22 14.55 52.50 43.91 14.87 53.60 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 10 3 # 10 412 GLU B 329 GLU~? 2.54 ZN ZN B 402s 516 HIS B 98 HIS~? 5.02 ZN ZN B 402 559 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 49.01 14.50 52.53 46.99 14.61 52.78 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 41.59 7.83 54.15 41.16 9.87 53.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 42.22 14.55 52.50 43.91 14.87 53.60 -45.27 94.95 7.47 -43.74 96.36 7.67 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 10 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 229 GLU^? 28.63 ZN ZN A 401 A 47 ASP A 226 ASP^? 42.28 ZN ZN A 401 A 161 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 37.12 18.35 73.76 37.09 16.69 72.44 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 29.81 8.06 73.13 30.21 10.11 72.95 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 37.29 15.56 67.90 37.37 13.79 70.08 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 47 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 161 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 37.12 18.35 73.76 37.09 16.69 72.44 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 29.81 8.06 73.13 30.21 10.11 72.95 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 37.29 15.56 67.90 37.37 13.79 70.08 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 47 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 161 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 37.12 18.35 73.76 37.09 16.69 72.44 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 29.81 8.06 73.13 30.21 10.11 72.95 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 37.29 15.56 67.90 37.37 13.79 70.08 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 47 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 161 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 37.12 18.35 73.76 37.09 16.69 72.44 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 29.81 8.06 73.13 30.21 10.11 72.95 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 37.29 15.56 67.90 37.37 13.79 70.08 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 47 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 161 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 37.12 18.35 73.76 37.09 16.69 72.44 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 29.81 8.06 73.13 30.21 10.11 72.95 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 37.29 15.56 67.90 37.37 13.79 70.08 -35.81 95.23 5.63 -35.48 92.50 6.11 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 5 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 229 GLU^? 28.63 ZN ZN A 401 B 47 ASP A 226 ASP^? 42.28 ZN ZN A 401 B 161 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 53.87 35.49 53.22 55.44 35.72 54.61 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 63.47 43.65 53.95 61.45 43.07 54.06 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 56.38 35.81 59.19 58.25 35.77 57.10 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 290 GLU~? 16.18 ZN ZN A 402 B 47 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 161 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 53.87 35.49 53.22 55.44 35.72 54.61 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 63.47 43.65 53.95 61.45 43.07 54.06 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 56.38 35.81 59.19 58.25 35.77 57.10 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 47 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 161 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 53.87 35.49 53.22 55.44 35.72 54.61 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 63.47 43.65 53.95 61.45 43.07 54.06 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 56.38 35.81 59.19 58.25 35.77 57.10 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU B 290 GLU~? 16.07 ZN ZN B 401 B 47 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 161 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 53.87 35.49 53.22 55.44 35.72 54.61 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 63.47 43.65 53.95 61.45 43.07 54.06 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 56.38 35.81 59.19 58.25 35.77 57.10 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 47 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 161 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 53.87 35.49 53.22 55.44 35.72 54.61 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 63.47 43.65 53.95 61.45 43.07 54.06 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 56.38 35.81 59.19 58.25 35.77 57.10 -35.81 95.23 5.63 -35.48 92.50 6.11 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 5 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 64 HIS A 12 HIS~? 21.70 ZN ZN A 401 A 155 ASN A 342 ASN~? 22.18 ZN ZN A 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 1.90 38.00 29.77 3.91 38.35 29.95 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 9.89 36.55 37.38 9.27 37.99 36.08 -29.33 125.76 -27.31 -29.81 125.41 -29.36 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 64 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 155 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 1.90 38.00 29.77 3.91 38.35 29.95 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.89 36.55 37.38 9.27 37.99 36.08 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 64 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 155 ASN A 109 ASN~? 6.71 ZN ZN A 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 1.90 38.00 29.77 3.91 38.35 29.95 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.89 36.55 37.38 9.27 37.99 36.08 -37.82 111.74 -18.14 -38.65 111.91 -16.17 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 64 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 155 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 1.90 38.00 29.77 3.91 38.35 29.95 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.89 36.55 37.38 9.27 37.99 36.08 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 64 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 155 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 1.90 38.00 29.77 3.91 38.35 29.95 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.89 36.55 37.38 9.27 37.99 36.08 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 64 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 155 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 1.90 38.00 29.77 3.91 38.35 29.95 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.89 36.55 37.38 9.27 37.99 36.08 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 3 1gns_c00 SUBTILISIN BPN' user 7 3 # 7 A 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 64 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 155 ASN A 109 ASN~? 6.71 ZN ZN A 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 1.90 38.00 29.77 3.91 38.35 29.95 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.89 36.55 37.38 9.27 37.99 36.08 -37.82 111.74 -18.14 -38.65 111.91 -16.17 ULMN 3 1gns_c00 SUBTILISIN BPN' user 8 3 # 8 A 32 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 64 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 155 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 1.90 38.00 29.77 3.91 38.35 29.95 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.89 36.55 37.38 9.27 37.99 36.08 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 3 1gns_c00 SUBTILISIN BPN' user 9 3 # 9 A 32 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 64 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 155 ASN B 24 ASN.? 14.57 ZN ZN B 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 1.90 38.00 29.77 3.91 38.35 29.95 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.89 36.55 37.38 9.27 37.99 36.08 -56.06 94.54 8.52 -57.34 92.84 8.20 ULMN 3 1gns_c00 SUBTILISIN BPN' user 10 3 # 10 A 32 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 64 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 155 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 1.90 38.00 29.77 3.91 38.35 29.95 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.89 36.55 37.38 9.27 37.99 36.08 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 3 1gns_c00 SUBTILISIN BPN' user 11 3 # 11 A 32 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 64 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 155 ASN B 342 ASN~? 21.94 ZN ZN B 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 1.90 38.00 29.77 3.91 38.35 29.95 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 9.89 36.55 37.38 9.27 37.99 36.08 -40.74 85.47 27.90 -41.03 86.13 29.94 ULMN 3 1gns_c00 SUBTILISIN BPN' user 12 3 # 12 A 32 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 64 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 155 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 1.90 38.00 29.77 3.91 38.35 29.95 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.89 36.55 37.38 9.27 37.99 36.08 -46.36 96.74 22.46 -46.71 95.57 24.21 ULMN 3 1gns_c00 SUBTILISIN BPN' user 13 3 # 13 A 32 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 64 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 155 ASN B 109 ASN~? 6.75 ZN ZN B 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 1.90 38.00 29.77 3.91 38.35 29.95 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.89 36.55 37.38 9.27 37.99 36.08 -40.37 101.87 19.09 -41.17 102.25 17.16 ULMN 3 1gns_c00 SUBTILISIN BPN' user 14 3 # 14 A 32 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 64 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 155 ASN B 24 ASN.? 14.57 ZN ZN B 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 1.90 38.00 29.77 3.91 38.35 29.95 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.89 36.55 37.38 9.27 37.99 36.08 -56.06 94.54 8.52 -57.34 92.84 8.20 ULMN 3 1gns_c00 SUBTILISIN BPN' user 15 3 # 15 A 32 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 64 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 155 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 1.90 38.00 29.77 3.91 38.35 29.95 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.89 36.55 37.38 9.27 37.99 36.08 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 3 1gns_c00 SUBTILISIN BPN' user 16 3 # 16 A 32 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 64 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 155 ASN B 24 ASN.? 14.57 ZN ZN B 401 coo 3.12 38.70 24.20 3.24 38.59 26.33 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 1.90 38.00 29.77 3.91 38.35 29.95 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.89 36.55 37.38 9.27 37.99 36.08 -56.06 94.54 8.52 -57.34 92.84 8.20 ULMN 3 1gns_c00 SUBTILISIN BPN' user 17 3 # 17 A 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 64 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 155 ASN B 109 ASN~? 6.75 ZN ZN B 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 1.90 38.00 29.77 3.91 38.35 29.95 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.89 36.55 37.38 9.27 37.99 36.08 -40.37 101.87 19.09 -41.17 102.25 17.16 ULMN 3 1gns_c00 SUBTILISIN BPN' user 18 3 # 18 A 32 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 64 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 155 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 1.90 38.00 29.77 3.91 38.35 29.95 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.89 36.55 37.38 9.27 37.99 36.08 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1gns_c00 SUBTILISIN BPN' user 19 3 # 19 A 32 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 64 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 155 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 1.90 38.00 29.77 3.91 38.35 29.95 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.89 36.55 37.38 9.27 37.99 36.08 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 3 1gns_c00 SUBTILISIN BPN' user 20 3 # 20 A 32 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 64 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 155 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 3.12 38.70 24.20 3.24 38.59 26.33 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 1.90 38.00 29.77 3.91 38.35 29.95 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.89 36.55 37.38 9.27 37.99 36.08 -31.91 109.24 -4.57 -30.97 107.55 -3.66 1gns_c00 source 1gns SUBTILISIN BPN' : 20 hits 1gns_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 24 ASN.? 14.49 ZN ZN A 402 A 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 51.28 61.14 17.85 51.16 61.61 19.96 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 52.62 57.63 23.12 50.77 57.51 22.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.65 56.95 20.09 48.42 58.17 20.01 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 A 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 144 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 51.28 61.14 17.85 51.16 61.61 19.96 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 52.62 57.63 23.12 50.77 57.51 22.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.65 56.95 20.09 48.42 58.17 20.01 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN A 100 ASN~? 9.95 ZN ZN A 401 A 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 144 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 51.28 61.14 17.85 51.16 61.61 19.96 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 52.62 57.63 23.12 50.77 57.51 22.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.65 56.95 20.09 48.42 58.17 20.01 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 51.28 61.14 17.85 51.16 61.61 19.96 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 52.62 57.63 23.12 50.77 57.51 22.26 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 46.65 56.95 20.09 48.42 58.17 20.01 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 A 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 108 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 51.28 61.14 17.85 51.16 61.61 19.96 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 52.62 57.63 23.12 50.77 57.51 22.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 46.65 56.95 20.09 48.42 58.17 20.01 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 A 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 108 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 144 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 51.28 61.14 17.85 51.16 61.61 19.96 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 52.62 57.63 23.12 50.77 57.51 22.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 46.65 56.95 20.09 48.42 58.17 20.01 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 3 # 7 A 106 ASN B 24 ASN.? 14.57 ZN ZN B 401 A 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 51.28 61.14 17.85 51.16 61.61 19.96 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 52.62 57.63 23.12 50.77 57.51 22.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.65 56.95 20.09 48.42 58.17 20.01 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 3 # 8 A 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 A 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 144 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 51.28 61.14 17.85 51.16 61.61 19.96 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 52.62 57.63 23.12 50.77 57.51 22.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.65 56.95 20.09 48.42 58.17 20.01 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 3 # 9 A 106 ASN B 100 ASN~? 9.88 ZN ZN B 402 A 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 144 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 51.28 61.14 17.85 51.16 61.61 19.96 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 52.62 57.63 23.12 50.77 57.51 22.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.65 56.95 20.09 48.42 58.17 20.01 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 10 3 # 10 A 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 108 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 51.28 61.14 17.85 51.16 61.61 19.96 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 52.62 57.63 23.12 50.77 57.51 22.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 46.65 56.95 20.09 48.42 58.17 20.01 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 11 3 # 11 A 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 108 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 144 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 51.28 61.14 17.85 51.16 61.61 19.96 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 52.62 57.63 23.12 50.77 57.51 22.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 46.65 56.95 20.09 48.42 58.17 20.01 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 12 3 # 12 A 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 51.28 61.14 17.85 51.16 61.61 19.96 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 52.62 57.63 23.12 50.77 57.51 22.26 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 46.65 56.95 20.09 48.42 58.17 20.01 -40.41 105.08 4.17 -40.72 103.08 3.51 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 12 hits 1grc_c02 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 24 ASN.? 14.49 ZN ZN A 402 B 108 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 144 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 41.00 107.18 12.86 42.70 107.82 11.96 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 31.60 110.69 6.14 29.69 109.74 5.94 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 144 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 144 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 31.60 110.69 6.14 29.69 109.74 5.94 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 144 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 B 106 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 108 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 144 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 31.60 110.69 6.14 29.69 109.74 5.94 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 3 # 7 B 106 ASN B 24 ASN.? 14.57 ZN ZN B 401 B 108 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 144 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 41.00 107.18 12.86 42.70 107.82 11.96 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 31.60 110.69 6.14 29.69 109.74 5.94 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 3 # 8 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 31.60 110.69 6.14 29.69 109.74 5.94 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 3 # 9 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 144 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 31.60 110.69 6.14 29.69 109.74 5.94 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 10 3 # 10 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 144 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 31.60 110.69 6.14 29.69 109.74 5.94 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 11 3 # 11 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 144 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 31.60 110.69 6.14 29.69 109.74 5.94 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 12 3 # 12 B 106 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 108 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 144 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 31.60 110.69 6.14 29.69 109.74 5.94 -34.81 103.62 -5.28 -35.25 105.45 -4.26 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 12 hits 1grc_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 260 LYS~? 21.58 ZN ZN A 401 210 ARG A 267 ARG^? 13.45 ZN ZN B 401 225 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 17.51 28.50 73.42 17.24 23.02 75.86 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 24.74 11.56 73.05 25.29 14.32 71.80 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 27.81 15.44 77.10 25.66 16.50 75.19 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 260 LYS~? 21.58 ZN ZN A 401 210 ARG B 267 ARG^? 13.63 ZN ZN A 402 225 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 17.51 28.50 73.42 17.24 23.02 75.86 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 24.74 11.56 73.05 25.29 14.32 71.80 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 27.81 15.44 77.10 25.66 16.50 75.19 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 260 LYS~? 21.74 ZN ZN B 402 210 ARG A 267 ARG^? 13.45 ZN ZN B 401 225 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 17.51 28.50 73.42 17.24 23.02 75.86 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 24.74 11.56 73.05 25.29 14.32 71.80 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 27.81 15.44 77.10 25.66 16.50 75.19 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 260 LYS~? 21.74 ZN ZN B 402 210 ARG B 267 ARG^? 13.63 ZN ZN A 402 225 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 17.51 28.50 73.42 17.24 23.02 75.86 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 24.74 11.56 73.05 25.29 14.32 71.80 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 27.81 15.44 77.10 25.66 16.50 75.19 -33.35 101.79 -1.64 -34.99 103.61 0.18 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 4 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 2.59 0.29 25.55 4.65 0.18 25.07 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 12.42 6.10 23.27 9.95 1.57 20.16 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 329 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 2.59 0.29 25.55 4.65 0.18 25.07 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 12.42 6.10 23.27 9.95 1.57 20.16 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 2.59 0.29 25.55 4.65 0.18 25.07 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 12.42 6.10 23.27 9.95 1.57 20.16 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 2.59 0.29 25.55 4.65 0.18 25.07 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 12.42 6.10 23.27 9.95 1.57 20.16 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.42 6.10 23.27 9.95 1.57 20.16 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 2.59 0.29 25.55 4.65 0.18 25.07 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 12.42 6.10 23.27 9.95 1.57 20.16 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE A 363 PHE.? 13.25 ZN ZN A 402 A 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 329 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 2.59 0.29 25.55 4.65 0.18 25.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.42 6.10 23.27 9.95 1.57 20.16 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 146 PHE~? 50.49 ZN ZN B 402 A 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 2.59 0.29 25.55 4.65 0.18 25.07 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 12.42 6.10 23.27 9.95 1.57 20.16 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 2.59 0.29 25.55 4.65 0.18 25.07 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 12.42 6.10 23.27 9.95 1.57 20.16 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 298 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 329 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 2.59 0.29 25.55 4.65 0.18 25.07 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 12.42 6.10 23.27 9.95 1.57 20.16 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 298 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 2.59 0.29 25.55 4.65 0.18 25.07 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 12.42 6.10 23.27 9.95 1.57 20.16 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 A 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 2.59 0.29 25.55 4.65 0.18 25.07 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 12.42 6.10 23.27 9.95 1.57 20.16 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 A 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 2.59 0.29 25.55 4.65 0.18 25.07 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 12.42 6.10 23.27 9.95 1.57 20.16 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 A 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 2.59 0.29 25.55 4.65 0.18 25.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.42 6.10 23.27 9.95 1.57 20.16 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 A 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 2.59 0.29 25.55 4.65 0.18 25.07 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 12.42 6.10 23.27 9.95 1.57 20.16 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 A 189 PHE B 363 PHE^? 13.11 ZN ZN B 401 A 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 329 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.42 6.10 23.27 9.95 1.57 20.16 -38.53 111.12 1.13 -44.30 110.60 0.01 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 B 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 B 329 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 B 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 B 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE A 363 PHE.? 13.25 ZN ZN A 402 B 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 329 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 146 PHE~? 50.49 ZN ZN B 402 B 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 B 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE B 200 PHE^? 37.57 ZN ZN B 402 B 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 B 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE B 253 PHE~? 19.22 ZN ZN B 402 B 298 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 329 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 298 ASP B 252 ASP~? 28.52 ZN ZN B 402 B 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 B 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 B 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 B 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 B 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 B 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 B 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 B 189 PHE B 363 PHE^? 13.11 ZN ZN B 401 B 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 329 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -38.53 111.12 1.13 -44.30 110.60 0.01 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 C 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 24.10 66.43 63.33 24.18 64.30 63.40 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 27.64 56.61 58.17 22.18 57.92 60.36 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 C 329 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 24.10 66.43 63.33 24.18 64.30 63.40 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 27.64 56.61 58.17 22.18 57.92 60.36 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 24.10 66.43 63.33 24.18 64.30 63.40 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 27.64 56.61 58.17 22.18 57.92 60.36 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 24.10 66.43 63.33 24.18 64.30 63.40 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 27.64 56.61 58.17 22.18 57.92 60.36 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 C 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 17.41 60.57 64.39 18.40 58.12 65.34 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 27.64 56.61 58.17 22.18 57.92 60.36 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 C 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 17.41 60.57 64.39 18.40 58.12 65.34 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 24.10 66.43 63.33 24.18 64.30 63.40 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 27.64 56.61 58.17 22.18 57.92 60.36 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE A 363 PHE.? 13.25 ZN ZN A 402 C 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 329 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 17.41 60.57 64.39 18.40 58.12 65.34 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 24.10 66.43 63.33 24.18 64.30 63.40 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 27.64 56.61 58.17 22.18 57.92 60.36 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 146 PHE~? 50.49 ZN ZN B 402 C 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 C 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 24.10 66.43 63.33 24.18 64.30 63.40 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 27.64 56.61 58.17 22.18 57.92 60.36 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE B 200 PHE^? 37.57 ZN ZN B 402 C 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 C 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 24.10 66.43 63.33 24.18 64.30 63.40 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 27.64 56.61 58.17 22.18 57.92 60.36 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE B 253 PHE~? 19.22 ZN ZN B 402 C 298 ASP B 245 ASP^? 25.30 ZN ZN B 402 C 329 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 24.10 66.43 63.33 24.18 64.30 63.40 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 27.64 56.61 58.17 22.18 57.92 60.36 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 298 ASP B 252 ASP~? 28.52 ZN ZN B 402 C 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 17.41 60.57 64.39 18.40 58.12 65.34 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 24.10 66.43 63.33 24.18 64.30 63.40 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 27.64 56.61 58.17 22.18 57.92 60.36 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 C 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 17.41 60.57 64.39 18.40 58.12 65.34 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 24.10 66.43 63.33 24.18 64.30 63.40 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 27.64 56.61 58.17 22.18 57.92 60.36 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 C 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 24.10 66.43 63.33 24.18 64.30 63.40 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 27.64 56.61 58.17 22.18 57.92 60.36 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 C 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 C 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 24.10 66.43 63.33 24.18 64.30 63.40 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 27.64 56.61 58.17 22.18 57.92 60.36 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 C 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 C 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 24.10 66.43 63.33 24.18 64.30 63.40 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 27.64 56.61 58.17 22.18 57.92 60.36 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 C 189 PHE B 363 PHE^? 13.11 ZN ZN B 401 C 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 329 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 17.41 60.57 64.39 18.40 58.12 65.34 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 27.64 56.61 58.17 22.18 57.92 60.36 -38.53 111.12 1.13 -44.30 110.60 0.01 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 D 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 29.72 46.46 83.60 30.79 47.36 81.99 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 36.89 44.91 74.55 37.33 48.94 79.01 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 298 ASP A 252 ASP~? 28.57 ZN ZN A 401 D 329 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 29.72 46.46 83.60 30.79 47.36 81.99 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 36.89 44.91 74.55 37.33 48.94 79.01 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 329 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 29.72 46.46 83.60 30.79 47.36 81.99 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 36.89 44.91 74.55 37.33 48.94 79.01 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 29.72 46.46 83.60 30.79 47.36 81.99 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 36.89 44.91 74.55 37.33 48.94 79.01 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 D 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 35.44 53.35 83.81 35.65 54.53 81.28 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 36.89 44.91 74.55 37.33 48.94 79.01 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE A 301 PHE^? 12.99 ZN ZN A 401 D 298 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 329 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 35.44 53.35 83.81 35.65 54.53 81.28 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 29.72 46.46 83.60 30.79 47.36 81.99 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 36.89 44.91 74.55 37.33 48.94 79.01 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE A 363 PHE.? 13.25 ZN ZN A 402 D 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 329 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 35.44 53.35 83.81 35.65 54.53 81.28 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 29.72 46.46 83.60 30.79 47.36 81.99 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 36.89 44.91 74.55 37.33 48.94 79.01 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 146 PHE~? 50.49 ZN ZN B 402 D 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 D 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 29.72 46.46 83.60 30.79 47.36 81.99 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 36.89 44.91 74.55 37.33 48.94 79.01 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE B 200 PHE^? 37.57 ZN ZN B 402 D 298 ASP B 148 ASP~? 45.03 ZN ZN B 402 D 329 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 29.72 46.46 83.60 30.79 47.36 81.99 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 36.89 44.91 74.55 37.33 48.94 79.01 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE B 253 PHE~? 19.22 ZN ZN B 402 D 298 ASP B 245 ASP^? 25.30 ZN ZN B 402 D 329 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 29.72 46.46 83.60 30.79 47.36 81.99 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 36.89 44.91 74.55 37.33 48.94 79.01 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 298 ASP B 252 ASP~? 28.52 ZN ZN B 402 D 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 35.44 53.35 83.81 35.65 54.53 81.28 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 29.72 46.46 83.60 30.79 47.36 81.99 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 36.89 44.91 74.55 37.33 48.94 79.01 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 D 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 329 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 35.44 53.35 83.81 35.65 54.53 81.28 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 29.72 46.46 83.60 30.79 47.36 81.99 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 36.89 44.91 74.55 37.33 48.94 79.01 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 D 189 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 29.72 46.46 83.60 30.79 47.36 81.99 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 36.89 44.91 74.55 37.33 48.94 79.01 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 D 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 D 298 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 29.72 46.46 83.60 30.79 47.36 81.99 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 36.89 44.91 74.55 37.33 48.94 79.01 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 D 189 PHE B 301 PHE^? 12.96 ZN ZN B 402 D 298 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 329 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 29.72 46.46 83.60 30.79 47.36 81.99 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 36.89 44.91 74.55 37.33 48.94 79.01 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 D 189 PHE B 363 PHE^? 13.11 ZN ZN B 401 D 298 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 329 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 35.44 53.35 83.81 35.65 54.53 81.28 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 36.89 44.91 74.55 37.33 48.94 79.01 -38.53 111.12 1.13 -44.30 110.60 0.01 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER B 151 SER~? 41.75 ZN ZN B 402 A 164 TYR B 217 TYR~? 45.33 ZN ZN B 402 A 168 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 32.37 52.40 49.35 31.32 53.88 47.74 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 29.69 55.04 42.83 31.98 53.56 43.49 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 26.96 50.99 47.03 31.03 48.83 44.33 -73.22 97.33 48.85 -74.87 100.01 44.50 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER B 151 SER~? 41.75 ZN ZN B 402 B 164 TYR B 217 TYR~? 45.33 ZN ZN B 402 B 168 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 13.08 50.93 56.67 13.12 48.99 55.27 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 11.52 46.03 51.32 10.06 47.90 52.76 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 15.72 50.86 51.22 10.77 52.35 51.39 -73.22 97.33 48.85 -74.87 100.01 44.50 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER B 151 SER~? 41.75 ZN ZN B 402 C 164 TYR B 217 TYR~? 45.33 ZN ZN B 402 C 168 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 11.22 34.38 82.32 11.07 36.29 83.78 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 8.83 39.27 87.38 7.60 37.43 85.69 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 12.98 34.46 88.14 8.11 32.96 87.14 -73.22 97.33 48.85 -74.87 100.01 44.50 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER B 151 SER~? 41.75 ZN ZN B 402 D 164 TYR B 217 TYR~? 45.33 ZN ZN B 402 D 168 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 29.15 32.90 92.57 27.86 31.44 94.02 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 25.49 30.28 98.59 27.88 31.73 98.26 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 23.46 34.31 94.02 27.08 36.46 97.29 -73.22 97.33 48.85 -74.87 100.01 44.50 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 127 GLN^? 13.29 ZN ZN A 401 A 296 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 383 TYR A 289 TYR~? 11.74 ZN ZN A 401 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -49.65 115.70 -21.12 -49.19 117.77 -20.58 coo 40.93 4.45 2.36 38.91 3.75 2.26 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 30.54 7.22 6.23 31.38 5.79 3.97 -46.60 106.88 -13.53 -48.07 109.27 -13.63 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 135 GLN^? 40.33 ZN ZN A 401 A 296 GLU A 199 GLU.? 39.53 ZN ZN A 401 A 383 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -65.58 120.25 -41.64 -66.45 118.31 -41.51 coo 40.93 4.45 2.36 38.91 3.75 2.26 -61.23 119.64 -44.31 -61.84 117.61 -44.13 coo 30.54 7.22 6.23 31.38 5.79 3.97 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN A 135 GLN^? 40.33 ZN ZN A 401 A 296 GLU A 199 GLU.? 39.53 ZN ZN A 401 A 383 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -65.58 120.25 -41.64 -66.45 118.31 -41.51 coo 40.93 4.45 2.36 38.91 3.75 2.26 -61.23 119.64 -44.31 -61.84 117.61 -44.13 coo 30.54 7.22 6.23 31.38 5.79 3.97 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN A 212 GLN~? 40.10 ZN ZN A 401 A 296 GLU A 211 GLU~? 36.90 ZN ZN A 401 A 383 TYR A 205 TYR~? 27.31 ZN ZN A 401 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -65.29 137.79 -32.68 -64.16 139.42 -33.49 coo 40.93 4.45 2.36 38.91 3.75 2.26 -67.20 130.35 -33.30 -67.69 130.05 -31.26 coo 30.54 7.22 6.23 31.38 5.79 3.97 -55.75 130.32 -28.70 -53.61 130.45 -30.51 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN B 127 GLN^? 13.24 ZN ZN B 402 A 296 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 383 TYR B 289 TYR~? 11.74 ZN ZN B 402 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -52.38 104.73 22.37 -53.11 102.85 21.61 coo 40.93 4.45 2.36 38.91 3.75 2.26 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 30.54 7.22 6.23 31.38 5.79 3.97 -45.28 110.80 14.60 -47.79 109.56 14.66 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN B 135 GLN^? 40.27 ZN ZN B 402 A 296 GLU B 199 GLU^? 40.09 ZN ZN B 402 A 383 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -68.72 109.57 41.86 -68.54 111.71 42.02 coo 40.93 4.45 2.36 38.91 3.75 2.26 -65.13 107.83 45.37 -64.79 109.92 45.13 coo 30.54 7.22 6.23 31.38 5.79 3.97 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN B 212 GLN~? 38.73 ZN ZN B 402 A 296 GLU B 211 GLU~? 39.18 ZN ZN B 402 A 383 TYR B 205 TYR.? 27.03 ZN ZN B 402 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -77.18 95.70 33.92 -76.97 93.83 32.91 coo 40.93 4.45 2.36 38.91 3.75 2.26 -75.90 102.21 34.20 -77.49 103.04 33.09 coo 30.54 7.22 6.23 31.38 5.79 3.97 -65.21 96.58 29.25 -63.97 94.97 31.18 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN B 212 GLN~? 38.73 ZN ZN B 402 A 296 GLU B 211 GLU~? 39.18 ZN ZN B 402 A 383 TYR B 217 TYR~? 45.33 ZN ZN B 402 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -77.18 95.70 33.92 -76.97 93.83 32.91 coo 40.93 4.45 2.36 38.91 3.75 2.26 -75.90 102.21 34.20 -77.49 103.04 33.09 coo 30.54 7.22 6.23 31.38 5.79 3.97 -76.80 93.86 44.47 -76.40 91.42 43.11 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 8 hits 1h19_c00 naa= 3 ULMN 3 1hrk_c00 FERROCHELATASE user 1 3 # 1 A 263 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 341 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 343 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1hrk_c00 FERROCHELATASE user 2 3 # 2 A 263 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 341 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 343 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1hrk_c00 FERROCHELATASE user 3 3 # 3 A 263 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 341 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 343 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1hrk_c00 FERROCHELATASE user 4 3 # 4 A 263 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 341 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 343 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1hrk_c00 FERROCHELATASE user 5 3 # 5 A 263 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 341 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 343 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -40.29 98.42 11.20 -42.37 98.57 11.02 1hrk_c00 source 1hrk FERROCHELATASE : 5 hits 1hrk_c00 naa= 3 ULMN 3 1hrk_c01 FERROCHELATASE user 1 3 # 1 B 263 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 341 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 343 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1hrk_c01 FERROCHELATASE user 2 3 # 2 B 263 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 341 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 343 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1hrk_c01 FERROCHELATASE user 3 3 # 3 B 263 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 341 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 343 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1hrk_c01 FERROCHELATASE user 4 3 # 4 B 263 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 341 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 343 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -40.29 98.42 11.20 -42.37 98.57 11.02 1hrk_c01 source 1hrk FERROCHELATASE : 4 hits 1hrk_c01 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 327 GLU B 243 GLU^? 24.39 ZN ZN B 402 A 339 ARG B 278 ARG^? 23.19 ZN ZN B 402 coo 85.81 57.99 116.01 86.03 55.86 115.89 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 75.11 41.01 160.30 76.65 40.06 161.41 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 82.23 40.35 159.87 85.09 40.67 161.01 -33.11 114.47 25.89 -35.97 114.81 26.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 327 GLU A 243 GLU^? 24.16 ZN ZN A 401 A 339 ARG A 278 ARG^? 22.96 ZN ZN A 401 coo 85.81 57.99 116.01 86.03 55.86 115.89 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 75.11 41.01 160.30 76.65 40.06 161.41 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 82.23 40.35 159.87 85.09 40.67 161.01 -38.45 97.22 -24.87 -40.97 98.73 -25.80 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 2 hits 1hto_c00 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 107 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 137 SER A 356 SER.? 15.95 ZN ZN A 402 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -25.62 125.96 -9.58 -26.36 125.95 -7.28 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 107 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 137 SER B 356 SER.? 15.96 ZN ZN B 401 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -37.69 83.51 10.20 -38.30 83.95 7.88 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 107 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 137 SER A 356 SER.? 15.95 ZN ZN A 402 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -25.62 125.96 -9.58 -26.36 125.95 -7.28 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 B 47 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 107 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 137 SER B 356 SER.? 15.96 ZN ZN B 401 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -37.69 83.51 10.20 -38.30 83.95 7.88 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 200 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 226 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 23.24 46.58 4.39 24.43 46.59 2.66 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 200 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 226 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 23.24 46.58 4.39 24.43 46.59 2.66 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 226 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 23.24 46.58 4.39 24.43 46.59 2.66 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 226 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 23.24 46.58 4.39 24.43 46.59 2.66 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 200 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 226 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 23.24 46.58 4.39 24.43 46.59 2.66 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 200 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 226 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 23.24 46.58 4.39 24.43 46.59 2.66 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.47 51.09 7.19 28.58 51.18 7.53 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1i29_c01 CSDB user 7 3 # 7 A 123 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 200 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 226 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 23.24 46.58 4.39 24.43 46.59 2.66 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 24.51 43.28 11.18 25.17 44.50 9.58 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.15 73.23 9.47 -36.32 78.07 10.66 ULMN 3 1i29_c01 CSDB user 8 3 # 8 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 200 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 226 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 23.24 46.58 4.39 24.43 46.59 2.66 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1i29_c01 CSDB user 9 3 # 9 A 123 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 226 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 23.24 46.58 4.39 24.43 46.59 2.66 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1i29_c01 CSDB user 10 3 # 10 A 123 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 226 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1i29_c01 CSDB user 11 3 # 11 A 123 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 200 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 226 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 23.24 46.58 4.39 24.43 46.59 2.66 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 34.47 51.09 7.19 28.58 51.18 7.53 -48.76 125.53 -1.26 -51.29 120.16 0.88 1i29_c01 source 1i29 CSDB : 11 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 34 VAL.? 27.36 ZN ZN A 401 A 200 ASP A -1 ASP.? 33.70 ZN ZN A 401 A 226 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -36.56 143.85 -14.36 -35.79 143.59 -12.32 coo 24.51 43.28 11.18 25.17 44.50 9.58 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 34.47 51.09 7.19 28.58 51.18 7.53 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 50 VAL~? 19.23 ZN ZN A 402 A 200 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 226 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -29.56 132.44 -3.36 -31.35 133.31 -2.44 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 115 VAL~? 15.02 ZN ZN A 401 A 200 ASP A 245 ASP^? 25.73 ZN ZN A 401 A 226 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -26.88 110.98 -18.55 -26.78 112.31 -16.83 coo 24.51 43.28 11.18 25.17 44.50 9.58 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 115 VAL~? 15.02 ZN ZN A 401 A 200 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 226 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -26.88 110.98 -18.55 -26.78 112.31 -16.83 coo 24.51 43.28 11.18 25.17 44.50 9.58 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 34.47 51.09 7.19 28.58 51.18 7.53 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 240 VAL^? 12.47 ZN ZN A 401 A 200 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 226 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -39.36 108.32 -21.22 -37.48 109.56 -21.24 coo 24.51 43.28 11.18 25.17 44.50 9.58 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 34.47 51.09 7.19 28.58 51.18 7.53 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 266 VAL.? 17.13 ZN ZN A 402 A 200 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 226 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.67 103.03 -5.24 -28.58 103.20 -7.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 34.47 51.09 7.19 28.58 51.18 7.53 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL A 266 VAL.? 17.13 ZN ZN A 402 A 200 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 226 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.67 103.03 -5.24 -28.58 103.20 -7.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 34.47 51.09 7.19 28.58 51.18 7.53 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL A 266 VAL.? 17.13 ZN ZN A 402 A 200 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 226 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.67 103.03 -5.24 -28.58 103.20 -7.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 34.47 51.09 7.19 28.58 51.18 7.53 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL A 266 VAL.? 17.13 ZN ZN A 402 A 200 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 226 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.67 103.03 -5.24 -28.58 103.20 -7.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.47 51.09 7.19 28.58 51.18 7.53 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL A 266 VAL.? 17.13 ZN ZN A 402 A 200 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 226 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.67 103.03 -5.24 -28.58 103.20 -7.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL A 269 VAL^? 16.91 ZN ZN B 401 A 200 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 226 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -35.99 95.53 -6.65 -37.89 96.14 -5.69 coo 24.51 43.28 11.18 25.17 44.50 9.58 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 34.47 51.09 7.19 28.58 51.18 7.53 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL A 300 VAL^? 18.88 ZN ZN A 401 A 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 226 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -37.31 98.05 -15.24 -35.26 98.67 -14.63 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL A 302 VAL^? 13.47 ZN ZN A 401 A 200 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 226 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -36.35 103.87 -12.63 -34.29 104.02 -13.41 coo 24.51 43.28 11.18 25.17 44.50 9.58 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL A 319 VAL.? 20.98 ZN ZN B 401 A 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 226 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -41.97 94.33 -11.50 -43.49 95.81 -11.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL A 319 VAL.? 20.98 ZN ZN B 401 A 200 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 226 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -41.97 94.33 -11.50 -43.49 95.81 -11.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL B 34 VAL.? 27.39 ZN ZN B 402 A 200 ASP B -1 ASP.? 32.96 ZN ZN B 402 A 226 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -56.68 74.21 14.85 -55.84 74.06 12.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 34.47 51.09 7.19 28.58 51.18 7.53 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL B 49 VAL~? 16.01 ZN ZN B 401 A 200 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 226 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -41.62 82.52 4.60 -41.85 84.21 6.04 coo 24.51 43.28 11.18 25.17 44.50 9.58 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL B 50 VAL~? 19.22 ZN ZN B 401 A 200 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 226 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -44.61 80.22 3.98 -46.57 80.59 3.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.47 51.09 7.19 28.58 51.18 7.53 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL B 50 VAL~? 19.22 ZN ZN B 401 A 200 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 226 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -44.61 80.22 3.98 -46.57 80.59 3.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 34.47 51.09 7.19 28.58 51.18 7.53 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1i29_c03 CSDB user 20 3 # 20 A 128 VAL B 115 VAL~? 15.24 ZN ZN B 402 A 200 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 226 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -30.58 96.84 19.47 -31.11 95.55 17.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 34.47 51.09 7.19 28.58 51.18 7.53 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1i29_c03 CSDB user 21 3 # 21 A 128 VAL B 115 VAL~? 15.24 ZN ZN B 402 A 200 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 226 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -30.58 96.84 19.47 -31.11 95.55 17.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 1i29_c03 CSDB user 22 3 # 22 A 128 VAL B 196 VAL^? 49.46 ZN ZN B 402 A 200 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 226 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -72.14 107.90 52.39 -70.88 106.47 53.54 coo 24.51 43.28 11.18 25.17 44.50 9.58 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1i29_c03 CSDB user 23 3 # 23 A 128 VAL B 240 VAL^? 12.46 ZN ZN B 402 A 200 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 226 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -39.89 105.67 22.15 -38.95 103.61 22.20 coo 24.51 43.28 11.18 25.17 44.50 9.58 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1i29_c03 CSDB user 24 3 # 24 A 128 VAL B 266 VAL^? 17.10 ZN ZN B 401 A 200 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 226 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.04 104.71 6.09 -28.07 104.46 8.29 coo 24.51 43.28 11.18 25.17 44.50 9.58 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1i29_c03 CSDB user 25 3 # 25 A 128 VAL B 266 VAL^? 17.10 ZN ZN B 401 A 200 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 226 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.04 104.71 6.09 -28.07 104.46 8.29 coo 24.51 43.28 11.18 25.17 44.50 9.58 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 34.47 51.09 7.19 28.58 51.18 7.53 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1i29_c03 CSDB user 26 3 # 26 A 128 VAL B 266 VAL^? 17.10 ZN ZN B 401 A 200 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 226 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.04 104.71 6.09 -28.07 104.46 8.29 coo 24.51 43.28 11.18 25.17 44.50 9.58 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1i29_c03 CSDB user 27 3 # 27 A 128 VAL B 266 VAL^? 17.10 ZN ZN B 401 A 200 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 226 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.04 104.71 6.09 -28.07 104.46 8.29 coo 24.51 43.28 11.18 25.17 44.50 9.58 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1i29_c03 CSDB user 28 3 # 28 A 128 VAL B 266 VAL^? 17.10 ZN ZN B 401 A 200 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 226 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.04 104.71 6.09 -28.07 104.46 8.29 coo 24.51 43.28 11.18 25.17 44.50 9.58 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1i29_c03 CSDB user 29 3 # 29 A 128 VAL B 269 VAL^? 17.06 ZN ZN A 402 A 200 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 226 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -30.30 114.86 7.63 -32.15 115.47 6.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 34.47 51.09 7.19 28.58 51.18 7.53 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 1i29_c03 CSDB user 30 3 # 30 A 128 VAL B 300 VAL^? 18.81 ZN ZN B 402 A 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 226 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -32.78 113.31 16.18 -31.32 111.68 15.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1i29_c03 CSDB user 31 3 # 31 A 128 VAL B 302 VAL^? 13.49 ZN ZN B 402 A 200 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 226 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -34.96 107.92 13.63 -33.31 106.71 14.43 coo 24.51 43.28 11.18 25.17 44.50 9.58 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1i29_c03 CSDB user 32 3 # 32 A 128 VAL B 319 VAL.? 21.03 ZN ZN A 402 A 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 226 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -34.86 118.87 12.59 -37.01 118.35 12.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1i29_c03 CSDB user 33 3 # 33 A 128 VAL B 319 VAL.? 21.03 ZN ZN A 402 A 200 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 226 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -34.86 118.87 12.59 -37.01 118.35 12.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.89 103.09 -0.15 -45.35 106.49 1.62 1i29_c03 source 1i29 CSDB : 33 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 165 GLU A 334 GLU~? 17.80 ZN ZN A 401 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -24.53 120.44 -15.33 -23.13 122.04 -15.66 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 165 GLU B 334 GLU~? 17.83 ZN ZN B 402 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -33.85 87.37 15.86 -33.56 85.28 16.19 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -40.29 98.42 11.20 -42.37 98.57 11.02 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 8 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -73.22 97.33 48.85 -74.87 100.01 44.50 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -69.50 93.01 49.28 -67.77 93.79 54.77 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -69.50 93.01 49.28 -67.77 93.79 54.77 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -73.22 97.33 48.85 -74.87 100.01 44.50 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -40.29 98.42 11.20 -42.37 98.57 11.02 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 6 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 23 ASP.? 8.14 ZN ZN A 401 158 THR A 18 THR~? 13.01 ZN ZN A 401 317 ASP A 11 ASP~? 18.10 ZN ZN A 401 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -48.15 121.40 -19.77 -46.63 121.38 -21.33 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -44.11 130.33 -22.09 -46.09 129.62 -22.27 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 299 ASP.? 24.38 ZN ZN A 401 158 THR A 249 THR^? 28.75 ZN ZN A 401 317 ASP A 245 ASP^? 25.73 ZN ZN A 401 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -28.13 92.44 -15.75 -26.55 91.22 -14.88 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -25.62 99.57 -26.57 -25.42 101.64 -26.90 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 305 ASP.? 7.62 ZN ZN A 402 158 THR A 303 THR^? 9.94 ZN ZN A 402 317 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -37.48 106.60 -10.18 -39.53 106.67 -9.37 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 11 ASP~? 18.05 ZN ZN B 402 158 THR B 18 THR~? 13.04 ZN ZN B 402 317 ASP B 203 ASP^? 26.15 ZN ZN B 402 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -54.27 99.11 20.76 -52.97 98.30 22.29 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -62.37 99.36 31.88 -60.64 98.73 32.96 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP B 23 ASP.? 8.15 ZN ZN B 402 158 THR B 18 THR~? 13.04 ZN ZN B 402 317 ASP B 11 ASP~? 18.05 ZN ZN B 402 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -54.27 99.11 20.76 -52.97 98.30 22.29 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -55.43 89.37 22.82 -56.66 91.02 23.20 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP B 299 ASP.? 24.19 ZN ZN B 402 158 THR B 249 THR^? 28.72 ZN ZN B 402 317 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -22.07 113.36 16.80 -20.03 113.44 15.95 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP B 305 ASP.? 7.64 ZN ZN B 401 158 THR B 303 THR^? 9.94 ZN ZN B 401 317 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -37.37 106.23 11.12 -39.15 107.32 10.30 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP B 352 ASP.? 26.97 ZN ZN B 402 158 THR B 37 THR.? 27.08 ZN ZN B 402 317 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.65 72.83 15.84 -48.15 72.05 13.90 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -55.09 78.54 23.42 -56.64 77.16 23.83 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 8 hits 1inp_c02 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 167 SER A 285 SER.? 7.68 ZN ZN A 402 A 201 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 12.95 4.49 19.05 14.87 4.39 19.77 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 10.44 7.96 22.51 12.16 7.57 20.82 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 19.43 6.74 22.83 19.09 5.15 21.60 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 167 SER B 285 SER.? 7.72 ZN ZN B 401 A 201 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 12.95 4.49 19.05 14.87 4.39 19.77 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 10.44 7.96 22.51 12.16 7.57 20.82 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 19.43 6.74 22.83 19.09 5.15 21.60 -34.08 101.07 5.49 -32.41 102.02 4.50 1iph_c00 source 1iph CATALASE HPII : 2 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 167 SER A 285 SER.? 7.68 ZN ZN A 402 B 201 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 167 SER B 285 SER.? 7.72 ZN ZN B 401 B 201 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -34.08 101.07 5.49 -32.41 102.02 4.50 1iph_c01 source 1iph CATALASE HPII : 2 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 167 SER A 285 SER.? 7.68 ZN ZN A 402 C 201 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 167 SER B 285 SER.? 7.72 ZN ZN B 401 C 201 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -34.08 101.07 5.49 -32.41 102.02 4.50 1iph_c02 source 1iph CATALASE HPII : 2 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 167 SER A 285 SER.? 7.68 ZN ZN A 402 D 201 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 167 SER B 285 SER.? 7.72 ZN ZN B 401 D 201 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -34.08 101.07 5.49 -32.41 102.02 4.50 1iph_c03 source 1iph CATALASE HPII : 2 hits 1iph_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 102 ASP~? -1.98 ZN ZN A 401s A1134 ALA A 19 ALA~? 10.49 ZN ZN A 401 A1137 ASN A 100 ASN~? 9.95 ZN ZN A 401 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -44.05 122.82 -17.82 -42.95 124.35 -16.78 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 102 ASP~? -1.99 ZN ZN B 402s A1134 ALA B 19 ALA~? 10.41 ZN ZN B 402 A1137 ASN B 100 ASN~? 9.88 ZN ZN B 402 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -53.87 98.79 16.99 -54.12 97.55 16.16 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -51.48 95.86 18.73 -51.39 94.02 17.58 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 2 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 204 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 279 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 5.85 5.60 30.32 5.00 7.49 29.88 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 7.79 1.83 27.81 9.08 3.25 26.92 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 8.22 7.77 18.64 7.58 8.47 21.28 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 204 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 279 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 5.85 5.60 30.32 5.00 7.49 29.88 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 7.79 1.83 27.81 9.08 3.25 26.92 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 8.22 7.77 18.64 7.58 8.47 21.28 -50.67 100.24 25.02 -50.96 97.90 26.55 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 2 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 61 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 162 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 61 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 162 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 61 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 162 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -52.94 103.12 14.27 -53.36 104.69 15.60 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 61 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 162 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -52.94 103.12 14.27 -53.36 104.69 15.60 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -45.27 94.95 7.47 -43.74 96.36 7.67 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 4 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 201 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 201 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 204 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 201 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 201 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1j70_c00 ATP SULPHURYLASE user 5 3 # 5 A 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 201 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1j70_c00 ATP SULPHURYLASE user 6 3 # 6 A 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 201 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 204 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -41.00 97.85 3.28 -40.98 95.80 3.73 1j70_c00 source 1j70 ATP SULPHURYLASE : 6 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 201 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 201 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 204 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 201 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 201 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 201 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 201 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 204 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -41.00 97.85 3.28 -40.98 95.80 3.73 1j70_c01 source 1j70 ATP SULPHURYLASE : 6 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 201 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 30.92 14.23 15.70 28.82 13.90 13.48 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 20.16 5.55 18.86 20.00 7.59 19.34 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 24.92 3.29 16.90 24.41 4.92 15.69 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 201 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 204 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 30.92 14.23 15.70 28.82 13.90 13.48 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 20.16 5.55 18.86 20.00 7.59 19.34 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 24.92 3.29 16.90 24.41 4.92 15.69 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 201 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 30.92 14.23 15.70 28.82 13.90 13.48 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 20.16 5.55 18.86 20.00 7.59 19.34 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 24.92 3.29 16.90 24.41 4.92 15.69 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 201 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 204 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 30.92 14.23 15.70 28.82 13.90 13.48 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 20.16 5.55 18.86 20.00 7.59 19.34 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 24.92 3.29 16.90 24.41 4.92 15.69 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 201 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 204 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 30.92 14.23 15.70 28.82 13.90 13.48 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 20.16 5.55 18.86 20.00 7.59 19.34 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 24.92 3.29 16.90 24.41 4.92 15.69 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1j70_c02 ATP SULPHURYLASE user 6 3 # 6 C 197 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 201 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 204 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 30.92 14.23 15.70 28.82 13.90 13.48 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 20.16 5.55 18.86 20.00 7.59 19.34 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 24.92 3.29 16.90 24.41 4.92 15.69 -41.00 97.85 3.28 -40.98 95.80 3.73 1j70_c02 source 1j70 ATP SULPHURYLASE : 6 hits 1j70_c02 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN B 135 GLN^? 40.27 ZN ZN B 402 A 79 PHE B 225 PHE^? 41.94 ZN ZN B 402 A 80 THR B 136 THR^? 43.30 ZN ZN B 402 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -68.72 109.57 41.86 -68.54 111.71 42.02 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -76.20 105.02 39.40 -77.72 103.97 37.26 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -73.17 106.15 44.31 -73.94 104.19 43.69 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 1 hits 1j7g_c00 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER A 63 SER^? 10.35 ZN ZN A 402 A 308 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 338 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 37.44 15.05 21.90 37.18 17.02 20.71 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 45.75 18.77 19.41 43.72 18.70 19.99 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 41.13 18.39 17.83 39.67 17.70 19.17 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 2 3 # 2 A 202 SER A 328 SER~? 11.01 ZN ZN A 402 A 308 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 338 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 37.44 15.05 21.90 37.18 17.02 20.71 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 45.75 18.77 19.41 43.72 18.70 19.99 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 41.13 18.39 17.83 39.67 17.70 19.17 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 3 3 # 3 A 202 SER B 328 SER~? 10.89 ZN ZN B 401 A 308 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 338 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 37.44 15.05 21.90 37.18 17.02 20.71 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 45.75 18.77 19.41 43.72 18.70 19.99 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 41.13 18.39 17.83 39.67 17.70 19.17 -40.92 100.43 6.30 -42.93 100.06 6.77 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 3 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER A 63 SER^? 10.35 ZN ZN A 402 B 308 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 338 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 67.81 2.11 21.29 69.09 3.00 23.04 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 64.20 9.21 26.15 65.67 7.96 25.24 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 66.92 5.20 26.82 67.69 4.22 25.14 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 2 3 # 2 B 202 SER A 328 SER~? 11.01 ZN ZN A 402 B 308 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 338 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 67.81 2.11 21.29 69.09 3.00 23.04 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 64.20 9.21 26.15 65.67 7.96 25.24 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 66.92 5.20 26.82 67.69 4.22 25.14 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 3 3 # 3 B 202 SER B 63 SER^? 10.37 ZN ZN B 401 B 308 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 338 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 67.81 2.11 21.29 69.09 3.00 23.04 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 64.20 9.21 26.15 65.67 7.96 25.24 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 66.92 5.20 26.82 67.69 4.22 25.14 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 4 3 # 4 B 202 SER B 328 SER~? 10.89 ZN ZN B 401 B 308 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 338 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 67.81 2.11 21.29 69.09 3.00 23.04 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 64.20 9.21 26.15 65.67 7.96 25.24 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 66.92 5.20 26.82 67.69 4.22 25.14 -40.92 100.43 6.30 -42.93 100.06 6.77 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 4 hits 1jkm_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 58 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 424 GLU A 35 GLU.? 32.19 ZN ZN A 401 coo 58.42 47.76 20.67 58.01 49.10 19.12 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 58.59 41.80 18.81 58.94 43.89 18.94 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 52.85 46.34 13.34 54.09 44.97 14.42 -33.44 145.48 -18.21 -32.23 147.05 -19.00 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 58 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 424 GLU A 35 GLU.? 32.19 ZN ZN A 401 coo 58.42 47.76 20.67 58.01 49.10 19.12 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 58.59 41.80 18.81 58.94 43.89 18.94 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 52.85 46.34 13.34 54.09 44.97 14.42 -33.44 145.48 -18.21 -32.23 147.05 -19.00 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP B -1 ASP.? 32.96 ZN ZN B 402 A 58 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 424 GLU B 35 GLU.? 31.39 ZN ZN B 402 coo 58.42 47.76 20.67 58.01 49.10 19.12 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 58.59 41.80 18.81 58.94 43.89 18.94 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 52.85 46.34 13.34 54.09 44.97 14.42 -52.36 70.88 17.88 -52.36 69.23 19.26 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP B -1 ASP.? 32.96 ZN ZN B 402 A 58 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 424 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo 58.42 47.76 20.67 58.01 49.10 19.12 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 58.59 41.80 18.81 58.94 43.89 18.94 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 52.85 46.34 13.34 54.09 44.97 14.42 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 58 ASP B -1 ASP.? 32.96 ZN ZN B 402 A 424 GLU B 35 GLU.? 31.39 ZN ZN B 402 coo 58.42 47.76 20.67 58.01 49.10 19.12 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 58.59 41.80 18.81 58.94 43.89 18.94 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 52.85 46.34 13.34 54.09 44.97 14.42 -52.36 70.88 17.88 -52.36 69.23 19.26 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 58 ASP B -1 ASP.? 32.96 ZN ZN B 402 A 424 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo 58.42 47.76 20.67 58.01 49.10 19.12 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 58.59 41.80 18.81 58.94 43.89 18.94 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 52.85 46.34 13.34 54.09 44.97 14.42 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP B 31 ASP.? 28.05 ZN ZN B 402 A 58 ASP B 33 ASP.? 29.43 ZN ZN B 402 A 424 GLU B 35 GLU.? 31.39 ZN ZN B 402 coo 58.42 47.76 20.67 58.01 49.10 19.12 -58.98 76.97 11.28 -60.60 75.86 12.07 coo 58.59 41.80 18.81 58.94 43.89 18.94 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 52.85 46.34 13.34 54.09 44.97 14.42 -52.36 70.88 17.88 -52.36 69.23 19.26 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 58 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 424 GLU B 229 GLU^? 28.52 ZN ZN B 402 coo 58.42 47.76 20.67 58.01 49.10 19.12 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 58.59 41.80 18.81 58.94 43.89 18.94 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 52.85 46.34 13.34 54.09 44.97 14.42 -65.20 109.92 29.95 -64.70 111.14 28.31 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 8 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 31 ASP.? 28.20 ZN ZN A 401 B 58 ASP A 33 ASP.? 31.33 ZN ZN A 401 B 424 GLU A 35 GLU.? 32.19 ZN ZN A 401 coo 112.10 61.46 19.99 111.82 60.65 18.07 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 117.85 63.62 21.08 115.96 63.25 20.18 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 118.47 57.23 15.57 119.32 58.77 16.73 -33.44 145.48 -18.21 -32.23 147.05 -19.00 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 33 ASP.? 31.33 ZN ZN A 401 B 58 ASP A 31 ASP.? 28.20 ZN ZN A 401 B 424 GLU A 35 GLU.? 32.19 ZN ZN A 401 coo 112.10 61.46 19.99 111.82 60.65 18.07 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 117.85 63.62 21.08 115.96 63.25 20.18 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 118.47 57.23 15.57 119.32 58.77 16.73 -33.44 145.48 -18.21 -32.23 147.05 -19.00 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 58 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 424 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 112.10 61.46 19.99 111.82 60.65 18.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 117.85 63.62 21.08 115.96 63.25 20.18 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 118.47 57.23 15.57 119.32 58.77 16.73 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 58 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 424 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 112.10 61.46 19.99 111.82 60.65 18.07 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 117.85 63.62 21.08 115.96 63.25 20.18 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 118.47 57.23 15.57 119.32 58.77 16.73 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP B -1 ASP.? 32.96 ZN ZN B 402 B 58 ASP B 5 ASP~? 27.35 ZN ZN B 402 B 424 GLU B 35 GLU.? 31.39 ZN ZN B 402 coo 112.10 61.46 19.99 111.82 60.65 18.07 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 117.85 63.62 21.08 115.96 63.25 20.18 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 118.47 57.23 15.57 119.32 58.77 16.73 -52.36 70.88 17.88 -52.36 69.23 19.26 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP B -1 ASP.? 32.96 ZN ZN B 402 B 58 ASP B 5 ASP~? 27.35 ZN ZN B 402 B 424 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo 112.10 61.46 19.99 111.82 60.65 18.07 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 117.85 63.62 21.08 115.96 63.25 20.18 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 118.47 57.23 15.57 119.32 58.77 16.73 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP B 5 ASP~? 27.35 ZN ZN B 402 B 58 ASP B -1 ASP.? 32.96 ZN ZN B 402 B 424 GLU B 35 GLU.? 31.39 ZN ZN B 402 coo 112.10 61.46 19.99 111.82 60.65 18.07 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 117.85 63.62 21.08 115.96 63.25 20.18 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 118.47 57.23 15.57 119.32 58.77 16.73 -52.36 70.88 17.88 -52.36 69.23 19.26 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 58 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 424 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 112.10 61.46 19.99 111.82 60.65 18.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 117.85 63.62 21.08 115.96 63.25 20.18 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 118.47 57.23 15.57 119.32 58.77 16.73 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 58 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 424 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 112.10 61.46 19.99 111.82 60.65 18.07 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 117.85 63.62 21.08 115.96 63.25 20.18 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 118.47 57.23 15.57 119.32 58.77 16.73 -39.98 115.46 11.22 -41.44 114.62 9.91 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 9 hits 1js4_c01 naa= 3 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 689 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 732 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 22.52 29.89 18.33 23.85 28.06 20.03 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 24.46 23.36 17.42 25.88 24.61 18.33 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 27.06 24.40 21.98 27.51 26.43 21.46 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 689 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 732 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 22.52 29.89 18.33 23.85 28.06 20.03 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 24.46 23.36 17.42 25.88 24.61 18.33 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 27.06 24.40 21.98 27.51 26.43 21.46 -34.08 101.07 5.49 -32.41 102.02 4.50 1kdg_c02 source 1kdg CELLOBIOSE DEHYDROGENASE : 2 hits 1kdg_c02 naa= 3 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 689 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 732 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 689 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 732 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -34.08 101.07 5.49 -32.41 102.02 4.50 1kdg_c03 source 1kdg CELLOBIOSE DEHYDROGENASE : 2 hits 1kdg_c03 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 19.46 3.44 61.93 23.95 1.12 60.13 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 24.97 5.82 58.78 26.79 1.97 55.46 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 24.97 5.82 58.78 26.79 1.97 55.46 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 19.46 3.44 61.93 23.95 1.12 60.13 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 24.97 5.82 58.78 26.79 1.97 55.46 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 19.46 3.44 61.93 23.95 1.12 60.13 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 165 GLU B 334 GLU~? 17.83 ZN ZN B 402 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -33.85 87.37 15.86 -33.56 85.28 16.19 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -40.29 98.42 11.20 -42.37 98.57 11.02 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 7 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 10.43 2.88 20.75 5.72 0.41 23.95 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 4.84 5.09 23.75 3.30 1.39 27.48 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 4.84 5.09 23.75 3.30 1.39 27.48 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 10.43 2.88 20.75 5.72 0.41 23.95 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 4.84 5.09 23.75 3.30 1.39 27.48 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 10.43 2.88 20.75 5.72 0.41 23.95 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 165 GLU B 334 GLU~? 17.83 ZN ZN B 402 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -33.85 87.37 15.86 -33.56 85.28 16.19 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -40.29 98.42 11.20 -42.37 98.57 11.02 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 7 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 C 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 C 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 12.29 34.52 28.11 16.84 32.47 25.43 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 C 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 C 165 GLU A 334 GLU~? 17.80 ZN ZN A 401 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 12.29 34.52 28.11 16.84 32.47 25.43 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -24.53 120.44 -15.33 -23.13 122.04 -15.66 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 C 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 C 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 17.59 37.25 25.80 19.64 34.15 21.60 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 12.06 27.10 15.56 13.23 27.02 13.80 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 C 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 C 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 17.59 37.25 25.80 19.64 34.15 21.60 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 12.29 34.52 28.11 16.84 32.47 25.43 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 12.06 27.10 15.56 13.23 27.02 13.80 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 C 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 C 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 17.59 37.25 25.80 19.64 34.15 21.60 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 12.29 34.52 28.11 16.84 32.47 25.43 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 12.06 27.10 15.56 13.23 27.02 13.80 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 C 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 C 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 12.06 27.10 15.56 13.23 27.02 13.80 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 C 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 C 165 GLU B 334 GLU~? 17.83 ZN ZN B 402 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 12.06 27.10 15.56 13.23 27.02 13.80 -33.85 87.37 15.86 -33.56 85.28 16.19 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 C 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 C 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 12.06 27.10 15.56 13.23 27.02 13.80 -40.29 98.42 11.20 -42.37 98.57 11.02 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 D 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 D 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 D 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 D 165 GLU A 334 GLU~? 17.80 ZN ZN A 401 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -24.53 120.44 -15.33 -23.13 122.04 -15.66 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 D 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 D 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 D 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 D 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 D 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 D 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 D 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 D 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 D 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 D 165 GLU B 334 GLU~? 17.83 ZN ZN B 402 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -33.85 87.37 15.86 -33.56 85.28 16.19 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 D 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 D 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -40.29 98.42 11.20 -42.37 98.57 11.02 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 203 ASP.? 24.56 ZN ZN A 401 262 LYS A 133 LYS^? 35.89 ZN ZN A 401 336 ARG A 209 ARG~? 31.96 ZN ZN A 401 coo 61.88 50.78 12.96 63.84 50.60 13.71 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 63.59 44.40 18.32 63.20 49.74 17.95 -61.15 120.63 -37.55 -60.60 115.73 -40.56 coo 72.60 57.42 15.86 71.61 56.68 18.70 -58.90 136.31 -33.11 -57.17 134.66 -31.15 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 1 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 267 ARG^? 13.45 ZN ZN B 401 245 HIS A 326 HIS~? -3.60 ZN ZN A 402s 343 THR A 303 THR^? 9.94 ZN ZN A 402 coo 18.11 85.25 41.19 18.04 83.33 43.59 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 5.34 86.23 43.48 6.16 87.26 45.12 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.06 92.76 42.80 7.04 92.63 42.14 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG B 267 ARG^? 13.63 ZN ZN A 402 245 HIS B 326 HIS~? -3.48 ZN ZN B 401s 343 THR B 303 THR^? 9.94 ZN ZN B 401 coo 18.11 85.25 41.19 18.04 83.33 43.59 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 5.34 86.23 43.48 6.16 87.26 45.12 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.06 92.76 42.80 7.04 92.63 42.14 -37.37 106.23 11.12 -39.15 107.32 10.30 1lci_c00 source 1lci LUCIFERASE : 2 hits 1lci_c00 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 12 HIS~? 21.70 ZN ZN A 401 A 45 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 261 PHE A 344 PHE~? 21.75 ZN ZN A 401 coo 49.89 1.93 30.83 50.54 1.43 32.81 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -30.23 132.91 -23.69 -31.48 133.59 -21.26 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 45 HIS A 12 HIS~? 21.70 ZN ZN A 401 A 261 PHE A 16 PHE~? 14.00 ZN ZN A 401 coo 49.89 1.93 30.83 50.54 1.43 32.81 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -44.69 128.21 -17.73 -42.08 129.17 -17.23 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 45 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 261 PHE A 16 PHE~? 14.00 ZN ZN A 401 coo 49.89 1.93 30.83 50.54 1.43 32.81 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -44.69 128.21 -17.73 -42.08 129.17 -17.23 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 45 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 261 PHE A 16 PHE~? 14.00 ZN ZN A 401 coo 49.89 1.93 30.83 50.54 1.43 32.81 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -44.69 128.21 -17.73 -42.08 129.17 -17.23 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 45 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 261 PHE A 16 PHE~? 14.00 ZN ZN A 401 coo 49.89 1.93 30.83 50.54 1.43 32.81 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -44.69 128.21 -17.73 -42.08 129.17 -17.23 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 45 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 261 PHE A 363 PHE.? 13.25 ZN ZN A 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -31.41 111.93 2.28 -34.10 111.18 2.79 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 7 3 # 7 A 44 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 45 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 261 PHE B 363 PHE^? 13.11 ZN ZN B 401 coo 49.89 1.93 30.83 50.54 1.43 32.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -35.37 98.65 -1.40 -37.23 100.69 -1.90 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 8 3 # 8 A 44 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 45 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 261 PHE B 16 PHE~? 14.05 ZN ZN B 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -55.07 91.67 18.58 -53.33 89.51 18.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 9 3 # 9 A 44 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 45 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 261 PHE B 344 PHE~? 21.77 ZN ZN B 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -45.25 79.78 24.19 -46.74 79.97 21.79 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 10 3 # 10 A 44 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 45 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 261 PHE B 16 PHE~? 14.05 ZN ZN B 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -55.07 91.67 18.58 -53.33 89.51 18.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 11 3 # 11 A 44 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 45 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 261 PHE B 16 PHE~? 14.05 ZN ZN B 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -55.07 91.67 18.58 -53.33 89.51 18.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 12 3 # 12 A 44 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 45 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 261 PHE B 363 PHE^? 13.11 ZN ZN B 401 coo 49.89 1.93 30.83 50.54 1.43 32.81 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -35.37 98.65 -1.40 -37.23 100.69 -1.90 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 13 3 # 13 A 44 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 45 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 261 PHE B 16 PHE~? 14.05 ZN ZN B 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -55.07 91.67 18.58 -53.33 89.51 18.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 14 3 # 14 A 44 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 45 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 261 PHE B 16 PHE~? 14.05 ZN ZN B 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -55.07 91.67 18.58 -53.33 89.51 18.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 15 3 # 15 A 44 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 45 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 261 PHE A 363 PHE.? 13.25 ZN ZN A 402 coo 49.89 1.93 30.83 50.54 1.43 32.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -31.41 111.93 2.28 -34.10 111.18 2.79 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 15 hits 1luc_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 295 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 369 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 11.74 38.14 80.19 10.63 36.40 80.65 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 16.11 33.72 80.99 14.10 33.54 81.63 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 295 GLU A 32 GLU.? 25.81 ZN ZN A 401 A 369 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 16.11 33.72 80.99 14.10 33.54 81.63 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 295 GLU A 35 GLU.? 32.19 ZN ZN A 401 A 369 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 16.11 33.72 80.99 14.10 33.54 81.63 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 12.19 31.08 87.29 11.13 32.66 86.38 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 295 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 369 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 11.74 38.14 80.19 10.63 36.40 80.65 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 16.11 33.72 80.99 14.10 33.54 81.63 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.20 100.05 15.92 -45.42 99.37 14.07 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 265 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 369 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 17.36 23.57 72.04 18.68 21.92 71.98 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 265 GLU A 199 GLU.? 39.53 ZN ZN A 401 A 369 ASP A 129 ASP^? 19.65 ZN ZN A 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 -61.23 119.64 -44.31 -61.84 117.61 -44.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 -52.93 118.26 -28.24 -51.00 118.44 -27.37 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 265 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 369 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 17.36 23.57 72.04 18.68 21.92 71.98 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 265 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 369 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 265 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 369 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 17.36 23.57 72.04 18.68 21.92 71.98 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 265 GLU A 271 GLU.? 22.11 ZN ZN B 401 A 369 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 265 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 369 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 17.36 23.57 72.04 18.68 21.92 71.98 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 265 GLU A 271 GLU.? 22.11 ZN ZN B 401 A 369 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 265 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 369 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 17.36 23.57 72.04 18.68 21.92 71.98 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 265 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 369 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 265 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 369 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 17.36 23.57 72.04 18.68 21.92 71.98 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 265 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 369 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 17.36 23.57 72.04 18.68 21.92 71.98 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 265 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 369 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 17.36 23.57 72.04 18.68 21.92 71.98 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 265 GLU B 271 GLU.? 25.84 ZN ZN A 402 A 369 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 265 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 369 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 265 GLU B 271 GLU.? 25.84 ZN ZN A 402 A 369 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 265 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 369 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -43.07 90.95 4.66 -43.22 93.08 4.74 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 17 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 279 GLU A 354 GLU^? 23.23 ZN ZN A 401 A 369 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 16.54 46.37 63.94 14.77 45.79 62.95 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 279 GLU A 48 GLU~? 19.37 ZN ZN A 402 A 369 ASP A 33 ASP.? 31.33 ZN ZN A 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 16.54 46.37 63.94 14.77 45.79 62.95 -25.72 127.18 1.29 -24.86 125.22 1.74 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.68 145.88 -15.27 -39.90 147.57 -16.36 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 279 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 369 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 16.54 46.37 63.94 14.77 45.79 62.95 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 279 GLU B 48 GLU~? 19.33 ZN ZN B 401 A 369 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 16.54 46.37 63.94 14.77 45.79 62.95 -38.69 82.94 -0.70 -36.82 83.91 -1.11 coo 12.19 31.08 87.29 11.13 32.66 86.38 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 279 GLU B 354 GLU^? 23.36 ZN ZN B 402 A 369 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 16.54 46.37 63.94 14.77 45.79 62.95 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 279 GLU B 48 GLU~? 19.33 ZN ZN B 401 A 369 ASP B 33 ASP.? 29.43 ZN ZN B 402 coo 11.74 38.14 80.19 10.63 36.40 80.65 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 16.54 46.37 63.94 14.77 45.79 62.95 -38.69 82.94 -0.70 -36.82 83.91 -1.11 coo 12.19 31.08 87.29 11.13 32.66 86.38 -61.26 74.82 15.61 -62.97 76.13 15.50 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 279 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 369 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 16.54 46.37 63.94 14.77 45.79 62.95 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 279 GLU A 48 GLU~? 19.37 ZN ZN A 402 A 369 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 16.54 46.37 63.94 14.77 45.79 62.95 -25.72 127.18 1.29 -24.86 125.22 1.74 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.41 105.08 4.17 -40.72 103.08 3.51 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 168 ASN A 59 ASN.? 24.94 ZN ZN A 401 A 241 HIS A 90 HIS~? 26.77 ZN ZN A 402 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -30.92 139.81 -10.79 -31.57 140.22 -12.79 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -30.00 140.26 -1.63 -28.87 140.48 0.12 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP B 31 ASP.? 28.05 ZN ZN B 402 A 168 ASN B 59 ASN.? 24.90 ZN ZN B 402 A 241 HIS B 90 HIS~? 26.84 ZN ZN B 401 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -58.98 76.97 11.28 -60.60 75.86 12.07 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -49.65 74.63 11.24 -50.47 74.68 13.21 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -49.12 73.85 2.19 -48.21 73.06 0.48 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 31 ASP.? 28.20 ZN ZN A 401 B 168 ASN A 59 ASN.? 24.94 ZN ZN A 401 B 241 HIS A 90 HIS~? 26.77 ZN ZN A 402 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -30.92 139.81 -10.79 -31.57 140.22 -12.79 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -30.00 140.26 -1.63 -28.87 140.48 0.12 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 168 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 241 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 B 10 ASP B 31 ASP.? 28.05 ZN ZN B 402 B 168 ASN B 59 ASN.? 24.90 ZN ZN B 402 B 241 HIS B 90 HIS~? 26.84 ZN ZN B 401 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -58.98 76.97 11.28 -60.60 75.86 12.07 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -49.65 74.63 11.24 -50.47 74.68 13.21 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -49.12 73.85 2.19 -48.21 73.06 0.48 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 B 10 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 168 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 241 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -34.08 101.07 5.49 -32.41 102.02 4.50 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -41.00 97.85 3.28 -40.98 95.80 3.73 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 4 hits 1mas_c01 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 114 LYS~? 19.79 ZN ZN A 401 166 LYS A 119 LYS^? 25.23 ZN ZN A 401 324 SER A 272 SER.? 25.47 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 27.27 1.43 25.09 29.18 5.25 22.89 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 119 LYS^? 25.23 ZN ZN A 401 166 LYS A 114 LYS~? 19.79 ZN ZN A 401 324 SER A 272 SER.? 25.47 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 258 LYS~? 21.92 ZN ZN A 402 166 LYS A 260 LYS~? 21.58 ZN ZN A 401 324 SER A 63 SER^? 10.35 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 27.27 1.43 25.09 29.18 5.25 22.89 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 46.32 14.55 19.93 45.95 12.72 21.27 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 260 LYS~? 21.58 ZN ZN A 401 166 LYS A 258 LYS~? 21.92 ZN ZN A 402 324 SER A 63 SER^? 10.35 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 46.32 14.55 19.93 45.95 12.72 21.27 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 260 LYS~? 21.58 ZN ZN A 401 166 LYS A 258 LYS~? 21.92 ZN ZN A 402 324 SER A 122 SER^? 18.54 ZN ZN A 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 46.32 14.55 19.93 45.95 12.72 21.27 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS A 275 LYS^? 30.46 ZN ZN A 401 166 LYS A 277 LYS^? 27.09 ZN ZN A 401 324 SER A 265 SER.? 18.83 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 27.27 1.43 25.09 29.18 5.25 22.89 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.26 104.74 -2.86 -27.40 103.51 -1.11 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS A 275 LYS^? 30.46 ZN ZN A 401 166 LYS A 277 LYS^? 27.09 ZN ZN A 401 324 SER A 285 SER.? 7.68 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 27.27 1.43 25.09 29.18 5.25 22.89 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS A 277 LYS^? 27.09 ZN ZN A 401 166 LYS A 275 LYS^? 30.46 ZN ZN A 401 324 SER A 285 SER.? 7.68 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 46.32 14.55 19.93 45.95 12.72 21.27 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS A 277 LYS^? 27.09 ZN ZN A 401 166 LYS A 275 LYS^? 30.46 ZN ZN A 401 324 SER A 328 SER~? 11.01 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 46.32 14.55 19.93 45.95 12.72 21.27 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS A 307 LYS~? 10.65 ZN ZN B 401 166 LYS B 307 LYS~? 11.14 ZN ZN A 402 324 SER A 259 SER~? 22.94 ZN ZN A 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 -21.63 105.68 -11.35 -19.60 105.39 -12.58 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS A 307 LYS~? 10.65 ZN ZN B 401 166 LYS B 307 LYS~? 11.14 ZN ZN A 402 324 SER B 21 SER.? 15.71 ZN ZN B 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 -58.60 101.69 13.65 -59.34 103.93 13.19 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS A 307 LYS~? 10.65 ZN ZN B 401 166 LYS B 307 LYS~? 11.14 ZN ZN A 402 324 SER B 259 SER~? 23.06 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.46 98.59 12.15 -21.45 97.88 13.30 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS B 114 LYS~? 19.44 ZN ZN B 402 166 LYS B 119 LYS^? 26.96 ZN ZN B 402 324 SER B 265 SER.? 18.70 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 27.27 1.43 25.09 29.18 5.25 22.89 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.94 101.98 3.65 -27.40 103.69 1.94 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS B 114 LYS~? 19.44 ZN ZN B 402 166 LYS B 119 LYS^? 26.96 ZN ZN B 402 324 SER B 272 SER.? 25.31 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 27.27 1.43 25.09 29.18 5.25 22.89 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 46.32 14.55 19.93 45.95 12.72 21.27 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 15 3 # 15 164 LYS B 119 LYS^? 26.96 ZN ZN B 402 166 LYS B 114 LYS~? 19.44 ZN ZN B 402 324 SER B 272 SER.? 25.31 ZN ZN A 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 27.27 1.43 25.09 29.18 5.25 22.89 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 46.32 14.55 19.93 45.95 12.72 21.27 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 16 3 # 16 164 LYS B 258 LYS~? 21.85 ZN ZN B 401 166 LYS B 260 LYS~? 21.74 ZN ZN B 402 324 SER B 63 SER^? 10.37 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 27.27 1.43 25.09 29.18 5.25 22.89 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 46.32 14.55 19.93 45.95 12.72 21.27 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 17 3 # 17 164 LYS B 260 LYS~? 21.74 ZN ZN B 402 166 LYS B 258 LYS~? 21.85 ZN ZN B 401 324 SER B 63 SER^? 10.37 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 27.27 1.43 25.09 29.18 5.25 22.89 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 46.32 14.55 19.93 45.95 12.72 21.27 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 18 3 # 18 164 LYS B 260 LYS~? 21.74 ZN ZN B 402 166 LYS B 258 LYS~? 21.85 ZN ZN B 401 324 SER B 122 SER^? 18.54 ZN ZN B 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 27.27 1.43 25.09 29.18 5.25 22.89 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 46.32 14.55 19.93 45.95 12.72 21.27 -39.61 105.40 27.34 -40.83 107.01 28.62 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 19 3 # 19 164 LYS B 275 LYS^? 32.38 ZN ZN B 402 166 LYS B 277 LYS^? 26.47 ZN ZN B 402 324 SER B 265 SER.? 18.70 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 27.27 1.43 25.09 29.18 5.25 22.89 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.94 101.98 3.65 -27.40 103.69 1.94 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 20 3 # 20 164 LYS B 277 LYS^? 26.47 ZN ZN B 402 166 LYS B 275 LYS^? 32.38 ZN ZN B 402 324 SER B 285 SER.? 7.72 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 27.27 1.43 25.09 29.18 5.25 22.89 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 46.32 14.55 19.93 45.95 12.72 21.27 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 21 3 # 21 164 LYS B 277 LYS^? 26.47 ZN ZN B 402 166 LYS B 275 LYS^? 32.38 ZN ZN B 402 324 SER B 328 SER~? 10.89 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 27.27 1.43 25.09 29.18 5.25 22.89 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 46.32 14.55 19.93 45.95 12.72 21.27 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 22 3 # 22 164 LYS B 307 LYS~? 11.14 ZN ZN A 402 166 LYS A 307 LYS~? 10.65 ZN ZN B 401 324 SER A 21 SER.? 15.75 ZN ZN A 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 46.32 14.55 19.93 45.95 12.72 21.27 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 23 3 # 23 164 LYS B 307 LYS~? 11.14 ZN ZN A 402 166 LYS A 307 LYS~? 10.65 ZN ZN B 401 324 SER A 259 SER~? 22.94 ZN ZN A 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 46.32 14.55 19.93 45.95 12.72 21.27 -21.63 105.68 -11.35 -19.60 105.39 -12.58 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 24 3 # 24 164 LYS B 307 LYS~? 11.14 ZN ZN A 402 166 LYS A 307 LYS~? 10.65 ZN ZN B 401 324 SER B 259 SER~? 23.06 ZN ZN B 401 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 46.32 14.55 19.93 45.95 12.72 21.27 -23.46 98.59 12.15 -21.45 97.88 13.30 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 25 3 # 25 164 LYS B 333 LYS~? 13.39 ZN ZN B 401 166 LYS B 337 LYS~? 20.93 ZN ZN B 402 324 SER B 122 SER^? 18.54 ZN ZN B 402 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 27.27 1.43 25.09 29.18 5.25 22.89 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 46.32 14.55 19.93 45.95 12.72 21.27 -39.61 105.40 27.34 -40.83 107.01 28.62 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 25 hits 1mdr_c01 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 20.97 14.47 32.28 19.66 15.96 31.62 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 16.04 14.72 33.82 17.27 13.71 31.95 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 20.65 22.00 33.80 20.06 20.56 32.39 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 20.97 14.47 32.28 19.66 15.96 31.62 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 16.04 14.72 33.82 17.27 13.71 31.95 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 20.65 22.00 33.80 20.06 20.56 32.39 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 20.97 14.47 32.28 19.66 15.96 31.62 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 16.04 14.72 33.82 17.27 13.71 31.95 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 20.65 22.00 33.80 20.06 20.56 32.39 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 20.97 14.47 32.28 19.66 15.96 31.62 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 16.04 14.72 33.82 17.27 13.71 31.95 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 20.65 22.00 33.80 20.06 20.56 32.39 -33.57 107.34 6.30 -34.87 106.07 5.21 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 4 hits 1mpp_c04 naa= 3 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 A 199 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 246 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 255 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 A 199 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 246 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 255 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 A 199 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 246 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 255 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 A 199 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 246 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 255 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 A 199 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 246 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 255 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 A 199 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 246 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 255 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -35.81 95.23 5.63 -35.48 92.50 6.11 1mpy_c00 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 246 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 255 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 246 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 255 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -35.81 95.23 5.63 -35.48 92.50 6.11 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 2 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 246 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 255 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 246 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 255 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -35.81 95.23 5.63 -35.48 92.50 6.11 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 2 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 246 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 255 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 246 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 255 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 D 199 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 246 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 255 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 D 199 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 246 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 255 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -35.81 95.23 5.63 -35.48 92.50 6.11 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 4 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 A 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 B 367 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 A 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 B 367 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 A 501 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 367 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 A 501 ASP A 352 ASP.? 27.02 ZN ZN A 401 B 367 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.81 119.15 12.42 -40.61 119.58 9.91 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 30 GLY.? 22.34 ZN ZN A 402 A 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 B 367 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -40.03 138.80 -8.81 -40.82 138.90 -8.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 30 GLY.? 22.34 ZN ZN A 402 A 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 B 367 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -40.03 138.80 -8.81 -40.82 138.90 -8.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 71 GLY.? 18.01 ZN ZN A 402 A 501 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 367 TYR A 205 TYR~? 27.31 ZN ZN A 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -49.58 129.10 -0.33 -49.28 128.51 0.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -55.75 130.32 -28.70 -53.61 130.45 -30.51 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY A 239 GLY.? 9.93 ZN ZN A 401 A 501 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -41.47 109.72 -18.36 -41.63 110.22 -18.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY A 239 GLY.? 9.93 ZN ZN A 401 A 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 B 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -41.47 109.72 -18.36 -41.63 110.22 -18.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 501 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 367 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.81 119.15 12.42 -40.61 119.58 9.91 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 501 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 367 TYR A 58 TYR.? 23.12 ZN ZN A 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -25.94 134.94 -12.27 -23.89 133.93 -13.91 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 501 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 B 367 TYR A 58 TYR.? 23.12 ZN ZN A 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -25.94 134.94 -12.27 -23.89 133.93 -13.91 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 B 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 A 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 B 367 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY A 288 GLY.? 14.54 ZN ZN A 401 A 501 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -47.81 104.86 -9.26 -47.13 104.59 -9.75 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY A 297 GLY.? 22.49 ZN ZN A 401 A 501 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 367 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -42.64 97.26 -22.49 -42.62 97.67 -21.88 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY B 26 GLY^? 14.44 ZN ZN B 402 A 501 ASP B -1 ASP.? 32.96 ZN ZN B 402 B 367 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -55.22 89.41 14.53 -54.89 89.43 13.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY B 26 GLY^? 14.44 ZN ZN B 402 A 501 ASP B 352 ASP.? 26.97 ZN ZN B 402 B 367 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -55.22 89.41 14.53 -54.89 89.43 13.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY B 30 GLY.? 22.35 ZN ZN B 402 A 501 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 367 TYR B 205 TYR.? 27.03 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -56.71 80.35 9.42 -57.43 80.74 9.40 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -65.21 96.58 29.25 -63.97 94.97 31.18 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY B 71 GLY.? 18.04 ZN ZN B 401 A 501 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 367 TYR B 205 TYR.? 27.03 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -59.65 93.73 1.35 -59.07 94.10 0.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -65.21 96.58 29.25 -63.97 94.97 31.18 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY B 239 GLY.? 9.90 ZN ZN B 402 A 501 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -42.47 105.54 19.38 -42.87 105.20 20.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY B 239 GLY.? 9.90 ZN ZN B 402 A 501 ASP B 203 ASP^? 26.15 ZN ZN B 402 B 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -42.47 105.54 19.38 -42.87 105.20 20.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 501 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 367 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 501 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 501 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 367 TYR B 58 TYR.? 23.40 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -42.81 75.85 12.88 -40.52 75.44 14.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 367 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 367 TYR B 58 TYR.? 23.40 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -42.81 75.85 12.88 -40.52 75.44 14.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 A 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 367 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -60.00 104.47 33.20 -57.62 103.10 32.62 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY B 288 GLY.? 14.50 ZN ZN B 401 A 501 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 367 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -45.18 113.19 10.25 -44.48 113.02 10.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -60.00 104.47 33.20 -57.62 103.10 32.62 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 32 3 # 32 A 465 GLY B 297 GLY.? 22.39 ZN ZN B 402 A 501 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 367 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -36.97 116.79 23.45 -37.15 116.39 22.80 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -60.00 104.47 33.20 -57.62 103.10 32.62 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 32 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 D 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 E 367 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 D 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 E 367 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 D 501 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 367 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 26 GLY^? 14.60 ZN ZN A 401 D 501 ASP A 352 ASP.? 27.02 ZN ZN A 401 E 367 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -43.76 130.44 -13.71 -43.42 130.21 -12.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.81 119.15 12.42 -40.61 119.58 9.91 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 30 GLY.? 22.34 ZN ZN A 402 D 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 E 367 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -40.03 138.80 -8.81 -40.82 138.90 -8.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 30 GLY.? 22.34 ZN ZN A 402 D 501 ASP A -1 ASP.? 33.70 ZN ZN A 401 E 367 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -40.03 138.80 -8.81 -40.82 138.90 -8.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 71 GLY.? 18.01 ZN ZN A 402 D 501 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 367 TYR A 205 TYR~? 27.31 ZN ZN A 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -49.58 129.10 -0.33 -49.28 128.51 0.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -55.75 130.32 -28.70 -53.61 130.45 -30.51 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY A 239 GLY.? 9.93 ZN ZN A 401 D 501 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -41.47 109.72 -18.36 -41.63 110.22 -18.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY A 239 GLY.? 9.93 ZN ZN A 401 D 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 E 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -41.47 109.72 -18.36 -41.63 110.22 -18.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 D 501 ASP A 11 ASP~? 18.10 ZN ZN A 401 E 367 TYR B 291 TYR~? 19.42 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.81 119.15 12.42 -40.61 119.58 9.91 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 D 501 ASP A 129 ASP^? 19.65 ZN ZN A 401 E 367 TYR A 58 TYR.? 23.12 ZN ZN A 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -25.94 134.94 -12.27 -23.89 133.93 -13.91 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 D 501 ASP A 129 ASP^? 19.65 ZN ZN A 401 E 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 D 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 E 367 TYR A 58 TYR.? 23.12 ZN ZN A 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -25.94 134.94 -12.27 -23.89 133.93 -13.91 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 D 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 E 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY A 283 GLY.? 5.77 ZN ZN A 401 D 501 ASP A 245 ASP^? 25.73 ZN ZN A 401 E 367 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -37.34 111.36 -12.24 -38.16 111.32 -12.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY A 288 GLY.? 14.54 ZN ZN A 401 D 501 ASP A 129 ASP^? 19.65 ZN ZN A 401 E 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -47.81 104.86 -9.26 -47.13 104.59 -9.75 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY A 297 GLY.? 22.49 ZN ZN A 401 D 501 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 367 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -42.64 97.26 -22.49 -42.62 97.67 -21.88 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY B 26 GLY^? 14.44 ZN ZN B 402 D 501 ASP B -1 ASP.? 32.96 ZN ZN B 402 E 367 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -55.22 89.41 14.53 -54.89 89.43 13.78 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY B 26 GLY^? 14.44 ZN ZN B 402 D 501 ASP B 352 ASP.? 26.97 ZN ZN B 402 E 367 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -55.22 89.41 14.53 -54.89 89.43 13.78 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY B 30 GLY.? 22.35 ZN ZN B 402 D 501 ASP A 313 ASP~? 12.18 ZN ZN B 401 E 367 TYR B 205 TYR.? 27.03 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -56.71 80.35 9.42 -57.43 80.74 9.40 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -65.21 96.58 29.25 -63.97 94.97 31.18 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY B 57 GLY~? 27.22 ZN ZN B 401 D 501 ASP B -1 ASP.? 32.96 ZN ZN B 402 E 367 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -43.51 71.61 10.24 -43.32 72.40 10.37 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY B 71 GLY.? 18.04 ZN ZN B 401 D 501 ASP B 305 ASP.? 7.64 ZN ZN B 401 E 367 TYR B 205 TYR.? 27.03 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -59.65 93.73 1.35 -59.07 94.10 0.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -65.21 96.58 29.25 -63.97 94.97 31.18 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY B 239 GLY.? 9.90 ZN ZN B 402 D 501 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -42.47 105.54 19.38 -42.87 105.20 20.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY B 239 GLY.? 9.90 ZN ZN B 402 D 501 ASP B 203 ASP^? 26.15 ZN ZN B 402 E 367 TYR B 80 TYR~? 13.91 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -42.47 105.54 19.38 -42.87 105.20 20.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.82 90.33 -2.11 -47.80 92.21 -1.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 D 501 ASP B 11 ASP~? 18.05 ZN ZN B 402 E 367 TYR A 291 TYR~? 19.48 ZN ZN B 401 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -48.19 97.96 -11.45 -47.23 97.05 -8.98 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 D 501 ASP B 129 ASP^? 19.14 ZN ZN B 402 E 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 D 501 ASP B 129 ASP^? 19.14 ZN ZN B 402 E 367 TYR B 58 TYR.? 23.40 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -42.81 75.85 12.88 -40.52 75.44 14.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 D 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 E 367 TYR A 80 TYR~? 13.91 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.16 126.74 3.00 -38.55 124.04 2.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 D 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 E 367 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 D 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 E 367 TYR B 58 TYR.? 23.40 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -42.81 75.85 12.88 -40.52 75.44 14.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY B 283 GLY.? 5.97 ZN ZN B 402 D 501 ASP B 245 ASP^? 25.30 ZN ZN B 402 E 367 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -39.59 102.15 13.09 -40.35 102.56 13.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -60.00 104.47 33.20 -57.62 103.10 32.62 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY B 288 GLY.? 14.50 ZN ZN B 401 D 501 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 367 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -45.18 113.19 10.25 -44.48 113.02 10.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -60.00 104.47 33.20 -57.62 103.10 32.62 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 33 3 # 33 D 465 GLY B 297 GLY.? 22.39 ZN ZN B 402 D 501 ASP B 305 ASP.? 7.64 ZN ZN B 401 E 367 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -36.97 116.79 23.45 -37.15 116.39 22.80 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -60.00 104.47 33.20 -57.62 103.10 32.62 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 33 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 55 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 84 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.09 42.89 24.44 11.32 42.06 22.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 4.60 40.33 20.42 7.25 39.50 20.05 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 9.71 44.83 15.47 10.13 41.43 19.93 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 55 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 84 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 11.09 42.89 24.44 11.32 42.06 22.49 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 4.60 40.33 20.42 7.25 39.50 20.05 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 9.71 44.83 15.47 10.13 41.43 19.93 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 55 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 84 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 11.09 42.89 24.44 11.32 42.06 22.49 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 4.60 40.33 20.42 7.25 39.50 20.05 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 9.71 44.83 15.47 10.13 41.43 19.93 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 55 TYR B 132 TYR^? 30.83 ZN ZN B 402 A 84 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 11.09 42.89 24.44 11.32 42.06 22.49 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 4.60 40.33 20.42 7.25 39.50 20.05 -67.13 105.92 32.85 -67.85 106.57 30.23 coo 9.71 44.83 15.47 10.13 41.43 19.93 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 55 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 84 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 11.09 42.89 24.44 11.32 42.06 22.49 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 4.60 40.33 20.42 7.25 39.50 20.05 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 9.71 44.83 15.47 10.13 41.43 19.93 -33.07 120.28 7.09 -27.74 119.98 5.88 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 5 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 337 LYS~? 20.91 ZN ZN A 401 A 169 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 327 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo 20.73 15.53 25.54 22.09 15.64 19.40 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 24.31 10.25 23.71 29.02 12.05 20.75 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 21.86 20.40 18.59 22.12 18.33 18.33 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 169 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 327 GLU B 162 GLU^? 46.76 ZN ZN B 402 coo 20.73 15.53 25.54 22.09 15.64 19.40 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 24.31 10.25 23.71 29.02 12.05 20.75 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 21.86 20.40 18.59 22.12 18.33 18.33 -66.72 104.17 51.47 -67.64 102.80 52.82 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 169 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 327 GLU B 158 GLU.? 36.73 ZN ZN B 402 coo 20.73 15.53 25.54 22.09 15.64 19.40 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 24.31 10.25 23.71 29.02 12.05 20.75 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 21.86 20.40 18.59 22.12 18.33 18.33 -60.87 94.33 46.47 -60.36 92.90 44.98 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS B 337 LYS~? 20.93 ZN ZN B 402 A 169 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 327 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 20.73 15.53 25.54 22.09 15.64 19.40 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 24.31 10.25 23.71 29.02 12.05 20.75 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 21.86 20.40 18.59 22.12 18.33 18.33 -37.43 78.09 15.20 -36.78 76.82 13.66 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 337 LYS~? 20.91 ZN ZN A 401 B 169 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 327 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 169 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 327 GLU B 162 GLU^? 46.76 ZN ZN B 402 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -66.72 104.17 51.47 -67.64 102.80 52.82 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 169 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 327 GLU B 158 GLU.? 36.73 ZN ZN B 402 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -60.87 94.33 46.47 -60.36 92.90 44.98 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS B 337 LYS~? 20.93 ZN ZN B 402 B 169 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 327 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -37.43 78.09 15.20 -36.78 76.82 13.66 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 223 ALA A 355 ALA^? 16.20 ZN ZN A 401 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -25.75 125.60 -13.37 -25.45 124.21 -13.86 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 197 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 223 ALA A 42 ALA^? 12.34 ZN ZN A 402 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -31.20 125.03 -9.65 -31.46 126.10 -8.55 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 197 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 223 ALA B 42 ALA^? 12.31 ZN ZN B 401 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -41.84 87.26 10.29 -42.65 86.57 9.20 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 197 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 223 ALA A 293 ALA~? 16.37 ZN ZN A 401 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -44.42 101.07 -17.63 -43.28 101.58 -16.75 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 197 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 223 ALA B 355 ALA^? 16.21 ZN ZN B 402 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -37.64 83.78 14.03 -36.69 84.81 14.61 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 197 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 223 ALA B 42 ALA^? 12.31 ZN ZN B 401 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -41.84 87.26 10.29 -42.65 86.57 9.20 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 197 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 223 ALA A 42 ALA^? 12.34 ZN ZN A 402 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -31.20 125.03 -9.65 -31.46 126.10 -8.55 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 197 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 223 ALA B 293 ALA~? 16.28 ZN ZN B 402 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -38.40 123.74 9.47 -39.77 124.82 8.30 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -40.44 114.49 18.56 -39.75 113.50 17.61 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 8 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 197 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 223 ALA A 355 ALA^? 16.20 ZN ZN A 401 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -25.75 125.60 -13.37 -25.45 124.21 -13.86 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 197 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 223 ALA A 42 ALA^? 12.34 ZN ZN A 402 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -31.20 125.03 -9.65 -31.46 126.10 -8.55 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 197 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 223 ALA B 42 ALA^? 12.31 ZN ZN B 401 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -41.84 87.26 10.29 -42.65 86.57 9.20 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 197 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 223 ALA A 293 ALA~? 16.37 ZN ZN A 401 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -44.42 101.07 -17.63 -43.28 101.58 -16.75 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 197 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 223 ALA B 355 ALA^? 16.21 ZN ZN B 402 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -37.64 83.78 14.03 -36.69 84.81 14.61 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 197 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 223 ALA B 42 ALA^? 12.31 ZN ZN B 401 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -41.84 87.26 10.29 -42.65 86.57 9.20 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 197 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 223 ALA A 42 ALA^? 12.34 ZN ZN A 402 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -31.20 125.03 -9.65 -31.46 126.10 -8.55 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 197 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 223 ALA B 293 ALA~? 16.28 ZN ZN B 402 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -38.40 123.74 9.47 -39.77 124.82 8.30 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -40.44 114.49 18.56 -39.75 113.50 17.61 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 8 hits 1n2t_c03 naa= 3 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 689 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 732 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 23.89 30.33 18.51 26.53 29.83 17.65 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 24.69 23.24 17.44 26.23 24.43 18.22 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 27.47 24.40 22.13 27.89 26.42 21.78 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 689 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 732 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 23.89 30.33 18.51 26.53 29.83 17.65 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 24.69 23.24 17.44 26.23 24.43 18.22 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 27.47 24.40 22.13 27.89 26.42 21.78 -34.08 101.07 5.49 -32.41 102.02 4.50 1naa_c02 source 1naa CELLOBIOSE DEHYDROGENASE : 2 hits 1naa_c02 naa= 3 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 689 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 732 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 689 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 732 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -34.08 101.07 5.49 -32.41 102.02 4.50 1naa_c03 source 1naa CELLOBIOSE DEHYDROGENASE : 2 hits 1naa_c03 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 104 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 20.72 31.33 73.27 20.15 33.36 73.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 17.00 33.82 71.84 16.59 31.98 70.88 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 20.06 38.06 74.21 21.19 36.81 72.96 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 104 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 20.72 31.33 73.27 20.15 33.36 73.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 17.00 33.82 71.84 16.59 31.98 70.88 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 20.06 38.06 74.21 21.19 36.81 72.96 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 104 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 20.72 31.33 73.27 20.15 33.36 73.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 17.00 33.82 71.84 16.59 31.98 70.88 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 20.06 38.06 74.21 21.19 36.81 72.96 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 205 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 208 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 104 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 20.72 31.33 73.27 20.15 33.36 73.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 17.00 33.82 71.84 16.59 31.98 70.88 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 20.06 38.06 74.21 21.19 36.81 72.96 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 205 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 208 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 104 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 20.72 31.33 73.27 20.15 33.36 73.56 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 17.00 33.82 71.84 16.59 31.98 70.88 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 20.06 38.06 74.21 21.19 36.81 72.96 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 205 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 208 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 104 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 20.72 31.33 73.27 20.15 33.36 73.56 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 17.00 33.82 71.84 16.59 31.98 70.88 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 20.06 38.06 74.21 21.19 36.81 72.96 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 7 3 # 7 A 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 104 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 20.72 31.33 73.27 20.15 33.36 73.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 17.00 33.82 71.84 16.59 31.98 70.88 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 20.06 38.06 74.21 21.19 36.81 72.96 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 8 3 # 8 A 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 104 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 20.72 31.33 73.27 20.15 33.36 73.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 17.00 33.82 71.84 16.59 31.98 70.88 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 20.06 38.06 74.21 21.19 36.81 72.96 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 9 3 # 9 A 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 104 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 20.72 31.33 73.27 20.15 33.36 73.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 17.00 33.82 71.84 16.59 31.98 70.88 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 20.06 38.06 74.21 21.19 36.81 72.96 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 10 3 # 10 A 205 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 208 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 104 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 20.72 31.33 73.27 20.15 33.36 73.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 17.00 33.82 71.84 16.59 31.98 70.88 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 20.06 38.06 74.21 21.19 36.81 72.96 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 11 3 # 11 A 205 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 208 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 104 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 20.72 31.33 73.27 20.15 33.36 73.56 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 17.00 33.82 71.84 16.59 31.98 70.88 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 20.06 38.06 74.21 21.19 36.81 72.96 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 12 3 # 12 A 205 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 208 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 104 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 20.72 31.33 73.27 20.15 33.36 73.56 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 17.00 33.82 71.84 16.59 31.98 70.88 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 20.06 38.06 74.21 21.19 36.81 72.96 -45.80 98.45 2.85 -45.82 97.45 4.71 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 12 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 36.32 11.24 30.83 37.00 13.22 30.81 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 38.79 15.70 26.44 37.66 14.35 27.62 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.24 14.63 26.81 34.14 16.25 25.49 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 104 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 205 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 208 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 36.32 11.24 30.83 37.00 13.22 30.81 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 38.79 15.70 26.44 37.66 14.35 27.62 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 34.24 14.63 26.81 34.14 16.25 25.49 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 104 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 36.32 11.24 30.83 37.00 13.22 30.81 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 38.79 15.70 26.44 37.66 14.35 27.62 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.24 14.63 26.81 34.14 16.25 25.49 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 104 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 205 ASP B 305 ASP.? 7.64 ZN ZN B 401 E 208 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 36.32 11.24 30.83 37.00 13.22 30.81 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 38.79 15.70 26.44 37.66 14.35 27.62 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 34.24 14.63 26.81 34.14 16.25 25.49 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 104 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 36.32 11.24 30.83 37.00 13.22 30.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 38.79 15.70 26.44 37.66 14.35 27.62 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.24 14.63 26.81 34.14 16.25 25.49 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 104 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 205 ASP B 305 ASP.? 7.64 ZN ZN B 401 E 208 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 36.32 11.24 30.83 37.00 13.22 30.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 38.79 15.70 26.44 37.66 14.35 27.62 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 34.24 14.63 26.81 34.14 16.25 25.49 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 7 3 # 7 A 104 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 36.32 11.24 30.83 37.00 13.22 30.81 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 38.79 15.70 26.44 37.66 14.35 27.62 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.24 14.63 26.81 34.14 16.25 25.49 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 8 3 # 8 A 104 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 205 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 208 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 36.32 11.24 30.83 37.00 13.22 30.81 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 38.79 15.70 26.44 37.66 14.35 27.62 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 34.24 14.63 26.81 34.14 16.25 25.49 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 9 3 # 9 A 104 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 36.32 11.24 30.83 37.00 13.22 30.81 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 38.79 15.70 26.44 37.66 14.35 27.62 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.24 14.63 26.81 34.14 16.25 25.49 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 10 3 # 10 A 104 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 205 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 208 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 36.32 11.24 30.83 37.00 13.22 30.81 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 38.79 15.70 26.44 37.66 14.35 27.62 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 34.24 14.63 26.81 34.14 16.25 25.49 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 11 3 # 11 A 104 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 36.32 11.24 30.83 37.00 13.22 30.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 38.79 15.70 26.44 37.66 14.35 27.62 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.24 14.63 26.81 34.14 16.25 25.49 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 12 3 # 12 A 104 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 205 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 208 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 36.32 11.24 30.83 37.00 13.22 30.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 38.79 15.70 26.44 37.66 14.35 27.62 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 34.24 14.63 26.81 34.14 16.25 25.49 -37.32 113.39 -5.27 -38.85 114.75 -5.76 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 12 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 104 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 36.50 67.03 37.59 36.77 66.38 35.61 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 33.45 66.12 34.16 32.13 66.40 35.76 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 38.29 64.94 31.33 38.08 64.16 33.27 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 104 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 36.50 67.03 37.59 36.77 66.38 35.61 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 33.45 66.12 34.16 32.13 66.40 35.76 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 38.29 64.94 31.33 38.08 64.16 33.27 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 C 205 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 208 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 104 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 36.50 67.03 37.59 36.77 66.38 35.61 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 33.45 66.12 34.16 32.13 66.40 35.76 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 38.29 64.94 31.33 38.08 64.16 33.27 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 C 205 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 208 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 104 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 36.50 67.03 37.59 36.77 66.38 35.61 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 33.45 66.12 34.16 32.13 66.40 35.76 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 38.29 64.94 31.33 38.08 64.16 33.27 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 C 205 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 208 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 104 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 36.50 67.03 37.59 36.77 66.38 35.61 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 33.45 66.12 34.16 32.13 66.40 35.76 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 38.29 64.94 31.33 38.08 64.16 33.27 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 C 205 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 208 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 104 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 36.50 67.03 37.59 36.77 66.38 35.61 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 33.45 66.12 34.16 32.13 66.40 35.76 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 38.29 64.94 31.33 38.08 64.16 33.27 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 7 3 # 7 C 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 104 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 36.50 67.03 37.59 36.77 66.38 35.61 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 33.45 66.12 34.16 32.13 66.40 35.76 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 38.29 64.94 31.33 38.08 64.16 33.27 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 8 3 # 8 C 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 104 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 36.50 67.03 37.59 36.77 66.38 35.61 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 33.45 66.12 34.16 32.13 66.40 35.76 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 38.29 64.94 31.33 38.08 64.16 33.27 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 9 3 # 9 C 205 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 208 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 104 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 36.50 67.03 37.59 36.77 66.38 35.61 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 33.45 66.12 34.16 32.13 66.40 35.76 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 38.29 64.94 31.33 38.08 64.16 33.27 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 10 3 # 10 C 205 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 208 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 104 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 36.50 67.03 37.59 36.77 66.38 35.61 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 33.45 66.12 34.16 32.13 66.40 35.76 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 38.29 64.94 31.33 38.08 64.16 33.27 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 11 3 # 11 C 205 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 208 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 104 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 36.50 67.03 37.59 36.77 66.38 35.61 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 33.45 66.12 34.16 32.13 66.40 35.76 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 38.29 64.94 31.33 38.08 64.16 33.27 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 12 3 # 12 C 205 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 208 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 104 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 36.50 67.03 37.59 36.77 66.38 35.61 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 33.45 66.12 34.16 32.13 66.40 35.76 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 38.29 64.94 31.33 38.08 64.16 33.27 -45.80 98.45 2.85 -45.82 97.45 4.71 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 12 hits 1ndo_c02 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 20 GLU.? 10.86 ZN ZN A 401 B 128 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 263 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 6.12 5.94 82.00 7.16 6.32 83.81 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 12.51 16.35 80.99 13.16 14.90 82.37 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 11.58 14.94 93.26 12.25 14.03 91.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 20 GLU.? 10.86 ZN ZN A 401 B 128 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 263 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 6.12 5.94 82.00 7.16 6.32 83.81 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 12.51 16.35 80.99 13.16 14.90 82.37 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 11.58 14.94 93.26 12.25 14.03 91.50 -40.27 117.69 -1.83 -39.84 118.53 -3.70 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 2 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 59 GLU B 20 GLU.? 11.09 ZN ZN B 402 D 128 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 59 GLU B 20 GLU.? 11.09 ZN ZN B 402 D 128 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 59 GLU A 20 GLU.? 10.86 ZN ZN A 401 D 128 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 59 GLU A 20 GLU.? 10.86 ZN ZN A 401 D 128 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -37.47 120.38 -11.48 -38.85 119.05 -12.30 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 4 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 86 LYS~? 24.82 ZN ZN A 402 631 LYS A 337 LYS~? 20.91 ZN ZN A 401 708 LYS A 76 LYS.? 26.59 ZN ZN A 402 coo 8.61 33.06 11.15 10.12 29.19 8.82 -33.51 137.11 0.86 -27.79 135.78 2.74 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 18.16 32.86 9.85 16.06 28.20 13.56 -40.70 135.50 8.63 -43.88 132.62 12.69 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 119 LYS^? 25.23 ZN ZN A 401 631 LYS A 337 LYS~? 20.91 ZN ZN A 401 708 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 8.61 33.06 11.15 10.12 29.19 8.82 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 18.16 32.86 9.85 16.06 28.20 13.56 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS B 86 LYS~? 24.89 ZN ZN B 401 631 LYS B 337 LYS~? 20.93 ZN ZN B 402 708 LYS B 76 LYS.? 26.34 ZN ZN B 401 coo 8.61 33.06 11.15 10.12 29.19 8.82 -50.53 78.48 -0.34 -44.96 76.41 -1.96 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 18.16 32.86 9.85 16.06 28.20 13.56 -55.68 83.88 -8.02 -56.83 88.29 -11.63 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS B 119 LYS^? 26.96 ZN ZN B 402 631 LYS B 337 LYS~? 20.93 ZN ZN B 402 708 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 8.61 33.06 11.15 10.12 29.19 8.82 -30.71 103.60 27.70 -26.87 107.57 30.82 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 18.16 32.86 9.85 16.06 28.20 13.56 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS B 133 LYS^? 36.11 ZN ZN B 402 631 LYS B 140 LYS.? 53.20 ZN ZN B 402 708 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 8.61 33.06 11.15 10.12 29.19 8.82 -65.38 107.19 38.20 -61.64 109.75 42.23 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -74.22 104.46 56.49 -70.63 102.62 58.58 coo 18.16 32.86 9.85 16.06 28.20 13.56 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS B 197 LYS^? 42.64 ZN ZN B 402 631 LYS B 231 LYS^? 25.02 ZN ZN B 402 708 LYS B 140 LYS.? 53.20 ZN ZN B 402 coo 8.61 33.06 11.15 10.12 29.19 8.82 -70.80 108.71 48.92 -67.91 112.78 45.19 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -59.06 109.88 30.77 -61.50 111.95 25.23 coo 18.16 32.86 9.85 16.06 28.20 13.56 -74.22 104.46 56.49 -70.63 102.62 58.58 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 6 hits 1nsf_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 208 SER~? 31.99 ZN ZN A 401 A 154 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 261 ARG A 209 ARG~? 31.96 ZN ZN A 401 coo 16.10 74.10 3.11 17.18 73.52 5.20 -63.56 131.66 -30.21 -62.69 131.40 -27.94 coo 16.07 84.71 8.14 15.20 82.81 8.14 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 10.59 77.85 4.81 13.09 76.36 5.76 -58.90 136.31 -33.11 -57.17 134.66 -31.15 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 265 SER.? 18.83 ZN ZN A 402 A 154 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 16.10 74.10 3.11 17.18 73.52 5.20 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo 16.07 84.71 8.14 15.20 82.81 8.14 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 10.59 77.85 4.81 13.09 76.36 5.76 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER A 265 SER.? 18.83 ZN ZN A 402 A 154 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 16.10 74.10 3.11 17.18 73.52 5.20 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo 16.07 84.71 8.14 15.20 82.81 8.14 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 10.59 77.85 4.81 13.09 76.36 5.76 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 265 SER.? 18.70 ZN ZN B 401 A 154 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 261 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 16.10 74.10 3.11 17.18 73.52 5.20 -26.94 101.98 3.65 -27.40 103.69 1.94 coo 16.07 84.71 8.14 15.20 82.81 8.14 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 10.59 77.85 4.81 13.09 76.36 5.76 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER B 265 SER.? 18.70 ZN ZN B 401 A 154 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 16.10 74.10 3.11 17.18 73.52 5.20 -26.94 101.98 3.65 -27.40 103.69 1.94 coo 16.07 84.71 8.14 15.20 82.81 8.14 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 10.59 77.85 4.81 13.09 76.36 5.76 -33.35 101.79 -1.64 -34.99 103.61 0.18 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 5 hits 1o98_c00 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 315 LYS~? 18.17 ZN ZN B 401 A 208 GLN A 274 GLN.? 26.07 ZN ZN B 401 A 209 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -34.74 90.10 -12.94 -36.29 89.21 -14.09 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 208 GLN B 216 GLN~? 45.02 ZN ZN B 402 A 209 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -79.83 92.90 41.31 -78.63 91.23 40.74 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS B 315 LYS~? 18.28 ZN ZN A 402 A 208 GLN B 274 GLN.? 26.97 ZN ZN A 402 A 209 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -26.92 118.19 15.60 -27.10 120.29 15.87 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -24.21 116.63 19.13 -19.07 117.25 20.30 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 315 LYS~? 18.17 ZN ZN B 401 B 208 GLN A 274 GLN.? 26.07 ZN ZN B 401 B 209 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 105.03 46.01 19.55 106.59 42.35 15.55 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 113.93 46.99 13.56 113.37 48.52 14.95 -34.74 90.10 -12.94 -36.29 89.21 -14.09 coo 115.66 49.12 8.60 111.19 49.52 4.73 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS B 315 LYS~? 18.28 ZN ZN A 402 B 208 GLN B 274 GLN.? 26.97 ZN ZN A 402 B 209 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 105.03 46.01 19.55 106.59 42.35 15.55 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 113.93 46.99 13.56 113.37 48.52 14.95 -26.92 118.19 15.60 -27.10 120.29 15.87 coo 115.66 49.12 8.60 111.19 49.52 4.73 -24.21 116.63 19.13 -19.07 117.25 20.30 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 2 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS B 149 LYS~? 48.62 ZN ZN B 402 C 208 GLN B 216 GLN~? 45.02 ZN ZN B 402 C 209 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -79.83 92.90 41.31 -78.63 91.23 40.74 coo 113.62 1.19 33.65 109.52 3.92 36.47 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS B 315 LYS~? 18.28 ZN ZN A 402 C 208 GLN B 274 GLN.? 26.97 ZN ZN A 402 C 209 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -26.92 118.19 15.60 -27.10 120.29 15.87 coo 113.62 1.19 33.65 109.52 3.92 36.47 -24.21 116.63 19.13 -19.07 117.25 20.30 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 2 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 1.87 119.38 16.45 1.41 122.11 16.84 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 A 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 1.87 119.38 16.45 1.41 122.11 16.84 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 A 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 1.87 119.38 16.45 1.41 122.11 16.84 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 A 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 1.87 119.38 16.45 1.41 122.11 16.84 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 1.87 119.38 16.45 1.41 122.11 16.84 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 A 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 1.87 119.38 16.45 1.41 122.11 16.84 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 A 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 1.87 119.38 16.45 1.41 122.11 16.84 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 A 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 1.87 119.38 16.45 1.41 122.11 16.84 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 A 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 1.87 119.38 16.45 1.41 122.11 16.84 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 B 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 B 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 B 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 B 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 B 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 B 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 B 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 B 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 B 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 B 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 C 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 C 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 C 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 C 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 C 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 C 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 C 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 C 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 C 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 C 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 C 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 C 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 C 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 C 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 C 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 C 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 D 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 D 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 D 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 D 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 D 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 D 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 D 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 D 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 D 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 D 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 D 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 D 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 D 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 D 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 D 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 D 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 E 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 E 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 E 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 E 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 E 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 E 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 E 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 E 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 E 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 E 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 E 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 E 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 E 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 E 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 E 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 E 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 F 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 F 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 F 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 F 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 F 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 F 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 F 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 F 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 F 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 F 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 F 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 F 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 F 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 F 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 F 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 F 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 G 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 G 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 G 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 G 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 G 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 G 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 G 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 G 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 G 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 G 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 G 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 G 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 G 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 G 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 G 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 G 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 G 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 G 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 H 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 H 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 H 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 H 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 H 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 H 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 H 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 H 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 H 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 H 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 H 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 H 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 H 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 H 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 H 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 H 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 H 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 H 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 I 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 I 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 I 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 I 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 I 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 I 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 I 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 I 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 I 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 I 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 I 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 I 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 I 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 I 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 I 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 I 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 I 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 I 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 44 ASP.? 7.09 ZN ZN A 402 J 146 TYR A 330 TYR~? 12.28 ZN ZN A 402 J 177 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 J 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 J 177 LYS A 133 LYS^? 35.89 ZN ZN A 401 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -61.15 120.63 -37.55 -60.60 115.73 -40.56 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 J 146 TYR A 132 TYR^? 30.56 ZN ZN A 401 J 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP A 129 ASP^? 19.65 ZN ZN A 401 J 146 TYR A 205 TYR~? 27.31 ZN ZN A 401 J 177 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -55.75 130.32 -28.70 -53.61 130.45 -30.51 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP B 44 ASP.? 7.11 ZN ZN B 401 J 146 TYR B 330 TYR~? 12.23 ZN ZN B 401 J 177 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -34.63 93.02 10.28 -32.00 93.52 11.20 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 J 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 J 177 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 J 146 TYR B 132 TYR^? 30.83 ZN ZN B 402 J 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -67.13 105.92 32.85 -67.85 106.57 30.23 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP B 129 ASP^? 19.14 ZN ZN B 402 J 146 TYR B 205 TYR.? 27.03 ZN ZN B 402 J 177 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -65.21 96.58 29.25 -63.97 94.97 31.18 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP B 148 ASP~? 45.03 ZN ZN B 402 J 146 TYR B 161 TYR^? 41.82 ZN ZN B 402 J 177 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -70.80 108.71 48.92 -67.91 112.78 45.19 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A -1 ASP.? 33.70 ZN ZN A 401 A 96 GLU A 347 GLU~? 25.70 ZN ZN A 401 A 132 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 31.23 12.29 16.44 30.82 11.56 18.39 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 26.82 3.20 24.36 27.99 4.86 24.98 -34.82 134.94 -29.37 -35.77 133.46 -30.53 coo 29.99 0.62 22.18 30.38 6.69 20.81 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 96 GLU A 35 GLU.? 32.19 ZN ZN A 401 A 132 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 31.23 12.29 16.44 30.82 11.56 18.39 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 26.82 3.20 24.36 27.99 4.86 24.98 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 29.99 0.62 22.18 30.38 6.69 20.81 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 96 GLU A 229 GLU^? 28.63 ZN ZN A 401 A 132 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 31.23 12.29 16.44 30.82 11.56 18.39 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 26.82 3.20 24.36 27.99 4.86 24.98 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 29.99 0.62 22.18 30.38 6.69 20.81 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 96 GLU A 243 GLU^? 24.16 ZN ZN A 401 A 132 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 31.23 12.29 16.44 30.82 11.56 18.39 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 26.82 3.20 24.36 27.99 4.86 24.98 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 29.99 0.62 22.18 30.38 6.69 20.81 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 96 GLU A 243 GLU^? 24.16 ZN ZN A 401 A 132 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 31.23 12.29 16.44 30.82 11.56 18.39 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 26.82 3.20 24.36 27.99 4.86 24.98 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 29.99 0.62 22.18 30.38 6.69 20.81 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 96 GLU A 35 GLU.? 32.19 ZN ZN A 401 A 132 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 31.23 12.29 16.44 30.82 11.56 18.39 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 26.82 3.20 24.36 27.99 4.86 24.98 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 29.99 0.62 22.18 30.38 6.69 20.81 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 96 GLU A 334 GLU~? 17.80 ZN ZN A 401 A 132 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 31.23 12.29 16.44 30.82 11.56 18.39 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 26.82 3.20 24.36 27.99 4.86 24.98 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 29.99 0.62 22.18 30.38 6.69 20.81 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 96 GLU B 35 GLU.? 31.39 ZN ZN B 402 A 132 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 31.23 12.29 16.44 30.82 11.56 18.39 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 26.82 3.20 24.36 27.99 4.86 24.98 -52.36 70.88 17.88 -52.36 69.23 19.26 coo 29.99 0.62 22.18 30.38 6.69 20.81 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 96 GLU B 243 GLU^? 24.39 ZN ZN B 402 A 132 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 31.23 12.29 16.44 30.82 11.56 18.39 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 26.82 3.20 24.36 27.99 4.86 24.98 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 29.99 0.62 22.18 30.38 6.69 20.81 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 96 GLU B 243 GLU^? 24.39 ZN ZN B 402 A 132 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 31.23 12.29 16.44 30.82 11.56 18.39 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 26.82 3.20 24.36 27.99 4.86 24.98 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 29.99 0.62 22.18 30.38 6.69 20.81 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1onr_c00 TRANSALDOLASE B user 11 3 # 11 A 17 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 96 GLU B 35 GLU.? 31.39 ZN ZN B 402 A 132 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 31.23 12.29 16.44 30.82 11.56 18.39 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 26.82 3.20 24.36 27.99 4.86 24.98 -52.36 70.88 17.88 -52.36 69.23 19.26 coo 29.99 0.62 22.18 30.38 6.69 20.81 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1onr_c00 TRANSALDOLASE B user 12 3 # 12 A 17 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 96 GLU B 334 GLU~? 17.83 ZN ZN B 402 A 132 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 31.23 12.29 16.44 30.82 11.56 18.39 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 26.82 3.20 24.36 27.99 4.86 24.98 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.73 88.63 14.36 -36.14 88.00 9.08 1onr_c00 source 1onr TRANSALDOLASE B : 12 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A -1 ASP.? 33.70 ZN ZN A 401 B 96 GLU A 347 GLU~? 25.70 ZN ZN A 401 B 132 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 26.69 48.45 7.18 27.85 50.13 7.74 -34.82 134.94 -29.37 -35.77 133.46 -30.53 coo 29.82 45.80 5.07 30.26 51.81 3.56 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 91 ASP.? 28.84 ZN ZN A 402 B 96 GLU A 35 GLU.? 32.19 ZN ZN A 401 B 132 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 26.69 48.45 7.18 27.85 50.13 7.74 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 29.82 45.80 5.07 30.26 51.81 3.56 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 203 ASP.? 24.56 ZN ZN A 401 B 96 GLU A 229 GLU^? 28.63 ZN ZN A 401 B 132 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 26.69 48.45 7.18 27.85 50.13 7.74 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 29.82 45.80 5.07 30.26 51.81 3.56 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP A 256 ASP~? 22.47 ZN ZN A 401 B 96 GLU A 243 GLU^? 24.16 ZN ZN A 401 B 132 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 26.69 48.45 7.18 27.85 50.13 7.74 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 29.82 45.80 5.07 30.26 51.81 3.56 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP A 256 ASP~? 22.47 ZN ZN A 401 B 96 GLU A 243 GLU^? 24.16 ZN ZN A 401 B 132 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 26.69 48.45 7.18 27.85 50.13 7.74 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 29.82 45.80 5.07 30.26 51.81 3.56 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP A 352 ASP.? 27.02 ZN ZN A 401 B 96 GLU A 35 GLU.? 32.19 ZN ZN A 401 B 132 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 26.69 48.45 7.18 27.85 50.13 7.74 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 29.82 45.80 5.07 30.26 51.81 3.56 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP A 352 ASP.? 27.02 ZN ZN A 401 B 96 GLU A 334 GLU~? 17.80 ZN ZN A 401 B 132 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 26.69 48.45 7.18 27.85 50.13 7.74 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 29.82 45.80 5.07 30.26 51.81 3.56 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP B 91 ASP.? 28.82 ZN ZN B 401 B 96 GLU B 35 GLU.? 31.39 ZN ZN B 402 B 132 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 26.69 48.45 7.18 27.85 50.13 7.74 -52.36 70.88 17.88 -52.36 69.23 19.26 coo 29.82 45.80 5.07 30.26 51.81 3.56 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP B 256 ASP~? 22.51 ZN ZN B 402 B 96 GLU B 243 GLU^? 24.39 ZN ZN B 402 B 132 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 26.69 48.45 7.18 27.85 50.13 7.74 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 29.82 45.80 5.07 30.26 51.81 3.56 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP B 256 ASP~? 22.51 ZN ZN B 402 B 96 GLU B 243 GLU^? 24.39 ZN ZN B 402 B 132 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 26.69 48.45 7.18 27.85 50.13 7.74 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 29.82 45.80 5.07 30.26 51.81 3.56 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 1onr_c01 TRANSALDOLASE B user 11 3 # 11 B 17 ASP B 352 ASP.? 26.97 ZN ZN B 402 B 96 GLU B 35 GLU.? 31.39 ZN ZN B 402 B 132 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 26.69 48.45 7.18 27.85 50.13 7.74 -52.36 70.88 17.88 -52.36 69.23 19.26 coo 29.82 45.80 5.07 30.26 51.81 3.56 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1onr_c01 TRANSALDOLASE B user 12 3 # 12 B 17 ASP B 352 ASP.? 26.97 ZN ZN B 402 B 96 GLU B 334 GLU~? 17.83 ZN ZN B 402 B 132 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 26.69 48.45 7.18 27.85 50.13 7.74 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.73 88.63 14.36 -36.14 88.00 9.08 1onr_c01 source 1onr TRANSALDOLASE B : 12 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 17 SER~? 16.79 ZN ZN A 401 A 239 VAL A 14 VAL~? 12.56 ZN ZN A 401 A 413 ASN A 100 ASN~? 9.95 ZN ZN A 401 coo 80.14 40.76 52.28 77.73 40.59 51.94 -49.61 124.95 -19.53 -49.72 125.00 -21.92 coo 75.67 35.37 52.30 76.00 35.96 50.23 -41.38 124.40 -22.30 -39.86 123.55 -20.93 coo 81.75 35.21 52.13 80.92 37.12 51.69 -44.05 122.82 -17.82 -42.95 124.35 -16.78 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER B 17 SER~? 16.82 ZN ZN B 402 A 239 VAL B 14 VAL~? 12.52 ZN ZN B 402 A 413 ASN B 100 ASN~? 9.88 ZN ZN B 402 coo 80.14 40.76 52.28 77.73 40.59 51.94 -57.40 96.88 20.57 -57.44 97.10 23.00 coo 75.67 35.37 52.30 76.00 35.96 50.23 -50.03 93.03 23.11 -48.21 92.90 21.76 coo 81.75 35.21 52.13 80.92 37.12 51.69 -51.48 95.86 18.73 -51.39 94.02 17.58 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 2 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 17 SER~? 16.79 ZN ZN A 401 B 239 VAL A 14 VAL~? 12.56 ZN ZN A 401 B 413 ASN A 100 ASN~? 9.95 ZN ZN A 401 coo 25.22 6.41 2.90 27.67 6.33 3.11 -49.61 124.95 -19.53 -49.72 125.00 -21.92 coo 29.71 1.00 2.66 29.43 1.57 4.74 -41.38 124.40 -22.30 -39.86 123.55 -20.93 coo 23.72 0.88 2.95 24.56 2.79 3.34 -44.05 122.82 -17.82 -42.95 124.35 -16.78 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER B 17 SER~? 16.82 ZN ZN B 402 B 239 VAL B 14 VAL~? 12.52 ZN ZN B 402 B 413 ASN B 100 ASN~? 9.88 ZN ZN B 402 coo 25.22 6.41 2.90 27.67 6.33 3.11 -57.40 96.88 20.57 -57.44 97.10 23.00 coo 29.71 1.00 2.66 29.43 1.57 4.74 -50.03 93.03 23.11 -48.21 92.90 21.76 coo 23.72 0.88 2.95 24.56 2.79 3.34 -51.48 95.86 18.73 -51.39 94.02 17.58 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 2 hits 1oqz_c01 naa= 3 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 1 3 # 1 191 HIS A 326 HIS~? -3.60 ZN ZN A 402s 194 ASN A 325 ASN~? 12.89 ZN ZN A 402 196 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 40.21 70.60 24.49 39.36 69.94 22.74 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 39.62 68.39 19.02 38.50 66.72 19.87 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 40.89 73.30 19.79 38.36 73.12 18.60 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 2 3 # 2 191 HIS B 308 HIS~? 6.54 ZN ZN A 402 194 ASN A 325 ASN~? 12.89 ZN ZN A 402 196 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 40.21 70.60 24.49 39.36 69.94 22.74 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 39.62 68.39 19.02 38.50 66.72 19.87 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 40.89 73.30 19.79 38.36 73.12 18.60 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 3 3 # 3 191 HIS B 326 HIS~? -3.48 ZN ZN B 401s 194 ASN B 325 ASN~? 12.86 ZN ZN B 401 196 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 40.21 70.60 24.49 39.36 69.94 22.74 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 39.62 68.39 19.02 38.50 66.72 19.87 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 40.89 73.30 19.79 38.36 73.12 18.60 -35.81 95.23 5.63 -35.48 92.50 6.11 1oya_c00 source 1oya OLD YELLOW ENZYME (OXIDIZED) (OYE) (E.C.1.6.99: 3 hits 1oya_c00 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A -1 ASP.? 33.70 ZN ZN A 401 A 247 ASP A 5 ASP~? 27.21 ZN ZN A 401 A 342 GLU A 347 GLU~? 25.70 ZN ZN A 401 coo 44.36 35.68 9.71 43.29 36.20 11.51 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 41.40 28.81 12.91 40.82 30.90 12.97 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 40.37 33.11 18.06 39.99 34.93 17.06 -34.82 134.94 -29.37 -35.77 133.46 -30.53 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 247 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 342 GLU A 251 GLU~? 26.78 ZN ZN B 401 coo 44.36 35.68 9.71 43.29 36.20 11.51 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 41.40 28.81 12.91 40.82 30.90 12.97 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 40.37 33.11 18.06 39.99 34.93 17.06 -25.70 93.68 -9.35 -24.99 91.85 -8.59 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 247 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 342 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 44.36 35.68 9.71 43.29 36.20 11.51 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 41.40 28.81 12.91 40.82 30.90 12.97 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 40.37 33.11 18.06 39.99 34.93 17.06 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1oyg_c00 LEVANSUCRASE user 4 3 # 4 A 86 ASP B -1 ASP.? 32.96 ZN ZN B 402 A 247 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 342 GLU B 347 GLU~? 25.41 ZN ZN B 402 coo 44.36 35.68 9.71 43.29 36.20 11.51 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 41.40 28.81 12.91 40.82 30.90 12.97 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 40.37 33.11 18.06 39.99 34.93 17.06 -50.18 80.14 30.04 -50.60 82.14 30.54 ULMN 3 1oyg_c00 LEVANSUCRASE user 5 3 # 5 A 86 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 247 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 342 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 44.36 35.68 9.71 43.29 36.20 11.51 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 41.40 28.81 12.91 40.82 30.90 12.97 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 40.37 33.11 18.06 39.99 34.93 17.06 -20.38 111.90 11.61 -18.92 112.78 10.34 1oyg_c00 source 1oyg LEVANSUCRASE : 5 hits 1oyg_c00 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 328 SER~? 11.01 ZN ZN A 402 A 708 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 740 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 328 SER~? 10.89 ZN ZN B 401 A 708 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 740 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -40.92 100.43 6.30 -42.93 100.06 6.77 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 328 SER~? 11.01 ZN ZN A 402 B 708 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 740 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 4.44 13.29 37.64 6.01 11.66 38.49 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 6.39 7.18 30.33 6.92 8.20 32.17 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 8.57 10.09 34.47 7.10 10.73 35.82 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 328 SER~? 10.89 ZN ZN B 401 B 708 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 740 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 4.44 13.29 37.64 6.01 11.66 38.49 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 6.39 7.18 30.33 6.92 8.20 32.17 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 8.57 10.09 34.47 7.10 10.73 35.82 -40.92 100.43 6.30 -42.93 100.06 6.77 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 63 SER^? 10.35 ZN ZN A 402 A 709 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 740 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER A 285 SER.? 7.68 ZN ZN A 402 A 709 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 740 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER B 63 SER^? 10.37 ZN ZN B 401 A 709 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 740 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -46.04 88.60 10.98 -47.67 89.08 9.23 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER B 285 SER.? 7.72 ZN ZN B 401 A 709 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 740 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -40.92 100.43 6.30 -42.93 100.06 6.77 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 4 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 63 SER^? 10.35 ZN ZN A 402 B 709 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 740 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 4.44 13.29 37.64 6.01 11.66 38.49 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 10.26 2.81 31.69 11.64 4.30 32.43 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 8.57 10.09 34.47 7.10 10.73 35.82 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 63 SER^? 10.35 ZN ZN A 402 B 709 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 740 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 4.44 13.29 37.64 6.01 11.66 38.49 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 10.26 2.81 31.69 11.64 4.30 32.43 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 8.57 10.09 34.47 7.10 10.73 35.82 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER A 285 SER.? 7.68 ZN ZN A 402 B 709 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 740 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 4.44 13.29 37.64 6.01 11.66 38.49 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 10.26 2.81 31.69 11.64 4.30 32.43 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 8.57 10.09 34.47 7.10 10.73 35.82 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER A 285 SER.? 7.68 ZN ZN A 402 B 709 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 740 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 4.44 13.29 37.64 6.01 11.66 38.49 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 10.26 2.81 31.69 11.64 4.30 32.43 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 8.57 10.09 34.47 7.10 10.73 35.82 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER A 328 SER~? 11.01 ZN ZN A 402 B 709 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 740 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 4.44 13.29 37.64 6.01 11.66 38.49 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 10.26 2.81 31.69 11.64 4.30 32.43 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 8.57 10.09 34.47 7.10 10.73 35.82 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER B 63 SER^? 10.37 ZN ZN B 401 B 709 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 740 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 4.44 13.29 37.64 6.01 11.66 38.49 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 10.26 2.81 31.69 11.64 4.30 32.43 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 8.57 10.09 34.47 7.10 10.73 35.82 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER B 63 SER^? 10.37 ZN ZN B 401 B 709 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 740 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 4.44 13.29 37.64 6.01 11.66 38.49 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 10.26 2.81 31.69 11.64 4.30 32.43 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 8.57 10.09 34.47 7.10 10.73 35.82 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER B 285 SER.? 7.72 ZN ZN B 401 B 709 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 740 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 4.44 13.29 37.64 6.01 11.66 38.49 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 10.26 2.81 31.69 11.64 4.30 32.43 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 8.57 10.09 34.47 7.10 10.73 35.82 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 9 3 # 9 B 630 SER B 285 SER.? 7.72 ZN ZN B 401 B 709 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 740 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 4.44 13.29 37.64 6.01 11.66 38.49 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 10.26 2.81 31.69 11.64 4.30 32.43 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 8.57 10.09 34.47 7.10 10.73 35.82 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 10 3 # 10 B 630 SER B 328 SER~? 10.89 ZN ZN B 401 B 709 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 740 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 4.44 13.29 37.64 6.01 11.66 38.49 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 10.26 2.81 31.69 11.64 4.30 32.43 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 8.57 10.09 34.47 7.10 10.73 35.82 -40.92 100.43 6.30 -42.93 100.06 6.77 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 10 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 259 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 552 ASP B 129 ASP^? 19.14 ZN ZN B 402 coo 11.34 95.90 25.54 12.13 96.42 23.67 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 14.91 97.39 18.63 13.39 95.60 20.20 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 46.37 82.54 38.83 45.97 84.66 38.77 -57.17 104.15 28.46 -55.58 103.29 27.35 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 259 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 552 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 11.34 95.90 25.54 12.13 96.42 23.67 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 14.91 97.39 18.63 13.39 95.60 20.20 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 46.37 82.54 38.83 45.97 84.66 38.77 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 259 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 552 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 11.34 95.90 25.54 12.13 96.42 23.67 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 14.91 97.39 18.63 13.39 95.60 20.20 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 46.37 82.54 38.83 45.97 84.66 38.77 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 259 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 552 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 11.34 95.90 25.54 12.13 96.42 23.67 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 14.91 97.39 18.63 13.39 95.60 20.20 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 46.37 82.54 38.83 45.97 84.66 38.77 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 259 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 552 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 11.34 95.90 25.54 12.13 96.42 23.67 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 14.91 97.39 18.63 13.39 95.60 20.20 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 46.37 82.54 38.83 45.97 84.66 38.77 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 259 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 552 ASP A -1 ASP.? 33.70 ZN ZN A 401 coo 11.34 95.90 25.54 12.13 96.42 23.67 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 14.91 97.39 18.63 13.39 95.60 20.20 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 -34.17 145.98 -27.25 -35.93 146.68 -26.30 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 7 3 # 7 A 225 HIS B 218 HIS~? 47.61 ZN ZN B 402 A 259 TYR B 137 TYR^? 46.12 ZN ZN B 402 A 552 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 11.34 95.90 25.54 12.13 96.42 23.67 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 14.91 97.39 18.63 13.39 95.60 20.20 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 46.37 82.54 38.83 45.97 84.66 38.77 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 8 3 # 8 A 225 HIS B 218 HIS~? 47.61 ZN ZN B 402 A 259 TYR B 217 TYR~? 45.33 ZN ZN B 402 A 552 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 11.34 95.90 25.54 12.13 96.42 23.67 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 14.91 97.39 18.63 13.39 95.60 20.20 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 46.37 82.54 38.83 45.97 84.66 38.77 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 9 3 # 9 A 225 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 259 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 552 ASP A -1 ASP.? 33.70 ZN ZN A 401 coo 11.34 95.90 25.54 12.13 96.42 23.67 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 14.91 97.39 18.63 13.39 95.60 20.20 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 -34.17 145.98 -27.25 -35.93 146.68 -26.30 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 10 3 # 10 A 225 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 259 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 552 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 11.34 95.90 25.54 12.13 96.42 23.67 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 14.91 97.39 18.63 13.39 95.60 20.20 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 46.37 82.54 38.83 45.97 84.66 38.77 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 11 3 # 11 A 225 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 259 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 552 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 11.34 95.90 25.54 12.13 96.42 23.67 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 14.91 97.39 18.63 13.39 95.60 20.20 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 46.37 82.54 38.83 45.97 84.66 38.77 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 12 3 # 12 A 225 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 259 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 552 ASP A 129 ASP^? 19.65 ZN ZN A 401 coo 11.34 95.90 25.54 12.13 96.42 23.67 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 14.91 97.39 18.63 13.39 95.60 20.20 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 -52.93 118.26 -28.24 -51.00 118.44 -27.37 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 13 3 # 13 A 225 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 259 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 552 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 11.34 95.90 25.54 12.13 96.42 23.67 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 14.91 97.39 18.63 13.39 95.60 20.20 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 14 3 # 14 A 225 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 259 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 552 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 11.34 95.90 25.54 12.13 96.42 23.67 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 14.91 97.39 18.63 13.39 95.60 20.20 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 -36.54 95.17 -18.71 -36.75 94.18 -20.57 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 14 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 A 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 A 158 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 A 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 A 158 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 A 126 LEU A 43 LEU.? 6.88 ZN ZN A 402 A 158 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -32.46 120.53 -8.10 -33.63 118.65 -7.87 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 53 ALA~? 20.65 ZN ZN A 402 A 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 A 158 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -26.69 133.97 -7.40 -28.24 134.00 -7.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 113 ALA~? 14.03 ZN ZN A 401 A 126 LEU A 118 LEU.? 17.93 ZN ZN A 401 A 158 GLU A 243 GLU^? 24.16 ZN ZN A 401 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -31.81 108.96 -20.05 -32.90 108.80 -21.03 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -30.67 105.34 -22.45 -30.63 104.16 -20.59 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -33.02 100.94 -26.53 -34.09 99.87 -28.01 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 126 LEU A 321 LEU^? 17.19 ZN ZN A 402 A 158 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -38.24 99.25 -8.68 -40.42 99.39 -8.43 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA A 355 ALA^? 16.20 ZN ZN A 401 A 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 A 158 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.75 125.60 -13.37 -25.45 124.21 -13.86 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 A 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 A 158 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 A 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 A 158 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 A 126 LEU B 43 LEU.? 6.82 ZN ZN B 401 A 158 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -40.65 91.81 8.75 -40.59 94.01 8.67 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA B 53 ALA~? 20.77 ZN ZN B 401 A 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 A 158 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -42.94 77.21 7.81 -44.21 78.04 8.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA B 113 ALA~? 14.04 ZN ZN B 402 A 126 LEU B 118 LEU.? 17.96 ZN ZN B 402 A 158 GLU B 243 GLU^? 24.39 ZN ZN B 402 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -33.76 101.16 20.95 -34.69 101.89 21.96 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -30.73 103.70 23.32 -30.35 104.63 21.37 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -30.57 108.69 27.52 -30.74 110.20 29.01 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 126 LEU B 321 LEU^? 17.10 ZN ZN B 401 A 158 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -34.15 112.90 9.63 -36.13 113.84 9.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA B 355 ALA^? 16.21 ZN ZN B 402 A 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 A 158 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -37.64 83.78 14.03 -36.69 84.81 14.61 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -38.47 79.19 7.21 -37.79 81.13 7.79 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 14 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 B 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 B 158 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 B 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 B 158 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 B 126 LEU A 43 LEU.? 6.88 ZN ZN A 402 B 158 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -32.46 120.53 -8.10 -33.63 118.65 -7.87 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 53 ALA~? 20.65 ZN ZN A 402 B 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 B 158 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -26.69 133.97 -7.40 -28.24 134.00 -7.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 113 ALA~? 14.03 ZN ZN A 401 B 126 LEU A 118 LEU.? 17.93 ZN ZN A 401 B 158 GLU A 243 GLU^? 24.16 ZN ZN A 401 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -31.81 108.96 -20.05 -32.90 108.80 -21.03 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -30.67 105.34 -22.45 -30.63 104.16 -20.59 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -33.02 100.94 -26.53 -34.09 99.87 -28.01 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA A 311 ALA~? 12.40 ZN ZN B 401 B 126 LEU A 321 LEU^? 17.19 ZN ZN A 402 B 158 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -38.24 99.25 -8.68 -40.42 99.39 -8.43 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA A 355 ALA^? 16.20 ZN ZN A 401 B 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 B 158 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.75 125.60 -13.37 -25.45 124.21 -13.86 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 B 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 B 158 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 B 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 B 158 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 B 126 LEU B 43 LEU.? 6.82 ZN ZN B 401 B 158 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -40.65 91.81 8.75 -40.59 94.01 8.67 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA B 53 ALA~? 20.77 ZN ZN B 401 B 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 B 158 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -42.94 77.21 7.81 -44.21 78.04 8.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA B 113 ALA~? 14.04 ZN ZN B 402 B 126 LEU B 118 LEU.? 17.96 ZN ZN B 402 B 158 GLU B 243 GLU^? 24.39 ZN ZN B 402 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -33.76 101.16 20.95 -34.69 101.89 21.96 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -30.73 103.70 23.32 -30.35 104.63 21.37 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -30.57 108.69 27.52 -30.74 110.20 29.01 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA B 311 ALA~? 12.53 ZN ZN A 402 B 126 LEU B 321 LEU^? 17.10 ZN ZN B 401 B 158 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -34.15 112.90 9.63 -36.13 113.84 9.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA B 355 ALA^? 16.21 ZN ZN B 402 B 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 B 158 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -37.64 83.78 14.03 -36.69 84.81 14.61 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -42.47 80.64 11.47 -40.75 80.68 10.12 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -38.47 79.19 7.21 -37.79 81.13 7.79 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 14 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 C 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 C 158 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 C 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 C 158 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 42 ALA^? 12.34 ZN ZN A 402 C 126 LEU A 43 LEU.? 6.88 ZN ZN A 402 C 158 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -32.46 120.53 -8.10 -33.63 118.65 -7.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 53 ALA~? 20.65 ZN ZN A 402 C 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 C 158 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -26.69 133.97 -7.40 -28.24 134.00 -7.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 113 ALA~? 14.03 ZN ZN A 401 C 126 LEU A 118 LEU.? 17.93 ZN ZN A 401 C 158 GLU A 243 GLU^? 24.16 ZN ZN A 401 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -31.81 108.96 -20.05 -32.90 108.80 -21.03 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.67 105.34 -22.45 -30.63 104.16 -20.59 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -33.02 100.94 -26.53 -34.09 99.87 -28.01 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 311 ALA~? 12.40 ZN ZN B 401 C 126 LEU A 321 LEU^? 17.19 ZN ZN A 402 C 158 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -38.24 99.25 -8.68 -40.42 99.39 -8.43 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA A 355 ALA^? 16.20 ZN ZN A 401 C 126 LEU A 40 LEU^? 18.32 ZN ZN A 402 C 158 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.75 125.60 -13.37 -25.45 124.21 -13.86 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -28.16 130.78 -11.00 -26.73 129.94 -9.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 C 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 C 158 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -42.47 80.64 11.47 -40.75 80.68 10.12 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 C 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 C 158 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -42.47 80.64 11.47 -40.75 80.68 10.12 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 42 ALA^? 12.31 ZN ZN B 401 C 126 LEU B 43 LEU.? 6.82 ZN ZN B 401 C 158 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -40.65 91.81 8.75 -40.59 94.01 8.67 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA B 53 ALA~? 20.77 ZN ZN B 401 C 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 C 158 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -42.94 77.21 7.81 -44.21 78.04 8.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -42.47 80.64 11.47 -40.75 80.68 10.12 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA B 113 ALA~? 14.04 ZN ZN B 402 C 126 LEU B 118 LEU.? 17.96 ZN ZN B 402 C 158 GLU B 243 GLU^? 24.39 ZN ZN B 402 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -33.76 101.16 20.95 -34.69 101.89 21.96 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.73 103.70 23.32 -30.35 104.63 21.37 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -30.57 108.69 27.52 -30.74 110.20 29.01 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA B 311 ALA~? 12.53 ZN ZN A 402 C 126 LEU B 321 LEU^? 17.10 ZN ZN B 401 C 158 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -34.15 112.90 9.63 -36.13 113.84 9.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA B 355 ALA^? 16.21 ZN ZN B 402 C 126 LEU B 40 LEU^? 18.40 ZN ZN B 401 C 158 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -37.64 83.78 14.03 -36.69 84.81 14.61 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -42.47 80.64 11.47 -40.75 80.68 10.12 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -38.47 79.19 7.21 -37.79 81.13 7.79 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 14 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 270 LYS A 275 LYS^? 30.46 ZN ZN A 401 A 382 MET A 116 MET~? 14.45 ZN ZN A 401 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -27.36 107.17 -18.44 -30.84 106.22 -16.40 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 270 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 382 MET A 111 MET~? 9.64 ZN ZN A 401 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -31.92 114.42 -19.41 -32.73 118.27 -18.08 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 270 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 382 MET A 241 MET^? 18.08 ZN ZN A 401 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -38.84 104.75 -22.44 -40.00 101.63 -21.58 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 270 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 382 MET A 241 MET^? 18.08 ZN ZN A 401 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -38.84 104.75 -22.44 -40.00 101.63 -21.58 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 270 LYS A 56 LYS~? 22.91 ZN ZN A 402 A 382 MET A 1 MET.? 23.48 ZN ZN A 401 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -34.05 141.05 -22.04 -33.75 136.86 -21.88 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 270 LYS A 337 LYS~? 20.91 ZN ZN A 401 A 382 MET A 1 MET.? 23.48 ZN ZN A 401 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -34.05 141.05 -22.04 -33.75 136.86 -21.88 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 7 3 # 7 A 248 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 270 LYS B 277 LYS^? 26.47 ZN ZN B 402 A 382 MET B 110 MET~? 14.90 ZN ZN B 402 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -23.71 105.07 26.59 -24.46 103.20 27.20 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -28.04 112.73 23.24 -26.21 110.17 27.80 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -38.37 99.21 22.44 -37.41 98.89 25.50 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 8 3 # 8 A 248 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 270 LYS B 275 LYS^? 32.38 ZN ZN B 402 A 382 MET B 116 MET~? 14.46 ZN ZN B 402 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -20.29 109.25 15.64 -18.38 109.99 15.02 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -24.21 116.63 19.13 -19.07 117.25 20.30 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -29.07 100.36 19.21 -31.52 102.97 17.24 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 9 3 # 9 A 248 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 270 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 382 MET B 111 MET~? 9.78 ZN ZN B 402 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -36.71 96.50 20.31 -39.36 93.71 18.94 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 10 3 # 10 A 248 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 270 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 382 MET B 241 MET^? 18.03 ZN ZN B 402 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -37.55 108.36 23.42 -36.92 111.66 22.54 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 11 3 # 11 A 248 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 270 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 382 MET B 241 MET^? 18.03 ZN ZN B 402 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -37.55 108.36 23.42 -36.92 111.66 22.54 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 12 3 # 12 A 248 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 270 LYS B 56 LYS~? 22.19 ZN ZN B 401 A 382 MET B 1 MET.? 23.52 ZN ZN B 402 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -40.15 73.23 9.47 -36.32 78.07 10.66 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -52.87 74.99 22.48 -50.39 78.40 22.42 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 13 3 # 13 A 248 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 270 LYS B 337 LYS~? 20.93 ZN ZN B 402 A 382 MET B 1 MET.? 23.52 ZN ZN B 402 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -40.82 74.97 18.30 -40.24 73.02 18.95 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -39.69 85.19 19.25 -35.37 81.01 18.46 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -52.87 74.99 22.48 -50.39 78.40 22.42 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 13 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 256 ASP~? 22.47 ZN ZN A 401 B 270 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 382 MET A 111 MET~? 9.64 ZN ZN A 401 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -31.92 114.42 -19.41 -32.73 118.27 -18.08 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP B 256 ASP~? 22.51 ZN ZN B 402 B 270 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 382 MET B 111 MET~? 9.78 ZN ZN B 402 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -23.25 103.81 16.30 -22.99 102.51 17.90 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -36.71 96.50 20.31 -39.36 93.71 18.94 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 364 GLN^? 21.84 ZN ZN A 402 294 GLU B 271 GLU.? 25.84 ZN ZN A 402 304 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 15.89 18.45 46.53 15.82 16.91 48.02 -23.65 112.84 4.68 -22.28 114.13 5.68 coo 22.84 13.44 52.91 20.84 13.18 52.38 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 8.71 17.11 46.51 7.23 17.64 49.20 -31.38 108.30 2.45 -33.79 107.47 0.72 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 1 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 17 SER~? 16.79 ZN ZN A 401 B 69 ALA A 19 ALA~? 10.49 ZN ZN A 401 B 241 ASN A 100 ASN~? 9.95 ZN ZN A 401 coo 13.24 41.94 33.13 13.08 39.54 33.17 -49.61 124.95 -19.53 -49.72 125.00 -21.92 coo 9.15 37.89 36.69 10.55 37.76 37.22 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo 10.91 43.03 38.47 11.81 41.82 36.93 -44.05 122.82 -17.82 -42.95 124.35 -16.78 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 122 SER^? 18.54 ZN ZN A 401 B 69 ALA A 242 ALA^? 17.05 ZN ZN A 401 B 241 ASN A 120 ASN^? 24.40 ZN ZN A 401 coo 13.24 41.94 33.13 13.08 39.54 33.17 -39.13 108.46 -26.41 -40.41 106.51 -26.99 coo 9.15 37.89 36.69 10.55 37.76 37.22 -35.28 104.10 -23.67 -34.41 105.16 -22.99 coo 10.91 43.03 38.47 11.81 41.82 36.93 -34.37 103.73 -29.04 -33.12 102.96 -30.64 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 17 SER~? 16.82 ZN ZN B 402 B 69 ALA B 19 ALA~? 10.41 ZN ZN B 402 B 241 ASN B 100 ASN~? 9.88 ZN ZN B 402 coo 13.24 41.94 33.13 13.08 39.54 33.17 -57.40 96.88 20.57 -57.44 97.10 23.00 coo 9.15 37.89 36.69 10.55 37.76 37.22 -53.87 98.79 16.99 -54.12 97.55 16.16 coo 10.91 43.03 38.47 11.81 41.82 36.93 -51.48 95.86 18.73 -51.39 94.02 17.58 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 122 SER^? 18.54 ZN ZN B 402 B 69 ALA B 242 ALA^? 17.24 ZN ZN B 402 B 241 ASN B 120 ASN^? 24.35 ZN ZN B 402 coo 13.24 41.94 33.13 13.08 39.54 33.17 -39.61 105.40 27.34 -40.83 107.01 28.62 coo 9.15 37.89 36.69 10.55 37.76 37.22 -34.17 107.07 24.62 -33.83 105.72 24.06 coo 10.91 43.03 38.47 11.81 41.82 36.93 -33.10 106.72 29.88 -31.69 106.80 31.50 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 4 hits 1pnl_c00 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 24 ASN.? 14.49 ZN ZN A 402 A 192 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 195 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 2.03 47.14 19.75 1.72 46.26 21.64 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN A 24 ASN.? 14.49 ZN ZN A 402 A 192 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 195 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 2.03 47.14 19.75 1.72 46.26 21.64 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN A 51 ASN~? 22.86 ZN ZN A 402 A 192 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 195 HIS A 90 HIS~? 26.77 ZN ZN A 402 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 2.03 47.14 19.75 1.72 46.26 21.64 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -30.00 140.26 -1.63 -28.87 140.48 0.12 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN A 104 ASN.? 12.54 ZN ZN A 401 A 192 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 195 HIS A 12 HIS~? 21.70 ZN ZN A 401 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 2.03 47.14 19.75 1.72 46.26 21.64 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -41.32 129.27 -28.34 -41.29 128.49 -30.29 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN A 104 ASN.? 12.54 ZN ZN A 401 A 192 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 195 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 2.03 47.14 19.75 1.72 46.26 21.64 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 A 74 ASN A 320 ASN.? 23.41 ZN ZN B 401 A 192 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 195 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -37.23 94.97 -12.31 -37.23 92.90 -12.72 coo 2.03 47.14 19.75 1.72 46.26 21.64 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 A 74 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 192 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 195 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 2.03 47.14 19.75 1.72 46.26 21.64 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 A 74 ASN B 24 ASN.? 14.57 ZN ZN B 401 A 192 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 195 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 2.03 47.14 19.75 1.72 46.26 21.64 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 9 3 # 9 A 74 ASN B 24 ASN.? 14.57 ZN ZN B 401 A 192 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 195 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 2.03 47.14 19.75 1.72 46.26 21.64 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 10 3 # 10 A 74 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 192 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 195 HIS B 90 HIS~? 26.84 ZN ZN B 401 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 2.03 47.14 19.75 1.72 46.26 21.64 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -49.12 73.85 2.19 -48.21 73.06 0.48 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 11 3 # 11 A 74 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 192 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 195 HIS B 12 HIS~? 21.73 ZN ZN B 402 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 2.03 47.14 19.75 1.72 46.26 21.64 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -52.58 88.71 29.10 -52.20 89.31 31.07 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 12 3 # 12 A 74 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 192 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 195 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 2.03 47.14 19.75 1.72 46.26 21.64 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 13 3 # 13 A 74 ASN B 320 ASN.? 23.67 ZN ZN A 402 A 192 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 195 HIS B 317 HIS~? 18.53 ZN ZN A 402 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -31.14 115.93 13.50 -30.16 117.79 13.90 coo 2.03 47.14 19.75 1.72 46.26 21.64 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -38.40 123.74 9.47 -39.77 124.82 8.30 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 14 3 # 14 A 74 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 192 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 195 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 2.03 47.14 19.75 1.72 46.26 21.64 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -45.80 98.45 2.85 -45.82 97.45 4.71 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 14 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 24 ASN.? 14.49 ZN ZN A 402 B 192 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 195 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -1.08 51.41 10.34 0.65 52.62 10.17 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 11.36 52.33 5.59 10.18 53.87 6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.99 56.74 7.55 6.88 55.39 8.70 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN A 24 ASN.? 14.49 ZN ZN A 402 B 192 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 195 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo -1.08 51.41 10.34 0.65 52.62 10.17 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 11.36 52.33 5.59 10.18 53.87 6.47 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 7.99 56.74 7.55 6.88 55.39 8.70 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN A 104 ASN.? 12.54 ZN ZN A 401 B 192 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 195 HIS A 12 HIS~? 21.70 ZN ZN A 401 coo -1.08 51.41 10.34 0.65 52.62 10.17 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 11.36 52.33 5.59 10.18 53.87 6.47 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 7.99 56.74 7.55 6.88 55.39 8.70 -41.32 129.27 -28.34 -41.29 128.49 -30.29 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN A 104 ASN.? 12.54 ZN ZN A 401 B 192 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 195 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo -1.08 51.41 10.34 0.65 52.62 10.17 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 11.36 52.33 5.59 10.18 53.87 6.47 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 7.99 56.74 7.55 6.88 55.39 8.70 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN A 320 ASN.? 23.41 ZN ZN B 401 B 192 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 195 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo -1.08 51.41 10.34 0.65 52.62 10.17 -37.23 94.97 -12.31 -37.23 92.90 -12.72 coo 11.36 52.33 5.59 10.18 53.87 6.47 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 7.99 56.74 7.55 6.88 55.39 8.70 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 B 74 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 192 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 195 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -1.08 51.41 10.34 0.65 52.62 10.17 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 11.36 52.33 5.59 10.18 53.87 6.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.99 56.74 7.55 6.88 55.39 8.70 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 B 74 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 192 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 195 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo -1.08 51.41 10.34 0.65 52.62 10.17 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 11.36 52.33 5.59 10.18 53.87 6.47 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 7.99 56.74 7.55 6.88 55.39 8.70 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 B 74 ASN B 24 ASN.? 14.57 ZN ZN B 401 B 192 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 195 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo -1.08 51.41 10.34 0.65 52.62 10.17 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 11.36 52.33 5.59 10.18 53.87 6.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.99 56.74 7.55 6.88 55.39 8.70 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 9 3 # 9 B 74 ASN B 24 ASN.? 14.57 ZN ZN B 401 B 192 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 195 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo -1.08 51.41 10.34 0.65 52.62 10.17 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 11.36 52.33 5.59 10.18 53.87 6.47 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 7.99 56.74 7.55 6.88 55.39 8.70 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 10 3 # 10 B 74 ASN B 104 ASN.? 12.46 ZN ZN B 402 B 192 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 195 HIS B 12 HIS~? 21.73 ZN ZN B 402 coo -1.08 51.41 10.34 0.65 52.62 10.17 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 11.36 52.33 5.59 10.18 53.87 6.47 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 7.99 56.74 7.55 6.88 55.39 8.70 -52.58 88.71 29.10 -52.20 89.31 31.07 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 11 3 # 11 B 74 ASN B 104 ASN.? 12.46 ZN ZN B 402 B 192 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 195 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo -1.08 51.41 10.34 0.65 52.62 10.17 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 11.36 52.33 5.59 10.18 53.87 6.47 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 7.99 56.74 7.55 6.88 55.39 8.70 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 12 3 # 12 B 74 ASN B 109 ASN~? 6.75 ZN ZN B 402 B 192 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 195 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -1.08 51.41 10.34 0.65 52.62 10.17 -40.37 101.87 19.09 -41.17 102.25 17.16 coo 11.36 52.33 5.59 10.18 53.87 6.47 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.99 56.74 7.55 6.88 55.39 8.70 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 13 3 # 13 B 74 ASN B 320 ASN.? 23.67 ZN ZN A 402 B 192 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 195 HIS B 317 HIS~? 18.53 ZN ZN A 402 coo -1.08 51.41 10.34 0.65 52.62 10.17 -31.14 115.93 13.50 -30.16 117.79 13.90 coo 11.36 52.33 5.59 10.18 53.87 6.47 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 7.99 56.74 7.55 6.88 55.39 8.70 -38.40 123.74 9.47 -39.77 124.82 8.30 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 14 3 # 14 B 74 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 192 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 195 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo -1.08 51.41 10.34 0.65 52.62 10.17 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 11.36 52.33 5.59 10.18 53.87 6.47 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 7.99 56.74 7.55 6.88 55.39 8.70 -45.80 98.45 2.85 -45.82 97.45 4.71 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 14 hits 1pp4_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 321 LEU^? 17.19 ZN ZN A 402 A 58 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 120 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 34.02 69.29 75.26 34.82 67.82 76.74 -38.24 99.25 -8.68 -40.42 99.39 -8.43 coo 34.46 72.45 78.57 32.82 72.75 77.28 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 28.96 77.64 81.19 29.05 74.53 77.51 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU B 321 LEU^? 17.10 ZN ZN B 401 A 58 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 120 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 34.02 69.29 75.26 34.82 67.82 76.74 -34.15 112.90 9.63 -36.13 113.84 9.47 coo 34.46 72.45 78.57 32.82 72.75 77.28 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 28.96 77.64 81.19 29.05 74.53 77.51 -38.53 111.12 1.13 -44.30 110.60 0.01 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 321 LEU^? 17.19 ZN ZN A 402 B 58 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 120 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 54.50 104.32 58.69 55.83 105.69 59.81 -38.24 99.25 -8.68 -40.42 99.39 -8.43 coo 57.63 101.19 59.83 56.60 100.89 57.99 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 61.58 95.88 55.22 58.18 99.30 54.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 321 LEU^? 17.10 ZN ZN B 401 B 58 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 120 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 54.50 104.32 58.69 55.83 105.69 59.81 -34.15 112.90 9.63 -36.13 113.84 9.47 coo 57.63 101.19 59.83 56.60 100.89 57.99 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 61.58 95.88 55.22 58.18 99.30 54.71 -38.53 111.12 1.13 -44.30 110.60 0.01 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 68 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 72 LEU A 312 LEU~? 9.93 ZN ZN B 401 coo 46.76 7.59 18.65 45.27 6.01 18.52 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 48.88 4.35 16.59 48.73 5.09 15.20 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 53.89 6.25 15.09 52.88 7.92 14.14 -42.97 94.69 -0.33 -43.02 92.95 1.02 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 68 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 72 LEU A 321 LEU^? 17.19 ZN ZN A 402 coo 46.76 7.59 18.65 45.27 6.01 18.52 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 48.88 4.35 16.59 48.73 5.09 15.20 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 53.89 6.25 15.09 52.88 7.92 14.14 -38.24 99.25 -8.68 -40.42 99.39 -8.43 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 68 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 72 LEU A 321 LEU^? 17.19 ZN ZN A 402 coo 46.76 7.59 18.65 45.27 6.01 18.52 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 48.88 4.35 16.59 48.73 5.09 15.20 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 53.89 6.25 15.09 52.88 7.92 14.14 -38.24 99.25 -8.68 -40.42 99.39 -8.43 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 68 ALA A 314 ALA~? 16.60 ZN ZN B 401 A 72 LEU A 321 LEU^? 17.19 ZN ZN A 402 coo 46.76 7.59 18.65 45.27 6.01 18.52 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 48.88 4.35 16.59 48.73 5.09 15.20 -43.51 95.31 -7.19 -42.51 96.46 -7.49 coo 53.89 6.25 15.09 52.88 7.92 14.14 -38.24 99.25 -8.68 -40.42 99.39 -8.43 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 68 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 72 LEU B 312 LEU~? 9.97 ZN ZN A 402 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 48.88 4.35 16.59 48.73 5.09 15.20 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 53.89 6.25 15.09 52.88 7.92 14.14 -36.04 119.44 1.32 -35.12 120.85 -0.09 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 68 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 72 LEU B 321 LEU^? 17.10 ZN ZN B 401 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 48.88 4.35 16.59 48.73 5.09 15.20 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 53.89 6.25 15.09 52.88 7.92 14.14 -34.15 112.90 9.63 -36.13 113.84 9.47 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 68 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 72 LEU B 321 LEU^? 17.10 ZN ZN B 401 coo 46.76 7.59 18.65 45.27 6.01 18.52 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 48.88 4.35 16.59 48.73 5.09 15.20 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 53.89 6.25 15.09 52.88 7.92 14.14 -34.15 112.90 9.63 -36.13 113.84 9.47 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 68 ALA B 314 ALA~? 16.61 ZN ZN A 402 A 72 LEU B 321 LEU^? 17.10 ZN ZN B 401 coo 46.76 7.59 18.65 45.27 6.01 18.52 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 48.88 4.35 16.59 48.73 5.09 15.20 -36.50 118.91 8.14 -36.25 117.42 8.39 coo 53.89 6.25 15.09 52.88 7.92 14.14 -34.15 112.90 9.63 -36.13 113.84 9.47 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 8 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 239 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 246 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 2.50 7.27 18.06 0.76 7.28 16.81 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -26.53 108.54 0.92 -29.08 108.89 -0.28 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 239 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 246 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 2.50 7.27 18.06 0.76 7.28 16.81 -34.08 101.07 5.49 -32.41 102.02 4.50 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -29.29 98.99 -0.08 -31.62 99.98 1.12 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 2 hits 1qaz_c00 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 285 SER.? 7.68 ZN ZN A 402 A 310 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 399 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 2.67 37.96 55.23 1.78 40.01 56.16 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 6.61 38.44 63.61 6.69 38.31 61.50 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 4.95 41.82 59.53 3.85 40.70 58.14 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 285 SER.? 7.72 ZN ZN B 401 A 310 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 399 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 2.67 37.96 55.23 1.78 40.01 56.16 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 6.61 38.44 63.61 6.69 38.31 61.50 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 4.95 41.82 59.53 3.85 40.70 58.14 -40.92 100.43 6.30 -42.93 100.06 6.77 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 2 hits 1qe3_c00 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 143 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 170 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 1.36 26.79 49.43 3.17 26.89 50.50 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 7.24 31.80 48.14 6.27 25.92 49.70 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 A 86 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 143 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 170 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 1.36 26.79 49.43 3.17 26.89 50.50 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 7.24 31.80 48.14 6.27 25.92 49.70 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 A 86 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 143 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 170 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 1.36 26.79 49.43 3.17 26.89 50.50 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 7.24 31.80 48.14 6.27 25.92 49.70 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 A 86 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 143 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 170 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 1.36 26.79 49.43 3.17 26.89 50.50 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 7.24 31.80 48.14 6.27 25.92 49.70 -40.89 103.09 -0.15 -45.35 106.49 1.62 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 143 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 170 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 13.90 37.16 5.96 12.00 36.26 6.12 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 13.52 33.69 9.79 13.20 31.83 8.88 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 7.52 28.83 11.02 13.59 28.74 9.95 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 B 86 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 143 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 170 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 13.90 37.16 5.96 12.00 36.26 6.12 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 13.52 33.69 9.79 13.20 31.83 8.88 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 7.52 28.83 11.02 13.59 28.74 9.95 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 B 86 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 143 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 170 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 13.90 37.16 5.96 12.00 36.26 6.12 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 13.52 33.69 9.79 13.20 31.83 8.88 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 7.52 28.83 11.02 13.59 28.74 9.95 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 B 86 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 143 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 170 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 13.90 37.16 5.96 12.00 36.26 6.12 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 13.52 33.69 9.79 13.20 31.83 8.88 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 7.52 28.83 11.02 13.59 28.74 9.95 -40.89 103.09 -0.15 -45.35 106.49 1.62 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1qfe_c01 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 63 SER^? 10.35 ZN ZN A 402 A 641 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 680 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 34.48 40.33 79.08 36.40 39.98 80.55 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 40.64 47.22 77.43 39.90 45.49 78.43 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 38.53 44.50 81.45 37.60 42.73 80.84 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 2 3 # 2 A 554 SER A 328 SER~? 11.01 ZN ZN A 402 A 641 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 680 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 34.48 40.33 79.08 36.40 39.98 80.55 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 40.64 47.22 77.43 39.90 45.49 78.43 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 38.53 44.50 81.45 37.60 42.73 80.84 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 3 3 # 3 A 554 SER B 328 SER~? 10.89 ZN ZN B 401 A 641 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 680 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 34.48 40.33 79.08 36.40 39.98 80.55 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 40.64 47.22 77.43 39.90 45.49 78.43 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 38.53 44.50 81.45 37.60 42.73 80.84 -40.92 100.43 6.30 -42.93 100.06 6.77 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 3 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 55.45 46.76 42.08 57.34 46.16 42.75 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 47.58 17.35 41.83 51.40 20.85 40.83 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 55.45 46.76 42.08 57.34 46.16 42.75 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 55.45 46.76 42.08 57.34 46.16 42.75 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 55.45 46.76 42.08 57.34 46.16 42.75 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 47.58 17.35 41.83 51.40 20.85 40.83 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 55.45 46.76 42.08 57.34 46.16 42.75 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 48.87 29.19 44.63 49.10 27.34 43.63 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 47.58 17.35 41.83 51.40 20.85 40.83 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 55.45 46.76 42.08 57.34 46.16 42.75 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.58 17.35 41.83 51.40 20.85 40.83 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 55.45 46.76 42.08 57.34 46.16 42.75 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 48.87 29.19 44.63 49.10 27.34 43.63 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.58 17.35 41.83 51.40 20.85 40.83 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 55.45 46.76 42.08 57.34 46.16 42.75 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 48.87 29.19 44.63 49.10 27.34 43.63 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 47.58 17.35 41.83 51.40 20.85 40.83 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 55.45 46.76 42.08 57.34 46.16 42.75 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 48.87 29.19 44.63 49.10 27.34 43.63 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 47.58 17.35 41.83 51.40 20.85 40.83 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 55.45 46.76 42.08 57.34 46.16 42.75 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.58 17.35 41.83 51.40 20.85 40.83 -33.07 120.28 7.09 -27.74 119.98 5.88 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 B 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 155 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 155 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 B 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 155 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 55.11 47.10 12.61 53.44 47.85 11.58 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 37.54 22.37 12.10 37.83 27.55 13.24 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 55.11 47.10 12.61 53.44 47.85 11.58 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 55.11 47.10 12.61 53.44 47.85 11.58 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 C 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 55.11 47.10 12.61 53.44 47.85 11.58 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 37.54 22.37 12.10 37.83 27.55 13.24 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 55.11 47.10 12.61 53.44 47.85 11.58 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 37.54 22.37 12.10 37.83 27.55 13.24 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 155 HIS A 317 HIS~? 18.34 ZN ZN B 401 C 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 55.11 47.10 12.61 53.44 47.85 11.58 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 55.11 47.10 12.61 53.44 47.85 11.58 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 155 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 55.11 47.10 12.61 53.44 47.85 11.58 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 55.11 47.10 12.61 53.44 47.85 11.58 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 45.78 31.11 9.51 44.25 30.06 10.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.54 22.37 12.10 37.83 27.55 13.24 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 C 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 55.11 47.10 12.61 53.44 47.85 11.58 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 45.78 31.11 9.51 44.25 30.06 10.53 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 37.54 22.37 12.10 37.83 27.55 13.24 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 C 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 55.11 47.10 12.61 53.44 47.85 11.58 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 45.78 31.11 9.51 44.25 30.06 10.53 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 37.54 22.37 12.10 37.83 27.55 13.24 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 55.11 47.10 12.61 53.44 47.85 11.58 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 155 HIS B 317 HIS~? 18.53 ZN ZN A 402 C 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 55.11 47.10 12.61 53.44 47.85 11.58 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 D 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 D 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 D 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 D 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 D 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 D 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 D 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -33.07 120.28 7.09 -27.74 119.98 5.88 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 E 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 E 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 E 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 E 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 E 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 E 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 E 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 E 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 E 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 E 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 E 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 E 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -33.07 120.28 7.09 -27.74 119.98 5.88 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 12 HIS~? 21.70 ZN ZN A 401 F 236 ASP A 23 ASP.? 8.14 ZN ZN A 401 F 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s F 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 F 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s F 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 F 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 F 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 F 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 F 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 F 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 155 HIS A 317 HIS~? 18.34 ZN ZN B 401 F 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 F 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 155 HIS B 12 HIS~? 21.73 ZN ZN B 402 F 236 ASP B 23 ASP.? 8.15 ZN ZN B 402 F 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s F 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 F 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 155 HIS B 65 HIS.? -3.43 ZN ZN B 401s F 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 F 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 F 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 F 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 F 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 F 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 F 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 155 HIS B 317 HIS~? 18.53 ZN ZN A 402 F 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 F 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 15 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s G 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 G 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s G 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 G 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 G 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 G 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 G 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 G 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 G 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 G 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 155 HIS A 317 HIS~? 18.34 ZN ZN B 401 G 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 G 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s G 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 G 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 155 HIS B 65 HIS.? -3.43 ZN ZN B 401s G 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 G 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 G 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 G 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 G 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 G 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 G 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 G 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 G 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 G 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 155 HIS B 317 HIS~? 18.53 ZN ZN A 402 G 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 G 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 64 HIS.? -3.42 ZN ZN A 401s H 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 H 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS A 65 HIS.? -3.39 ZN ZN A 402s H 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 H 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 H 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 H 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 155 HIS A 90 HIS~? 26.77 ZN ZN A 402 H 236 ASP A 352 ASP.? 27.02 ZN ZN A 401 H 261 LYS A 348 LYS.? 34.92 ZN ZN A 401 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -28.96 136.28 -30.18 -27.29 138.47 -35.81 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 155 HIS A 98 HIS~? 4.98 ZN ZN A 401 H 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 H 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 155 HIS B 64 HIS.? -3.45 ZN ZN B 402s H 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 H 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 H 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 H 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 155 HIS B 90 HIS~? 26.84 ZN ZN B 401 H 236 ASP B 352 ASP.? 26.97 ZN ZN B 402 H 261 LYS B 348 LYS.? 30.27 ZN ZN B 402 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -45.82 76.15 30.63 -44.25 78.32 34.65 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 236 ASP B 129 ASP^? 19.14 ZN ZN B 402 H 261 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 155 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 H 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -33.07 120.28 7.09 -27.74 119.98 5.88 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 48.87 29.19 44.63 49.10 27.34 43.63 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 47.58 17.35 41.83 51.40 20.85 40.83 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 A 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 48.87 29.19 44.63 49.10 27.34 43.63 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 47.58 17.35 41.83 51.40 20.85 40.83 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.58 17.35 41.83 51.40 20.85 40.83 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.58 17.35 41.83 51.40 20.85 40.83 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 A 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 48.87 29.19 44.63 49.10 27.34 43.63 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 48.87 29.19 44.63 49.10 27.34 43.63 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 48.87 29.19 44.63 49.10 27.34 43.63 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 47.58 17.35 41.83 51.40 20.85 40.83 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 A 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 47.58 17.35 41.83 51.40 20.85 40.83 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 48.87 29.19 44.63 49.10 27.34 43.63 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.58 17.35 41.83 51.40 20.85 40.83 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 48.87 29.19 44.63 49.10 27.34 43.63 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.58 17.35 41.83 51.40 20.85 40.83 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 48.87 29.19 44.63 49.10 27.34 43.63 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.58 17.35 41.83 51.40 20.85 40.83 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 48.87 29.19 44.63 49.10 27.34 43.63 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 A 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 47.58 17.35 41.83 51.40 20.85 40.83 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 A 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 B 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 B 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 B 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 B 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 B 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 B 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 B 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 B 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 C 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 45.78 31.11 9.51 44.25 30.06 10.53 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.54 22.37 12.10 37.83 27.55 13.24 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 C 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 C 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 45.78 31.11 9.51 44.25 30.06 10.53 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 37.54 22.37 12.10 37.83 27.55 13.24 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 C 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.54 22.37 12.10 37.83 27.55 13.24 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 C 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 C 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.54 22.37 12.10 37.83 27.55 13.24 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 C 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 45.78 31.11 9.51 44.25 30.06 10.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 C 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 45.78 31.11 9.51 44.25 30.06 10.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 C 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 45.78 31.11 9.51 44.25 30.06 10.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 C 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 C 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.54 22.37 12.10 37.83 27.55 13.24 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 C 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 C 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 37.54 22.37 12.10 37.83 27.55 13.24 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 C 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 45.78 31.11 9.51 44.25 30.06 10.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.54 22.37 12.10 37.83 27.55 13.24 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 C 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 45.78 31.11 9.51 44.25 30.06 10.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.54 22.37 12.10 37.83 27.55 13.24 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 C 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 C 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 45.78 31.11 9.51 44.25 30.06 10.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.54 22.37 12.10 37.83 27.55 13.24 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 C 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 C 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 C 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 C 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 C 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 C 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.54 22.37 12.10 37.83 27.55 13.24 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 C 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 C 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 D 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 D 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 D 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 D 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 D 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 D 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 D 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 D 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 D 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 D 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 D 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 D 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 D 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 D 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 D 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 D 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 D 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 D 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 D 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 D 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 D 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 D 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 D 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 D 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 D 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 D 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 D 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 E 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 E 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 E 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 E 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 E 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 E 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 E 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 E 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 E 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 E 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 E 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 E 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 E 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 E 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 E 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 E 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 E 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 E 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 E 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 E 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 E 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 E 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 E 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 E 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 E 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 E 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 E 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 E 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 E 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 E 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 E 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 E 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 F 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 F 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 F 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 F 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 F 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 F 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 F 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 F 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 F 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 F 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 F 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 F 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 F 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 F 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 F 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 F 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 F 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 F 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 F 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 F 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 F 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 F 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 F 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 F 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 F 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 F 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 F 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 F 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 F 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 F 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 F 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 F 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 G 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 G 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 G 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 G 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 G 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 G 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 G 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 G 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 G 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 G 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 G 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 G 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 G 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 G 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 G 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 G 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 G 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 G 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 G 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 G 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 G 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 G 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 G 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 G 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 G 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 G 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 G 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 G 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 G 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 G 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 G 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 G 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 G 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 G 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 G 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 G 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 G 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 G 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 G 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 G 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 G 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 80 TYR~? 13.91 ZN ZN A 402 H 236 ASP B 313 ASP~? 12.28 ZN ZN A 402 H 261 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 131 TYR^? 29.63 ZN ZN A 401 H 236 ASP A 129 ASP^? 19.65 ZN ZN A 401 H 261 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 H 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 H 261 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 H 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 H 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 H 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 H 261 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR A 330 TYR~? 12.28 ZN ZN A 402 H 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 H 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -28.08 116.36 -9.49 -26.20 114.52 -10.52 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 H 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 H 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 H 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 H 261 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 H 236 ASP B 323 ASP^? 12.28 ZN ZN B 401 H 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 163 TYR B 80 TYR~? 13.91 ZN ZN B 401 H 236 ASP A 313 ASP~? 12.18 ZN ZN B 401 H 261 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 H 163 TYR B 137 TYR^? 46.12 ZN ZN B 402 H 236 ASP B 226 ASP^? 42.35 ZN ZN B 402 H 261 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 H 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 H 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 H 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 H 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 H 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 H 261 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 H 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 H 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 H 261 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 H 163 TYR B 330 TYR~? 12.23 ZN ZN B 401 H 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 H 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 H 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 H 236 ASP A 323 ASP^? 12.30 ZN ZN A 402 H 261 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 H 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 H 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 H 261 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 H 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 H 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 H 261 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.96 101.08 10.72 -22.73 101.83 5.25 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 C 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 39.01 29.77 22.02 37.48 31.30 19.84 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 39.51 34.34 13.63 37.63 32.61 14.79 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 45.78 31.11 9.51 44.25 30.06 10.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 C 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 39.01 29.77 22.02 37.48 31.30 19.84 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 39.51 34.34 13.63 37.63 32.61 14.79 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 45.78 31.11 9.51 44.25 30.06 10.53 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 C 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 39.01 29.77 22.02 37.48 31.30 19.84 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 C 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 39.01 29.77 22.02 37.48 31.30 19.84 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -34.85 93.86 2.41 -34.87 96.02 2.16 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 D 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 D 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 D 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 D 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 D 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 D 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 D 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 D 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -34.85 93.86 2.41 -34.87 96.02 2.16 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 52.39 23.42 32.10 54.51 23.27 34.29 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 48.87 29.19 44.63 49.10 27.34 43.63 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 52.39 23.42 32.10 54.51 23.27 34.29 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 55.48 26.51 40.65 55.39 23.99 39.43 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 48.87 29.19 44.63 49.10 27.34 43.63 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 52.39 23.42 32.10 54.51 23.27 34.29 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 52.39 23.42 32.10 54.51 23.27 34.29 -31.38 108.30 2.45 -33.79 107.47 0.72 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -31.38 108.30 2.45 -33.79 107.47 0.72 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 G 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 G 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 G 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 G 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 G 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 G 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 G 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 G 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -34.85 93.86 2.41 -34.87 96.02 2.16 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 H 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 H 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 H 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 H 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 H 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 H 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 H 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 H 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.85 93.86 2.41 -34.87 96.02 2.16 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 E 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 G 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 E 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 G 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 E 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 G 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 E 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 G 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -31.38 108.30 2.45 -33.79 107.47 0.72 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 327 TYR~? 10.33 ZN ZN A 402 F 236 ASP A 44 ASP.? 7.09 ZN ZN A 402 H 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 365 TYR^? 16.07 ZN ZN A 402 F 236 ASP A 361 ASP.? 11.77 ZN ZN A 402 H 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 327 TYR~? 10.21 ZN ZN B 401 F 236 ASP B 44 ASP.? 7.11 ZN ZN B 401 H 110 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 365 TYR^? 15.98 ZN ZN B 401 F 236 ASP B 361 ASP.? 11.71 ZN ZN B 401 H 110 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -31.38 108.30 2.45 -33.79 107.47 0.72 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 147 THR A 18 THR~? 13.01 ZN ZN A 401 A 294 ASP A 11 ASP~? 18.10 ZN ZN A 401 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -48.15 121.40 -19.77 -46.63 121.38 -21.33 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -44.11 130.33 -22.09 -46.09 129.62 -22.27 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 147 THR A 99 THR~? 6.77 ZN ZN A 401 A 294 ASP A 11 ASP~? 18.10 ZN ZN A 401 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -43.91 119.63 -14.00 -45.67 119.24 -12.83 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -44.11 130.33 -22.09 -46.09 129.62 -22.27 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 147 THR A 303 THR^? 9.94 ZN ZN A 402 A 294 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -37.48 106.60 -10.18 -39.53 106.67 -9.37 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 147 THR A 37 THR.? 27.03 ZN ZN A 401 A 294 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -28.34 140.20 -15.53 -28.28 141.11 -13.55 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 147 THR B 18 THR~? 13.04 ZN ZN B 402 A 294 ASP B 11 ASP~? 18.05 ZN ZN B 402 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -54.27 99.11 20.76 -52.97 98.30 22.29 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -55.43 89.37 22.82 -56.66 91.02 23.20 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 147 THR B 99 THR~? 6.68 ZN ZN B 402 A 294 ASP B 11 ASP~? 18.05 ZN ZN B 402 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -49.64 98.60 14.96 -50.95 99.87 13.75 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -55.43 89.37 22.82 -56.66 91.02 23.20 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 147 THR B 303 THR^? 9.94 ZN ZN B 401 A 294 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -37.37 106.23 11.12 -39.15 107.32 10.30 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 147 THR B 37 THR.? 27.08 ZN ZN B 402 A 294 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.65 72.83 15.84 -48.15 72.05 13.90 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -55.09 78.54 23.42 -56.64 77.16 23.83 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 8 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 256 GLU A 20 GLU.? 10.86 ZN ZN A 401 A 329 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 28.46 69.88 26.74 30.40 70.70 26.53 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 30.54 71.65 32.58 31.73 72.26 30.92 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 256 GLU A 35 GLU.? 32.19 ZN ZN A 401 A 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 30.54 71.65 32.58 31.73 72.26 30.92 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 256 GLU B 20 GLU.? 11.09 ZN ZN B 402 A 329 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 30.54 71.65 32.58 31.73 72.26 30.92 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.20 100.05 15.92 -45.42 99.37 14.07 1qho_c04 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A -1 ASP.? 33.70 ZN ZN A 401 A 261 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 34.02 79.89 42.60 34.73 78.01 41.86 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 261 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 34.02 79.89 42.60 34.73 78.01 41.86 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 261 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 34.02 79.89 42.60 34.73 78.01 41.86 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 329 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 329 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 329 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 261 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 329 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 261 ASP A -1 ASP.? 33.70 ZN ZN A 401 A 329 ASP A 33 ASP.? 31.33 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 34.02 79.89 42.60 34.73 78.01 41.86 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.68 145.88 -15.27 -39.90 147.57 -16.36 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 261 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 34.02 79.89 42.60 34.73 78.01 41.86 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 261 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 261 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1qho_c05 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 261 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1qho_c05 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 261 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 261 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 261 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 261 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 261 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 329 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 34.02 79.89 42.60 34.73 78.01 41.86 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 37.87 70.12 31.80 36.61 69.74 30.15 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qho_c05 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 261 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 329 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qho_c05 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 261 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.02 79.89 42.60 34.73 78.01 41.86 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 261 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 261 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 329 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qho_c05 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 261 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 261 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 329 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 34.02 79.89 42.60 34.73 78.01 41.86 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1qho_c05 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP B 33 ASP.? 29.43 ZN ZN B 402 A 261 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 329 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 34.02 79.89 42.60 34.73 78.01 41.86 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1qho_c05 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 329 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1qho_c05 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 329 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qho_c05 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 329 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.02 79.89 42.60 34.73 78.01 41.86 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1qho_c05 ALPHA-AMYLASE user 32 3 # 32 A 228 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 261 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 329 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.02 79.89 42.60 34.73 78.01 41.86 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qho_c05 ALPHA-AMYLASE user 33 3 # 33 A 228 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 261 ASP B -1 ASP.? 32.96 ZN ZN B 402 A 329 ASP B 33 ASP.? 29.43 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 34.02 79.89 42.60 34.73 78.01 41.86 -55.89 71.67 27.30 -54.45 72.03 28.78 coo 37.87 70.12 31.80 36.61 69.74 30.15 -61.26 74.82 15.61 -62.97 76.13 15.50 ULMN 3 1qho_c05 ALPHA-AMYLASE user 34 3 # 34 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 261 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 34.02 79.89 42.60 34.73 78.01 41.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 35 3 # 35 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 261 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 34.02 79.89 42.60 34.73 78.01 41.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1qho_c05 ALPHA-AMYLASE user 36 3 # 36 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 261 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.02 79.89 42.60 34.73 78.01 41.86 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 37 3 # 37 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 261 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 38 3 # 38 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 261 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 39 3 # 39 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 261 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 40 3 # 40 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 261 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.02 79.89 42.60 34.73 78.01 41.86 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 41 3 # 41 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 261 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.02 79.89 42.60 34.73 78.01 41.86 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 42 3 # 42 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 261 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 34.02 79.89 42.60 34.73 78.01 41.86 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 43 3 # 43 A 228 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 261 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 329 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qho_c05 ALPHA-AMYLASE user 44 3 # 44 A 228 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 261 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 329 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qho_c05 ALPHA-AMYLASE user 45 3 # 45 A 228 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 46 3 # 46 A 228 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1qho_c05 ALPHA-AMYLASE user 47 3 # 47 A 228 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 48 3 # 48 A 228 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 261 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1qho_c05 ALPHA-AMYLASE user 49 3 # 49 A 228 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1qho_c05 ALPHA-AMYLASE user 50 3 # 50 A 228 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1qho_c05 ALPHA-AMYLASE user 51 3 # 51 A 228 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 329 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qho_c05 ALPHA-AMYLASE user 52 3 # 52 A 228 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 53 3 # 53 A 228 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 261 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 1qho_c05 source 1qho ALPHA-AMYLASE : 53 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A -1 ASP.? 33.70 ZN ZN A 401 A 260 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 30.73 81.29 37.61 31.23 82.07 35.69 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 260 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 260 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 329 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 28.46 69.88 26.74 30.40 70.70 26.53 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 260 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 329 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 28.46 69.88 26.74 30.40 70.70 26.53 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 30.73 81.29 37.61 31.23 82.07 35.69 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 260 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 329 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 28.46 69.88 26.74 30.40 70.70 26.53 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 260 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 329 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 260 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 329 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 260 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 329 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 260 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 329 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 30.73 81.29 37.61 31.23 82.07 35.69 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP A 245 ASP^? 25.73 ZN ZN A 401 A 260 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 329 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 30.73 81.29 37.61 31.23 82.07 35.69 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP A 245 ASP^? 25.73 ZN ZN A 401 A 260 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 329 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 30.73 81.29 37.61 31.23 82.07 35.69 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 260 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 329 ASP A 245 ASP^? 25.73 ZN ZN A 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 30.73 81.29 37.61 31.23 82.07 35.69 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.62 99.57 -26.57 -25.42 101.64 -26.90 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 260 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.73 81.29 37.61 31.23 82.07 35.69 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 260 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.73 81.29 37.61 31.23 82.07 35.69 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 260 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.73 81.29 37.61 31.23 82.07 35.69 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 260 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.73 81.29 37.61 31.23 82.07 35.69 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 260 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.73 81.29 37.61 31.23 82.07 35.69 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 260 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1qho_c07 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 260 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 30.73 81.29 37.61 31.23 82.07 35.69 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qho_c07 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 260 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 329 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 30.73 81.29 37.61 31.23 82.07 35.69 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qho_c07 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 260 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c07 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 260 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1qho_c07 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 260 ASP B 31 ASP.? 28.05 ZN ZN B 402 A 329 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 30.73 81.29 37.61 31.23 82.07 35.69 -58.98 76.97 11.28 -60.60 75.86 12.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1qho_c07 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 260 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 329 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 30.73 81.29 37.61 31.23 82.07 35.69 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qho_c07 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 260 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 329 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 30.73 81.29 37.61 31.23 82.07 35.69 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qho_c07 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 260 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 329 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qho_c07 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 260 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 329 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1qho_c07 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 260 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 329 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qho_c07 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 260 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 329 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 30.73 81.29 37.61 31.23 82.07 35.69 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 37.87 70.12 31.80 36.61 69.74 30.15 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qho_c07 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 260 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 329 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 30.73 81.29 37.61 31.23 82.07 35.69 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qho_c07 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 260 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 329 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 30.73 81.29 37.61 31.23 82.07 35.69 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 1qho_c07 ALPHA-AMYLASE user 32 3 # 32 A 228 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 260 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 329 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 30.73 81.29 37.61 31.23 82.07 35.69 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 1qho_c07 ALPHA-AMYLASE user 33 3 # 33 A 228 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 260 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 329 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 30.73 81.29 37.61 31.23 82.07 35.69 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 1qho_c07 ALPHA-AMYLASE user 34 3 # 34 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 260 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c07 ALPHA-AMYLASE user 35 3 # 35 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 260 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1qho_c07 ALPHA-AMYLASE user 36 3 # 36 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 260 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1qho_c07 ALPHA-AMYLASE user 37 3 # 37 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 260 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.73 81.29 37.61 31.23 82.07 35.69 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1qho_c07 ALPHA-AMYLASE user 38 3 # 38 A 228 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 260 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c07 ALPHA-AMYLASE user 39 3 # 39 A 228 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 260 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1qho_c07 ALPHA-AMYLASE user 40 3 # 40 A 228 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 260 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1qho_c07 ALPHA-AMYLASE user 41 3 # 41 A 228 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 260 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1qho_c07 ALPHA-AMYLASE user 42 3 # 42 A 228 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 260 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 329 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 30.73 81.29 37.61 31.23 82.07 35.69 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qho_c07 source 1qho ALPHA-AMYLASE : 42 hits 1qho_c07 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 328 SER~? 11.01 ZN ZN A 402 A 207 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 235 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 15.54 46.73 17.13 17.06 48.44 16.17 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 23.60 50.31 20.82 21.66 50.51 20.06 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 20.17 51.16 17.08 18.31 50.28 17.44 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 328 SER~? 10.89 ZN ZN B 401 A 207 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 235 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 15.54 46.73 17.13 17.06 48.44 16.17 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 23.60 50.31 20.82 21.66 50.51 20.06 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 20.17 51.16 17.08 18.31 50.28 17.44 -40.92 100.43 6.30 -42.93 100.06 6.77 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 2 hits 1qj4_c00 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 A 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 1.42 19.18 21.84 1.11 19.57 23.28 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo 0.71 19.67 27.92 2.43 19.16 26.83 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 7.15 16.22 27.50 6.15 18.00 27.94 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA A 42 ALA^? 12.34 ZN ZN A 402 A 148 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 163 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 1.42 19.18 21.84 1.11 19.57 23.28 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 0.71 19.67 27.92 2.43 19.16 26.83 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 7.15 16.22 27.50 6.15 18.00 27.94 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 A 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 1.42 19.18 21.84 1.11 19.57 23.28 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 0.71 19.67 27.92 2.43 19.16 26.83 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 7.15 16.22 27.50 6.15 18.00 27.94 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 1.42 19.18 21.84 1.11 19.57 23.28 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 0.71 19.67 27.92 2.43 19.16 26.83 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 7.15 16.22 27.50 6.15 18.00 27.94 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 A 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 1.42 19.18 21.84 1.11 19.57 23.28 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 0.71 19.67 27.92 2.43 19.16 26.83 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 7.15 16.22 27.50 6.15 18.00 27.94 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 A 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 A 148 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 1.42 19.18 21.84 1.11 19.57 23.28 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 0.71 19.67 27.92 2.43 19.16 26.83 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 7.15 16.22 27.50 6.15 18.00 27.94 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 A 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 A 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 1.42 19.18 21.84 1.11 19.57 23.28 -53.87 98.79 16.99 -54.12 97.55 16.16 coo 0.71 19.67 27.92 2.43 19.16 26.83 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 7.15 16.22 27.50 6.15 18.00 27.94 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 A 51 ALA B 42 ALA^? 12.31 ZN ZN B 401 A 148 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 163 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 1.42 19.18 21.84 1.11 19.57 23.28 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 0.71 19.67 27.92 2.43 19.16 26.83 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 7.15 16.22 27.50 6.15 18.00 27.94 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 A 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 A 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 1.42 19.18 21.84 1.11 19.57 23.28 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 0.71 19.67 27.92 2.43 19.16 26.83 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 7.15 16.22 27.50 6.15 18.00 27.94 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 A 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 1.42 19.18 21.84 1.11 19.57 23.28 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 0.71 19.67 27.92 2.43 19.16 26.83 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 7.15 16.22 27.50 6.15 18.00 27.94 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 10 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 B 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -33.97 19.78 54.18 -33.40 20.11 52.82 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA A 42 ALA^? 12.34 ZN ZN A 402 B 148 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 163 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 B 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 B 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 B 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 B 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 B 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 B 148 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 B 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 B 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -33.97 19.78 54.18 -33.40 20.11 52.82 -53.87 98.79 16.99 -54.12 97.55 16.16 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 B 51 ALA B 42 ALA^? 12.31 ZN ZN B 401 B 148 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 163 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 B 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 B 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -50.76 89.87 12.12 -51.42 90.77 11.02 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 B 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 B 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 10 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 C 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 C 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 C 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 C 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 C 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 C 148 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 C 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 C 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -53.87 98.79 16.99 -54.12 97.55 16.16 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 C 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 C 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -50.76 89.87 12.12 -51.42 90.77 11.02 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 C 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 C 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 D 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 42 ALA^? 12.34 ZN ZN A 402 D 148 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 163 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 D 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 D 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 D 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 D 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 D 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 D 148 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 D 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 D 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -53.87 98.79 16.99 -54.12 97.55 16.16 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 D 51 ALA B 42 ALA^? 12.31 ZN ZN B 401 D 148 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 163 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 D 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 D 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -50.76 89.87 12.12 -51.42 90.77 11.02 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 D 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 D 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 10 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 E 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 E 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 E 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 E 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 E 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -53.87 98.79 16.99 -54.12 97.55 16.16 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 E 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 E 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 E 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 E 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 6 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 F 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 F 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 F 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 F 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 F 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 F 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 F 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 F 148 HIS A 309 HIS~? 5.45 ZN ZN B 401 F 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 F 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 F 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -53.87 98.79 16.99 -54.12 97.55 16.16 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 F 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 F 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 F 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 F 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 F 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 G 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 G 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA A 42 ALA^? 12.34 ZN ZN A 402 G 148 HIS A 64 HIS.? -3.42 ZN ZN A 401s G 163 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 G 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 G 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 G 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 G 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 G 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 G 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -53.87 98.79 16.99 -54.12 97.55 16.16 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 G 51 ALA B 42 ALA^? 12.31 ZN ZN B 401 G 148 HIS B 64 HIS.? -3.45 ZN ZN B 402s G 163 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -41.84 87.26 10.29 -42.65 86.57 9.20 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 G 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 G 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 G 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -50.76 89.87 12.12 -51.42 90.77 11.02 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 G 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 G 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 G 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 19 ALA~? 10.49 ZN ZN A 401 H 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 H 163 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA A 96 ALA^? 10.78 ZN ZN A 401 H 148 HIS A 98 HIS~? 4.98 ZN ZN A 401 H 163 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 H 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 H 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 H 148 HIS A 308 HIS~? 6.49 ZN ZN B 401 H 163 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 H 51 ALA A 311 ALA~? 12.40 ZN ZN B 401 H 148 HIS A 309 HIS~? 5.45 ZN ZN B 401 H 163 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 H 51 ALA B 19 ALA~? 10.41 ZN ZN B 402 H 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 163 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -53.87 98.79 16.99 -54.12 97.55 16.16 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 H 51 ALA B 96 ALA^? 10.72 ZN ZN B 402 H 148 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 163 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -50.76 89.87 12.12 -51.42 90.77 11.02 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 H 51 ALA B 311 ALA~? 12.53 ZN ZN A 402 H 148 HIS B 308 HIS~? 6.54 ZN ZN A 402 H 163 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -28.63 115.74 -1.62 -29.77 113.98 -1.34 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 233 THR^? 21.55 ZN ZN A 401 A 182 TYR A 131 TYR^? 29.63 ZN ZN A 401 A 186 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 69.38 87.38 24.64 71.11 88.47 25.40 -51.48 112.38 -28.84 -50.80 110.31 -28.76 coo 73.61 90.42 31.12 71.36 89.66 29.64 -56.56 119.62 -34.10 -57.10 118.87 -36.76 coo 73.54 84.00 28.64 69.01 86.68 29.71 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 233 THR^? 21.46 ZN ZN B 402 A 182 TYR B 131 TYR^? 25.51 ZN ZN B 402 A 186 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 69.38 87.38 24.64 71.11 88.47 25.40 -52.42 108.39 29.83 -50.75 109.78 29.75 coo 73.61 90.42 31.12 71.36 89.66 29.64 -60.00 104.47 33.20 -57.62 103.10 32.62 coo 73.54 84.00 28.64 69.01 86.68 29.71 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR B 357 THR.? 20.15 ZN ZN B 401 A 182 TYR B 330 TYR~? 12.23 ZN ZN B 401 A 186 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 69.38 87.38 24.64 71.11 88.47 25.40 -34.09 83.81 8.88 -33.33 81.74 8.97 coo 73.61 90.42 31.12 71.36 89.66 29.64 -34.63 93.02 10.28 -32.00 93.52 11.20 coo 73.54 84.00 28.64 69.01 86.68 29.71 -38.73 88.63 14.36 -36.14 88.00 9.08 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 3 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c12 PLASMINOGEN user 11 3 # 11 A 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c12 PLASMINOGEN user 12 3 # 12 A 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c12 PLASMINOGEN user 13 3 # 13 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c12 PLASMINOGEN user 14 3 # 14 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1qrz_c12 PLASMINOGEN user 15 3 # 15 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c12 PLASMINOGEN user 16 3 # 16 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1qrz_c12 PLASMINOGEN user 17 3 # 17 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c12 PLASMINOGEN user 18 3 # 18 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -35.17 97.75 10.01 -33.21 99.13 9.77 1qrz_c12 source 1qrz PLASMINOGEN : 18 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1qrz_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1qrz_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c13 PLASMINOGEN user 11 3 # 11 B 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c13 PLASMINOGEN user 12 3 # 12 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c13 PLASMINOGEN user 13 3 # 13 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c13 PLASMINOGEN user 14 3 # 14 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c13 PLASMINOGEN user 15 3 # 15 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c13 PLASMINOGEN user 16 3 # 16 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1qrz_c13 PLASMINOGEN user 17 3 # 17 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c13 PLASMINOGEN user 18 3 # 18 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -35.17 97.75 10.01 -33.21 99.13 9.77 1qrz_c13 source 1qrz PLASMINOGEN : 18 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c14 PLASMINOGEN user 10 3 # 10 C 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c14 PLASMINOGEN user 11 3 # 11 C 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c14 PLASMINOGEN user 12 3 # 12 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c14 PLASMINOGEN user 13 3 # 13 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1qrz_c14 PLASMINOGEN user 14 3 # 14 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c14 PLASMINOGEN user 15 3 # 15 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -35.17 97.75 10.01 -33.21 99.13 9.77 1qrz_c14 source 1qrz PLASMINOGEN : 15 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 741 SER A 63 SER^? 10.35 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 741 SER A 328 SER~? 11.01 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1qrz_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 741 SER A 285 SER.? 7.68 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 1qrz_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 741 SER B 63 SER^? 10.37 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1qrz_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 1qrz_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 741 SER B 285 SER.? 7.72 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 1qrz_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 741 SER B 328 SER~? 10.89 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -35.17 97.75 10.01 -33.21 99.13 9.77 1qrz_c15 source 1qrz PLASMINOGEN : 10 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c20 PLASMINOGEN user 7 3 # 7 A 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c20 PLASMINOGEN user 8 3 # 8 A 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 9 3 # 9 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c20 PLASMINOGEN user 10 3 # 10 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c20 PLASMINOGEN user 11 3 # 11 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 12 3 # 12 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c20 PLASMINOGEN user 13 3 # 13 A 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1qrz_c20 PLASMINOGEN user 14 3 # 14 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 15 3 # 15 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c20 PLASMINOGEN user 16 3 # 16 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1qrz_c20 PLASMINOGEN user 17 3 # 17 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 18 3 # 18 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c20 PLASMINOGEN user 19 3 # 19 A 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 20 3 # 20 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c20 PLASMINOGEN user 21 3 # 21 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c20 PLASMINOGEN user 22 3 # 22 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c20 PLASMINOGEN user 23 3 # 23 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c20 PLASMINOGEN user 24 3 # 24 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 25 3 # 25 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c20 PLASMINOGEN user 26 3 # 26 A 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 739 GLY A 288 GLY.? 14.54 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -47.81 104.86 -9.26 -47.13 104.59 -9.75 ULMN 3 1qrz_c20 PLASMINOGEN user 27 3 # 27 A 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c20 PLASMINOGEN user 28 3 # 28 A 603 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1qrz_c20 PLASMINOGEN user 29 3 # 29 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1qrz_c20 PLASMINOGEN user 30 3 # 30 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 31 3 # 31 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1qrz_c20 PLASMINOGEN user 32 3 # 32 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 33 3 # 33 A 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c20 PLASMINOGEN user 34 3 # 34 A 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c20 PLASMINOGEN user 35 3 # 35 A 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 36 3 # 36 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c20 PLASMINOGEN user 37 3 # 37 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c20 PLASMINOGEN user 38 3 # 38 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c20 PLASMINOGEN user 39 3 # 39 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c20 PLASMINOGEN user 40 3 # 40 A 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1qrz_c20 PLASMINOGEN user 41 3 # 41 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 42 3 # 42 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1qrz_c20 PLASMINOGEN user 43 3 # 43 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 44 3 # 44 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c20 PLASMINOGEN user 45 3 # 45 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 46 3 # 46 A 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c20 PLASMINOGEN user 47 3 # 47 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c20 PLASMINOGEN user 48 3 # 48 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1qrz_c20 PLASMINOGEN user 49 3 # 49 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c20 PLASMINOGEN user 50 3 # 50 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c20 PLASMINOGEN user 51 3 # 51 A 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c20 PLASMINOGEN user 52 3 # 52 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c20 PLASMINOGEN user 53 3 # 53 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c20 PLASMINOGEN user 54 3 # 54 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c20 PLASMINOGEN user 55 3 # 55 A 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.47 105.54 19.38 -42.87 105.20 20.03 1qrz_c20 source 1qrz PLASMINOGEN : 55 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 12 HIS~? 21.70 ZN ZN A 401 B 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c21 PLASMINOGEN user 9 3 # 9 B 603 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 646 ASP A 91 ASP.? 28.84 ZN ZN A 402 B 739 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -39.26 132.56 4.99 -38.51 132.20 4.81 ULMN 3 1qrz_c21 PLASMINOGEN user 10 3 # 10 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c21 PLASMINOGEN user 11 3 # 11 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 12 3 # 12 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c21 PLASMINOGEN user 13 3 # 13 B 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1qrz_c21 PLASMINOGEN user 14 3 # 14 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 15 3 # 15 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c21 PLASMINOGEN user 16 3 # 16 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1qrz_c21 PLASMINOGEN user 17 3 # 17 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 18 3 # 18 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c21 PLASMINOGEN user 19 3 # 19 B 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 20 3 # 20 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c21 PLASMINOGEN user 21 3 # 21 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1qrz_c21 PLASMINOGEN user 22 3 # 22 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c21 PLASMINOGEN user 23 3 # 23 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 24 3 # 24 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c21 PLASMINOGEN user 25 3 # 25 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c21 PLASMINOGEN user 26 3 # 26 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c21 PLASMINOGEN user 27 3 # 27 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 28 3 # 28 B 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 739 GLY A 288 GLY.? 14.54 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -47.81 104.86 -9.26 -47.13 104.59 -9.75 ULMN 3 1qrz_c21 PLASMINOGEN user 29 3 # 29 B 603 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c21 PLASMINOGEN user 30 3 # 30 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c21 PLASMINOGEN user 31 3 # 31 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c21 PLASMINOGEN user 32 3 # 32 B 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c21 PLASMINOGEN user 33 3 # 33 B 603 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -52.58 88.71 29.10 -52.20 89.31 31.07 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c21 PLASMINOGEN user 34 3 # 34 B 603 HIS B 13 HIS~? 19.30 ZN ZN B 402 B 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1qrz_c21 PLASMINOGEN user 35 3 # 35 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1qrz_c21 PLASMINOGEN user 36 3 # 36 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 37 3 # 37 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1qrz_c21 PLASMINOGEN user 38 3 # 38 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 39 3 # 39 B 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c21 PLASMINOGEN user 40 3 # 40 B 603 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 646 ASP B 91 ASP.? 28.82 ZN ZN B 401 B 739 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1qrz_c21 PLASMINOGEN user 41 3 # 41 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c21 PLASMINOGEN user 42 3 # 42 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c21 PLASMINOGEN user 43 3 # 43 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c21 PLASMINOGEN user 44 3 # 44 B 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1qrz_c21 PLASMINOGEN user 45 3 # 45 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 46 3 # 46 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1qrz_c21 PLASMINOGEN user 47 3 # 47 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 48 3 # 48 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c21 PLASMINOGEN user 49 3 # 49 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 50 3 # 50 B 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c21 PLASMINOGEN user 51 3 # 51 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c21 PLASMINOGEN user 52 3 # 52 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1qrz_c21 PLASMINOGEN user 53 3 # 53 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 54 3 # 54 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c21 PLASMINOGEN user 55 3 # 55 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c21 PLASMINOGEN user 56 3 # 56 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1qrz_c21 PLASMINOGEN user 57 3 # 57 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1qrz_c21 PLASMINOGEN user 58 3 # 58 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c21 PLASMINOGEN user 59 3 # 59 B 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c21 PLASMINOGEN user 60 3 # 60 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c21 PLASMINOGEN user 61 3 # 61 B 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -42.47 105.54 19.38 -42.87 105.20 20.03 1qrz_c21 source 1qrz PLASMINOGEN : 61 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 12 HIS~? 21.70 ZN ZN A 401 C 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 7.82 1.25 3.03 7.30 1.31 3.65 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c22 PLASMINOGEN user 8 3 # 8 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 9 3 # 9 C 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 7.82 1.25 3.03 7.30 1.31 3.65 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c22 PLASMINOGEN user 10 3 # 10 C 603 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 646 ASP A 91 ASP.? 28.84 ZN ZN A 402 C 739 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 7.82 1.25 3.03 7.30 1.31 3.65 -39.26 132.56 4.99 -38.51 132.20 4.81 ULMN 3 1qrz_c22 PLASMINOGEN user 11 3 # 11 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c22 PLASMINOGEN user 12 3 # 12 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c22 PLASMINOGEN user 13 3 # 13 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 14 3 # 14 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c22 PLASMINOGEN user 15 3 # 15 C 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1qrz_c22 PLASMINOGEN user 16 3 # 16 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 17 3 # 17 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c22 PLASMINOGEN user 18 3 # 18 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1qrz_c22 PLASMINOGEN user 19 3 # 19 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 20 3 # 20 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c22 PLASMINOGEN user 21 3 # 21 C 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 22 3 # 22 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c22 PLASMINOGEN user 23 3 # 23 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1qrz_c22 PLASMINOGEN user 24 3 # 24 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c22 PLASMINOGEN user 25 3 # 25 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 26 3 # 26 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 7.82 1.25 3.03 7.30 1.31 3.65 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c22 PLASMINOGEN user 27 3 # 27 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c22 PLASMINOGEN user 28 3 # 28 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c22 PLASMINOGEN user 29 3 # 29 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c22 PLASMINOGEN user 30 3 # 30 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 31 3 # 31 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c22 PLASMINOGEN user 32 3 # 32 C 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 739 GLY A 288 GLY.? 14.54 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.82 1.25 3.03 7.30 1.31 3.65 -47.81 104.86 -9.26 -47.13 104.59 -9.75 ULMN 3 1qrz_c22 PLASMINOGEN user 33 3 # 33 C 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 7.82 1.25 3.03 7.30 1.31 3.65 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c22 PLASMINOGEN user 34 3 # 34 C 603 HIS B 12 HIS~? 21.73 ZN ZN B 402 C 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 C 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c22 PLASMINOGEN user 35 3 # 35 C 603 HIS B 13 HIS~? 19.30 ZN ZN B 402 C 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 C 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1qrz_c22 PLASMINOGEN user 36 3 # 36 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1qrz_c22 PLASMINOGEN user 37 3 # 37 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 38 3 # 38 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1qrz_c22 PLASMINOGEN user 39 3 # 39 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 40 3 # 40 C 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c22 PLASMINOGEN user 41 3 # 41 C 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c22 PLASMINOGEN user 42 3 # 42 C 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 43 3 # 43 C 603 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 646 ASP B 91 ASP.? 28.82 ZN ZN B 401 C 739 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 7.82 1.25 3.03 7.30 1.31 3.65 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1qrz_c22 PLASMINOGEN user 44 3 # 44 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c22 PLASMINOGEN user 45 3 # 45 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c22 PLASMINOGEN user 46 3 # 46 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c22 PLASMINOGEN user 47 3 # 47 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c22 PLASMINOGEN user 48 3 # 48 C 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1qrz_c22 PLASMINOGEN user 49 3 # 49 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 50 3 # 50 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1qrz_c22 PLASMINOGEN user 51 3 # 51 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 52 3 # 52 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c22 PLASMINOGEN user 53 3 # 53 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 54 3 # 54 C 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c22 PLASMINOGEN user 55 3 # 55 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c22 PLASMINOGEN user 56 3 # 56 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1qrz_c22 PLASMINOGEN user 57 3 # 57 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 58 3 # 58 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.82 1.25 3.03 7.30 1.31 3.65 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c22 PLASMINOGEN user 59 3 # 59 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 7.82 1.25 3.03 7.30 1.31 3.65 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c22 PLASMINOGEN user 60 3 # 60 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1qrz_c22 PLASMINOGEN user 61 3 # 61 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1qrz_c22 PLASMINOGEN user 62 3 # 62 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c22 PLASMINOGEN user 63 3 # 63 C 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 7.82 1.25 3.03 7.30 1.31 3.65 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c22 PLASMINOGEN user 64 3 # 64 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c22 PLASMINOGEN user 65 3 # 65 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c22 PLASMINOGEN user 66 3 # 66 C 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.47 105.54 19.38 -42.87 105.20 20.03 1qrz_c22 source 1qrz PLASMINOGEN : 66 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 12 HIS~? 21.70 ZN ZN A 401 D 646 ASP A 11 ASP~? 18.10 ZN ZN A 401 D 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c23 PLASMINOGEN user 8 3 # 8 D 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 646 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 9 3 # 9 D 603 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 646 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 739 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1qrz_c23 PLASMINOGEN user 10 3 # 10 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c23 PLASMINOGEN user 11 3 # 11 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1qrz_c23 PLASMINOGEN user 12 3 # 12 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 13 3 # 13 D 603 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c23 PLASMINOGEN user 14 3 # 14 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 15 3 # 15 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c23 PLASMINOGEN user 16 3 # 16 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY A 270 GLY.? 20.46 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -35.76 92.29 -8.66 -35.13 92.39 -8.06 ULMN 3 1qrz_c23 PLASMINOGEN user 17 3 # 17 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 18 3 # 18 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c23 PLASMINOGEN user 19 3 # 19 D 603 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 646 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 20 3 # 20 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c23 PLASMINOGEN user 21 3 # 21 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 79 GLY~? 19.61 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -48.98 87.93 -6.69 -49.20 87.16 -6.43 ULMN 3 1qrz_c23 PLASMINOGEN user 22 3 # 22 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c23 PLASMINOGEN user 23 3 # 23 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 24 3 # 24 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c23 PLASMINOGEN user 25 3 # 25 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP A 313 ASP~? 12.18 ZN ZN B 401 D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c23 PLASMINOGEN user 26 3 # 26 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c23 PLASMINOGEN user 27 3 # 27 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c23 PLASMINOGEN user 28 3 # 28 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 29 3 # 29 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c23 PLASMINOGEN user 30 3 # 30 D 603 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 646 ASP B 305 ASP.? 7.64 ZN ZN B 401 D 739 GLY A 288 GLY.? 14.54 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -47.81 104.86 -9.26 -47.13 104.59 -9.75 ULMN 3 1qrz_c23 PLASMINOGEN user 31 3 # 31 D 603 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 646 ASP A 323 ASP^? 12.30 ZN ZN A 402 D 739 GLY A 239 GLY.? 9.93 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -41.47 109.72 -18.36 -41.63 110.22 -18.97 ULMN 3 1qrz_c23 PLASMINOGEN user 32 3 # 32 D 603 HIS B 12 HIS~? 21.73 ZN ZN B 402 D 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 D 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -52.58 88.71 29.10 -52.20 89.31 31.07 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c23 PLASMINOGEN user 33 3 # 33 D 603 HIS B 13 HIS~? 19.30 ZN ZN B 402 D 646 ASP B 11 ASP~? 18.05 ZN ZN B 402 D 739 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1qrz_c23 PLASMINOGEN user 34 3 # 34 D 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.47 105.54 19.38 -42.87 105.20 20.03 ULMN 3 1qrz_c23 PLASMINOGEN user 35 3 # 35 D 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 36 3 # 36 D 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1qrz_c23 PLASMINOGEN user 37 3 # 37 D 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 38 3 # 38 D 603 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c23 PLASMINOGEN user 39 3 # 39 D 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c23 PLASMINOGEN user 40 3 # 40 D 603 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 646 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 41 3 # 41 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 71 GLY.? 18.04 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -59.65 93.73 1.35 -59.07 94.10 0.89 ULMN 3 1qrz_c23 PLASMINOGEN user 42 3 # 42 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c23 PLASMINOGEN user 43 3 # 43 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1qrz_c23 PLASMINOGEN user 44 3 # 44 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1qrz_c23 PLASMINOGEN user 45 3 # 45 D 603 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c23 PLASMINOGEN user 46 3 # 46 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 47 3 # 47 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY B 270 GLY.? 20.67 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -28.43 117.43 9.69 -27.94 117.09 9.08 ULMN 3 1qrz_c23 PLASMINOGEN user 48 3 # 48 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 49 3 # 49 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c23 PLASMINOGEN user 50 3 # 50 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 51 3 # 51 D 603 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 739 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1qrz_c23 PLASMINOGEN user 52 3 # 52 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c23 PLASMINOGEN user 53 3 # 53 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1qrz_c23 PLASMINOGEN user 54 3 # 54 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 55 3 # 55 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c23 PLASMINOGEN user 56 3 # 56 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP A 305 ASP.? 7.62 ZN ZN A 402 D 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c23 PLASMINOGEN user 57 3 # 57 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c23 PLASMINOGEN user 58 3 # 58 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 739 GLY A 79 GLY~? 19.65 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.15 128.46 7.52 -36.89 129.22 7.25 ULMN 3 1qrz_c23 PLASMINOGEN user 59 3 # 59 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 739 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1qrz_c23 PLASMINOGEN user 60 3 # 60 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 310 ASP~? 12.35 ZN ZN A 402 D 739 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1qrz_c23 PLASMINOGEN user 61 3 # 61 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 739 GLY A 71 GLY.? 18.01 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -49.58 129.10 -0.33 -49.28 128.51 0.13 ULMN 3 1qrz_c23 PLASMINOGEN user 62 3 # 62 D 603 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 646 ASP B 313 ASP~? 12.28 ZN ZN A 402 D 739 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1qrz_c23 PLASMINOGEN user 63 3 # 63 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP A 310 ASP~? 12.24 ZN ZN B 401 D 739 GLY B 288 GLY.? 14.50 ZN ZN B 401 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -45.18 113.19 10.25 -44.48 113.02 10.77 ULMN 3 1qrz_c23 PLASMINOGEN user 64 3 # 64 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 739 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1qrz_c23 PLASMINOGEN user 65 3 # 65 D 603 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 646 ASP B 323 ASP^? 12.28 ZN ZN B 401 D 739 GLY B 239 GLY.? 9.90 ZN ZN B 402 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.47 105.54 19.38 -42.87 105.20 20.03 1qrz_c23 source 1qrz PLASMINOGEN : 65 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 225 PHE.? 41.61 ZN ZN A 401 A 201 ASP A 226 ASP^? 42.28 ZN ZN A 401 A 227 LYS A 207 LYS~? 33.08 ZN ZN A 401 coo 23.39 49.81 32.16 21.33 51.68 32.26 -69.45 128.20 -38.50 -69.89 129.88 -36.28 coo 25.52 45.12 37.98 23.98 46.65 37.85 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 12.68 46.83 36.69 18.26 48.67 34.51 -62.26 128.30 -31.49 -66.46 124.09 -29.25 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 201 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 227 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 23.39 49.81 32.16 21.33 51.68 32.26 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 12.68 46.83 36.69 18.26 48.67 34.51 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 201 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 227 LYS A 119 LYS^? 25.23 ZN ZN A 401 coo 23.39 49.81 32.16 21.33 51.68 32.26 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 12.68 46.83 36.69 18.26 48.67 34.51 -30.64 105.03 -26.92 -25.62 104.22 -28.46 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 201 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 227 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 12.68 46.83 36.69 18.26 48.67 34.51 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE A 344 PHE~? 21.75 ZN ZN A 401 A 201 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 227 LYS A 2 LYS~? 31.84 ZN ZN A 401 coo 23.39 49.81 32.16 21.33 51.68 32.26 -30.23 132.91 -23.69 -31.48 133.59 -21.26 coo 25.52 45.12 37.98 23.98 46.65 37.85 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 12.68 46.83 36.69 18.26 48.67 34.51 -36.47 141.55 -19.14 -38.98 147.34 -19.86 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE A 363 PHE.? 13.25 ZN ZN A 402 A 201 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 227 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 25.52 45.12 37.98 23.98 46.65 37.85 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.68 46.83 36.69 18.26 48.67 34.51 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE B 146 PHE~? 50.49 ZN ZN B 402 A 201 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 227 LYS B 140 LYS.? 53.20 ZN ZN B 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 25.52 45.12 37.98 23.98 46.65 37.85 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 12.68 46.83 36.69 18.26 48.67 34.51 -74.22 104.46 56.49 -70.63 102.62 58.58 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 201 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 227 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 25.52 45.12 37.98 23.98 46.65 37.85 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 12.68 46.83 36.69 18.26 48.67 34.51 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE B 227 PHE^? 36.29 ZN ZN B 402 A 201 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 227 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -71.43 105.73 35.02 -72.67 103.28 35.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 201 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 227 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 25.52 45.12 37.98 23.98 46.65 37.85 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 12.68 46.83 36.69 18.26 48.67 34.51 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 1qz9_c02 KYNURENINASE user 11 3 # 11 A 129 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 201 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 227 LYS B 119 LYS^? 26.96 ZN ZN B 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 25.52 45.12 37.98 23.98 46.65 37.85 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 12.68 46.83 36.69 18.26 48.67 34.51 -30.71 103.60 27.70 -26.87 107.57 30.82 ULMN 3 1qz9_c02 KYNURENINASE user 12 3 # 12 A 129 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 201 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 227 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 23.39 49.81 32.16 21.33 51.68 32.26 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 12.68 46.83 36.69 18.26 48.67 34.51 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 1qz9_c02 KYNURENINASE user 13 3 # 13 A 129 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 201 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 227 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 12.68 46.83 36.69 18.26 48.67 34.51 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 1qz9_c02 KYNURENINASE user 14 3 # 14 A 129 PHE B 344 PHE~? 21.77 ZN ZN B 402 A 201 ASP B 352 ASP.? 26.97 ZN ZN B 402 A 227 LYS B 2 LYS~? 31.85 ZN ZN B 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -45.25 79.78 24.19 -46.74 79.97 21.79 coo 25.52 45.12 37.98 23.98 46.65 37.85 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 12.68 46.83 36.69 18.26 48.67 34.51 -55.28 75.86 19.60 -60.60 72.43 20.00 ULMN 3 1qz9_c02 KYNURENINASE user 15 3 # 15 A 129 PHE B 363 PHE^? 13.11 ZN ZN B 401 A 201 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 227 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 23.39 49.81 32.16 21.33 51.68 32.26 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.53 111.12 1.13 -44.30 110.60 0.01 1qz9_c02 source 1qz9 KYNURENINASE : 15 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 186 ASN A 100 ASN~? 9.95 ZN ZN A 401 A 260 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 11.81 33.10 11.71 13.07 31.45 11.40 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 11.43 26.53 7.41 13.01 27.56 8.43 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 21.53 26.33 6.96 20.26 25.69 7.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 186 ASN A 93 ASN^? 23.13 ZN ZN A 401 A 260 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo 11.81 33.10 11.71 13.07 31.45 11.40 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 11.43 26.53 7.41 13.01 27.56 8.43 -36.46 137.39 -10.90 -36.25 139.51 -10.83 coo 21.53 26.33 6.96 20.26 25.69 7.52 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 186 ASN A 100 ASN~? 9.95 ZN ZN A 401 A 260 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.43 26.53 7.41 13.01 27.56 8.43 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 21.53 26.33 6.96 20.26 25.69 7.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 186 ASN A 109 ASN~? 6.71 ZN ZN A 401 A 260 ALA A 280 ALA^? 15.08 ZN ZN A 401 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.43 26.53 7.41 13.01 27.56 8.43 -37.82 111.74 -18.14 -38.65 111.91 -16.17 coo 21.53 26.33 6.96 20.26 25.69 7.52 -38.75 103.47 -18.17 -40.17 102.98 -17.87 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 186 ASN A 320 ASN.? 23.41 ZN ZN B 401 A 260 ALA A 254 ALA~? 20.55 ZN ZN A 402 coo 11.81 33.10 11.71 13.07 31.45 11.40 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 11.43 26.53 7.41 13.01 27.56 8.43 -37.23 94.97 -12.31 -37.23 92.90 -12.72 coo 21.53 26.33 6.96 20.26 25.69 7.52 -28.06 99.81 -11.39 -28.64 99.01 -10.20 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 186 ASN A 320 ASN.? 23.41 ZN ZN B 401 A 260 ALA A 314 ALA~? 16.60 ZN ZN B 401 coo 11.81 33.10 11.71 13.07 31.45 11.40 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 11.43 26.53 7.41 13.01 27.56 8.43 -37.23 94.97 -12.31 -37.23 92.90 -12.72 coo 21.53 26.33 6.96 20.26 25.69 7.52 -43.51 95.31 -7.19 -42.51 96.46 -7.49 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 186 ASN B 100 ASN~? 9.88 ZN ZN B 402 A 260 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 11.81 33.10 11.71 13.07 31.45 11.40 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 11.43 26.53 7.41 13.01 27.56 8.43 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 21.53 26.33 6.96 20.26 25.69 7.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 186 ASN B 93 ASN^? 23.03 ZN ZN B 402 A 260 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo 11.81 33.10 11.71 13.07 31.45 11.40 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 11.43 26.53 7.41 13.01 27.56 8.43 -52.93 79.71 11.45 -53.96 77.86 11.50 coo 21.53 26.33 6.96 20.26 25.69 7.52 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 186 ASN B 100 ASN~? 9.88 ZN ZN B 402 A 260 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 11.81 33.10 11.71 13.07 31.45 11.40 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.43 26.53 7.41 13.01 27.56 8.43 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 21.53 26.33 6.96 20.26 25.69 7.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 10 3 # 10 A 10 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 186 ASN B 109 ASN~? 6.75 ZN ZN B 402 A 260 ALA B 280 ALA^? 15.00 ZN ZN B 402 coo 11.81 33.10 11.71 13.07 31.45 11.40 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.43 26.53 7.41 13.01 27.56 8.43 -40.37 101.87 19.09 -41.17 102.25 17.16 coo 21.53 26.33 6.96 20.26 25.69 7.52 -36.85 109.46 19.16 -37.78 110.59 18.83 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 11 3 # 11 A 10 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 186 ASN B 160 ASN.? 40.65 ZN ZN B 402 A 260 ALA B 156 ALA.? 35.75 ZN ZN B 402 coo 11.81 33.10 11.71 13.07 31.45 11.40 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 11.43 26.53 7.41 13.01 27.56 8.43 -64.74 101.16 47.93 -66.09 99.91 46.81 coo 21.53 26.33 6.96 20.26 25.69 7.52 -65.63 95.66 39.80 -66.97 96.37 40.09 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 12 3 # 12 A 10 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 186 ASN B 320 ASN.? 23.67 ZN ZN A 402 A 260 ALA B 254 ALA~? 20.56 ZN ZN B 401 coo 11.81 33.10 11.71 13.07 31.45 11.40 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 11.43 26.53 7.41 13.01 27.56 8.43 -31.14 115.93 13.50 -30.16 117.79 13.90 coo 21.53 26.33 6.96 20.26 25.69 7.52 -25.75 107.09 12.28 -25.85 108.07 11.12 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 13 3 # 13 A 10 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 186 ASN B 320 ASN.? 23.67 ZN ZN A 402 A 260 ALA B 314 ALA~? 16.61 ZN ZN A 402 coo 11.81 33.10 11.71 13.07 31.45 11.40 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 11.43 26.53 7.41 13.01 27.56 8.43 -31.14 115.93 13.50 -30.16 117.79 13.90 coo 21.53 26.33 6.96 20.26 25.69 7.52 -36.50 118.91 8.14 -36.25 117.42 8.39 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 13 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 41 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 119 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 41 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 119 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 41 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 119 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 4 3 # 4 A 12 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 41 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 119 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 5 3 # 5 A 12 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 41 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 119 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 6 3 # 6 A 12 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 41 LYS B 70 LYS.? 12.56 ZN ZN B 401 A 119 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 7 3 # 7 A 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 41 LYS B 70 LYS.? 12.56 ZN ZN B 401 A 119 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 8 3 # 8 A 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 41 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 119 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 9 3 # 9 A 12 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 41 LYS B 70 LYS.? 12.56 ZN ZN B 401 A 119 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 10 3 # 10 A 12 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 41 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 119 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 11 3 # 11 A 12 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 41 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 119 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 12 3 # 12 A 12 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 41 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 119 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -37.47 120.38 -11.48 -38.85 119.05 -12.30 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 12 hits 1rbn_c01 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 610 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 661 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 75.99 81.56 1.86 73.91 81.34 2.28 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 71.04 78.84 0.46 71.54 76.90 1.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 75.40 81.38 12.06 74.88 79.42 12.63 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 610 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 661 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo 75.99 81.56 1.86 73.91 81.34 2.28 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 71.04 78.84 0.46 71.54 76.90 1.02 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 75.40 81.38 12.06 74.88 79.42 12.63 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 610 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 661 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 75.99 81.56 1.86 73.91 81.34 2.28 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 71.04 78.84 0.46 71.54 76.90 1.02 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 75.40 81.38 12.06 74.88 79.42 12.63 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 610 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 661 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 75.99 81.56 1.86 73.91 81.34 2.28 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 71.04 78.84 0.46 71.54 76.90 1.02 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 75.40 81.38 12.06 74.88 79.42 12.63 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 5 3 # 5 A 608 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 610 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 661 HIS B 317 HIS~? 18.53 ZN ZN A 402 coo 75.99 81.56 1.86 73.91 81.34 2.28 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 71.04 78.84 0.46 71.54 76.90 1.02 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 75.40 81.38 12.06 74.88 79.42 12.63 -38.40 123.74 9.47 -39.77 124.82 8.30 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 6 3 # 6 A 608 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 610 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 661 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 75.99 81.56 1.86 73.91 81.34 2.28 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 71.04 78.84 0.46 71.54 76.90 1.02 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 75.40 81.38 12.06 74.88 79.42 12.63 -35.94 115.60 -2.36 -34.88 117.34 -2.86 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 6 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 610 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 661 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 610 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 661 HIS A 317 HIS~? 18.34 ZN ZN B 401 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -47.71 92.42 -8.32 -49.42 92.44 -7.12 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 610 HIS A 317 HIS~? 18.34 ZN ZN B 401 C 661 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 610 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 661 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 5 3 # 5 C 608 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 610 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 661 HIS B 317 HIS~? 18.53 ZN ZN A 402 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -38.40 123.74 9.47 -39.77 124.82 8.30 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 6 3 # 6 C 608 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 610 HIS B 317 HIS~? 18.53 ZN ZN A 402 C 661 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -38.40 123.74 9.47 -39.77 124.82 8.30 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 6 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 84 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 140 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 84 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 140 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 84 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 140 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 84 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 140 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 84 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 140 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 84 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 140 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rgq_c01 NS4A PEPTIDE user 7 3 # 7 B 60 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 84 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 140 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1rgq_c01 NS4A PEPTIDE user 8 3 # 8 B 60 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 84 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 140 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1rgq_c01 NS4A PEPTIDE user 9 3 # 9 B 60 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 84 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 140 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rgq_c01 NS4A PEPTIDE user 10 3 # 10 B 60 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 84 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 140 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rgq_c01 NS4A PEPTIDE user 11 3 # 11 B 60 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 84 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 140 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rgq_c01 NS4A PEPTIDE user 12 3 # 12 B 60 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 84 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 140 GLY B 286 GLY.? 9.05 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -42.82 107.61 10.95 -42.53 107.90 10.27 ULMN 3 1rgq_c01 NS4A PEPTIDE user 13 3 # 13 B 60 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 84 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 140 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1rgq_c01 NS4A PEPTIDE user 14 3 # 14 B 60 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 84 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 140 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1rgq_c01 NS4A PEPTIDE user 15 3 # 15 B 60 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 84 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 140 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1rgq_c01 NS4A PEPTIDE user 16 3 # 16 B 60 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 84 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 140 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1rgq_c01 NS4A PEPTIDE user 17 3 # 17 B 60 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 84 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 140 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rgq_c01 NS4A PEPTIDE user 18 3 # 18 B 60 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 84 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 140 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1rgq_c01 NS4A PEPTIDE user 19 3 # 19 B 60 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 84 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 140 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1rgq_c01 NS4A PEPTIDE user 20 3 # 20 B 60 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 84 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 140 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rgq_c01 NS4A PEPTIDE user 21 3 # 21 B 60 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 84 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 140 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1rgq_c01 NS4A PEPTIDE user 22 3 # 22 B 60 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 84 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 140 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1rgq_c01 NS4A PEPTIDE user 23 3 # 23 B 60 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 84 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 140 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rgq_c01 NS4A PEPTIDE user 24 3 # 24 B 60 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 84 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 140 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rgq_c01 NS4A PEPTIDE user 25 3 # 25 B 60 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 84 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 140 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rgq_c01 NS4A PEPTIDE user 26 3 # 26 B 60 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 84 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 140 GLY A 286 GLY.? 9.05 ZN ZN A 401 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -42.79 108.31 -9.97 -42.74 107.91 -9.28 ULMN 3 1rgq_c01 NS4A PEPTIDE user 27 3 # 27 B 60 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 84 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 140 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1rgq_c01 NS4A PEPTIDE user 28 3 # 28 B 60 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 84 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 140 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -36.73 108.01 -6.68 -37.53 107.81 -6.81 1rgq_c01 source 1rgq NS4A PEPTIDE : 28 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 35 SER A 285 SER.? 7.68 ZN ZN A 402 215 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 11.85 17.24 72.81 11.09 15.37 72.36 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 12.20 12.71 75.45 13.69 13.84 74.03 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 5.22 15.03 71.43 7.19 14.88 70.83 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 35 SER B 285 SER.? 7.72 ZN ZN B 401 215 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 11.85 17.24 72.81 11.09 15.37 72.36 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 12.20 12.71 75.45 13.69 13.84 74.03 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 5.22 15.03 71.43 7.19 14.88 70.83 -33.57 107.34 6.30 -34.87 106.07 5.21 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 2 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 288 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 329 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 29.27 18.78 14.99 27.16 18.62 14.76 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 49.52 10.06 10.36 50.99 9.65 8.92 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 57.80 12.92 13.83 53.77 8.42 12.15 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 288 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 329 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 29.27 18.78 14.99 27.16 18.62 14.76 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 49.52 10.06 10.36 50.99 9.65 8.92 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 57.80 12.92 13.83 53.77 8.42 12.15 -29.32 122.04 -13.64 -26.61 121.37 -8.37 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 290 GLU~? 16.18 ZN ZN A 402 B 288 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 329 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU B 290 GLU~? 16.07 ZN ZN B 401 B 288 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 329 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -29.32 122.04 -13.64 -26.61 121.37 -8.37 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 195 SER A 63 SER^? 10.35 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 102 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 195 SER A 328 SER~? 11.01 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 195 SER B 63 SER^? 10.37 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 102 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 195 SER B 328 SER~? 10.89 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -35.17 97.75 10.01 -33.21 99.13 9.77 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 193 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 3 # 8 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 9 3 # 9 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 10 3 # 10 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 11 3 # 11 B 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 12 3 # 12 B 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 13 3 # 13 B 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 14 3 # 14 B 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 B 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 193 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 15 3 # 15 B 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 16 3 # 16 B 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 17 3 # 17 B 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 18 3 # 18 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 193 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 19 3 # 19 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 20 3 # 20 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 21 3 # 21 B 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 22 3 # 22 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 23 3 # 23 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 24 3 # 24 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 25 3 # 25 B 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 26 3 # 26 B 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 27 3 # 27 B 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 28 3 # 28 B 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 B 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.40 123.74 9.47 -39.77 124.82 8.30 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -39.26 132.56 4.99 -38.51 132.20 4.81 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 28 hits 1rtf_c06 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 64 HIS.? -3.42 ZN ZN A 401s 62 GLU A 329 GLU~? 2.55 ZN ZN A 401s 101 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 13.91 26.31 13.70 14.98 27.08 12.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 9.15 26.32 13.85 8.75 28.20 13.02 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 7.90 34.31 7.89 9.24 33.73 9.42 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS A 326 HIS~? -3.60 ZN ZN A 402s 62 GLU A 329 GLU~? 2.55 ZN ZN A 401s 101 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 13.91 26.31 13.70 14.98 27.08 12.06 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 9.15 26.32 13.85 8.75 28.20 13.02 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 7.90 34.31 7.89 9.24 33.73 9.42 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 3 3 # 3 41 HIS B 64 HIS.? -3.45 ZN ZN B 402s 62 GLU B 329 GLU~? 2.54 ZN ZN B 402s 101 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 13.91 26.31 13.70 14.98 27.08 12.06 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 9.15 26.32 13.85 8.75 28.20 13.02 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 7.90 34.31 7.89 9.24 33.73 9.42 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 4 3 # 4 41 HIS B 326 HIS~? -3.48 ZN ZN B 401s 62 GLU B 329 GLU~? 2.54 ZN ZN B 402s 101 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 13.91 26.31 13.70 14.98 27.08 12.06 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 9.15 26.32 13.85 8.75 28.20 13.02 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 7.90 34.31 7.89 9.24 33.73 9.42 -49.25 96.40 11.26 -48.45 97.80 9.92 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 4 hits 1rtu_c00 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 88 ILE~? 24.29 ZN ZN A 402 A 106 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 142 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -38.22 139.89 -1.64 -39.64 139.99 -1.52 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE A 92 ILE.? 21.85 ZN ZN A 402 A 106 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 142 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -32.76 137.13 -6.54 -31.42 137.13 -7.09 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE A 316 ILE~? 15.52 ZN ZN B 401 A 106 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 142 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -45.28 90.15 -4.45 -45.68 89.80 -3.16 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 3 # 4 A 104 ILE B 88 ILE~? 24.40 ZN ZN B 401 A 106 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 142 ASP B 91 ASP.? 28.82 ZN ZN B 401 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -55.93 78.57 2.22 -57.18 79.30 2.20 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -53.83 73.30 7.14 -55.54 72.50 6.14 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 5 3 # 5 A 104 ILE B 92 ILE.? 21.89 ZN ZN B 401 A 106 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 142 ASP B 91 ASP.? 28.82 ZN ZN B 401 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -49.79 77.93 6.97 -48.64 77.24 7.58 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -53.83 73.30 7.14 -55.54 72.50 6.14 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 6 3 # 6 A 104 ILE B 316 ILE~? 16.17 ZN ZN A 402 A 106 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 142 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -35.12 124.50 5.59 -36.00 125.53 5.05 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -38.40 123.74 9.47 -39.77 124.82 8.30 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -39.61 120.08 5.22 -40.78 120.61 3.53 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 6 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 44 ASP.? 7.09 ZN ZN A 402 64 HIS A 65 HIS.? -3.39 ZN ZN A 402s 221 SER A 63 SER^? 10.35 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 78.27 67.69 61.83 79.58 67.76 60.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 83.63 66.07 58.16 81.31 66.75 57.98 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 64 HIS A 326 HIS~? -3.60 ZN ZN A 402s 221 SER A 328 SER~? 11.01 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 78.27 67.69 61.83 79.58 67.76 60.19 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 83.63 66.07 58.16 81.31 66.75 57.98 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 44 ASP.? 7.11 ZN ZN B 401 64 HIS B 65 HIS.? -3.43 ZN ZN B 401s 221 SER B 63 SER^? 10.37 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 78.27 67.69 61.83 79.58 67.76 60.19 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 83.63 66.07 58.16 81.31 66.75 57.98 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 64 HIS B 326 HIS~? -3.48 ZN ZN B 401s 221 SER B 328 SER~? 10.89 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 83.63 66.07 58.16 81.31 66.75 57.98 -35.17 97.75 10.01 -33.21 99.13 9.77 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 4 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 11 ASP~? 18.10 ZN ZN A 401 64 HIS A 12 HIS~? 21.70 ZN ZN A 401 155 ASN A 342 ASN~? 22.18 ZN ZN A 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 78.27 67.69 61.83 79.58 67.76 60.19 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 80.34 61.88 52.75 81.25 63.19 54.35 -29.33 125.76 -27.31 -29.81 125.41 -29.36 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 23 ASP.? 8.14 ZN ZN A 401 64 HIS A 98 HIS~? 4.98 ZN ZN A 401 155 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 78.27 67.69 61.83 79.58 67.76 60.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 80.34 61.88 52.75 81.25 63.19 54.35 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP A 44 ASP.? 7.09 ZN ZN A 402 64 HIS A 65 HIS.? -3.39 ZN ZN A 402s 155 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 78.27 67.69 61.83 79.58 67.76 60.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 80.34 61.88 52.75 81.25 63.19 54.35 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP A 44 ASP.? 7.09 ZN ZN A 402 64 HIS A 65 HIS.? -3.39 ZN ZN A 402s 155 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 78.27 67.69 61.83 79.58 67.76 60.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 80.34 61.88 52.75 81.25 63.19 54.35 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP A 102 ASP~? -1.98 ZN ZN A 401s 64 HIS A 64 HIS.? -3.42 ZN ZN A 401s 155 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 78.27 67.69 61.83 79.58 67.76 60.19 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 80.34 61.88 52.75 81.25 63.19 54.35 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 64 HIS A 326 HIS~? -3.60 ZN ZN A 402s 155 ASN A 109 ASN~? 6.71 ZN ZN A 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 78.27 67.69 61.83 79.58 67.76 60.19 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 80.34 61.88 52.75 81.25 63.19 54.35 -37.82 111.74 -18.14 -38.65 111.91 -16.17 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP A 310 ASP~? 12.24 ZN ZN B 401 64 HIS A 309 HIS~? 5.45 ZN ZN B 401 155 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 78.27 67.69 61.83 79.58 67.76 60.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 80.34 61.88 52.75 81.25 63.19 54.35 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP A 313 ASP~? 12.18 ZN ZN B 401 64 HIS A 309 HIS~? 5.45 ZN ZN B 401 155 ASN B 24 ASN.? 14.57 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 78.27 67.69 61.83 79.58 67.76 60.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 80.34 61.88 52.75 81.25 63.19 54.35 -56.06 94.54 8.52 -57.34 92.84 8.20 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 9 3 # 9 32 ASP A 313 ASP~? 12.18 ZN ZN B 401 64 HIS A 309 HIS~? 5.45 ZN ZN B 401 155 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 78.27 67.69 61.83 79.58 67.76 60.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 80.34 61.88 52.75 81.25 63.19 54.35 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 10 3 # 10 32 ASP B 11 ASP~? 18.05 ZN ZN B 402 64 HIS B 12 HIS~? 21.73 ZN ZN B 402 155 ASN B 342 ASN~? 21.94 ZN ZN B 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 78.27 67.69 61.83 79.58 67.76 60.19 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 80.34 61.88 52.75 81.25 63.19 54.35 -40.74 85.47 27.90 -41.03 86.13 29.94 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 11 3 # 11 32 ASP B 23 ASP.? 8.15 ZN ZN B 402 64 HIS B 98 HIS~? 5.02 ZN ZN B 402 155 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 78.27 67.69 61.83 79.58 67.76 60.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 80.34 61.88 52.75 81.25 63.19 54.35 -46.36 96.74 22.46 -46.71 95.57 24.21 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 12 3 # 12 32 ASP B 44 ASP.? 7.11 ZN ZN B 401 64 HIS B 65 HIS.? -3.43 ZN ZN B 401s 155 ASN B 24 ASN.? 14.57 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 78.27 67.69 61.83 79.58 67.76 60.19 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 80.34 61.88 52.75 81.25 63.19 54.35 -56.06 94.54 8.52 -57.34 92.84 8.20 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 13 3 # 13 32 ASP B 44 ASP.? 7.11 ZN ZN B 401 64 HIS B 65 HIS.? -3.43 ZN ZN B 401s 155 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 78.27 67.69 61.83 79.58 67.76 60.19 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 80.34 61.88 52.75 81.25 63.19 54.35 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 14 3 # 14 32 ASP B 102 ASP~? -1.99 ZN ZN B 402s 64 HIS B 64 HIS.? -3.45 ZN ZN B 402s 155 ASN B 24 ASN.? 14.57 ZN ZN B 401 coo 80.16 73.25 62.48 80.01 71.25 61.82 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 78.27 67.69 61.83 79.58 67.76 60.19 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 80.34 61.88 52.75 81.25 63.19 54.35 -56.06 94.54 8.52 -57.34 92.84 8.20 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 15 3 # 15 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 64 HIS B 326 HIS~? -3.48 ZN ZN B 401s 155 ASN B 109 ASN~? 6.75 ZN ZN B 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 80.34 61.88 52.75 81.25 63.19 54.35 -40.37 101.87 19.09 -41.17 102.25 17.16 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 16 3 # 16 32 ASP B 310 ASP~? 12.35 ZN ZN A 402 64 HIS B 309 HIS~? 5.48 ZN ZN A 402 155 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 80.34 61.88 52.75 81.25 63.19 54.35 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 17 3 # 17 32 ASP B 313 ASP~? 12.28 ZN ZN A 402 64 HIS B 309 HIS~? 5.48 ZN ZN A 402 155 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 80.34 61.88 52.75 81.25 63.19 54.35 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 18 3 # 18 32 ASP B 313 ASP~? 12.28 ZN ZN A 402 64 HIS B 309 HIS~? 5.48 ZN ZN A 402 155 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 80.16 73.25 62.48 80.01 71.25 61.82 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 78.27 67.69 61.83 79.58 67.76 60.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 80.34 61.88 52.75 81.25 63.19 54.35 -31.91 109.24 -4.57 -30.97 107.55 -3.66 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 18 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 44 ASP.? 7.09 ZN ZN A 402 595 GLU A 329 GLU~? 2.55 ZN ZN A 401s 713 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 5.64 2.82 38.49 4.59 4.19 37.25 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 4.35 13.73 37.63 3.39 12.18 36.55 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 3.76 10.25 31.38 3.16 9.87 34.10 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP A 129 ASP^? 19.65 ZN ZN A 401 595 GLU A 229 GLU^? 28.63 ZN ZN A 401 713 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 5.64 2.82 38.49 4.59 4.19 37.25 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 4.35 13.73 37.63 3.39 12.18 36.55 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 3.76 10.25 31.38 3.16 9.87 34.10 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP A 226 ASP^? 42.28 ZN ZN A 401 595 GLU A 229 GLU^? 28.63 ZN ZN A 401 713 TYR A 132 TYR^? 30.56 ZN ZN A 401 coo 5.64 2.82 38.49 4.59 4.19 37.25 -69.19 121.99 -38.15 -70.92 121.97 -39.34 coo 4.35 13.73 37.63 3.39 12.18 36.55 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo 3.76 10.25 31.38 3.16 9.87 34.10 -62.09 122.49 -32.07 -63.03 122.42 -29.44 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP A 305 ASP.? 7.62 ZN ZN A 402 595 GLU A 329 GLU~? 2.55 ZN ZN A 401s 713 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 5.64 2.82 38.49 4.59 4.19 37.25 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 4.35 13.73 37.63 3.39 12.18 36.55 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 3.76 10.25 31.38 3.16 9.87 34.10 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP A 323 ASP^? 12.30 ZN ZN A 402 595 GLU A 329 GLU~? 2.55 ZN ZN A 401s 713 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 5.64 2.82 38.49 4.59 4.19 37.25 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 4.35 13.73 37.63 3.39 12.18 36.55 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 3.76 10.25 31.38 3.16 9.87 34.10 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP B 44 ASP.? 7.11 ZN ZN B 401 595 GLU B 329 GLU~? 2.54 ZN ZN B 402s 713 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 5.64 2.82 38.49 4.59 4.19 37.25 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 4.35 13.73 37.63 3.39 12.18 36.55 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 3.76 10.25 31.38 3.16 9.87 34.10 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP B 129 ASP^? 19.14 ZN ZN B 402 595 GLU B 229 GLU^? 28.52 ZN ZN B 402 713 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 5.64 2.82 38.49 4.59 4.19 37.25 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 4.35 13.73 37.63 3.39 12.18 36.55 -65.20 109.92 29.95 -64.70 111.14 28.31 coo 3.76 10.25 31.38 3.16 9.87 34.10 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP B 226 ASP^? 42.35 ZN ZN B 402 595 GLU B 229 GLU^? 28.52 ZN ZN B 402 713 TYR B 132 TYR^? 30.83 ZN ZN B 402 coo 5.64 2.82 38.49 4.59 4.19 37.25 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 4.35 13.73 37.63 3.39 12.18 36.55 -65.20 109.92 29.95 -64.70 111.14 28.31 coo 3.76 10.25 31.38 3.16 9.87 34.10 -67.13 105.92 32.85 -67.85 106.57 30.23 ULMN 3 1sll_c00 SIALIDASE L user 9 3 # 9 318 ASP B 305 ASP.? 7.64 ZN ZN B 401 595 GLU B 329 GLU~? 2.54 ZN ZN B 402s 713 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 5.64 2.82 38.49 4.59 4.19 37.25 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 4.35 13.73 37.63 3.39 12.18 36.55 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 3.76 10.25 31.38 3.16 9.87 34.10 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1sll_c00 SIALIDASE L user 10 3 # 10 318 ASP B 323 ASP^? 12.28 ZN ZN B 401 595 GLU B 329 GLU~? 2.54 ZN ZN B 402s 713 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 5.64 2.82 38.49 4.59 4.19 37.25 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 4.35 13.73 37.63 3.39 12.18 36.55 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 3.76 10.25 31.38 3.16 9.87 34.10 -35.81 95.23 5.63 -35.48 92.50 6.11 1sll_c00 source 1sll SIALIDASE L : 10 hits 1sll_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 37 SER A 285 SER.? 7.68 ZN ZN A 402 A 214 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 51.75 60.57 19.10 52.05 60.90 21.19 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 51.10 65.11 20.73 52.62 63.74 19.42 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 48.59 58.89 25.78 50.13 59.74 24.61 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 37 SER B 285 SER.? 7.72 ZN ZN B 401 A 214 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 51.75 60.57 19.10 52.05 60.90 21.19 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 51.10 65.11 20.73 52.62 63.74 19.42 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 48.59 58.89 25.78 50.13 59.74 24.61 -33.57 107.34 6.30 -34.87 106.07 5.21 1sme_c04 source 1sme PLASMEPSIN II : 2 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 37 SER A 285 SER.? 7.68 ZN ZN A 402 B 214 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 17.69 97.58 52.73 17.33 97.19 54.77 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 20.67 100.44 55.84 20.21 98.51 54.45 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 12.41 98.71 58.47 14.37 98.17 58.05 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 37 SER A 285 SER.? 7.68 ZN ZN A 402 B 214 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 17.69 97.58 52.73 17.33 97.19 54.77 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 20.67 100.44 55.84 20.21 98.51 54.45 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 12.41 98.71 58.47 14.37 98.17 58.05 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 37 SER B 285 SER.? 7.72 ZN ZN B 401 B 214 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 17.69 97.58 52.73 17.33 97.19 54.77 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 20.67 100.44 55.84 20.21 98.51 54.45 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 12.41 98.71 58.47 14.37 98.17 58.05 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 37 SER B 285 SER.? 7.72 ZN ZN B 401 B 214 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 17.69 97.58 52.73 17.33 97.19 54.77 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 20.67 100.44 55.84 20.21 98.51 54.45 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 12.41 98.71 58.47 14.37 98.17 58.05 -33.57 107.34 6.30 -34.87 106.07 5.21 1sme_c05 source 1sme PLASMEPSIN II : 4 hits 1sme_c05 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.52 29.10 10.01 15.08 29.66 10.19 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.67 30.58 22.61 18.30 29.87 21.17 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.67 30.58 22.61 18.30 29.87 21.17 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.52 29.10 10.01 15.08 29.66 10.19 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.52 29.10 10.01 15.08 29.66 10.19 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.52 29.10 10.01 15.08 29.66 10.19 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.52 29.10 10.01 15.08 29.66 10.19 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 11 3 # 11 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.52 29.10 10.01 15.08 29.66 10.19 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 12 3 # 12 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 13 3 # 13 A 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.67 30.58 22.61 18.30 29.87 21.17 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.52 29.10 10.01 15.08 29.66 10.19 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 14 3 # 14 A 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 193 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 19.67 30.58 22.61 18.30 29.87 21.17 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 14.52 29.10 10.01 15.08 29.66 10.19 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 15 3 # 15 A 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.67 30.58 22.61 18.30 29.87 21.17 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 16 3 # 16 A 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 19.67 30.58 22.61 18.30 29.87 21.17 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.52 29.10 10.01 15.08 29.66 10.19 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 17 3 # 17 A 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 19.67 30.58 22.61 18.30 29.87 21.17 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.52 29.10 10.01 15.08 29.66 10.19 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 18 3 # 18 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.67 30.58 22.61 18.30 29.87 21.17 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 14.52 29.10 10.01 15.08 29.66 10.19 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 19 3 # 19 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.67 30.58 22.61 18.30 29.87 21.17 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 14.52 29.10 10.01 15.08 29.66 10.19 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 20 3 # 20 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.67 30.58 22.61 18.30 29.87 21.17 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.52 29.10 10.01 15.08 29.66 10.19 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 21 3 # 21 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 22 3 # 22 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 23 3 # 23 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.52 29.10 10.01 15.08 29.66 10.19 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 24 3 # 24 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 15.02 29.17 19.44 15.63 29.96 17.60 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 25 3 # 25 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 26 3 # 26 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.52 29.10 10.01 15.08 29.66 10.19 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 27 3 # 27 A 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.67 30.58 22.61 18.30 29.87 21.17 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 28 3 # 28 A 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.67 30.58 22.61 18.30 29.87 21.17 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.52 29.10 10.01 15.08 29.66 10.19 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 29 3 # 29 A 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 15.02 29.17 19.44 15.63 29.96 17.60 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 19.67 30.58 22.61 18.30 29.87 21.17 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 14.52 29.10 10.01 15.08 29.66 10.19 -39.26 132.56 4.99 -38.51 132.20 4.81 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 29 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 352 ASP.? 27.02 ZN ZN A 401 E 168 LYS A 56 LYS~? 22.91 ZN ZN A 402 E 201 THR A 37 THR.? 27.03 ZN ZN A 401 coo 5.36 16.20 22.10 3.88 17.00 23.31 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 5.06 22.32 18.11 1.02 22.08 22.74 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -28.34 140.20 -15.53 -28.28 141.11 -13.55 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 129 ASP^? 19.14 ZN ZN B 402 E 168 LYS B 231 LYS^? 25.02 ZN ZN B 402 E 201 THR B 233 THR^? 21.46 ZN ZN B 402 coo 5.36 16.20 22.10 3.88 17.00 23.31 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 5.06 22.32 18.11 1.02 22.08 22.74 -59.06 109.88 30.77 -61.50 111.95 25.23 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -52.42 108.39 29.83 -50.75 109.78 29.75 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 226 ASP^? 42.35 ZN ZN B 402 E 168 LYS B 133 LYS^? 36.11 ZN ZN B 402 E 201 THR B 136 THR^? 43.30 ZN ZN B 402 coo 5.36 16.20 22.10 3.88 17.00 23.31 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 5.06 22.32 18.11 1.02 22.08 22.74 -65.38 107.19 38.20 -61.64 109.75 42.23 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -73.17 106.15 44.31 -73.94 104.19 43.69 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 352 ASP.? 26.97 ZN ZN B 402 E 168 LYS B 56 LYS~? 22.19 ZN ZN B 401 E 201 THR B 37 THR.? 27.08 ZN ZN B 402 coo 5.36 16.20 22.10 3.88 17.00 23.31 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 5.06 22.32 18.11 1.02 22.08 22.74 -40.15 73.23 9.47 -36.32 78.07 10.66 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -47.65 72.83 15.84 -48.15 72.05 13.90 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c02 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 288 GLY.? 14.54 ZN ZN A 401 B 17 GLN A 292 GLN~? 17.94 ZN ZN A 401 B 140 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 61.49 19.86 5.96 61.52 19.46 5.16 -47.81 104.86 -9.26 -47.13 104.59 -9.75 coo 63.76 11.90 7.93 65.18 13.07 6.77 -50.01 102.63 -16.47 -50.74 104.11 -17.85 coo 66.44 19.00 7.38 67.69 17.67 8.37 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 159 GLY.? 37.15 ZN ZN B 402 B 17 GLN B 157 GLN.? 30.14 ZN ZN B 402 B 140 GLU B 158 GLU.? 36.73 ZN ZN B 402 coo 61.49 19.86 5.96 61.52 19.46 5.16 -60.88 99.41 45.73 -61.71 99.23 45.50 coo 63.76 11.90 7.93 65.18 13.07 6.77 -60.64 95.29 39.72 -58.86 95.89 38.72 coo 66.44 19.00 7.38 67.69 17.67 8.37 -60.87 94.33 46.47 -60.36 92.90 44.98 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY B 288 GLY.? 14.50 ZN ZN B 401 B 17 GLN B 292 GLN~? 17.13 ZN ZN B 402 B 140 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 61.49 19.86 5.96 61.52 19.46 5.16 -45.18 113.19 10.25 -44.48 113.02 10.77 coo 63.76 11.90 7.93 65.18 13.07 6.77 -45.46 115.49 18.78 -47.34 114.68 18.22 coo 66.44 19.00 7.38 67.69 17.67 8.37 -39.98 115.46 11.22 -41.44 114.62 9.91 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 3 hits 1t4c_c02 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER A 328 SER~? 11.01 ZN ZN A 402 B 263 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 285 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1tah_c00 LIPASE user 2 3 # 2 B 87 SER B 328 SER~? 10.89 ZN ZN B 401 B 263 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 285 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -40.92 100.43 6.30 -42.93 100.06 6.77 1tah_c00 source 1tah LIPASE : 2 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER A 328 SER~? 11.01 ZN ZN A 402 A 263 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 285 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1tah_c01 LIPASE user 2 3 # 2 A 87 SER B 328 SER~? 10.89 ZN ZN B 401 A 263 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 285 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -40.92 100.43 6.30 -42.93 100.06 6.77 1tah_c01 source 1tah LIPASE : 2 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER A 328 SER~? 11.01 ZN ZN A 402 C 263 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 285 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1tah_c02 LIPASE user 2 3 # 2 C 87 SER B 328 SER~? 10.89 ZN ZN B 401 C 263 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 285 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -40.92 100.43 6.30 -42.93 100.06 6.77 1tah_c02 source 1tah LIPASE : 2 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER A 328 SER~? 11.01 ZN ZN A 402 D 263 ASP A 305 ASP.? 7.62 ZN ZN A 402 D 285 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1tah_c03 LIPASE user 2 3 # 2 D 87 SER B 328 SER~? 10.89 ZN ZN B 401 D 263 ASP B 305 ASP.? 7.64 ZN ZN B 401 D 285 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -40.92 100.43 6.30 -42.93 100.06 6.77 1tah_c03 source 1tah LIPASE : 2 hits 1tah_c03 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 285 SER.? 7.68 ZN ZN A 402 354 GLU A 329 GLU~? 2.55 ZN ZN A 401s 463 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 48.87 13.74 2.81 48.49 11.54 3.93 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 39.95 14.43 3.01 41.55 14.10 1.63 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 43.90 10.50 2.81 45.63 11.48 3.27 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 285 SER.? 7.72 ZN ZN B 401 354 GLU B 329 GLU~? 2.54 ZN ZN B 402s 463 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 48.87 13.74 2.81 48.49 11.54 3.93 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 39.95 14.43 3.01 41.55 14.10 1.63 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 43.90 10.50 2.81 45.63 11.48 3.27 -40.92 100.43 6.30 -42.93 100.06 6.77 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 2 hits 1thg_c00 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 174 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 404 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 174 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 174 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 A 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 A 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 A 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 174 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 A 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 174 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 A 144 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 174 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 404 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 A 144 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 A 144 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 174 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 A 144 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 174 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 A 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 174 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 A 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 A 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 A 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 174 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -34.63 93.02 10.28 -32.00 93.52 11.20 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 16 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 13 HIS~? 19.28 ZN ZN A 401 C 174 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 404 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 174 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 174 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 C 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 C 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 C 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 174 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 C 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 174 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 C 144 HIS B 13 HIS~? 19.30 ZN ZN B 402 C 174 ASP B 11 ASP~? 18.05 ZN ZN B 402 C 404 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 C 144 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 C 144 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 174 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 C 144 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 174 ASP B 313 ASP~? 12.28 ZN ZN A 402 C 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 C 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 174 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 C 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 C 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 C 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 174 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -34.63 93.02 10.28 -32.00 93.52 11.20 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 16 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 13 HIS~? 19.28 ZN ZN A 401 E 174 ASP A 11 ASP~? 18.10 ZN ZN A 401 E 404 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 174 ASP B 305 ASP.? 7.64 ZN ZN B 401 E 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS A 309 HIS~? 5.45 ZN ZN B 401 E 174 ASP A 313 ASP~? 12.18 ZN ZN B 401 E 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 E 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 E 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 E 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 174 ASP A 323 ASP^? 12.30 ZN ZN A 402 E 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 E 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 174 ASP B 310 ASP~? 12.35 ZN ZN A 402 E 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 E 144 HIS B 13 HIS~? 19.30 ZN ZN B 402 E 174 ASP B 11 ASP~? 18.05 ZN ZN B 402 E 404 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 E 144 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 E 144 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 174 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 E 144 HIS B 309 HIS~? 5.48 ZN ZN A 402 E 174 ASP B 313 ASP~? 12.28 ZN ZN A 402 E 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 E 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 174 ASP A 310 ASP~? 12.24 ZN ZN B 401 E 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 E 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 E 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 E 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 174 ASP B 323 ASP^? 12.28 ZN ZN B 401 E 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -34.63 93.02 10.28 -32.00 93.52 11.20 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 16 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 13 HIS~? 19.28 ZN ZN A 401 G 174 ASP A 11 ASP~? 18.10 ZN ZN A 401 G 404 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 58.10-108.15 40.62 59.57-106.86 41.51 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 65 HIS.? -3.39 ZN ZN A 402s G 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s G 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 58.10-108.15 40.62 59.57-106.86 41.51 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS A 308 HIS~? 6.49 ZN ZN B 401 G 174 ASP B 305 ASP.? 7.64 ZN ZN B 401 G 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 58.10-108.15 40.62 59.57-106.86 41.51 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS A 309 HIS~? 5.45 ZN ZN B 401 G 174 ASP A 313 ASP~? 12.18 ZN ZN B 401 G 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 58.10-108.15 40.62 59.57-106.86 41.51 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 G 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s G 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s G 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 58.10-108.15 40.62 59.57-106.86 41.51 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 G 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s G 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s G 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 58.10-108.15 40.62 59.57-106.86 41.51 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 G 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s G 174 ASP A 323 ASP^? 12.30 ZN ZN A 402 G 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 58.10-108.15 40.62 59.57-106.86 41.51 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 G 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s G 174 ASP B 310 ASP~? 12.35 ZN ZN A 402 G 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 58.10-108.15 40.62 59.57-106.86 41.51 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 G 144 HIS B 13 HIS~? 19.30 ZN ZN B 402 G 174 ASP B 11 ASP~? 18.05 ZN ZN B 402 G 404 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 58.10-108.15 40.62 59.57-106.86 41.51 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 G 144 HIS B 65 HIS.? -3.43 ZN ZN B 401s G 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s G 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 58.10-108.15 40.62 59.57-106.86 41.51 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 G 144 HIS B 308 HIS~? 6.54 ZN ZN A 402 G 174 ASP A 305 ASP.? 7.62 ZN ZN A 402 G 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 58.10-108.15 40.62 59.57-106.86 41.51 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 G 144 HIS B 309 HIS~? 5.48 ZN ZN A 402 G 174 ASP B 313 ASP~? 12.28 ZN ZN A 402 G 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 58.10-108.15 40.62 59.57-106.86 41.51 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 G 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s G 174 ASP A 310 ASP~? 12.24 ZN ZN B 401 G 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 G 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s G 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s G 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 G 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s G 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s G 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 G 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s G 174 ASP B 323 ASP^? 12.28 ZN ZN B 401 G 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 60.48-101.16 45.95 60.56-101.20 43.85 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -34.63 93.02 10.28 -32.00 93.52 11.20 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 16 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 13 HIS~? 19.28 ZN ZN A 401 I 174 ASP A 11 ASP~? 18.10 ZN ZN A 401 I 404 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 65 HIS.? -3.39 ZN ZN A 402s I 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s I 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS A 308 HIS~? 6.49 ZN ZN B 401 I 174 ASP B 305 ASP.? 7.64 ZN ZN B 401 I 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS A 309 HIS~? 5.45 ZN ZN B 401 I 174 ASP A 313 ASP~? 12.18 ZN ZN B 401 I 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 I 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s I 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s I 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 I 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s I 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s I 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 I 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s I 174 ASP A 323 ASP^? 12.30 ZN ZN A 402 I 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 I 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s I 174 ASP B 310 ASP~? 12.35 ZN ZN A 402 I 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 I 144 HIS B 13 HIS~? 19.30 ZN ZN B 402 I 174 ASP B 11 ASP~? 18.05 ZN ZN B 402 I 404 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -48.35 88.91 27.28 -48.07 87.61 28.91 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 I 144 HIS B 65 HIS.? -3.43 ZN ZN B 401s I 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s I 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 I 144 HIS B 308 HIS~? 6.54 ZN ZN A 402 I 174 ASP A 305 ASP.? 7.62 ZN ZN A 402 I 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 I 144 HIS B 309 HIS~? 5.48 ZN ZN A 402 I 174 ASP B 313 ASP~? 12.28 ZN ZN A 402 I 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 I 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s I 174 ASP A 310 ASP~? 12.24 ZN ZN B 401 I 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 I 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s I 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s I 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 I 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s I 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s I 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 I 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s I 174 ASP B 323 ASP^? 12.28 ZN ZN B 401 I 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -34.63 93.02 10.28 -32.00 93.52 11.20 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 16 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 13 HIS~? 19.28 ZN ZN A 401 K 174 ASP A 11 ASP~? 18.10 ZN ZN A 401 K 404 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 102.36 30.86 6.31 102.45 29.08 5.12 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 65 HIS.? -3.39 ZN ZN A 402s K 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s K 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 102.36 30.86 6.31 102.45 29.08 5.12 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS A 308 HIS~? 6.49 ZN ZN B 401 K 174 ASP B 305 ASP.? 7.64 ZN ZN B 401 K 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 102.36 30.86 6.31 102.45 29.08 5.12 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS A 309 HIS~? 5.45 ZN ZN B 401 K 174 ASP A 313 ASP~? 12.18 ZN ZN B 401 K 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 102.36 30.86 6.31 102.45 29.08 5.12 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 K 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s K 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s K 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 102.36 30.86 6.31 102.45 29.08 5.12 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 K 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s K 174 ASP A 102 ASP~? -1.98 ZN ZN A 401s K 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 102.36 30.86 6.31 102.45 29.08 5.12 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 K 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s K 174 ASP A 323 ASP^? 12.30 ZN ZN A 402 K 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 102.36 30.86 6.31 102.45 29.08 5.12 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 K 144 HIS A 326 HIS~? -3.60 ZN ZN A 402s K 174 ASP B 310 ASP~? 12.35 ZN ZN A 402 K 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 102.36 30.86 6.31 102.45 29.08 5.12 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 9 3 # 9 K 144 HIS B 13 HIS~? 19.30 ZN ZN B 402 K 174 ASP B 11 ASP~? 18.05 ZN ZN B 402 K 404 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 102.36 30.86 6.31 102.45 29.08 5.12 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 10 3 # 10 K 144 HIS B 65 HIS.? -3.43 ZN ZN B 401s K 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s K 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 102.36 30.86 6.31 102.45 29.08 5.12 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 11 3 # 11 K 144 HIS B 308 HIS~? 6.54 ZN ZN A 402 K 174 ASP A 305 ASP.? 7.62 ZN ZN A 402 K 404 TYR A 330 TYR~? 12.28 ZN ZN A 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 102.36 30.86 6.31 102.45 29.08 5.12 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -28.08 116.36 -9.49 -26.20 114.52 -10.52 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 12 3 # 12 K 144 HIS B 309 HIS~? 5.48 ZN ZN A 402 K 174 ASP B 313 ASP~? 12.28 ZN ZN A 402 K 404 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 102.36 30.86 6.31 102.45 29.08 5.12 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 13 3 # 13 K 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s K 174 ASP A 310 ASP~? 12.24 ZN ZN B 401 K 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 14 3 # 14 K 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s K 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s K 404 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 15 3 # 15 K 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s K 174 ASP B 102 ASP~? -1.99 ZN ZN B 402s K 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -34.63 93.02 10.28 -32.00 93.52 11.20 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 16 3 # 16 K 144 HIS B 326 HIS~? -3.48 ZN ZN B 401s K 174 ASP B 323 ASP^? 12.28 ZN ZN B 401 K 404 TYR B 330 TYR~? 12.23 ZN ZN B 401 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -34.63 93.02 10.28 -32.00 93.52 11.20 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 16 hits 1ti6_c11 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 56 LYS~? 22.91 ZN ZN A 402 138 ASN A 51 ASN~? 22.86 ZN ZN A 402 183 HIS A 90 HIS~? 26.77 ZN ZN A 402 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -30.00 140.26 -1.63 -28.87 140.48 0.12 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS A 56 LYS~? 22.91 ZN ZN A 402 138 ASN A 59 ASN.? 24.94 ZN ZN A 401 183 HIS A 90 HIS~? 26.77 ZN ZN A 402 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -30.92 139.81 -10.79 -31.57 140.22 -12.79 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -30.00 140.26 -1.63 -28.87 140.48 0.12 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS A 70 LYS.? 15.41 ZN ZN A 402 138 ASN A 24 ASN.? 14.49 ZN ZN A 402 183 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 4 3 # 4 115 LYS A 70 LYS.? 15.41 ZN ZN A 402 138 ASN A 24 ASN.? 14.49 ZN ZN A 402 183 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 5 3 # 5 115 LYS B 56 LYS~? 22.19 ZN ZN B 401 138 ASN B 51 ASN~? 22.98 ZN ZN B 401 183 HIS B 90 HIS~? 26.84 ZN ZN B 401 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -40.15 73.23 9.47 -36.32 78.07 10.66 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -49.12 73.85 2.19 -48.21 73.06 0.48 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 6 3 # 6 115 LYS B 56 LYS~? 22.19 ZN ZN B 401 138 ASN B 59 ASN.? 24.90 ZN ZN B 402 183 HIS B 90 HIS~? 26.84 ZN ZN B 401 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -40.15 73.23 9.47 -36.32 78.07 10.66 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -49.65 74.63 11.24 -50.47 74.68 13.21 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -49.12 73.85 2.19 -48.21 73.06 0.48 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 7 3 # 7 115 LYS B 70 LYS.? 12.56 ZN ZN B 401 138 ASN B 24 ASN.? 14.57 ZN ZN B 401 183 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 8 3 # 8 115 LYS B 70 LYS.? 12.56 ZN ZN B 401 138 ASN B 24 ASN.? 14.57 ZN ZN B 401 183 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 9 3 # 9 115 LYS B 348 LYS.? 30.27 ZN ZN B 402 138 ASN B 345 ASN~? 27.56 ZN ZN B 402 183 HIS B 13 HIS~? 19.30 ZN ZN B 402 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -45.82 76.15 30.63 -44.25 78.32 34.65 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -41.25 80.30 29.90 -40.44 79.74 31.83 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -48.35 88.91 27.28 -48.07 87.61 28.91 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 9 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 243 GLU^? 24.16 ZN ZN A 401 A 126 LYS A 277 LYS^? 27.09 ZN ZN A 401 A 171 ALA A 242 ALA^? 17.05 ZN ZN A 401 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -35.28 104.10 -23.67 -34.41 105.16 -22.99 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU B 211 GLU~? 39.18 ZN ZN B 402 A 126 LYS B 215 LYS~? 43.78 ZN ZN B 402 A 171 ALA B 210 ALA~? 35.92 ZN ZN B 402 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -75.90 102.21 34.20 -77.49 103.04 33.09 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -72.12 98.80 36.60 -71.08 99.90 36.52 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU B 243 GLU^? 24.39 ZN ZN B 402 A 126 LYS B 277 LYS^? 26.47 ZN ZN B 402 A 171 ALA B 242 ALA^? 17.24 ZN ZN B 402 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -34.17 107.07 24.62 -33.83 105.72 24.06 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 3 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 243 GLU^? 24.16 ZN ZN A 401 B 126 LYS A 277 LYS^? 27.09 ZN ZN A 401 B 171 ALA A 242 ALA^? 17.05 ZN ZN A 401 coo 20.47 87.42 16.54 20.16 87.17 14.45 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 24.73 94.37 14.59 21.08 89.84 11.98 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 24.38 86.32 12.71 22.88 86.54 12.71 -35.28 104.10 -23.67 -34.41 105.16 -22.99 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 211 GLU~? 39.18 ZN ZN B 402 B 126 LYS B 215 LYS~? 43.78 ZN ZN B 402 B 171 ALA B 210 ALA~? 35.92 ZN ZN B 402 coo 20.47 87.42 16.54 20.16 87.17 14.45 -75.90 102.21 34.20 -77.49 103.04 33.09 coo 24.73 94.37 14.59 21.08 89.84 11.98 -79.75 99.05 40.27 -81.86 101.81 35.01 coo 24.38 86.32 12.71 22.88 86.54 12.71 -72.12 98.80 36.60 -71.08 99.90 36.52 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU B 243 GLU^? 24.39 ZN ZN B 402 B 126 LYS B 277 LYS^? 26.47 ZN ZN B 402 B 171 ALA B 242 ALA^? 17.24 ZN ZN B 402 coo 20.47 87.42 16.54 20.16 87.17 14.45 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 24.73 94.37 14.59 21.08 89.84 11.98 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 24.38 86.32 12.71 22.88 86.54 12.71 -34.17 107.07 24.62 -33.83 105.72 24.06 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 3 hits 1uf7_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 19 ALA~? 10.49 ZN ZN A 401 A 224 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 252 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 96 ALA^? 10.78 ZN ZN A 401 A 224 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 252 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA B 19 ALA~? 10.41 ZN ZN B 402 A 224 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 252 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -53.87 98.79 16.99 -54.12 97.55 16.16 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA B 96 ALA^? 10.72 ZN ZN B 402 A 224 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 252 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1uk7_c00 3.07.01.0009 user 5 3 # 5 A 103 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 224 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 252 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -35.94 115.60 -2.36 -34.88 117.34 -2.86 1uk7_c00 source 1uk7 3.07.01.0009 : 5 hits 1uk7_c00 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS B 326 HIS~? -3.48 ZN ZN B 401s 89 GLU B 329 GLU~? 2.54 ZN ZN B 402s 243 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 5.83 15.74 17.38 6.41 17.70 17.86 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 3.11 16.19 13.44 4.96 17.09 13.42 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 0.53 21.81 31.33 1.05 20.47 29.70 -31.91 109.24 -4.57 -30.97 107.55 -3.66 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 1 hits 1ula_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 23 ASP.? 8.14 ZN ZN A 401 255 GLU A 20 GLU.? 10.86 ZN ZN A 401 329 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 49.16 35.16 15.19 51.08 34.43 15.65 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 52.57 37.12 10.17 53.37 35.95 11.75 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 33 ASP.? 31.33 ZN ZN A 401 255 GLU A 35 GLU.? 32.19 ZN ZN A 401 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 52.57 37.12 10.17 53.37 35.95 11.75 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 23 ASP.? 8.15 ZN ZN B 402 255 GLU B 20 GLU.? 11.09 ZN ZN B 402 329 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 49.16 35.16 15.19 51.08 34.43 15.65 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 52.57 37.12 10.17 53.37 35.95 11.75 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.20 100.05 15.92 -45.42 99.37 14.07 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 23 ASP.? 8.14 ZN ZN A 401 218 GLU A 55 GLU~? 25.21 ZN ZN A 402 329 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 49.16 35.16 15.19 51.08 34.43 15.65 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 33 ASP.? 31.33 ZN ZN A 401 218 GLU A 329 GLU~? 2.55 ZN ZN A 401s 329 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 33 ASP.? 31.33 ZN ZN A 401 218 GLU A 329 GLU~? 2.55 ZN ZN A 401s 329 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 44 ASP.? 7.09 ZN ZN A 402 218 GLU A 243 GLU^? 24.16 ZN ZN A 401 329 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 70.09 11.71 8.46 70.56 12.89 6.77 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 91 ASP.? 28.84 ZN ZN A 402 218 GLU A 20 GLU.? 10.86 ZN ZN A 401 329 ASP A 33 ASP.? 31.33 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.68 145.88 -15.27 -39.90 147.57 -16.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 102 ASP~? -1.98 ZN ZN A 401s 218 GLU A 35 GLU.? 32.19 ZN ZN A 401 329 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 245 ASP^? 25.73 ZN ZN A 401 218 GLU A 20 GLU.? 10.86 ZN ZN A 401 329 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 245 ASP^? 25.73 ZN ZN A 401 218 GLU A 354 GLU^? 23.23 ZN ZN A 401 329 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 245 ASP^? 25.73 ZN ZN A 401 218 GLU B 48 GLU~? 19.33 ZN ZN B 401 329 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -38.69 82.94 -0.70 -36.82 83.91 -1.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 305 ASP.? 7.62 ZN ZN A 402 218 GLU A 55 GLU~? 25.21 ZN ZN A 402 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 305 ASP.? 7.62 ZN ZN A 402 218 GLU B 52 GLU~? 18.78 ZN ZN B 401 329 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 70.09 11.71 8.46 70.56 12.89 6.77 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP A 310 ASP~? 12.24 ZN ZN B 401 218 GLU B 354 GLU^? 23.36 ZN ZN B 402 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP A 323 ASP^? 12.30 ZN ZN A 402 218 GLU B 55 GLU~? 25.91 ZN ZN B 401 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP A 323 ASP^? 12.30 ZN ZN A 402 218 GLU B 354 GLU^? 23.36 ZN ZN B 402 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP A 323 ASP^? 12.30 ZN ZN A 402 218 GLU B 354 GLU^? 23.36 ZN ZN B 402 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 23 ASP.? 8.15 ZN ZN B 402 218 GLU A 271 GLU.? 22.11 ZN ZN B 401 329 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 49.16 35.16 15.19 51.08 34.43 15.65 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 23 ASP.? 8.15 ZN ZN B 402 218 GLU B 55 GLU~? 25.91 ZN ZN B 401 329 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 49.16 35.16 15.19 51.08 34.43 15.65 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 33 ASP.? 29.43 ZN ZN B 402 218 GLU B 329 GLU~? 2.54 ZN ZN B 402s 329 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 59.16 37.82 13.95 57.63 37.03 15.12 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 33 ASP.? 29.43 ZN ZN B 402 218 GLU B 329 GLU~? 2.54 ZN ZN B 402s 329 ASP B 91 ASP.? 28.82 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 59.16 37.82 13.95 57.63 37.03 15.12 -53.83 73.30 7.14 -55.54 72.50 6.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP B 44 ASP.? 7.11 ZN ZN B 401 218 GLU B 243 GLU^? 24.39 ZN ZN B 402 329 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 70.09 11.71 8.46 70.56 12.89 6.77 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP B 91 ASP.? 28.82 ZN ZN B 401 218 GLU B 20 GLU.? 11.09 ZN ZN B 402 329 ASP B 33 ASP.? 29.43 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 70.09 11.71 8.46 70.56 12.89 6.77 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 -61.26 74.82 15.61 -62.97 76.13 15.50 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP B 102 ASP~? -1.99 ZN ZN B 402s 218 GLU B 55 GLU~? 25.91 ZN ZN B 401 329 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP B 245 ASP^? 25.30 ZN ZN B 402 218 GLU A 48 GLU~? 19.37 ZN ZN A 402 329 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 70.09 11.71 8.46 70.56 12.89 6.77 -25.72 127.18 1.29 -24.86 125.22 1.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP B 245 ASP^? 25.30 ZN ZN B 402 218 GLU B 20 GLU.? 11.09 ZN ZN B 402 329 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 70.09 11.71 8.46 70.56 12.89 6.77 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP B 245 ASP^? 25.30 ZN ZN B 402 218 GLU B 354 GLU^? 23.36 ZN ZN B 402 329 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 218 GLU A 52 GLU~? 18.80 ZN ZN A 402 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 70.09 11.71 8.46 70.56 12.89 6.77 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 218 GLU B 55 GLU~? 25.91 ZN ZN B 401 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP B 310 ASP~? 12.35 ZN ZN A 402 218 GLU A 354 GLU^? 23.23 ZN ZN A 401 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP B 310 ASP~? 12.35 ZN ZN A 402 218 GLU B 334 GLU~? 17.83 ZN ZN B 402 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 70.09 11.71 8.46 70.56 12.89 6.77 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP B 313 ASP~? 12.28 ZN ZN A 402 218 GLU A 251 GLU~? 26.78 ZN ZN B 401 329 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 70.09 11.71 8.46 70.56 12.89 6.77 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 218 GLU A 55 GLU~? 25.21 ZN ZN A 402 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 218 GLU A 354 GLU^? 23.23 ZN ZN A 401 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 218 GLU A 354 GLU^? 23.23 ZN ZN A 401 329 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 218 GLU A 354 GLU^? 23.23 ZN ZN A 401 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 34 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 91 ASP.? 28.84 ZN ZN A 402 242 GLU A 48 GLU~? 19.37 ZN ZN A 402 329 ASP A 33 ASP.? 31.33 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 30.42 34.74 5.00 29.09 35.09 3.38 -25.72 127.18 1.29 -24.86 125.22 1.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.68 145.88 -15.27 -39.90 147.57 -16.36 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 102 ASP~? -1.98 ZN ZN A 401s 242 GLU A 243 GLU^? 24.16 ZN ZN A 401 329 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 30.42 34.74 5.00 29.09 35.09 3.38 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 305 ASP.? 7.62 ZN ZN A 402 242 GLU A 48 GLU~? 19.37 ZN ZN A 402 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -25.72 127.18 1.29 -24.86 125.22 1.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 305 ASP.? 7.62 ZN ZN A 402 242 GLU A 251 GLU~? 26.78 ZN ZN B 401 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 305 ASP.? 7.62 ZN ZN A 402 242 GLU A 271 GLU.? 22.11 ZN ZN B 401 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 305 ASP.? 7.62 ZN ZN A 402 242 GLU A 334 GLU~? 17.80 ZN ZN A 401 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 305 ASP.? 7.62 ZN ZN A 402 242 GLU A 334 GLU~? 17.80 ZN ZN A 401 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 313 ASP~? 12.18 ZN ZN B 401 242 GLU A 329 GLU~? 2.55 ZN ZN A 401s 329 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 30.42 34.74 5.00 29.09 35.09 3.38 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 323 ASP^? 12.30 ZN ZN A 402 242 GLU A 243 GLU^? 24.16 ZN ZN A 401 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 -33.02 100.94 -26.53 -34.09 99.87 -28.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 323 ASP^? 12.30 ZN ZN A 402 242 GLU A 334 GLU~? 17.80 ZN ZN A 401 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 323 ASP^? 12.30 ZN ZN A 402 242 GLU A 334 GLU~? 17.80 ZN ZN A 401 329 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 44 ASP.? 7.11 ZN ZN B 401 242 GLU B 32 GLU.? 22.53 ZN ZN B 402 329 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 30.42 34.74 5.00 29.09 35.09 3.38 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 44 ASP.? 7.11 ZN ZN B 401 242 GLU B 32 GLU.? 22.53 ZN ZN B 402 329 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 30.42 34.74 5.00 29.09 35.09 3.38 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP B 91 ASP.? 28.82 ZN ZN B 401 242 GLU B 48 GLU~? 19.33 ZN ZN B 401 329 ASP B 33 ASP.? 29.43 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 -38.69 82.94 -0.70 -36.82 83.91 -1.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -61.26 74.82 15.61 -62.97 76.13 15.50 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 102 ASP~? -1.99 ZN ZN B 402s 242 GLU B 243 GLU^? 24.39 ZN ZN B 402 329 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 30.42 34.74 5.00 29.09 35.09 3.38 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 242 GLU A 251 GLU~? 26.78 ZN ZN B 401 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 242 GLU A 271 GLU.? 22.11 ZN ZN B 401 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 242 GLU B 48 GLU~? 19.33 ZN ZN B 401 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 -38.69 82.94 -0.70 -36.82 83.91 -1.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 242 GLU B 251 GLU~? 27.55 ZN ZN A 402 329 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.38 111.90 11.61 -18.92 112.78 10.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 242 GLU B 334 GLU~? 17.83 ZN ZN B 402 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP B 305 ASP.? 7.64 ZN ZN B 401 242 GLU B 334 GLU~? 17.83 ZN ZN B 402 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP B 313 ASP~? 12.28 ZN ZN A 402 242 GLU B 329 GLU~? 2.54 ZN ZN B 402s 329 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 30.42 34.74 5.00 29.09 35.09 3.38 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 242 GLU A 251 GLU~? 26.78 ZN ZN B 401 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 30.42 34.74 5.00 29.09 35.09 3.38 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 242 GLU B 243 GLU^? 24.39 ZN ZN B 402 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 30.42 34.74 5.00 29.09 35.09 3.38 -30.57 108.69 27.52 -30.74 110.20 29.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 242 GLU B 334 GLU~? 17.83 ZN ZN B 402 329 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 30.42 34.74 5.00 29.09 35.09 3.38 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP B 323 ASP^? 12.28 ZN ZN B 401 242 GLU B 334 GLU~? 17.83 ZN ZN B 402 329 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 30.42 34.74 5.00 29.09 35.09 3.38 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.42 114.63 4.44 -42.44 114.56 3.83 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 26 hits 1uok_c05 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 40 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 103 LEU A 67 LEU.? 13.44 ZN ZN A 402 coo 12.09 16.13 10.57 11.28 18.80 10.73 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 7.55 25.51 14.34 9.65 25.73 14.24 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 11.83 18.73 16.99 10.99 19.71 15.26 -39.04 128.48 -3.57 -37.88 129.26 -1.90 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 80 TYR~? 13.91 ZN ZN A 402 A 40 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 103 LEU B 312 LEU~? 9.97 ZN ZN A 402 coo 12.09 16.13 10.57 11.28 18.80 10.73 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 7.55 25.51 14.34 9.65 25.73 14.24 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 11.83 18.73 16.99 10.99 19.71 15.26 -36.04 119.44 1.32 -35.12 120.85 -0.09 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 40 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 103 LEU A 312 LEU~? 9.93 ZN ZN B 401 coo 12.09 16.13 10.57 11.28 18.80 10.73 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 7.55 25.51 14.34 9.65 25.73 14.24 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 11.83 18.73 16.99 10.99 19.71 15.26 -42.97 94.69 -0.33 -43.02 92.95 1.02 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 80 TYR~? 13.91 ZN ZN B 401 A 40 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 103 LEU B 67 LEU.? 13.42 ZN ZN B 401 coo 12.09 16.13 10.57 11.28 18.80 10.73 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 7.55 25.51 14.34 9.65 25.73 14.24 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 11.83 18.73 16.99 10.99 19.71 15.26 -50.48 88.67 4.38 -49.74 87.49 2.65 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 80 TYR~? 13.91 ZN ZN A 402 B 40 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 103 LEU A 67 LEU.? 13.44 ZN ZN A 402 coo 14.25 20.09 37.35 13.48 17.40 37.38 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 9.39 10.77 34.53 11.50 10.63 34.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 12.89 17.60 31.13 12.34 16.51 32.90 -39.04 128.48 -3.57 -37.88 129.26 -1.90 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 80 TYR~? 13.91 ZN ZN A 402 B 40 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 103 LEU B 312 LEU~? 9.97 ZN ZN A 402 coo 14.25 20.09 37.35 13.48 17.40 37.38 -39.16 126.74 3.00 -38.55 124.04 2.52 coo 9.39 10.77 34.53 11.50 10.63 34.41 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.89 17.60 31.13 12.34 16.51 32.90 -36.04 119.44 1.32 -35.12 120.85 -0.09 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 80 TYR~? 13.91 ZN ZN B 401 B 40 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 103 LEU A 312 LEU~? 9.93 ZN ZN B 401 coo 14.25 20.09 37.35 13.48 17.40 37.38 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.89 17.60 31.13 12.34 16.51 32.90 -42.97 94.69 -0.33 -43.02 92.95 1.02 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 80 TYR~? 13.91 ZN ZN B 401 B 40 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 103 LEU B 67 LEU.? 13.42 ZN ZN B 401 coo 14.25 20.09 37.35 13.48 17.40 37.38 -49.82 90.33 -2.11 -47.80 92.21 -1.52 coo 9.39 10.77 34.53 11.50 10.63 34.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 12.89 17.60 31.13 12.34 16.51 32.90 -50.48 88.67 4.38 -49.74 87.49 2.65 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 169 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 288 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 67.72 35.99 30.87 69.77 36.13 31.33 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 73.17 30.66 22.56 72.87 30.30 20.46 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 74.06 28.51 15.92 73.77 29.56 17.73 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 169 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 288 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 67.72 35.99 30.87 69.77 36.13 31.33 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 73.17 30.66 22.56 72.87 30.30 20.46 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 74.06 28.51 15.92 73.77 29.56 17.73 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 169 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 288 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 67.72 35.99 30.87 69.77 36.13 31.33 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 73.17 30.66 22.56 72.87 30.30 20.46 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 74.06 28.51 15.92 73.77 29.56 17.73 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 169 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 288 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 67.72 35.99 30.87 69.77 36.13 31.33 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 73.17 30.66 22.56 72.87 30.30 20.46 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 74.06 28.51 15.92 73.77 29.56 17.73 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 169 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 288 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 67.72 35.99 30.87 69.77 36.13 31.33 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 73.17 30.66 22.56 72.87 30.30 20.46 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 74.06 28.51 15.92 73.77 29.56 17.73 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 169 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 288 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 67.72 35.99 30.87 69.77 36.13 31.33 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 73.17 30.66 22.56 72.87 30.30 20.46 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 74.06 28.51 15.92 73.77 29.56 17.73 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS B 218 HIS~? 47.61 ZN ZN B 402 A 169 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 288 GLU B 158 GLU.? 36.73 ZN ZN B 402 coo 67.72 35.99 30.87 69.77 36.13 31.33 -78.43 101.94 45.47 -77.59 103.59 46.47 coo 73.17 30.66 22.56 72.87 30.30 20.46 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 74.06 28.51 15.92 73.77 29.56 17.73 -60.87 94.33 46.47 -60.36 92.90 44.98 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 8 3 # 8 A 105 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 169 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 288 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 67.72 35.99 30.87 69.77 36.13 31.33 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 73.17 30.66 22.56 72.87 30.30 20.46 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 74.06 28.51 15.92 73.77 29.56 17.73 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 9 3 # 9 A 105 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 169 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 288 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 67.72 35.99 30.87 69.77 36.13 31.33 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 73.17 30.66 22.56 72.87 30.30 20.46 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 74.06 28.51 15.92 73.77 29.56 17.73 -44.60 100.09 -10.25 -45.29 101.54 -8.87 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 9 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 79 GLY~? 19.65 ZN ZN A 402 B 419 GLY A 81 GLY~? 20.61 ZN ZN A 402 B 420 ALA A 77 ALA.? 26.87 ZN ZN A 402 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -37.15 128.46 7.52 -36.89 129.22 7.25 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -39.26 132.56 4.99 -38.51 132.20 4.81 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -36.92 135.43 9.04 -36.12 136.57 9.66 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY B 79 GLY~? 19.61 ZN ZN B 401 B 419 GLY B 81 GLY~? 20.66 ZN ZN B 401 B 420 ALA B 77 ALA.? 26.95 ZN ZN B 401 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -48.98 87.93 -6.69 -49.20 87.16 -6.43 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -53.02 85.53 -4.18 -52.23 85.45 -4.06 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -52.41 81.95 -8.48 -52.31 80.63 -9.24 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 2 hits 1xny_c00 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 19 ALA~? 10.49 ZN ZN A 401 A 244 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 271 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 15.05 3.71 6.93 14.58 4.88 7.78 -47.57 121.56 -16.00 -47.15 122.83 -15.24 coo 9.85 8.15 0.76 10.61 7.04 2.39 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 10.61 7.65 6.01 12.39 6.55 6.23 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 96 ALA^? 10.78 ZN ZN A 401 A 244 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 271 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 15.05 3.71 6.93 14.58 4.88 7.78 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 9.85 8.15 0.76 10.61 7.04 2.39 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 10.61 7.65 6.01 12.39 6.55 6.23 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA B 19 ALA~? 10.41 ZN ZN B 402 A 244 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 271 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 15.05 3.71 6.93 14.58 4.88 7.78 -53.87 98.79 16.99 -54.12 97.55 16.16 coo 9.85 8.15 0.76 10.61 7.04 2.39 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 10.61 7.65 6.01 12.39 6.55 6.23 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA B 96 ALA^? 10.72 ZN ZN B 402 A 244 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 271 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 15.05 3.71 6.93 14.58 4.88 7.78 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 9.85 8.15 0.76 10.61 7.04 2.39 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 10.61 7.65 6.01 12.39 6.55 6.23 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 105 ALA B 311 ALA~? 12.53 ZN ZN A 402 A 244 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 271 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 15.05 3.71 6.93 14.58 4.88 7.78 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 9.85 8.15 0.76 10.61 7.04 2.39 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 10.61 7.65 6.01 12.39 6.55 6.23 -35.94 115.60 -2.36 -34.88 117.34 -2.86 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 5 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 293 ALA~? 16.37 ZN ZN A 401 B 126 ARG A 278 ARG^? 22.96 ZN ZN A 401 B 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 2.11 4.00 19.31 3.14 4.86 19.99 -44.42 101.07 -17.63 -43.28 101.58 -16.75 coo 2.45 5.53 11.28 3.59 7.56 13.29 -38.45 97.22 -24.87 -40.97 98.73 -25.80 coo 6.10 2.00 25.24 6.12 1.84 23.13 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 311 ALA~? 12.40 ZN ZN B 401 B 126 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 2.11 4.00 19.31 3.14 4.86 19.99 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 2.45 5.53 11.28 3.59 7.56 13.29 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 6.10 2.00 25.24 6.12 1.84 23.13 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA B 311 ALA~? 12.53 ZN ZN A 402 B 126 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 138 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 2.11 4.00 19.31 3.14 4.86 19.99 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 6.10 2.00 25.24 6.12 1.84 23.13 -39.98 115.46 11.22 -41.44 114.62 9.91 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 293 ALA~? 16.37 ZN ZN A 401 C 126 ARG A 278 ARG^? 22.96 ZN ZN A 401 C 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -44.42 101.07 -17.63 -43.28 101.58 -16.75 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -38.45 97.22 -24.87 -40.97 98.73 -25.80 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 311 ALA~? 12.40 ZN ZN B 401 C 126 ARG A 267 ARG^? 13.45 ZN ZN B 401 C 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA B 311 ALA~? 12.53 ZN ZN A 402 C 126 ARG B 267 ARG^? 13.63 ZN ZN A 402 C 138 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -39.98 115.46 11.22 -41.44 114.62 9.91 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 311 ALA~? 12.40 ZN ZN B 401 D 126 ARG A 267 ARG^? 13.45 ZN ZN B 401 D 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 6.23 0.50 57.10 5.93 0.72 59.19 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 311 ALA~? 12.53 ZN ZN A 402 D 126 ARG B 267 ARG^? 13.63 ZN ZN A 402 D 138 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -35.94 115.65 4.45 -34.97 114.68 3.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 6.23 0.50 57.10 5.93 0.72 59.19 -39.98 115.46 11.22 -41.44 114.62 9.91 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 311 ALA~? 12.40 ZN ZN B 401 E 126 ARG A 267 ARG^? 13.45 ZN ZN B 401 E 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 311 ALA~? 12.53 ZN ZN A 402 E 126 ARG B 267 ARG^? 13.63 ZN ZN A 402 E 138 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -39.98 115.46 11.22 -41.44 114.62 9.91 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 293 ALA~? 16.37 ZN ZN A 401 F 126 ARG A 278 ARG^? 22.96 ZN ZN A 401 F 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -44.42 101.07 -17.63 -43.28 101.58 -16.75 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -38.45 97.22 -24.87 -40.97 98.73 -25.80 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 311 ALA~? 12.40 ZN ZN B 401 F 126 ARG A 267 ARG^? 13.45 ZN ZN B 401 F 138 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -41.15 97.96 -3.49 -39.81 98.24 -2.76 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA B 311 ALA~? 12.53 ZN ZN A 402 F 126 ARG B 267 ARG^? 13.63 ZN ZN A 402 F 138 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -35.94 115.65 4.45 -34.97 114.68 3.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -31.38 108.30 2.45 -33.79 107.47 0.72 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -39.98 115.46 11.22 -41.44 114.62 9.91 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 304 GLY.? 8.93 ZN ZN A 402 B 175 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 242 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 99.45 58.28 3.33 99.57 58.61 4.10 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 100.93 69.04 4.38 99.52 68.48 2.09 -26.53 108.54 0.92 -29.08 108.89 -0.28 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 304 GLY.? 8.93 ZN ZN A 402 B 175 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 242 TYR A 327 TYR~? 10.33 ZN ZN A 402 coo 99.45 58.28 3.33 99.57 58.61 4.10 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 100.93 69.04 4.38 99.52 68.48 2.09 -30.20 115.07 -4.84 -28.36 117.13 -5.30 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 304 GLY.? 8.91 ZN ZN B 401 B 175 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 242 TYR B 327 TYR~? 10.21 ZN ZN B 401 coo 99.45 58.28 3.33 99.57 58.61 4.10 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 100.93 69.04 4.38 99.52 68.48 2.09 -35.81 95.23 5.63 -35.48 92.50 6.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 304 GLY.? 8.91 ZN ZN B 401 B 175 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 242 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 99.45 58.28 3.33 99.57 58.61 4.10 -37.52 104.72 7.61 -38.13 105.28 7.78 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 100.93 69.04 4.38 99.52 68.48 2.09 -29.29 98.99 -0.08 -31.62 99.98 1.12 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 4 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER B 151 SER~? 41.75 ZN ZN B 402 A 178 TYR B 217 TYR~? 45.33 ZN ZN B 402 A 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 81.46 10.53 21.66 82.20 10.82 19.39 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 87.67 8.69 17.10 86.62 10.83 18.52 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 85.30 6.17 22.83 87.26 11.02 23.50 -73.22 97.33 48.85 -74.87 100.01 44.50 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER B 151 SER~? 41.75 ZN ZN B 402 B 178 TYR B 217 TYR~? 45.33 ZN ZN B 402 B 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 coo 61.22 3.61 34.51 60.46 1.86 35.98 -70.52 94.90 44.12 -71.51 97.15 44.18 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -76.80 93.86 44.47 -76.40 91.42 43.11 coo 57.40 2.23 30.19 55.43 5.44 33.87 -73.22 97.33 48.85 -74.87 100.01 44.50 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 14.16 13.09 37.03 20.00 12.44 37.49 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 165 GLU A 334 GLU~? 17.80 ZN ZN A 401 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 14.16 13.09 37.03 20.00 12.44 37.49 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -24.53 120.44 -15.33 -23.13 122.04 -15.66 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 18.28 7.83 36.39 22.82 8.75 39.52 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 22.22 16.06 48.76 23.94 15.33 49.78 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 18.28 7.83 36.39 22.82 8.75 39.52 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 14.16 13.09 37.03 20.00 12.44 37.49 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 18.28 7.83 36.39 22.82 8.75 39.52 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 14.16 13.09 37.03 20.00 12.44 37.49 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 22.22 16.06 48.76 23.94 15.33 49.78 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 22.22 16.06 48.76 23.94 15.33 49.78 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 165 GLU B 334 GLU~? 17.83 ZN ZN B 402 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 22.22 16.06 48.76 23.94 15.33 49.78 -33.85 87.37 15.86 -33.56 85.28 16.19 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 22.22 16.06 48.76 23.94 15.33 49.78 -40.29 98.42 11.20 -42.37 98.57 11.02 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 74 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 165 GLU A 334 GLU~? 17.80 ZN ZN A 401 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -24.53 120.44 -15.33 -23.13 122.04 -15.66 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 74 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 165 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 13.51 0.92 76.10 12.98 6.13 74.68 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 21.39 11.56 68.52 20.24 13.13 67.73 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 74 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 13.51 0.92 76.10 12.98 6.13 74.68 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 74 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 165 GLU B 199 GLU^? 40.09 ZN ZN B 402 coo 13.51 0.92 76.10 12.98 6.13 74.68 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 21.39 11.56 68.52 20.24 13.13 67.73 -65.13 107.83 45.37 -64.79 109.92 45.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 21.39 11.56 68.52 20.24 13.13 67.73 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 74 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 165 GLU B 334 GLU~? 17.83 ZN ZN B 402 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 21.39 11.56 68.52 20.24 13.13 67.73 -33.85 87.37 15.86 -33.56 85.28 16.19 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 74 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 165 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 21.39 11.56 68.52 20.24 13.13 67.73 -40.29 98.42 11.20 -42.37 98.57 11.02 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1ylu_c01 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 63 SER^? 10.35 ZN ZN A 402 338 ASP A 44 ASP.? 7.09 ZN ZN A 402 397 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 2 3 # 2 146 SER A 328 SER~? 11.01 ZN ZN A 402 338 ASP A 305 ASP.? 7.62 ZN ZN A 402 397 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 3 3 # 3 146 SER B 328 SER~? 10.89 ZN ZN B 401 338 ASP B 305 ASP.? 7.64 ZN ZN B 401 397 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -40.92 100.43 6.30 -42.93 100.06 6.77 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 3 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 63 SER^? 10.35 ZN ZN A 402 A 227 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 256 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 64.84 24.93 59.62 66.28 24.42 57.72 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 73.80 27.56 60.96 72.24 26.45 60.08 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 70.86 23.63 59.28 68.91 24.23 58.80 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1zoi_c00 ESTERASE user 2 3 # 2 A 97 SER A 328 SER~? 11.01 ZN ZN A 402 A 227 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 256 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 64.84 24.93 59.62 66.28 24.42 57.72 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 73.80 27.56 60.96 72.24 26.45 60.08 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 70.86 23.63 59.28 68.91 24.23 58.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1zoi_c00 ESTERASE user 3 3 # 3 A 97 SER B 328 SER~? 10.89 ZN ZN B 401 A 227 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 256 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 64.84 24.93 59.62 66.28 24.42 57.72 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 73.80 27.56 60.96 72.24 26.45 60.08 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 70.86 23.63 59.28 68.91 24.23 58.80 -40.92 100.43 6.30 -42.93 100.06 6.77 1zoi_c00 source 1zoi ESTERASE : 3 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 63 SER^? 10.35 ZN ZN A 402 B 227 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 256 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 1zoi_c01 ESTERASE user 2 3 # 2 B 97 SER A 328 SER~? 11.01 ZN ZN A 402 B 227 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 256 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1zoi_c01 ESTERASE user 3 3 # 3 B 97 SER B 328 SER~? 10.89 ZN ZN B 401 B 227 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 256 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -40.92 100.43 6.30 -42.93 100.06 6.77 1zoi_c01 source 1zoi ESTERASE : 3 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 328 SER~? 11.01 ZN ZN A 402 C 227 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 256 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 1zoi_c02 ESTERASE user 2 3 # 2 C 97 SER B 328 SER~? 10.89 ZN ZN B 401 C 227 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 256 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -40.92 100.43 6.30 -42.93 100.06 6.77 1zoi_c02 source 1zoi ESTERASE : 2 hits 1zoi_c02 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 371 LYS A 231 LYS^? 23.23 ZN ZN A 401 A 407 THR A 233 THR^? 21.55 ZN ZN A 401 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -57.94 114.56 -29.95 -58.70 114.72 -24.54 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -51.48 112.38 -28.84 -50.80 110.31 -28.76 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 371 LYS B 231 LYS^? 25.02 ZN ZN B 402 A 407 THR B 233 THR^? 21.46 ZN ZN B 402 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -59.06 109.88 30.77 -61.50 111.95 25.23 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -52.42 108.39 29.83 -50.75 109.78 29.75 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c02 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 285 SER.? 7.68 ZN ZN A 402 327 GLU A 329 GLU~? 2.55 ZN ZN A 401s 440 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 6.96 64.04 57.84 6.74 63.69 60.26 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 14.82 64.63 62.37 13.47 65.72 61.17 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 9.52 66.51 63.07 8.75 65.02 61.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 285 SER.? 7.72 ZN ZN B 401 327 GLU B 329 GLU~? 2.54 ZN ZN B 402s 440 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 6.96 64.04 57.84 6.74 63.69 60.26 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 14.82 64.63 62.37 13.47 65.72 61.17 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 9.52 66.51 63.07 8.75 65.02 61.81 -40.92 100.43 6.30 -42.93 100.06 6.77 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 48 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 77 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 13.04 30.41 72.50 12.95 30.65 70.36 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 12.77 23.50 68.33 13.58 25.42 68.49 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 7.53 29.84 65.06 12.29 29.41 67.79 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 77 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 13.04 30.41 72.50 12.95 30.65 70.36 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.77 23.50 68.33 13.58 25.42 68.49 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 7.53 29.84 65.06 12.29 29.41 67.79 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 3 3 # 3 A 43 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 48 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 77 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 13.04 30.41 72.50 12.95 30.65 70.36 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 12.77 23.50 68.33 13.58 25.42 68.49 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 7.53 29.84 65.06 12.29 29.41 67.79 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 4 3 # 4 A 43 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 48 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 77 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 13.04 30.41 72.50 12.95 30.65 70.36 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 12.77 23.50 68.33 13.58 25.42 68.49 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 7.53 29.84 65.06 12.29 29.41 67.79 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 5 3 # 5 A 43 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 48 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 77 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 13.04 30.41 72.50 12.95 30.65 70.36 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 12.77 23.50 68.33 13.58 25.42 68.49 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 7.53 29.84 65.06 12.29 29.41 67.79 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 6 3 # 6 A 43 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 77 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 13.04 30.41 72.50 12.95 30.65 70.36 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 12.77 23.50 68.33 13.58 25.42 68.49 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 7.53 29.84 65.06 12.29 29.41 67.79 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 7 3 # 7 A 43 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 48 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 77 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 13.04 30.41 72.50 12.95 30.65 70.36 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 12.77 23.50 68.33 13.58 25.42 68.49 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 7.53 29.84 65.06 12.29 29.41 67.79 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 8 3 # 8 A 43 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 48 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 77 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 13.04 30.41 72.50 12.95 30.65 70.36 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 12.77 23.50 68.33 13.58 25.42 68.49 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 7.53 29.84 65.06 12.29 29.41 67.79 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 9 3 # 9 A 43 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 48 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 77 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 13.04 30.41 72.50 12.95 30.65 70.36 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 12.77 23.50 68.33 13.58 25.42 68.49 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 7.53 29.84 65.06 12.29 29.41 67.79 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 10 3 # 10 A 43 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 48 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 77 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 13.04 30.41 72.50 12.95 30.65 70.36 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 12.77 23.50 68.33 13.58 25.42 68.49 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 7.53 29.84 65.06 12.29 29.41 67.79 -41.26 92.47 -6.07 -36.28 89.98 -4.98 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 10 hits 2acu_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 100 ASN~? 9.95 ZN ZN A 401 A 106 PRO A 15 PRO~? 15.33 ZN ZN A 401 A 108 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 34.91 38.94 20.48 33.53 38.20 19.00 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 36.18 33.51 20.99 37.11 35.33 20.14 -45.15 124.47 -24.33 -44.42 125.20 -22.34 coo 33.01 33.46 15.68 31.96 34.97 17.80 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 A 105 ASN A 104 ASN.? 12.54 ZN ZN A 401 A 106 PRO A 105 PRO.? 13.76 ZN ZN A 401 A 108 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo 34.91 38.94 20.48 33.53 38.20 19.00 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 36.18 33.51 20.99 37.11 35.33 20.14 -41.23 116.98 -26.08 -39.87 116.51 -24.35 coo 33.01 33.46 15.68 31.96 34.97 17.80 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 A 105 ASN A 104 ASN.? 12.54 ZN ZN A 401 A 106 PRO A 105 PRO.? 13.76 ZN ZN A 401 A 108 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 34.91 38.94 20.48 33.53 38.20 19.00 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 36.18 33.51 20.99 37.11 35.33 20.14 -41.23 116.98 -26.08 -39.87 116.51 -24.35 coo 33.01 33.46 15.68 31.96 34.97 17.80 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 A 105 ASN B 100 ASN~? 9.88 ZN ZN B 402 A 106 PRO B 15 PRO~? 15.22 ZN ZN B 402 A 108 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 34.91 38.94 20.48 33.53 38.20 19.00 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 36.18 33.51 20.99 37.11 35.33 20.14 -53.25 95.07 25.10 -53.02 93.89 23.18 coo 33.01 33.46 15.68 31.96 34.97 17.80 -50.67 100.24 25.02 -50.96 97.90 26.55 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 A 105 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 106 PRO B 15 PRO~? 15.22 ZN ZN B 402 A 108 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 34.91 38.94 20.48 33.53 38.20 19.00 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 36.18 33.51 20.99 37.11 35.33 20.14 -53.25 95.07 25.10 -53.02 93.89 23.18 coo 33.01 33.46 15.68 31.96 34.97 17.80 -50.67 100.24 25.02 -50.96 97.90 26.55 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 A 105 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 106 PRO B 105 PRO.? 13.84 ZN ZN B 402 A 108 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo 34.91 38.94 20.48 33.53 38.20 19.00 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 36.18 33.51 20.99 37.11 35.33 20.14 -45.95 99.11 27.10 -44.58 98.82 25.31 coo 33.01 33.46 15.68 31.96 34.97 17.80 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 A 105 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 106 PRO B 105 PRO.? 13.84 ZN ZN B 402 A 108 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 34.91 38.94 20.48 33.53 38.20 19.00 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 36.18 33.51 20.99 37.11 35.33 20.14 -45.95 99.11 27.10 -44.58 98.82 25.31 coo 33.01 33.46 15.68 31.96 34.97 17.80 -50.67 100.24 25.02 -50.96 97.90 26.55 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 7 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 100 ASN~? 9.95 ZN ZN A 401 B 106 PRO A 15 PRO~? 15.33 ZN ZN A 401 B 108 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 5.98 38.14 46.94 7.30 38.92 45.46 -44.05 122.82 -17.82 -42.95 124.35 -16.78 coo 4.66 43.53 47.47 3.74 41.73 46.59 -45.15 124.47 -24.33 -44.42 125.20 -22.34 coo 7.86 43.80 42.15 8.87 42.26 44.27 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 B 105 ASN A 104 ASN.? 12.54 ZN ZN A 401 B 106 PRO A 105 PRO.? 13.76 ZN ZN A 401 B 108 TYR A 106 TYR.? 16.47 ZN ZN A 401 coo 5.98 38.14 46.94 7.30 38.92 45.46 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 4.66 43.53 47.47 3.74 41.73 46.59 -41.23 116.98 -26.08 -39.87 116.51 -24.35 coo 7.86 43.80 42.15 8.87 42.26 44.27 -35.63 118.61 -26.09 -35.73 117.84 -28.73 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 B 105 ASN A 104 ASN.? 12.54 ZN ZN A 401 B 106 PRO A 105 PRO.? 13.76 ZN ZN A 401 B 108 TYR A 236 TYR^? 14.83 ZN ZN A 401 coo 5.98 38.14 46.94 7.30 38.92 45.46 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 4.66 43.53 47.47 3.74 41.73 46.59 -41.23 116.98 -26.08 -39.87 116.51 -24.35 coo 7.86 43.80 42.15 8.87 42.26 44.27 -45.72 118.51 -24.14 -44.72 120.68 -25.62 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 B 105 ASN B 100 ASN~? 9.88 ZN ZN B 402 B 106 PRO B 15 PRO~? 15.22 ZN ZN B 402 B 108 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 5.98 38.14 46.94 7.30 38.92 45.46 -51.48 95.86 18.73 -51.39 94.02 17.58 coo 4.66 43.53 47.47 3.74 41.73 46.59 -53.25 95.07 25.10 -53.02 93.89 23.18 coo 7.86 43.80 42.15 8.87 42.26 44.27 -50.67 100.24 25.02 -50.96 97.90 26.55 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 B 105 ASN B 104 ASN.? 12.46 ZN ZN B 402 B 106 PRO B 15 PRO~? 15.22 ZN ZN B 402 B 108 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 5.98 38.14 46.94 7.30 38.92 45.46 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 4.66 43.53 47.47 3.74 41.73 46.59 -53.25 95.07 25.10 -53.02 93.89 23.18 coo 7.86 43.80 42.15 8.87 42.26 44.27 -50.67 100.24 25.02 -50.96 97.90 26.55 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 B 105 ASN B 104 ASN.? 12.46 ZN ZN B 402 B 106 PRO B 105 PRO.? 13.84 ZN ZN B 402 B 108 TYR B 106 TYR.? 16.25 ZN ZN B 402 coo 5.98 38.14 46.94 7.30 38.92 45.46 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 4.66 43.53 47.47 3.74 41.73 46.59 -45.95 99.11 27.10 -44.58 98.82 25.31 coo 7.86 43.80 42.15 8.87 42.26 44.27 -42.51 94.75 26.81 -43.21 95.38 29.42 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 B 105 ASN B 104 ASN.? 12.46 ZN ZN B 402 B 106 PRO B 105 PRO.? 13.84 ZN ZN B 402 B 108 TYR B 236 TYR^? 14.81 ZN ZN B 402 coo 5.98 38.14 46.94 7.30 38.92 45.46 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 4.66 43.53 47.47 3.74 41.73 46.59 -45.95 99.11 27.10 -44.58 98.82 25.31 coo 7.86 43.80 42.15 8.87 42.26 44.27 -50.67 100.24 25.02 -50.96 97.90 26.55 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 7 hits 2adm_c01 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A -1 ASP.? 33.70 ZN ZN A 401 219 GLU A 35 GLU.? 32.19 ZN ZN A 401 294 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo 25.84 105.87 9.06 27.86 105.55 8.74 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 5 ASP~? 27.21 ZN ZN A 401 219 GLU A 35 GLU.? 32.19 ZN ZN A 401 294 ASP A -1 ASP.? 33.70 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 25.84 105.87 9.06 27.86 105.55 8.74 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 -34.17 145.98 -27.25 -35.93 146.68 -26.30 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 5 ASP~? 27.21 ZN ZN A 401 219 GLU A 35 GLU.? 32.19 ZN ZN A 401 294 ASP A 33 ASP.? 31.33 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 25.84 105.87 9.06 27.86 105.55 8.74 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.68 145.88 -15.27 -39.90 147.57 -16.36 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 23 ASP.? 8.14 ZN ZN A 401 219 GLU A 20 GLU.? 10.86 ZN ZN A 401 294 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 27.89 102.52 14.98 29.35 101.92 13.57 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 25.84 105.87 9.06 27.86 105.55 8.74 -48.90 117.49 -13.24 -50.05 116.06 -14.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 33 ASP.? 31.33 ZN ZN A 401 219 GLU A 35 GLU.? 32.19 ZN ZN A 401 294 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 25.84 105.87 9.06 27.86 105.55 8.74 -33.44 145.48 -18.21 -32.23 147.05 -19.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 23 ASP.? 8.15 ZN ZN B 402 219 GLU B 20 GLU.? 11.09 ZN ZN B 402 294 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 27.89 102.52 14.98 29.35 101.92 13.57 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 25.84 105.87 9.06 27.86 105.55 8.74 -52.94 103.12 14.27 -53.36 104.69 15.60 coo 33.16 106.80 7.72 33.34 104.87 6.92 -46.20 100.05 15.92 -45.42 99.37 14.07 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 6 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 5 ASP~? 27.21 ZN ZN A 401 231 ASP A 23 ASP.? 8.14 ZN ZN A 401 294 ASP A 33 ASP.? 31.33 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.68 145.88 -15.27 -39.90 147.57 -16.36 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 11 ASP~? 18.10 ZN ZN A 401 231 ASP A 44 ASP.? 7.09 ZN ZN A 402 294 ASP A 5 ASP~? 27.21 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 33.16 106.80 7.72 33.34 104.87 6.92 -38.08 139.21 -22.86 -38.80 141.16 -23.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 23 ASP.? 8.14 ZN ZN A 401 231 ASP A 5 ASP~? 27.21 ZN ZN A 401 294 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 27.89 102.52 14.98 29.35 101.92 13.57 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 23 ASP.? 8.14 ZN ZN A 401 231 ASP A 203 ASP.? 24.56 ZN ZN A 401 294 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 27.89 102.52 14.98 29.35 101.92 13.57 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 44 ASP.? 7.09 ZN ZN A 402 231 ASP A 352 ASP.? 27.02 ZN ZN A 401 294 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP A 102 ASP~? -1.98 ZN ZN A 401s 231 ASP A 5 ASP~? 27.21 ZN ZN A 401 294 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP A 102 ASP~? -1.98 ZN ZN A 401s 231 ASP B 305 ASP.? 7.64 ZN ZN B 401 294 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 33.16 106.80 7.72 33.34 104.87 6.92 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP A 203 ASP.? 24.56 ZN ZN A 401 231 ASP A 5 ASP~? 27.21 ZN ZN A 401 294 ASP A 129 ASP^? 19.65 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -52.93 118.26 -28.24 -51.00 118.44 -27.37 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP A 256 ASP~? 22.47 ZN ZN A 401 231 ASP A 102 ASP~? -1.98 ZN ZN A 401s 294 ASP A 245 ASP^? 25.73 ZN ZN A 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 -25.62 99.57 -26.57 -25.42 101.64 -26.90 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP A 305 ASP.? 7.62 ZN ZN A 402 231 ASP A 252 ASP~? 28.57 ZN ZN A 401 294 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP A 305 ASP.? 7.62 ZN ZN A 402 231 ASP A 252 ASP~? 28.57 ZN ZN A 401 294 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP A 305 ASP.? 7.62 ZN ZN A 402 231 ASP A 256 ASP~? 22.47 ZN ZN A 401 294 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP A 305 ASP.? 7.62 ZN ZN A 402 231 ASP A 256 ASP~? 22.47 ZN ZN A 401 294 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP A 305 ASP.? 7.62 ZN ZN A 402 231 ASP A 256 ASP~? 22.47 ZN ZN A 401 294 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP A 305 ASP.? 7.62 ZN ZN A 402 231 ASP A 299 ASP.? 24.38 ZN ZN A 401 294 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP A 305 ASP.? 7.62 ZN ZN A 402 231 ASP B 23 ASP.? 8.15 ZN ZN B 402 294 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP A 310 ASP~? 12.24 ZN ZN B 401 231 ASP A 23 ASP.? 8.14 ZN ZN A 401 294 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 106.80 7.72 33.34 104.87 6.92 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP A 310 ASP~? 12.24 ZN ZN B 401 231 ASP A 23 ASP.? 8.14 ZN ZN A 401 294 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP A 310 ASP~? 12.24 ZN ZN B 401 231 ASP A 252 ASP~? 28.57 ZN ZN A 401 294 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP A 310 ASP~? 12.24 ZN ZN B 401 231 ASP A 256 ASP~? 22.47 ZN ZN A 401 294 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP A 313 ASP~? 12.18 ZN ZN B 401 231 ASP B 310 ASP~? 12.35 ZN ZN A 402 294 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP A 323 ASP^? 12.30 ZN ZN A 402 231 ASP A 23 ASP.? 8.14 ZN ZN A 401 294 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP A 361 ASP.? 11.77 ZN ZN A 402 231 ASP A 310 ASP~? 12.24 ZN ZN B 401 294 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP A 361 ASP.? 11.77 ZN ZN A 402 231 ASP B 299 ASP.? 24.19 ZN ZN B 402 294 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP B 5 ASP~? 27.35 ZN ZN B 402 231 ASP B 23 ASP.? 8.15 ZN ZN B 402 294 ASP B 33 ASP.? 29.43 ZN ZN B 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 -61.26 74.82 15.61 -62.97 76.13 15.50 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP B 11 ASP~? 18.05 ZN ZN B 402 231 ASP B 44 ASP.? 7.11 ZN ZN B 401 294 ASP B 5 ASP~? 27.35 ZN ZN B 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 33.16 106.80 7.72 33.34 104.87 6.92 -55.09 78.54 23.42 -56.64 77.16 23.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP B 23 ASP.? 8.15 ZN ZN B 402 231 ASP B 5 ASP~? 27.35 ZN ZN B 402 294 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 27.89 102.52 14.98 29.35 101.92 13.57 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP B 23 ASP.? 8.15 ZN ZN B 402 231 ASP B 203 ASP^? 26.15 ZN ZN B 402 294 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 27.89 102.52 14.98 29.35 101.92 13.57 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 33.16 106.80 7.72 33.34 104.87 6.92 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP B 44 ASP.? 7.11 ZN ZN B 401 231 ASP B 91 ASP.? 28.82 ZN ZN B 401 294 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 33.16 106.80 7.72 33.34 104.87 6.92 -46.65 96.06 -4.18 -47.89 96.35 -2.43 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 30 3 # 30 193 ASP B 44 ASP.? 7.11 ZN ZN B 401 231 ASP B 352 ASP.? 26.97 ZN ZN B 402 294 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -40.82 74.97 18.30 -40.24 73.02 18.95 coo 33.16 106.80 7.72 33.34 104.87 6.92 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 31 3 # 31 193 ASP B 102 ASP~? -1.99 ZN ZN B 402s 231 ASP A 305 ASP.? 7.62 ZN ZN A 402 294 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 33.16 106.80 7.72 33.34 104.87 6.92 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 32 3 # 32 193 ASP B 102 ASP~? -1.99 ZN ZN B 402s 231 ASP A 323 ASP^? 12.30 ZN ZN A 402 294 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 33.16 106.80 7.72 33.34 104.87 6.92 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 33 3 # 33 193 ASP B 102 ASP~? -1.99 ZN ZN B 402s 231 ASP B 5 ASP~? 27.35 ZN ZN B 402 294 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 34 3 # 34 193 ASP B 256 ASP~? 22.51 ZN ZN B 402 231 ASP B 102 ASP~? -1.99 ZN ZN B 402s 294 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 35 3 # 35 193 ASP B 305 ASP.? 7.64 ZN ZN B 401 231 ASP A 23 ASP.? 8.14 ZN ZN A 401 294 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 33.16 106.80 7.72 33.34 104.87 6.92 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 36 3 # 36 193 ASP B 305 ASP.? 7.64 ZN ZN B 401 231 ASP B 252 ASP~? 28.52 ZN ZN B 402 294 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 33.16 106.80 7.72 33.34 104.87 6.92 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 37 3 # 37 193 ASP B 305 ASP.? 7.64 ZN ZN B 401 231 ASP B 252 ASP~? 28.52 ZN ZN B 402 294 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 38 3 # 38 193 ASP B 305 ASP.? 7.64 ZN ZN B 401 231 ASP B 256 ASP~? 22.51 ZN ZN B 402 294 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 39 3 # 39 193 ASP B 305 ASP.? 7.64 ZN ZN B 401 231 ASP B 256 ASP~? 22.51 ZN ZN B 402 294 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 40 3 # 40 193 ASP B 305 ASP.? 7.64 ZN ZN B 401 231 ASP B 256 ASP~? 22.51 ZN ZN B 402 294 ASP B 310 ASP~? 12.35 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.42 114.63 4.44 -42.44 114.56 3.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 41 3 # 41 193 ASP B 305 ASP.? 7.64 ZN ZN B 401 231 ASP B 299 ASP.? 24.19 ZN ZN B 402 294 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 42 3 # 42 193 ASP B 310 ASP~? 12.35 ZN ZN A 402 231 ASP B 23 ASP.? 8.15 ZN ZN B 402 294 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 43 3 # 43 193 ASP B 310 ASP~? 12.35 ZN ZN A 402 231 ASP B 23 ASP.? 8.15 ZN ZN B 402 294 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 44 3 # 44 193 ASP B 310 ASP~? 12.35 ZN ZN A 402 231 ASP B 252 ASP~? 28.52 ZN ZN B 402 294 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 45 3 # 45 193 ASP B 310 ASP~? 12.35 ZN ZN A 402 231 ASP B 256 ASP~? 22.51 ZN ZN B 402 294 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 46 3 # 46 193 ASP B 313 ASP~? 12.28 ZN ZN A 402 231 ASP A 310 ASP~? 12.24 ZN ZN B 401 294 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 47 3 # 47 193 ASP B 323 ASP^? 12.28 ZN ZN B 401 231 ASP B 23 ASP.? 8.15 ZN ZN B 402 294 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 33.16 106.80 7.72 33.34 104.87 6.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 48 3 # 48 193 ASP B 361 ASP.? 11.71 ZN ZN B 401 231 ASP A 299 ASP.? 24.38 ZN ZN A 401 294 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 33.16 106.80 7.72 33.34 104.87 6.92 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 49 3 # 49 193 ASP B 361 ASP.? 11.71 ZN ZN B 401 231 ASP B 310 ASP~? 12.35 ZN ZN A 402 294 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 27.89 102.52 14.98 29.35 101.92 13.57 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -43.07 90.95 4.66 -43.22 93.08 4.74 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 49 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 305 ASP.? 7.62 ZN ZN A 402 38 SER A 285 SER.? 7.68 ZN ZN A 402 218 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 41.14 58.72 105.19 42.39 59.85 103.92 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 46.04 57.35 103.96 44.97 58.52 105.78 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo 41.33 60.20 97.63 42.00 60.96 99.49 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP B 305 ASP.? 7.64 ZN ZN B 401 38 SER B 285 SER.? 7.72 ZN ZN B 401 218 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 41.14 58.72 105.19 42.39 59.85 103.92 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 46.04 57.35 103.96 44.97 58.52 105.78 -42.52 104.99 8.17 -43.54 106.03 6.21 coo 41.33 60.20 97.63 42.00 60.96 99.49 -33.57 107.34 6.30 -34.87 106.07 5.21 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 2 hits 2apr_c04 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 163 ALA A 42 ALA^? 12.34 ZN ZN A 402 B 182 SER A 63 SER^? 10.35 ZN ZN A 402 coo 30.42 1.98 4.36 29.07 0.41 4.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 163 ALA A 96 ALA^? 10.78 ZN ZN A 401 B 182 SER A 63 SER^? 10.35 ZN ZN A 402 coo 30.42 1.98 4.36 29.07 0.41 4.68 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 163 ALA A 42 ALA^? 12.34 ZN ZN A 402 B 182 SER A 63 SER^? 10.35 ZN ZN A 402 coo 30.42 1.98 4.36 29.07 0.41 4.68 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -31.20 125.03 -9.65 -31.46 126.10 -8.55 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 163 ALA A 96 ALA^? 10.78 ZN ZN A 401 B 182 SER A 63 SER^? 10.35 ZN ZN A 402 coo 30.42 1.98 4.36 29.07 0.41 4.68 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 163 ALA A 96 ALA^? 10.78 ZN ZN A 401 B 182 SER A 63 SER^? 10.35 ZN ZN A 402 coo 30.42 1.98 4.36 29.07 0.41 4.68 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -40.12 127.57 -11.44 -41.05 127.23 -10.25 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 6 3 # 6 B 46 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 163 ALA B 42 ALA^? 12.31 ZN ZN B 401 B 182 SER B 63 SER^? 10.37 ZN ZN B 401 coo 30.42 1.98 4.36 29.07 0.41 4.68 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 7 3 # 7 B 46 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 163 ALA B 96 ALA^? 10.72 ZN ZN B 402 B 182 SER B 63 SER^? 10.37 ZN ZN B 401 coo 30.42 1.98 4.36 29.07 0.41 4.68 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 8 3 # 8 B 46 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 163 ALA B 42 ALA^? 12.31 ZN ZN B 401 B 182 SER B 63 SER^? 10.37 ZN ZN B 401 coo 30.42 1.98 4.36 29.07 0.41 4.68 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -41.84 87.26 10.29 -42.65 86.57 9.20 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 9 3 # 9 B 46 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 163 ALA B 96 ALA^? 10.72 ZN ZN B 402 B 182 SER B 63 SER^? 10.37 ZN ZN B 401 coo 30.42 1.98 4.36 29.07 0.41 4.68 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 10 3 # 10 B 46 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 163 ALA B 96 ALA^? 10.72 ZN ZN B 402 B 182 SER B 63 SER^? 10.37 ZN ZN B 401 coo 30.42 1.98 4.36 29.07 0.41 4.68 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -50.76 89.87 12.12 -51.42 90.77 11.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -46.04 88.60 10.98 -47.67 89.08 9.23 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 10 hits 2bhg_c02 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 33 ASP.? 31.33 ZN ZN A 401 A 233 GLU A 32 GLU.? 25.81 ZN ZN A 401 A 300 ASN A 93 ASN^? 23.13 ZN ZN A 401 coo 12.51 17.07 49.46 12.44 16.89 47.35 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo 6.52 19.14 48.16 7.77 18.42 46.61 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 9.30 22.40 41.76 10.10 20.96 40.36 -36.46 137.39 -10.90 -36.25 139.51 -10.83 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 233 GLU A 251 GLU~? 26.78 ZN ZN B 401 A 300 ASN A 273 ASN.? 28.39 ZN ZN B 401 coo 12.51 17.07 49.46 12.44 16.89 47.35 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 6.52 19.14 48.16 7.77 18.42 46.61 -25.70 93.68 -9.35 -24.99 91.85 -8.59 coo 9.30 22.40 41.76 10.10 20.96 40.36 -28.95 87.11 -12.66 -30.56 85.68 -12.38 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 3 3 # 3 A 197 ASP B 33 ASP.? 29.43 ZN ZN B 402 A 233 GLU B 32 GLU.? 22.53 ZN ZN B 402 A 300 ASN B 93 ASN^? 23.03 ZN ZN B 402 coo 12.51 17.07 49.46 12.44 16.89 47.35 -61.26 74.82 15.61 -62.97 76.13 15.50 coo 6.52 19.14 48.16 7.77 18.42 46.61 -60.68 81.34 15.57 -59.87 82.93 16.69 coo 9.30 22.40 41.76 10.10 20.96 40.36 -52.93 79.71 11.45 -53.96 77.86 11.50 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 4 3 # 4 A 197 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 233 GLU B 251 GLU~? 27.55 ZN ZN A 402 A 300 ASN B 273 ASN.? 28.81 ZN ZN A 402 coo 12.51 17.07 49.46 12.44 16.89 47.35 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 6.52 19.14 48.16 7.77 18.42 46.61 -20.38 111.90 11.61 -18.92 112.78 10.34 coo 9.30 22.40 41.76 10.10 20.96 40.36 -19.74 117.99 13.68 -20.11 120.10 13.35 2cpu_c01 source 2cpu ALPHA-AMYLASE : 4 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 55 GLU~? 25.21 ZN ZN A 402 A 156 GLU A 354 GLU^? 23.23 ZN ZN A 401 A 194 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 74.14 15.91 8.55 72.08 15.36 8.63 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 67.47 20.07 1.34 65.99 20.06 2.88 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 67.44 25.26 13.91 67.54 23.65 15.28 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 334 GLU~? 17.80 ZN ZN A 401 A 156 GLU A 354 GLU^? 23.23 ZN ZN A 401 A 194 ASN A 342 ASN~? 22.18 ZN ZN A 401 coo 74.14 15.91 8.55 72.08 15.36 8.63 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 67.47 20.07 1.34 65.99 20.06 2.88 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 67.44 25.26 13.91 67.54 23.65 15.28 -29.33 125.76 -27.31 -29.81 125.41 -29.36 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 354 GLU^? 23.23 ZN ZN A 401 A 156 GLU A 55 GLU~? 25.21 ZN ZN A 402 A 194 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 74.14 15.91 8.55 72.08 15.36 8.63 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 67.47 20.07 1.34 65.99 20.06 2.88 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 67.44 25.26 13.91 67.54 23.65 15.28 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 55 GLU~? 25.91 ZN ZN B 401 A 156 GLU B 354 GLU^? 23.36 ZN ZN B 402 A 194 ASN B 59 ASN.? 24.90 ZN ZN B 402 coo 74.14 15.91 8.55 72.08 15.36 8.63 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 67.47 20.07 1.34 65.99 20.06 2.88 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 67.44 25.26 13.91 67.54 23.65 15.28 -49.65 74.63 11.24 -50.47 74.68 13.21 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU B 334 GLU~? 17.83 ZN ZN B 402 A 156 GLU B 354 GLU^? 23.36 ZN ZN B 402 A 194 ASN B 342 ASN~? 21.94 ZN ZN B 402 coo 74.14 15.91 8.55 72.08 15.36 8.63 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 67.47 20.07 1.34 65.99 20.06 2.88 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 67.44 25.26 13.91 67.54 23.65 15.28 -40.74 85.47 27.90 -41.03 86.13 29.94 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU B 354 GLU^? 23.36 ZN ZN B 402 A 156 GLU B 55 GLU~? 25.91 ZN ZN B 401 A 194 ASN B 59 ASN.? 24.90 ZN ZN B 402 coo 74.14 15.91 8.55 72.08 15.36 8.63 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 67.47 20.07 1.34 65.99 20.06 2.88 -39.07 73.47 3.56 -37.44 74.53 2.68 coo 67.44 25.26 13.91 67.54 23.65 15.28 -49.65 74.63 11.24 -50.47 74.68 13.21 2dbt_c00 source 2dbt CHITINASE C : 6 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 55 GLU~? 25.21 ZN ZN A 402 B 156 GLU A 354 GLU^? 23.23 ZN ZN A 401 B 194 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 45.64 63.11 17.20 47.48 62.43 16.45 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 54.43 67.89 19.82 55.62 67.90 18.07 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 49.79 70.75 7.78 50.10 68.90 6.86 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 334 GLU~? 17.80 ZN ZN A 401 B 156 GLU A 354 GLU^? 23.23 ZN ZN A 401 B 194 ASN A 342 ASN~? 22.18 ZN ZN A 401 coo 45.64 63.11 17.20 47.48 62.43 16.45 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 54.43 67.89 19.82 55.62 67.90 18.07 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 49.79 70.75 7.78 50.10 68.90 6.86 -29.33 125.76 -27.31 -29.81 125.41 -29.36 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 354 GLU^? 23.23 ZN ZN A 401 B 156 GLU A 55 GLU~? 25.21 ZN ZN A 402 B 194 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 45.64 63.11 17.20 47.48 62.43 16.45 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 54.43 67.89 19.82 55.62 67.90 18.07 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 49.79 70.75 7.78 50.10 68.90 6.86 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 334 GLU~? 17.83 ZN ZN B 402 B 156 GLU B 354 GLU^? 23.36 ZN ZN B 402 B 194 ASN B 342 ASN~? 21.94 ZN ZN B 402 coo 45.64 63.11 17.20 47.48 62.43 16.45 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 54.43 67.89 19.82 55.62 67.90 18.07 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 49.79 70.75 7.78 50.10 68.90 6.86 -40.74 85.47 27.90 -41.03 86.13 29.94 2dbt_c01 source 2dbt CHITINASE C : 4 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 55 GLU~? 25.21 ZN ZN A 402 C 156 GLU A 354 GLU^? 23.23 ZN ZN A 401 C 194 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 41.23 29.31 13.28 43.03 29.85 12.29 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 44.75 23.09 5.51 46.77 22.91 6.12 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 49.75 21.00 18.12 50.45 23.02 18.26 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 334 GLU~? 17.80 ZN ZN A 401 C 156 GLU A 354 GLU^? 23.23 ZN ZN A 401 C 194 ASN A 342 ASN~? 22.18 ZN ZN A 401 coo 41.23 29.31 13.28 43.03 29.85 12.29 -24.53 120.44 -15.33 -23.13 122.04 -15.66 coo 44.75 23.09 5.51 46.77 22.91 6.12 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 49.75 21.00 18.12 50.45 23.02 18.26 -29.33 125.76 -27.31 -29.81 125.41 -29.36 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 354 GLU^? 23.23 ZN ZN A 401 C 156 GLU A 55 GLU~? 25.21 ZN ZN A 402 C 194 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 41.23 29.31 13.28 43.03 29.85 12.29 -22.49 130.04 -14.63 -21.36 130.96 -13.14 coo 44.75 23.09 5.51 46.77 22.91 6.12 -20.38 134.54 -4.38 -20.41 132.67 -3.34 coo 49.75 21.00 18.12 50.45 23.02 18.26 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 334 GLU~? 17.83 ZN ZN B 402 C 156 GLU B 354 GLU^? 23.36 ZN ZN B 402 C 194 ASN B 342 ASN~? 21.94 ZN ZN B 402 coo 41.23 29.31 13.28 43.03 29.85 12.29 -33.85 87.37 15.86 -33.56 85.28 16.19 coo 44.75 23.09 5.51 46.77 22.91 6.12 -37.43 78.09 15.20 -36.78 76.82 13.66 coo 49.75 21.00 18.12 50.45 23.02 18.26 -40.74 85.47 27.90 -41.03 86.13 29.94 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 A 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 A 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 5.98 42.76 7.73 10.19 38.62 9.02 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 2.77 37.17 4.99 6.33 34.76 8.06 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 A 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 A 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 5.98 42.76 7.73 10.19 38.62 9.02 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 2.77 37.17 4.99 6.33 34.76 8.06 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 5.98 42.76 7.73 10.19 38.62 9.02 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 2.77 37.17 4.99 6.33 34.76 8.06 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 2.77 37.17 4.99 6.33 34.76 8.06 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 2.77 37.17 4.99 6.33 34.76 8.06 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 A 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 A 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 5.98 42.76 7.73 10.19 38.62 9.02 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 2.77 37.17 4.99 6.33 34.76 8.06 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 A 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 2.77 37.17 4.99 6.33 34.76 8.06 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 A 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 2.77 37.17 4.99 6.33 34.76 8.06 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 9 3 # 9 A 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 A 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 A 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 2.77 37.17 4.99 6.33 34.76 8.06 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 10 3 # 10 A 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 A 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 A 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 2.77 37.17 4.99 6.33 34.76 8.06 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 11 3 # 11 A 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 2.77 37.17 4.99 6.33 34.76 8.06 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 12 3 # 12 A 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 5.98 42.76 7.73 10.19 38.62 9.02 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 2.77 37.17 4.99 6.33 34.76 8.06 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 13 3 # 13 A 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 A 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 A 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 5.98 42.76 7.73 10.19 38.62 9.02 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 2.77 37.17 4.99 6.33 34.76 8.06 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 14 3 # 14 A 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 A 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 A 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 5.98 42.76 7.73 10.19 38.62 9.02 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 2.77 37.17 4.99 6.33 34.76 8.06 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 15 3 # 15 A 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 A 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 5.98 42.76 7.73 10.19 38.62 9.02 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 2.77 37.17 4.99 6.33 34.76 8.06 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -43.07 90.95 4.66 -43.22 93.08 4.74 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 B 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 B 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 38.76 2.27 4.00 34.00 5.99 4.37 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 40.63 7.13 9.06 35.85 7.36 8.95 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 38.76 2.27 4.00 34.00 5.99 4.37 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 40.63 7.13 9.06 35.85 7.36 8.95 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 260 LYS~? 21.58 ZN ZN A 401 B 184 LYS A 258 LYS~? 21.92 ZN ZN A 402 B 345 ASP A 245 ASP^? 25.73 ZN ZN A 401 coo 38.76 2.27 4.00 34.00 5.99 4.37 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 40.63 7.13 9.06 35.85 7.36 8.95 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -25.62 99.57 -26.57 -25.42 101.64 -26.90 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 B 345 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 38.76 2.27 4.00 34.00 5.99 4.37 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 40.63 7.13 9.06 35.85 7.36 8.95 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 B 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 B 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 38.76 2.27 4.00 34.00 5.99 4.37 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 40.63 7.13 9.06 35.85 7.36 8.95 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 B 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 B 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 38.76 2.27 4.00 34.00 5.99 4.37 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 40.63 7.13 9.06 35.85 7.36 8.95 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 38.76 2.27 4.00 34.00 5.99 4.37 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 40.63 7.13 9.06 35.85 7.36 8.95 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS B 260 LYS~? 21.74 ZN ZN B 402 B 184 LYS B 258 LYS~? 21.85 ZN ZN B 401 B 345 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 38.76 2.27 4.00 34.00 5.99 4.37 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 40.63 7.13 9.06 35.85 7.36 8.95 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 B 345 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 38.76 2.27 4.00 34.00 5.99 4.37 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 40.63 7.13 9.06 35.85 7.36 8.95 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -46.20 100.05 15.92 -45.42 99.37 14.07 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 C 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 C 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 0.95 12.72 73.51 1.58 12.72 68.31 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 C 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 C 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 0.95 12.72 73.51 1.58 12.72 68.31 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 C 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 C 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 0.95 12.72 73.51 1.58 12.72 68.31 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 C 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 C 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 0.95 12.72 73.51 1.58 12.72 68.31 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 C 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 C 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 0.95 12.72 73.51 1.58 12.72 68.31 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 C 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 C 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 0.95 12.72 73.51 1.58 12.72 68.31 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 C 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 C 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 0.95 12.72 73.51 1.58 12.72 68.31 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 C 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 C 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 0.95 12.72 73.51 1.58 12.72 68.31 -30.71 103.60 27.70 -26.87 107.57 30.82 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 9 3 # 9 C 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 C 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 C 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 0.95 12.72 73.51 1.58 12.72 68.31 -32.38 97.99 22.64 -33.06 97.84 28.07 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 10 3 # 10 C 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 C 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 C 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 0.95 12.72 73.51 1.58 12.72 68.31 -69.50 93.01 49.28 -67.77 93.79 54.77 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 11 3 # 11 C 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 C 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 C 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 0.95 12.72 73.51 1.58 12.72 68.31 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 12 3 # 12 C 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 C 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 C 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 0.95 12.72 73.51 1.58 12.72 68.31 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 13 3 # 13 C 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 C 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 C 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 0.95 12.72 73.51 1.58 12.72 68.31 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 14 3 # 14 C 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 C 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 C 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 0.95 12.72 73.51 1.58 12.72 68.31 -24.21 116.63 19.13 -19.07 117.25 20.30 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 15 3 # 15 C 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 C 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 C 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 0.95 12.72 73.51 1.58 12.72 68.31 -39.69 85.19 19.25 -35.37 81.01 18.46 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -43.07 90.95 4.66 -43.22 93.08 4.74 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 D 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 D 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 D 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 D 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 D 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 D 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 D 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 D 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 D 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 D 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 D 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 D 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 7 3 # 7 D 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 D 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 D 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 8 3 # 8 D 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 D 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 D 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 9 3 # 9 D 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 D 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 D 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 10 3 # 10 D 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 D 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 D 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 11 3 # 11 D 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 D 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 D 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 12 3 # 12 D 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 D 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 D 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 13 3 # 13 D 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 D 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 D 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 14 3 # 14 D 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 D 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 D 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 15 3 # 15 D 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 D 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 D 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -43.07 90.95 4.66 -43.22 93.08 4.74 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 E 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 E 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 E 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 E 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 E 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 E 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 E 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 E 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 E 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 E 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 E 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 E 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 7 3 # 7 E 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 E 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 E 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 8 3 # 8 E 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 E 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 E 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -32.38 97.99 22.64 -33.06 97.84 28.07 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -30.71 103.60 27.70 -26.87 107.57 30.82 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 9 3 # 9 E 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 E 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 E 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -30.71 103.60 27.70 -26.87 107.57 30.82 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -32.38 97.99 22.64 -33.06 97.84 28.07 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 10 3 # 10 E 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 E 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 E 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -73.22 97.33 48.85 -74.87 100.01 44.50 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -69.50 93.01 49.28 -67.77 93.79 54.77 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 11 3 # 11 E 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 E 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 E 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 12 3 # 12 E 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 E 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 E 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 13 3 # 13 E 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 E 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 E 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 14 3 # 14 E 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 E 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 E 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -28.04 112.73 23.24 -26.21 110.17 27.80 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -24.21 116.63 19.13 -19.07 117.25 20.30 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 15 3 # 15 E 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 E 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 E 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -39.69 85.19 19.25 -35.37 81.01 18.46 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -43.07 90.95 4.66 -43.22 93.08 4.74 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 F 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 F 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 13.75 39.76 94.12 11.42 37.23 97.89 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 16.35 26.90 99.56 16.81 25.90 97.75 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 F 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 F 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 13.75 39.76 94.12 11.42 37.23 97.89 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 16.35 26.90 99.56 16.81 25.90 97.75 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 F 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 F 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 13.75 39.76 94.12 11.42 37.23 97.89 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 16.35 26.90 99.56 16.81 25.90 97.75 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 F 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 F 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 13.75 39.76 94.12 11.42 37.23 97.89 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 16.35 26.90 99.56 16.81 25.90 97.75 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 F 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 F 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 13.75 39.76 94.12 11.42 37.23 97.89 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 16.35 26.90 99.56 16.81 25.90 97.75 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 F 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 F 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 13.75 39.76 94.12 11.42 37.23 97.89 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 16.35 26.90 99.56 16.81 25.90 97.75 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 7 3 # 7 F 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 F 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 F 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 13.75 39.76 94.12 11.42 37.23 97.89 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 16.35 26.90 99.56 16.81 25.90 97.75 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 8 3 # 8 F 182 LYS A 337 LYS~? 20.91 ZN ZN A 401 F 184 LYS A 333 LYS~? 13.50 ZN ZN A 402 F 345 ASP A 352 ASP.? 27.02 ZN ZN A 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 13.75 39.76 94.12 11.42 37.23 97.89 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 16.35 26.90 99.56 16.81 25.90 97.75 -23.78 134.83 -17.90 -22.09 135.98 -18.58 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 9 3 # 9 F 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 F 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 F 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 13.75 39.76 94.12 11.42 37.23 97.89 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 16.35 26.90 99.56 16.81 25.90 97.75 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 10 3 # 10 F 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 F 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 F 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 13.75 39.76 94.12 11.42 37.23 97.89 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 16.35 26.90 99.56 16.81 25.90 97.75 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 11 3 # 11 F 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 F 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 F 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 13.75 39.76 94.12 11.42 37.23 97.89 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 16.35 26.90 99.56 16.81 25.90 97.75 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 12 3 # 12 F 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 F 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 F 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 13.75 39.76 94.12 11.42 37.23 97.89 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 16.35 26.90 99.56 16.81 25.90 97.75 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 13 3 # 13 F 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 F 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 F 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 13.75 39.76 94.12 11.42 37.23 97.89 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 16.35 26.90 99.56 16.81 25.90 97.75 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 14 3 # 14 F 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 F 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 F 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 13.75 39.76 94.12 11.42 37.23 97.89 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 16.35 26.90 99.56 16.81 25.90 97.75 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 15 3 # 15 F 182 LYS B 275 LYS^? 32.38 ZN ZN B 402 F 184 LYS B 277 LYS^? 26.47 ZN ZN B 402 F 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 13.75 39.76 94.12 11.42 37.23 97.89 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 16.35 26.90 99.56 16.81 25.90 97.75 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 16 3 # 16 F 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 F 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 F 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 13.75 39.76 94.12 11.42 37.23 97.89 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 16.35 26.90 99.56 16.81 25.90 97.75 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 17 3 # 17 F 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 F 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 F 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 10.64 34.02 91.30 6.30 35.60 95.11 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 13.75 39.76 94.12 11.42 37.23 97.89 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 16.35 26.90 99.56 16.81 25.90 97.75 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 18 3 # 18 F 182 LYS B 337 LYS~? 20.93 ZN ZN B 402 F 184 LYS B 333 LYS~? 13.39 ZN ZN B 401 F 345 ASP B 352 ASP.? 26.97 ZN ZN B 402 coo 10.64 34.02 91.30 6.30 35.60 95.11 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 13.75 39.76 94.12 11.42 37.23 97.89 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 16.35 26.90 99.56 16.81 25.90 97.75 -40.82 74.97 18.30 -40.24 73.02 18.95 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 18 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 G 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 G 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 39.68 42.04 76.11 43.42 46.43 74.96 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 36.69 47.69 78.93 39.38 50.40 75.35 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 33.43 44.37 65.47 33.10 42.30 65.37 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 G 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 G 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 39.68 42.04 76.11 43.42 46.43 74.96 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 36.69 47.69 78.93 39.38 50.40 75.35 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 33.43 44.37 65.47 33.10 42.30 65.37 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 G 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 G 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 39.68 42.04 76.11 43.42 46.43 74.96 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 36.69 47.69 78.93 39.38 50.40 75.35 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 33.43 44.37 65.47 33.10 42.30 65.37 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 G 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 G 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 36.69 47.69 78.93 39.38 50.40 75.35 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 33.43 44.37 65.47 33.10 42.30 65.37 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 G 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 G 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 36.69 47.69 78.93 39.38 50.40 75.35 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 33.43 44.37 65.47 33.10 42.30 65.37 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 G 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 G 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 39.68 42.04 76.11 43.42 46.43 74.96 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 36.69 47.69 78.93 39.38 50.40 75.35 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 33.43 44.37 65.47 33.10 42.30 65.37 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 G 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 G 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 36.69 47.69 78.93 39.38 50.40 75.35 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 33.43 44.37 65.47 33.10 42.30 65.37 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 G 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 G 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 36.69 47.69 78.93 39.38 50.40 75.35 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 33.43 44.37 65.47 33.10 42.30 65.37 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 9 3 # 9 G 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 G 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 G 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 36.69 47.69 78.93 39.38 50.40 75.35 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 33.43 44.37 65.47 33.10 42.30 65.37 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 10 3 # 10 G 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 G 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 G 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 36.69 47.69 78.93 39.38 50.40 75.35 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 33.43 44.37 65.47 33.10 42.30 65.37 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 11 3 # 11 G 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 G 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 G 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 36.69 47.69 78.93 39.38 50.40 75.35 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 33.43 44.37 65.47 33.10 42.30 65.37 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 12 3 # 12 G 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 G 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 G 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 39.68 42.04 76.11 43.42 46.43 74.96 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 36.69 47.69 78.93 39.38 50.40 75.35 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 33.43 44.37 65.47 33.10 42.30 65.37 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 13 3 # 13 G 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 G 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 G 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 39.68 42.04 76.11 43.42 46.43 74.96 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 36.69 47.69 78.93 39.38 50.40 75.35 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 33.43 44.37 65.47 33.10 42.30 65.37 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 14 3 # 14 G 182 LYS B 275 LYS^? 32.38 ZN ZN B 402 G 184 LYS B 277 LYS^? 26.47 ZN ZN B 402 G 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 36.69 47.69 78.93 39.38 50.40 75.35 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 33.43 44.37 65.47 33.10 42.30 65.37 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 15 3 # 15 G 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 G 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 G 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 39.68 42.04 76.11 43.42 46.43 74.96 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 36.69 47.69 78.93 39.38 50.40 75.35 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 33.43 44.37 65.47 33.10 42.30 65.37 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 16 3 # 16 G 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 G 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 G 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 39.68 42.04 76.11 43.42 46.43 74.96 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 36.69 47.69 78.93 39.38 50.40 75.35 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 33.43 44.37 65.47 33.10 42.30 65.37 -43.07 90.95 4.66 -43.22 93.08 4.74 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 16 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 H 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 H 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 71.58 83.18 80.51 66.88 79.77 79.84 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 73.65 78.64 75.66 68.14 79.07 75.04 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 67.43 90.73 71.39 68.27 92.30 72.52 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 H 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 H 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 71.58 83.18 80.51 66.88 79.77 79.84 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 73.65 78.64 75.66 68.14 79.07 75.04 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 67.43 90.73 71.39 68.27 92.30 72.52 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 H 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 H 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 71.58 83.18 80.51 66.88 79.77 79.84 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 73.65 78.64 75.66 68.14 79.07 75.04 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 67.43 90.73 71.39 68.27 92.30 72.52 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 H 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 H 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 73.65 78.64 75.66 68.14 79.07 75.04 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 67.43 90.73 71.39 68.27 92.30 72.52 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 H 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 H 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 73.65 78.64 75.66 68.14 79.07 75.04 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 67.43 90.73 71.39 68.27 92.30 72.52 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 H 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 H 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 71.58 83.18 80.51 66.88 79.77 79.84 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 73.65 78.64 75.66 68.14 79.07 75.04 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 67.43 90.73 71.39 68.27 92.30 72.52 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 H 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 H 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 73.65 78.64 75.66 68.14 79.07 75.04 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 67.43 90.73 71.39 68.27 92.30 72.52 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 8 3 # 8 H 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 H 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 H 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 73.65 78.64 75.66 68.14 79.07 75.04 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 67.43 90.73 71.39 68.27 92.30 72.52 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 9 3 # 9 H 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 H 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 H 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 73.65 78.64 75.66 68.14 79.07 75.04 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 67.43 90.73 71.39 68.27 92.30 72.52 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 10 3 # 10 H 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 H 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 H 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 73.65 78.64 75.66 68.14 79.07 75.04 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 67.43 90.73 71.39 68.27 92.30 72.52 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 11 3 # 11 H 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 H 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 H 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 73.65 78.64 75.66 68.14 79.07 75.04 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 67.43 90.73 71.39 68.27 92.30 72.52 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 12 3 # 12 H 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 H 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 H 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 71.58 83.18 80.51 66.88 79.77 79.84 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 73.65 78.64 75.66 68.14 79.07 75.04 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 67.43 90.73 71.39 68.27 92.30 72.52 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 13 3 # 13 H 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 H 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 H 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 71.58 83.18 80.51 66.88 79.77 79.84 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 73.65 78.64 75.66 68.14 79.07 75.04 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 67.43 90.73 71.39 68.27 92.30 72.52 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 14 3 # 14 H 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 H 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 H 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 71.58 83.18 80.51 66.88 79.77 79.84 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 73.65 78.64 75.66 68.14 79.07 75.04 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 67.43 90.73 71.39 68.27 92.30 72.52 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 15 3 # 15 H 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 H 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 H 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 71.58 83.18 80.51 66.88 79.77 79.84 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 73.65 78.64 75.66 68.14 79.07 75.04 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 67.43 90.73 71.39 68.27 92.30 72.52 -43.07 90.95 4.66 -43.22 93.08 4.74 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 I 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 I 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 60.20 96.92 42.53 57.60 93.13 38.67 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 54.31 95.46 46.01 55.34 91.59 42.65 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 66.35 87.81 48.53 68.10 89.01 48.77 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 I 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 I 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 60.20 96.92 42.53 57.60 93.13 38.67 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 54.31 95.46 46.01 55.34 91.59 42.65 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 66.35 87.81 48.53 68.10 89.01 48.77 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 I 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 I 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 60.20 96.92 42.53 57.60 93.13 38.67 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 54.31 95.46 46.01 55.34 91.59 42.65 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 66.35 87.81 48.53 68.10 89.01 48.77 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 I 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 I 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 54.31 95.46 46.01 55.34 91.59 42.65 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 66.35 87.81 48.53 68.10 89.01 48.77 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 I 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 I 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 54.31 95.46 46.01 55.34 91.59 42.65 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 66.35 87.81 48.53 68.10 89.01 48.77 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 I 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 I 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 60.20 96.92 42.53 57.60 93.13 38.67 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 54.31 95.46 46.01 55.34 91.59 42.65 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 66.35 87.81 48.53 68.10 89.01 48.77 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 7 3 # 7 I 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 I 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 I 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 54.31 95.46 46.01 55.34 91.59 42.65 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 66.35 87.81 48.53 68.10 89.01 48.77 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 8 3 # 8 I 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 I 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 I 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 54.31 95.46 46.01 55.34 91.59 42.65 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 66.35 87.81 48.53 68.10 89.01 48.77 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 9 3 # 9 I 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 I 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 I 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 54.31 95.46 46.01 55.34 91.59 42.65 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 66.35 87.81 48.53 68.10 89.01 48.77 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 10 3 # 10 I 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 I 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 I 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 54.31 95.46 46.01 55.34 91.59 42.65 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 66.35 87.81 48.53 68.10 89.01 48.77 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 11 3 # 11 I 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 I 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 I 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 54.31 95.46 46.01 55.34 91.59 42.65 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 66.35 87.81 48.53 68.10 89.01 48.77 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 12 3 # 12 I 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 I 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 I 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 60.20 96.92 42.53 57.60 93.13 38.67 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 54.31 95.46 46.01 55.34 91.59 42.65 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 66.35 87.81 48.53 68.10 89.01 48.77 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 13 3 # 13 I 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 I 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 I 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 60.20 96.92 42.53 57.60 93.13 38.67 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 54.31 95.46 46.01 55.34 91.59 42.65 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 66.35 87.81 48.53 68.10 89.01 48.77 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 14 3 # 14 I 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 I 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 I 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 60.20 96.92 42.53 57.60 93.13 38.67 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 54.31 95.46 46.01 55.34 91.59 42.65 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 66.35 87.81 48.53 68.10 89.01 48.77 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 15 3 # 15 I 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 I 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 I 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 60.20 96.92 42.53 57.60 93.13 38.67 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 54.31 95.46 46.01 55.34 91.59 42.65 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 66.35 87.81 48.53 68.10 89.01 48.77 -43.07 90.95 4.66 -43.22 93.08 4.74 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 J 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 J 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 25.22 70.55 14.03 27.64 73.07 18.65 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 31.73 69.87 11.50 32.73 70.19 16.40 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 25.87 58.42 18.79 23.95 58.54 17.90 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 J 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 J 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 25.22 70.55 14.03 27.64 73.07 18.65 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 31.73 69.87 11.50 32.73 70.19 16.40 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 25.87 58.42 18.79 23.95 58.54 17.90 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 J 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 J 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 25.22 70.55 14.03 27.64 73.07 18.65 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 31.73 69.87 11.50 32.73 70.19 16.40 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 25.87 58.42 18.79 23.95 58.54 17.90 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 J 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 J 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 25.22 70.55 14.03 27.64 73.07 18.65 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 31.73 69.87 11.50 32.73 70.19 16.40 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 25.87 58.42 18.79 23.95 58.54 17.90 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 J 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 J 345 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 25.22 70.55 14.03 27.64 73.07 18.65 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 31.73 69.87 11.50 32.73 70.19 16.40 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 25.87 58.42 18.79 23.95 58.54 17.90 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 J 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 J 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 25.22 70.55 14.03 27.64 73.07 18.65 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 31.73 69.87 11.50 32.73 70.19 16.40 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 25.87 58.42 18.79 23.95 58.54 17.90 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 7 3 # 7 J 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 J 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 J 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 25.22 70.55 14.03 27.64 73.07 18.65 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 31.73 69.87 11.50 32.73 70.19 16.40 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 25.87 58.42 18.79 23.95 58.54 17.90 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 8 3 # 8 J 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 J 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 J 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 25.22 70.55 14.03 27.64 73.07 18.65 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 31.73 69.87 11.50 32.73 70.19 16.40 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 25.87 58.42 18.79 23.95 58.54 17.90 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 9 3 # 9 J 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 J 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 J 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 25.22 70.55 14.03 27.64 73.07 18.65 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 31.73 69.87 11.50 32.73 70.19 16.40 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 25.87 58.42 18.79 23.95 58.54 17.90 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 10 3 # 10 J 182 LYS B 260 LYS~? 21.74 ZN ZN B 402 J 184 LYS B 258 LYS~? 21.85 ZN ZN B 401 J 345 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 25.22 70.55 14.03 27.64 73.07 18.65 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 31.73 69.87 11.50 32.73 70.19 16.40 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 25.87 58.42 18.79 23.95 58.54 17.90 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 11 3 # 11 J 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 J 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 J 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 25.22 70.55 14.03 27.64 73.07 18.65 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 31.73 69.87 11.50 32.73 70.19 16.40 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 25.87 58.42 18.79 23.95 58.54 17.90 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 12 3 # 12 J 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 J 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 J 345 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 25.22 70.55 14.03 27.64 73.07 18.65 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 31.73 69.87 11.50 32.73 70.19 16.40 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 25.87 58.42 18.79 23.95 58.54 17.90 -46.20 100.05 15.92 -45.42 99.37 14.07 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 12 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 K 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 K 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 K 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 K 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 K 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 K 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 K 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 K 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 K 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 K 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 K 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 K 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 K 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 K 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 K 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 K 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 9 3 # 9 K 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 K 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 K 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 10 3 # 10 K 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 K 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 K 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 11 3 # 11 K 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 K 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 K 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 12 3 # 12 K 182 LYS B 260 LYS~? 21.74 ZN ZN B 402 K 184 LYS B 258 LYS~? 21.85 ZN ZN B 401 K 345 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 13 3 # 13 K 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 K 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 K 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 14 3 # 14 K 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 K 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 K 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 15 3 # 15 K 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 K 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 K 345 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -46.20 100.05 15.92 -45.42 99.37 14.07 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 L 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 L 345 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 L 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 L 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 260 LYS~? 21.58 ZN ZN A 401 L 184 LYS A 258 LYS~? 21.92 ZN ZN A 402 L 345 ASP A 245 ASP^? 25.73 ZN ZN A 401 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -25.62 99.57 -26.57 -25.42 101.64 -26.90 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 L 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 L 345 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 L 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 L 345 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 L 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 L 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 L 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 L 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS B 260 LYS~? 21.74 ZN ZN B 402 L 184 LYS B 258 LYS~? 21.85 ZN ZN B 401 L 345 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 L 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 L 345 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -46.20 100.05 15.92 -45.42 99.37 14.07 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 M 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 M 345 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 M 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 M 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 260 LYS~? 21.58 ZN ZN A 401 M 184 LYS A 258 LYS~? 21.92 ZN ZN A 402 M 345 ASP A 245 ASP^? 25.73 ZN ZN A 401 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -25.62 99.57 -26.57 -25.42 101.64 -26.90 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 M 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 M 345 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 M 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 M 345 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -30.71 103.60 27.70 -26.87 107.57 30.82 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -32.38 97.99 22.64 -33.06 97.84 28.07 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 M 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 M 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS B 260 LYS~? 21.74 ZN ZN B 402 M 184 LYS B 258 LYS~? 21.85 ZN ZN B 401 M 345 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -25.65 97.38 15.05 -24.29 100.72 20.18 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -25.96 101.08 10.72 -22.73 101.83 5.25 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 M 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 M 345 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -39.69 85.19 19.25 -35.37 81.01 18.46 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -46.20 100.05 15.92 -45.42 99.37 14.07 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 N 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 N 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 N 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 N 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 N 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 N 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 N 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 N 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 N 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 N 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS A 275 LYS^? 30.46 ZN ZN A 401 N 184 LYS A 277 LYS^? 27.09 ZN ZN A 401 N 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 7 3 # 7 N 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 N 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 N 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 8 3 # 8 N 182 LYS A 337 LYS~? 20.91 ZN ZN A 401 N 184 LYS A 333 LYS~? 13.50 ZN ZN A 402 N 345 ASP A 352 ASP.? 27.02 ZN ZN A 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -23.78 134.83 -17.90 -22.09 135.98 -18.58 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 9 3 # 9 N 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 N 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 N 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 10 3 # 10 N 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 N 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 N 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 11 3 # 11 N 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 N 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 N 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 12 3 # 12 N 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 N 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 N 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 13 3 # 13 N 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 N 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 N 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 14 3 # 14 N 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 N 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 N 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 15 3 # 15 N 182 LYS B 275 LYS^? 32.38 ZN ZN B 402 N 184 LYS B 277 LYS^? 26.47 ZN ZN B 402 N 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 16 3 # 16 N 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 N 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 N 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 17 3 # 17 N 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 N 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 N 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 18 3 # 18 N 182 LYS B 337 LYS~? 20.93 ZN ZN B 402 N 184 LYS B 333 LYS~? 13.39 ZN ZN B 401 N 345 ASP B 352 ASP.? 26.97 ZN ZN B 402 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -40.82 74.97 18.30 -40.24 73.02 18.95 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 18 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 114 LYS~? 19.79 ZN ZN A 401 O 184 LYS A 119 LYS^? 25.23 ZN ZN A 401 O 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 O 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 O 345 ASP A 252 ASP~? 28.57 ZN ZN A 401 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -24.45 95.00 -14.78 -23.16 93.40 -14.21 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 O 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 O 345 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 O 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 O 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS A 277 LYS^? 27.09 ZN ZN A 401 O 184 LYS A 275 LYS^? 30.46 ZN ZN A 401 O 345 ASP A 256 ASP~? 22.47 ZN ZN A 401 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -24.24 101.11 -15.51 -23.37 102.12 -17.14 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 O 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 O 345 ASP A 44 ASP.? 7.09 ZN ZN A 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -33.96 122.51 -3.83 -35.32 120.86 -3.91 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS B 114 LYS~? 19.44 ZN ZN B 402 O 184 LYS B 119 LYS^? 26.96 ZN ZN B 402 O 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS B 147 LYS~? 44.21 ZN ZN B 402 O 184 LYS B 149 LYS~? 48.62 ZN ZN B 402 O 345 ASP B 141 ASP.? 56.65 ZN ZN B 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -73.22 97.33 48.85 -74.87 100.01 44.50 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -69.50 93.01 49.28 -67.77 93.79 54.77 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -75.94 101.33 59.57 -77.56 101.84 58.29 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 9 3 # 9 O 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 O 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 O 345 ASP B 252 ASP~? 28.52 ZN ZN B 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -20.29 109.25 15.64 -18.38 109.99 15.02 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 10 3 # 10 O 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 O 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 O 345 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -33.57 107.34 6.30 -34.87 106.07 5.21 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 11 3 # 11 O 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 O 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 O 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 12 3 # 12 O 182 LYS B 260 LYS~? 21.74 ZN ZN B 402 O 184 LYS B 258 LYS~? 21.85 ZN ZN B 401 O 345 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 13 3 # 13 O 182 LYS B 277 LYS^? 26.47 ZN ZN B 402 O 184 LYS B 275 LYS^? 32.38 ZN ZN B 402 O 345 ASP B 256 ASP~? 22.51 ZN ZN B 402 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -23.25 103.81 16.30 -22.99 102.51 17.90 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 14 3 # 14 O 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 O 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 O 345 ASP B 44 ASP.? 7.11 ZN ZN B 401 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -43.07 90.95 4.66 -43.22 93.08 4.74 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 15 3 # 15 O 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 O 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 O 345 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -46.20 100.05 15.92 -45.42 99.37 14.07 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 119 LYS^? 25.23 ZN ZN A 401 P 184 LYS A 114 LYS~? 19.79 ZN ZN A 401 P 345 ASP A 299 ASP.? 24.38 ZN ZN A 401 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -30.64 105.03 -26.92 -25.62 104.22 -28.46 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -28.96 110.92 -21.77 -28.27 111.19 -26.80 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -36.54 95.17 -18.71 -36.75 94.18 -20.57 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 258 LYS~? 21.92 ZN ZN A 402 P 184 LYS A 260 LYS~? 21.58 ZN ZN A 401 P 345 ASP A 361 ASP.? 11.77 ZN ZN A 402 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -28.63 115.74 -1.62 -29.77 113.98 -1.34 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 260 LYS~? 21.58 ZN ZN A 401 P 184 LYS A 258 LYS~? 21.92 ZN ZN A 402 P 345 ASP A 245 ASP^? 25.73 ZN ZN A 401 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -25.62 99.57 -26.57 -25.42 101.64 -26.90 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 333 LYS~? 13.50 ZN ZN A 402 P 184 LYS A 337 LYS~? 20.91 ZN ZN A 401 P 345 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -28.24 125.46 -18.64 -22.85 126.80 -18.85 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS B 119 LYS^? 26.96 ZN ZN B 402 P 184 LYS B 114 LYS~? 19.44 ZN ZN B 402 P 345 ASP B 299 ASP.? 24.19 ZN ZN B 402 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -30.71 103.60 27.70 -26.87 107.57 30.82 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -32.38 97.99 22.64 -33.06 97.84 28.07 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -30.65 115.42 19.76 -30.54 116.24 21.74 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS B 258 LYS~? 21.85 ZN ZN B 401 P 184 LYS B 260 LYS~? 21.74 ZN ZN B 402 P 345 ASP B 361 ASP.? 11.71 ZN ZN B 401 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -34.85 93.86 2.41 -34.87 96.02 2.16 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS B 260 LYS~? 21.74 ZN ZN B 402 P 184 LYS B 258 LYS~? 21.85 ZN ZN B 401 P 345 ASP B 245 ASP^? 25.30 ZN ZN B 402 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -25.65 97.38 15.05 -24.29 100.72 20.18 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -25.96 101.08 10.72 -22.73 101.83 5.25 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -23.71 105.07 26.59 -24.46 103.20 27.20 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS B 333 LYS~? 13.39 ZN ZN B 401 P 184 LYS B 337 LYS~? 20.93 ZN ZN B 402 P 345 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -39.69 85.19 19.25 -35.37 81.01 18.46 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -46.20 100.05 15.92 -45.42 99.37 14.07 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c47 naa= 3 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 1 3 # 1 B 235 GLU B 167 GLU^? 53.31 ZN ZN B 402 B 340 GLU B 195 GLU^? 52.10 ZN ZN B 402 B 342 CYH B 164 CYH^? 52.47 ZN ZN B 402 coo 41.63 98.81 4.74 43.45 99.80 5.19 -79.62 113.37 49.20 -81.22 112.07 48.69 coo 40.49 105.59 6.14 40.82 103.64 6.89 -77.28 109.06 51.77 -78.42 110.03 50.31 coo 45.58 109.64 7.60 45.90 106.93 8.23 -69.72 111.23 54.77 -68.94 110.31 57.38 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 2 3 # 2 B 235 GLU B 199 GLU^? 40.09 ZN ZN B 402 B 340 GLU B 162 GLU^? 46.76 ZN ZN B 402 B 342 CYH B 164 CYH^? 52.47 ZN ZN B 402 coo 41.63 98.81 4.74 43.45 99.80 5.19 -65.13 107.83 45.37 -64.79 109.92 45.13 coo 40.49 105.59 6.14 40.82 103.64 6.89 -66.72 104.17 51.47 -67.64 102.80 52.82 coo 45.58 109.64 7.60 45.90 106.93 8.23 -69.72 111.23 54.77 -68.94 110.31 57.38 2f61_c01 source 2f61 ACID BETA-GLUCOSIDASE : 2 hits 2f61_c01 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 245 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 245 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 273 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 245 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 245 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 245 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 245 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 273 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.96 101.08 10.72 -22.73 101.83 5.25 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 245 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 150 TYR B 137 TYR^? 46.12 ZN ZN B 402 A 245 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 273 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -74.76 109.88 46.51 -73.14 111.68 45.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 150 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 245 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 150 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 245 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 273 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 150 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 245 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 273 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 150 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 245 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 273 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 150 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 245 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 273 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 150 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 245 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 150 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 245 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 273 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -41.26 92.47 -6.07 -36.28 89.98 -4.98 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 15 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 16 PHE~? 14.00 ZN ZN A 401 A 245 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 273 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -44.69 128.21 -17.73 -42.08 129.17 -17.23 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 245 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 273 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 245 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 273 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -22.91 107.85 -14.23 -23.69 104.38 -19.46 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 245 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 245 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 245 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 273 LYS A 258 LYS~? 21.92 ZN ZN A 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.04 104.86 -9.89 -22.57 102.68 -4.34 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 245 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 273 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE B 16 PHE~? 14.05 ZN ZN B 402 A 245 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 273 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -55.07 91.67 18.58 -53.33 89.51 18.07 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 245 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 273 LYS B 140 LYS.? 53.20 ZN ZN B 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -74.22 104.46 56.49 -70.63 102.62 58.58 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 245 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 273 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 245 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 273 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -20.29 109.25 15.64 -18.38 109.99 15.02 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 157 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 245 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 157 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 245 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 157 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 245 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 273 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 157 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 245 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 273 LYS B 258 LYS~? 21.85 ZN ZN B 401 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.96 101.08 10.72 -22.73 101.83 5.25 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 15 hits 2gsa_c04 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 341 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 356 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 121.00 36.37 19.26 121.57 38.37 19.56 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 125.72 32.70 19.75 124.44 34.16 18.84 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 124.34 41.73 25.55 123.79 42.60 23.72 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 341 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 356 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 121.00 36.37 19.26 121.57 38.37 19.56 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 125.72 32.70 19.75 124.44 34.16 18.84 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 124.34 41.73 25.55 123.79 42.60 23.72 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 341 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 356 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 121.00 36.37 19.26 121.57 38.37 19.56 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 125.72 32.70 19.75 124.44 34.16 18.84 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 124.34 41.73 25.55 123.79 42.60 23.72 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 A 311 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 341 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 356 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 121.00 36.37 19.26 121.57 38.37 19.56 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 125.72 32.70 19.75 124.44 34.16 18.84 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 124.34 41.73 25.55 123.79 42.60 23.72 -49.25 96.40 11.26 -48.45 97.80 9.92 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 4 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 341 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 356 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 341 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 356 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 341 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 356 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 B 311 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 341 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 356 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -49.25 96.40 11.26 -48.45 97.80 9.92 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 4 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 35 SER A 285 SER.? 7.68 ZN ZN A 402 A 215 ASP A 310 ASP~? 12.24 ZN ZN B 401 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -44.34 101.21 -3.37 -45.95 102.39 -2.67 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 35 SER A 285 SER.? 7.68 ZN ZN A 402 A 215 ASP A 323 ASP^? 12.30 ZN ZN A 402 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -34.81 103.62 -5.28 -35.25 105.45 -4.26 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 35 SER B 285 SER.? 7.72 ZN ZN B 401 A 215 ASP B 323 ASP^? 12.28 ZN ZN B 401 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -33.57 107.34 6.30 -34.87 106.07 5.21 2jxr_c04 source 2jxr LIGAND CP-081282 : 3 hits 2jxr_c04 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 328 SER~? 11.01 ZN ZN A 402 264 ASP A 305 ASP.? 7.62 ZN ZN A 402 286 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 10.47 25.91 18.67 10.67 27.13 20.84 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 2.34 22.49 22.56 3.80 23.95 22.00 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.10 24.11 23.40 8.18 25.09 21.87 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2lip_c00 LIPASE user 2 3 # 2 87 SER B 328 SER~? 10.89 ZN ZN B 401 264 ASP B 305 ASP.? 7.64 ZN ZN B 401 286 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 10.47 25.91 18.67 10.67 27.13 20.84 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 2.34 22.49 22.56 3.80 23.95 22.00 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.10 24.11 23.40 8.18 25.09 21.87 -40.92 100.43 6.30 -42.93 100.06 6.77 2lip_c00 source 2lip LIPASE : 2 hits 2lip_c00 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 193 GLY A 335 GLY~? 12.90 ZN ZN A 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.54 28.99 9.76 15.06 29.59 10.02 -29.44 120.06 -18.71 -29.40 120.83 -18.33 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 107 GLY~? 9.03 ZN ZN A 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.64 30.69 22.61 18.18 29.94 21.25 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.54 28.99 9.76 15.06 29.59 10.02 -36.84 117.84 -20.01 -36.52 117.15 -20.30 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.64 30.69 22.61 18.18 29.94 21.25 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.64 30.69 22.61 18.18 29.94 21.25 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 102 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 193 GLY A 26 GLY^? 14.60 ZN ZN A 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 14.54 28.99 9.76 15.06 29.59 10.02 -43.76 130.44 -13.71 -43.42 130.21 -12.98 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.54 28.99 9.76 15.06 29.59 10.02 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.54 28.99 9.76 15.06 29.59 10.02 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 11 3 # 11 A 57 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 102 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 12 3 # 12 A 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.64 30.69 22.61 18.18 29.94 21.25 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.54 28.99 9.76 15.06 29.59 10.02 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 13 3 # 13 A 57 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 102 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 193 GLY B 304 GLY.? 8.91 ZN ZN B 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.64 30.69 22.61 18.18 29.94 21.25 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.52 104.72 7.61 -38.13 105.28 7.78 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 14 3 # 14 A 57 HIS A 317 HIS~? 18.34 ZN ZN B 401 A 102 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 193 GLY B 81 GLY~? 20.66 ZN ZN B 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 19.64 30.69 22.61 18.18 29.94 21.25 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 14.54 28.99 9.76 15.06 29.59 10.02 -53.02 85.53 -4.18 -52.23 85.45 -4.06 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 15 3 # 15 A 57 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 193 GLY B 335 GLY~? 12.98 ZN ZN B 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.64 30.69 22.61 18.18 29.94 21.25 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.70 90.31 19.42 -38.03 89.63 19.05 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 16 3 # 16 A 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 19.64 30.69 22.61 18.18 29.94 21.25 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.54 28.99 9.76 15.06 29.59 10.02 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 17 3 # 17 A 57 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 102 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 19.64 30.69 22.61 18.18 29.94 21.25 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 14.54 28.99 9.76 15.06 29.59 10.02 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 18 3 # 18 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 107 GLY~? 9.03 ZN ZN B 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.64 30.69 22.61 18.18 29.94 21.25 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 14.54 28.99 9.76 15.06 29.59 10.02 -42.81 96.22 20.86 -42.14 96.60 21.16 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 19 3 # 19 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 283 GLY.? 5.97 ZN ZN B 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.64 30.69 22.61 18.18 29.94 21.25 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 14.54 28.99 9.76 15.06 29.59 10.02 -39.59 102.15 13.09 -40.35 102.56 13.10 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 20 3 # 20 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 193 GLY B 284 GLY.? 4.14 ZN ZN B 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.64 30.69 22.61 18.18 29.94 21.25 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 14.54 28.99 9.76 15.06 29.59 10.02 -41.31 101.77 9.74 -40.78 102.45 9.84 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 21 3 # 21 A 57 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 102 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 193 GLY B 26 GLY^? 14.44 ZN ZN B 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.64 30.69 22.61 18.18 29.94 21.25 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 14.54 28.99 9.76 15.06 29.59 10.02 -55.22 89.41 14.53 -54.89 89.43 13.78 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 22 3 # 22 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 23 3 # 23 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 14.54 28.99 9.76 15.06 29.59 10.02 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 24 3 # 24 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 193 GLY A 283 GLY.? 5.77 ZN ZN A 401 coo 14.96 29.22 19.55 15.62 29.93 17.67 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.64 30.69 22.61 18.18 29.94 21.25 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.34 111.36 -12.24 -38.16 111.32 -12.20 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 25 3 # 25 A 57 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 102 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.64 30.69 22.61 18.18 29.94 21.25 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 14.54 28.99 9.76 15.06 29.59 10.02 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 26 3 # 26 A 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 193 GLY A 284 GLY.? 4.19 ZN ZN A 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.64 30.69 22.61 18.18 29.94 21.25 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.37 112.47 -8.74 -38.34 111.64 -8.92 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 27 3 # 27 A 57 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 102 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 193 GLY A 304 GLY.? 8.93 ZN ZN A 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.64 30.69 22.61 18.18 29.94 21.25 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 14.54 28.99 9.76 15.06 29.59 10.02 -36.73 108.01 -6.68 -37.53 107.81 -6.81 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 28 3 # 28 A 57 HIS B 317 HIS~? 18.53 ZN ZN A 402 A 102 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 193 GLY A 81 GLY~? 20.61 ZN ZN A 402 coo 14.96 29.22 19.55 15.62 29.93 17.67 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 19.64 30.69 22.61 18.18 29.94 21.25 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 14.54 28.99 9.76 15.06 29.59 10.02 -39.26 132.56 4.99 -38.51 132.20 4.81 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 28 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 227 PHE^? 35.88 ZN ZN A 401 A 263 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 292 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -65.47 125.21 -34.29 -64.76 127.80 -35.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 263 ASP A 245 ASP^? 25.73 ZN ZN A 401 A 292 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 63.95 45.30 16.71 59.11 49.15 16.05 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 263 ASP A 252 ASP~? 28.57 ZN ZN A 401 A 292 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 263 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 292 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 63.95 45.30 16.71 59.11 49.15 16.05 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 263 ASP A 256 ASP~? 22.47 ZN ZN A 401 A 292 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 263 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 263 ASP A 299 ASP.? 24.38 ZN ZN A 401 A 292 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 54.43 44.82 23.74 55.21 45.06 21.80 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 63.95 45.30 16.71 59.11 49.15 16.05 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE A 301 PHE^? 12.99 ZN ZN A 401 A 263 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 292 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 54.43 44.82 23.74 55.21 45.06 21.80 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 63.95 45.30 16.71 59.11 49.15 16.05 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE A 363 PHE.? 13.25 ZN ZN A 402 A 263 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE B 69 PHE.? 9.95 ZN ZN B 401 A 263 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 51.51 50.32 16.39 52.13 49.68 13.75 -53.31 97.22 4.88 -53.54 99.70 6.20 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE B 146 PHE~? 50.49 ZN ZN B 402 A 263 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 292 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 54.43 44.82 23.74 55.21 45.06 21.80 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 63.95 45.30 16.71 59.11 49.15 16.05 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 263 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 292 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 54.43 44.82 23.74 55.21 45.06 21.80 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 63.95 45.30 16.71 59.11 49.15 16.05 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE B 227 PHE^? 36.29 ZN ZN B 402 A 263 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 292 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -71.43 105.73 35.02 -72.67 103.28 35.62 coo 54.43 44.82 23.74 55.21 45.06 21.80 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 63.95 45.30 16.71 59.11 49.15 16.05 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 263 ASP B 245 ASP^? 25.30 ZN ZN B 402 A 292 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 263 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 292 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 54.43 44.82 23.74 55.21 45.06 21.80 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 263 ASP B 252 ASP~? 28.52 ZN ZN B 402 A 292 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 54.43 44.82 23.74 55.21 45.06 21.80 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 63.95 45.30 16.71 59.11 49.15 16.05 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 A 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 263 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 292 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 54.43 44.82 23.74 55.21 45.06 21.80 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 63.95 45.30 16.71 59.11 49.15 16.05 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 A 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 263 ASP B 256 ASP~? 22.51 ZN ZN B 402 A 292 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 54.43 44.82 23.74 55.21 45.06 21.80 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 63.95 45.30 16.71 59.11 49.15 16.05 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 A 177 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 263 ASP B 299 ASP.? 24.19 ZN ZN B 402 A 292 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 54.43 44.82 23.74 55.21 45.06 21.80 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 A 177 PHE B 301 PHE^? 12.96 ZN ZN B 402 A 263 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 292 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 54.43 44.82 23.74 55.21 45.06 21.80 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 63.95 45.30 16.71 59.11 49.15 16.05 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 A 177 PHE B 363 PHE^? 13.11 ZN ZN B 401 A 263 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 292 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 51.51 50.32 16.39 52.13 49.68 13.75 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 63.95 45.30 16.71 59.11 49.15 16.05 -38.53 111.12 1.13 -44.30 110.60 0.01 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 21 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 227 PHE^? 35.88 ZN ZN A 401 B 263 ASP A 203 ASP.? 24.56 ZN ZN A 401 B 292 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 49.99 26.05 6.28 51.46 26.87 8.49 -65.47 125.21 -34.29 -64.76 127.80 -35.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 253 PHE~? 19.21 ZN ZN A 401 B 263 ASP A 245 ASP^? 25.73 ZN ZN A 401 B 292 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 49.99 26.05 6.28 51.46 26.87 8.49 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 60.53 31.67 0.97 57.79 27.51 3.63 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 263 ASP A 252 ASP~? 28.57 ZN ZN A 401 B 292 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 263 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE A 301 PHE^? 12.99 ZN ZN A 401 B 263 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 292 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 49.99 26.05 6.28 51.46 26.87 8.49 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 60.53 31.67 0.97 57.79 27.51 3.63 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE A 363 PHE.? 13.25 ZN ZN A 402 B 263 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 69 PHE.? 9.95 ZN ZN B 401 B 263 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 49.99 26.05 6.28 51.46 26.87 8.49 -53.31 97.22 4.88 -53.54 99.70 6.20 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE B 146 PHE~? 50.49 ZN ZN B 402 B 263 ASP B 148 ASP~? 45.03 ZN ZN B 402 B 292 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 49.99 26.05 6.28 51.46 26.87 8.49 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 60.53 31.67 0.97 57.79 27.51 3.63 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE B 200 PHE^? 37.57 ZN ZN B 402 B 263 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 292 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 49.99 26.05 6.28 51.46 26.87 8.49 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 60.53 31.67 0.97 57.79 27.51 3.63 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE B 253 PHE~? 19.22 ZN ZN B 402 B 263 ASP B 245 ASP^? 25.30 ZN ZN B 402 B 292 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 49.99 26.05 6.28 51.46 26.87 8.49 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 263 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 292 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 49.99 26.05 6.28 51.46 26.87 8.49 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 263 ASP B 252 ASP~? 28.52 ZN ZN B 402 B 292 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 49.99 26.05 6.28 51.46 26.87 8.49 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 60.53 31.67 0.97 57.79 27.51 3.63 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE B 301 PHE^? 12.96 ZN ZN B 402 B 263 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 292 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 49.99 26.05 6.28 51.46 26.87 8.49 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 60.53 31.67 0.97 57.79 27.51 3.63 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 177 PHE B 363 PHE^? 13.11 ZN ZN B 401 B 263 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 292 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 49.99 26.05 6.28 51.46 26.87 8.49 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 60.53 31.67 0.97 57.79 27.51 3.63 -38.53 111.12 1.13 -44.30 110.60 0.01 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 14 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 227 PHE^? 35.88 ZN ZN A 401 C 263 ASP A 203 ASP.? 24.56 ZN ZN A 401 C 292 LYS A 231 LYS^? 23.23 ZN ZN A 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -65.47 125.21 -34.29 -64.76 127.80 -35.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 -57.94 114.56 -29.95 -58.70 114.72 -24.54 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 253 PHE~? 19.21 ZN ZN A 401 C 263 ASP A 245 ASP^? 25.73 ZN ZN A 401 C 292 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 -25.62 99.57 -26.57 -25.42 101.64 -26.90 coo 12.82 3.49 4.98 17.80 5.59 1.90 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 263 ASP A 252 ASP~? 28.57 ZN ZN A 401 C 292 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 263 ASP A 256 ASP~? 22.47 ZN ZN A 401 C 292 LYS A 275 LYS^? 30.46 ZN ZN A 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 12.82 3.49 4.98 17.80 5.59 1.90 -31.91 90.95 -17.97 -26.97 90.03 -19.32 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 263 ASP A 256 ASP~? 22.47 ZN ZN A 401 C 292 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -24.24 101.11 -15.51 -23.37 102.12 -17.14 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 263 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE A 301 PHE^? 12.99 ZN ZN A 401 C 263 ASP A 299 ASP.? 24.38 ZN ZN A 401 C 292 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 19.84 12.02 9.33 18.68 11.23 7.75 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo 12.82 3.49 4.98 17.80 5.59 1.90 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE A 301 PHE^? 12.99 ZN ZN A 401 C 263 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 292 LYS A 315 LYS~? 18.17 ZN ZN B 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.93 102.60 -13.06 -42.03 105.12 -12.64 coo 19.84 12.02 9.33 18.68 11.23 7.75 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 12.82 3.49 4.98 17.80 5.59 1.90 -41.26 92.47 -6.07 -36.28 89.98 -4.98 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE A 363 PHE.? 13.25 ZN ZN A 402 C 263 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.41 111.93 2.28 -34.10 111.18 2.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE B 69 PHE.? 9.95 ZN ZN B 401 C 263 ASP A 313 ASP~? 12.18 ZN ZN B 401 C 292 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -53.31 97.22 4.88 -53.54 99.70 6.20 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE B 146 PHE~? 50.49 ZN ZN B 402 C 263 ASP B 148 ASP~? 45.03 ZN ZN B 402 C 292 LYS B 197 LYS^? 42.64 ZN ZN B 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -76.50 95.56 51.39 -78.55 95.73 49.49 coo 19.84 12.02 9.33 18.68 11.23 7.75 -68.50 97.10 50.23 -68.22 99.17 50.65 coo 12.82 3.49 4.98 17.80 5.59 1.90 -70.80 108.71 48.92 -67.91 112.78 45.19 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE B 200 PHE^? 37.57 ZN ZN B 402 C 263 ASP B 226 ASP^? 42.35 ZN ZN B 402 C 292 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -66.40 101.63 42.29 -68.97 100.93 41.41 coo 19.84 12.02 9.33 18.68 11.23 7.75 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE B 227 PHE^? 36.29 ZN ZN B 402 C 263 ASP B 203 ASP^? 26.15 ZN ZN B 402 C 292 LYS B 231 LYS^? 25.02 ZN ZN B 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -71.43 105.73 35.02 -72.67 103.28 35.62 coo 19.84 12.02 9.33 18.68 11.23 7.75 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 12.82 3.49 4.98 17.80 5.59 1.90 -59.06 109.88 30.77 -61.50 111.95 25.23 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE B 253 PHE~? 19.22 ZN ZN B 402 C 263 ASP B 245 ASP^? 25.30 ZN ZN B 402 C 292 LYS B 114 LYS~? 19.44 ZN ZN B 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -26.85 108.02 16.99 -29.11 106.57 17.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 -23.71 105.07 26.59 -24.46 103.20 27.20 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.38 97.99 22.64 -33.06 97.84 28.07 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 263 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 292 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 19.84 12.02 9.33 18.68 11.23 7.75 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 263 ASP B 252 ASP~? 28.52 ZN ZN B 402 C 292 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 19.84 12.02 9.33 18.68 11.23 7.75 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 12.82 3.49 4.98 17.80 5.59 1.90 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 C 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 263 ASP B 256 ASP~? 22.51 ZN ZN B 402 C 292 LYS B 275 LYS^? 32.38 ZN ZN B 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 19.84 12.02 9.33 18.68 11.23 7.75 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 12.82 3.49 4.98 17.80 5.59 1.90 -24.21 116.63 19.13 -19.07 117.25 20.30 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 C 177 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 263 ASP B 256 ASP~? 22.51 ZN ZN B 402 C 292 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -26.71 111.70 8.71 -24.07 112.53 8.31 coo 19.84 12.02 9.33 18.68 11.23 7.75 -23.25 103.81 16.30 -22.99 102.51 17.90 coo 12.82 3.49 4.98 17.80 5.59 1.90 -28.04 112.73 23.24 -26.21 110.17 27.80 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 C 177 PHE B 301 PHE^? 12.96 ZN ZN B 402 C 263 ASP B 299 ASP.? 24.19 ZN ZN B 402 C 292 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 19.84 12.02 9.33 18.68 11.23 7.75 -30.65 115.42 19.76 -30.54 116.24 21.74 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 C 177 PHE B 301 PHE^? 12.96 ZN ZN B 402 C 263 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 292 LYS B 315 LYS~? 18.28 ZN ZN A 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -38.16 111.38 14.04 -40.48 109.86 13.65 coo 19.84 12.02 9.33 18.68 11.23 7.75 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 12.82 3.49 4.98 17.80 5.59 1.90 -33.07 120.28 7.09 -27.74 119.98 5.88 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 C 177 PHE B 363 PHE^? 13.11 ZN ZN B 401 C 263 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 292 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 12.82 3.49 4.98 17.80 5.59 1.90 -38.53 111.12 1.13 -44.30 110.60 0.01 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 21 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 129 ASP^? 19.65 ZN ZN A 401 A 151 LYS A 231 LYS^? 23.23 ZN ZN A 401 A 186 THR A 233 THR^? 21.55 ZN ZN A 401 coo 41.42 17.90 44.98 43.39 18.36 45.61 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo 45.75 16.58 39.61 47.43 18.26 45.54 -57.94 114.56 -29.95 -58.70 114.72 -24.54 coo 45.88 23.02 44.72 46.99 21.16 44.68 -51.48 112.38 -28.84 -50.80 110.31 -28.76 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 352 ASP.? 27.02 ZN ZN A 401 A 151 LYS A 56 LYS~? 22.91 ZN ZN A 402 A 186 THR A 37 THR.? 27.03 ZN ZN A 401 coo 41.42 17.90 44.98 43.39 18.36 45.61 -23.78 134.83 -17.90 -22.09 135.98 -18.58 coo 45.75 16.58 39.61 47.43 18.26 45.54 -22.18 135.65 -9.28 -21.07 130.49 -8.67 coo 45.88 23.02 44.72 46.99 21.16 44.68 -28.34 140.20 -15.53 -28.28 141.11 -13.55 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 151 LYS B 231 LYS^? 25.02 ZN ZN B 402 A 186 THR B 233 THR^? 21.46 ZN ZN B 402 coo 41.42 17.90 44.98 43.39 18.36 45.61 -57.17 104.15 28.46 -55.58 103.29 27.35 coo 45.75 16.58 39.61 47.43 18.26 45.54 -59.06 109.88 30.77 -61.50 111.95 25.23 coo 45.88 23.02 44.72 46.99 21.16 44.68 -52.42 108.39 29.83 -50.75 109.78 29.75 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 151 LYS B 133 LYS^? 36.11 ZN ZN B 402 A 186 THR B 136 THR^? 43.30 ZN ZN B 402 coo 41.42 17.90 44.98 43.39 18.36 45.61 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 45.75 16.58 39.61 47.43 18.26 45.54 -65.38 107.19 38.20 -61.64 109.75 42.23 coo 45.88 23.02 44.72 46.99 21.16 44.68 -73.17 106.15 44.31 -73.94 104.19 43.69 2phk_c02 source 2phk MC-PEPTIDE : 4 hits 2phk_c02 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 78 ASN.? 23.55 ZN ZN A 402 20 HIS B 317 HIS~? 18.53 ZN ZN A 402 93 ASP B 313 ASP~? 12.28 ZN ZN A 402 coo 45.21 45.27 48.24 46.79 44.92 46.88 -37.79 131.52 10.85 -37.74 129.57 11.59 coo 47.05 39.55 45.24 48.99 39.30 44.46 -38.40 123.74 9.47 -39.77 124.82 8.30 coo 46.96 34.22 47.29 47.91 35.95 46.52 -39.61 120.08 5.22 -40.78 120.61 3.53 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN B 78 ASN~? 23.25 ZN ZN B 401 20 HIS A 317 HIS~? 18.34 ZN ZN B 401 93 ASP A 313 ASP~? 12.18 ZN ZN B 401 coo 45.21 45.27 48.24 46.79 44.92 46.88 -51.19 85.79 -10.02 -50.50 87.71 -10.52 coo 47.05 39.55 45.24 48.99 39.30 44.46 -47.71 92.42 -8.32 -49.42 92.44 -7.12 coo 46.96 34.22 47.29 47.91 35.95 46.52 -46.65 96.06 -4.18 -47.89 96.35 -2.43 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 2 hits 2pth_c00 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 116 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 18.50 3.53 20.10 16.17 2.61 14.41 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 14.70 6.01 5.61 14.27 7.69 6.78 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 116 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 18.50 3.53 20.10 16.17 2.61 14.41 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 14.70 6.01 5.61 14.27 7.69 6.78 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 116 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 18.50 3.53 20.10 16.17 2.61 14.41 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 14.70 6.01 5.61 14.27 7.69 6.78 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 4 3 # 4 A 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 116 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 18.50 3.53 20.10 16.17 2.61 14.41 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 14.70 6.01 5.61 14.27 7.69 6.78 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 5 3 # 5 A 12 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 116 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.50 3.53 20.10 16.17 2.61 14.41 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 14.70 6.01 5.61 14.27 7.69 6.78 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 6 3 # 6 A 12 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 116 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.50 3.53 20.10 16.17 2.61 14.41 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 14.70 6.01 5.61 14.27 7.69 6.78 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 7 3 # 7 A 12 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 116 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.50 3.53 20.10 16.17 2.61 14.41 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 14.70 6.01 5.61 14.27 7.69 6.78 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 8 3 # 8 A 12 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 40 LYS A 315 LYS~? 18.17 ZN ZN B 401 A 116 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 18.50 3.53 20.10 16.17 2.61 14.41 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 14.70 6.01 5.61 14.27 7.69 6.78 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 9 3 # 9 A 12 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 A 116 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.50 3.53 20.10 16.17 2.61 14.41 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 14.70 6.01 5.61 14.27 7.69 6.78 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 10 3 # 10 A 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 A 116 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.50 3.53 20.10 16.17 2.61 14.41 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 14.70 6.01 5.61 14.27 7.69 6.78 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 11 3 # 11 A 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 A 116 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.50 3.53 20.10 16.17 2.61 14.41 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 14.70 6.01 5.61 14.27 7.69 6.78 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 12 3 # 12 A 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 116 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.50 3.53 20.10 16.17 2.61 14.41 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 14.70 6.01 5.61 14.27 7.69 6.78 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 13 3 # 13 A 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 116 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 18.50 3.53 20.10 16.17 2.61 14.41 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 14.70 6.01 5.61 14.27 7.69 6.78 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 14 3 # 14 A 12 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 A 116 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.50 3.53 20.10 16.17 2.61 14.41 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 14.70 6.01 5.61 14.27 7.69 6.78 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 15 3 # 15 A 12 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 116 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.50 3.53 20.10 16.17 2.61 14.41 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 14.70 6.01 5.61 14.27 7.69 6.78 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 16 3 # 16 A 12 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 116 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.50 3.53 20.10 16.17 2.61 14.41 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 14.70 6.01 5.61 14.27 7.69 6.78 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 17 3 # 17 A 12 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 40 LYS B 315 LYS~? 18.28 ZN ZN A 402 A 116 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 18.50 3.53 20.10 16.17 2.61 14.41 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 14.70 6.01 5.61 14.27 7.69 6.78 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 18 3 # 18 A 12 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 A 116 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.50 3.53 20.10 16.17 2.61 14.41 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 14.70 6.01 5.61 14.27 7.69 6.78 -37.47 120.38 -11.48 -38.85 119.05 -12.30 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 18 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 B 116 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 40 LYS A 70 LYS.? 15.41 ZN ZN A 402 B 116 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 116 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 4 3 # 4 B 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 116 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 5 3 # 5 B 12 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 40 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 116 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 6 3 # 6 B 12 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 40 LYS A 315 LYS~? 18.17 ZN ZN B 401 B 116 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 7 3 # 7 B 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 B 116 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -57.09 96.40 2.21 -54.35 101.68 2.27 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 8 3 # 8 B 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 40 LYS B 70 LYS.? 12.56 ZN ZN B 401 B 116 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -57.09 96.40 2.21 -54.35 101.68 2.27 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 9 3 # 9 B 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 116 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 10 3 # 10 B 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 116 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 11 3 # 11 B 12 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 40 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 116 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -38.73 88.63 14.36 -36.14 88.00 9.08 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 12 3 # 12 B 12 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 40 LYS B 315 LYS~? 18.28 ZN ZN A 402 B 116 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -33.07 120.28 7.09 -27.74 119.98 5.88 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -38.08 120.38 -6.61 -37.64 118.32 -6.74 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 12 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A -1 ASP.? 33.70 ZN ZN A 401 166 GLY A 38 GLY.? 23.39 ZN ZN A 401 169 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.17 145.98 -27.25 -35.93 146.68 -26.30 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -27.76 136.39 -15.64 -28.52 136.55 -15.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 5 ASP~? 27.21 ZN ZN A 401 166 GLY A 57 GLY~? 27.09 ZN ZN A 402 169 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -24.08 138.90 -9.86 -24.32 138.15 -10.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 5 ASP~? 27.21 ZN ZN A 401 166 GLY A 57 GLY~? 27.09 ZN ZN A 402 169 GLU A 55 GLU~? 25.21 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -24.08 138.90 -9.86 -24.32 138.15 -10.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.38 134.54 -4.38 -20.41 132.67 -3.34 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 11 ASP~? 18.10 ZN ZN A 401 166 GLY A 38 GLY.? 23.39 ZN ZN A 401 169 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -27.76 136.39 -15.64 -28.52 136.55 -15.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 33 ASP.? 31.33 ZN ZN A 401 166 GLY A 57 GLY~? 27.09 ZN ZN A 402 169 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -24.08 138.90 -9.86 -24.32 138.15 -10.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 33 ASP.? 31.33 ZN ZN A 401 166 GLY A 57 GLY~? 27.09 ZN ZN A 402 169 GLU A 55 GLU~? 25.21 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -24.08 138.90 -9.86 -24.32 138.15 -10.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.38 134.54 -4.38 -20.41 132.67 -3.34 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 33 ASP.? 31.33 ZN ZN A 401 166 GLY A 57 GLY~? 27.09 ZN ZN A 402 169 GLU A 354 GLU^? 23.23 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -40.68 145.88 -15.27 -39.90 147.57 -16.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -24.08 138.90 -9.86 -24.32 138.15 -10.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.49 130.04 -14.63 -21.36 130.96 -13.14 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 44 ASP.? 7.09 ZN ZN A 402 166 GLY A 30 GLY.? 22.34 ZN ZN A 402 169 GLU A 32 GLU.? 25.81 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -40.03 138.80 -8.81 -40.82 138.90 -8.71 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -43.68 141.75 -15.46 -45.31 141.26 -16.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 44 ASP.? 7.09 ZN ZN A 402 166 GLY A 286 GLY.? 9.05 ZN ZN A 401 169 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.79 108.31 -9.97 -42.74 107.91 -9.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 129 ASP^? 19.65 ZN ZN A 401 166 GLY A 107 GLY~? 9.03 ZN ZN A 401 169 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 8.28 6.87 1.62 10.08 5.77 1.34 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -36.84 117.84 -20.01 -36.52 117.15 -20.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP A 129 ASP^? 19.65 ZN ZN A 401 166 GLY A 239 GLY.? 9.93 ZN ZN A 401 169 GLU A 329 GLU~? 2.55 ZN ZN A 401s coo 8.28 6.87 1.62 10.08 5.77 1.34 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -41.47 109.72 -18.36 -41.63 110.22 -18.97 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -35.80 114.72 -10.28 -37.63 115.69 -10.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP A 299 ASP.? 24.38 ZN ZN A 401 166 GLY A 286 GLY.? 9.05 ZN ZN A 401 169 GLU A 20 GLU.? 10.86 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -36.54 95.17 -18.71 -36.75 94.18 -20.57 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.79 108.31 -9.97 -42.74 107.91 -9.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -48.90 117.49 -13.24 -50.05 116.06 -14.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP A 305 ASP.? 7.62 ZN ZN A 402 166 GLY B 270 GLY.? 20.67 ZN ZN A 402 169 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.43 117.43 9.69 -27.94 117.09 9.08 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.38 111.90 11.61 -18.92 112.78 10.34 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP A 310 ASP~? 12.24 ZN ZN B 401 166 GLY A 297 GLY.? 22.49 ZN ZN A 401 169 GLU A 243 GLU^? 24.16 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.64 97.26 -22.49 -42.62 97.67 -21.88 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.02 100.94 -26.53 -34.09 99.87 -28.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP A 313 ASP~? 12.18 ZN ZN B 401 166 GLY A 297 GLY.? 22.49 ZN ZN A 401 169 GLU A 243 GLU^? 24.16 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.64 97.26 -22.49 -42.62 97.67 -21.88 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.02 100.94 -26.53 -34.09 99.87 -28.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP A 313 ASP~? 12.18 ZN ZN B 401 166 GLY B 286 GLY.? 9.05 ZN ZN B 402 169 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.82 107.61 10.95 -42.53 107.90 10.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP A 313 ASP~? 12.18 ZN ZN B 401 166 GLY B 304 GLY.? 8.91 ZN ZN B 401 169 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -37.52 104.72 7.61 -38.13 105.28 7.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP A 323 ASP^? 12.30 ZN ZN A 402 166 GLY B 286 GLY.? 9.05 ZN ZN B 402 169 GLU B 20 GLU.? 11.09 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.82 107.61 10.95 -42.53 107.90 10.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -52.94 103.12 14.27 -53.36 104.69 15.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP A 361 ASP.? 11.77 ZN ZN A 402 166 GLY A 286 GLY.? 9.05 ZN ZN A 401 169 GLU A 20 GLU.? 10.86 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.79 108.31 -9.97 -42.74 107.91 -9.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -48.90 117.49 -13.24 -50.05 116.06 -14.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP A 361 ASP.? 11.77 ZN ZN A 402 166 GLY A 286 GLY.? 9.05 ZN ZN A 401 169 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.79 108.31 -9.97 -42.74 107.91 -9.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP A 361 ASP.? 11.77 ZN ZN A 402 166 GLY B 304 GLY.? 8.91 ZN ZN B 401 169 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 8.28 6.87 1.62 10.08 5.77 1.34 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -37.52 104.72 7.61 -38.13 105.28 7.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP B 5 ASP~? 27.35 ZN ZN B 402 166 GLY B 57 GLY~? 27.22 ZN ZN B 401 169 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -55.09 78.54 23.42 -56.64 77.16 23.83 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.51 71.61 10.24 -43.32 72.40 10.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP B 5 ASP~? 27.35 ZN ZN B 402 166 GLY B 57 GLY~? 27.22 ZN ZN B 401 169 GLU B 55 GLU~? 25.91 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -55.09 78.54 23.42 -56.64 77.16 23.83 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.51 71.61 10.24 -43.32 72.40 10.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.07 73.47 3.56 -37.44 74.53 2.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP B 11 ASP~? 18.05 ZN ZN B 402 166 GLY B 38 GLY.? 23.53 ZN ZN B 402 169 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -45.02 75.58 15.94 -45.75 75.90 15.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP B 33 ASP.? 29.43 ZN ZN B 402 166 GLY B 38 GLY.? 23.53 ZN ZN B 402 169 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -61.26 74.82 15.61 -62.97 76.13 15.50 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -45.02 75.58 15.94 -45.75 75.90 15.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 26 3 # 26 141 ASP B 33 ASP.? 29.43 ZN ZN B 402 166 GLY B 38 GLY.? 23.53 ZN ZN B 402 169 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -61.26 74.82 15.61 -62.97 76.13 15.50 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -45.02 75.58 15.94 -45.75 75.90 15.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 27 3 # 27 141 ASP B 33 ASP.? 29.43 ZN ZN B 402 166 GLY B 57 GLY~? 27.22 ZN ZN B 401 169 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -61.26 74.82 15.61 -62.97 76.13 15.50 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.51 71.61 10.24 -43.32 72.40 10.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 28 3 # 28 141 ASP B 33 ASP.? 29.43 ZN ZN B 402 166 GLY B 57 GLY~? 27.22 ZN ZN B 401 169 GLU B 55 GLU~? 25.91 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -61.26 74.82 15.61 -62.97 76.13 15.50 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.51 71.61 10.24 -43.32 72.40 10.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.07 73.47 3.56 -37.44 74.53 2.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 29 3 # 29 141 ASP B 33 ASP.? 29.43 ZN ZN B 402 166 GLY B 57 GLY~? 27.22 ZN ZN B 401 169 GLU B 354 GLU^? 23.36 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -61.26 74.82 15.61 -62.97 76.13 15.50 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.51 71.61 10.24 -43.32 72.40 10.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -37.43 78.09 15.20 -36.78 76.82 13.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 30 3 # 30 141 ASP B 44 ASP.? 7.11 ZN ZN B 401 166 GLY B 38 GLY.? 23.53 ZN ZN B 402 169 GLU B 35 GLU.? 31.39 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -45.02 75.58 15.94 -45.75 75.90 15.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -52.36 70.88 17.88 -52.36 69.23 19.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 31 3 # 31 141 ASP B 44 ASP.? 7.11 ZN ZN B 401 166 GLY B 286 GLY.? 9.05 ZN ZN B 402 169 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.82 107.61 10.95 -42.53 107.90 10.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.98 115.46 11.22 -41.44 114.62 9.91 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 32 3 # 32 141 ASP B 129 ASP^? 19.14 ZN ZN B 402 166 GLY B 107 GLY~? 9.03 ZN ZN B 402 169 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 8.28 6.87 1.62 10.08 5.77 1.34 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.81 96.22 20.86 -42.14 96.60 21.16 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 33 3 # 33 141 ASP B 129 ASP^? 19.14 ZN ZN B 402 166 GLY B 159 GLY.? 37.15 ZN ZN B 402 169 GLU B 162 GLU^? 46.76 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -60.88 99.41 45.73 -61.71 99.23 45.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -66.72 104.17 51.47 -67.64 102.80 52.82 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 34 3 # 34 141 ASP B 129 ASP^? 19.14 ZN ZN B 402 166 GLY B 239 GLY.? 9.90 ZN ZN B 402 169 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 8.28 6.87 1.62 10.08 5.77 1.34 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.47 105.54 19.38 -42.87 105.20 20.03 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 35 3 # 35 141 ASP B 252 ASP~? 28.52 ZN ZN B 402 166 GLY B 304 GLY.? 8.91 ZN ZN B 401 169 GLU B 329 GLU~? 2.54 ZN ZN B 402s coo 8.28 6.87 1.62 10.08 5.77 1.34 -20.29 109.25 15.64 -18.38 109.99 15.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -37.52 104.72 7.61 -38.13 105.28 7.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.29 98.42 11.20 -42.37 98.57 11.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 36 3 # 36 141 ASP B 299 ASP.? 24.19 ZN ZN B 402 166 GLY B 286 GLY.? 9.05 ZN ZN B 402 169 GLU B 20 GLU.? 11.09 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.65 115.42 19.76 -30.54 116.24 21.74 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.82 107.61 10.95 -42.53 107.90 10.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -52.94 103.12 14.27 -53.36 104.69 15.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 37 3 # 37 141 ASP B 305 ASP.? 7.64 ZN ZN B 401 166 GLY A 270 GLY.? 20.46 ZN ZN B 401 169 GLU A 251 GLU~? 26.78 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -35.76 92.29 -8.66 -35.13 92.39 -8.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -25.70 93.68 -9.35 -24.99 91.85 -8.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 38 3 # 38 141 ASP B 310 ASP~? 12.35 ZN ZN A 402 166 GLY B 297 GLY.? 22.39 ZN ZN B 402 169 GLU B 243 GLU^? 24.39 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -36.97 116.79 23.45 -37.15 116.39 22.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.57 108.69 27.52 -30.74 110.20 29.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 39 3 # 39 141 ASP B 313 ASP~? 12.28 ZN ZN A 402 166 GLY A 286 GLY.? 9.05 ZN ZN A 401 169 GLU A 290 GLU~? 16.18 ZN ZN A 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.79 108.31 -9.97 -42.74 107.91 -9.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -44.60 100.09 -10.25 -45.29 101.54 -8.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 40 3 # 40 141 ASP B 313 ASP~? 12.28 ZN ZN A 402 166 GLY B 297 GLY.? 22.39 ZN ZN B 402 169 GLU B 243 GLU^? 24.39 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -36.97 116.79 23.45 -37.15 116.39 22.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.57 108.69 27.52 -30.74 110.20 29.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 41 3 # 41 141 ASP B 323 ASP^? 12.28 ZN ZN B 401 166 GLY A 286 GLY.? 9.05 ZN ZN A 401 169 GLU A 20 GLU.? 10.86 ZN ZN A 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.79 108.31 -9.97 -42.74 107.91 -9.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -48.90 117.49 -13.24 -50.05 116.06 -14.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 42 3 # 42 141 ASP B 361 ASP.? 11.71 ZN ZN B 401 166 GLY B 286 GLY.? 9.05 ZN ZN B 402 169 GLU B 20 GLU.? 11.09 ZN ZN B 402 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.82 107.61 10.95 -42.53 107.90 10.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -52.94 103.12 14.27 -53.36 104.69 15.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 43 3 # 43 141 ASP B 361 ASP.? 11.71 ZN ZN B 401 166 GLY B 286 GLY.? 9.05 ZN ZN B 402 169 GLU B 290 GLU~? 16.07 ZN ZN B 401 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -42.82 107.61 10.95 -42.53 107.90 10.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.98 115.46 11.22 -41.44 114.62 9.91 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 43 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 172 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 267 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 26.78 20.44 0.03 28.51 18.26 0.09 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR A 327 TYR~? 10.33 ZN ZN A 402 A 172 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 267 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 26.78 20.44 0.03 28.51 18.26 0.09 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 172 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 267 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 26.78 20.44 0.03 28.51 18.26 0.09 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 172 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 267 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 26.78 20.44 0.03 28.51 18.26 0.09 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -40.41 105.08 4.17 -40.72 103.08 3.51 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 172 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 267 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 44.86 1.98 33.27 42.75 1.12 31.67 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 172 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 267 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 44.86 1.98 33.27 42.75 1.12 31.67 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 172 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 267 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 44.86 1.98 33.27 42.75 1.12 31.67 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -40.41 105.08 4.17 -40.72 103.08 3.51 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 172 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 267 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 44.86 1.98 33.27 42.75 1.12 31.67 -35.81 95.23 5.63 -35.48 92.50 6.11 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -40.41 105.08 4.17 -40.72 103.08 3.51 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c01 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 236 TYR^? 14.83 ZN ZN A 401 A 214 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 256 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 291 TYR~? 19.48 ZN ZN B 401 A 214 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 256 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR B 161 TYR^? 41.82 ZN ZN B 402 A 214 ASP B 148 ASP~? 45.03 ZN ZN B 402 A 256 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR B 236 TYR^? 14.81 ZN ZN B 402 A 214 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 256 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -50.67 100.24 25.02 -50.96 97.90 26.55 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR B 236 TYR^? 14.81 ZN ZN B 402 A 214 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 256 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -50.67 100.24 25.02 -50.96 97.90 26.55 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 236 TYR^? 14.81 ZN ZN B 402 A 214 ASP B 129 ASP^? 19.14 ZN ZN B 402 A 256 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -50.67 100.24 25.02 -50.96 97.90 26.55 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR B 291 TYR~? 19.42 ZN ZN A 402 A 214 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 256 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -41.81 119.15 12.42 -40.61 119.58 9.91 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR B 327 TYR~? 10.21 ZN ZN B 401 A 214 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 256 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -35.81 95.23 5.63 -35.48 92.50 6.11 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -57.09 96.40 2.21 -54.35 101.68 2.27 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 8 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 236 TYR^? 14.83 ZN ZN A 401 B 214 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 256 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 236 TYR^? 14.83 ZN ZN A 401 B 214 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 256 LYS A 333 LYS~? 13.50 ZN ZN A 402 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -29.32 122.04 -13.64 -26.61 121.37 -8.37 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 289 TYR~? 11.74 ZN ZN A 401 B 214 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 256 LYS A 114 LYS~? 19.79 ZN ZN A 401 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -46.60 106.88 -13.53 -48.07 109.27 -13.63 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -28.96 110.92 -21.77 -28.27 111.19 -26.80 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 289 TYR~? 11.74 ZN ZN A 401 B 214 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 256 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -46.60 106.88 -13.53 -48.07 109.27 -13.63 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR A 291 TYR~? 19.48 ZN ZN B 401 B 214 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 256 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR A 327 TYR~? 10.33 ZN ZN A 402 B 214 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 256 LYS A 70 LYS.? 15.41 ZN ZN A 402 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -30.20 115.07 -4.84 -28.36 117.13 -5.30 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -48.76 125.53 -1.26 -51.29 120.16 0.88 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR A 365 TYR^? 16.07 ZN ZN A 402 B 214 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 256 LYS B 260 LYS~? 21.74 ZN ZN B 402 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -25.65 97.38 15.05 -24.29 100.72 20.18 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR B 161 TYR^? 41.82 ZN ZN B 402 B 214 ASP B 148 ASP~? 45.03 ZN ZN B 402 B 256 LYS B 215 LYS~? 43.78 ZN ZN B 402 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -68.50 97.10 50.23 -68.22 99.17 50.65 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -79.75 99.05 40.27 -81.86 101.81 35.01 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR B 236 TYR^? 14.81 ZN ZN B 402 B 214 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 256 LYS B 333 LYS~? 13.39 ZN ZN B 401 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -50.67 100.24 25.02 -50.96 97.90 26.55 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -38.73 88.63 14.36 -36.14 88.00 9.08 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR B 236 TYR^? 14.81 ZN ZN B 402 B 214 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 256 LYS B 133 LYS^? 36.11 ZN ZN B 402 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -50.67 100.24 25.02 -50.96 97.90 26.55 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -65.38 107.19 38.20 -61.64 109.75 42.23 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR B 236 TYR^? 14.81 ZN ZN B 402 B 214 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 256 LYS B 207 LYS~? 33.65 ZN ZN B 402 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -50.67 100.24 25.02 -50.96 97.90 26.55 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -70.47 101.07 32.25 -71.74 107.13 30.32 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR B 291 TYR~? 19.42 ZN ZN A 402 B 214 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 256 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -41.81 119.15 12.42 -40.61 119.58 9.91 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR B 327 TYR~? 10.21 ZN ZN B 401 B 214 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 256 LYS B 70 LYS.? 12.56 ZN ZN B 401 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -35.81 95.23 5.63 -35.48 92.50 6.11 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -57.09 96.40 2.21 -54.35 101.68 2.27 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 14 3 # 14 B 122 TYR B 365 TYR^? 15.98 ZN ZN B 401 B 214 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 256 LYS A 260 LYS~? 21.58 ZN ZN A 401 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -22.91 107.85 -14.23 -23.69 104.38 -19.46 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 14 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 130 SER B 328 SER~? 10.89 ZN ZN B 401 A 159 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 18.35 45.84 20.99 16.20 47.83 21.89 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 15.14 43.67 10.77 15.61 44.43 13.04 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 11.57 48.49 22.18 13.51 49.99 17.21 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 278 ARG^? 22.96 ZN ZN A 401 A 130 SER A 122 SER^? 18.54 ZN ZN A 401 A 159 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 18.35 45.84 20.99 16.20 47.83 21.89 -38.45 97.22 -24.87 -40.97 98.73 -25.80 coo 15.14 43.67 10.77 15.61 44.43 13.04 -39.13 108.46 -26.41 -40.41 106.51 -26.99 coo 11.57 48.49 22.18 13.51 49.99 17.21 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 130 SER A 328 SER~? 11.01 ZN ZN A 402 A 159 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 18.35 45.84 20.99 16.20 47.83 21.89 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 15.14 43.67 10.77 15.61 44.43 13.04 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 11.57 48.49 22.18 13.51 49.99 17.21 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG B 278 ARG^? 23.19 ZN ZN B 402 A 130 SER B 122 SER^? 18.54 ZN ZN B 402 A 159 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 18.35 45.84 20.99 16.20 47.83 21.89 -33.11 114.47 25.89 -35.97 114.81 26.88 coo 15.14 43.67 10.77 15.61 44.43 13.04 -39.61 105.40 27.34 -40.83 107.01 28.62 coo 11.57 48.49 22.18 13.51 49.99 17.21 -28.04 112.73 23.24 -26.21 110.17 27.80 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 130 SER B 328 SER~? 10.89 ZN ZN B 401 B 159 LYS A 307 LYS~? 10.65 ZN ZN B 401 coo 58.72 31.58 20.45 60.80 29.39 20.94 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 61.66 35.17 10.39 61.29 34.14 12.56 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 65.38 28.77 21.17 63.49 28.03 16.12 -40.89 103.09 -0.15 -45.35 106.49 1.62 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 278 ARG^? 22.96 ZN ZN A 401 B 130 SER A 122 SER^? 18.54 ZN ZN A 401 B 159 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 58.72 31.58 20.45 60.80 29.39 20.94 -38.45 97.22 -24.87 -40.97 98.73 -25.80 coo 61.66 35.17 10.39 61.29 34.14 12.56 -39.13 108.46 -26.41 -40.41 106.51 -26.99 coo 65.38 28.77 21.17 63.49 28.03 16.12 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 130 SER A 328 SER~? 11.01 ZN ZN A 402 B 159 LYS B 307 LYS~? 11.14 ZN ZN A 402 coo 58.72 31.58 20.45 60.80 29.39 20.94 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 61.66 35.17 10.39 61.29 34.14 12.56 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 65.38 28.77 21.17 63.49 28.03 16.12 -38.53 111.12 1.13 -44.30 110.60 0.01 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 278 ARG^? 23.19 ZN ZN B 402 B 130 SER B 122 SER^? 18.54 ZN ZN B 402 B 159 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 58.72 31.58 20.45 60.80 29.39 20.94 -33.11 114.47 25.89 -35.97 114.81 26.88 coo 61.66 35.17 10.39 61.29 34.14 12.56 -39.61 105.40 27.34 -40.83 107.01 28.62 coo 65.38 28.77 21.17 63.49 28.03 16.12 -28.04 112.73 23.24 -26.21 110.17 27.80 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c01 naa= 3 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 1 3 # 1 183 LYS A 86 LYS~? 24.82 ZN ZN A 402 220 HIS A 90 HIS~? 26.77 ZN ZN A 402 255 ASP A 91 ASP.? 28.84 ZN ZN A 402 coo 11.94 40.77 50.56 7.67 36.15 49.76 -33.51 137.11 0.86 -27.79 135.78 2.74 coo 10.50 40.09 46.76 10.54 37.99 46.56 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 4.47 38.05 47.65 5.63 36.87 46.50 -33.63 143.19 -6.63 -34.37 144.83 -5.55 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 2 3 # 2 183 LYS B 86 LYS~? 24.89 ZN ZN B 401 220 HIS B 90 HIS~? 26.84 ZN ZN B 401 255 ASP B 91 ASP.? 28.82 ZN ZN B 401 coo 11.94 40.77 50.56 7.67 36.15 49.76 -50.53 78.48 -0.34 -44.96 76.41 -1.96 coo 10.50 40.09 46.76 10.54 37.99 46.56 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 4.47 38.05 47.65 5.63 36.87 46.50 -53.83 73.30 7.14 -55.54 72.50 6.14 2xis_c00 source 2xis XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH XY: 2 hits 2xis_c00 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 65.34 65.04 50.22 63.95 63.70 51.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.46 53.34 50.98 63.08 55.39 51.17 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 64.71 54.80 47.28 63.92 56.57 48.06 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 65.34 65.04 50.22 63.95 63.70 51.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.46 53.34 50.98 63.08 55.39 51.17 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 64.71 54.80 47.28 63.92 56.57 48.06 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 3 3 # 3 A 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 295 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 65.34 65.04 50.22 63.95 63.70 51.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.46 53.34 50.98 63.08 55.39 51.17 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 64.71 54.80 47.28 63.92 56.57 48.06 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 4 3 # 4 A 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 295 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 65.34 65.04 50.22 63.95 63.70 51.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.46 53.34 50.98 63.08 55.39 51.17 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 64.71 54.80 47.28 63.92 56.57 48.06 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 5 3 # 5 A 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 65.34 65.04 50.22 63.95 63.70 51.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.46 53.34 50.98 63.08 55.39 51.17 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 64.71 54.80 47.28 63.92 56.57 48.06 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 6 3 # 6 A 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 65.34 65.04 50.22 63.95 63.70 51.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.46 53.34 50.98 63.08 55.39 51.17 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 64.71 54.80 47.28 63.92 56.57 48.06 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 7 3 # 7 A 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 65.34 65.04 50.22 63.95 63.70 51.06 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.46 53.34 50.98 63.08 55.39 51.17 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 64.71 54.80 47.28 63.92 56.57 48.06 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 8 3 # 8 A 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 65.34 65.04 50.22 63.95 63.70 51.06 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.46 53.34 50.98 63.08 55.39 51.17 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 64.71 54.80 47.28 63.92 56.57 48.06 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 9 3 # 9 A 202 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 65.34 65.04 50.22 63.95 63.70 51.06 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 63.46 53.34 50.98 63.08 55.39 51.17 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 64.71 54.80 47.28 63.92 56.57 48.06 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 10 3 # 10 A 202 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 65.34 65.04 50.22 63.95 63.70 51.06 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 63.46 53.34 50.98 63.08 55.39 51.17 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 64.71 54.80 47.28 63.92 56.57 48.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 11 3 # 11 A 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 65.34 65.04 50.22 63.95 63.70 51.06 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.46 53.34 50.98 63.08 55.39 51.17 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 64.71 54.80 47.28 63.92 56.57 48.06 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 12 3 # 12 A 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 65.34 65.04 50.22 63.95 63.70 51.06 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.46 53.34 50.98 63.08 55.39 51.17 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 64.71 54.80 47.28 63.92 56.57 48.06 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 13 3 # 13 A 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 295 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 65.34 65.04 50.22 63.95 63.70 51.06 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.46 53.34 50.98 63.08 55.39 51.17 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 64.71 54.80 47.28 63.92 56.57 48.06 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 14 3 # 14 A 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 65.34 65.04 50.22 63.95 63.70 51.06 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.46 53.34 50.98 63.08 55.39 51.17 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 64.71 54.80 47.28 63.92 56.57 48.06 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 15 3 # 15 A 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 65.34 65.04 50.22 63.95 63.70 51.06 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.46 53.34 50.98 63.08 55.39 51.17 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 64.71 54.80 47.28 63.92 56.57 48.06 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 16 3 # 16 A 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 295 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 65.34 65.04 50.22 63.95 63.70 51.06 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.46 53.34 50.98 63.08 55.39 51.17 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 64.71 54.80 47.28 63.92 56.57 48.06 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 17 3 # 17 A 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 65.34 65.04 50.22 63.95 63.70 51.06 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.46 53.34 50.98 63.08 55.39 51.17 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 64.71 54.80 47.28 63.92 56.57 48.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 18 3 # 18 A 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 65.34 65.04 50.22 63.95 63.70 51.06 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.46 53.34 50.98 63.08 55.39 51.17 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 64.71 54.80 47.28 63.92 56.57 48.06 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 19 3 # 19 A 202 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 65.34 65.04 50.22 63.95 63.70 51.06 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 63.46 53.34 50.98 63.08 55.39 51.17 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 64.71 54.80 47.28 63.92 56.57 48.06 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 20 3 # 20 A 202 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 65.34 65.04 50.22 63.95 63.70 51.06 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 63.46 53.34 50.98 63.08 55.39 51.17 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 64.71 54.80 47.28 63.92 56.57 48.06 -44.69 94.49 12.33 -45.14 96.36 13.15 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 20 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 20.09 23.80 58.44 19.07 25.34 59.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.00 35.58 58.05 18.83 33.61 58.74 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.88 34.01 57.66 22.04 32.37 58.63 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 20.09 23.80 58.44 19.07 25.34 59.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.00 35.58 58.05 18.83 33.61 58.74 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.88 34.01 57.66 22.04 32.37 58.63 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 3 3 # 3 B 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 295 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 20.09 23.80 58.44 19.07 25.34 59.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 19.00 35.58 58.05 18.83 33.61 58.74 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 22.88 34.01 57.66 22.04 32.37 58.63 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 4 3 # 4 B 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 295 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 20.09 23.80 58.44 19.07 25.34 59.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.00 35.58 58.05 18.83 33.61 58.74 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 22.88 34.01 57.66 22.04 32.37 58.63 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 5 3 # 5 B 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 20.09 23.80 58.44 19.07 25.34 59.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.00 35.58 58.05 18.83 33.61 58.74 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.88 34.01 57.66 22.04 32.37 58.63 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 6 3 # 6 B 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 20.09 23.80 58.44 19.07 25.34 59.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 19.00 35.58 58.05 18.83 33.61 58.74 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 22.88 34.01 57.66 22.04 32.37 58.63 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 7 3 # 7 B 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 20.09 23.80 58.44 19.07 25.34 59.44 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.00 35.58 58.05 18.83 33.61 58.74 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 22.88 34.01 57.66 22.04 32.37 58.63 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 8 3 # 8 B 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 20.09 23.80 58.44 19.07 25.34 59.44 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 19.00 35.58 58.05 18.83 33.61 58.74 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.88 34.01 57.66 22.04 32.37 58.63 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 9 3 # 9 B 202 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 20.09 23.80 58.44 19.07 25.34 59.44 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 19.00 35.58 58.05 18.83 33.61 58.74 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 22.88 34.01 57.66 22.04 32.37 58.63 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 10 3 # 10 B 202 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 20.09 23.80 58.44 19.07 25.34 59.44 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 19.00 35.58 58.05 18.83 33.61 58.74 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.88 34.01 57.66 22.04 32.37 58.63 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 11 3 # 11 B 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 20.09 23.80 58.44 19.07 25.34 59.44 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.00 35.58 58.05 18.83 33.61 58.74 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.88 34.01 57.66 22.04 32.37 58.63 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 12 3 # 12 B 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 20.09 23.80 58.44 19.07 25.34 59.44 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.00 35.58 58.05 18.83 33.61 58.74 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.88 34.01 57.66 22.04 32.37 58.63 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 13 3 # 13 B 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 295 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 20.09 23.80 58.44 19.07 25.34 59.44 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 19.00 35.58 58.05 18.83 33.61 58.74 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 22.88 34.01 57.66 22.04 32.37 58.63 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 14 3 # 14 B 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 20.09 23.80 58.44 19.07 25.34 59.44 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.00 35.58 58.05 18.83 33.61 58.74 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.88 34.01 57.66 22.04 32.37 58.63 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 15 3 # 15 B 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 20.09 23.80 58.44 19.07 25.34 59.44 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.00 35.58 58.05 18.83 33.61 58.74 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 22.88 34.01 57.66 22.04 32.37 58.63 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 16 3 # 16 B 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 295 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 20.09 23.80 58.44 19.07 25.34 59.44 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 19.00 35.58 58.05 18.83 33.61 58.74 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 22.88 34.01 57.66 22.04 32.37 58.63 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 17 3 # 17 B 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 20.09 23.80 58.44 19.07 25.34 59.44 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.00 35.58 58.05 18.83 33.61 58.74 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 22.88 34.01 57.66 22.04 32.37 58.63 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 18 3 # 18 B 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 20.09 23.80 58.44 19.07 25.34 59.44 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 19.00 35.58 58.05 18.83 33.61 58.74 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 22.88 34.01 57.66 22.04 32.37 58.63 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 19 3 # 19 B 202 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 20.09 23.80 58.44 19.07 25.34 59.44 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 19.00 35.58 58.05 18.83 33.61 58.74 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 22.88 34.01 57.66 22.04 32.37 58.63 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 20 3 # 20 B 202 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 20.09 23.80 58.44 19.07 25.34 59.44 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 19.00 35.58 58.05 18.83 33.61 58.74 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 22.88 34.01 57.66 22.04 32.37 58.63 -44.69 94.49 12.33 -45.14 96.36 13.15 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 20 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 56.07 24.38 61.64 57.15 25.46 60.21 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 57.19 35.56 57.82 57.34 33.47 57.88 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 53.24 34.19 58.78 54.08 32.31 58.44 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 56.07 24.38 61.64 57.15 25.46 60.21 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 57.19 35.56 57.82 57.34 33.47 57.88 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 53.24 34.19 58.78 54.08 32.31 58.44 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 3 3 # 3 C 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 295 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 56.07 24.38 61.64 57.15 25.46 60.21 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 57.19 35.56 57.82 57.34 33.47 57.88 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 53.24 34.19 58.78 54.08 32.31 58.44 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 4 3 # 4 C 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 295 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 56.07 24.38 61.64 57.15 25.46 60.21 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 57.19 35.56 57.82 57.34 33.47 57.88 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 53.24 34.19 58.78 54.08 32.31 58.44 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 5 3 # 5 C 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 295 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 56.07 24.38 61.64 57.15 25.46 60.21 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 57.19 35.56 57.82 57.34 33.47 57.88 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 53.24 34.19 58.78 54.08 32.31 58.44 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 6 3 # 6 C 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 295 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 56.07 24.38 61.64 57.15 25.46 60.21 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 57.19 35.56 57.82 57.34 33.47 57.88 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 53.24 34.19 58.78 54.08 32.31 58.44 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 7 3 # 7 C 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 56.07 24.38 61.64 57.15 25.46 60.21 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 57.19 35.56 57.82 57.34 33.47 57.88 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 53.24 34.19 58.78 54.08 32.31 58.44 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 8 3 # 8 C 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 56.07 24.38 61.64 57.15 25.46 60.21 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 57.19 35.56 57.82 57.34 33.47 57.88 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 53.24 34.19 58.78 54.08 32.31 58.44 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 9 3 # 9 C 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 56.07 24.38 61.64 57.15 25.46 60.21 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 57.19 35.56 57.82 57.34 33.47 57.88 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 53.24 34.19 58.78 54.08 32.31 58.44 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 10 3 # 10 C 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 56.07 24.38 61.64 57.15 25.46 60.21 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 57.19 35.56 57.82 57.34 33.47 57.88 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 53.24 34.19 58.78 54.08 32.31 58.44 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 11 3 # 11 C 202 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 56.07 24.38 61.64 57.15 25.46 60.21 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 57.19 35.56 57.82 57.34 33.47 57.88 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 53.24 34.19 58.78 54.08 32.31 58.44 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 12 3 # 12 C 202 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 56.07 24.38 61.64 57.15 25.46 60.21 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 57.19 35.56 57.82 57.34 33.47 57.88 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 53.24 34.19 58.78 54.08 32.31 58.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 13 3 # 13 C 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 56.07 24.38 61.64 57.15 25.46 60.21 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 57.19 35.56 57.82 57.34 33.47 57.88 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 53.24 34.19 58.78 54.08 32.31 58.44 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 14 3 # 14 C 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 56.07 24.38 61.64 57.15 25.46 60.21 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 57.19 35.56 57.82 57.34 33.47 57.88 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 53.24 34.19 58.78 54.08 32.31 58.44 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 15 3 # 15 C 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 295 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 56.07 24.38 61.64 57.15 25.46 60.21 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 57.19 35.56 57.82 57.34 33.47 57.88 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 53.24 34.19 58.78 54.08 32.31 58.44 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 16 3 # 16 C 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 295 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 56.07 24.38 61.64 57.15 25.46 60.21 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 57.19 35.56 57.82 57.34 33.47 57.88 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 53.24 34.19 58.78 54.08 32.31 58.44 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 17 3 # 17 C 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 56.07 24.38 61.64 57.15 25.46 60.21 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 57.19 35.56 57.82 57.34 33.47 57.88 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 53.24 34.19 58.78 54.08 32.31 58.44 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 18 3 # 18 C 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 56.07 24.38 61.64 57.15 25.46 60.21 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 57.19 35.56 57.82 57.34 33.47 57.88 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 53.24 34.19 58.78 54.08 32.31 58.44 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 19 3 # 19 C 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 295 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 56.07 24.38 61.64 57.15 25.46 60.21 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 57.19 35.56 57.82 57.34 33.47 57.88 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 53.24 34.19 58.78 54.08 32.31 58.44 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 20 3 # 20 C 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 295 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 56.07 24.38 61.64 57.15 25.46 60.21 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 57.19 35.56 57.82 57.34 33.47 57.88 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 53.24 34.19 58.78 54.08 32.31 58.44 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 21 3 # 21 C 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 56.07 24.38 61.64 57.15 25.46 60.21 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 57.19 35.56 57.82 57.34 33.47 57.88 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 53.24 34.19 58.78 54.08 32.31 58.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 22 3 # 22 C 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 56.07 24.38 61.64 57.15 25.46 60.21 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 57.19 35.56 57.82 57.34 33.47 57.88 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 53.24 34.19 58.78 54.08 32.31 58.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 23 3 # 23 C 202 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 56.07 24.38 61.64 57.15 25.46 60.21 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 57.19 35.56 57.82 57.34 33.47 57.88 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 53.24 34.19 58.78 54.08 32.31 58.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 24 3 # 24 C 202 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 56.07 24.38 61.64 57.15 25.46 60.21 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 57.19 35.56 57.82 57.34 33.47 57.88 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 53.24 34.19 58.78 54.08 32.31 58.44 -44.69 94.49 12.33 -45.14 96.36 13.15 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 24 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 61.78 113.98 49.61 62.80 115.33 50.85 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.27 125.61 50.94 63.59 123.54 51.16 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.24 124.12 46.99 63.79 122.40 48.02 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 61.78 113.98 49.61 62.80 115.33 50.85 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.27 125.61 50.94 63.59 123.54 51.16 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.24 124.12 46.99 63.79 122.40 48.02 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 3 3 # 3 D 202 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 295 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 61.78 113.98 49.61 62.80 115.33 50.85 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.27 125.61 50.94 63.59 123.54 51.16 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 63.24 124.12 46.99 63.79 122.40 48.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 4 3 # 4 D 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 295 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 296 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 61.78 113.98 49.61 62.80 115.33 50.85 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.27 125.61 50.94 63.59 123.54 51.16 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 63.24 124.12 46.99 63.79 122.40 48.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 5 3 # 5 D 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 296 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 61.78 113.98 49.61 62.80 115.33 50.85 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.27 125.61 50.94 63.59 123.54 51.16 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.24 124.12 46.99 63.79 122.40 48.02 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 6 3 # 6 D 202 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 295 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 296 HIS B 309 HIS~? 5.48 ZN ZN A 402 coo 61.78 113.98 49.61 62.80 115.33 50.85 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.27 125.61 50.94 63.59 123.54 51.16 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.24 124.12 46.99 63.79 122.40 48.02 -40.27 117.69 -1.83 -39.84 118.53 -3.70 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 7 3 # 7 D 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 61.78 113.98 49.61 62.80 115.33 50.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.27 125.61 50.94 63.59 123.54 51.16 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.24 124.12 46.99 63.79 122.40 48.02 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 8 3 # 8 D 202 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 61.78 113.98 49.61 62.80 115.33 50.85 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.27 125.61 50.94 63.59 123.54 51.16 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.24 124.12 46.99 63.79 122.40 48.02 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 9 3 # 9 D 202 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 295 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 296 HIS B 98 HIS~? 5.02 ZN ZN B 402 coo 61.78 113.98 49.61 62.80 115.33 50.85 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 63.27 125.61 50.94 63.59 123.54 51.16 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.24 124.12 46.99 63.79 122.40 48.02 -49.25 96.40 11.26 -48.45 97.80 9.92 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 10 3 # 10 D 202 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 61.78 113.98 49.61 62.80 115.33 50.85 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 63.27 125.61 50.94 63.59 123.54 51.16 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.24 124.12 46.99 63.79 122.40 48.02 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 11 3 # 11 D 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 61.78 113.98 49.61 62.80 115.33 50.85 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.27 125.61 50.94 63.59 123.54 51.16 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.24 124.12 46.99 63.79 122.40 48.02 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 12 3 # 12 D 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 61.78 113.98 49.61 62.80 115.33 50.85 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.27 125.61 50.94 63.59 123.54 51.16 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.24 124.12 46.99 63.79 122.40 48.02 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 13 3 # 13 D 202 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 295 HIS A 309 HIS~? 5.45 ZN ZN B 401 D 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 61.78 113.98 49.61 62.80 115.33 50.85 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 63.27 125.61 50.94 63.59 123.54 51.16 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 63.24 124.12 46.99 63.79 122.40 48.02 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 14 3 # 14 D 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 296 HIS A 309 HIS~? 5.45 ZN ZN B 401 coo 61.78 113.98 49.61 62.80 115.33 50.85 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.27 125.61 50.94 63.59 123.54 51.16 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.24 124.12 46.99 63.79 122.40 48.02 -45.80 98.45 2.85 -45.82 97.45 4.71 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 15 3 # 15 D 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 295 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 296 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 61.78 113.98 49.61 62.80 115.33 50.85 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.27 125.61 50.94 63.59 123.54 51.16 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 63.24 124.12 46.99 63.79 122.40 48.02 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 16 3 # 16 D 202 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 295 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 296 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 61.78 113.98 49.61 62.80 115.33 50.85 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.27 125.61 50.94 63.59 123.54 51.16 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 63.24 124.12 46.99 63.79 122.40 48.02 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 17 3 # 17 D 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 61.78 113.98 49.61 62.80 115.33 50.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.27 125.61 50.94 63.59 123.54 51.16 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.24 124.12 46.99 63.79 122.40 48.02 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 18 3 # 18 D 202 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 295 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 296 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 61.78 113.98 49.61 62.80 115.33 50.85 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 63.27 125.61 50.94 63.59 123.54 51.16 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 63.24 124.12 46.99 63.79 122.40 48.02 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 19 3 # 19 D 202 HIS B 309 HIS~? 5.48 ZN ZN A 402 D 295 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 296 HIS A 98 HIS~? 4.98 ZN ZN A 401 coo 61.78 113.98 49.61 62.80 115.33 50.85 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 63.27 125.61 50.94 63.59 123.54 51.16 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 63.24 124.12 46.99 63.79 122.40 48.02 -42.20 121.23 -10.32 -42.26 119.61 -8.99 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 20 3 # 20 D 202 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 295 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 296 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 61.78 113.98 49.61 62.80 115.33 50.85 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 63.27 125.61 50.94 63.59 123.54 51.16 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 63.24 124.12 46.99 63.79 122.40 48.02 -44.69 94.49 12.33 -45.14 96.36 13.15 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 20 hits 4kbp_c03 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s 41 LYS A 70 LYS.? 15.41 ZN ZN A 402 119 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.18 18.67 11.43 28.83 17.39 9.89 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 25.33 8.32 6.30 27.86 13.90 7.82 -48.76 125.53 -1.26 -51.29 120.16 0.88 coo 33.68 19.99 5.35 34.98 18.36 5.19 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s 41 LYS A 333 LYS~? 13.50 ZN ZN A 402 119 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 28.18 18.67 11.43 28.83 17.39 9.89 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 25.33 8.32 6.30 27.86 13.90 7.82 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 33.68 19.99 5.35 34.98 18.36 5.19 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS A 65 HIS.? -3.39 ZN ZN A 402s 41 LYS A 333 LYS~? 13.50 ZN ZN A 402 119 HIS B 308 HIS~? 6.54 ZN ZN A 402 coo 28.18 18.67 11.43 28.83 17.39 9.89 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 25.33 8.32 6.30 27.86 13.90 7.82 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 33.68 19.99 5.35 34.98 18.36 5.19 -35.94 115.60 -2.36 -34.88 117.34 -2.86 ULMN 3 5rsa_c01 RIBONUCLEASE A user 4 3 # 4 12 HIS A 308 HIS~? 6.49 ZN ZN B 401 41 LYS A 315 LYS~? 18.17 ZN ZN B 401 119 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 28.18 18.67 11.43 28.83 17.39 9.89 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 25.33 8.32 6.30 27.86 13.90 7.82 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 33.68 19.99 5.35 34.98 18.36 5.19 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 5rsa_c01 RIBONUCLEASE A user 5 3 # 5 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s 41 LYS B 70 LYS.? 12.56 ZN ZN B 401 119 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.18 18.67 11.43 28.83 17.39 9.89 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 25.33 8.32 6.30 27.86 13.90 7.82 -57.09 96.40 2.21 -54.35 101.68 2.27 coo 33.68 19.99 5.35 34.98 18.36 5.19 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 5rsa_c01 RIBONUCLEASE A user 6 3 # 6 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s 41 LYS B 333 LYS~? 13.39 ZN ZN B 401 119 HIS A 308 HIS~? 6.49 ZN ZN B 401 coo 28.18 18.67 11.43 28.83 17.39 9.89 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 25.33 8.32 6.30 27.86 13.90 7.82 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 33.68 19.99 5.35 34.98 18.36 5.19 -41.00 97.85 3.28 -40.98 95.80 3.73 ULMN 3 5rsa_c01 RIBONUCLEASE A user 7 3 # 7 12 HIS B 65 HIS.? -3.43 ZN ZN B 401s 41 LYS B 333 LYS~? 13.39 ZN ZN B 401 119 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 28.18 18.67 11.43 28.83 17.39 9.89 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 25.33 8.32 6.30 27.86 13.90 7.82 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 33.68 19.99 5.35 34.98 18.36 5.19 -40.92 100.43 6.30 -42.93 100.06 6.77 ULMN 3 5rsa_c01 RIBONUCLEASE A user 8 3 # 8 12 HIS B 308 HIS~? 6.54 ZN ZN A 402 41 LYS B 315 LYS~? 18.28 ZN ZN A 402 119 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 28.18 18.67 11.43 28.83 17.39 9.89 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 25.33 8.32 6.30 27.86 13.90 7.82 -33.07 120.28 7.09 -27.74 119.98 5.88 coo 33.68 19.99 5.35 34.98 18.36 5.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 5rsa_c01 source 5rsa RIBONUCLEASE A : 8 hits 5rsa_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 31 ASP.? 28.20 ZN ZN A 401 A 99 GLY A 30 GLY.? 22.34 ZN ZN A 402 A 125 ASN A 93 ASN^? 23.13 ZN ZN A 401 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -40.02 142.98 -10.54 -40.76 144.80 -11.28 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -40.03 138.80 -8.81 -40.82 138.90 -8.71 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -36.46 137.39 -10.90 -36.25 139.51 -10.83 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 99 GLY A 304 GLY.? 8.93 ZN ZN A 402 A 125 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 99 GLY A 304 GLY.? 8.93 ZN ZN A 402 A 125 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -36.73 108.01 -6.68 -37.53 107.81 -6.81 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 4 3 # 4 A 81 ASP B 31 ASP.? 28.05 ZN ZN B 402 A 99 GLY B 30 GLY.? 22.35 ZN ZN B 402 A 125 ASN B 93 ASN^? 23.03 ZN ZN B 402 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -58.98 76.97 11.28 -60.60 75.86 12.07 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -56.71 80.35 9.42 -57.43 80.74 9.40 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -52.93 79.71 11.45 -53.96 77.86 11.50 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 5 3 # 5 A 81 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 99 GLY B 304 GLY.? 8.91 ZN ZN B 401 A 125 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -37.52 104.72 7.61 -38.13 105.28 7.78 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 6 3 # 6 A 81 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 99 GLY B 304 GLY.? 8.91 ZN ZN B 401 A 125 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -37.52 104.72 7.61 -38.13 105.28 7.78 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -34.08 101.07 5.49 -32.41 102.02 4.50 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 6 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 51 ASN~? 22.86 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -25.46 132.69 -0.66 -26.43 133.12 1.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 78 ASN.? 23.55 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.79 131.52 10.85 -37.74 129.57 11.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 93 ASN^? 23.13 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -36.46 137.39 -10.90 -36.25 139.51 -10.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 100 ASN~? 9.95 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -44.05 122.82 -17.82 -42.95 124.35 -16.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 109 ASN~? 6.71 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.82 111.74 -18.14 -38.65 111.91 -16.17 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 120 ASN^? 24.40 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.37 103.73 -29.04 -33.12 102.96 -30.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 125 ASN.? 13.89 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -47.13 108.77 -19.31 -46.75 106.92 -18.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN A 126 ASN^? 17.03 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -48.36 110.95 -24.95 -46.52 110.11 -25.61 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN A 246 ASN^? 30.29 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -25.31 95.10 -25.18 -24.51 95.46 -27.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN A 262 ASN.? 19.00 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.99 111.54 -9.12 -20.99 112.00 -10.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN A 273 ASN.? 28.39 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.95 87.11 -12.66 -30.56 85.68 -12.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN A 320 ASN.? 23.41 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.23 94.97 -12.31 -37.23 92.90 -12.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN A 325 ASN~? 12.89 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.91 109.24 -4.57 -30.97 107.55 -3.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN A 342 ASN~? 22.18 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -29.33 125.76 -27.31 -29.81 125.41 -29.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN A 345 ASN~? 27.62 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -27.24 130.39 -29.33 -25.68 130.66 -30.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN A 350 ASN.? 30.79 ZN ZN A 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.92 138.63 -25.22 -24.60 138.40 -27.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN A 359 ASN.? 14.84 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.17 118.80 -3.45 -25.14 116.90 -3.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN B 24 ASN.? 14.57 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -56.06 94.54 8.52 -57.34 92.84 8.20 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN B 51 ASN~? 22.98 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -41.35 77.93 1.13 -42.45 77.97 -0.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN B 59 ASN.? 24.90 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -49.65 74.63 11.24 -50.47 74.68 13.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN B 78 ASN~? 23.25 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -51.19 85.79 -10.02 -50.50 87.71 -10.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN B 93 ASN^? 23.03 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -52.93 79.71 11.45 -53.96 77.86 11.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN B 100 ASN~? 9.88 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -51.48 95.86 18.73 -51.39 94.02 17.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.36 96.74 22.46 -46.71 95.57 24.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN B 109 ASN~? 6.75 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -40.37 101.87 19.09 -41.17 102.25 17.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN B 120 ASN^? 24.35 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -33.10 106.72 29.88 -31.69 106.80 31.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN B 125 ASN.? 13.83 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.89 109.38 20.39 -45.54 110.71 19.40 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN B 126 ASN^? 17.05 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -49.00 108.11 26.08 -47.01 107.77 26.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN B 160 ASN.? 40.65 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -64.74 101.16 47.93 -66.09 99.91 46.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN B 246 ASN^? 29.55 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -20.88 108.47 25.55 -20.19 107.11 27.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN B 262 ASN.? 19.45 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -26.72 93.92 9.92 -25.54 92.85 8.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN B 273 ASN.? 28.81 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.74 117.99 13.68 -20.11 120.10 13.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN B 320 ASN.? 23.67 ZN ZN A 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.14 115.93 13.50 -30.16 117.79 13.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN B 325 ASN~? 12.86 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.08 101.07 5.49 -32.41 102.02 4.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN B 342 ASN~? 21.94 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -40.74 85.47 27.90 -41.03 86.13 29.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN B 345 ASN~? 27.56 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -41.25 80.30 29.90 -40.44 79.74 31.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN B 350 ASN.? 30.96 ZN ZN B 402 coo 5.80 63.03 55.85 5.52 65.03 56.45 -43.56 72.18 25.31 -43.16 71.77 27.37 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN B 359 ASN.? 14.74 ZN ZN B 401 coo 5.80 63.03 55.85 5.52 65.03 56.45 -32.68 88.91 3.99 -32.53 91.05 3.94 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 41 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR B 161 TYR^? 41.82 ZN ZN B 402 A 112 PHE B 200 PHE^? 37.57 ZN ZN B 402 A 140 ASN B 160 ASN.? 40.65 ZN ZN B 402 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -62.32 107.54 48.40 -61.64 109.88 49.75 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -66.40 101.63 42.29 -68.97 100.93 41.41 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -64.74 101.16 47.93 -66.09 99.91 46.81 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 1 hits 1o8s_p00 naa= 3 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE A 68 ILE.? 15.54 ZN ZN A 402 A 52 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 53 VAL B 103 VAL~? 8.70 ZN ZN B 402 A 78 ASN A 24 ASN.? 14.49 ZN ZN A 402 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -44.13 129.68 -3.22 -44.58 130.96 -2.87 coo 81.20 29.47 37.49 79.47 28.44 38.24 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 82.17 24.86 36.27 81.03 23.67 37.80 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -47.02 126.48 -7.57 -47.15 128.60 -7.27 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE A 92 ILE.? 21.85 ZN ZN A 402 A 52 ASN A 320 ASN.? 23.41 ZN ZN B 401 A 53 VAL A 300 VAL^? 18.88 ZN ZN A 401 A 78 ASN A 93 ASN^? 23.13 ZN ZN A 401 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -32.76 137.13 -6.54 -31.42 137.13 -7.09 coo 81.20 29.47 37.49 79.47 28.44 38.24 -37.23 94.97 -12.31 -37.23 92.90 -12.72 coo 82.17 24.86 36.27 81.03 23.67 37.80 -37.31 98.05 -15.24 -35.26 98.67 -14.63 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -36.46 137.39 -10.90 -36.25 139.51 -10.83 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 3 4 # 3 A 25 ILE A 276 ILE^? 22.81 ZN ZN A 401 A 52 ASN A 51 ASN~? 22.86 ZN ZN A 402 A 53 VAL A 50 VAL~? 19.23 ZN ZN A 402 A 78 ASN A 320 ASN.? 23.41 ZN ZN B 401 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -31.97 95.64 -17.87 -33.06 95.94 -17.17 coo 81.20 29.47 37.49 79.47 28.44 38.24 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 82.17 24.86 36.27 81.03 23.67 37.80 -29.56 132.44 -3.36 -31.35 133.31 -2.44 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -37.23 94.97 -12.31 -37.23 92.90 -12.72 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 4 4 # 4 A 25 ILE A 358 ILE.? 17.15 ZN ZN A 402 A 52 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 53 VAL B 103 VAL~? 8.70 ZN ZN B 402 A 78 ASN A 359 ASN.? 14.84 ZN ZN A 402 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -25.01 124.56 -4.02 -24.99 125.48 -2.89 coo 81.20 29.47 37.49 79.47 28.44 38.24 -46.36 96.74 22.46 -46.71 95.57 24.21 coo 82.17 24.86 36.27 81.03 23.67 37.80 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -24.17 118.80 -3.45 -25.14 116.90 -3.22 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 5 4 # 5 A 25 ILE B 3 ILE~? 21.99 ZN ZN B 402 A 52 ASN B 320 ASN.? 23.67 ZN ZN A 402 A 53 VAL B 300 VAL^? 18.81 ZN ZN B 402 A 78 ASN B 93 ASN^? 23.03 ZN ZN B 402 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -55.47 79.33 16.06 -54.36 80.21 15.46 coo 81.20 29.47 37.49 79.47 28.44 38.24 -31.14 115.93 13.50 -30.16 117.79 13.90 coo 82.17 24.86 36.27 81.03 23.67 37.80 -32.78 113.31 16.18 -31.32 111.68 15.56 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -52.93 79.71 11.45 -53.96 77.86 11.50 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 6 4 # 6 A 25 ILE B 92 ILE.? 21.89 ZN ZN B 401 A 52 ASN B 320 ASN.? 23.67 ZN ZN A 402 A 53 VAL B 300 VAL^? 18.81 ZN ZN B 402 A 78 ASN B 93 ASN^? 23.03 ZN ZN B 402 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -49.79 77.93 6.97 -48.64 77.24 7.58 coo 81.20 29.47 37.49 79.47 28.44 38.24 -31.14 115.93 13.50 -30.16 117.79 13.90 coo 82.17 24.86 36.27 81.03 23.67 37.80 -32.78 113.31 16.18 -31.32 111.68 15.56 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -52.93 79.71 11.45 -53.96 77.86 11.50 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 7 4 # 7 A 25 ILE B 198 ILE^? 43.88 ZN ZN B 402 A 52 ASN B 24 ASN.? 14.57 ZN ZN B 401 A 53 VAL B 25 VAL.? 11.30 ZN ZN B 402 A 78 ASN B 160 ASN.? 40.65 ZN ZN B 402 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -69.46 104.25 47.75 -69.65 102.99 48.43 coo 81.20 29.47 37.49 79.47 28.44 38.24 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 82.17 24.86 36.27 81.03 23.67 37.80 -54.76 92.82 12.94 -54.20 94.54 14.27 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -64.74 101.16 47.93 -66.09 99.91 46.81 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 8 4 # 8 A 25 ILE B 276 ILE^? 23.03 ZN ZN B 402 A 52 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 53 VAL B 50 VAL~? 19.22 ZN ZN B 401 A 78 ASN B 320 ASN.? 23.67 ZN ZN A 402 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -26.84 112.79 18.77 -27.86 113.13 18.13 coo 81.20 29.47 37.49 79.47 28.44 38.24 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 82.17 24.86 36.27 81.03 23.67 37.80 -44.61 80.22 3.98 -46.57 80.59 3.08 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -31.14 115.93 13.50 -30.16 117.79 13.90 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 9 4 # 9 A 25 ILE B 351 ILE.? 24.87 ZN ZN B 402 A 52 ASN B 246 ASN^? 29.55 ZN ZN B 402 A 53 VAL B 244 VAL^? 22.57 ZN ZN B 402 A 78 ASN B 350 ASN.? 30.96 ZN ZN B 402 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -45.86 75.47 21.01 -47.10 75.51 20.46 coo 81.20 29.47 37.49 79.47 28.44 38.24 -20.88 108.47 25.55 -20.19 107.11 27.02 coo 82.17 24.86 36.27 81.03 23.67 37.80 -27.13 107.26 23.99 -26.46 108.40 22.25 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -43.56 72.18 25.31 -43.16 71.77 27.37 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 10 4 # 10 A 25 ILE B 358 ILE.? 17.20 ZN ZN B 401 A 52 ASN A 104 ASN.? 12.54 ZN ZN A 401 A 53 VAL A 103 VAL~? 8.69 ZN ZN A 401 A 78 ASN B 359 ASN.? 14.74 ZN ZN B 401 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -36.35 84.41 4.61 -36.91 83.61 3.74 coo 81.20 29.47 37.49 79.47 28.44 38.24 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo 82.17 24.86 36.27 81.03 23.67 37.80 -43.08 116.22 -19.23 -45.08 116.92 -18.60 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -32.68 88.91 3.99 -32.53 91.05 3.94 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 10 hits 1qfw_p00 naa= 4 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 58 TYR.? 23.12 ZN ZN A 401 A 108 ASN A 93 ASN^? 23.13 ZN ZN A 401 A 135 ASN A 59 ASN.? 24.94 ZN ZN A 401 coo 17.50 4.57 17.85 15.28 5.88 18.97 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 12.22 15.98 15.24 11.94 14.05 16.09 -36.46 137.39 -10.90 -36.25 139.51 -10.83 coo 17.94 11.43 12.65 17.42 10.61 14.53 -30.92 139.81 -10.79 -31.57 140.22 -12.79 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 236 TYR^? 14.83 ZN ZN A 401 A 108 ASN A 125 ASN.? 13.89 ZN ZN A 401 A 135 ASN A 126 ASN^? 17.03 ZN ZN A 401 coo 17.50 4.57 17.85 15.28 5.88 18.97 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo 12.22 15.98 15.24 11.94 14.05 16.09 -47.13 108.77 -19.31 -46.75 106.92 -18.35 coo 17.94 11.43 12.65 17.42 10.61 14.53 -48.36 110.95 -24.95 -46.52 110.11 -25.61 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR B 58 TYR.? 23.40 ZN ZN B 402 A 108 ASN B 93 ASN^? 23.03 ZN ZN B 402 A 135 ASN B 59 ASN.? 24.90 ZN ZN B 402 coo 17.50 4.57 17.85 15.28 5.88 18.97 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 12.22 15.98 15.24 11.94 14.05 16.09 -52.93 79.71 11.45 -53.96 77.86 11.50 coo 17.94 11.43 12.65 17.42 10.61 14.53 -49.65 74.63 11.24 -50.47 74.68 13.21 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 236 TYR^? 14.81 ZN ZN B 402 A 108 ASN B 125 ASN.? 13.83 ZN ZN B 402 A 135 ASN B 126 ASN^? 17.05 ZN ZN B 402 coo 17.50 4.57 17.85 15.28 5.88 18.97 -50.67 100.24 25.02 -50.96 97.90 26.55 coo 12.22 15.98 15.24 11.94 14.05 16.09 -46.89 109.38 20.39 -45.54 110.71 19.40 coo 17.94 11.43 12.65 17.42 10.61 14.53 -49.00 108.11 26.08 -47.01 107.77 26.68 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 4 hits 1uy4_p00 naa= 3 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 104 ASN.? 12.54 ZN ZN A 401 A 213 PRO A 105 PRO.? 13.76 ZN ZN A 401 A 219 ASN A 125 ASN.? 13.89 ZN ZN A 401 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -41.23 116.98 -26.08 -39.87 116.51 -24.35 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -47.13 108.77 -19.31 -46.75 106.92 -18.35 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN A 104 ASN.? 12.54 ZN ZN A 401 A 213 PRO A 105 PRO.? 13.76 ZN ZN A 401 A 219 ASN A 342 ASN~? 22.18 ZN ZN A 401 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -40.15 119.29 -21.61 -39.88 120.42 -23.44 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -41.23 116.98 -26.08 -39.87 116.51 -24.35 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -29.33 125.76 -27.31 -29.81 125.41 -29.36 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 3 3 # 3 A 44 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 213 PRO B 105 PRO.? 13.84 ZN ZN B 402 A 219 ASN B 125 ASN.? 13.83 ZN ZN B 402 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -46.36 96.74 22.46 -46.71 95.57 24.21 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -45.95 99.11 27.10 -44.58 98.82 25.31 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -46.89 109.38 20.39 -45.54 110.71 19.40 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 4 3 # 4 A 44 ASN B 104 ASN.? 12.46 ZN ZN B 402 A 213 PRO B 105 PRO.? 13.84 ZN ZN B 402 A 219 ASN B 342 ASN~? 21.94 ZN ZN B 402 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -46.36 96.74 22.46 -46.71 95.57 24.21 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -45.95 99.11 27.10 -44.58 98.82 25.31 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -40.74 85.47 27.90 -41.03 86.13 29.94 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 4 hits 1wbf_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 76 ASN A 24 ASN.? 14.49 ZN ZN A 402 A 81 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 4.09 43.69 67.89 2.45 42.40 68.10 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 4.75 48.17 75.81 4.99 47.30 77.74 -47.02 126.48 -7.57 -47.15 128.60 -7.27 coo 0.57 50.41 73.18 0.46 48.28 73.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 76 ASN B 24 ASN.? 14.57 ZN ZN B 401 A 81 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 4.09 43.69 67.89 2.45 42.40 68.10 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 4.75 48.17 75.81 4.99 47.30 77.74 -56.06 94.54 8.52 -57.34 92.84 8.20 coo 0.57 50.41 73.18 0.46 48.28 73.56 -54.33 98.57 11.88 -52.50 97.53 11.52 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 2 hits 2c3x_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 188 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 190 SER A 265 SER.? 18.83 ZN ZN A 402 coo 37.69 7.64 13.51 38.82 8.84 16.11 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 47.14 12.10 13.73 48.75 12.33 16.01 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 43.77 6.93 15.46 45.49 7.21 17.11 -26.26 104.74 -2.86 -27.40 103.51 -1.11 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 188 TYR A 365 TYR^? 16.07 ZN ZN A 402 A 190 SER B 265 SER.? 18.70 ZN ZN B 401 coo 37.69 7.64 13.51 38.82 8.84 16.11 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 47.14 12.10 13.73 48.75 12.33 16.01 -26.53 108.54 0.92 -29.08 108.89 -0.28 coo 43.77 6.93 15.46 45.49 7.21 17.11 -26.94 101.98 3.65 -27.40 103.69 1.94 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 188 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 190 SER A 265 SER.? 18.83 ZN ZN A 402 coo 37.69 7.64 13.51 38.82 8.84 16.11 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 47.14 12.10 13.73 48.75 12.33 16.01 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 43.77 6.93 15.46 45.49 7.21 17.11 -26.26 104.74 -2.86 -27.40 103.51 -1.11 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 188 TYR B 365 TYR^? 15.98 ZN ZN B 401 A 190 SER B 265 SER.? 18.70 ZN ZN B 401 coo 37.69 7.64 13.51 38.82 8.84 16.11 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 47.14 12.10 13.73 48.75 12.33 16.01 -29.29 98.99 -0.08 -31.62 99.98 1.12 coo 43.77 6.93 15.46 45.49 7.21 17.11 -26.94 101.98 3.65 -27.40 103.69 1.94 2p3i_p00 source 2p3i VP4 : 4 hits 2p3i_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 125 ASN.? 13.89 ZN ZN A 401 A 460 GLY A 237 GLY^? 12.04 ZN ZN A 401 A 461 ASN A 126 ASN^? 17.03 ZN ZN A 401 coo 15.00 94.38 6.97 13.00 93.59 6.99 -47.13 108.77 -19.31 -46.75 106.92 -18.35 coo 19.48 94.04 5.03 19.26 94.00 5.78 -45.65 113.20 -21.30 -44.96 113.62 -21.16 coo 20.23 95.69 9.16 21.55 97.37 9.20 -48.36 110.95 -24.95 -46.52 110.11 -25.61 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 126 ASN^? 17.03 ZN ZN A 401 A 460 GLY A 237 GLY^? 12.04 ZN ZN A 401 A 461 ASN A 125 ASN.? 13.89 ZN ZN A 401 coo 15.00 94.38 6.97 13.00 93.59 6.99 -48.36 110.95 -24.95 -46.52 110.11 -25.61 coo 19.48 94.04 5.03 19.26 94.00 5.78 -45.65 113.20 -21.30 -44.96 113.62 -21.16 coo 20.23 95.69 9.16 21.55 97.37 9.20 -47.13 108.77 -19.31 -46.75 106.92 -18.35 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN B 125 ASN.? 13.83 ZN ZN B 402 A 460 GLY B 237 GLY^? 12.12 ZN ZN B 402 A 461 ASN B 126 ASN^? 17.05 ZN ZN B 402 coo 15.00 94.38 6.97 13.00 93.59 6.99 -46.89 109.38 20.39 -45.54 110.71 19.40 coo 19.48 94.04 5.03 19.26 94.00 5.78 -47.85 104.85 22.36 -47.42 104.12 22.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 -49.00 108.11 26.08 -47.01 107.77 26.68 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN B 126 ASN^? 17.05 ZN ZN B 402 A 460 GLY B 237 GLY^? 12.12 ZN ZN B 402 A 461 ASN B 125 ASN.? 13.83 ZN ZN B 402 coo 15.00 94.38 6.97 13.00 93.59 6.99 -49.00 108.11 26.08 -47.01 107.77 26.68 coo 19.48 94.04 5.03 19.26 94.00 5.78 -47.85 104.85 22.36 -47.42 104.12 22.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 -46.89 109.38 20.39 -45.54 110.71 19.40 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 4 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 262 ASN.? 19.00 ZN ZN A 402 A 384 ASN A 51 ASN~? 22.86 ZN ZN A 402 A 385 GLU A 48 GLU~? 19.37 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -21.99 111.54 -9.12 -20.99 112.00 -10.95 coo 7.06 50.07 96.17 8.50 48.54 96.31 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -25.72 127.18 1.29 -24.86 125.22 1.74 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 262 ASN.? 19.00 ZN ZN A 402 A 384 ASN A 51 ASN~? 22.86 ZN ZN A 402 A 385 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -21.99 111.54 -9.12 -20.99 112.00 -10.95 coo 7.06 50.07 96.17 8.50 48.54 96.31 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 262 ASN.? 19.00 ZN ZN A 402 A 384 ASN B 273 ASN.? 28.81 ZN ZN A 402 A 385 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -21.99 111.54 -9.12 -20.99 112.00 -10.95 coo 7.06 50.07 96.17 8.50 48.54 96.31 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 -20.38 111.90 11.61 -18.92 112.78 10.34 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 273 ASN.? 28.39 ZN ZN B 401 A 384 ASN A 120 ASN^? 24.40 ZN ZN A 401 A 385 GLU A 243 GLU^? 24.16 ZN ZN A 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -28.95 87.11 -12.66 -30.56 85.68 -12.38 coo 7.06 50.07 96.17 8.50 48.54 96.31 -34.37 103.73 -29.04 -33.12 102.96 -30.64 coo 11.59 49.83 99.41 10.92 47.97 100.16 -33.02 100.94 -26.53 -34.09 99.87 -28.01 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 384 ASN A 51 ASN~? 22.86 ZN ZN A 402 A 385 GLU A 48 GLU~? 19.37 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 7.06 50.07 96.17 8.50 48.54 96.31 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -25.72 127.18 1.29 -24.86 125.22 1.74 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 384 ASN B 273 ASN.? 28.81 ZN ZN A 402 A 385 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 7.06 50.07 96.17 8.50 48.54 96.31 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 -20.38 111.90 11.61 -18.92 112.78 10.34 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN A 325 ASN~? 12.89 ZN ZN A 402 A 384 ASN B 273 ASN.? 28.81 ZN ZN A 402 A 385 GLU B 271 GLU.? 25.84 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 7.06 50.07 96.17 8.50 48.54 96.31 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 -25.27 121.46 10.97 -24.72 123.08 12.43 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN A 350 ASN.? 30.79 ZN ZN A 401 A 384 ASN A 51 ASN~? 22.86 ZN ZN A 402 A 385 GLU A 52 GLU~? 18.80 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -24.92 138.63 -25.22 -24.60 138.40 -27.31 coo 7.06 50.07 96.17 8.50 48.54 96.31 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -23.95 130.06 -6.80 -24.35 128.02 -7.40 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN A 350 ASN.? 30.79 ZN ZN A 401 A 384 ASN A 51 ASN~? 22.86 ZN ZN A 402 A 385 GLU A 55 GLU~? 25.21 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -24.92 138.63 -25.22 -24.60 138.40 -27.31 coo 7.06 50.07 96.17 8.50 48.54 96.31 -25.46 132.69 -0.66 -26.43 133.12 1.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -20.38 134.54 -4.38 -20.41 132.67 -3.34 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN B 262 ASN.? 19.45 ZN ZN B 401 A 384 ASN A 273 ASN.? 28.39 ZN ZN B 401 A 385 GLU A 271 GLU.? 22.11 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -26.72 93.92 9.92 -25.54 92.85 8.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -28.95 87.11 -12.66 -30.56 85.68 -12.38 coo 11.59 49.83 99.41 10.92 47.97 100.16 -34.83 87.36 -9.28 -34.64 86.91 -7.21 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN B 262 ASN.? 19.45 ZN ZN B 401 A 384 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 385 GLU B 48 GLU~? 19.33 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -26.72 93.92 9.92 -25.54 92.85 8.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 -38.69 82.94 -0.70 -36.82 83.91 -1.11 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN B 262 ASN.? 19.45 ZN ZN B 401 A 384 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 385 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -26.72 93.92 9.92 -25.54 92.85 8.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 13 3 # 13 A 270 ASN B 262 ASN.? 19.45 ZN ZN B 401 A 384 ASN B 273 ASN.? 28.81 ZN ZN A 402 A 385 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -26.72 93.92 9.92 -25.54 92.85 8.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 -20.38 111.90 11.61 -18.92 112.78 10.34 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 14 3 # 14 A 270 ASN B 273 ASN.? 28.81 ZN ZN A 402 A 384 ASN B 120 ASN^? 24.35 ZN ZN B 402 A 385 GLU B 243 GLU^? 24.39 ZN ZN B 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 7.06 50.07 96.17 8.50 48.54 96.31 -33.10 106.72 29.88 -31.69 106.80 31.50 coo 11.59 49.83 99.41 10.92 47.97 100.16 -30.57 108.69 27.52 -30.74 110.20 29.01 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 15 3 # 15 A 270 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 384 ASN A 273 ASN.? 28.39 ZN ZN B 401 A 385 GLU A 271 GLU.? 22.11 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -28.95 87.11 -12.66 -30.56 85.68 -12.38 coo 11.59 49.83 99.41 10.92 47.97 100.16 -34.83 87.36 -9.28 -34.64 86.91 -7.21 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 16 3 # 16 A 270 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 384 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 385 GLU B 48 GLU~? 19.33 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 -38.69 82.94 -0.70 -36.82 83.91 -1.11 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 17 3 # 17 A 270 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 384 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 385 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 18 3 # 18 A 270 ASN B 325 ASN~? 12.86 ZN ZN B 401 A 384 ASN B 273 ASN.? 28.81 ZN ZN A 402 A 385 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 22.28 63.17 110.61 22.47 65.06 111.53 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 -20.38 111.90 11.61 -18.92 112.78 10.34 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 19 3 # 19 A 270 ASN B 350 ASN.? 30.96 ZN ZN B 402 A 384 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 385 GLU B 52 GLU~? 18.78 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -43.56 72.18 25.31 -43.16 71.77 27.37 coo 7.06 50.07 96.17 8.50 48.54 96.31 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 -38.47 79.19 7.21 -37.79 81.13 7.79 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 20 3 # 20 A 270 ASN B 350 ASN.? 30.96 ZN ZN B 402 A 384 ASN B 51 ASN~? 22.98 ZN ZN B 401 A 385 GLU B 55 GLU~? 25.91 ZN ZN B 401 coo 22.28 63.17 110.61 22.47 65.06 111.53 -43.56 72.18 25.31 -43.16 71.77 27.37 coo 7.06 50.07 96.17 8.50 48.54 96.31 -41.35 77.93 1.13 -42.45 77.97 -0.69 coo 11.59 49.83 99.41 10.92 47.97 100.16 -39.07 73.47 3.56 -37.44 74.53 2.68 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 20 hits 2v3r_p00 naa= 3 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 1 3 # 1 A 82 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 166 SER A 63 SER^? 10.35 ZN ZN A 402 A 168 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 2 3 # 2 A 82 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 166 SER A 63 SER^? 10.35 ZN ZN A 402 A 168 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 3 3 # 3 A 82 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 166 SER B 63 SER^? 10.37 ZN ZN B 401 A 168 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 4 3 # 4 A 82 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 166 SER B 63 SER^? 10.37 ZN ZN B 401 A 168 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -44.69 94.49 12.33 -45.14 96.36 13.15 2vmg_p00 source 2vmg FIBRONECTIN TYPE III DOMAIN PROTEIN : 4 hits 2vmg_p00 naa= 3 ULMN 4 1cf7_d01 TRANSCRIPTION/DNA user 1 4 # 1 B 118 ASN A 325 ASN~? 12.89 ZN ZN A 402 B 121 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 122 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 124 TYR B 365 TYR^? 15.98 ZN ZN B 401 coo 43.23 33.97 15.91 42.50 32.05 15.39 -31.91 109.24 -4.57 -30.97 107.55 -3.66 coo 34.72 34.23 15.94 33.05 32.00 17.31 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 39.23 30.42 19.06 37.28 30.09 16.76 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 32.79 36.91 20.45 33.09 39.73 20.13 -29.29 98.99 -0.08 -31.62 99.98 1.12 ULMN 4 1cf7_d01 TRANSCRIPTION/DNA user 2 4 # 2 B 118 ASN B 325 ASN~? 12.86 ZN ZN B 401 B 121 ARG B 267 ARG^? 13.63 ZN ZN A 402 B 122 ARG A 267 ARG^? 13.45 ZN ZN B 401 B 124 TYR A 365 TYR^? 16.07 ZN ZN A 402 coo 43.23 33.97 15.91 42.50 32.05 15.39 -34.08 101.07 5.49 -32.41 102.02 4.50 coo 34.72 34.23 15.94 33.05 32.00 17.31 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 39.23 30.42 19.06 37.28 30.09 16.76 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 32.79 36.91 20.45 33.09 39.73 20.13 -26.53 108.54 0.92 -29.08 108.89 -0.28 1cf7_d01 source 1cf7 TRANSCRIPTION/DNA : 2 hits 1cf7_d01 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 236 TYR^? 14.83 ZN ZN A 401 I 306 VAL A 103 VAL~? 8.69 ZN ZN A 401 I 308 VAL A 108 VAL~? 5.43 ZN ZN A 401 coo 26.18 35.24 6.87 24.33 35.18 8.97 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo 23.55 29.53 9.81 23.15 27.39 10.24 -43.08 116.22 -19.23 -45.08 116.92 -18.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 -36.00 115.90 -16.85 -36.58 116.24 -14.73 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 236 TYR^? 14.83 ZN ZN A 401 I 306 VAL A 103 VAL~? 8.69 ZN ZN A 401 I 308 VAL A 240 VAL^? 12.47 ZN ZN A 401 coo 26.18 35.24 6.87 24.33 35.18 8.97 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo 23.55 29.53 9.81 23.15 27.39 10.24 -43.08 116.22 -19.23 -45.08 116.92 -18.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 -39.36 108.32 -21.22 -37.48 109.56 -21.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 291 TYR~? 19.48 ZN ZN B 401 I 306 VAL A 294 VAL~? 21.33 ZN ZN A 401 I 308 VAL A 300 VAL^? 18.88 ZN ZN A 401 coo 26.18 35.24 6.87 24.33 35.18 8.97 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 -44.19 97.29 -17.65 -43.88 95.69 -16.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 -37.31 98.05 -15.24 -35.26 98.67 -14.63 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 291 TYR~? 19.48 ZN ZN B 401 I 306 VAL A 319 VAL.? 20.98 ZN ZN B 401 I 308 VAL A 300 VAL^? 18.88 ZN ZN A 401 coo 26.18 35.24 6.87 24.33 35.18 8.97 -48.19 97.96 -11.45 -47.23 97.05 -8.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 -41.97 94.33 -11.50 -43.49 95.81 -11.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 -37.31 98.05 -15.24 -35.26 98.67 -14.63 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 106 TYR.? 16.25 ZN ZN B 402 I 306 VAL B 14 VAL~? 12.52 ZN ZN B 402 I 308 VAL B 103 VAL~? 8.70 ZN ZN B 402 coo 26.18 35.24 6.87 24.33 35.18 8.97 -42.51 94.75 26.81 -43.21 95.38 29.42 coo 23.55 29.53 9.81 23.15 27.39 10.24 -50.03 93.03 23.11 -48.21 92.90 21.76 coo 16.43 30.18 9.35 15.05 30.67 11.01 -47.19 100.88 20.23 -49.27 101.27 19.60 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 236 TYR^? 14.81 ZN ZN B 402 I 306 VAL B 103 VAL~? 8.70 ZN ZN B 402 I 308 VAL B 108 VAL~? 5.50 ZN ZN B 402 coo 26.18 35.24 6.87 24.33 35.18 8.97 -50.67 100.24 25.02 -50.96 97.90 26.55 coo 23.55 29.53 9.81 23.15 27.39 10.24 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 -40.96 97.36 17.68 -41.61 97.38 15.53 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 236 TYR^? 14.81 ZN ZN B 402 I 306 VAL B 103 VAL~? 8.70 ZN ZN B 402 I 308 VAL B 240 VAL^? 12.46 ZN ZN B 402 coo 26.18 35.24 6.87 24.33 35.18 8.97 -50.67 100.24 25.02 -50.96 97.90 26.55 coo 23.55 29.53 9.81 23.15 27.39 10.24 -47.19 100.88 20.23 -49.27 101.27 19.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 -39.89 105.67 22.15 -38.95 103.61 22.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 291 TYR~? 19.42 ZN ZN A 402 I 306 VAL B 294 VAL~? 21.27 ZN ZN B 402 I 308 VAL B 300 VAL^? 18.81 ZN ZN B 402 coo 26.18 35.24 6.87 24.33 35.18 8.97 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 23.55 29.53 9.81 23.15 27.39 10.24 -38.27 117.65 18.59 -37.06 118.77 17.15 coo 16.43 30.18 9.35 15.05 30.67 11.01 -32.78 113.31 16.18 -31.32 111.68 15.56 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 291 TYR~? 19.42 ZN ZN A 402 I 306 VAL B 319 VAL.? 21.03 ZN ZN A 402 I 308 VAL B 269 VAL^? 17.06 ZN ZN A 402 coo 26.18 35.24 6.87 24.33 35.18 8.97 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 23.55 29.53 9.81 23.15 27.39 10.24 -34.86 118.87 12.59 -37.01 118.35 12.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 -30.30 114.86 7.63 -32.15 115.47 6.55 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 291 TYR~? 19.42 ZN ZN A 402 I 306 VAL B 319 VAL.? 21.03 ZN ZN A 402 I 308 VAL B 300 VAL^? 18.81 ZN ZN B 402 coo 26.18 35.24 6.87 24.33 35.18 8.97 -41.81 119.15 12.42 -40.61 119.58 9.91 coo 23.55 29.53 9.81 23.15 27.39 10.24 -34.86 118.87 12.59 -37.01 118.35 12.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 -32.78 113.31 16.18 -31.32 111.68 15.56 1cqt_d00 source 1cqt GENE REGULATION/DNA : 10 hits 1cqt_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 277 LYS^? 27.09 ZN ZN A 401 D 25 THR A 249 THR^? 28.75 ZN ZN A 401 D 27 SER A 272 SER.? 25.47 ZN ZN B 401 coo 86.60 33.38 44.00 87.05 39.52 42.71 -32.97 96.06 -22.32 -30.26 96.48 -27.01 coo 81.20 31.58 48.03 79.23 32.24 47.54 -28.13 92.44 -15.75 -26.55 91.22 -14.88 coo 79.09 29.82 54.20 77.17 28.90 53.05 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS B 277 LYS^? 26.47 ZN ZN B 402 D 25 THR B 249 THR^? 28.72 ZN ZN B 402 D 27 SER B 272 SER.? 25.31 ZN ZN A 402 coo 86.60 33.38 44.00 87.05 39.52 42.71 -28.04 112.73 23.24 -26.21 110.17 27.80 coo 81.20 31.58 48.03 79.23 32.24 47.54 -22.07 113.36 16.80 -20.03 113.44 15.95 coo 79.09 29.82 54.20 77.17 28.90 53.05 -22.66 115.72 10.55 -20.64 116.23 9.28 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 41 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 42 ILE A 257 ILE~? 16.95 ZN ZN A 401 coo 36.07 63.73 124.22 32.72 60.75 122.39 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 38.49 66.12 125.64 35.69 66.71 131.25 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 41.08 63.27 123.17 40.13 62.43 122.44 -27.83 104.40 -13.77 -29.11 103.71 -14.11 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 2 3 # 2 A 40 LYS A 260 LYS~? 21.58 ZN ZN A 401 A 41 LYS A 258 LYS~? 21.92 ZN ZN A 402 A 42 ILE A 257 ILE~? 16.95 ZN ZN A 401 coo 36.07 63.73 124.22 32.72 60.75 122.39 -22.91 107.85 -14.23 -23.69 104.38 -19.46 coo 38.49 66.12 125.64 35.69 66.71 131.25 -25.04 104.86 -9.89 -22.57 102.68 -4.34 coo 41.08 63.27 123.17 40.13 62.43 122.44 -27.83 104.40 -13.77 -29.11 103.71 -14.11 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 2 hits 1pyi_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 275 LYS^? 30.46 ZN ZN A 401 A1294 ASN A 273 ASN.? 28.39 ZN ZN B 401 A1297 GLU A 251 GLU~? 26.78 ZN ZN B 401 coo 39.24 18.84-161.99 36.62 21.47-165.99 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 33.53 17.37-161.81 34.31 17.81-163.76 -28.95 87.11 -12.66 -30.56 85.68 -12.38 coo 29.78 23.31-161.30 31.23 23.66-162.84 -25.70 93.68 -9.35 -24.99 91.85 -8.59 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 275 LYS^? 30.46 ZN ZN A 401 A1294 ASN A 273 ASN.? 28.39 ZN ZN B 401 A1297 GLU A 271 GLU.? 22.11 ZN ZN B 401 coo 39.24 18.84-161.99 36.62 21.47-165.99 -31.91 90.95 -17.97 -26.97 90.03 -19.32 coo 33.53 17.37-161.81 34.31 17.81-163.76 -28.95 87.11 -12.66 -30.56 85.68 -12.38 coo 29.78 23.31-161.30 31.23 23.66-162.84 -34.83 87.36 -9.28 -34.64 86.91 -7.21 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS A 315 LYS~? 18.17 ZN ZN B 401 A1294 ASN A 320 ASN.? 23.41 ZN ZN B 401 A1297 GLU A 271 GLU.? 22.11 ZN ZN B 401 coo 39.24 18.84-161.99 36.62 21.47-165.99 -41.26 92.47 -6.07 -36.28 89.98 -4.98 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.23 94.97 -12.31 -37.23 92.90 -12.72 coo 29.78 23.31-161.30 31.23 23.66-162.84 -34.83 87.36 -9.28 -34.64 86.91 -7.21 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS B 275 LYS^? 32.38 ZN ZN B 402 A1294 ASN B 273 ASN.? 28.81 ZN ZN A 402 A1297 GLU B 251 GLU~? 27.55 ZN ZN A 402 coo 39.24 18.84-161.99 36.62 21.47-165.99 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 33.53 17.37-161.81 34.31 17.81-163.76 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 29.78 23.31-161.30 31.23 23.66-162.84 -20.38 111.90 11.61 -18.92 112.78 10.34 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS B 275 LYS^? 32.38 ZN ZN B 402 A1294 ASN B 273 ASN.? 28.81 ZN ZN A 402 A1297 GLU B 271 GLU.? 25.84 ZN ZN A 402 coo 39.24 18.84-161.99 36.62 21.47-165.99 -24.21 116.63 19.13 -19.07 117.25 20.30 coo 33.53 17.37-161.81 34.31 17.81-163.76 -19.74 117.99 13.68 -20.11 120.10 13.35 coo 29.78 23.31-161.30 31.23 23.66-162.84 -25.27 121.46 10.97 -24.72 123.08 12.43 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 5 hits 1xpx_d00 naa= 3 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN A 89 GLN~? 28.26 ZN ZN A 402 C 44 LYS A 86 LYS~? 24.82 ZN ZN A 402 C 75 ARG A 85 ARG~? 27.75 ZN ZN A 402 coo 34.33 34.01 1.06 32.24 34.35 1.22 -35.15 142.23 1.94 -34.95 141.76 3.99 coo 36.27 30.15 5.40 32.93 24.83 5.96 -33.51 137.11 0.86 -27.79 135.78 2.74 coo 30.88 29.31 6.12 29.39 29.02 3.47 -38.62 137.12 5.68 -38.61 140.01 6.80 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 2 3 # 2 C 43 GLN B 89 GLN~? 28.26 ZN ZN B 401 C 44 LYS B 86 LYS~? 24.89 ZN ZN B 401 C 75 ARG B 85 ARG~? 27.92 ZN ZN B 401 coo 34.33 34.01 1.06 32.24 34.35 1.22 -54.34 75.28 -1.41 -53.88 75.35 -3.47 coo 36.27 30.15 5.40 32.93 24.83 5.96 -50.53 78.48 -0.34 -44.96 76.41 -1.96 coo 30.88 29.31 6.12 29.39 29.02 3.47 -54.73 81.18 -5.11 -56.41 78.78 -6.16 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 2 hits 2er8_d00 naa= 3 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 1 4 # 1 C 766 SER A 234 SER^? 16.92 ZN ZN A 401 C 769 GLN A 127 GLN^? 13.29 ZN ZN A 401 C 776 TYR A 236 TYR^? 14.83 ZN ZN A 401 C 777 ASN A 104 ASN.? 12.54 ZN ZN A 401 coo 23.61 29.92 45.10 24.50 29.24 47.28 -49.27 115.09 -27.36 -48.74 116.76 -25.71 coo 23.11 26.56 42.17 23.52 25.54 43.99 -49.65 115.70 -21.12 -49.19 117.77 -20.58 coo 27.75 23.53 43.88 30.40 24.12 44.60 -45.72 118.51 -24.14 -44.72 120.68 -25.62 coo 29.40 21.48 39.64 30.54 20.83 41.35 -40.15 119.29 -21.61 -39.88 120.42 -23.44 ULMN 4 2ve9_d00 TRANSPORT PROTEIN user 2 4 # 2 C 766 SER B 234 SER^? 16.76 ZN ZN B 402 C 769 GLN B 127 GLN^? 13.24 ZN ZN B 402 C 776 TYR B 236 TYR^? 14.81 ZN ZN B 402 C 777 ASN B 104 ASN.? 12.46 ZN ZN B 402 coo 23.61 29.92 45.10 24.50 29.24 47.28 -51.96 104.93 28.41 -52.09 103.33 26.64 coo 23.11 26.56 42.17 23.52 25.54 43.99 -52.38 104.73 22.37 -53.11 102.85 21.61 coo 27.75 23.53 43.88 30.40 24.12 44.60 -50.67 100.24 25.02 -50.96 97.90 26.55 coo 29.40 21.48 39.64 30.54 20.83 41.35 -46.36 96.74 22.46 -46.71 95.57 24.21 2ve9_d00 source 2ve9 TRANSPORT PROTEIN : 2 hits 2ve9_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 234 SER^? 16.92 ZN ZN A 401 B 37 ASN A 126 ASN^? 17.03 ZN ZN A 401 B 45 THR A 99 THR~? 6.77 ZN ZN A 401 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -49.27 115.09 -27.36 -48.74 116.76 -25.71 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -48.36 110.95 -24.95 -46.52 110.11 -25.61 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -43.91 119.63 -14.00 -45.67 119.24 -12.83 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 234 SER^? 16.76 ZN ZN B 402 B 37 ASN B 126 ASN^? 17.05 ZN ZN B 402 B 45 THR B 99 THR~? 6.68 ZN ZN B 402 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -51.96 104.93 28.41 -52.09 103.33 26.64 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -49.00 108.11 26.08 -47.01 107.77 26.68 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -49.64 98.60 14.96 -50.95 99.87 13.75 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 4 3cbb_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 69 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 72 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 76 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 77 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 9.42 -0.85 -10.61 7.95 -0.24 -12.03 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.81 -2.90 -13.11 11.72 2.11 -15.49 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 19.33 3.10 -14.10 17.43 4.12 -11.91 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 20.27 2.02 -7.55 17.74 0.41 -6.90 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 4 3cbb_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 69 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 72 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 76 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 77 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 9.42 -0.85 -10.61 7.95 -0.24 -12.03 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 14.81 -2.90 -13.11 11.72 2.11 -15.49 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 19.33 3.10 -14.10 17.43 4.12 -11.91 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 20.27 2.02 -7.55 17.74 0.41 -6.90 -33.35 101.79 -1.64 -34.99 103.61 0.18 ULMN 4 3cbb_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 69 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 72 LYS A 307 LYS~? 10.65 ZN ZN B 401 A 76 ARG A 267 ARG^? 13.45 ZN ZN B 401 A 77 ARG B 267 ARG^? 13.63 ZN ZN A 402 coo 9.42 -0.85 -10.61 7.95 -0.24 -12.03 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.81 -2.90 -13.11 11.72 2.11 -15.49 -40.89 103.09 -0.15 -45.35 106.49 1.62 coo 19.33 3.10 -14.10 17.43 4.12 -11.91 -33.35 101.79 -1.64 -34.99 103.61 0.18 coo 20.27 2.02 -7.55 17.74 0.41 -6.90 -31.38 108.30 2.45 -33.79 107.47 0.72 ULMN 4 3cbb_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 69 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 72 LYS B 307 LYS~? 11.14 ZN ZN A 402 A 76 ARG B 267 ARG^? 13.63 ZN ZN A 402 A 77 ARG A 267 ARG^? 13.45 ZN ZN B 401 coo 9.42 -0.85 -10.61 7.95 -0.24 -12.03 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 14.81 -2.90 -13.11 11.72 2.11 -15.49 -38.53 111.12 1.13 -44.30 110.60 0.01 coo 19.33 3.10 -14.10 17.43 4.12 -11.91 -31.38 108.30 2.45 -33.79 107.47 0.72 coo 20.27 2.02 -7.55 17.74 0.41 -6.90 -33.35 101.79 -1.64 -34.99 103.61 0.18 3cbb_d00 source 3cbb TRANSCRIPTION/DNA : 4 hits 3cbb_d00 naa= 4 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 63 SER^? 10.35 ZN ZN A 402 A 20 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 22 LEU B 312 LEU~? 9.97 ZN ZN A 402 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -36.04 119.44 1.32 -35.12 120.85 -0.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 285 SER.? 7.68 ZN ZN A 402 A 20 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 22 LEU A 43 LEU.? 6.88 ZN ZN A 402 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -41.15 110.37 -7.29 -42.42 110.07 -5.23 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -32.46 120.53 -8.10 -33.63 118.65 -7.87 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 328 SER~? 11.01 ZN ZN A 402 A 20 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 22 LEU B 312 LEU~? 9.97 ZN ZN A 402 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -36.04 119.44 1.32 -35.12 120.85 -0.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER B 63 SER^? 10.37 ZN ZN B 401 A 20 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 22 LEU A 312 LEU~? 9.93 ZN ZN B 401 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -46.04 88.60 10.98 -47.67 89.08 9.23 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -42.97 94.69 -0.33 -43.02 92.95 1.02 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER B 285 SER.? 7.72 ZN ZN B 401 A 20 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 22 LEU B 43 LEU.? 6.82 ZN ZN B 401 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -42.52 104.99 8.17 -43.54 106.03 6.21 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -40.65 91.81 8.75 -40.59 94.01 8.67 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 328 SER~? 10.89 ZN ZN B 401 A 20 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 22 LEU A 312 LEU~? 9.93 ZN ZN B 401 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -42.97 94.69 -0.33 -43.02 92.95 1.02 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 6 hits 3gxq_d00 naa= 3 ULMN 3 3kmp_d00 TRANSCRIPTION REGULATOR/DNA user 1 3 # 1 A 74 ARG B 85 ARG~? 27.92 ZN ZN B 401 A 76 GLN B 89 GLN~? 28.26 ZN ZN B 401 A 81 LYS B 86 LYS~? 24.89 ZN ZN B 401 coo -17.53 -1.82 -11.90 -18.53 0.50 -13.59 -54.73 81.18 -5.11 -56.41 78.78 -6.16 coo -11.64 3.92 -10.28 -12.34 5.87 -10.62 -54.34 75.28 -1.41 -53.88 75.35 -3.47 coo -12.79 -0.17 -12.32 -15.96 3.61 -9.93 -50.53 78.48 -0.34 -44.96 76.41 -1.96 ULMN 3 3kmp_d00 TRANSCRIPTION REGULATOR/DNA user 2 3 # 2 A 74 ARG B 278 ARG^? 23.19 ZN ZN B 402 A 76 GLN B 247 GLN^? 30.66 ZN ZN B 402 A 81 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo -17.53 -1.82 -11.90 -18.53 0.50 -13.59 -33.11 114.47 25.89 -35.97 114.81 26.88 coo -11.64 3.92 -10.28 -12.34 5.87 -10.62 -23.26 114.62 23.41 -22.24 116.39 24.06 coo -12.79 -0.17 -12.32 -15.96 3.61 -9.93 -28.04 112.73 23.24 -26.21 110.17 27.80 3kmp_d00 source 3kmp TRANSCRIPTION REGULATOR/DNA : 2 hits 3kmp_d00 naa= 3 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 81 ARG A 85 ARG~? 27.75 ZN ZN A 402 A 83 GLN A 89 GLN~? 28.26 ZN ZN A 402 A 88 LYS A 86 LYS~? 24.82 ZN ZN A 402 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -38.62 137.12 5.68 -38.61 140.01 6.80 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -35.15 142.23 1.94 -34.95 141.76 3.99 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -33.51 137.11 0.86 -27.79 135.78 2.74 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 81 ARG A 278 ARG^? 22.96 ZN ZN A 401 A 83 GLN A 247 GLN^? 30.51 ZN ZN A 401 A 88 LYS A 277 LYS^? 27.09 ZN ZN A 401 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -38.45 97.22 -24.87 -40.97 98.73 -25.80 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -29.97 91.66 -21.94 -30.44 89.69 -22.53 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -32.97 96.06 -22.32 -30.26 96.48 -27.01 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 81 ARG B 278 ARG^? 23.19 ZN ZN B 402 A 83 GLN B 247 GLN^? 30.66 ZN ZN B 402 A 88 LYS B 277 LYS^? 26.47 ZN ZN B 402 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -33.11 114.47 25.89 -35.97 114.81 26.88 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -23.26 114.62 23.41 -22.24 116.39 24.06 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -28.04 112.73 23.24 -26.21 110.17 27.80 3qsv_d00 source 3qsv TRANSCRIPTION/DNA : 3 hits 3qsv_d00 naa= 3 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 292 GLN~? 17.94 ZN ZN A 401 A 41 TYR A 289 TYR~? 11.74 ZN ZN A 401 A 43 ASN A 125 ASN.? 13.89 ZN ZN A 401 coo 22.03 6.35 12.16 20.71 6.08 10.54 -50.01 102.63 -16.47 -50.74 104.11 -17.85 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -46.60 106.88 -13.53 -48.07 109.27 -13.63 coo 14.90 7.30 8.78 14.25 8.14 6.97 -47.13 108.77 -19.31 -46.75 106.92 -18.35 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN A 296 GLN~? 16.93 ZN ZN A 401 A 41 TYR A 289 TYR~? 11.74 ZN ZN A 401 A 43 ASN A 125 ASN.? 13.89 ZN ZN A 401 coo 22.03 6.35 12.16 20.71 6.08 10.54 -46.68 102.14 -21.54 -46.53 103.91 -20.23 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -46.60 106.88 -13.53 -48.07 109.27 -13.63 coo 14.90 7.30 8.78 14.25 8.14 6.97 -47.13 108.77 -19.31 -46.75 106.92 -18.35 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 21 GLN B 292 GLN~? 17.13 ZN ZN B 402 A 41 TYR B 289 TYR~? 11.74 ZN ZN B 402 A 43 ASN B 125 ASN.? 13.83 ZN ZN B 402 coo 22.03 6.35 12.16 20.71 6.08 10.54 -45.46 115.49 18.78 -47.34 114.68 18.22 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -45.28 110.80 14.60 -47.79 109.56 14.66 coo 14.90 7.30 8.78 14.25 8.14 6.97 -46.89 109.38 20.39 -45.54 110.71 19.40 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 21 GLN B 296 GLN~? 16.90 ZN ZN B 402 A 41 TYR B 289 TYR~? 11.74 ZN ZN B 402 A 43 ASN B 125 ASN.? 13.83 ZN ZN B 402 coo 22.03 6.35 12.16 20.71 6.08 10.54 -42.88 114.74 22.57 -43.68 113.24 21.18 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -45.28 110.80 14.60 -47.79 109.56 14.66 coo 14.90 7.30 8.78 14.25 8.14 6.97 -46.89 109.38 20.39 -45.54 110.71 19.40 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 4 hits 3ssc_d00 naa= 3 ULMN 3 3uby_d00 HYDROLASE/DNA user 1 3 # 1 A 162 TYR A 132 TYR^? 30.56 ZN ZN A 401 A 164 MET A 201 MET^? 29.33 ZN ZN A 401 A 165 TYR A 131 TYR^? 29.63 ZN ZN A 401 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 -62.09 122.49 -32.07 -63.03 122.42 -29.44 coo 15.31 0.97 33.48 17.04 -1.81 36.11 -57.11 122.98 -38.47 -53.56 121.40 -36.82 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 -56.56 119.62 -34.10 -57.10 118.87 -36.76 ULMN 3 3uby_d00 HYDROLASE/DNA user 2 3 # 2 A 162 TYR B 132 TYR^? 30.83 ZN ZN B 402 A 164 MET B 201 MET^? 32.30 ZN ZN B 402 A 165 TYR B 131 TYR^? 25.51 ZN ZN B 402 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 -67.13 105.92 32.85 -67.85 106.57 30.23 coo 15.31 0.97 33.48 17.04 -1.81 36.11 -63.06 103.01 38.96 -61.35 105.81 39.05 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 -60.00 104.47 33.20 -57.62 103.10 32.62 3uby_d00 source 3uby HYDROLASE/DNA : 2 hits 3uby_d00 naa= 3 ULMN 4 1e3w_o00 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 1 4 # 1 A 41 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 64 ASN A 359 ASN.? 14.84 ZN ZN A 402 A 168 TYR A 58 TYR.? 23.12 ZN ZN A 401 A 172 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 29.31 2.47 30.64 27.42 3.34 30.67 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 28.76 0.05 39.20 27.05 1.09 39.77 -24.17 118.80 -3.45 -25.14 116.90 -3.22 coo 18.34 15.14 38.14 19.89 15.29 35.79 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 23.68 18.08 40.55 24.55 14.70 36.44 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 4 1e3w_o00 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 2 4 # 2 A 41 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 64 ASN B 359 ASN.? 14.74 ZN ZN B 401 A 168 TYR B 58 TYR.? 23.40 ZN ZN B 402 A 172 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 29.31 2.47 30.64 27.42 3.34 30.67 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 28.76 0.05 39.20 27.05 1.09 39.77 -32.68 88.91 3.99 -32.53 91.05 3.94 coo 18.34 15.14 38.14 19.89 15.29 35.79 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 23.68 18.08 40.55 24.55 14.70 36.44 -40.15 73.23 9.47 -36.32 78.07 10.66 1e3w_o00 source 1E3W SHORT CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE : 2 hits 1e3w_o00 naa= 4 ULMN 4 1e3w_o01 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 1 4 # 1 B 41 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 64 ASN A 359 ASN.? 14.84 ZN ZN A 402 B 168 TYR A 58 TYR.? 23.12 ZN ZN A 401 B 172 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 19.32 16.82 68.75 21.27 17.38 68.21 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 19.81 9.29 63.74 21.59 9.79 62.74 -24.17 118.80 -3.45 -25.14 116.90 -3.22 coo 30.76 21.17 55.02 29.25 22.88 56.57 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 25.62 21.96 51.22 24.55 22.11 56.49 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 4 1e3w_o01 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 2 4 # 2 B 41 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 64 ASN B 359 ASN.? 14.74 ZN ZN B 401 B 168 TYR B 58 TYR.? 23.40 ZN ZN B 402 B 172 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 19.32 16.82 68.75 21.27 17.38 68.21 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 19.81 9.29 63.74 21.59 9.79 62.74 -32.68 88.91 3.99 -32.53 91.05 3.94 coo 30.76 21.17 55.02 29.25 22.88 56.57 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 25.62 21.96 51.22 24.55 22.11 56.49 -40.15 73.23 9.47 -36.32 78.07 10.66 1e3w_o01 source 1E3W SHORT CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE : 2 hits 1e3w_o01 naa= 4 ULMN 4 1e3w_o02 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 1 4 # 1 C 41 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 64 ASN A 359 ASN.? 14.84 ZN ZN A 402 C 168 TYR A 58 TYR.? 23.12 ZN ZN A 401 C 172 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 40.69 50.52 19.33 41.33 50.42 21.37 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.72 56.95 21.18 34.76 56.91 23.30 -24.17 118.80 -3.45 -25.14 116.90 -3.22 coo 35.94 47.42 36.81 37.06 45.66 35.01 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 30.46 44.57 34.70 34.50 45.03 31.11 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 4 1e3w_o02 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 2 4 # 2 C 41 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 64 ASN B 359 ASN.? 14.74 ZN ZN B 401 C 168 TYR B 58 TYR.? 23.40 ZN ZN B 402 C 172 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 40.69 50.52 19.33 41.33 50.42 21.37 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.72 56.95 21.18 34.76 56.91 23.30 -32.68 88.91 3.99 -32.53 91.05 3.94 coo 35.94 47.42 36.81 37.06 45.66 35.01 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 30.46 44.57 34.70 34.50 45.03 31.11 -40.15 73.23 9.47 -36.32 78.07 10.66 1e3w_o02 source 1E3W SHORT CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE : 2 hits 1e3w_o02 naa= 4 ULMN 4 1e3w_o03 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 1 4 # 1 D 41 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 64 ASN A 359 ASN.? 14.84 ZN ZN A 402 D 168 TYR A 58 TYR.? 23.12 ZN ZN A 401 D 172 LYS A 56 LYS~? 22.91 ZN ZN A 402 coo 9.77 60.85 45.83 9.14 59.48 44.33 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 15.92 64.33 40.44 15.87 63.01 38.79 -24.17 118.80 -3.45 -25.14 116.90 -3.22 coo 14.20 46.99 34.69 13.14 46.88 37.21 -25.94 134.94 -12.27 -23.89 133.93 -13.91 coo 19.65 46.02 38.25 15.67 48.80 40.68 -22.18 135.65 -9.28 -21.07 130.49 -8.67 ULMN 4 1e3w_o03 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 2 4 # 2 D 41 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 64 ASN B 359 ASN.? 14.74 ZN ZN B 401 D 168 TYR B 58 TYR.? 23.40 ZN ZN B 402 D 172 LYS B 56 LYS~? 22.19 ZN ZN B 401 coo 9.77 60.85 45.83 9.14 59.48 44.33 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 15.92 64.33 40.44 15.87 63.01 38.79 -32.68 88.91 3.99 -32.53 91.05 3.94 coo 14.20 46.99 34.69 13.14 46.88 37.21 -42.81 75.85 12.88 -40.52 75.44 14.46 coo 19.65 46.02 38.25 15.67 48.80 40.68 -40.15 73.23 9.47 -36.32 78.07 10.66 1e3w_o03 source 1E3W SHORT CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE : 2 hits 1e3w_o03 naa= 4 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 12 HIS~? 21.70 ZN ZN A 401 A 208 ASP A 203 ASP.? 24.56 ZN ZN A 401 A 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo 18.47 29.19 29.68 19.30 29.17 27.75 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 208 ASP A 5 ASP~? 27.21 ZN ZN A 401 A 296 SER A 21 SER.? 15.75 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 18.47 29.19 29.68 19.30 29.17 27.75 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 6.89 17.22 46.63 5.08 16.21 47.91 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS A 13 HIS~? 19.28 ZN ZN A 401 A 208 ASP A 5 ASP~? 27.21 ZN ZN A 401 A 296 SER A 356 SER.? 15.95 ZN ZN A 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo 18.47 29.19 29.68 19.30 29.17 27.75 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo 6.89 17.22 46.63 5.08 16.21 47.91 -25.62 125.96 -9.58 -26.36 125.95 -7.28 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 208 ASP A 11 ASP~? 18.10 ZN ZN A 401 A 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 208 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 296 SER A 265 SER.? 18.83 ZN ZN A 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 6.89 17.22 46.63 5.08 16.21 47.91 -26.26 104.74 -2.86 -27.40 103.51 -1.11 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 296 SER B 259 SER~? 23.06 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.47 29.19 29.68 19.30 29.17 27.75 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.89 17.22 46.63 5.08 16.21 47.91 -23.46 98.59 12.15 -21.45 97.88 13.30 ULMN 3 2odj_o00 PORIN D user 8 3 # 8 A 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 208 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 296 SER B 259 SER~? 23.06 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.47 29.19 29.68 19.30 29.17 27.75 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 6.89 17.22 46.63 5.08 16.21 47.91 -23.46 98.59 12.15 -21.45 97.88 13.30 ULMN 3 2odj_o00 PORIN D user 9 3 # 9 A 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 208 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -45.80 98.45 2.85 -45.82 97.45 4.71 coo 18.47 29.19 29.68 19.30 29.17 27.75 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 6.89 17.22 46.63 5.08 16.21 47.91 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o00 PORIN D user 10 3 # 10 A 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 208 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o00 PORIN D user 11 3 # 11 A 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 208 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o00 PORIN D user 12 3 # 12 A 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.89 17.22 46.63 5.08 16.21 47.91 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o00 PORIN D user 13 3 # 13 A 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 208 ASP B 313 ASP~? 12.28 ZN ZN A 402 A 296 SER B 328 SER~? 10.89 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -39.61 120.08 5.22 -40.78 120.61 3.53 coo 6.89 17.22 46.63 5.08 16.21 47.91 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 2odj_o00 PORIN D user 14 3 # 14 A 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 208 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 6.89 17.22 46.63 5.08 16.21 47.91 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o00 PORIN D user 15 3 # 15 A 156 HIS B 12 HIS~? 21.73 ZN ZN B 402 A 208 ASP B 203 ASP^? 26.15 ZN ZN B 402 A 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -52.58 88.71 29.10 -52.20 89.31 31.07 coo 18.47 29.19 29.68 19.30 29.17 27.75 -62.37 99.36 31.88 -60.64 98.73 32.96 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.61 105.40 27.34 -40.83 107.01 28.62 ULMN 3 2odj_o00 PORIN D user 16 3 # 16 A 156 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 208 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 296 SER B 21 SER.? 15.71 ZN ZN B 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 18.47 29.19 29.68 19.30 29.17 27.75 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 6.89 17.22 46.63 5.08 16.21 47.91 -58.60 101.69 13.65 -59.34 103.93 13.19 ULMN 3 2odj_o00 PORIN D user 17 3 # 17 A 156 HIS B 13 HIS~? 19.30 ZN ZN B 402 A 208 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 296 SER B 356 SER.? 15.96 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -48.35 88.91 27.28 -48.07 87.61 28.91 coo 18.47 29.19 29.68 19.30 29.17 27.75 -55.09 78.54 23.42 -56.64 77.16 23.83 coo 6.89 17.22 46.63 5.08 16.21 47.91 -37.69 83.51 10.20 -38.30 83.95 7.88 ULMN 3 2odj_o00 PORIN D user 18 3 # 18 A 156 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 208 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 296 SER B 265 SER.? 18.70 ZN ZN B 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.47 29.19 29.68 19.30 29.17 27.75 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 6.89 17.22 46.63 5.08 16.21 47.91 -26.94 101.98 3.65 -27.40 103.69 1.94 ULMN 3 2odj_o00 PORIN D user 19 3 # 19 A 156 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 208 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.47 29.19 29.68 19.30 29.17 27.75 -55.43 89.37 22.82 -56.66 91.02 23.20 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.61 105.40 27.34 -40.83 107.01 28.62 ULMN 3 2odj_o00 PORIN D user 20 3 # 20 A 156 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 18.47 29.19 29.68 19.30 29.17 27.75 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.61 105.40 27.34 -40.83 107.01 28.62 ULMN 3 2odj_o00 PORIN D user 21 3 # 21 A 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 208 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 296 SER A 259 SER~? 22.94 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 6.89 17.22 46.63 5.08 16.21 47.91 -21.63 105.68 -11.35 -19.60 105.39 -12.58 ULMN 3 2odj_o00 PORIN D user 22 3 # 22 A 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 208 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 6.89 17.22 46.63 5.08 16.21 47.91 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o00 PORIN D user 23 3 # 23 A 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 296 SER A 259 SER~? 22.94 ZN ZN A 401 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 6.89 17.22 46.63 5.08 16.21 47.91 -21.63 105.68 -11.35 -19.60 105.39 -12.58 ULMN 3 2odj_o00 PORIN D user 24 3 # 24 A 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 18.47 29.19 29.68 19.30 29.17 27.75 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 6.89 17.22 46.63 5.08 16.21 47.91 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o00 PORIN D user 25 3 # 25 A 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 208 ASP A 313 ASP~? 12.18 ZN ZN B 401 A 296 SER A 328 SER~? 11.01 ZN ZN A 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 18.47 29.19 29.68 19.30 29.17 27.75 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo 6.89 17.22 46.63 5.08 16.21 47.91 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 2odj_o00 PORIN D user 26 3 # 26 A 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 208 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 18.47 29.19 29.68 19.30 29.17 27.75 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 6.89 17.22 46.63 5.08 16.21 47.91 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o00 PORIN D user 27 3 # 27 A 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 208 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 18.47 29.19 29.68 19.30 29.17 27.75 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.61 105.40 27.34 -40.83 107.01 28.62 ULMN 3 2odj_o00 PORIN D user 28 3 # 28 A 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 208 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo 12.72 17.48 24.71 12.80 19.37 23.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 18.47 29.19 29.68 19.30 29.17 27.75 -40.42 114.63 4.44 -42.44 114.56 3.83 coo 6.89 17.22 46.63 5.08 16.21 47.91 -39.61 105.40 27.34 -40.83 107.01 28.62 2odj_o00 source 2ODJ PORIN D : 28 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 12 HIS~? 21.70 ZN ZN A 401 B 208 ASP A 203 ASP.? 24.56 ZN ZN A 401 B 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -41.32 129.27 -28.34 -41.29 128.49 -30.29 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -54.58 125.94 -31.48 -53.46 125.13 -29.87 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 13 HIS~? 19.28 ZN ZN A 401 B 208 ASP A 5 ASP~? 27.21 ZN ZN A 401 B 296 SER A 21 SER.? 15.75 ZN ZN A 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -37.83 126.93 -26.50 -37.00 127.82 -28.21 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 208 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 296 SER A 265 SER.? 18.83 ZN ZN A 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -26.26 104.74 -2.86 -27.40 103.51 -1.11 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 296 SER B 259 SER~? 23.06 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -23.46 98.59 12.15 -21.45 97.88 13.30 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 208 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 296 SER B 259 SER~? 23.06 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -23.46 98.59 12.15 -21.45 97.88 13.30 ULMN 3 2odj_o01 PORIN D user 7 3 # 7 B 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 208 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 296 SER B 259 SER~? 23.06 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -23.46 98.59 12.15 -21.45 97.88 13.30 ULMN 3 2odj_o01 PORIN D user 8 3 # 8 B 156 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 208 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o01 PORIN D user 9 3 # 9 B 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 208 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o01 PORIN D user 10 3 # 10 B 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 208 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 296 SER A 122 SER^? 18.54 ZN ZN A 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -39.13 108.46 -26.41 -40.41 106.51 -26.99 ULMN 3 2odj_o01 PORIN D user 11 3 # 11 B 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o01 PORIN D user 12 3 # 12 B 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o01 PORIN D user 13 3 # 13 B 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 208 ASP B 313 ASP~? 12.28 ZN ZN A 402 B 296 SER B 328 SER~? 10.89 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -39.61 120.08 5.22 -40.78 120.61 3.53 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 2odj_o01 PORIN D user 14 3 # 14 B 156 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 208 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o01 PORIN D user 15 3 # 15 B 156 HIS B 12 HIS~? 21.73 ZN ZN B 402 B 208 ASP B 203 ASP^? 26.15 ZN ZN B 402 B 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -52.58 88.71 29.10 -52.20 89.31 31.07 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -62.37 99.36 31.88 -60.64 98.73 32.96 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -39.61 105.40 27.34 -40.83 107.01 28.62 ULMN 3 2odj_o01 PORIN D user 16 3 # 16 B 156 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 208 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 296 SER B 265 SER.? 18.70 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -26.94 101.98 3.65 -27.40 103.69 1.94 ULMN 3 2odj_o01 PORIN D user 17 3 # 17 B 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 208 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 296 SER A 259 SER~? 22.94 ZN ZN A 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -21.63 105.68 -11.35 -19.60 105.39 -12.58 ULMN 3 2odj_o01 PORIN D user 18 3 # 18 B 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 208 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o01 PORIN D user 19 3 # 19 B 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 296 SER A 259 SER~? 22.94 ZN ZN A 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -21.63 105.68 -11.35 -19.60 105.39 -12.58 ULMN 3 2odj_o01 PORIN D user 20 3 # 20 B 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 208 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o01 PORIN D user 21 3 # 21 B 156 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 208 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 296 SER A 259 SER~? 22.94 ZN ZN A 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -21.63 105.68 -11.35 -19.60 105.39 -12.58 ULMN 3 2odj_o01 PORIN D user 22 3 # 22 B 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 296 SER A 272 SER.? 25.47 ZN ZN B 401 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -29.78 90.76 -9.64 -28.14 89.32 -8.60 ULMN 3 2odj_o01 PORIN D user 23 3 # 23 B 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 208 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o01 PORIN D user 24 3 # 24 B 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 208 ASP A 313 ASP~? 12.18 ZN ZN B 401 B 296 SER A 328 SER~? 11.01 ZN ZN A 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -46.65 96.06 -4.18 -47.89 96.35 -2.43 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 2odj_o01 PORIN D user 25 3 # 25 B 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 208 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 296 SER B 272 SER.? 25.31 ZN ZN A 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -22.66 115.72 10.55 -20.64 116.23 9.28 ULMN 3 2odj_o01 PORIN D user 26 3 # 26 B 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 208 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -39.61 105.40 27.34 -40.83 107.01 28.62 ULMN 3 2odj_o01 PORIN D user 27 3 # 27 B 156 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 208 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 296 SER B 122 SER^? 18.54 ZN ZN B 402 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -40.92 100.43 6.30 -42.93 100.06 6.77 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -39.61 105.40 27.34 -40.83 107.01 28.62 2odj_o01 source 2ODJ PORIN D : 27 hits 2odj_o01 naa= 3 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 A 75 SER A 328 SER~? 11.01 ZN ZN A 402 A 138 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 165 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -3.36 14.75 15.05 -1.15 14.48 16.07 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 A 75 SER B 328 SER~? 10.89 ZN ZN B 401 A 138 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 165 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -3.36 14.75 15.05 -1.15 14.48 16.07 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -40.92 100.43 6.30 -42.93 100.06 6.77 2qs9_o00 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 2 hits 2qs9_o00 naa= 3 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 B 75 SER A 328 SER~? 11.01 ZN ZN A 402 B 138 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 165 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 6.59 48.30 3.28 6.43 48.98 5.63 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 13.13 55.06 6.15 11.38 53.90 6.43 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.83 53.78 5.96 7.73 51.68 6.00 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 B 75 SER B 328 SER~? 10.89 ZN ZN B 401 B 138 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 165 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 6.59 48.30 3.28 6.43 48.98 5.63 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 13.13 55.06 6.15 11.38 53.90 6.43 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.83 53.78 5.96 7.73 51.68 6.00 -40.92 100.43 6.30 -42.93 100.06 6.77 2qs9_o01 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 2 hits 2qs9_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 259 SER~? 22.94 ZN ZN A 401 A 166 PHE A 253 PHE~? 19.21 ZN ZN A 401 A 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -21.63 105.68 -11.35 -19.60 105.39 -12.58 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -31.28 96.31 -7.83 -29.38 94.26 -7.46 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 265 SER.? 18.83 ZN ZN A 402 A 166 PHE A 268 PHE^? 21.77 ZN ZN B 401 A 182 PHE A 253 PHE~? 19.21 ZN ZN A 401 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -29.44 99.49 -16.08 -30.76 101.88 -16.92 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 265 SER.? 18.83 ZN ZN A 402 A 166 PHE A 363 PHE.? 13.25 ZN ZN A 402 A 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -31.41 111.93 2.28 -34.10 111.18 2.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER B 259 SER~? 23.06 ZN ZN B 401 A 166 PHE B 253 PHE~? 19.22 ZN ZN B 402 A 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -23.46 98.59 12.15 -21.45 97.88 13.30 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -26.85 108.02 16.99 -29.11 106.57 17.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER B 265 SER.? 18.70 ZN ZN B 401 A 166 PHE B 268 PHE^? 21.91 ZN ZN A 402 A 182 PHE B 253 PHE~? 19.22 ZN ZN B 402 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -26.85 108.02 16.99 -29.11 106.57 17.79 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 265 SER.? 18.70 ZN ZN B 401 A 166 PHE B 363 PHE^? 13.11 ZN ZN B 401 A 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -31.28 96.31 -7.83 -29.38 94.26 -7.46 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 259 SER~? 22.94 ZN ZN A 401 B 166 PHE A 253 PHE~? 19.21 ZN ZN A 401 B 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -21.63 105.68 -11.35 -19.60 105.39 -12.58 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -31.28 96.31 -7.83 -29.38 94.26 -7.46 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 265 SER.? 18.83 ZN ZN A 402 B 166 PHE A 268 PHE^? 21.77 ZN ZN B 401 B 182 PHE A 253 PHE~? 19.21 ZN ZN A 401 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -29.44 99.49 -16.08 -30.76 101.88 -16.92 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 265 SER.? 18.83 ZN ZN A 402 B 166 PHE A 363 PHE.? 13.25 ZN ZN A 402 B 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -31.41 111.93 2.28 -34.10 111.18 2.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER B 259 SER~? 23.06 ZN ZN B 401 B 166 PHE B 253 PHE~? 19.22 ZN ZN B 402 B 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -23.46 98.59 12.15 -21.45 97.88 13.30 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -26.85 108.02 16.99 -29.11 106.57 17.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER B 265 SER.? 18.70 ZN ZN B 401 B 166 PHE B 268 PHE^? 21.91 ZN ZN A 402 B 182 PHE B 253 PHE~? 19.22 ZN ZN B 402 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -26.85 108.02 16.99 -29.11 106.57 17.79 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER B 265 SER.? 18.70 ZN ZN B 401 B 166 PHE B 363 PHE^? 13.11 ZN ZN B 401 B 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -31.28 96.31 -7.83 -29.38 94.26 -7.46 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 259 SER~? 22.94 ZN ZN A 401 C 166 PHE A 253 PHE~? 19.21 ZN ZN A 401 C 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -21.63 105.68 -11.35 -19.60 105.39 -12.58 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -31.28 96.31 -7.83 -29.38 94.26 -7.46 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 265 SER.? 18.83 ZN ZN A 402 C 166 PHE A 268 PHE^? 21.77 ZN ZN B 401 C 182 PHE A 253 PHE~? 19.21 ZN ZN A 401 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -29.44 99.49 -16.08 -30.76 101.88 -16.92 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 265 SER.? 18.83 ZN ZN A 402 C 166 PHE A 363 PHE.? 13.25 ZN ZN A 402 C 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -31.41 111.93 2.28 -34.10 111.18 2.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER B 259 SER~? 23.06 ZN ZN B 401 C 166 PHE B 253 PHE~? 19.22 ZN ZN B 402 C 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -23.46 98.59 12.15 -21.45 97.88 13.30 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -26.85 108.02 16.99 -29.11 106.57 17.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER B 265 SER.? 18.70 ZN ZN B 401 C 166 PHE B 268 PHE^? 21.91 ZN ZN A 402 C 182 PHE B 253 PHE~? 19.22 ZN ZN B 402 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -26.85 108.02 16.99 -29.11 106.57 17.79 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER B 265 SER.? 18.70 ZN ZN B 401 C 166 PHE B 363 PHE^? 13.11 ZN ZN B 401 C 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -31.28 96.31 -7.83 -29.38 94.26 -7.46 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 259 SER~? 22.94 ZN ZN A 401 D 166 PHE A 253 PHE~? 19.21 ZN ZN A 401 D 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -21.63 105.68 -11.35 -19.60 105.39 -12.58 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -29.44 99.49 -16.08 -30.76 101.88 -16.92 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -31.28 96.31 -7.83 -29.38 94.26 -7.46 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 265 SER.? 18.83 ZN ZN A 402 D 166 PHE A 268 PHE^? 21.77 ZN ZN B 401 D 182 PHE A 253 PHE~? 19.21 ZN ZN A 401 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -31.28 96.31 -7.83 -29.38 94.26 -7.46 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -29.44 99.49 -16.08 -30.76 101.88 -16.92 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 265 SER.? 18.83 ZN ZN A 402 D 166 PHE A 363 PHE.? 13.25 ZN ZN A 402 D 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -26.26 104.74 -2.86 -27.40 103.51 -1.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -31.41 111.93 2.28 -34.10 111.18 2.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER B 259 SER~? 23.06 ZN ZN B 401 D 166 PHE B 253 PHE~? 19.22 ZN ZN B 402 D 182 PHE B 268 PHE^? 21.91 ZN ZN A 402 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -23.46 98.59 12.15 -21.45 97.88 13.30 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -26.85 108.02 16.99 -29.11 106.57 17.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -26.71 111.70 8.71 -24.07 112.53 8.31 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER B 265 SER.? 18.70 ZN ZN B 401 D 166 PHE B 268 PHE^? 21.91 ZN ZN A 402 D 182 PHE B 253 PHE~? 19.22 ZN ZN B 402 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -26.71 111.70 8.71 -24.07 112.53 8.31 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -26.85 108.02 16.99 -29.11 106.57 17.79 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER B 265 SER.? 18.70 ZN ZN B 401 D 166 PHE B 363 PHE^? 13.11 ZN ZN B 401 D 182 PHE A 268 PHE^? 21.77 ZN ZN B 401 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -26.94 101.98 3.65 -27.40 103.69 1.94 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -35.37 98.65 -1.40 -37.23 100.69 -1.90 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -31.28 96.31 -7.83 -29.38 94.26 -7.46 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o03 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 86 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP A 91 ASP.? 28.84 ZN ZN A 402 A 86 HIS A 90 HIS~? 26.77 ZN ZN A 402 A 250 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 86 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP A 361 ASP.? 11.77 ZN ZN A 402 A 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 A 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 A 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 A 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 86 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 A 49 ASP B 91 ASP.? 28.82 ZN ZN B 401 A 86 HIS B 90 HIS~? 26.84 ZN ZN B 401 A 250 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 A 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 86 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 A 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 A 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 A 49 ASP B 361 ASP.? 11.71 ZN ZN B 401 A 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -41.15 97.96 -3.49 -39.81 98.24 -2.76 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 86 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP A 91 ASP.? 28.84 ZN ZN A 402 B 86 HIS A 90 HIS~? 26.77 ZN ZN A 402 B 250 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 B 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 86 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 B 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 B 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 B 49 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 B 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 B 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 B 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 86 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 B 49 ASP B 91 ASP.? 28.82 ZN ZN B 401 B 86 HIS B 90 HIS~? 26.84 ZN ZN B 401 B 250 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 B 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 86 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 B 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 B 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 B 49 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -41.15 97.96 -3.49 -39.81 98.24 -2.76 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 86 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 C 49 ASP A 91 ASP.? 28.84 ZN ZN A 402 C 86 HIS A 90 HIS~? 26.77 ZN ZN A 402 C 250 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 C 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 86 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 C 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 C 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 C 49 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 C 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 C 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 C 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 86 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 C 49 ASP B 91 ASP.? 28.82 ZN ZN B 401 C 86 HIS B 90 HIS~? 26.84 ZN ZN B 401 C 250 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 C 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 86 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 C 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 C 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 C 49 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -41.15 97.96 -3.49 -39.81 98.24 -2.76 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 D 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 86 HIS A 65 HIS.? -3.39 ZN ZN A 402s D 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP A 91 ASP.? 28.84 ZN ZN A 402 D 86 HIS A 90 HIS~? 26.77 ZN ZN A 402 D 250 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 D 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 86 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 D 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s D 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 D 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 D 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 D 49 ASP A 361 ASP.? 11.77 ZN ZN A 402 D 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 D 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 D 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 D 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 D 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 D 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 86 HIS B 65 HIS.? -3.43 ZN ZN B 401s D 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -45.27 94.95 7.47 -43.74 96.36 7.67 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 D 49 ASP B 91 ASP.? 28.82 ZN ZN B 401 D 86 HIS B 90 HIS~? 26.84 ZN ZN B 401 D 250 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -53.83 73.30 7.14 -55.54 72.50 6.14 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -49.12 73.85 2.19 -48.21 73.06 0.48 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 D 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 86 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 D 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s D 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 D 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 D 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 D 49 ASP B 361 ASP.? 11.71 ZN ZN B 401 D 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 D 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -41.15 97.96 -3.49 -39.81 98.24 -2.76 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 E 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 86 HIS A 65 HIS.? -3.39 ZN ZN A 402s E 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP A 91 ASP.? 28.84 ZN ZN A 402 E 86 HIS A 90 HIS~? 26.77 ZN ZN A 402 E 250 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 E 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 86 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 E 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s E 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 E 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 E 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 E 49 ASP A 361 ASP.? 11.77 ZN ZN A 402 E 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 E 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 E 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 E 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 E 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 E 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 86 HIS B 65 HIS.? -3.43 ZN ZN B 401s E 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 E 49 ASP B 91 ASP.? 28.82 ZN ZN B 401 E 86 HIS B 90 HIS~? 26.84 ZN ZN B 401 E 250 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 E 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 86 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 E 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s E 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 E 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 E 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 E 49 ASP B 361 ASP.? 11.71 ZN ZN B 401 E 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 E 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -41.15 97.96 -3.49 -39.81 98.24 -2.76 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 23 ASP.? 8.14 ZN ZN A 401 F 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 86 HIS A 65 HIS.? -3.39 ZN ZN A 402s F 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 F 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP A 91 ASP.? 28.84 ZN ZN A 402 F 86 HIS A 90 HIS~? 26.77 ZN ZN A 402 F 250 ALA A 53 ALA~? 20.65 ZN ZN A 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -33.63 143.19 -6.63 -34.37 144.83 -5.55 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -30.00 140.26 -1.63 -28.87 140.48 0.12 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -26.69 133.97 -7.40 -28.24 134.00 -7.47 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 F 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s F 86 HIS A 64 HIS.? -3.42 ZN ZN A 401s F 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 F 49 ASP A 102 ASP~? -1.98 ZN ZN A 401s F 86 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 250 ALA A 96 ALA^? 10.78 ZN ZN A 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -40.12 127.57 -11.44 -41.05 127.23 -10.25 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 F 49 ASP A 305 ASP.? 7.62 ZN ZN A 402 F 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 F 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 F 49 ASP A 361 ASP.? 11.77 ZN ZN A 402 F 86 HIS B 308 HIS~? 6.54 ZN ZN A 402 F 250 ALA B 311 ALA~? 12.53 ZN ZN A 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -35.94 115.65 4.45 -34.97 114.68 3.72 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 F 49 ASP B 23 ASP.? 8.15 ZN ZN B 402 F 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 F 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 F 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 F 49 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 86 HIS B 65 HIS.? -3.43 ZN ZN B 401s F 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 F 49 ASP B 91 ASP.? 28.82 ZN ZN B 401 F 86 HIS B 90 HIS~? 26.84 ZN ZN B 401 F 250 ALA B 53 ALA~? 20.77 ZN ZN B 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -53.83 73.30 7.14 -55.54 72.50 6.14 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -49.12 73.85 2.19 -48.21 73.06 0.48 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -42.94 77.21 7.81 -44.21 78.04 8.00 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 F 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s F 86 HIS B 64 HIS.? -3.45 ZN ZN B 402s F 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 F 49 ASP B 102 ASP~? -1.99 ZN ZN B 402s F 86 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 250 ALA B 96 ALA^? 10.72 ZN ZN B 402 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -50.76 89.87 12.12 -51.42 90.77 11.02 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 F 49 ASP B 305 ASP.? 7.64 ZN ZN B 401 F 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 F 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -41.15 97.96 -3.49 -39.81 98.24 -2.76 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 F 49 ASP B 361 ASP.? 11.71 ZN ZN B 401 F 86 HIS A 308 HIS~? 6.49 ZN ZN B 401 F 250 ALA A 311 ALA~? 12.40 ZN ZN B 401 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -41.15 97.96 -3.49 -39.81 98.24 -2.76 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o05 naa= 3 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 1 3 # 1 A 89 SER A 63 SER^? 10.35 ZN ZN A 402 A 216 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 243 HIS A 64 HIS.? -3.42 ZN ZN A 401s coo 11.52 10.39 18.97 12.10 9.11 20.95 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 20.60 4.89 19.19 18.56 4.62 19.55 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo 16.75 7.77 21.42 14.85 7.46 20.58 -37.47 120.38 -11.48 -38.85 119.05 -12.30 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 2 3 # 2 A 89 SER A 328 SER~? 11.01 ZN ZN A 402 A 216 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 243 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 11.52 10.39 18.97 12.10 9.11 20.95 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 20.60 4.89 19.19 18.56 4.62 19.55 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 16.75 7.77 21.42 14.85 7.46 20.58 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 3 3 # 3 A 89 SER B 63 SER^? 10.37 ZN ZN B 401 A 216 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 243 HIS B 64 HIS.? -3.45 ZN ZN B 402s coo 11.52 10.39 18.97 12.10 9.11 20.95 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 20.60 4.89 19.19 18.56 4.62 19.55 -46.20 100.05 15.92 -45.42 99.37 14.07 coo 16.75 7.77 21.42 14.85 7.46 20.58 -44.69 94.49 12.33 -45.14 96.36 13.15 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 4 3 # 4 A 89 SER B 328 SER~? 10.89 ZN ZN B 401 A 216 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 243 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 11.52 10.39 18.97 12.10 9.11 20.95 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 20.60 4.89 19.19 18.56 4.62 19.55 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 16.75 7.77 21.42 14.85 7.46 20.58 -40.92 100.43 6.30 -42.93 100.06 6.77 2xmz_o00 source 2XMZ HYDROLASE, ALPHA/BETA HYDROLASE FOLD FAMILY : 4 hits 2xmz_o00 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 32 GLU.? 25.81 ZN ZN A 401 A 44 ASP A 5 ASP~? 27.21 ZN ZN A 401 A 50 THR A 8 THR~? 23.36 ZN ZN A 401 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -42.13 134.27 -23.06 -42.94 135.85 -24.33 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 290 GLU~? 16.18 ZN ZN A 402 A 44 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 50 THR A 303 THR^? 9.94 ZN ZN A 402 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 44 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 50 THR A 303 THR^? 9.94 ZN ZN A 402 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU A 329 GLU~? 2.55 ZN ZN A 401s A 44 ASP A 323 ASP^? 12.30 ZN ZN A 402 A 50 THR A 303 THR^? 9.94 ZN ZN A 402 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU A 347 GLU~? 25.70 ZN ZN A 401 A 44 ASP A 5 ASP~? 27.21 ZN ZN A 401 A 50 THR A 8 THR~? 23.36 ZN ZN A 401 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -34.82 134.94 -29.37 -35.77 133.46 -30.53 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -38.08 139.21 -22.86 -38.80 141.16 -23.24 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -42.13 134.27 -23.06 -42.94 135.85 -24.33 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU B 32 GLU.? 22.53 ZN ZN B 402 A 44 ASP B 5 ASP~? 27.35 ZN ZN B 402 A 50 THR B 8 THR~? 23.37 ZN ZN B 402 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -60.68 81.34 15.57 -59.87 82.93 16.69 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -55.09 78.54 23.42 -56.64 77.16 23.83 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -55.91 85.05 23.85 -57.36 84.03 25.10 ULMN 3 3hde_o00 LYSOZYME user 7 3 # 7 A 35 GLU B 32 GLU.? 22.53 ZN ZN B 402 A 44 ASP B 11 ASP~? 18.05 ZN ZN B 402 A 50 THR B 8 THR~? 23.37 ZN ZN B 402 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -60.68 81.34 15.57 -59.87 82.93 16.69 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -55.91 85.05 23.85 -57.36 84.03 25.10 ULMN 3 3hde_o00 LYSOZYME user 8 3 # 8 A 35 GLU B 199 GLU^? 40.09 ZN ZN B 402 A 44 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 50 THR B 136 THR^? 43.30 ZN ZN B 402 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -65.13 107.83 45.37 -64.79 109.92 45.13 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -73.17 106.15 44.31 -73.94 104.19 43.69 ULMN 3 3hde_o00 LYSOZYME user 9 3 # 9 A 35 GLU B 211 GLU~? 39.18 ZN ZN B 402 A 44 ASP B 226 ASP^? 42.35 ZN ZN B 402 A 50 THR B 136 THR^? 43.30 ZN ZN B 402 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -75.90 102.21 34.20 -77.49 103.04 33.09 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -73.17 106.15 44.31 -73.94 104.19 43.69 ULMN 3 3hde_o00 LYSOZYME user 10 3 # 10 A 35 GLU B 290 GLU~? 16.07 ZN ZN B 401 A 44 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 50 THR B 303 THR^? 9.94 ZN ZN B 401 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -39.98 115.46 11.22 -41.44 114.62 9.91 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 3 3hde_o00 LYSOZYME user 11 3 # 11 A 35 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 44 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 50 THR B 303 THR^? 9.94 ZN ZN B 401 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 3 3hde_o00 LYSOZYME user 12 3 # 12 A 35 GLU B 329 GLU~? 2.54 ZN ZN B 402s A 44 ASP B 323 ASP^? 12.28 ZN ZN B 401 A 50 THR B 303 THR^? 9.94 ZN ZN B 401 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -37.37 106.23 11.12 -39.15 107.32 10.30 3hde_o00 source 3HDE LYSOZYME : 12 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 32 GLU.? 25.81 ZN ZN A 401 B 44 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 50 THR A 8 THR~? 23.36 ZN ZN A 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -42.13 134.27 -23.06 -42.94 135.85 -24.33 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 52 GLU~? 18.80 ZN ZN A 402 B 44 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 50 THR A 46 THR~? 14.02 ZN ZN A 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -31.91 126.83 -1.04 -30.53 125.17 -1.13 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU A 52 GLU~? 18.80 ZN ZN A 402 B 44 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 50 THR A 360 THR.? 11.95 ZN ZN A 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -28.53 120.60 -2.22 -29.42 121.92 -3.70 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU A 229 GLU^? 28.63 ZN ZN A 401 B 44 ASP A 129 ASP^? 19.65 ZN ZN A 401 B 50 THR A 233 THR^? 21.55 ZN ZN A 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -62.71 117.83 -29.19 -63.22 116.50 -27.60 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -52.93 118.26 -28.24 -51.00 118.44 -27.37 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -51.48 112.38 -28.84 -50.80 110.31 -28.76 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU A 271 GLU.? 22.11 ZN ZN B 401 B 44 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.37 89.63 2.92 -38.80 89.04 4.49 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU A 290 GLU~? 16.18 ZN ZN A 402 B 44 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 50 THR A 303 THR^? 9.94 ZN ZN A 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 3hde_o01 LYSOZYME user 7 3 # 7 B 35 GLU A 290 GLU~? 16.18 ZN ZN A 402 B 44 ASP A 323 ASP^? 12.30 ZN ZN A 402 B 50 THR A 303 THR^? 9.94 ZN ZN A 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 3hde_o01 LYSOZYME user 8 3 # 8 B 35 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 44 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 50 THR A 360 THR.? 11.95 ZN ZN A 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -28.53 120.60 -2.22 -29.42 121.92 -3.70 ULMN 3 3hde_o01 LYSOZYME user 9 3 # 9 B 35 GLU A 329 GLU~? 2.55 ZN ZN A 401s B 44 ASP A 361 ASP.? 11.77 ZN ZN A 402 B 50 THR A 360 THR.? 11.95 ZN ZN A 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -28.53 120.60 -2.22 -29.42 121.92 -3.70 ULMN 3 3hde_o01 LYSOZYME user 10 3 # 10 B 35 GLU A 347 GLU~? 25.70 ZN ZN A 401 B 44 ASP A 11 ASP~? 18.10 ZN ZN A 401 B 50 THR A 8 THR~? 23.36 ZN ZN A 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -34.82 134.94 -29.37 -35.77 133.46 -30.53 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -42.13 134.27 -23.06 -42.94 135.85 -24.33 ULMN 3 3hde_o01 LYSOZYME user 11 3 # 11 B 35 GLU B 32 GLU.? 22.53 ZN ZN B 402 B 44 ASP B 5 ASP~? 27.35 ZN ZN B 402 B 50 THR B 8 THR~? 23.37 ZN ZN B 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -60.68 81.34 15.57 -59.87 82.93 16.69 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -55.09 78.54 23.42 -56.64 77.16 23.83 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -55.91 85.05 23.85 -57.36 84.03 25.10 ULMN 3 3hde_o01 LYSOZYME user 12 3 # 12 B 35 GLU B 32 GLU.? 22.53 ZN ZN B 402 B 44 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 50 THR B 8 THR~? 23.37 ZN ZN B 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -60.68 81.34 15.57 -59.87 82.93 16.69 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -55.91 85.05 23.85 -57.36 84.03 25.10 ULMN 3 3hde_o01 LYSOZYME user 13 3 # 13 B 35 GLU B 52 GLU~? 18.78 ZN ZN B 401 B 44 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 50 THR B 46 THR~? 13.88 ZN ZN B 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -38.47 79.19 7.21 -37.79 81.13 7.79 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -43.66 86.34 1.76 -41.66 87.08 1.85 ULMN 3 3hde_o01 LYSOZYME user 14 3 # 14 B 35 GLU B 52 GLU~? 18.78 ZN ZN B 401 B 44 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -38.47 79.19 7.21 -37.79 81.13 7.79 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.37 89.63 2.92 -38.80 89.04 4.49 ULMN 3 3hde_o01 LYSOZYME user 15 3 # 15 B 35 GLU B 167 GLU^? 53.31 ZN ZN B 402 B 44 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 50 THR B 136 THR^? 43.30 ZN ZN B 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -79.62 113.37 49.20 -81.22 112.07 48.69 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -73.17 106.15 44.31 -73.94 104.19 43.69 ULMN 3 3hde_o01 LYSOZYME user 16 3 # 16 B 35 GLU B 211 GLU~? 39.18 ZN ZN B 402 B 44 ASP B 226 ASP^? 42.35 ZN ZN B 402 B 50 THR B 136 THR^? 43.30 ZN ZN B 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -75.90 102.21 34.20 -77.49 103.04 33.09 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -72.70 110.32 38.88 -74.33 111.41 39.69 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -73.17 106.15 44.31 -73.94 104.19 43.69 ULMN 3 3hde_o01 LYSOZYME user 17 3 # 17 B 35 GLU B 229 GLU^? 28.52 ZN ZN B 402 B 44 ASP B 129 ASP^? 19.14 ZN ZN B 402 B 50 THR B 233 THR^? 21.46 ZN ZN B 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -65.20 109.92 29.95 -64.70 111.14 28.31 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -57.17 104.15 28.46 -55.58 103.29 27.35 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -52.42 108.39 29.83 -50.75 109.78 29.75 ULMN 3 3hde_o01 LYSOZYME user 18 3 # 18 B 35 GLU B 290 GLU~? 16.07 ZN ZN B 401 B 44 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 50 THR B 303 THR^? 9.94 ZN ZN B 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -39.98 115.46 11.22 -41.44 114.62 9.91 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 3 3hde_o01 LYSOZYME user 19 3 # 19 B 35 GLU B 290 GLU~? 16.07 ZN ZN B 401 B 44 ASP B 323 ASP^? 12.28 ZN ZN B 401 B 50 THR B 303 THR^? 9.94 ZN ZN B 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -39.98 115.46 11.22 -41.44 114.62 9.91 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -33.57 107.34 6.30 -34.87 106.07 5.21 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 3 3hde_o01 LYSOZYME user 20 3 # 20 B 35 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 44 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.37 89.63 2.92 -38.80 89.04 4.49 ULMN 3 3hde_o01 LYSOZYME user 21 3 # 21 B 35 GLU B 329 GLU~? 2.54 ZN ZN B 402s B 44 ASP B 361 ASP.? 11.71 ZN ZN B 401 B 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -40.29 98.42 11.20 -42.37 98.57 11.02 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -34.85 93.86 2.41 -34.87 96.02 2.16 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.37 89.63 2.92 -38.80 89.04 4.49 ULMN 3 3hde_o01 LYSOZYME user 22 3 # 22 B 35 GLU B 347 GLU~? 25.41 ZN ZN B 402 B 44 ASP B 11 ASP~? 18.05 ZN ZN B 402 B 50 THR B 8 THR~? 23.37 ZN ZN B 402 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -50.18 80.14 30.04 -50.60 82.14 30.54 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -55.43 89.37 22.82 -56.66 91.02 23.20 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -55.91 85.05 23.85 -57.36 84.03 25.10 3hde_o01 source 3HDE LYSOZYME : 22 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 32 GLU.? 25.81 ZN ZN A 401 C 44 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 50 THR A 8 THR~? 23.36 ZN ZN A 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -43.68 141.75 -15.46 -45.31 141.26 -16.67 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 25.48 4.87 1.60 23.90 4.95 0.15 -42.13 134.27 -23.06 -42.94 135.85 -24.33 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 52 GLU~? 18.80 ZN ZN A 402 C 44 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 50 THR A 46 THR~? 14.02 ZN ZN A 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 25.48 4.87 1.60 23.90 4.95 0.15 -31.91 126.83 -1.04 -30.53 125.17 -1.13 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU A 52 GLU~? 18.80 ZN ZN A 402 C 44 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 50 THR A 360 THR.? 11.95 ZN ZN A 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -23.95 130.06 -6.80 -24.35 128.02 -7.40 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 25.48 4.87 1.60 23.90 4.95 0.15 -28.53 120.60 -2.22 -29.42 121.92 -3.70 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU A 271 GLU.? 22.11 ZN ZN B 401 C 44 ASP A 252 ASP~? 28.57 ZN ZN A 401 C 50 THR A 249 THR^? 28.75 ZN ZN A 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -24.45 95.00 -14.78 -23.16 93.40 -14.21 coo 25.48 4.87 1.60 23.90 4.95 0.15 -28.13 92.44 -15.75 -26.55 91.22 -14.88 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU A 271 GLU.? 22.11 ZN ZN B 401 C 44 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.83 87.36 -9.28 -34.64 86.91 -7.21 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.37 89.63 2.92 -38.80 89.04 4.49 ULMN 3 3hde_o02 LYSOZYME user 6 3 # 6 C 35 GLU A 290 GLU~? 16.18 ZN ZN A 402 C 44 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 50 THR A 303 THR^? 9.94 ZN ZN A 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 3hde_o02 LYSOZYME user 7 3 # 7 C 35 GLU A 290 GLU~? 16.18 ZN ZN A 402 C 44 ASP A 323 ASP^? 12.30 ZN ZN A 402 C 50 THR A 303 THR^? 9.94 ZN ZN A 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -44.60 100.09 -10.25 -45.29 101.54 -8.87 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -34.81 103.62 -5.28 -35.25 105.45 -4.26 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.48 106.60 -10.18 -39.53 106.67 -9.37 ULMN 3 3hde_o02 LYSOZYME user 8 3 # 8 C 35 GLU A 329 GLU~? 2.55 ZN ZN A 401s C 44 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 50 THR A 99 THR~? 6.77 ZN ZN A 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo 25.48 4.87 1.60 23.90 4.95 0.15 -43.91 119.63 -14.00 -45.67 119.24 -12.83 ULMN 3 3hde_o02 LYSOZYME user 9 3 # 9 C 35 GLU A 329 GLU~? 2.55 ZN ZN A 401s C 44 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 50 THR A 360 THR.? 11.95 ZN ZN A 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 25.48 4.87 1.60 23.90 4.95 0.15 -28.53 120.60 -2.22 -29.42 121.92 -3.70 ULMN 3 3hde_o02 LYSOZYME user 10 3 # 10 C 35 GLU A 329 GLU~? 2.55 ZN ZN A 401s C 44 ASP A 361 ASP.? 11.77 ZN ZN A 402 C 50 THR A 360 THR.? 11.95 ZN ZN A 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -35.80 114.72 -10.28 -37.63 115.69 -10.11 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -28.63 115.74 -1.62 -29.77 113.98 -1.34 coo 25.48 4.87 1.60 23.90 4.95 0.15 -28.53 120.60 -2.22 -29.42 121.92 -3.70 ULMN 3 3hde_o02 LYSOZYME user 11 3 # 11 C 35 GLU A 347 GLU~? 25.70 ZN ZN A 401 C 44 ASP A 11 ASP~? 18.10 ZN ZN A 401 C 50 THR A 8 THR~? 23.36 ZN ZN A 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.82 134.94 -29.37 -35.77 133.46 -30.53 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -44.11 130.33 -22.09 -46.09 129.62 -22.27 coo 25.48 4.87 1.60 23.90 4.95 0.15 -42.13 134.27 -23.06 -42.94 135.85 -24.33 ULMN 3 3hde_o02 LYSOZYME user 12 3 # 12 C 35 GLU B 52 GLU~? 18.78 ZN ZN B 401 C 44 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 50 THR B 46 THR~? 13.88 ZN ZN B 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 25.48 4.87 1.60 23.90 4.95 0.15 -43.66 86.34 1.76 -41.66 87.08 1.85 ULMN 3 3hde_o02 LYSOZYME user 13 3 # 13 C 35 GLU B 52 GLU~? 18.78 ZN ZN B 401 C 44 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -38.47 79.19 7.21 -37.79 81.13 7.79 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.37 89.63 2.92 -38.80 89.04 4.49 ULMN 3 3hde_o02 LYSOZYME user 14 3 # 14 C 35 GLU B 167 GLU^? 53.31 ZN ZN B 402 C 44 ASP B 226 ASP^? 42.35 ZN ZN B 402 C 50 THR B 136 THR^? 43.30 ZN ZN B 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -79.62 113.37 49.20 -81.22 112.07 48.69 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 25.48 4.87 1.60 23.90 4.95 0.15 -73.17 106.15 44.31 -73.94 104.19 43.69 ULMN 3 3hde_o02 LYSOZYME user 15 3 # 15 C 35 GLU B 195 GLU^? 52.10 ZN ZN B 402 C 44 ASP B 226 ASP^? 42.35 ZN ZN B 402 C 50 THR B 136 THR^? 43.30 ZN ZN B 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -77.28 109.06 51.77 -78.42 110.03 50.31 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -72.70 110.32 38.88 -74.33 111.41 39.69 coo 25.48 4.87 1.60 23.90 4.95 0.15 -73.17 106.15 44.31 -73.94 104.19 43.69 ULMN 3 3hde_o02 LYSOZYME user 16 3 # 16 C 35 GLU B 271 GLU.? 25.84 ZN ZN A 402 C 44 ASP B 252 ASP~? 28.52 ZN ZN B 402 C 50 THR B 249 THR^? 28.72 ZN ZN B 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -25.27 121.46 10.97 -24.72 123.08 12.43 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -20.29 109.25 15.64 -18.38 109.99 15.02 coo 25.48 4.87 1.60 23.90 4.95 0.15 -22.07 113.36 16.80 -20.03 113.44 15.95 ULMN 3 3hde_o02 LYSOZYME user 17 3 # 17 C 35 GLU B 290 GLU~? 16.07 ZN ZN B 401 C 44 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 50 THR B 303 THR^? 9.94 ZN ZN B 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 3 3hde_o02 LYSOZYME user 18 3 # 18 C 35 GLU B 290 GLU~? 16.07 ZN ZN B 401 C 44 ASP B 323 ASP^? 12.28 ZN ZN B 401 C 50 THR B 303 THR^? 9.94 ZN ZN B 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -39.98 115.46 11.22 -41.44 114.62 9.91 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -33.57 107.34 6.30 -34.87 106.07 5.21 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.37 106.23 11.12 -39.15 107.32 10.30 ULMN 3 3hde_o02 LYSOZYME user 19 3 # 19 C 35 GLU B 329 GLU~? 2.54 ZN ZN B 402s C 44 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 50 THR B 99 THR~? 6.68 ZN ZN B 402 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -54.33 98.57 11.88 -52.50 97.53 11.52 coo 25.48 4.87 1.60 23.90 4.95 0.15 -49.64 98.60 14.96 -50.95 99.87 13.75 ULMN 3 3hde_o02 LYSOZYME user 20 3 # 20 C 35 GLU B 329 GLU~? 2.54 ZN ZN B 402s C 44 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.37 89.63 2.92 -38.80 89.04 4.49 ULMN 3 3hde_o02 LYSOZYME user 21 3 # 21 C 35 GLU B 329 GLU~? 2.54 ZN ZN B 402s C 44 ASP B 361 ASP.? 11.71 ZN ZN B 401 C 50 THR B 360 THR.? 11.92 ZN ZN B 401 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -40.29 98.42 11.20 -42.37 98.57 11.02 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -34.85 93.86 2.41 -34.87 96.02 2.16 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.37 89.63 2.92 -38.80 89.04 4.49 3hde_o02 source 3HDE LYSOZYME : 21 hits 3hde_o02 naa= 3 ULMN 3 3iu0_o00 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANuser 1 3 # 1 A 110 CYH A 45 CYH.? 14.73 ZN ZN A 402 A 301 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 320 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -1.82 -20.48 -11.98 0.91 -20.78 -13.68 -33.61 127.04 -4.42 -33.82 129.83 -4.72 coo -1.58 -17.18 -17.34 -1.56 -16.12 -15.50 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -4.05 -14.06 -11.86 -3.22 -12.14 -12.04 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 3iu0_o00 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANuser 2 3 # 2 A 110 CYH B 45 CYH.? 14.80 ZN ZN B 401 A 301 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 320 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo -1.82 -20.48 -11.98 0.91 -20.78 -13.68 -45.21 86.91 5.22 -46.81 84.67 5.41 coo -1.58 -17.18 -17.34 -1.56 -16.12 -15.50 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -4.05 -14.06 -11.86 -3.22 -12.14 -12.04 -45.27 94.95 7.47 -43.74 96.36 7.67 3iu0_o00 source 3IU0 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE : 2 hits 3iu0_o00 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 2 3 # 2 A 220 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 3 3 # 3 A 220 HIS A 65 HIS.? -3.39 ZN ZN A 402s A 250 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 4 3 # 4 A 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ASP A 23 ASP.? 8.14 ZN ZN A 401 A 328 SER A 63 SER^? 10.35 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 5 3 # 5 A 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 328 SER A 21 SER.? 15.75 ZN ZN A 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 6 3 # 6 A 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 328 SER A 63 SER^? 10.35 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 7 3 # 7 A 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s A 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 8 3 # 8 A 220 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 9 3 # 9 A 220 HIS A 308 HIS~? 6.49 ZN ZN B 401 A 250 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 10 3 # 10 A 220 HIS A 309 HIS~? 5.45 ZN ZN B 401 A 250 ASP A 310 ASP~? 12.24 ZN ZN B 401 A 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 11 3 # 11 A 220 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 12 3 # 12 A 220 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 13 3 # 13 A 220 HIS B 65 HIS.? -3.43 ZN ZN B 401s A 250 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 14 3 # 14 A 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ASP B 23 ASP.? 8.15 ZN ZN B 402 A 328 SER B 63 SER^? 10.37 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 15 3 # 15 A 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 328 SER B 21 SER.? 15.71 ZN ZN B 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -58.60 101.69 13.65 -59.34 103.93 13.19 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 16 3 # 16 A 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 328 SER B 63 SER^? 10.37 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 17 3 # 17 A 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s A 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 18 3 # 18 A 220 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 19 3 # 19 A 220 HIS B 308 HIS~? 6.54 ZN ZN A 402 A 250 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 20 3 # 20 A 220 HIS B 309 HIS~? 5.48 ZN ZN A 402 A 250 ASP B 310 ASP~? 12.35 ZN ZN A 402 A 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -41.15 110.37 -7.29 -42.42 110.07 -5.23 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 20 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 2 3 # 2 B 220 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 3 3 # 3 B 220 HIS A 65 HIS.? -3.39 ZN ZN A 402s B 250 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 4 3 # 4 B 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 250 ASP A 23 ASP.? 8.14 ZN ZN A 401 B 328 SER A 63 SER^? 10.35 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 5 3 # 5 B 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 328 SER A 21 SER.? 15.75 ZN ZN A 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 6 3 # 6 B 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 328 SER A 63 SER^? 10.35 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 7 3 # 7 B 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s B 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 8 3 # 8 B 220 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 250 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 9 3 # 9 B 220 HIS A 308 HIS~? 6.49 ZN ZN B 401 B 250 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 10 3 # 10 B 220 HIS A 309 HIS~? 5.45 ZN ZN B 401 B 250 ASP A 310 ASP~? 12.24 ZN ZN B 401 B 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 11 3 # 11 B 220 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 12 3 # 12 B 220 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 13 3 # 13 B 220 HIS B 65 HIS.? -3.43 ZN ZN B 401s B 250 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 14 3 # 14 B 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 250 ASP B 23 ASP.? 8.15 ZN ZN B 402 B 328 SER B 63 SER^? 10.37 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 15 3 # 15 B 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 328 SER B 21 SER.? 15.71 ZN ZN B 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -58.60 101.69 13.65 -59.34 103.93 13.19 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 16 3 # 16 B 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 328 SER B 63 SER^? 10.37 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 17 3 # 17 B 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s B 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 18 3 # 18 B 220 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 250 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 19 3 # 19 B 220 HIS B 308 HIS~? 6.54 ZN ZN A 402 B 250 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 20 3 # 20 B 220 HIS B 309 HIS~? 5.48 ZN ZN A 402 B 250 ASP B 310 ASP~? 12.35 ZN ZN A 402 B 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -41.15 110.37 -7.29 -42.42 110.07 -5.23 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 20 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 2 3 # 2 C 220 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 3 3 # 3 C 220 HIS A 65 HIS.? -3.39 ZN ZN A 402s C 250 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -38.08 120.38 -6.61 -37.64 118.32 -6.74 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 4 3 # 4 C 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 250 ASP A 23 ASP.? 8.14 ZN ZN A 401 C 328 SER A 63 SER^? 10.35 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -47.74 122.17 -10.88 -45.62 122.01 -10.64 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 5 3 # 5 C 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 328 SER A 21 SER.? 15.75 ZN ZN A 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -53.09 121.68 -12.53 -54.91 120.14 -12.04 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 6 3 # 6 C 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 328 SER A 63 SER^? 10.35 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -35.41 126.07 -10.22 -37.10 126.62 -8.50 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 7 3 # 7 C 220 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 250 ASP A 102 ASP~? -1.98 ZN ZN A 401s C 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -41.70 116.42 -14.94 -40.64 116.61 -13.15 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -41.15 110.37 -7.29 -42.42 110.07 -5.23 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 8 3 # 8 C 220 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 250 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 9 3 # 9 C 220 HIS A 308 HIS~? 6.49 ZN ZN B 401 C 250 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -41.00 97.85 3.28 -40.98 95.80 3.73 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 10 3 # 10 C 220 HIS A 309 HIS~? 5.45 ZN ZN B 401 C 250 ASP A 310 ASP~? 12.24 ZN ZN B 401 C 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -45.80 98.45 2.85 -45.82 97.45 4.71 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -44.34 101.21 -3.37 -45.95 102.39 -2.67 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 11 3 # 11 C 220 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 12 3 # 12 C 220 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -44.69 94.49 12.33 -45.14 96.36 13.15 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 13 3 # 13 C 220 HIS B 65 HIS.? -3.43 ZN ZN B 401s C 250 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 328 SER B 328 SER~? 10.89 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -45.27 94.95 7.47 -43.74 96.36 7.67 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -35.17 97.75 10.01 -33.21 99.13 9.77 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 14 3 # 14 C 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 250 ASP B 23 ASP.? 8.15 ZN ZN B 402 C 328 SER B 63 SER^? 10.37 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -54.33 98.57 11.88 -52.50 97.53 11.52 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 15 3 # 15 C 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 328 SER B 21 SER.? 15.71 ZN ZN B 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -58.60 101.69 13.65 -59.34 103.93 13.19 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 16 3 # 16 C 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 328 SER B 63 SER^? 10.37 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -46.04 88.60 10.98 -47.67 89.08 9.23 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 17 3 # 17 C 220 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 250 ASP B 102 ASP~? -1.99 ZN ZN B 402s C 328 SER B 285 SER.? 7.72 ZN ZN B 401 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -49.25 96.40 11.26 -48.45 97.80 9.92 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -46.20 100.05 15.92 -45.42 99.37 14.07 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -42.52 104.99 8.17 -43.54 106.03 6.21 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 18 3 # 18 C 220 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 250 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 19 3 # 19 C 220 HIS B 308 HIS~? 6.54 ZN ZN A 402 C 250 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 328 SER A 328 SER~? 11.01 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -35.94 115.60 -2.36 -34.88 117.34 -2.86 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -31.13 112.55 -9.15 -30.14 110.33 -8.98 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 20 3 # 20 C 220 HIS B 309 HIS~? 5.48 ZN ZN A 402 C 250 ASP B 310 ASP~? 12.35 ZN ZN A 402 C 328 SER A 285 SER.? 7.68 ZN ZN A 402 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -40.27 117.69 -1.83 -39.84 118.53 -3.70 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -40.42 114.63 4.44 -42.44 114.56 3.83 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -41.15 110.37 -7.29 -42.42 110.07 -5.23 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 20 hits 3nwu_o02 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 63 SER^? 10.35 ZN ZN A 402 A 524 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 556 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER A 328 SER~? 11.01 ZN ZN A 402 A 524 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 556 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER B 63 SER^? 10.37 ZN ZN B 401 A 524 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 556 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER B 328 SER~? 10.89 ZN ZN B 401 A 524 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 556 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -40.41 105.08 4.17 -40.72 103.08 3.51 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -40.92 100.43 6.30 -42.93 100.06 6.77 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o00 naa= 3 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 C 445 SER A 63 SER^? 10.35 ZN ZN A 402 C 524 ASP A 44 ASP.? 7.09 ZN ZN A 402 C 556 HIS A 65 HIS.? -3.39 ZN ZN A 402s coo -35.83 1.21 57.61 -37.94 0.15 57.18 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -38.08 120.38 -6.61 -37.64 118.32 -6.74 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 C 445 SER A 328 SER~? 11.01 ZN ZN A 402 C 524 ASP A 305 ASP.? 7.62 ZN ZN A 402 C 556 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -35.83 1.21 57.61 -37.94 0.15 57.18 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 C 445 SER B 63 SER^? 10.37 ZN ZN B 401 C 524 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 556 HIS B 65 HIS.? -3.43 ZN ZN B 401s coo -35.83 1.21 57.61 -37.94 0.15 57.18 -46.04 88.60 10.98 -47.67 89.08 9.23 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -43.07 90.95 4.66 -43.22 93.08 4.74 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -45.27 94.95 7.47 -43.74 96.36 7.67 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 C 445 SER B 328 SER~? 10.89 ZN ZN B 401 C 524 ASP B 305 ASP.? 7.64 ZN ZN B 401 C 556 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -35.83 1.21 57.61 -37.94 0.15 57.18 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -40.92 100.43 6.30 -42.93 100.06 6.77 3o4g_o02 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o02 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 63 SER^? 10.35 ZN ZN A 402 A 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s A 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 44.17 25.61 37.60 45.21 25.56 35.81 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 39.85 24.35 34.94 41.12 25.58 33.83 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER A 63 SER^? 10.35 ZN ZN A 402 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 44.17 25.61 37.60 45.21 25.56 35.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 A 98 SER A 63 SER^? 10.35 ZN ZN A 402 A 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 A 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 44.17 25.61 37.60 45.21 25.56 35.81 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 A 98 SER A 328 SER~? 11.01 ZN ZN A 402 A 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s A 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 45.74 29.80 42.79 47.58 31.06 41.64 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 44.17 25.61 37.60 45.21 25.56 35.81 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 39.85 24.35 34.94 41.12 25.58 33.83 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 A 98 SER B 63 SER^? 10.37 ZN ZN B 401 A 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s A 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 45.74 29.80 42.79 47.58 31.06 41.64 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 44.17 25.61 37.60 45.21 25.56 35.81 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 39.85 24.35 34.94 41.12 25.58 33.83 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 A 98 SER B 63 SER^? 10.37 ZN ZN B 401 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 45.74 29.80 42.79 47.58 31.06 41.64 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 44.17 25.61 37.60 45.21 25.56 35.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 39.85 24.35 34.94 41.12 25.58 33.83 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 A 98 SER B 63 SER^? 10.37 ZN ZN B 401 A 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 A 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 45.74 29.80 42.79 47.58 31.06 41.64 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 44.17 25.61 37.60 45.21 25.56 35.81 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 39.85 24.35 34.94 41.12 25.58 33.83 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 A 98 SER B 328 SER~? 10.89 ZN ZN B 401 A 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s A 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 45.74 29.80 42.79 47.58 31.06 41.64 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 44.17 25.61 37.60 45.21 25.56 35.81 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 39.85 24.35 34.94 41.12 25.58 33.83 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o00 naa= 3 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 B 98 SER A 63 SER^? 10.35 ZN ZN A 402 B 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s B 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 71.87 39.14 40.71 71.75 41.26 39.36 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 73.25 34.64 35.72 73.65 35.23 33.78 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 70.98 30.38 33.77 70.74 32.03 32.50 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 B 98 SER A 63 SER^? 10.35 ZN ZN A 402 B 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 71.87 39.14 40.71 71.75 41.26 39.36 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 73.25 34.64 35.72 73.65 35.23 33.78 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 70.98 30.38 33.77 70.74 32.03 32.50 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 B 98 SER A 63 SER^? 10.35 ZN ZN A 402 B 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 B 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 71.87 39.14 40.71 71.75 41.26 39.36 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 73.25 34.64 35.72 73.65 35.23 33.78 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 70.98 30.38 33.77 70.74 32.03 32.50 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 B 98 SER A 328 SER~? 11.01 ZN ZN A 402 B 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s B 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 71.87 39.14 40.71 71.75 41.26 39.36 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 73.25 34.64 35.72 73.65 35.23 33.78 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 70.98 30.38 33.77 70.74 32.03 32.50 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 B 98 SER B 63 SER^? 10.37 ZN ZN B 401 B 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s B 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 71.87 39.14 40.71 71.75 41.26 39.36 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 73.25 34.64 35.72 73.65 35.23 33.78 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 70.98 30.38 33.77 70.74 32.03 32.50 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 B 98 SER B 63 SER^? 10.37 ZN ZN B 401 B 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 71.87 39.14 40.71 71.75 41.26 39.36 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 73.25 34.64 35.72 73.65 35.23 33.78 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 70.98 30.38 33.77 70.74 32.03 32.50 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 B 98 SER B 63 SER^? 10.37 ZN ZN B 401 B 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 B 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 71.87 39.14 40.71 71.75 41.26 39.36 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 73.25 34.64 35.72 73.65 35.23 33.78 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 70.98 30.38 33.77 70.74 32.03 32.50 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 B 98 SER B 328 SER~? 10.89 ZN ZN B 401 B 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s B 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 71.87 39.14 40.71 71.75 41.26 39.36 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 73.25 34.64 35.72 73.65 35.23 33.78 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 70.98 30.38 33.77 70.74 32.03 32.50 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o01 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o01 naa= 3 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 C 98 SER A 63 SER^? 10.35 ZN ZN A 402 C 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s C 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 80.36 64.80 34.44 78.44 65.95 33.29 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 83.70 62.42 29.01 83.15 62.88 27.08 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 85.17 57.73 27.21 83.46 58.45 26.25 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 C 98 SER A 63 SER^? 10.35 ZN ZN A 402 C 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 80.36 64.80 34.44 78.44 65.95 33.29 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 83.70 62.42 29.01 83.15 62.88 27.08 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 85.17 57.73 27.21 83.46 58.45 26.25 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 C 98 SER A 63 SER^? 10.35 ZN ZN A 402 C 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 C 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 80.36 64.80 34.44 78.44 65.95 33.29 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 83.70 62.42 29.01 83.15 62.88 27.08 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 85.17 57.73 27.21 83.46 58.45 26.25 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 C 98 SER A 328 SER~? 11.01 ZN ZN A 402 C 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s C 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 80.36 64.80 34.44 78.44 65.95 33.29 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 83.70 62.42 29.01 83.15 62.88 27.08 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 85.17 57.73 27.21 83.46 58.45 26.25 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 C 98 SER B 63 SER^? 10.37 ZN ZN B 401 C 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s C 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 80.36 64.80 34.44 78.44 65.95 33.29 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 83.70 62.42 29.01 83.15 62.88 27.08 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 85.17 57.73 27.21 83.46 58.45 26.25 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 C 98 SER B 63 SER^? 10.37 ZN ZN B 401 C 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 80.36 64.80 34.44 78.44 65.95 33.29 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 83.70 62.42 29.01 83.15 62.88 27.08 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 85.17 57.73 27.21 83.46 58.45 26.25 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 C 98 SER B 63 SER^? 10.37 ZN ZN B 401 C 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 C 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 80.36 64.80 34.44 78.44 65.95 33.29 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 83.70 62.42 29.01 83.15 62.88 27.08 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 85.17 57.73 27.21 83.46 58.45 26.25 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 C 98 SER B 328 SER~? 10.89 ZN ZN B 401 C 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s C 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 80.36 64.80 34.44 78.44 65.95 33.29 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 83.70 62.42 29.01 83.15 62.88 27.08 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 85.17 57.73 27.21 83.46 58.45 26.25 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o02 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o02 naa= 3 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 D 98 SER A 63 SER^? 10.35 ZN ZN A 402 D 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s D 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 65.12 87.33 28.49 62.90 86.32 27.74 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 67.96 87.91 22.28 66.90 87.63 20.52 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 72.12 85.84 19.92 70.35 84.94 19.30 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 D 98 SER A 63 SER^? 10.35 ZN ZN A 402 D 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 65.12 87.33 28.49 62.90 86.32 27.74 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 67.96 87.91 22.28 66.90 87.63 20.52 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 72.12 85.84 19.92 70.35 84.94 19.30 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 D 98 SER A 63 SER^? 10.35 ZN ZN A 402 D 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 D 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 65.12 87.33 28.49 62.90 86.32 27.74 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 67.96 87.91 22.28 66.90 87.63 20.52 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 72.12 85.84 19.92 70.35 84.94 19.30 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 D 98 SER A 328 SER~? 11.01 ZN ZN A 402 D 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s D 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 65.12 87.33 28.49 62.90 86.32 27.74 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 67.96 87.91 22.28 66.90 87.63 20.52 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 72.12 85.84 19.92 70.35 84.94 19.30 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 D 98 SER B 63 SER^? 10.37 ZN ZN B 401 D 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s D 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 65.12 87.33 28.49 62.90 86.32 27.74 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 67.96 87.91 22.28 66.90 87.63 20.52 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 72.12 85.84 19.92 70.35 84.94 19.30 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 D 98 SER B 63 SER^? 10.37 ZN ZN B 401 D 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 65.12 87.33 28.49 62.90 86.32 27.74 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 67.96 87.91 22.28 66.90 87.63 20.52 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 72.12 85.84 19.92 70.35 84.94 19.30 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 D 98 SER B 63 SER^? 10.37 ZN ZN B 401 D 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 D 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 65.12 87.33 28.49 62.90 86.32 27.74 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 67.96 87.91 22.28 66.90 87.63 20.52 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 72.12 85.84 19.92 70.35 84.94 19.30 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 D 98 SER B 328 SER~? 10.89 ZN ZN B 401 D 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s D 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 65.12 87.33 28.49 62.90 86.32 27.74 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 67.96 87.91 22.28 66.90 87.63 20.52 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 72.12 85.84 19.92 70.35 84.94 19.30 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o03 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o03 naa= 3 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 E 98 SER A 63 SER^? 10.35 ZN ZN A 402 E 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s E 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 37.23 89.57 27.33 36.32 87.23 27.07 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 37.64 91.40 20.82 36.88 90.22 19.31 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 41.40 92.80 17.47 40.89 90.79 17.30 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 E 98 SER A 63 SER^? 10.35 ZN ZN A 402 E 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 37.23 89.57 27.33 36.32 87.23 27.07 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 37.64 91.40 20.82 36.88 90.22 19.31 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 41.40 92.80 17.47 40.89 90.79 17.30 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 E 98 SER A 63 SER^? 10.35 ZN ZN A 402 E 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 E 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 37.23 89.57 27.33 36.32 87.23 27.07 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 37.64 91.40 20.82 36.88 90.22 19.31 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 41.40 92.80 17.47 40.89 90.79 17.30 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 E 98 SER A 328 SER~? 11.01 ZN ZN A 402 E 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s E 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 37.23 89.57 27.33 36.32 87.23 27.07 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 37.64 91.40 20.82 36.88 90.22 19.31 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 41.40 92.80 17.47 40.89 90.79 17.30 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 E 98 SER B 63 SER^? 10.37 ZN ZN B 401 E 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s E 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 37.23 89.57 27.33 36.32 87.23 27.07 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 37.64 91.40 20.82 36.88 90.22 19.31 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 41.40 92.80 17.47 40.89 90.79 17.30 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 E 98 SER B 63 SER^? 10.37 ZN ZN B 401 E 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 37.23 89.57 27.33 36.32 87.23 27.07 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 37.64 91.40 20.82 36.88 90.22 19.31 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 41.40 92.80 17.47 40.89 90.79 17.30 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 E 98 SER B 63 SER^? 10.37 ZN ZN B 401 E 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 E 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 37.23 89.57 27.33 36.32 87.23 27.07 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 37.64 91.40 20.82 36.88 90.22 19.31 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 41.40 92.80 17.47 40.89 90.79 17.30 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 E 98 SER B 328 SER~? 10.89 ZN ZN B 401 E 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s E 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 37.23 89.57 27.33 36.32 87.23 27.07 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 37.64 91.40 20.82 36.88 90.22 19.31 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 41.40 92.80 17.47 40.89 90.79 17.30 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o04 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o04 naa= 3 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 F 98 SER A 63 SER^? 10.35 ZN ZN A 402 F 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s F 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 17.74 70.20 32.16 18.92 67.99 31.89 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 15.23 70.97 25.89 15.37 69.49 24.46 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 15.81 74.47 22.06 16.86 72.70 21.69 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 F 98 SER A 63 SER^? 10.35 ZN ZN A 402 F 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 17.74 70.20 32.16 18.92 67.99 31.89 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 15.23 70.97 25.89 15.37 69.49 24.46 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 15.81 74.47 22.06 16.86 72.70 21.69 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 F 98 SER A 63 SER^? 10.35 ZN ZN A 402 F 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 F 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 17.74 70.20 32.16 18.92 67.99 31.89 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 15.23 70.97 25.89 15.37 69.49 24.46 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 15.81 74.47 22.06 16.86 72.70 21.69 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 F 98 SER A 328 SER~? 11.01 ZN ZN A 402 F 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s F 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 17.74 70.20 32.16 18.92 67.99 31.89 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 15.23 70.97 25.89 15.37 69.49 24.46 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 15.81 74.47 22.06 16.86 72.70 21.69 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 F 98 SER B 63 SER^? 10.37 ZN ZN B 401 F 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s F 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 17.74 70.20 32.16 18.92 67.99 31.89 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 15.23 70.97 25.89 15.37 69.49 24.46 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 15.81 74.47 22.06 16.86 72.70 21.69 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 F 98 SER B 63 SER^? 10.37 ZN ZN B 401 F 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 17.74 70.20 32.16 18.92 67.99 31.89 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 15.23 70.97 25.89 15.37 69.49 24.46 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 15.81 74.47 22.06 16.86 72.70 21.69 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 F 98 SER B 63 SER^? 10.37 ZN ZN B 401 F 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 F 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 17.74 70.20 32.16 18.92 67.99 31.89 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 15.23 70.97 25.89 15.37 69.49 24.46 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 15.81 74.47 22.06 16.86 72.70 21.69 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 F 98 SER B 328 SER~? 10.89 ZN ZN B 401 F 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s F 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 17.74 70.20 32.16 18.92 67.99 31.89 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 15.23 70.97 25.89 15.37 69.49 24.46 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 15.81 74.47 22.06 16.86 72.70 21.69 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o05 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o05 naa= 3 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 G 98 SER A 63 SER^? 10.35 ZN ZN A 402 G 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s G 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 21.77 43.27 39.21 24.15 42.72 38.52 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 18.42 41.13 33.64 19.33 40.10 32.10 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 15.38 43.36 30.02 17.34 43.09 29.34 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 G 98 SER A 63 SER^? 10.35 ZN ZN A 402 G 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 G 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 21.77 43.27 39.21 24.15 42.72 38.52 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 18.42 41.13 33.64 19.33 40.10 32.10 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 15.38 43.36 30.02 17.34 43.09 29.34 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 G 98 SER A 63 SER^? 10.35 ZN ZN A 402 G 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 G 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 21.77 43.27 39.21 24.15 42.72 38.52 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 18.42 41.13 33.64 19.33 40.10 32.10 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 15.38 43.36 30.02 17.34 43.09 29.34 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 G 98 SER A 328 SER~? 11.01 ZN ZN A 402 G 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s G 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 21.77 43.27 39.21 24.15 42.72 38.52 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 18.42 41.13 33.64 19.33 40.10 32.10 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 15.38 43.36 30.02 17.34 43.09 29.34 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 G 98 SER B 63 SER^? 10.37 ZN ZN B 401 G 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s G 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 21.77 43.27 39.21 24.15 42.72 38.52 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 18.42 41.13 33.64 19.33 40.10 32.10 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 15.38 43.36 30.02 17.34 43.09 29.34 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 G 98 SER B 63 SER^? 10.37 ZN ZN B 401 G 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 G 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 21.77 43.27 39.21 24.15 42.72 38.52 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 18.42 41.13 33.64 19.33 40.10 32.10 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 15.38 43.36 30.02 17.34 43.09 29.34 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 G 98 SER B 63 SER^? 10.37 ZN ZN B 401 G 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 G 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 21.77 43.27 39.21 24.15 42.72 38.52 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 18.42 41.13 33.64 19.33 40.10 32.10 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 15.38 43.36 30.02 17.34 43.09 29.34 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 G 98 SER B 328 SER~? 10.89 ZN ZN B 401 G 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s G 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 21.77 43.27 39.21 24.15 42.72 38.52 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 18.42 41.13 33.64 19.33 40.10 32.10 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 15.38 43.36 30.02 17.34 43.09 29.34 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o06 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o06 naa= 3 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 H 98 SER A 63 SER^? 10.35 ZN ZN A 402 H 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s H 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 156.20 56.60 78.78 153.83 56.16 78.10 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 159.24 56.62 72.66 158.17 56.50 70.89 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 162.98 53.88 70.28 161.08 53.28 69.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 H 98 SER A 63 SER^? 10.35 ZN ZN A 402 H 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 H 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 156.20 56.60 78.78 153.83 56.16 78.10 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 159.24 56.62 72.66 158.17 56.50 70.89 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 162.98 53.88 70.28 161.08 53.28 69.65 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 H 98 SER A 63 SER^? 10.35 ZN ZN A 402 H 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 H 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 156.20 56.60 78.78 153.83 56.16 78.10 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 159.24 56.62 72.66 158.17 56.50 70.89 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 162.98 53.88 70.28 161.08 53.28 69.65 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 H 98 SER A 328 SER~? 11.01 ZN ZN A 402 H 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s H 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 156.20 56.60 78.78 153.83 56.16 78.10 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 159.24 56.62 72.66 158.17 56.50 70.89 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 162.98 53.88 70.28 161.08 53.28 69.65 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 H 98 SER B 63 SER^? 10.37 ZN ZN B 401 H 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s H 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 156.20 56.60 78.78 153.83 56.16 78.10 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 159.24 56.62 72.66 158.17 56.50 70.89 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 162.98 53.88 70.28 161.08 53.28 69.65 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 H 98 SER B 63 SER^? 10.37 ZN ZN B 401 H 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 156.20 56.60 78.78 153.83 56.16 78.10 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 159.24 56.62 72.66 158.17 56.50 70.89 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 162.98 53.88 70.28 161.08 53.28 69.65 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 H 98 SER B 63 SER^? 10.37 ZN ZN B 401 H 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 H 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 156.20 56.60 78.78 153.83 56.16 78.10 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 159.24 56.62 72.66 158.17 56.50 70.89 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 162.98 53.88 70.28 161.08 53.28 69.65 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 H 98 SER B 328 SER~? 10.89 ZN ZN B 401 H 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s H 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 156.20 56.60 78.78 153.83 56.16 78.10 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 159.24 56.62 72.66 158.17 56.50 70.89 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 162.98 53.88 70.28 161.08 53.28 69.65 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o07 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o07 naa= 3 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 I 98 SER A 63 SER^? 10.35 ZN ZN A 402 I 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s I 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 129.29 63.53 77.27 127.98 61.40 77.00 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 129.99 65.24 70.73 129.03 64.19 69.22 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 133.90 66.07 67.39 133.05 64.19 67.15 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 I 98 SER A 63 SER^? 10.35 ZN ZN A 402 I 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 I 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 129.29 63.53 77.27 127.98 61.40 77.00 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 129.99 65.24 70.73 129.03 64.19 69.22 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 133.90 66.07 67.39 133.05 64.19 67.15 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 I 98 SER A 63 SER^? 10.35 ZN ZN A 402 I 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 I 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 129.29 63.53 77.27 127.98 61.40 77.00 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 129.99 65.24 70.73 129.03 64.19 69.22 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 133.90 66.07 67.39 133.05 64.19 67.15 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 I 98 SER A 328 SER~? 11.01 ZN ZN A 402 I 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s I 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 129.29 63.53 77.27 127.98 61.40 77.00 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 129.99 65.24 70.73 129.03 64.19 69.22 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 133.90 66.07 67.39 133.05 64.19 67.15 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 I 98 SER B 63 SER^? 10.37 ZN ZN B 401 I 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s I 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 129.29 63.53 77.27 127.98 61.40 77.00 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 129.99 65.24 70.73 129.03 64.19 69.22 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 133.90 66.07 67.39 133.05 64.19 67.15 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 I 98 SER B 63 SER^? 10.37 ZN ZN B 401 I 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 I 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 129.29 63.53 77.27 127.98 61.40 77.00 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 129.99 65.24 70.73 129.03 64.19 69.22 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 133.90 66.07 67.39 133.05 64.19 67.15 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 I 98 SER B 63 SER^? 10.37 ZN ZN B 401 I 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 I 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 129.29 63.53 77.27 127.98 61.40 77.00 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 129.99 65.24 70.73 129.03 64.19 69.22 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 133.90 66.07 67.39 133.05 64.19 67.15 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 I 98 SER B 328 SER~? 10.89 ZN ZN B 401 I 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s I 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 129.29 63.53 77.27 127.98 61.40 77.00 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 129.99 65.24 70.73 129.03 64.19 69.22 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 133.90 66.07 67.39 133.05 64.19 67.15 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o08 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o08 naa= 3 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 J 98 SER A 63 SER^? 10.35 ZN ZN A 402 J 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s J 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 106.76 47.89 81.70 107.53 45.50 81.44 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 104.68 49.18 75.33 104.59 47.70 73.89 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 105.94 52.49 71.50 106.71 50.57 71.17 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 J 98 SER A 63 SER^? 10.35 ZN ZN A 402 J 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 J 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 106.76 47.89 81.70 107.53 45.50 81.44 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 104.68 49.18 75.33 104.59 47.70 73.89 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 105.94 52.49 71.50 106.71 50.57 71.17 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 J 98 SER A 63 SER^? 10.35 ZN ZN A 402 J 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 J 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 106.76 47.89 81.70 107.53 45.50 81.44 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 104.68 49.18 75.33 104.59 47.70 73.89 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 105.94 52.49 71.50 106.71 50.57 71.17 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 J 98 SER A 328 SER~? 11.01 ZN ZN A 402 J 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s J 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 106.76 47.89 81.70 107.53 45.50 81.44 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 104.68 49.18 75.33 104.59 47.70 73.89 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 105.94 52.49 71.50 106.71 50.57 71.17 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 J 98 SER B 63 SER^? 10.37 ZN ZN B 401 J 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s J 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 106.76 47.89 81.70 107.53 45.50 81.44 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 104.68 49.18 75.33 104.59 47.70 73.89 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 105.94 52.49 71.50 106.71 50.57 71.17 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 J 98 SER B 63 SER^? 10.37 ZN ZN B 401 J 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 J 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 106.76 47.89 81.70 107.53 45.50 81.44 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 104.68 49.18 75.33 104.59 47.70 73.89 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 105.94 52.49 71.50 106.71 50.57 71.17 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 J 98 SER B 63 SER^? 10.37 ZN ZN B 401 J 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 J 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 106.76 47.89 81.70 107.53 45.50 81.44 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 104.68 49.18 75.33 104.59 47.70 73.89 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 105.94 52.49 71.50 106.71 50.57 71.17 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 J 98 SER B 328 SER~? 10.89 ZN ZN B 401 J 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s J 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 106.76 47.89 81.70 107.53 45.50 81.44 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 104.68 49.18 75.33 104.59 47.70 73.89 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 105.94 52.49 71.50 106.71 50.57 71.17 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o09 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o09 naa= 3 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 K 98 SER A 63 SER^? 10.35 ZN ZN A 402 K 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s K 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 105.44 20.79 88.82 107.67 19.79 88.18 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 101.74 19.42 83.14 102.50 18.27 81.61 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 99.17 22.17 79.49 101.04 21.51 78.80 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 K 98 SER A 63 SER^? 10.35 ZN ZN A 402 K 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 K 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 105.44 20.79 88.82 107.67 19.79 88.18 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 101.74 19.42 83.14 102.50 18.27 81.61 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 99.17 22.17 79.49 101.04 21.51 78.80 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 K 98 SER A 63 SER^? 10.35 ZN ZN A 402 K 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 K 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 105.44 20.79 88.82 107.67 19.79 88.18 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 101.74 19.42 83.14 102.50 18.27 81.61 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 99.17 22.17 79.49 101.04 21.51 78.80 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 K 98 SER A 328 SER~? 11.01 ZN ZN A 402 K 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s K 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 105.44 20.79 88.82 107.67 19.79 88.18 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 101.74 19.42 83.14 102.50 18.27 81.61 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 99.17 22.17 79.49 101.04 21.51 78.80 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 K 98 SER B 63 SER^? 10.37 ZN ZN B 401 K 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s K 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 105.44 20.79 88.82 107.67 19.79 88.18 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 101.74 19.42 83.14 102.50 18.27 81.61 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 99.17 22.17 79.49 101.04 21.51 78.80 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 K 98 SER B 63 SER^? 10.37 ZN ZN B 401 K 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 K 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 105.44 20.79 88.82 107.67 19.79 88.18 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 101.74 19.42 83.14 102.50 18.27 81.61 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 99.17 22.17 79.49 101.04 21.51 78.80 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 K 98 SER B 63 SER^? 10.37 ZN ZN B 401 K 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 K 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 105.44 20.79 88.82 107.67 19.79 88.18 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 101.74 19.42 83.14 102.50 18.27 81.61 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 99.17 22.17 79.49 101.04 21.51 78.80 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 K 98 SER B 328 SER~? 10.89 ZN ZN B 401 K 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s K 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 105.44 20.79 88.82 107.67 19.79 88.18 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 101.74 19.42 83.14 102.50 18.27 81.61 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 99.17 22.17 79.49 101.04 21.51 78.80 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o10 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o10 naa= 3 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 L 98 SER A 63 SER^? 10.35 ZN ZN A 402 L 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s L 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 126.72 3.21 92.89 128.70 4.33 91.79 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 L 98 SER A 63 SER^? 10.35 ZN ZN A 402 L 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 L 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 126.72 3.21 92.89 128.70 4.33 91.79 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 L 98 SER A 63 SER^? 10.35 ZN ZN A 402 L 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 L 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 126.72 3.21 92.89 128.70 4.33 91.79 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 L 98 SER A 328 SER~? 11.01 ZN ZN A 402 L 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s L 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 126.72 3.21 92.89 128.70 4.33 91.79 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 L 98 SER B 63 SER^? 10.37 ZN ZN B 401 L 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s L 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 126.72 3.21 92.89 128.70 4.33 91.79 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 L 98 SER B 63 SER^? 10.37 ZN ZN B 401 L 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 L 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 126.72 3.21 92.89 128.70 4.33 91.79 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 L 98 SER B 63 SER^? 10.37 ZN ZN B 401 L 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 L 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 126.72 3.21 92.89 128.70 4.33 91.79 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 L 98 SER B 328 SER~? 10.89 ZN ZN B 401 L 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s L 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 126.72 3.21 92.89 128.70 4.33 91.79 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o11 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o11 naa= 3 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 M 98 SER A 63 SER^? 10.35 ZN ZN A 402 M 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s M 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 154.12 8.07 91.14 154.40 10.16 89.78 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 154.65 3.37 86.18 155.13 3.88 84.24 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 M 98 SER A 63 SER^? 10.35 ZN ZN A 402 M 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 M 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 154.12 8.07 91.14 154.40 10.16 89.78 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 154.65 3.37 86.18 155.13 3.88 84.24 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 M 98 SER A 63 SER^? 10.35 ZN ZN A 402 M 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 M 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 154.12 8.07 91.14 154.40 10.16 89.78 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 154.65 3.37 86.18 155.13 3.88 84.24 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 M 98 SER A 328 SER~? 11.01 ZN ZN A 402 M 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s M 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 154.12 8.07 91.14 154.40 10.16 89.78 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 154.65 3.37 86.18 155.13 3.88 84.24 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 M 98 SER B 63 SER^? 10.37 ZN ZN B 401 M 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s M 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 154.12 8.07 91.14 154.40 10.16 89.78 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 154.65 3.37 86.18 155.13 3.88 84.24 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 M 98 SER B 63 SER^? 10.37 ZN ZN B 401 M 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 M 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 154.12 8.07 91.14 154.40 10.16 89.78 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 154.65 3.37 86.18 155.13 3.88 84.24 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 M 98 SER B 63 SER^? 10.37 ZN ZN B 401 M 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 M 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 154.12 8.07 91.14 154.40 10.16 89.78 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 154.65 3.37 86.18 155.13 3.88 84.24 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 M 98 SER B 328 SER~? 10.89 ZN ZN B 401 M 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s M 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 154.12 8.07 91.14 154.40 10.16 89.78 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 154.65 3.37 86.18 155.13 3.88 84.24 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o12 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o12 naa= 3 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 N 98 SER A 63 SER^? 10.35 ZN ZN A 402 N 123 HIS A 64 HIS.? -3.42 ZN ZN A 401s N 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 167.14 31.88 84.83 165.46 33.38 83.69 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 170.00 29.01 79.37 169.53 29.60 77.44 -37.47 120.38 -11.48 -38.85 119.05 -12.30 coo 170.55 24.16 77.55 169.03 25.18 76.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 N 98 SER A 63 SER^? 10.35 ZN ZN A 402 N 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 N 172 ASP A 23 ASP.? 8.14 ZN ZN A 401 coo 167.14 31.88 84.83 165.46 33.38 83.69 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 170.00 29.01 79.37 169.53 29.60 77.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 170.55 24.16 77.55 169.03 25.18 76.56 -47.74 122.17 -10.88 -45.62 122.01 -10.64 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 N 98 SER A 63 SER^? 10.35 ZN ZN A 402 N 123 HIS A 98 HIS~? 4.98 ZN ZN A 401 N 172 ASP A 102 ASP~? -1.98 ZN ZN A 401s coo 167.14 31.88 84.83 165.46 33.38 83.69 -35.41 126.07 -10.22 -37.10 126.62 -8.50 coo 170.00 29.01 79.37 169.53 29.60 77.44 -42.20 121.23 -10.32 -42.26 119.61 -8.99 coo 170.55 24.16 77.55 169.03 25.18 76.56 -41.70 116.42 -14.94 -40.64 116.61 -13.15 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 N 98 SER A 328 SER~? 11.01 ZN ZN A 402 N 123 HIS A 326 HIS~? -3.60 ZN ZN A 402s N 172 ASP A 305 ASP.? 7.62 ZN ZN A 402 coo 167.14 31.88 84.83 165.46 33.38 83.69 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo 170.00 29.01 79.37 169.53 29.60 77.44 -37.32 113.39 -5.27 -38.85 114.75 -5.76 coo 170.55 24.16 77.55 169.03 25.18 76.56 -39.33 109.24 -3.42 -38.58 111.13 -2.57 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 N 98 SER B 63 SER^? 10.37 ZN ZN B 401 N 123 HIS B 64 HIS.? -3.45 ZN ZN B 402s N 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 167.14 31.88 84.83 165.46 33.38 83.69 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 170.00 29.01 79.37 169.53 29.60 77.44 -44.69 94.49 12.33 -45.14 96.36 13.15 coo 170.55 24.16 77.55 169.03 25.18 76.56 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 6 3 # 6 N 98 SER B 63 SER^? 10.37 ZN ZN B 401 N 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 N 172 ASP B 23 ASP.? 8.15 ZN ZN B 402 coo 167.14 31.88 84.83 165.46 33.38 83.69 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 170.00 29.01 79.37 169.53 29.60 77.44 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 170.55 24.16 77.55 169.03 25.18 76.56 -54.33 98.57 11.88 -52.50 97.53 11.52 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 7 3 # 7 N 98 SER B 63 SER^? 10.37 ZN ZN B 401 N 123 HIS B 98 HIS~? 5.02 ZN ZN B 402 N 172 ASP B 102 ASP~? -1.99 ZN ZN B 402s coo 167.14 31.88 84.83 165.46 33.38 83.69 -46.04 88.60 10.98 -47.67 89.08 9.23 coo 170.00 29.01 79.37 169.53 29.60 77.44 -49.25 96.40 11.26 -48.45 97.80 9.92 coo 170.55 24.16 77.55 169.03 25.18 76.56 -46.20 100.05 15.92 -45.42 99.37 14.07 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 8 3 # 8 N 98 SER B 328 SER~? 10.89 ZN ZN B 401 N 123 HIS B 326 HIS~? -3.48 ZN ZN B 401s N 172 ASP B 305 ASP.? 7.64 ZN ZN B 401 coo 167.14 31.88 84.83 165.46 33.38 83.69 -35.17 97.75 10.01 -33.21 99.13 9.77 coo 170.00 29.01 79.37 169.53 29.60 77.44 -40.92 100.43 6.30 -42.93 100.06 6.77 coo 170.55 24.16 77.55 169.03 25.18 76.56 -40.41 105.08 4.17 -40.72 103.08 3.51 3qwd_o13 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 8 hits 3qwd_o13 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 44 ASP.? 7.09 ZN ZN A 402 A 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 A 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 37.97 47.82 5.46 38.65 48.02 7.40 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 41.02 51.33 13.36 40.18 47.06 9.99 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 39.17 42.30 8.54 40.94 44.26 7.78 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 A 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 A 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 37.97 47.82 5.46 38.65 48.02 7.40 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 41.02 51.33 13.36 40.18 47.06 9.99 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 39.17 42.30 8.54 40.94 44.26 7.78 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 1 3 # 1 B 29 ASP A 44 ASP.? 7.09 ZN ZN A 402 B 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 B 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 33.94 43.16 45.29 35.02 43.05 43.47 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 38.53 39.60 38.22 36.76 43.89 41.37 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 35.77 48.61 42.57 37.40 46.62 43.48 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 2 3 # 2 B 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 B 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 B 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 33.94 43.16 45.29 35.02 43.05 43.47 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 38.53 39.60 38.22 36.76 43.89 41.37 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 35.77 48.61 42.57 37.40 46.62 43.48 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o01 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o01 naa= 3 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 1 3 # 1 C 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 C 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 C 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o02 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o02 naa= 3 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 1 3 # 1 D 29 ASP A 44 ASP.? 7.09 ZN ZN A 402 D 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 D 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 25.05 13.27 54.10 26.66 12.10 53.60 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 33.45 10.03 51.76 28.31 9.37 53.37 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 24.32 7.20 55.59 24.80 8.07 53.08 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 2 3 # 2 D 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 D 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 D 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 25.05 13.27 54.10 26.66 12.10 53.60 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 33.45 10.03 51.76 28.31 9.37 53.37 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 24.32 7.20 55.59 24.80 8.07 53.08 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o03 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o03 naa= 3 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 1 3 # 1 E 29 ASP A 44 ASP.? 7.09 ZN ZN A 402 E 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 E 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 54.17 11.77 49.20 52.64 11.40 50.63 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 45.83 11.66 53.42 50.97 10.25 52.77 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 55.28 7.50 53.67 54.71 10.14 54.01 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 2 3 # 2 E 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 E 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 E 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 54.17 11.77 49.20 52.64 11.40 50.63 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 45.83 11.66 53.42 50.97 10.25 52.77 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 55.28 7.50 53.67 54.71 10.14 54.01 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o04 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o04 naa= 3 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 1 3 # 1 F 29 ASP A 44 ASP.? 7.09 ZN ZN A 402 F 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 F 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 41.67 65.37 28.64 40.76 63.70 27.74 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 38.34 58.97 23.05 39.26 61.42 28.02 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 39.64 61.25 32.92 38.08 62.62 31.22 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 2 3 # 2 F 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 F 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 F 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 41.67 65.37 28.64 40.76 63.70 27.74 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 38.34 58.97 23.05 39.26 61.42 28.02 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 39.64 61.25 32.92 38.08 62.62 31.22 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o05 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o05 naa= 3 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 1 3 # 1 G 29 ASP A 44 ASP.? 7.09 ZN ZN A 402 G 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 G 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 -33.96 122.51 -3.83 -35.32 120.86 -3.91 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 2 3 # 2 G 29 ASP B 44 ASP.? 7.11 ZN ZN B 401 G 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 G 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 -43.07 90.95 4.66 -43.22 93.08 4.74 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o06 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o06 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 49 VAL~? 15.97 ZN ZN A 402 H 117 LYS A 86 LYS~? 24.82 ZN ZN A 402 H 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 45.82 27.58 23.40 45.30 28.87 21.66 -28.26 128.88 -3.99 -29.42 127.54 -5.33 coo 38.01 32.08 28.20 39.46 29.85 23.57 -33.51 137.11 0.86 -27.79 135.78 2.74 coo 41.19 29.62 18.76 39.21 28.51 20.32 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL A 49 VAL~? 15.97 ZN ZN A 402 H 117 LYS A 333 LYS~? 13.50 ZN ZN A 402 H 150 CYH A 45 CYH.? 14.73 ZN ZN A 402 coo 45.82 27.58 23.40 45.30 28.87 21.66 -28.26 128.88 -3.99 -29.42 127.54 -5.33 coo 38.01 32.08 28.20 39.46 29.85 23.57 -29.32 122.04 -13.64 -26.61 121.37 -8.37 coo 41.19 29.62 18.76 39.21 28.51 20.32 -33.61 127.04 -4.42 -33.82 129.83 -4.72 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 3 3 # 3 H 28 VAL B 49 VAL~? 16.01 ZN ZN B 401 H 117 LYS B 86 LYS~? 24.89 ZN ZN B 401 H 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 45.82 27.58 23.40 45.30 28.87 21.66 -41.62 82.52 4.60 -41.85 84.21 6.04 coo 38.01 32.08 28.20 39.46 29.85 23.57 -50.53 78.48 -0.34 -44.96 76.41 -1.96 coo 41.19 29.62 18.76 39.21 28.51 20.32 -45.21 86.91 5.22 -46.81 84.67 5.41 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 4 3 # 4 H 28 VAL B 49 VAL~? 16.01 ZN ZN B 401 H 117 LYS B 333 LYS~? 13.39 ZN ZN B 401 H 150 CYH B 45 CYH.? 14.80 ZN ZN B 401 coo 45.82 27.58 23.40 45.30 28.87 21.66 -41.62 82.52 4.60 -41.85 84.21 6.04 coo 38.01 32.08 28.20 39.46 29.85 23.57 -38.73 88.63 14.36 -36.14 88.00 9.08 coo 41.19 29.62 18.76 39.21 28.51 20.32 -45.21 86.91 5.22 -46.81 84.67 5.41 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o07 naa= 3 ULMN 3 3zwq_o00 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 1 3 # 1 A 157 SER A 328 SER~? 11.01 ZN ZN A 402 A 254 ASP A 305 ASP.? 7.62 ZN ZN A 402 A 284 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -20.09 -13.76 4.99 -18.56 -11.94 4.87 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -21.52 -7.55 12.04 -21.23 -8.42 10.14 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -18.29 -9.68 9.15 -18.87 -10.69 7.41 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 3zwq_o00 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 2 3 # 2 A 157 SER B 328 SER~? 10.89 ZN ZN B 401 A 254 ASP B 305 ASP.? 7.64 ZN ZN B 401 A 284 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -20.09 -13.76 4.99 -18.56 -11.94 4.87 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -21.52 -7.55 12.04 -21.23 -8.42 10.14 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -18.29 -9.68 9.15 -18.87 -10.69 7.41 -40.92 100.43 6.30 -42.93 100.06 6.77 3zwq_o00 source 3ZWQ ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN : 2 hits 3zwq_o00 naa= 3 ULMN 3 3zwq_o01 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 1 3 # 1 B 157 SER A 328 SER~? 11.01 ZN ZN A 402 B 254 ASP A 305 ASP.? 7.62 ZN ZN A 402 B 284 HIS A 326 HIS~? -3.60 ZN ZN A 402s coo -37.32 -16.63 33.25 -39.45 -15.48 33.60 -31.13 112.55 -9.15 -30.14 110.33 -8.98 coo -37.64 -10.09 26.32 -37.69 -11.02 28.21 -39.33 109.24 -3.42 -38.58 111.13 -2.57 coo -40.12 -13.34 29.11 -39.19 -14.07 30.85 -37.32 113.39 -5.27 -38.85 114.75 -5.76 ULMN 3 3zwq_o01 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 2 3 # 2 B 157 SER B 328 SER~? 10.89 ZN ZN B 401 B 254 ASP B 305 ASP.? 7.64 ZN ZN B 401 B 284 HIS B 326 HIS~? -3.48 ZN ZN B 401s coo -37.32 -16.63 33.25 -39.45 -15.48 33.60 -35.17 97.75 10.01 -33.21 99.13 9.77 coo -37.64 -10.09 26.32 -37.69 -11.02 28.21 -40.41 105.08 4.17 -40.72 103.08 3.51 coo -40.12 -13.34 29.11 -39.19 -14.07 30.85 -40.92 100.43 6.30 -42.93 100.06 6.77 3zwq_o01 source 3ZWQ ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN : 2 hits 3zwq_o01 naa= 3